sign in sign up
<<
Home , Abetimus, Acefylline, Acetarsol, Acetohydroxamic acid, Acetoxolone, Acetrizoic acid

MTC

eHealth DSI

[eHDSI v3.0.0-RC1] eHealth DSI – Master Value Set Catalogue

Responsible : Terminologist CEF eHDSI Service Provider PublishDate : Tue Apr 30 16:24:21 CEST 2019

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 1 of 624 Service Provider MTC

Table of Contents

eHDSI-AbsentOrUnknownAllergies 4 eHDSI-AbsentOrUnknownDevices 5 eHDSI-AbsentOrUnknownMedication 6 eHDSI-AbsentOrUnknownProblems 7 eHDSI-AbsentOrUnknownProcedures 8 epSOSActiveIngredient 9 epSOSAdministrativeGender 166 epSOSAdverseEventType 167 epSOSAllergenNoDrugs 168 epSOSBloodGroup 173 epSOSBloodPressure 174 epSOSCodeProb 175 epSOSConfidentiality 176 epSOSCountry 177 epSOSDisplayLabel 184 epSOSDocumentCode 187 epSOSDoseForm 188 epSOSHealthcareProfessionalRoles 204 epSOSIllnessesandDisorders 206 © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 2 of 624 Service Provider MTC

epSOSLanguage 557 epSOSMedicalDevices 573 epSOSNullFavor 576 epSOSPackage 577 epSOSPersonalRelationship 580 epSOSPregnancyInformation 582 epSOSProcedures 583 epSOSReactionAllergy 587 epSOSResolutionOutcome 589 epSOSRoleClass 590 epSOSRouteofAdministration 591 epSOSSections 594 epSOSSeverity 595 epSOSSocialHistory 596 epSOSStatusCode 597 epSOSSubstitutionCode 598 epSOSTelecomAddress 599 epSOSTimingEvent 600 epSOSUnits 601 epSOSVaccine 622

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 3 of 624 Service Provider MTC eHDSI-AbsentOrUnknownAllergies

eHDSI-AbsentOrUnknownAllergies

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.47

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1150.1 0.2.0 no-allergy-info No information about allergies 2.16.840.1.113883.5.1150.1 0.2.0 no-known-allergies No known allergies 2.16.840.1.113883.5.1150.1 0.2.0 no-known-environmental-allergies No known environmental allergies 2.16.840.1.113883.5.1150.1 0.2.0 no-known-food-allergies No known food allergies 2.16.840.1.113883.5.1150.1 0.2.0 no-known--allergies No known medication allergies

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 4 of 624 Service Provider MTC eHDSI-AbsentOrUnknownDevices

eHDSI-AbsentOrUnknownDevices

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.48

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1150.1 0.2.0 no-device-info No information about devices 2.16.840.1.113883.5.1150.1 0.2.0 no-known-devices No known devices in use

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 5 of 624 Service Provider MTC eHDSI-AbsentOrUnknownMedication

eHDSI-AbsentOrUnknownMedication

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.49

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1150.1 0.2.0 no-known- No known medications 2.16.840.1.113883.5.1150.1 0.2.0 no-medication-info No information about medications

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 6 of 624 Service Provider MTC eHDSI-AbsentOrUnknownProblems

eHDSI-AbsentOrUnknownProblems

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.50

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1150.1 0.2.0 no-known-problems No known problems 2.16.840.1.113883.5.1150.1 0.2.0 no-problem-info No information about problems

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 7 of 624 Service Provider MTC eHDSI-AbsentOrUnknownProcedures

eHDSI-AbsentOrUnknownProcedures

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.51

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1150.1 0.2.0 no-known-procedures No known procedures 2.16.840.1.113883.5.1150.1 0.2.0 no-procedure-info No information about past history of procedures

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 8 of 624 Service Provider MTC epSOSActiveIngredient

epSOSActiveIngredient

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND Matsmältningsorgan och ämnesomsättning 2.16.840.1.113883.6.73 2017-01 A01 STOMATOLOGICAL Medel vid mun- och tandsjukdomar PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A01A STOMATOLOGICAL Medel vid mun- och tandsjukdomar PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A01AA Caries prophylactic agents Medel mot karies 2.16.840.1.113883.6.73 2017-01 A01AA01 fluoride Natriumfluorid 2.16.840.1.113883.6.73 2017-01 A01AA02 sodium monofluorophosphate Natriummonofluorofosfat 2.16.840.1.113883.6.73 2017-01 A01AA03 Olaflur 2.16.840.1.113883.6.73 2017-01 A01AA04 stannous fluoride Tennfluorid 2.16.840.1.113883.6.73 2017-01 A01AA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A01AA51 , combinations Natriumfluorid, kombinationer 2.16.840.1.113883.6.73 2017-01 A01AB Antiinfectives and for Antiinfektiva och antiseptiska medel local oral treatment för lokal behandling i munhålan 2.16.840.1.113883.6.73 2017-01 A01AB02 Väteperoxid 2.16.840.1.113883.6.73 2017-01 A01AB03 Klorhexidin 2.16.840.1.113883.6.73 2017-01 A01AB04 Amfotericin B 2.16.840.1.113883.6.73 2017-01 A01AB05 Polynoxylin 2.16.840.1.113883.6.73 2017-01 A01AB06 domiphen Domifen 2.16.840.1.113883.6.73 2017-01 A01AB07 oxyquinoline Hydroxikinolin 2.16.840.1.113883.6.73 2017-01 A01AB08 Neomycin 2.16.840.1.113883.6.73 2017-01 A01AB09 Mikonazol 2.16.840.1.113883.6.73 2017-01 A01AB10 Natamycin 2.16.840.1.113883.6.73 2017-01 A01AB11 various Övrigt 2.16.840.1.113883.6.73 2017-01 A01AB12 Hexetidin 2.16.840.1.113883.6.73 2017-01 A01AB13 Tetracyklin 2.16.840.1.113883.6.73 2017-01 A01AB14 Bensoxoniumklorid 2.16.840.1.113883.6.73 2017-01 A01AB15 Tibezoniumjodid 2.16.840.1.113883.6.73 2017-01 A01AB16 Mepartricin 2.16.840.1.113883.6.73 2017-01 A01AB17 Metronidazol 2.16.840.1.113883.6.73 2017-01 A01AB18 Klotrimazol 2.16.840.1.113883.6.73 2017-01 A01AB19 Natriumperborat

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 9 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A01AB21 Klortetracyklin 2.16.840.1.113883.6.73 2017-01 A01AB22 Doxycyklin 2.16.840.1.113883.6.73 2017-01 A01AB23 Minocyklin 2.16.840.1.113883.6.73 2017-01 A01AC for local oral Kortikosteroider för lokal behandling treatment i munhålan 2.16.840.1.113883.6.73 2017-01 A01AC01 Triamcinolon 2.16.840.1.113883.6.73 2017-01 A01AC02 Dexametason 2.16.840.1.113883.6.73 2017-01 A01AC03 Hydrokortison 2.16.840.1.113883.6.73 2017-01 A01AC54 , combinations Prednisolon, kombinationer 2.16.840.1.113883.6.73 2017-01 A01AD Other agents for local oral treatment Övriga medel för lokal behandling i munhålan 2.16.840.1.113883.6.73 2017-01 A01AD01 Adrenalin 2.16.840.1.113883.6.73 2017-01 A01AD02 Bensydamin 2.16.840.1.113883.6.73 2017-01 A01AD05 acetylsalicylic acid Acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 A01AD06 Adrenon 2.16.840.1.113883.6.73 2017-01 A01AD07 Amlexanox 2.16.840.1.113883.6.73 2017-01 A01AD08 Bekaplermin 2.16.840.1.113883.6.73 2017-01 A01AD11 various Övrigt 2.16.840.1.113883.6.73 2017-01 A02 FOR ACID RELATED Medel vid syrarelaterade symtom DISORDERS 2.16.840.1.113883.6.73 2017-01 A02A Antacida 2.16.840.1.113883.6.73 2017-01 A02AA compounds Magnesiumföreningar 2.16.840.1.113883.6.73 2017-01 A02AA01 Magnesiumkarbonat 2.16.840.1.113883.6.73 2017-01 A02AA02 Magnesiumoxid 2.16.840.1.113883.6.73 2017-01 A02AA03 Magnesiumperoxid 2.16.840.1.113883.6.73 2017-01 A02AA04 magnesium Magnesiumhydroxid 2.16.840.1.113883.6.73 2017-01 A02AA05 magnesium silicate Magnesiumsilikat 2.16.840.1.113883.6.73 2017-01 A02AA10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A02AB compounds Aluminiumföreningar 2.16.840.1.113883.6.73 2017-01 A02AB01 Aluminiumhydroxid 2.16.840.1.113883.6.73 2017-01 A02AB02 algeldrate Algeldrat 2.16.840.1.113883.6.73 2017-01 A02AB03 aluminium Aluminiumfosfat 2.16.840.1.113883.6.73 2017-01 A02AB04 dihydroxialumini sodium carbonate Dihydroxialuminiumnatriumkarbonat 2.16.840.1.113883.6.73 2017-01 A02AB05 aluminium acetoacetate Aluminiumacetoacetat 2.16.840.1.113883.6.73 2017-01 A02AB06 Aloglutamol 2.16.840.1.113883.6.73 2017-01 A02AB07 Aluminium glycinat 2.16.840.1.113883.6.73 2017-01 A02AB10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A02AC compounds Kalciumföreningar 2.16.840.1.113883.6.73 2017-01 A02AC01 Kalciumkarbonat 2.16.840.1.113883.6.73 2017-01 A02AC02 Kalciumsilikat 2.16.840.1.113883.6.73 2017-01 A02AC10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A02AD Combinations and complexes of Kombinationer och komplex av aluminium, calcium and magnesium aluminium-, kalcium- och compounds magnesiumföreningar

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 10 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A02AD01 ordinary combinations Aluminium-, kalcium- och magnesiumsalter 2.16.840.1.113883.6.73 2017-01 A02AD02 Magaldrat 2.16.840.1.113883.6.73 2017-01 A02AD03 Almagat 2.16.840.1.113883.6.73 2017-01 A02AD04 Hydrotalcit 2.16.840.1.113883.6.73 2017-01 A02AD05 Almasilat 2.16.840.1.113883.6.73 2017-01 A02AF Antacids with antiflatulents Antacida och medel mot meteorism 2.16.840.1.113883.6.73 2017-01 A02AF01 magaldrate and antiflatulents Magaldrat och medel mot meteorism 2.16.840.1.113883.6.73 2017-01 A02AF02 ordinary salt combinations and Aluminium-, kalcium- och antiflatulents magnesiumsalter samt medel mot meteorism 2.16.840.1.113883.6.73 2017-01 A02AG Antacids with Antacida och spasmolytika 2.16.840.1.113883.6.73 2017-01 A02AH Antacids with Antacida med natriumvätekarbonat 2.16.840.1.113883.6.73 2017-01 A02AX Antacids, other combinations Antacida, övriga kombinationer 2.16.840.1.113883.6.73 2017-01 A02B DRUGS FOR PEPTIC ULCER AND Medel vid magsår och GASTRO-OESOPHAGEAL gastroesofageal refluxsjukdom REFLUX DISEASE (GORD) 2.16.840.1.113883.6.73 2017-01 A02BA H2- antagonists Histamin-2-receptorantagonister 2.16.840.1.113883.6.73 2017-01 A02BA01 Cimetidin 2.16.840.1.113883.6.73 2017-01 A02BA02 Ranitidin 2.16.840.1.113883.6.73 2017-01 A02BA03 Famotidin 2.16.840.1.113883.6.73 2017-01 A02BA04 Nizatidin 2.16.840.1.113883.6.73 2017-01 A02BA05 Niperotidin 2.16.840.1.113883.6.73 2017-01 A02BA06 roxatidine Roxatidin 2.16.840.1.113883.6.73 2017-01 A02BA07 ranitidine bismuth citrate Ranitidinvismutcitrat 2.16.840.1.113883.6.73 2017-01 A02BA08 Lafutidin 2.16.840.1.113883.6.73 2017-01 A02BA51 cimetidine, combinations Cimetidin, kombinationer 2.16.840.1.113883.6.73 2017-01 A02BA53 famotidine, combinations Famotidin, kombinationer 2.16.840.1.113883.6.73 2017-01 A02BB Prostaglandiner 2.16.840.1.113883.6.73 2017-01 A02BB01 Misoprostol 2.16.840.1.113883.6.73 2017-01 A02BB02 Enprostil 2.16.840.1.113883.6.73 2017-01 A02BC Proton pump inhibitors Protonpumpshämmare 2.16.840.1.113883.6.73 2017-01 A02BC01 Omeprazol 2.16.840.1.113883.6.73 2017-01 A02BC02 Pantoprazol 2.16.840.1.113883.6.73 2017-01 A02BC03 Lansoprazol 2.16.840.1.113883.6.73 2017-01 A02BC04 Rabeprazol 2.16.840.1.113883.6.73 2017-01 A02BC05 Esomeprazol 2.16.840.1.113883.6.73 2017-01 A02BC06 Dexlansoprazol 2.16.840.1.113883.6.73 2017-01 A02BC07 dexrabeprazole Dexrabeprazol 2.16.840.1.113883.6.73 2017-01 A02BC53 lansoprazole, combinations Lansoprazol, kombinationer 2.16.840.1.113883.6.73 2017-01 A02BC54 rabeprazole, combinations Rabeprazol, kombinationer 2.16.840.1.113883.6.73 2017-01 A02BD Combinations for eradication of Kombinationer för eradikering av Helicobacter pylori Helicobacter pylori 2.16.840.1.113883.6.73 2017-01 A02BD01 omeprazole, amoxicillin and Omeprazol, amoxicillin och metronidazole metronidazol © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 11 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A02BD02 lansoprazole, tetracycline and Lansoprazol, tetracyklin och metronidazole metronidazol 2.16.840.1.113883.6.73 2017-01 A02BD03 lansoprazole, amoxicillin and Lansoprazol, amoxicillin och metronidazole metronidazol 2.16.840.1.113883.6.73 2017-01 A02BD04 pantoprazole, amoxicillin and Pantoprazol, amoxicillin och klaritromycin 2.16.840.1.113883.6.73 2017-01 A02BD05 omeprazole, amoxicillin and Omeprazol, amoxicillin och clarithromycin klaritromycin 2.16.840.1.113883.6.73 2017-01 A02BD06 esomeprazole, amoxicillin and Esomeprazol, amoxicillin och clarithromycin klaritromycin 2.16.840.1.113883.6.73 2017-01 A02BD07 lansoprazole, amoxicillin and Lansoprazol, amoxicillin och clarithromycin klaritromycin 2.16.840.1.113883.6.73 2017-01 A02BD08 , tetracycline and Vismutsubcitrat, tetracyklin och metronidazole metronidazol 2.16.840.1.113883.6.73 2017-01 A02BD09 lansoprazole, clarithromycin and Lansoprazol, klaritromycin och tinidazol 2.16.840.1.113883.6.73 2017-01 A02BD10 lansoprazole, amoxicillin and Lansoprazol, amoxicillin och levofloxacin levofloxacin 2.16.840.1.113883.6.73 2017-01 A02BD11 pantoprazole, amoxicillin, Pantoprazol, amoxicillin, clarithromycin and metronidazole klaritromycin och metronidazol 2.16.840.1.113883.6.73 2017-01 A02BX Other drugs for peptic ulcer and Övriga medel vid magsår och gastro-oesophageal reflux disease gastroesofageal refluxsjukdom (GORD) 2.16.840.1.113883.6.73 2017-01 A02BX01 Karbenoxolon 2.16.840.1.113883.6.73 2017-01 A02BX02 Sukralfat 2.16.840.1.113883.6.73 2017-01 A02BX03 Pirenzepin 2.16.840.1.113883.6.73 2017-01 A02BX04 methiosulfonium chloride Metiosulfonklorid 2.16.840.1.113883.6.73 2017-01 A02BX05 bismuth subcitrate Vismutsubcitrat 2.16.840.1.113883.6.73 2017-01 A02BX06 Proglumid 2.16.840.1.113883.6.73 2017-01 A02BX07 Gefarnat 2.16.840.1.113883.6.73 2017-01 A02BX08 Sulglikotid 2.16.840.1.113883.6.73 2017-01 A02BX09 Acetoxolon 2.16.840.1.113883.6.73 2017-01 A02BX10 Zolimidin 2.16.840.1.113883.6.73 2017-01 A02BX11 Troxipid 2.16.840.1.113883.6.73 2017-01 A02BX12 bismuth subnitrate Vismutsubnitrat 2.16.840.1.113883.6.73 2017-01 A02BX13 Alginsyra 2.16.840.1.113883.6.73 2017-01 A02BX51 carbenoxolone, combinations excl. Karbenoxolon, kombinationer exkl. psykoleptika 2.16.840.1.113883.6.73 2017-01 A02BX71 carbenoxolone, combinations with Karbenoxolon, kombination med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 A02BX77 gefarnate, combinations with Gefarnat, kombination med psycholeptics lugnande medel 2.16.840.1.113883.6.73 2017-01 A02X OTHER DRUGS FOR ACID Övriga medel vid syrarelaterade RELATED DISORDERS sjukdomar 2.16.840.1.113883.6.73 2017-01 A03 DRUGS FOR FUNCTIONAL Medel vid funktionella mag- GASTROINTESTINAL tarmsymtom DISORDERS 2.16.840.1.113883.6.73 2017-01 A03A DRUGS FOR FUNCTIONAL Medel vid funktionella mag- GASTROINTESTINAL tarmsymtom DISORDERS

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 12 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03AA Synthetic , esters Syntetiska antikolinergika, estrar with tertiary amino group med tertiär aminogrupp 2.16.840.1.113883.6.73 2017-01 A03AA01 Oxifencyklimin 2.16.840.1.113883.6.73 2017-01 A03AA03 Kamylofin 2.16.840.1.113883.6.73 2017-01 A03AA04 Mebeverin 2.16.840.1.113883.6.73 2017-01 A03AA05 Trimebutin 2.16.840.1.113883.6.73 2017-01 A03AA06 Rociverin 2.16.840.1.113883.6.73 2017-01 A03AA07 Dicycloverin 2.16.840.1.113883.6.73 2017-01 A03AA08 Dihexiverin 2.16.840.1.113883.6.73 2017-01 A03AA09 Difemerin 2.16.840.1.113883.6.73 2017-01 A03AA30 Piperidolat 2.16.840.1.113883.6.73 2017-01 A03AB Synthetic anticholinergics, Syntetiska antikolinergika, kvartära quaternary ammonium compounds ammoniumföreningar 2.16.840.1.113883.6.73 2017-01 A03AB01 Bensilon 2.16.840.1.113883.6.73 2017-01 A03AB02 glycopyrronium Glykopyrroniumbromid 2.16.840.1.113883.6.73 2017-01 A03AB03 oxyphenonium Oxyfenon 2.16.840.1.113883.6.73 2017-01 A03AB04 Pentienat 2.16.840.1.113883.6.73 2017-01 A03AB05 propantheline Propantelin 2.16.840.1.113883.6.73 2017-01 A03AB06 Otiloniumbromid 2.16.840.1.113883.6.73 2017-01 A03AB07 Metantelin 2.16.840.1.113883.6.73 2017-01 A03AB08 Tridihexetyl 2.16.840.1.113883.6.73 2017-01 A03AB09 Isopropon 2.16.840.1.113883.6.73 2017-01 A03AB10 Hexocyklium 2.16.840.1.113883.6.73 2017-01 A03AB11 Poldin 2.16.840.1.113883.6.73 2017-01 A03AB12 Mepensolat 2.16.840.1.113883.6.73 2017-01 A03AB13 Bevonium 2.16.840.1.113883.6.73 2017-01 A03AB14 pipenzolate Pipenzolat 2.16.840.1.113883.6.73 2017-01 A03AB15 diphemanil Difemanil 2.16.840.1.113883.6.73 2017-01 A03AB16 (2-benzhydryloxyethyl)diethyl- (2-Benshydryloxietyl) methylammonium iodide dietylmetylammoniumjodid 2.16.840.1.113883.6.73 2017-01 A03AB17 Tiemoniumjodid 2.16.840.1.113883.6.73 2017-01 A03AB18 Prifiniumbromid 2.16.840.1.113883.6.73 2017-01 A03AB19 Timepidiumbromid 2.16.840.1.113883.6.73 2017-01 A03AB21 Fenpiverinium 2.16.840.1.113883.6.73 2017-01 A03AB53 oxyphenonium, combinations Oxifenon, kombinationer 2.16.840.1.113883.6.73 2017-01 A03AC Synthetic antispasmodics, amides Syntetiska spasmolytika, amider with tertiary amines med tertiär aminogrupp 2.16.840.1.113883.6.73 2017-01 A03AC02 dimethylaminopropionylphenothiazin Dimetylaminopropionylfenotiazin e 2.16.840.1.113883.6.73 2017-01 A03AC04 nicofetamide Nikofetamid 2.16.840.1.113883.6.73 2017-01 A03AC05 Tiropramid 2.16.840.1.113883.6.73 2017-01 A03AD and derivatives Papaverin och derivat 2.16.840.1.113883.6.73 2017-01 A03AD01 papaverine Papaverin 2.16.840.1.113883.6.73 2017-01 A03AD02 Drotaverin 2.16.840.1.113883.6.73 2017-01 A03AD30 Moxaverin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 13 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03AE Serotonin receptor antagonists Serotoninreceptorantagonister 2.16.840.1.113883.6.73 2017-01 A03AE01 Alosetron 2.16.840.1.113883.6.73 2017-01 A03AE03 Cilansetron 2.16.840.1.113883.6.73 2017-01 A03AX Other drugs for functional Övriga medel vid funktionella mag- gastrointestinal disorders tarmsymtom 2.16.840.1.113883.6.73 2017-01 A03AX01 Fenpipran 2.16.840.1.113883.6.73 2017-01 A03AX02 Diisopromin 2.16.840.1.113883.6.73 2017-01 A03AX03 Klorbensoxamin 2.16.840.1.113883.6.73 2017-01 A03AX04 pinaverium Pinaverin 2.16.840.1.113883.6.73 2017-01 A03AX05 Fenoverin 2.16.840.1.113883.6.73 2017-01 A03AX06 Idanpramin 2.16.840.1.113883.6.73 2017-01 A03AX07 Proxazol 2.16.840.1.113883.6.73 2017-01 A03AX08 Alverin 2.16.840.1.113883.6.73 2017-01 A03AX09 Trepibuton 2.16.840.1.113883.6.73 2017-01 A03AX10 Isomethepten 2.16.840.1.113883.6.73 2017-01 A03AX11 Karoverin 2.16.840.1.113883.6.73 2017-01 A03AX12 Floroglucinol 2.16.840.1.113883.6.73 2017-01 A03AX13 silicones Silikoner 2.16.840.1.113883.6.73 2017-01 A03AX14 valethamate Valetamat 2.16.840.1.113883.6.73 2017-01 A03AX30 trimethyldiphenylpropylamine Trimetyldifenylpropylamin 2.16.840.1.113883.6.73 2017-01 A03AX58 alverine, combinations Alverin, kombinationer 2.16.840.1.113883.6.73 2017-01 A03B BELLADONNA AND Belladonnaalkaloider och derivat DERIVATIVES, PLAIN 2.16.840.1.113883.6.73 2017-01 A03BA Belladonna alkaloids, tertiary Belladonnaalkaloider med tertiär amines aminogrupp 2.16.840.1.113883.6.73 2017-01 A03BA01 Atropin 2.16.840.1.113883.6.73 2017-01 A03BA03 Hyoscyamin 2.16.840.1.113883.6.73 2017-01 A03BA04 belladonna total alkaloids Belladonnaalkaloider 2.16.840.1.113883.6.73 2017-01 A03BB Belladonna alkaloids, semisynthetic, Semisyntetiska belladonnalkaloider, quaternary ammonium compounds kvartära ammoniumföreningar 2.16.840.1.113883.6.73 2017-01 A03BB01 butylscopolamine Butylskopolamin 2.16.840.1.113883.6.73 2017-01 A03BB02 Metylatropin 2.16.840.1.113883.6.73 2017-01 A03BB03 methylscopolamine Metylskopolamin 2.16.840.1.113883.6.73 2017-01 A03BB04 fentonium Fentonin 2.16.840.1.113883.6.73 2017-01 A03BB05 Cimetropiumbromid 2.16.840.1.113883.6.73 2017-01 A03C ANTISPASMODICS IN Spasmolytika i kombination med COMBINATION WITH lugnande medel PSYCHOLEPTICS 2.16.840.1.113883.6.73 2017-01 A03CA Synthetic agents in Syntetiska antikolinergika i combination with psycholeptics kombination med lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA01 isopropamide and psycholeptics Isopropon och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA02 clidinium and psycholeptics Klidinium och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA03 oxyphencyclimine and psycholeptics Oxifencyklimin och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA04 otilonium bromide and psycholeptics Otiloniumbromid och lugnande medel

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 14 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03CA05 and Glykopyrroniumbromid och psycholeptics lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA06 bevonium and psycholeptics Bevonium och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA07 ambutonium and psycholeptics Ambutonium och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA08 diphemanil and psycholeptics Difemanil och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA09 pipenzolate and psycholeptics Pipenzolat och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA30 emepronium and psycholeptics Emepronium och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA34 propantheline and psycholeptics Propantelin och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CB Belladonna and derivatives in Belladonnaalkaloider och derivat i combination with psycholeptics kombination med lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CB01 methylscopolamine and Metylskopolamin och lugnande psycholeptics medel 2.16.840.1.113883.6.73 2017-01 A03CB02 belladonna total alkaloids and Belladonnaalkaloider och lugnande psycholeptics medel 2.16.840.1.113883.6.73 2017-01 A03CB03 atropine and psycholeptics Atropin och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CB04 methylhomatropine and Metylhomatropin och lugnande psycholeptics medel 2.16.840.1.113883.6.73 2017-01 A03CB31 hyoscyamine and psycholeptics Hyoscyamin och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CC Other antispasmodics in Övriga kombinationer med lugnande combination with psycholeptics medel 2.16.840.1.113883.6.73 2017-01 A03D ANTISPASMODICS IN Spasmolytika i kombination med COMBINATION WITH analgetika 2.16.840.1.113883.6.73 2017-01 A03DA Synthetic anticholinergic agents in Syntetiska antikolinergika i combination with analgesics kombination med analgetika 2.16.840.1.113883.6.73 2017-01 A03DA01 tropenzilone and analgesics Tropenzilon och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA02 pitofenone and analgesics Pitofenon och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA03 bevonium and analgesics Bevonium och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA04 ciclonium and analgesics Ciklonium och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA05 camylofin and analgesics Kamylofin och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA06 trospium and analgesics Trospium och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA07 tiemonium iodide and analgesics Tiemoniumjodid och analgetika 2.16.840.1.113883.6.73 2017-01 A03DB Belladonna and derivatives in Belladonnaalkaloider och derivat i combination with analgesics kombination med analgetika 2.16.840.1.113883.6.73 2017-01 A03DB04 butylscopolamine and analgesics Butylskopolamin och analgetika 2.16.840.1.113883.6.73 2017-01 A03DC Other antispasmodics in Övriga kombinationer med combination with analgesics analgetika 2.16.840.1.113883.6.73 2017-01 A03E ANTISPASMODICS AND Övriga kombinationer ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS 2.16.840.1.113883.6.73 2017-01 A03EA Antispasmodics, psycholeptics and Spasmolytika, lugnande medel och analgesics in combination analgetika i kombination 2.16.840.1.113883.6.73 2017-01 A03ED Antispasmodics in combination with Spasmolytika i kombination med other drugs andra medel 2.16.840.1.113883.6.73 2017-01 A03F PROPULSIVES Motilitetsstimulerande medel 2.16.840.1.113883.6.73 2017-01 A03FA Propulsives Motilitetsstimulerande medel 2.16.840.1.113883.6.73 2017-01 A03FA01 Metoklopramid 2.16.840.1.113883.6.73 2017-01 A03FA02 Cisaprid © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 15 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03FA03 Domperidon 2.16.840.1.113883.6.73 2017-01 A03FA04 Bromoprid 2.16.840.1.113883.6.73 2017-01 A03FA05 Alizaprid 2.16.840.1.113883.6.73 2017-01 A03FA06 Kleboprid 2.16.840.1.113883.6.73 2017-01 A03FA07 Itroprid 2.16.840.1.113883.6.73 2017-01 A03FA08 Cinitaprid 2.16.840.1.113883.6.73 2017-01 A04 AND Antiemetika ANTINAUSEANTS 2.16.840.1.113883.6.73 2017-01 A04A ANTIEMETICS AND Antiemetika ANTINAUSEANTS 2.16.840.1.113883.6.73 2017-01 A04AA Serotonin (5HT3) antagonists Serotonin (5HT3) receptorantagonister 2.16.840.1.113883.6.73 2017-01 A04AA01 ondansetron Ondansetron 2.16.840.1.113883.6.73 2017-01 A04AA02 granisetron Granisetron 2.16.840.1.113883.6.73 2017-01 A04AA03 Tropisetron 2.16.840.1.113883.6.73 2017-01 A04AA04 dolasetron Dolasetron 2.16.840.1.113883.6.73 2017-01 A04AA05 palonosetron Palonosetron 2.16.840.1.113883.6.73 2017-01 A04AA55 palonosetron, combinations Palonosetron, kombinationer 2.16.840.1.113883.6.73 2017-01 A04AD Other antiemetics Övriga antiemetika 2.16.840.1.113883.6.73 2017-01 A04AD01 Skopolamin 2.16.840.1.113883.6.73 2017-01 A04AD02 cerium Ceriumoxalat 2.16.840.1.113883.6.73 2017-01 A04AD04 Klorbutanol 2.16.840.1.113883.6.73 2017-01 A04AD05 Metopimazin 2.16.840.1.113883.6.73 2017-01 A04AD10 Dronabinol 2.16.840.1.113883.6.73 2017-01 A04AD11 Nabilon 2.16.840.1.113883.6.73 2017-01 A04AD12 Aprepitant 2.16.840.1.113883.6.73 2017-01 A04AD13 Kasopitant 2.16.840.1.113883.6.73 2017-01 A04AD14 rolapitant Rolapitant 2.16.840.1.113883.6.73 2017-01 A04AD51 scopolamine, combinations Skopolamin, kombinationer 2.16.840.1.113883.6.73 2017-01 A04AD54 chlorobutanol, combinations Klorbutanol, kombinationer 2.16.840.1.113883.6.73 2017-01 A05 AND Gall- och leverterapi 2.16.840.1.113883.6.73 2017-01 A05A BILE THERAPY Gallterapi 2.16.840.1.113883.6.73 2017-01 A05AA preparations Gallsyror och derivat 2.16.840.1.113883.6.73 2017-01 A05AA01 Kenodeoxicholsyra 2.16.840.1.113883.6.73 2017-01 A05AA02 Ursodeoxicholsyra 2.16.840.1.113883.6.73 2017-01 A05AA03 Cholsyra 2.16.840.1.113883.6.73 2017-01 A05AA04 Obeticholsyra 2.16.840.1.113883.6.73 2017-01 A05AB Preparations for biliary tract therapy Medel för behandling av sjukdomar i gallvägarna 2.16.840.1.113883.6.73 2017-01 A05AB01 nicotinyl methylamide Nikotinylmetylamid 2.16.840.1.113883.6.73 2017-01 A05AX Other drugs for bile therapy Övriga medel vid gallterapi 2.16.840.1.113883.6.73 2017-01 A05AX01 Piprozolin 2.16.840.1.113883.6.73 2017-01 A05AX02 Hymekromon 2.16.840.1.113883.6.73 2017-01 A05AX03 Cyklobutyrol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 16 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A05B LIVER THERAPY, LIPOTROPICS Leverterapi, lipotroper 2.16.840.1.113883.6.73 2017-01 A05BA Liver therapy Leverterapi 2.16.840.1.113883.6.73 2017-01 A05BA01 glutamate Argininglutamat 2.16.840.1.113883.6.73 2017-01 A05BA03 silymarin Silymarin 2.16.840.1.113883.6.73 2017-01 A05BA04 Citiolon 2.16.840.1.113883.6.73 2017-01 A05BA05 Epomediol 2.16.840.1.113883.6.73 2017-01 A05BA06 ornithine oxoglurate Ornitinoxoglurat 2.16.840.1.113883.6.73 2017-01 A05BA07 arginine Tidiacikarginin 2.16.840.1.113883.6.73 2017-01 A05BA08 glycyrrhizic acid Glycyrrhizinsyra 2.16.840.1.113883.6.73 2017-01 A05C DRUGS FOR BILE THERAPY AND Medel för gallterapi och lipotropa LIPOTROPICS IN COMBINATION medel, kombinationer 2.16.840.1.113883.6.73 2017-01 A06 DRUGS FOR CONSTIPATION Medel vid förstoppning 2.16.840.1.113883.6.73 2017-01 A06A DRUGS FOR CONSTIPATION Medel vid förstoppning 2.16.840.1.113883.6.73 2017-01 A06AA Softeners, emollients Mjukgörare, emulgeringsmedel 2.16.840.1.113883.6.73 2017-01 A06AA01 liquid paraffin Flytande paraffin 2.16.840.1.113883.6.73 2017-01 A06AA02 docusate sodium Dokusatnatrium 2.16.840.1.113883.6.73 2017-01 A06AA51 liquid paraffin, combinations Flytande paraffin, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AB Contact Tarmirriterande medel 2.16.840.1.113883.6.73 2017-01 A06AB01 oxyphenisatine Oxifenisatin 2.16.840.1.113883.6.73 2017-01 A06AB02 bisacodyl Bisakodyl 2.16.840.1.113883.6.73 2017-01 A06AB03 dantron Dantron 2.16.840.1.113883.6.73 2017-01 A06AB04 Fenolftalein 2.16.840.1.113883.6.73 2017-01 A06AB05 castor oil Ricinolja 2.16.840.1.113883.6.73 2017-01 A06AB06 senna glycosides Sennaglykosider 2.16.840.1.113883.6.73 2017-01 A06AB07 cascara Sagrada, bark 2.16.840.1.113883.6.73 2017-01 A06AB08 sodium picosulfate Natriumpikosulfat 2.16.840.1.113883.6.73 2017-01 A06AB09 bisoxatin Bisoxatin 2.16.840.1.113883.6.73 2017-01 A06AB20 contact laxatives in combination Kombinationer av tarmirriterande medel 2.16.840.1.113883.6.73 2017-01 A06AB30 contact laxatives in combination with Tarmirriterande medel i kombination belladonna alkaloids med belladonnaalkaloider 2.16.840.1.113883.6.73 2017-01 A06AB52 bisacodyl, combinations Bisakodyl, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AB53 dantron, combinations Dantron, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AB56 senna glycosides, combinations Sennaglykosider, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AB57 cascara, combinations Sagrada, bark med kombinationer 2.16.840.1.113883.6.73 2017-01 A06AB58 sodium picosulfate, combinations Natriumpikosulfat, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AC Bulk-forming laxatives Bulkbildande laxermedel 2.16.840.1.113883.6.73 2017-01 A06AC01 ispaghula (psylla seeds) Loppfrö och vitt loppfrö 2.16.840.1.113883.6.73 2017-01 A06AC02 ethulose Etulos 2.16.840.1.113883.6.73 2017-01 A06AC03 sterculia Sterkuliagummi 2.16.840.1.113883.6.73 2017-01 A06AC05 linseed Linfrö 2.16.840.1.113883.6.73 2017-01 A06AC06 methylcellulose Metylcellulosa 2.16.840.1.113883.6.73 2017-01 A06AC07 triticum (wheat fibre) Kostfiber av vetefröskal 2.16.840.1.113883.6.73 2017-01 A06AC08 polycarbophil calcium Polykarbofilkalcium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 17 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A06AC51 ispaghula, combinations Loppfrö och vitt loppfrö, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AC53 sterculia, combinations Sterkuliagummi, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AC55 linseed, combinations Linfrö, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AD Osmotically acting laxatives Osmotiskt aktiva laxermedel 2.16.840.1.113883.6.73 2017-01 A06AD01 magnesium carbonate Magnesiumkarbonat 2.16.840.1.113883.6.73 2017-01 A06AD02 magnesium oxide Magnesiumoxid 2.16.840.1.113883.6.73 2017-01 A06AD03 magnesium peroxide Magnesiumperoxid 2.16.840.1.113883.6.73 2017-01 A06AD04 Magnesiumsulfat 2.16.840.1.113883.6.73 2017-01 A06AD10 salts in combination Mineralsalter i kombination 2.16.840.1.113883.6.73 2017-01 A06AD11 lactulose Laktulos 2.16.840.1.113883.6.73 2017-01 A06AD12 lactitol Laktitol 2.16.840.1.113883.6.73 2017-01 A06AD13 sodium sulfate Natriumsulfat 2.16.840.1.113883.6.73 2017-01 A06AD14 pentaerithrityl Pentaeritrityl 2.16.840.1.113883.6.73 2017-01 A06AD15 macrogol Makrogol 2.16.840.1.113883.6.73 2017-01 A06AD16 Mannitol 2.16.840.1.113883.6.73 2017-01 A06AD17 sodium phosphate Natriumfosfat 2.16.840.1.113883.6.73 2017-01 A06AD18 Sorbitol 2.16.840.1.113883.6.73 2017-01 A06AD19 Magnesiumcitrat 2.16.840.1.113883.6.73 2017-01 A06AD21 sodium tartrate Natriumtartrat 2.16.840.1.113883.6.73 2017-01 A06AD61 lactulose, combinations Laktulos, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AD65 macrogol, combinations Makrogol, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AG Enemas Klysma 2.16.840.1.113883.6.73 2017-01 A06AG01 sodium phosphate Natriumfosfat 2.16.840.1.113883.6.73 2017-01 A06AG02 bisacodyl Bisakodyl 2.16.840.1.113883.6.73 2017-01 A06AG03 dantron, incl. combinations Dantron, inkl. kombinationer 2.16.840.1.113883.6.73 2017-01 A06AG04 Glycerol 2.16.840.1.113883.6.73 2017-01 A06AG06 oil Olja 2.16.840.1.113883.6.73 2017-01 A06AG07 sorbitol Sorbitol 2.16.840.1.113883.6.73 2017-01 A06AG10 docusate sodium, incl. combinations Dokusatnatrium, inkl. kombinationer 2.16.840.1.113883.6.73 2017-01 A06AG11 sodium lauryl sulfoacetate, incl. Natriumlaurylsulfoacetat, inkl. combinations kombinationer 2.16.840.1.113883.6.73 2017-01 A06AG20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A06AH Peripheral receptor Perifera opioidreceptorantagonister antagonists 2.16.840.1.113883.6.73 2017-01 A06AH01 methylnaltrexone bromide Metylnaltrexonbromid 2.16.840.1.113883.6.73 2017-01 A06AH02 alvimopan Alvimopan 2.16.840.1.113883.6.73 2017-01 A06AH03 naloxegol Naloxegol 2.16.840.1.113883.6.73 2017-01 A06AH04 Naloxon 2.16.840.1.113883.6.73 2017-01 A06AX Other drugs for constipation Övriga medel vid förstoppning 2.16.840.1.113883.6.73 2017-01 A06AX01 glycerol Glycerol 2.16.840.1.113883.6.73 2017-01 A06AX02 carbon dioxide producing drugs Koldioxidutvecklande medel 2.16.840.1.113883.6.73 2017-01 A06AX03 lubiprostone Lubiproston 2.16.840.1.113883.6.73 2017-01 A06AX04 linaclotide Linaklotid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 18 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A06AX05 prucalopride Prukaloprid 2.16.840.1.113883.6.73 2017-01 A06AX06 tegaserod Tegaserod 2.16.840.1.113883.6.73 2017-01 A07 ANTIDIARRHEALS, INTESTINAL Antidiarroika, intestinala ANTIINFLAMMATORY/ANTIINFEC antiinflammatoriska och antiinfektiva TIVE AGENTS medel 2.16.840.1.113883.6.73 2017-01 A07A INTESTINAL ANTIINFECTIVES Medel vid tarminfektioner 2.16.840.1.113883.6.73 2017-01 A07AA Antibiotika 2.16.840.1.113883.6.73 2017-01 A07AA01 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 A07AA02 Nystatin 2.16.840.1.113883.6.73 2017-01 A07AA03 natamycin Natamycin 2.16.840.1.113883.6.73 2017-01 A07AA04 Streptomycin 2.16.840.1.113883.6.73 2017-01 A07AA05 Polymyxin B 2.16.840.1.113883.6.73 2017-01 A07AA06 Paromomycin 2.16.840.1.113883.6.73 2017-01 A07AA07 amphotericin B Amfotericin B 2.16.840.1.113883.6.73 2017-01 A07AA08 kanamycin Kanamycin 2.16.840.1.113883.6.73 2017-01 A07AA09 Vankomycin 2.16.840.1.113883.6.73 2017-01 A07AA10 Kolistin 2.16.840.1.113883.6.73 2017-01 A07AA11 Rifaximin 2.16.840.1.113883.6.73 2017-01 A07AA12 Fidaxomicin 2.16.840.1.113883.6.73 2017-01 A07AA51 neomycin, combinations Neomycin, kombinationer 2.16.840.1.113883.6.73 2017-01 A07AA54 streptomycin, combinations Streptomycin, kombinationer 2.16.840.1.113883.6.73 2017-01 A07AB Sulfonamides Sulfonamider 2.16.840.1.113883.6.73 2017-01 A07AB02 Ftalylsulfatiazol 2.16.840.1.113883.6.73 2017-01 A07AB03 Sulfaguanidin 2.16.840.1.113883.6.73 2017-01 A07AB04 Succinylsulfatiazol 2.16.840.1.113883.6.73 2017-01 A07AC derivatives Imidazolderivat 2.16.840.1.113883.6.73 2017-01 A07AC01 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 A07AX Other intestinal antiinfectives Övriga medel vid intestinala infektioner 2.16.840.1.113883.6.73 2017-01 A07AX01 Broxykinoliner 2.16.840.1.113883.6.73 2017-01 A07AX02 Acetarsol 2.16.840.1.113883.6.73 2017-01 A07AX03 Nifuroxazid 2.16.840.1.113883.6.73 2017-01 A07AX04 Nifurzid 2.16.840.1.113883.6.73 2017-01 A07B INTESTINAL ADSORBENTS Antidiarroika 2.16.840.1.113883.6.73 2017-01 A07BA Charcoal preparations Adsorberande medel 2.16.840.1.113883.6.73 2017-01 A07BA01 medicinal charcoal Medicinskt kol 2.16.840.1.113883.6.73 2017-01 A07BA51 medicinal charcoal, combinations Medicinskt kol, kombinationer 2.16.840.1.113883.6.73 2017-01 A07BB Bismuth preparations Vismutpreparat 2.16.840.1.113883.6.73 2017-01 A07BC Other intestinal adsorbents Övriga antidiarroika 2.16.840.1.113883.6.73 2017-01 A07BC01 pectin Pektin 2.16.840.1.113883.6.73 2017-01 A07BC02 kaolin Kaolin 2.16.840.1.113883.6.73 2017-01 A07BC03 crospovidone Krospovidon 2.16.840.1.113883.6.73 2017-01 A07BC04 attapulgite Attapulgit 2.16.840.1.113883.6.73 2017-01 A07BC05 Diosmektit

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 19 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A07BC30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A07BC54 attapulgite, combinations Attapulgit, kombinationer 2.16.840.1.113883.6.73 2017-01 A07C ELECTROLYTES WITH Elektrolyter med kolhydrater 2.16.840.1.113883.6.73 2017-01 A07CA Oral rehydration salt formulations Elektrolyter med kolhydrater 2.16.840.1.113883.6.73 2017-01 A07D Propulsionsdämpande medel 2.16.840.1.113883.6.73 2017-01 A07DA Antipropulsives Propulsionsdämpande medel 2.16.840.1.113883.6.73 2017-01 A07DA01 Difenoxylat 2.16.840.1.113883.6.73 2017-01 A07DA02 Opium 2.16.840.1.113883.6.73 2017-01 A07DA03 Loperamid 2.16.840.1.113883.6.73 2017-01 A07DA04 Difenoxin 2.16.840.1.113883.6.73 2017-01 A07DA05 loperamide oxide Loperamidoxid 2.16.840.1.113883.6.73 2017-01 A07DA06 Eluxadolin 2.16.840.1.113883.6.73 2017-01 A07DA52 , combinations Morfin, kombinationer 2.16.840.1.113883.6.73 2017-01 A07DA53 loperamide, combinations Loperamid, kombinationer 2.16.840.1.113883.6.73 2017-01 A07E INTESTINAL Medel vid intestinala inflammationer ANTIINFLAMMATORY AGENTS 2.16.840.1.113883.6.73 2017-01 A07EA Corticosteroids acting locally Kortikosteroider för lokal behandling 2.16.840.1.113883.6.73 2017-01 A07EA01 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 A07EA02 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 A07EA03 Prednison 2.16.840.1.113883.6.73 2017-01 A07EA04 Betametason 2.16.840.1.113883.6.73 2017-01 A07EA05 Tixokortol 2.16.840.1.113883.6.73 2017-01 A07EA06 Budesonid 2.16.840.1.113883.6.73 2017-01 A07EA07 Beklometason 2.16.840.1.113883.6.73 2017-01 A07EB Antiallergic agents, excl. Antiallergika, exkl. kortikosteroider corticosteroids 2.16.840.1.113883.6.73 2017-01 A07EB01 Natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 A07EC Aminosalicylic acid and similar Aminosalicylsyra och liknande agents medel 2.16.840.1.113883.6.73 2017-01 A07EC01 Sulfasalazin 2.16.840.1.113883.6.73 2017-01 A07EC02 Mesalazin 2.16.840.1.113883.6.73 2017-01 A07EC03 Olsalazin 2.16.840.1.113883.6.73 2017-01 A07EC04 Balsalazid 2.16.840.1.113883.6.73 2017-01 A07F ANTIDIARRHEAL Antidiarroika, mikroorganismer MICROORGANISMS 2.16.840.1.113883.6.73 2017-01 A07FA Antidiarrheal microorganisms Antidiarroika, mikroorganismer 2.16.840.1.113883.6.73 2017-01 A07FA01 producing organisms Mjölksyreproducerande organismer 2.16.840.1.113883.6.73 2017-01 A07FA02 saccharomyces boulardii Saccharomyces boulardii 2.16.840.1.113883.6.73 2017-01 A07FA51 lactic acid producing organisms, Mjölksyreproducerande organismer, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 A07X OTHER ANTIDIARRHEALS Övriga medel mot diarre 2.16.840.1.113883.6.73 2017-01 A07XA Other antidiarrheals Övriga medel mot diarre 2.16.840.1.113883.6.73 2017-01 A07XA01 Albumintannat 2.16.840.1.113883.6.73 2017-01 A07XA02 ceratonia Ceratonia

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 20 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A07XA03 calcium compounds Kalciumföreningar 2.16.840.1.113883.6.73 2017-01 A07XA04 Racekadotril 2.16.840.1.113883.6.73 2017-01 A07XA51 albumin tannate, combinations Albumin tannat, kombinationer 2.16.840.1.113883.6.73 2017-01 A08 ANTIOBESITY PREPARATIONS, Antiobesitasmedel, exkl. EXCL. DIET PRODUCTS dietprodukter 2.16.840.1.113883.6.73 2017-01 A08A ANTIOBESITY PREPARATIONS, Antiobesitasmedel, exkl. EXCL. DIET PRODUCTS dietprodukter 2.16.840.1.113883.6.73 2017-01 A08AA Centrally acting antiobesity products Antiobesitasmedel, centralt verkande 2.16.840.1.113883.6.73 2017-01 A08AA01 phentermine Fentermin 2.16.840.1.113883.6.73 2017-01 A08AA02 Fenfluramin 2.16.840.1.113883.6.73 2017-01 A08AA03 amfepramone Amfepramon 2.16.840.1.113883.6.73 2017-01 A08AA04 dexfenfluramine Dexfenfluramin 2.16.840.1.113883.6.73 2017-01 A08AA05 mazindol Mazindol 2.16.840.1.113883.6.73 2017-01 A08AA06 etilamfetamine Etilamfetamin 2.16.840.1.113883.6.73 2017-01 A08AA07 Katin 2.16.840.1.113883.6.73 2017-01 A08AA08 clobenzorex Klobenzorex 2.16.840.1.113883.6.73 2017-01 A08AA09 mefenorex Mefenorex 2.16.840.1.113883.6.73 2017-01 A08AA10 sibutramine Sibutramin 2.16.840.1.113883.6.73 2017-01 A08AA11 lorcaserin Lorkaserin 2.16.840.1.113883.6.73 2017-01 A08AA56 , combinations Efedrin, kombinationer 2.16.840.1.113883.6.73 2017-01 A08AA62 and Bupropion och naltrexon 2.16.840.1.113883.6.73 2017-01 A08AB Peripherally acting antiobesity Antiobesitasmedel, perifert products verkande 2.16.840.1.113883.6.73 2017-01 A08AB01 orlistat Orlistat 2.16.840.1.113883.6.73 2017-01 A08AX Other antiobesity drugs Övriga antiobesitasmedel 2.16.840.1.113883.6.73 2017-01 A08AX01 rimonabant Rimonabant 2.16.840.1.113883.6.73 2017-01 A09 DIGESTIVES, INCL. Digestionsmedel, inkl. enzymer 2.16.840.1.113883.6.73 2017-01 A09A DIGESTIVES, INCL. ENZYMES Digestionsmedel, inkl. enzymer 2.16.840.1.113883.6.73 2017-01 A09AA preparations Digestionsenzymer 2.16.840.1.113883.6.73 2017-01 A09AA01 diastase Diastas 2.16.840.1.113883.6.73 2017-01 A09AA02 multienzymes (lipase, etc.) Multienzymer (lipas, proteas m.fl.) 2.16.840.1.113883.6.73 2017-01 A09AA03 pepsin Pepsin 2.16.840.1.113883.6.73 2017-01 A09AA04 tilactase Tilaktas 2.16.840.1.113883.6.73 2017-01 A09AB Acid preparations Saltsyraersättningsmedel 2.16.840.1.113883.6.73 2017-01 A09AB01 hydrochloride Aciglumin 2.16.840.1.113883.6.73 2017-01 A09AB02 betaine hydrochloride Betainhydroklorid 2.16.840.1.113883.6.73 2017-01 A09AB03 Saltsyra 2.16.840.1.113883.6.73 2017-01 A09AB04 Citronsyra 2.16.840.1.113883.6.73 2017-01 A09AC Enzyme and acid preparations, Enzym och syra, kombinationer combinations 2.16.840.1.113883.6.73 2017-01 A09AC01 pepsin and acid preparations Pepsin och syra 2.16.840.1.113883.6.73 2017-01 A09AC02 multienzymes and acid preparations Multienzymer och syra 2.16.840.1.113883.6.73 2017-01 A10 DRUGS USED IN Diabetesmedel 2.16.840.1.113883.6.73 2017-01 A10A INSULINS AND ANALOGUES Insuliner och analoger © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 21 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A10AB Insulins and analogues for , Insuliner och analoger för injektion, fast-acting snabbverkande 2.16.840.1.113883.6.73 2017-01 A10AB01 insulin (human) Insulin (humant) 2.16.840.1.113883.6.73 2017-01 A10AB02 insulin (beef) Insulin (bovint) 2.16.840.1.113883.6.73 2017-01 A10AB03 insulin (pork) Insulin (svin) 2.16.840.1.113883.6.73 2017-01 A10AB04 insulin lispro Insulin, lispro 2.16.840.1.113883.6.73 2017-01 A10AB05 insulin aspart Insulin, aspart 2.16.840.1.113883.6.73 2017-01 A10AB06 insulin glulisine Insulin, glulisin 2.16.840.1.113883.6.73 2017-01 A10AB30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A10AC Insulins and analogues for injection, Insuliner och analoger för injektion, intermediate-acting medellångverkande 2.16.840.1.113883.6.73 2017-01 A10AC01 insulin (human) Insulin (humant) 2.16.840.1.113883.6.73 2017-01 A10AC02 insulin (beef) Insulin (bovint) 2.16.840.1.113883.6.73 2017-01 A10AC03 insulin (pork) Insulin (svin) 2.16.840.1.113883.6.73 2017-01 A10AC04 insulin lispro Insulin, lispro 2.16.840.1.113883.6.73 2017-01 A10AC30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A10AD Insulins and analogues for injection, Insuliner och analoger för injektion, intermediate- or long-acting medellång- eller långverkande i combined with fast-acting kombination med snabbverkande 2.16.840.1.113883.6.73 2017-01 A10AD01 insulin (human) Insulin (humant) 2.16.840.1.113883.6.73 2017-01 A10AD02 insulin (beef) Insulin (bovint) 2.16.840.1.113883.6.73 2017-01 A10AD03 insulin (pork) Insulin (svin) 2.16.840.1.113883.6.73 2017-01 A10AD04 insulin lispro Insulin, lispro 2.16.840.1.113883.6.73 2017-01 A10AD05 insulin aspart Insulin, aspart 2.16.840.1.113883.6.73 2017-01 A10AD06 insulin degludec and insulin aspart Insulin, degludek och insulin, aspart 2.16.840.1.113883.6.73 2017-01 A10AD30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A10AE Insulins and analogues for injection, Insuliner och analoger för injektion, long-acting långverkande 2.16.840.1.113883.6.73 2017-01 A10AE01 insulin (human) Insulin (humant) 2.16.840.1.113883.6.73 2017-01 A10AE02 insulin (beef) Insulin (bovint) 2.16.840.1.113883.6.73 2017-01 A10AE03 insulin (pork) Insulin (svin) 2.16.840.1.113883.6.73 2017-01 A10AE04 insulin glargine Insulin, glargin 2.16.840.1.113883.6.73 2017-01 A10AE05 insulin detemir Insulin, detemir 2.16.840.1.113883.6.73 2017-01 A10AE06 insulin degludec Insulin, degludek 2.16.840.1.113883.6.73 2017-01 A10AE30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A10AE56 insulin degludec and liraglutide Insulin, degludek och liraglutid 2.16.840.1.113883.6.73 2017-01 A10AF Insulins and analogues for Insuliner och analoger för inhalation inhalation 2.16.840.1.113883.6.73 2017-01 A10AF01 insulin (human) Insulin (humant) 2.16.840.1.113883.6.73 2017-01 A10B LOWERING Blodglukossänkande medel, exkl. DRUGS, EXCL. INSULINS insuliner 2.16.840.1.113883.6.73 2017-01 A10BA Biguanidderivat 2.16.840.1.113883.6.73 2017-01 A10BA01 phenformin Fenformin 2.16.840.1.113883.6.73 2017-01 A10BA02 Metformin 2.16.840.1.113883.6.73 2017-01 A10BA03 buformin Buformin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 22 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A10BB Sulfonylureas Sulfonylureaföreningar 2.16.840.1.113883.6.73 2017-01 A10BB01 Glibenklamid 2.16.840.1.113883.6.73 2017-01 A10BB02 Klorpropamid 2.16.840.1.113883.6.73 2017-01 A10BB03 Tolbutamid 2.16.840.1.113883.6.73 2017-01 A10BB04 Glibornurid 2.16.840.1.113883.6.73 2017-01 A10BB05 Tolazamid 2.16.840.1.113883.6.73 2017-01 A10BB06 Karbutamid 2.16.840.1.113883.6.73 2017-01 A10BB07 Glipizid 2.16.840.1.113883.6.73 2017-01 A10BB08 Glikidon 2.16.840.1.113883.6.73 2017-01 A10BB09 Gliklazid 2.16.840.1.113883.6.73 2017-01 A10BB10 Metahexamid 2.16.840.1.113883.6.73 2017-01 A10BB11 Glisoxepid 2.16.840.1.113883.6.73 2017-01 A10BB12 Glimepirid 2.16.840.1.113883.6.73 2017-01 A10BB31 Acetohexamid 2.16.840.1.113883.6.73 2017-01 A10BC Sulfonamides (heterocyclic) Bensensulfonamidderivat 2.16.840.1.113883.6.73 2017-01 A10BC01 glymidine Glymidin 2.16.840.1.113883.6.73 2017-01 A10BD Combinations of oral blood glucose Perorala blodglukossänkande lowering drugs medel, kombinationer 2.16.840.1.113883.6.73 2017-01 A10BD01 phenformin and sulfonylureas Fenformin och sulfonylureaföreningar 2.16.840.1.113883.6.73 2017-01 A10BD02 metformin and sulfonylureas Metformin och sulfonylureaföreningar 2.16.840.1.113883.6.73 2017-01 A10BD03 metformin and rosiglitazone Metformin och rosiglitazon 2.16.840.1.113883.6.73 2017-01 A10BD04 glimepiride and rosiglitazone Glimepirid och rosiglitazon 2.16.840.1.113883.6.73 2017-01 A10BD05 metformin and pioglitazone Metformin och pioglitazon 2.16.840.1.113883.6.73 2017-01 A10BD06 glimepiride and pioglitazone Glimepirid och pioglitazon 2.16.840.1.113883.6.73 2017-01 A10BD07 metformin and sitagliptin Metformin och sitagliptin 2.16.840.1.113883.6.73 2017-01 A10BD08 metformin and vildagliptin Metformin och vildagliptin 2.16.840.1.113883.6.73 2017-01 A10BD09 pioglitazone and alogliptin Pioglitazon och alogliptin 2.16.840.1.113883.6.73 2017-01 A10BD10 metformin and saxagliptin Metformin och saxagliptin 2.16.840.1.113883.6.73 2017-01 A10BD11 metformin and linagliptin Metformin och linagliptin 2.16.840.1.113883.6.73 2017-01 A10BD12 pioglitazone and sitagliptin Pioglitazon och sitagliptin 2.16.840.1.113883.6.73 2017-01 A10BD13 metformin and alogliptin Metformin och alogliptin 2.16.840.1.113883.6.73 2017-01 A10BD14 metformin and Metformin och repaglinid 2.16.840.1.113883.6.73 2017-01 A10BD15 metformin and dapagliflozin Metformin och dapagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD16 metformin and canagliflozin Metformin och kanagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD17 metformin and acarbose Metformin och akarbos 2.16.840.1.113883.6.73 2017-01 A10BD18 metformin and gemigliptin Metformin och gemigliptin 2.16.840.1.113883.6.73 2017-01 A10BD19 linagliptin and empagliflozin Linagliptin och empagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD20 metformin and empagliflozin Metformin och empagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD21 saxagliptin and dapagliflozin Saxagliptin och dapagliflozin 2.16.840.1.113883.6.73 2017-01 A10BF Alpha glucosidase inhibitors Alfa-glukosidashämmare 2.16.840.1.113883.6.73 2017-01 A10BF01 acarbose Akarbos 2.16.840.1.113883.6.73 2017-01 A10BF02 miglitol Miglitol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 23 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A10BF03 voglibose Voglibos 2.16.840.1.113883.6.73 2017-01 A10BG Thiazolidinediones Tiazolidindioner 2.16.840.1.113883.6.73 2017-01 A10BG01 troglitazone Troglitazon 2.16.840.1.113883.6.73 2017-01 A10BG02 rosiglitazone Rosiglitazon 2.16.840.1.113883.6.73 2017-01 A10BG03 pioglitazone Pioglitazon 2.16.840.1.113883.6.73 2017-01 A10BH Dipeptidyl peptidase 4 (DPP-4) Dipeptidylpeptidas 4 (DPP-4) inhibitors hämmare 2.16.840.1.113883.6.73 2017-01 A10BH01 sitagliptin Sitagliptin 2.16.840.1.113883.6.73 2017-01 A10BH02 vildagliptin Vildagliptin 2.16.840.1.113883.6.73 2017-01 A10BH03 saxagliptin Saxagliptin 2.16.840.1.113883.6.73 2017-01 A10BH04 alogliptin Alogliptin 2.16.840.1.113883.6.73 2017-01 A10BH05 linagliptin Linagliptin 2.16.840.1.113883.6.73 2017-01 A10BH06 gemigliptin Gemigliptin 2.16.840.1.113883.6.73 2017-01 A10BH51 sitagliptin and Sitagliptin och simvastatin 2.16.840.1.113883.6.73 2017-01 A10BJ Glucagon-like -1 (GLP-1) Glukagonlikpeptid-1-receptor(Glp- analogues 1)analoger 2.16.840.1.113883.6.73 2017-01 A10BJ01 exenatide Exenatid 2.16.840.1.113883.6.73 2017-01 A10BJ02 liraglutide Liraglutid 2.16.840.1.113883.6.73 2017-01 A10BJ03 lixisenatide Lixisenatid 2.16.840.1.113883.6.73 2017-01 A10BJ04 albiglutide Albiglutid 2.16.840.1.113883.6.73 2017-01 A10BJ05 dulaglutide Dulaglutid 2.16.840.1.113883.6.73 2017-01 A10BK Sodium-glucose co-transporter 2 Natriumglukossamtransportör (SGLT2) inhibitors 2(Sglt2)hämmare 2.16.840.1.113883.6.73 2017-01 A10BK01 dapagliflozin Dapagliflozin 2.16.840.1.113883.6.73 2017-01 A10BK02 canagliflozin Kanagliflozin 2.16.840.1.113883.6.73 2017-01 A10BK03 empagliflozin Empagliflozin 2.16.840.1.113883.6.73 2017-01 A10BX Other blood glucose lowering drugs, Övriga blodglukossänkande medel, excl. insulins exkl insuliner 2.16.840.1.113883.6.73 2017-01 A10BX01 guar gum Guargummi 2.16.840.1.113883.6.73 2017-01 A10BX02 repaglinide Repaglinid 2.16.840.1.113883.6.73 2017-01 A10BX03 Nateglinid 2.16.840.1.113883.6.73 2017-01 A10BX05 pramlintide Pramlintid 2.16.840.1.113883.6.73 2017-01 A10BX06 Benfluorex 2.16.840.1.113883.6.73 2017-01 A10BX08 Mitiglinid 2.16.840.1.113883.6.73 2017-01 A10X OTHER DRUGS USED IN Övriga diabetesmedel DIABETES 2.16.840.1.113883.6.73 2017-01 A10XA Aldose reductase inhibitors Aldos reduktashämmare 2.16.840.1.113883.6.73 2017-01 A10XA01 tolrestat Tolrestat 2.16.840.1.113883.6.73 2017-01 A11 Vitaminer 2.16.840.1.113883.6.73 2017-01 A11A , COMBINATIONS Multivitaminer, kombinationer 2.16.840.1.113883.6.73 2017-01 A11AA Multivitamins with minerals Multivitaminer och mineralämnen 2.16.840.1.113883.6.73 2017-01 A11AA01 multivitamins and Multivitaminer och järn 2.16.840.1.113883.6.73 2017-01 A11AA02 multivitamins and calcium Multivitaminer och kalcium 2.16.840.1.113883.6.73 2017-01 A11AA03 multivitamins and other minerals, Multivitaminer och andra incl. combinations mineralämnen inkl. kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 24 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A11AA04 multivitamins and trace elements Multivitaminer och spårelement 2.16.840.1.113883.6.73 2017-01 A11AB Multivitamins, other combinations Multivitaminer, övriga kombinationer 2.16.840.1.113883.6.73 2017-01 A11B MULTIVITAMINS, PLAIN Multivitaminer 2.16.840.1.113883.6.73 2017-01 A11BA Multivitamins, plain Multivitaminer 2.16.840.1.113883.6.73 2017-01 A11C A AND D, INCL. och D, inkl. kombinationer COMBINATIONS OF THE TWO av de två 2.16.840.1.113883.6.73 2017-01 A11CA Vitamin A, plain (vitamin A) 2.16.840.1.113883.6.73 2017-01 A11CA01 retinol (vit A) Retinol (vitamin A) 2.16.840.1.113883.6.73 2017-01 A11CA02 betacarotene Betakaroten 2.16.840.1.113883.6.73 2017-01 A11CB Vitamin A and D in combination Vitamin A och D i kombination 2.16.840.1.113883.6.73 2017-01 A11CC and analogues Vitamin D och analoger 2.16.840.1.113883.6.73 2017-01 A11CC01 Ergokalciferol 2.16.840.1.113883.6.73 2017-01 A11CC02 Dihydrotakysterol 2.16.840.1.113883.6.73 2017-01 A11CC03 Alfakalcidol 2.16.840.1.113883.6.73 2017-01 A11CC04 Kalcitriol 2.16.840.1.113883.6.73 2017-01 A11CC05 colecalciferol Kolekalciferol 2.16.840.1.113883.6.73 2017-01 A11CC06 Kalcifediol 2.16.840.1.113883.6.73 2017-01 A11CC20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A11D VITAMIN B1, PLAIN AND IN Vitamin B1, inkl. kombinationer med COMBINATION WITH VITAMIN B6 vitamin B6 och B12 AND B12 2.16.840.1.113883.6.73 2017-01 A11DA Vitamin B1, plain Tiamin (vitamin B1) 2.16.840.1.113883.6.73 2017-01 A11DA01 (vit B1) Tiamin (vitamin B1) 2.16.840.1.113883.6.73 2017-01 A11DA02 Sulbutiamin 2.16.840.1.113883.6.73 2017-01 A11DA03 benfotiamine Benfotiamin 2.16.840.1.113883.6.73 2017-01 A11DB Vitamin B1 in combination with Vitamin B1 i kombination med vitamin B6 and/or vitamin B6 och/eller vitamin B12 2.16.840.1.113883.6.73 2017-01 A11E VITAMIN B-COMPLEX, INCL. Vitamin B-komplex, inkl. COMBINATIONS kombinationer 2.16.840.1.113883.6.73 2017-01 A11EA Vitamin B-complex, plain Vitamin B-komplex 2.16.840.1.113883.6.73 2017-01 A11EB Vitamin B-complex with Vitamin B-komplex med vitamin C 2.16.840.1.113883.6.73 2017-01 A11EC Vitamin B-complex with minerals Vitamin B-komplex med mineraler 2.16.840.1.113883.6.73 2017-01 A11ED Vitamin B-complex with anabolic Vitamin B-komplex med anabola steroids steroider 2.16.840.1.113883.6.73 2017-01 A11EX Vitamin B-complex, other Vitamin B-komplex, övriga combinations kombinationer 2.16.840.1.113883.6.73 2017-01 A11G ASCORBIC ACID (VITAMIN C), Askorbinsyra (vitamin C) inkl. INCL. COMBINATIONS kombinationer 2.16.840.1.113883.6.73 2017-01 A11GA Ascorbic acid (vitamin C), plain Askorbinsyra (vitamin C) 2.16.840.1.113883.6.73 2017-01 A11GA01 ascorbic acid (vit C) Askorbinsyra (vitamin C) 2.16.840.1.113883.6.73 2017-01 A11GB Ascorbic acid (vitamin C), Askorbinsyra (vitamin C), combinations kombinationer 2.16.840.1.113883.6.73 2017-01 A11GB01 ascorbic acid (vit C) and calcium Askorbinsyra (vitamin C) och kalcium 2.16.840.1.113883.6.73 2017-01 A11H OTHER PLAIN VITAMIN Övriga vitaminberedningar PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A11HA Other plain vitamin preparations Övriga vitaminberedningar © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 25 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A11HA01 Nikotinamid 2.16.840.1.113883.6.73 2017-01 A11HA02 (vit B6) Pyridoxin (vitamin B6) 2.16.840.1.113883.6.73 2017-01 A11HA03 (vit E) Tokoferol () 2.16.840.1.113883.6.73 2017-01 A11HA04 (vit B2) Riboflavin (vitamin B2) 2.16.840.1.113883.6.73 2017-01 A11HA05 Biotin 2.16.840.1.113883.6.73 2017-01 A11HA06 Pyridoxalfosfat 2.16.840.1.113883.6.73 2017-01 A11HA07 Inositol 2.16.840.1.113883.6.73 2017-01 A11HA08 Tokofersolan 2.16.840.1.113883.6.73 2017-01 A11HA30 dexpanthenol Dexapantenol 2.16.840.1.113883.6.73 2017-01 A11HA31 calcium pantothenate Kalciumpantotenat 2.16.840.1.113883.6.73 2017-01 A11HA32 Pantetin 2.16.840.1.113883.6.73 2017-01 A11J OTHER VITAMIN PRODUCTS, Övriga kombinationer med vitaminer COMBINATIONS 2.16.840.1.113883.6.73 2017-01 A11JA Combinations of vitamins Vitaminer, kombinationer 2.16.840.1.113883.6.73 2017-01 A11JB Vitamins with minerals Vitaminer med mineralämnen 2.16.840.1.113883.6.73 2017-01 A11JC Vitamins, other combinations Vitaminer, övriga kombinationer 2.16.840.1.113883.6.73 2017-01 A12 MINERAL SUPPLEMENTS Mineralämnen 2.16.840.1.113883.6.73 2017-01 A12A CALCIUM Kalcium 2.16.840.1.113883.6.73 2017-01 A12AA Calcium Kalcium 2.16.840.1.113883.6.73 2017-01 A12AA01 calcium phosphate Kalciumfosfat 2.16.840.1.113883.6.73 2017-01 A12AA02 calcium glubionate Kalciumglubionat 2.16.840.1.113883.6.73 2017-01 A12AA03 Kalciumglukonat 2.16.840.1.113883.6.73 2017-01 A12AA04 calcium carbonate Kalciumkarbonat 2.16.840.1.113883.6.73 2017-01 A12AA05 calcium lactate Kalciumlaktat 2.16.840.1.113883.6.73 2017-01 A12AA06 calcium lactate gluconate Kalciumlaktoglukonat 2.16.840.1.113883.6.73 2017-01 A12AA07 Kalciumklorid 2.16.840.1.113883.6.73 2017-01 A12AA08 calcium glycerylphosphate Kalciumglycerylfosfat 2.16.840.1.113883.6.73 2017-01 A12AA09 calcium citrate complex Kalciumcitratlysinkomplex 2.16.840.1.113883.6.73 2017-01 A12AA10 calcium glucoheptonate Kalciumglukoheptonat 2.16.840.1.113883.6.73 2017-01 A12AA11 calcium pangamate Kalcium pangamat 2.16.840.1.113883.6.73 2017-01 A12AA13 calcium citrate Kalciumcitrat 2.16.840.1.113883.6.73 2017-01 A12AA20 calcium (different salts in Kalcium (olika salter i kombination) combination) 2.16.840.1.113883.6.73 2017-01 A12AA30 calcium laevulate Kalciumlevulinat 2.16.840.1.113883.6.73 2017-01 A12AX Calcium, combinations with vitamin Kalcium, kombinationer med vitamin D and/or other drugs D och/eller övriga läkemedel 2.16.840.1.113883.6.73 2017-01 A12B Kalium 2.16.840.1.113883.6.73 2017-01 A12BA Potassium Kalium 2.16.840.1.113883.6.73 2017-01 A12BA01 Kaliumklorid 2.16.840.1.113883.6.73 2017-01 A12BA02 potassium citrate Kaliumcitrat 2.16.840.1.113883.6.73 2017-01 A12BA03 potassium hydrogentartrate Kaliumvätetartrat 2.16.840.1.113883.6.73 2017-01 A12BA04 potassium hydrogencarbonate Kaliumvätekarbonat 2.16.840.1.113883.6.73 2017-01 A12BA05 potassium gluconate Kaliumglukonat 2.16.840.1.113883.6.73 2017-01 A12BA30 combinations Kalium (olika salter i kombination)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 26 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A12BA51 potassium chloride, combinations Kaliumklorid, kombinationer 2.16.840.1.113883.6.73 2017-01 A12C OTHER MINERAL SUPPLEMENTS Övriga mineralämnen 2.16.840.1.113883.6.73 2017-01 A12CA Sodium Natrium 2.16.840.1.113883.6.73 2017-01 A12CA01 Natriumklorid 2.16.840.1.113883.6.73 2017-01 A12CA02 sodium sulfate Natriumsulfat 2.16.840.1.113883.6.73 2017-01 A12CB Zink 2.16.840.1.113883.6.73 2017-01 A12CB01 zinc sulfate Zinksulfat 2.16.840.1.113883.6.73 2017-01 A12CB02 Zinkglukonat 2.16.840.1.113883.6.73 2017-01 A12CB03 zinc protein complex Zinkproteinkomplex 2.16.840.1.113883.6.73 2017-01 A12CC Magnesium Magnesium 2.16.840.1.113883.6.73 2017-01 A12CC01 Magnesiumklorid 2.16.840.1.113883.6.73 2017-01 A12CC02 magnesium sulfate Magnesiumsulfat 2.16.840.1.113883.6.73 2017-01 A12CC03 magnesium gluconate Magnesiumglukonat 2.16.840.1.113883.6.73 2017-01 A12CC04 magnesium citrate Magnesiumcitrat 2.16.840.1.113883.6.73 2017-01 A12CC05 magnesium aspartate Magnesiumaspartat 2.16.840.1.113883.6.73 2017-01 A12CC06 magnesium lactate Magnesiumlaktat 2.16.840.1.113883.6.73 2017-01 A12CC07 magnesium levulinate Magnesiumlevulinat 2.16.840.1.113883.6.73 2017-01 A12CC08 magnesium pidolate Magnesiumpidolat 2.16.840.1.113883.6.73 2017-01 A12CC09 magnesium orotate Magnesiumorotat 2.16.840.1.113883.6.73 2017-01 A12CC10 magnesium oxide Magnesiumoxid 2.16.840.1.113883.6.73 2017-01 A12CC30 magnesium (different salts in Magnesium (olika salter i combination) kombination) 2.16.840.1.113883.6.73 2017-01 A12CD Fluoride Fluor 2.16.840.1.113883.6.73 2017-01 A12CD01 sodium fluoride Natriumfluorid 2.16.840.1.113883.6.73 2017-01 A12CD02 sodium monofluorophosphate Natriummonofluorofosfat 2.16.840.1.113883.6.73 2017-01 A12CD51 fluoride, combinations Fluor kombinationer 2.16.840.1.113883.6.73 2017-01 A12CE Selen 2.16.840.1.113883.6.73 2017-01 A12CE01 sodium selenate Natriumselenat 2.16.840.1.113883.6.73 2017-01 A12CE02 sodium selenite Natriumselenit 2.16.840.1.113883.6.73 2017-01 A12CX Other mineral products Övriga mineralämnen 2.16.840.1.113883.6.73 2017-01 A13 TONICS Tonika 2.16.840.1.113883.6.73 2017-01 A13A TONICS Tonika 2.16.840.1.113883.6.73 2017-01 A14 ANABOLIC AGENTS FOR Anabola steroider för systemiskt SYSTEMIC USE bruk 2.16.840.1.113883.6.73 2017-01 A14A ANABOLIC STEROIDS Anabola steroider 2.16.840.1.113883.6.73 2017-01 A14AA Androstan derivatives Androstanderivat 2.16.840.1.113883.6.73 2017-01 A14AA01 Androstanolon 2.16.840.1.113883.6.73 2017-01 A14AA02 Stanozolol 2.16.840.1.113883.6.73 2017-01 A14AA03 Metandienon 2.16.840.1.113883.6.73 2017-01 A14AA04 metenolone Metenolon 2.16.840.1.113883.6.73 2017-01 A14AA05 Oximetolon 2.16.840.1.113883.6.73 2017-01 A14AA06 Kinbolon 2.16.840.1.113883.6.73 2017-01 A14AA07 Prasteron 2.16.840.1.113883.6.73 2017-01 A14AA08 Oxandrolon © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 27 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A14AA09 Noretandrolon 2.16.840.1.113883.6.73 2017-01 A14AB Estren derivatives Östrenderivat 2.16.840.1.113883.6.73 2017-01 A14AB01 Nandrolon 2.16.840.1.113883.6.73 2017-01 A14AB02 Etylöstrenol 2.16.840.1.113883.6.73 2017-01 A14AB03 oxabolone cipionate Oxaboloncipionat 2.16.840.1.113883.6.73 2017-01 A14B OTHER ANABOLIC AGENTS Övriga anabola steroider 2.16.840.1.113883.6.73 2017-01 A15 APPETITE Aptitstimulerande medel 2.16.840.1.113883.6.73 2017-01 A16 OTHER ALIMENTARY TRACT AND Övriga medel för matsmältning och METABOLISM PRODUCTS ämnesomsättning 2.16.840.1.113883.6.73 2017-01 A16A OTHER ALIMENTARY TRACT AND Övriga medel för matsmältning och METABOLISM PRODUCTS ämnesomsättning 2.16.840.1.113883.6.73 2017-01 A16AA Amino acids and derivatives Aminosyror och derivat 2.16.840.1.113883.6.73 2017-01 A16AA01 levocarnitine Levokarnitin 2.16.840.1.113883.6.73 2017-01 A16AA02 ademetionine Ademetionin 2.16.840.1.113883.6.73 2017-01 A16AA03 Glutamin 2.16.840.1.113883.6.73 2017-01 A16AA04 mercaptamine Merkaptamin 2.16.840.1.113883.6.73 2017-01 A16AA05 Kargluminsyra 2.16.840.1.113883.6.73 2017-01 A16AA06 betaine Betain 2.16.840.1.113883.6.73 2017-01 A16AA07 Metreleptin 2.16.840.1.113883.6.73 2017-01 A16AB Enzymes Enzymer 2.16.840.1.113883.6.73 2017-01 A16AB01 Algluceras 2.16.840.1.113883.6.73 2017-01 A16AB02 Imiglukeras 2.16.840.1.113883.6.73 2017-01 A16AB03 agalsidase alfa Agalsidas alfa 2.16.840.1.113883.6.73 2017-01 A16AB04 agalsidase beta Agalsidas beta 2.16.840.1.113883.6.73 2017-01 A16AB05 laronidase Laronidas 2.16.840.1.113883.6.73 2017-01 A16AB06 Sakrosidas 2.16.840.1.113883.6.73 2017-01 A16AB07 Alglukosidas alfa 2.16.840.1.113883.6.73 2017-01 A16AB08 galsulfase Galsulfas 2.16.840.1.113883.6.73 2017-01 A16AB09 Idursulfas 2.16.840.1.113883.6.73 2017-01 A16AB10 Velagluceras alfa 2.16.840.1.113883.6.73 2017-01 A16AB11 Taligluceras alfa 2.16.840.1.113883.6.73 2017-01 A16AB12 elosulfase alfa Elosulfas alfa 2.16.840.1.113883.6.73 2017-01 A16AB13 Asfotas alfa 2.16.840.1.113883.6.73 2017-01 A16AB14 Sebelipas alfa 2.16.840.1.113883.6.73 2017-01 A16AX Various alimentary tract and Övriga medel för matsmältning och metabolism products ämnesomsättning 2.16.840.1.113883.6.73 2017-01 A16AX01 thioctic acid Tioktinsyra 2.16.840.1.113883.6.73 2017-01 A16AX02 trithione Anetoltrition 2.16.840.1.113883.6.73 2017-01 A16AX03 Natriumfenylbutyrat 2.16.840.1.113883.6.73 2017-01 A16AX04 Nitisinon 2.16.840.1.113883.6.73 2017-01 A16AX05 zinc Zinkacetat 2.16.840.1.113883.6.73 2017-01 A16AX06 Miglustat 2.16.840.1.113883.6.73 2017-01 A16AX07 sapropterin Sapropterin 2.16.840.1.113883.6.73 2017-01 A16AX08 Teduglutid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 28 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A16AX09 Glycerolfenylbutyrat 2.16.840.1.113883.6.73 2017-01 A16AX10 Eliglustat 2.16.840.1.113883.6.73 2017-01 A16AX11 Natriumbensoat 2.16.840.1.113883.6.73 2017-01 A16AX12 trientine Trientin 2.16.840.1.113883.6.73 2017-01 A16AX13 triacetate Uridintriacetat 2.16.840.1.113883.6.73 2017-01 B BLOOD AND BLOOD FORMING Blod och blodbildande organ ORGANS 2.16.840.1.113883.6.73 2017-01 B01 AGENTS Antikoagulantia 2.16.840.1.113883.6.73 2017-01 B01A ANTITHROMBOTIC AGENTS Antikoagulantia 2.16.840.1.113883.6.73 2017-01 B01AA antagonists Vitamin K-antagonister 2.16.840.1.113883.6.73 2017-01 B01AA01 Dikumarol 2.16.840.1.113883.6.73 2017-01 B01AA02 Fenindion 2.16.840.1.113883.6.73 2017-01 B01AA03 Warfarin 2.16.840.1.113883.6.73 2017-01 B01AA04 Fenprokumon 2.16.840.1.113883.6.73 2017-01 B01AA07 Acenokumarol 2.16.840.1.113883.6.73 2017-01 B01AA08 Etylbiskumacetat 2.16.840.1.113883.6.73 2017-01 B01AA09 Klorindion 2.16.840.1.113883.6.73 2017-01 B01AA10 Difenadion 2.16.840.1.113883.6.73 2017-01 B01AA11 Tioklomarol 2.16.840.1.113883.6.73 2017-01 B01AA12 fluindione Fluindion 2.16.840.1.113883.6.73 2017-01 B01AB group Heparingruppen 2.16.840.1.113883.6.73 2017-01 B01AB01 heparin Heparin 2.16.840.1.113883.6.73 2017-01 B01AB02 III Antitrombin III 2.16.840.1.113883.6.73 2017-01 B01AB04 dalteparin Dalteparin 2.16.840.1.113883.6.73 2017-01 B01AB05 enoxaparin Enoxaparin 2.16.840.1.113883.6.73 2017-01 B01AB06 nadroparin Nadroparin 2.16.840.1.113883.6.73 2017-01 B01AB07 parnaparin Parnaparin 2.16.840.1.113883.6.73 2017-01 B01AB08 reviparin Reviparin 2.16.840.1.113883.6.73 2017-01 B01AB09 Danaparoid 2.16.840.1.113883.6.73 2017-01 B01AB10 tinzaparin Tinzaparin 2.16.840.1.113883.6.73 2017-01 B01AB11 Sulodexid 2.16.840.1.113883.6.73 2017-01 B01AB12 bemiparin Bemiparin 2.16.840.1.113883.6.73 2017-01 B01AB51 heparin, combinations Heparin, kombinationer 2.16.840.1.113883.6.73 2017-01 B01AC aggregation inhibitors excl. Trombocytaggregationshämmande heparin medel, exkl. heparin 2.16.840.1.113883.6.73 2017-01 B01AC01 Ditazol 2.16.840.1.113883.6.73 2017-01 B01AC02 Klorikromen 2.16.840.1.113883.6.73 2017-01 B01AC03 Picotamid 2.16.840.1.113883.6.73 2017-01 B01AC04 Klopidogrel 2.16.840.1.113883.6.73 2017-01 B01AC05 Tiklopidin 2.16.840.1.113883.6.73 2017-01 B01AC06 acetylsalicylic acid Acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 B01AC07 Dipyridamol 2.16.840.1.113883.6.73 2017-01 B01AC08 Karbasalatkalcium 2.16.840.1.113883.6.73 2017-01 B01AC09 epoprostenol Epoprostenol © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 29 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B01AC10 Indobufen 2.16.840.1.113883.6.73 2017-01 B01AC11 Iloprost 2.16.840.1.113883.6.73 2017-01 B01AC13 Abciximab 2.16.840.1.113883.6.73 2017-01 B01AC15 Aloxiprin 2.16.840.1.113883.6.73 2017-01 B01AC16 Eptifibatid 2.16.840.1.113883.6.73 2017-01 B01AC17 Tirofiban 2.16.840.1.113883.6.73 2017-01 B01AC18 Triflusal 2.16.840.1.113883.6.73 2017-01 B01AC19 Beraprost 2.16.840.1.113883.6.73 2017-01 B01AC21 Treprostinil 2.16.840.1.113883.6.73 2017-01 B01AC22 Prasugrel 2.16.840.1.113883.6.73 2017-01 B01AC23 Cilostazol 2.16.840.1.113883.6.73 2017-01 B01AC24 Tikagrelor 2.16.840.1.113883.6.73 2017-01 B01AC25 Kangrelor 2.16.840.1.113883.6.73 2017-01 B01AC26 Vorapaxar 2.16.840.1.113883.6.73 2017-01 B01AC27 Selexipag 2.16.840.1.113883.6.73 2017-01 B01AC30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B01AC56 acetylsalicylic acid, combinations Acetylsalicylsyra, kombinationer with proton pump inhibitors med protonpumpshämmare 2.16.840.1.113883.6.73 2017-01 B01AD Enzymes Enzymer 2.16.840.1.113883.6.73 2017-01 B01AD01 Streptokinas 2.16.840.1.113883.6.73 2017-01 B01AD02 Alteplas 2.16.840.1.113883.6.73 2017-01 B01AD03 Anistreplas 2.16.840.1.113883.6.73 2017-01 B01AD04 Urokinas 2.16.840.1.113883.6.73 2017-01 B01AD05 Fibrinolysin 2.16.840.1.113883.6.73 2017-01 B01AD06 Brinas 2.16.840.1.113883.6.73 2017-01 B01AD07 Reteplas 2.16.840.1.113883.6.73 2017-01 B01AD08 Saruplas 2.16.840.1.113883.6.73 2017-01 B01AD09 Ankrod 2.16.840.1.113883.6.73 2017-01 B01AD10 (activated) Drotrekogin alfa (aktiverat) 2.16.840.1.113883.6.73 2017-01 B01AD11 Tenekteplas 2.16.840.1.113883.6.73 2017-01 B01AD12 Protein C 2.16.840.1.113883.6.73 2017-01 B01AE Direct inhibitors Direkt trombinhämmande medel 2.16.840.1.113883.6.73 2017-01 B01AE01 desirudin Desirudin 2.16.840.1.113883.6.73 2017-01 B01AE02 Lepirudin 2.16.840.1.113883.6.73 2017-01 B01AE03 Argatroban 2.16.840.1.113883.6.73 2017-01 B01AE04 melagatran Melagatran 2.16.840.1.113883.6.73 2017-01 B01AE05 Ximelagatran 2.16.840.1.113883.6.73 2017-01 B01AE06 Bivalirudin 2.16.840.1.113883.6.73 2017-01 B01AE07 etexilate Dabigatranetexilat 2.16.840.1.113883.6.73 2017-01 B01AF Direct factor Xa inhibitors Direktverkande faktor Xa-hämmare 2.16.840.1.113883.6.73 2017-01 B01AF01 Rivaroxaban 2.16.840.1.113883.6.73 2017-01 B01AF02 Apixaban 2.16.840.1.113883.6.73 2017-01 B01AF03 Edoxaban

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 30 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B01AX Other antithrombotic agents Övriga antitrombotiska medel 2.16.840.1.113883.6.73 2017-01 B01AX01 Defibrotid 2.16.840.1.113883.6.73 2017-01 B01AX04 Dermatansulfat 2.16.840.1.113883.6.73 2017-01 B01AX05 Fondaparinux 2.16.840.1.113883.6.73 2017-01 B02 Hemostatika 2.16.840.1.113883.6.73 2017-01 B02A Fibrinolyshämmande medel 2.16.840.1.113883.6.73 2017-01 B02AA Amino acids Aminosyror 2.16.840.1.113883.6.73 2017-01 B02AA01 Aminokapronsyra 2.16.840.1.113883.6.73 2017-01 B02AA02 Tranexamsyra 2.16.840.1.113883.6.73 2017-01 B02AA03 Aminometylbensoesyra 2.16.840.1.113883.6.73 2017-01 B02AB Proteinase inhibitors Proteinashämmande medel 2.16.840.1.113883.6.73 2017-01 B02AB01 Aprotinin 2.16.840.1.113883.6.73 2017-01 B02AB02 alfa1 antitrypsin Alfa-1-antitrypsin 2.16.840.1.113883.6.73 2017-01 B02AB04 camostat Kamostat 2.16.840.1.113883.6.73 2017-01 B02B VITAMIN K AND OTHER Vitamin K och andra HEMOSTATICS koagulationsfaktorer 2.16.840.1.113883.6.73 2017-01 B02BA Vitamin K Vitamin K 2.16.840.1.113883.6.73 2017-01 B02BA01 Fytomenadion 2.16.840.1.113883.6.73 2017-01 B02BA02 Menadion 2.16.840.1.113883.6.73 2017-01 B02BB Fibrinogen 2.16.840.1.113883.6.73 2017-01 B02BB01 fibrinogen, human Fibrinogen, humant 2.16.840.1.113883.6.73 2017-01 B02BC Local hemostatics Lokala hemostatika 2.16.840.1.113883.6.73 2017-01 B02BC01 absorbable gelatin sponge Gelatin, härdat 2.16.840.1.113883.6.73 2017-01 B02BC02 oxidized Cellulosa, oxiderat 2.16.840.1.113883.6.73 2017-01 B02BC03 tetragalacturonic acid Tetragalakturonsyra hydroxymethylester hydroximetylester 2.16.840.1.113883.6.73 2017-01 B02BC05 adrenalone Adrenalon 2.16.840.1.113883.6.73 2017-01 B02BC06 thrombin Trombin 2.16.840.1.113883.6.73 2017-01 B02BC07 collagen Kollagen 2.16.840.1.113883.6.73 2017-01 B02BC08 Kalciumalginat 2.16.840.1.113883.6.73 2017-01 B02BC09 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 B02BC30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B02BD Blood factors Koagulationsfaktorer 2.16.840.1.113883.6.73 2017-01 B02BD01 coagulation factor IX, II, VII and X in Koagulationsfaktor IX, II, VII och X i combination kombination 2.16.840.1.113883.6.73 2017-01 B02BD02 coagulation factor VIII Koagulationsfaktor VIII 2.16.840.1.113883.6.73 2017-01 B02BD03 factor VIII inhibitor bypassing activity Aktiverat protrombinkomplex mot faktor VIII-antikroppar 2.16.840.1.113883.6.73 2017-01 B02BD04 coagulation factor IX Koagulationsfaktor IX 2.16.840.1.113883.6.73 2017-01 B02BD05 coagulation factor VII Koagulationsfaktor VII 2.16.840.1.113883.6.73 2017-01 B02BD06 and von Willebrandfaktor och coagulation factor VIII in koagulationsfaktor VIII i kombination combination 2.16.840.1.113883.6.73 2017-01 B02BD07 coagulation factor XIII Koagulationsfaktor XIII 2.16.840.1.113883.6.73 2017-01 B02BD08 eptacog alfa (activated) Koagulationsfaktor VIIa

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 31 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B02BD10 von Willebrand factor von Willebrandfaktor 2.16.840.1.113883.6.73 2017-01 B02BD11 Katridekacog 2.16.840.1.113883.6.73 2017-01 B02BD13 coagulation Koagulationsfaktor X 2.16.840.1.113883.6.73 2017-01 B02BD14 Susoktokog alfa 2.16.840.1.113883.6.73 2017-01 B02BD30 thrombin Trombin 2.16.840.1.113883.6.73 2017-01 B02BX Other systemic hemostatics Övriga hemostatika för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 B02BX01 Etamsylat 2.16.840.1.113883.6.73 2017-01 B02BX02 Karbazokrom 2.16.840.1.113883.6.73 2017-01 B02BX03 Batroxobin 2.16.840.1.113883.6.73 2017-01 B02BX04 Romiplostim 2.16.840.1.113883.6.73 2017-01 B02BX05 Eltrombopag 2.16.840.1.113883.6.73 2017-01 B03 ANTIANEMIC PREPARATIONS Medel vid anemier 2.16.840.1.113883.6.73 2017-01 B03A IRON PREPARATIONS Medel vid järnbristanemier 2.16.840.1.113883.6.73 2017-01 B03AA Iron bivalent, oral preparations Tvåvärt järn, perorala preparat 2.16.840.1.113883.6.73 2017-01 B03AA01 ferrous sulfate Järn(II)glycinsulfat 2.16.840.1.113883.6.73 2017-01 B03AA02 ferrous fumarate Järn(II)fumarat 2.16.840.1.113883.6.73 2017-01 B03AA03 ferrous gluconate Järn(II)glukonat 2.16.840.1.113883.6.73 2017-01 B03AA04 ferrous carbonate Järn(II)karbonat 2.16.840.1.113883.6.73 2017-01 B03AA05 ferrous chloride Ferroklorid 2.16.840.1.113883.6.73 2017-01 B03AA06 ferrous succinate Ferrosuccinat 2.16.840.1.113883.6.73 2017-01 B03AA07 ferrous sulfate Ferrosulfat 2.16.840.1.113883.6.73 2017-01 B03AA08 Järn(II)tartrat 2.16.840.1.113883.6.73 2017-01 B03AA09 ferrous aspartate Järn(II)aspartat 2.16.840.1.113883.6.73 2017-01 B03AA10 ferrous ascorbate Järn(II)askorbat 2.16.840.1.113883.6.73 2017-01 B03AA11 ferrous Järn(II)jodid 2.16.840.1.113883.6.73 2017-01 B03AB Iron trivalent, oral preparations Trevärt järn, perorala preparat 2.16.840.1.113883.6.73 2017-01 B03AB01 ferric sodium citrate Järn(III)natriumcitrat 2.16.840.1.113883.6.73 2017-01 B03AB02 saccharated iron oxide Järnsackaros 2.16.840.1.113883.6.73 2017-01 B03AB03 sodium feredetate Natriumferedetat 2.16.840.1.113883.6.73 2017-01 B03AB04 ferric hydroxide Järn(III)hydroxid 2.16.840.1.113883.6.73 2017-01 B03AB05 ferric oxide polymaltose complexes Järnoxid polymaltoskomplexer 2.16.840.1.113883.6.73 2017-01 B03AB07 -iron complex Kondroitinsulfat-järnkomplex 2.16.840.1.113883.6.73 2017-01 B03AB08 ferric acetyl transferrin Järn(III)acetyltransferrin 2.16.840.1.113883.6.73 2017-01 B03AB09 ferric proteinsuccinylate Järn(III)proteinsuccinylat 2.16.840.1.113883.6.73 2017-01 B03AB10 Järn(III)maltol 2.16.840.1.113883.6.73 2017-01 B03AC Iron, parenteral preparations Järn, parenterala preparat 2.16.840.1.113883.6.73 2017-01 B03AD Iron in combination with folic acid Järn i kombination med folsyra 2.16.840.1.113883.6.73 2017-01 B03AD01 ferrous complex Järn(II)aminosyrakomplex 2.16.840.1.113883.6.73 2017-01 B03AD02 ferrous fumarate Järn(II)fumarat 2.16.840.1.113883.6.73 2017-01 B03AD03 ferrous sulfate Järn(II)sulfat 2.16.840.1.113883.6.73 2017-01 B03AD04 ferric oxide polymaltose complexes Järnoxid polymaltoskomplexer 2.16.840.1.113883.6.73 2017-01 B03AE Iron in other combinations Järn, övriga kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 32 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B03AE01 iron, vitamin B12 and folic acid Järn, vitamin B12 och folsyra 2.16.840.1.113883.6.73 2017-01 B03AE02 iron, multivitamins and folic acid Järn, multivitaminer och folsyra 2.16.840.1.113883.6.73 2017-01 B03AE03 iron and multivitamins Järn och multivitaminer 2.16.840.1.113883.6.73 2017-01 B03AE04 iron, multivitamins and minerals Järn, multivitaminer och mineraler 2.16.840.1.113883.6.73 2017-01 B03AE10 various combinations Övriga kombinationer 2.16.840.1.113883.6.73 2017-01 B03B VITAMIN B12 AND FOLIC ACID Vitamin B12 och folsyra 2.16.840.1.113883.6.73 2017-01 B03BA Vitamin B12 ( and Vitamin B12 (cyanokobalamin och analogues) analoger) 2.16.840.1.113883.6.73 2017-01 B03BA01 cyanocobalamin Cyanokobalamin 2.16.840.1.113883.6.73 2017-01 B03BA02 cyanocobalamin tannin complex Cyanokobalamin-tanninkomplex 2.16.840.1.113883.6.73 2017-01 B03BA03 Hydroxokobalamin 2.16.840.1.113883.6.73 2017-01 B03BA04 cobamamide Kobamamid 2.16.840.1.113883.6.73 2017-01 B03BA05 mecobalamin Mekobalamin 2.16.840.1.113883.6.73 2017-01 B03BA51 cyanocobalamin, combinations Cyanokobalamin, kombinationer 2.16.840.1.113883.6.73 2017-01 B03BA53 hydroxocobalamin, combinations Hydroxokobalamin, kombinationer 2.16.840.1.113883.6.73 2017-01 B03BB Folic acid and derivatives Folsyra och derivat 2.16.840.1.113883.6.73 2017-01 B03BB01 folic acid Folsyra 2.16.840.1.113883.6.73 2017-01 B03BB51 folic acid, combinations Folsyra, kombinationer 2.16.840.1.113883.6.73 2017-01 B03X OTHER ANTIANEMIC Övriga medel vid anemier PREPARATIONS 2.16.840.1.113883.6.73 2017-01 B03XA Other antianemic preparations Övriga medel vid anemier 2.16.840.1.113883.6.73 2017-01 B03XA01 Erytropoietin 2.16.840.1.113883.6.73 2017-01 B03XA02 Darbepoetin alfa 2.16.840.1.113883.6.73 2017-01 B03XA03 methoxy polyethylene glycol-epoetin Metoxi-polyetylenglykol- beta 2.16.840.1.113883.6.73 2017-01 B03XA04 Peginesatid 2.16.840.1.113883.6.73 2017-01 B05 BLOOD SUBSTITUTES AND Blodersättning och infusionsvätskor PERFUSION 2.16.840.1.113883.6.73 2017-01 B05A BLOOD AND RELATED Blod och relaterade produkter PRODUCTS 2.16.840.1.113883.6.73 2017-01 B05AA Blood substitutes and plasma Blodersättning och plasmaproteiner protein fractions 2.16.840.1.113883.6.73 2017-01 B05AA01 albumin Albumin 2.16.840.1.113883.6.73 2017-01 B05AA02 other plasma protein fractions Övriga plasmaproteiner 2.16.840.1.113883.6.73 2017-01 B05AA03 fluorocarbon blood substitutes Fluorkarbonblodersättning 2.16.840.1.113883.6.73 2017-01 B05AA05 Dextran 2.16.840.1.113883.6.73 2017-01 B05AA06 gelatin agents Gelatinpreparat 2.16.840.1.113883.6.73 2017-01 B05AA07 hydroxyethylstarch Polyhydroxietylstärkelse 2.16.840.1.113883.6.73 2017-01 B05AA08 hemoglobin crosfumaril Hemoglobin, krosfumaril 2.16.840.1.113883.6.73 2017-01 B05AA09 hemoglobin raffimer Hemoglobin raffimer 2.16.840.1.113883.6.73 2017-01 B05AA10 hemoglobin glutamer (bovine) Hemoglobin, glutamer (bovin) 2.16.840.1.113883.6.73 2017-01 B05AX Other blood products Övriga blodprodukter 2.16.840.1.113883.6.73 2017-01 B05AX01 erythrocytes Erytrocyter 2.16.840.1.113883.6.73 2017-01 B05AX02 thrombocytes Trombocyter 2.16.840.1.113883.6.73 2017-01 B05AX03 Blodplasma

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 33 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B05AX04 stem cells from umbilical Stamceller från navelsträngsblod 2.16.840.1.113883.6.73 2017-01 B05B I.V. SOLUTIONS Infusionsvätskor 2.16.840.1.113883.6.73 2017-01 B05BA Solutions for parenteral Lösningar för parenteral nutrition 2.16.840.1.113883.6.73 2017-01 B05BA01 amino acids Aminosyror 2.16.840.1.113883.6.73 2017-01 B05BA02 fat emulsions Fettemulsioner 2.16.840.1.113883.6.73 2017-01 B05BA03 carbohydrates Kolhydrater 2.16.840.1.113883.6.73 2017-01 B05BA04 protein hydrolysates Proteinhydrolysat 2.16.840.1.113883.6.73 2017-01 B05BA10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B05BB Solutions affecting the electrolyte Lösningar som påverkar balance elektrolytbalansen 2.16.840.1.113883.6.73 2017-01 B05BB01 electrolytes Elektrolyter 2.16.840.1.113883.6.73 2017-01 B05BB02 electrolytes with carbohydrates Elektrolyter och kolhydrater 2.16.840.1.113883.6.73 2017-01 B05BB03 trometamol Trometamol 2.16.840.1.113883.6.73 2017-01 B05BB04 electrolytes in combination with Elektrolyter i kombination med other drugs andra medel 2.16.840.1.113883.6.73 2017-01 B05BC Solutions producing osmotic Lösningar som framkallar osmotisk diuresis diures 2.16.840.1.113883.6.73 2017-01 B05BC01 mannitol Mannitol 2.16.840.1.113883.6.73 2017-01 B05BC02 carbamide Karbamid 2.16.840.1.113883.6.73 2017-01 B05C IRRIGATING SOLUTIONS Spolvätskor 2.16.840.1.113883.6.73 2017-01 B05CA Antiinfectives Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 B05CA01 cetylpyridinium Cetylpyridinium 2.16.840.1.113883.6.73 2017-01 B05CA02 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 B05CA03 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 B05CA04 Sulfametizol 2.16.840.1.113883.6.73 2017-01 B05CA05 taurolidine Taurolidin 2.16.840.1.113883.6.73 2017-01 B05CA06 mandelic acid Mandelinsyra 2.16.840.1.113883.6.73 2017-01 B05CA07 Noxytiolin 2.16.840.1.113883.6.73 2017-01 B05CA08 Etakridinlaktat 2.16.840.1.113883.6.73 2017-01 B05CA09 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 B05CA10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B05CB Salt solutions Saltlösningar 2.16.840.1.113883.6.73 2017-01 B05CB01 sodium chloride Natriumklorid 2.16.840.1.113883.6.73 2017-01 B05CB02 sodium citrate Natriumcitrat 2.16.840.1.113883.6.73 2017-01 B05CB03 magnesium citrate Magnesiumcitrat 2.16.840.1.113883.6.73 2017-01 B05CB04 sodium bicarbonate Natriumbikarbonat 2.16.840.1.113883.6.73 2017-01 B05CB10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B05CX Other irrigating solutions Övriga spolvätskor 2.16.840.1.113883.6.73 2017-01 B05CX01 glucose Glukos 2.16.840.1.113883.6.73 2017-01 B05CX02 sorbitol Sorbitol 2.16.840.1.113883.6.73 2017-01 B05CX03 glycine Glycin 2.16.840.1.113883.6.73 2017-01 B05CX04 mannitol Mannitol 2.16.840.1.113883.6.73 2017-01 B05CX10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B05D PERITONEAL DIALYTICS Peritonealdialysvätskor

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 34 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B05DA Isotonic solutions Isotona lösningar 2.16.840.1.113883.6.73 2017-01 B05DB Hypertonic solutions Hypertona lösningar 2.16.840.1.113883.6.73 2017-01 B05X I.V. ADDITIVES Infusionskoncentrat 2.16.840.1.113883.6.73 2017-01 B05XA Electrolyte solutions Elektrolytlösningar 2.16.840.1.113883.6.73 2017-01 B05XA01 potassium chloride Kaliumklorid 2.16.840.1.113883.6.73 2017-01 B05XA02 sodium bicarbonate Natriumbikarbonat 2.16.840.1.113883.6.73 2017-01 B05XA03 sodium chloride Natriumklorid 2.16.840.1.113883.6.73 2017-01 B05XA04 Ammoniumklorid 2.16.840.1.113883.6.73 2017-01 B05XA05 magnesium sulfate Magnesiumsulfat 2.16.840.1.113883.6.73 2017-01 B05XA06 potassium phosphate, incl. Kaliumfosfat, inkl. kombinationer combinations with other potassium med andra kaliumsalt salts 2.16.840.1.113883.6.73 2017-01 B05XA07 calcium chloride Kalciumklorid 2.16.840.1.113883.6.73 2017-01 B05XA08 Natriumacetat 2.16.840.1.113883.6.73 2017-01 B05XA09 sodium phosphate Natriumfosfat 2.16.840.1.113883.6.73 2017-01 B05XA10 magnesium phosphate Magnesiumfosfat 2.16.840.1.113883.6.73 2017-01 B05XA11 magnesium chloride Magnesiumklorid 2.16.840.1.113883.6.73 2017-01 B05XA12 Zinkklorid 2.16.840.1.113883.6.73 2017-01 B05XA13 hydrochloric acid Saltsyra 2.16.840.1.113883.6.73 2017-01 B05XA14 sodium glycerophosphate Natriumglycerofosfat 2.16.840.1.113883.6.73 2017-01 B05XA15 potassium lactate Kaliumlaktat 2.16.840.1.113883.6.73 2017-01 B05XA16 cardioplegia solutions Kardioplegilösningar 2.16.840.1.113883.6.73 2017-01 B05XA17 Kaliumacetat 2.16.840.1.113883.6.73 2017-01 B05XA30 combinations of electrolytes Kombinationer av elektrolyter 2.16.840.1.113883.6.73 2017-01 B05XA31 electrolytes in combination with Elektrolyter i kombination med other drugs andra medel 2.16.840.1.113883.6.73 2017-01 B05XB Amino acids Aminosyror 2.16.840.1.113883.6.73 2017-01 B05XB01 arginine hydrochloride Argininhydroklorid 2.16.840.1.113883.6.73 2017-01 B05XB02 alanyl glutamine Alanylglutamin 2.16.840.1.113883.6.73 2017-01 B05XB03 lysine Lysin 2.16.840.1.113883.6.73 2017-01 B05XC Vitamins Vitaminer 2.16.840.1.113883.6.73 2017-01 B05XX Other i.v. solution additives Övriga infusionskoncentrat 2.16.840.1.113883.6.73 2017-01 B05XX02 trometamol Trometamol 2.16.840.1.113883.6.73 2017-01 B05Z HEMODIALYTICS AND Hemodialysvätskor och HEMOFILTRATES hemofiltrationsvätskor 2.16.840.1.113883.6.73 2017-01 B05ZA Hemodialytics, concentrates Hypertona elektrolytlösningar 2.16.840.1.113883.6.73 2017-01 B05ZB Hemofiltrates Hemofiltrationsvätskor 2.16.840.1.113883.6.73 2017-01 B06 OTHER HEMATOLOGICAL Övriga hematologiska medel AGENTS 2.16.840.1.113883.6.73 2017-01 B06A OTHER HEMATOLOGICAL Övriga hematologiska medel AGENTS 2.16.840.1.113883.6.73 2017-01 B06AA Enzymes Enzymer 2.16.840.1.113883.6.73 2017-01 B06AA02 fibrinolysin and desoxyribonuclease Fibrinolysin och deoxiribonukleas 2.16.840.1.113883.6.73 2017-01 B06AA03 hyaluronidase Hyaluronidas 2.16.840.1.113883.6.73 2017-01 B06AA04 chymotrypsin Kymotrypsin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 35 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B06AA07 trypsin Trypsin 2.16.840.1.113883.6.73 2017-01 B06AA10 desoxyribonuclease Deoxiribonukleas 2.16.840.1.113883.6.73 2017-01 B06AA55 streptokinase, combinations Streptokinas, kombinationer 2.16.840.1.113883.6.73 2017-01 B06AB Other hem products Övriga hematologiska medel 2.16.840.1.113883.6.73 2017-01 B06AB01 hematin Hematin 2.16.840.1.113883.6.73 2017-01 B06AC Drugs used in hereditary Medel använda vid ärftligt angioedema angioödem 2.16.840.1.113883.6.73 2017-01 B06AC01 c1-inhibitor, plasma derived c1-hämmare, plasmaderiverad 2.16.840.1.113883.6.73 2017-01 B06AC02 icatibant Ikatibant 2.16.840.1.113883.6.73 2017-01 B06AC03 ecallantide Ekallantid 2.16.840.1.113883.6.73 2017-01 B06AC04 conestat alfa Konestat alfa 2.16.840.1.113883.6.73 2017-01 C CARDIOVASCULAR SYSTEM Hjärta och kretslopp 2.16.840.1.113883.6.73 2017-01 C01 CARDIAC THERAPY Medel vid hjärtsjukdomar 2.16.840.1.113883.6.73 2017-01 C01A CARDIAC GLYCOSIDES Hjärtglykosider 2.16.840.1.113883.6.73 2017-01 C01AA Digitalis glycosides Digitalisglykosider 2.16.840.1.113883.6.73 2017-01 C01AA01 acetyldigitoxin Acetyldigitoxin 2.16.840.1.113883.6.73 2017-01 C01AA02 acetyldigoxin Acetyldigoxin 2.16.840.1.113883.6.73 2017-01 C01AA03 digitalis leaves Digitalisblad 2.16.840.1.113883.6.73 2017-01 C01AA04 Digitoxin 2.16.840.1.113883.6.73 2017-01 C01AA05 Digoxin 2.16.840.1.113883.6.73 2017-01 C01AA06 Lanatosid C 2.16.840.1.113883.6.73 2017-01 C01AA07 Deslanosid 2.16.840.1.113883.6.73 2017-01 C01AA08 Metyldigoxin 2.16.840.1.113883.6.73 2017-01 C01AA09 Gitoformat 2.16.840.1.113883.6.73 2017-01 C01AA52 acetyldigoxin, combinations Acetyldigoxin, kombinationer 2.16.840.1.113883.6.73 2017-01 C01AB Scilla glycosides Sjölöksglykosider 2.16.840.1.113883.6.73 2017-01 C01AB01 Proscillaridin 2.16.840.1.113883.6.73 2017-01 C01AB51 proscillaridin, combinations Proscillaridin, kombinationer 2.16.840.1.113883.6.73 2017-01 C01AC Strophanthus glycosides Strofantusglykosider 2.16.840.1.113883.6.73 2017-01 C01AC01 g-strophanthin G-Strofantin 2.16.840.1.113883.6.73 2017-01 C01AC03 Cymarin 2.16.840.1.113883.6.73 2017-01 C01AX Other cardiac glycosides Övriga hjärtglykosider 2.16.840.1.113883.6.73 2017-01 C01AX02 Peruvosid 2.16.840.1.113883.6.73 2017-01 C01B ANTIARRHYTHMICS, CLASS I Antiarytmika, klass I och III AND III 2.16.840.1.113883.6.73 2017-01 C01BA Antiarrhythmics, class Ia Antiarytmika klass IA 2.16.840.1.113883.6.73 2017-01 C01BA01 Kinidin 2.16.840.1.113883.6.73 2017-01 C01BA02 Prokainamid 2.16.840.1.113883.6.73 2017-01 C01BA03 Disopyramid 2.16.840.1.113883.6.73 2017-01 C01BA04 Spartein 2.16.840.1.113883.6.73 2017-01 C01BA05 Ajmalin 2.16.840.1.113883.6.73 2017-01 C01BA08 prajmaline Prajmalin 2.16.840.1.113883.6.73 2017-01 C01BA12 Lorajmin 2.16.840.1.113883.6.73 2017-01 C01BA13 hydroquinidine Hydrokinidin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 36 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01BA51 quinidine, combinations excl. Kinidin, kombinationer exkl psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 C01BA71 quinidine, combinations with Kinidin, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 C01BB Antiarrhythmics, class Ib Antiarytmika klass IB 2.16.840.1.113883.6.73 2017-01 C01BB01 Lidokain 2.16.840.1.113883.6.73 2017-01 C01BB02 Mexiletin 2.16.840.1.113883.6.73 2017-01 C01BB03 Tokainid 2.16.840.1.113883.6.73 2017-01 C01BB04 aprindine Aprindin 2.16.840.1.113883.6.73 2017-01 C01BC Antiarrhythmics, class Ic Antiarytmika klass IC 2.16.840.1.113883.6.73 2017-01 C01BC03 Propafenon 2.16.840.1.113883.6.73 2017-01 C01BC04 Flekainid 2.16.840.1.113883.6.73 2017-01 C01BC07 lorcainide Lorkainid 2.16.840.1.113883.6.73 2017-01 C01BC08 Enkainid 2.16.840.1.113883.6.73 2017-01 C01BC09 Etacizin 2.16.840.1.113883.6.73 2017-01 C01BD Antiarrhythmics, class III Antiarytmika klass III 2.16.840.1.113883.6.73 2017-01 C01BD01 Amiodaron 2.16.840.1.113883.6.73 2017-01 C01BD02 tosilate Bretyltosilat 2.16.840.1.113883.6.73 2017-01 C01BD03 Bunaftin 2.16.840.1.113883.6.73 2017-01 C01BD04 Dofetilid 2.16.840.1.113883.6.73 2017-01 C01BD05 Ibutilid 2.16.840.1.113883.6.73 2017-01 C01BD06 Tedisamil 2.16.840.1.113883.6.73 2017-01 C01BD07 Dronedaron 2.16.840.1.113883.6.73 2017-01 C01BG Other antiarrhythmics, class I and III Övriga antiarytmika, klass I och III 2.16.840.1.113883.6.73 2017-01 C01BG01 Moracizin 2.16.840.1.113883.6.73 2017-01 C01BG07 cibenzoline Cibenzolin 2.16.840.1.113883.6.73 2017-01 C01BG11 Vernakalant 2.16.840.1.113883.6.73 2017-01 C01C CARDIAC STIMULANTS EXCL. Hjärtstimulerande medel exkl. CARDIAC GLYCOSIDES hjärtglykosider 2.16.840.1.113883.6.73 2017-01 C01CA Adrenergic and Adrenerga och dopaminerga medel agents 2.16.840.1.113883.6.73 2017-01 C01CA01 Etilefrin 2.16.840.1.113883.6.73 2017-01 C01CA02 Isoprenalin 2.16.840.1.113883.6.73 2017-01 C01CA03 Noradrenalin 2.16.840.1.113883.6.73 2017-01 C01CA04 Dopamin 2.16.840.1.113883.6.73 2017-01 C01CA05 Norfenefrin 2.16.840.1.113883.6.73 2017-01 C01CA06 Fenylefrin 2.16.840.1.113883.6.73 2017-01 C01CA07 Dobutamin 2.16.840.1.113883.6.73 2017-01 C01CA08 oxedrine Oxedrin 2.16.840.1.113883.6.73 2017-01 C01CA09 Metaraminol 2.16.840.1.113883.6.73 2017-01 C01CA10 Metoxamin 2.16.840.1.113883.6.73 2017-01 C01CA11 Mefentermin 2.16.840.1.113883.6.73 2017-01 C01CA12 Dimetofrin 2.16.840.1.113883.6.73 2017-01 C01CA13 Prenalterol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 37 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01CA14 Dopexamin 2.16.840.1.113883.6.73 2017-01 C01CA15 Gepefrin 2.16.840.1.113883.6.73 2017-01 C01CA16 Ibopamin 2.16.840.1.113883.6.73 2017-01 C01CA17 Midodrin 2.16.840.1.113883.6.73 2017-01 C01CA18 Oktopamin 2.16.840.1.113883.6.73 2017-01 C01CA19 Fenoldopam 2.16.840.1.113883.6.73 2017-01 C01CA21 Kafedrin 2.16.840.1.113883.6.73 2017-01 C01CA22 Arbutamin 2.16.840.1.113883.6.73 2017-01 C01CA23 Teodrenalin 2.16.840.1.113883.6.73 2017-01 C01CA24 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 C01CA25 Amezinium metylsulfat 2.16.840.1.113883.6.73 2017-01 C01CA26 ephedrine Efedrin 2.16.840.1.113883.6.73 2017-01 C01CA27 Droxidopa 2.16.840.1.113883.6.73 2017-01 C01CA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 C01CA51 etilefrine, combinations Etilefrin, kombinationer 2.16.840.1.113883.6.73 2017-01 C01CE Phosphodiesterase inhibitors Fosfodiesterashämmare 2.16.840.1.113883.6.73 2017-01 C01CE01 Amrinon 2.16.840.1.113883.6.73 2017-01 C01CE02 Milrinon 2.16.840.1.113883.6.73 2017-01 C01CE03 Enoximon 2.16.840.1.113883.6.73 2017-01 C01CE04 Bukladesin 2.16.840.1.113883.6.73 2017-01 C01CX Other cardiac stimulants Övriga hjärtstimulerande medel 2.16.840.1.113883.6.73 2017-01 C01CX06 Angiotensinamid 2.16.840.1.113883.6.73 2017-01 C01CX07 Xamoterol 2.16.840.1.113883.6.73 2017-01 C01CX08 Levosimendan 2.16.840.1.113883.6.73 2017-01 C01D VASODILATORS USED IN Kärlvidgande medel vid CARDIAC DISEASES hjärtsjukdomar 2.16.840.1.113883.6.73 2017-01 C01DA Organic nitrates Organiska nitrater 2.16.840.1.113883.6.73 2017-01 C01DA02 glyceryl trinitrate Glyceryltrinitrat 2.16.840.1.113883.6.73 2017-01 C01DA04 methylpropylpropanediol dinitrate Metylpropylpropandioldinitrat 2.16.840.1.113883.6.73 2017-01 C01DA05 pentaerithrityl tetranitrate Pentaeritrityltetranitrat 2.16.840.1.113883.6.73 2017-01 C01DA07 propatylnitrate Propatylnitrat 2.16.840.1.113883.6.73 2017-01 C01DA08 Isosorbiddinitrat 2.16.840.1.113883.6.73 2017-01 C01DA09 trolnitrate Trolnitrat 2.16.840.1.113883.6.73 2017-01 C01DA13 eritrityl tetranitrate Eritrityltetranitrat 2.16.840.1.113883.6.73 2017-01 C01DA14 isosorbide mononitrate Isosorbidmononitrat 2.16.840.1.113883.6.73 2017-01 C01DA20 organic nitrates in combination Organiska nitrater, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA38 tenitramine Tenitramin 2.16.840.1.113883.6.73 2017-01 C01DA52 glyceryl trinitrate, combinations Glyceryltrinitrat, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA54 methylpropylpropanediol dinitrate, Metylpropylpropandioldinitrat, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA55 pentaerithrityl tetranitrate, Pentaeritrityltetranitrat, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA57 propatylnitrate, combinations Propatylnitrat, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA58 isosorbide dinitrate, combinations Isosorbiddinitrat, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 38 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01DA59 trolnitrate, combinations Trolnitrat, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA63 eritrityl tetranitrate, combinations Eritrityltetranitrat, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA70 organic nitrates in combination with Organiska nitrater i kombination psycholeptics med neuroleptika 2.16.840.1.113883.6.73 2017-01 C01DB Quinolone vasodilators Kärlvidgande kinoloner 2.16.840.1.113883.6.73 2017-01 C01DB01 flosequinan Flosekinan 2.16.840.1.113883.6.73 2017-01 C01DX Other vasodilators used in cardiac Övriga kärlvidgande medel vid diseases hjärtsjukdomar 2.16.840.1.113883.6.73 2017-01 C01DX01 itramin tosilate Itramintosilat 2.16.840.1.113883.6.73 2017-01 C01DX02 Prenylamin 2.16.840.1.113883.6.73 2017-01 C01DX03 oxyfedrine Oxyfedrin 2.16.840.1.113883.6.73 2017-01 C01DX04 benziodarone Bensiodaron 2.16.840.1.113883.6.73 2017-01 C01DX05 carbocromen Karbokromen 2.16.840.1.113883.6.73 2017-01 C01DX06 Hexobendin 2.16.840.1.113883.6.73 2017-01 C01DX07 etafenone Etafenon 2.16.840.1.113883.6.73 2017-01 C01DX08 heptaminol Heptaminol 2.16.840.1.113883.6.73 2017-01 C01DX09 imolamine Imolamin 2.16.840.1.113883.6.73 2017-01 C01DX10 Dilazep 2.16.840.1.113883.6.73 2017-01 C01DX11 Trapidil 2.16.840.1.113883.6.73 2017-01 C01DX12 molsidomine Molsidomin 2.16.840.1.113883.6.73 2017-01 C01DX13 efloxate Efloxat 2.16.840.1.113883.6.73 2017-01 C01DX14 cinepazet Cinepazet 2.16.840.1.113883.6.73 2017-01 C01DX15 cloridarol Kloridarol 2.16.840.1.113883.6.73 2017-01 C01DX16 Nikorandil 2.16.840.1.113883.6.73 2017-01 C01DX18 linsidomine Linsidomin 2.16.840.1.113883.6.73 2017-01 C01DX19 nesiritide Nesiritid 2.16.840.1.113883.6.73 2017-01 C01DX21 serelaxin Serelaxin 2.16.840.1.113883.6.73 2017-01 C01DX51 itramin tosilate, combinations Itramintosilat, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DX52 prenylamine, combinations Prenylamin, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DX53 oxyfedrine, combinations Oxyfedrin, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DX54 benziodarone, combinations Bensiodaron, kombinationer 2.16.840.1.113883.6.73 2017-01 C01E OTHER CARDIAC Övriga medel vid hjärtsjukdomar PREPARATIONS 2.16.840.1.113883.6.73 2017-01 C01EA Prostaglandins Prostaglandiner 2.16.840.1.113883.6.73 2017-01 C01EA01 alprostadil Alprostadil 2.16.840.1.113883.6.73 2017-01 C01EB Other cardiac preparations Övriga medel vid hjärtsjukdomar 2.16.840.1.113883.6.73 2017-01 C01EB02 camphora Kamfer 2.16.840.1.113883.6.73 2017-01 C01EB03 Indometacin 2.16.840.1.113883.6.73 2017-01 C01EB04 crataegus glycosides Crataegusglykosider 2.16.840.1.113883.6.73 2017-01 C01EB05 creatinolfosfate Kreatinolfosfat 2.16.840.1.113883.6.73 2017-01 C01EB06 fosfocreatine Fosfokreatin 2.16.840.1.113883.6.73 2017-01 C01EB07 fructose 1,6-diphosphate Fruktos 1,6-difosfat 2.16.840.1.113883.6.73 2017-01 C01EB09 ubidecarenone Ubidekarenon 2.16.840.1.113883.6.73 2017-01 C01EB10 Adenosin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 39 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01EB11 tiracizine Tiracizin 2.16.840.1.113883.6.73 2017-01 C01EB13 acadesine Akadesin 2.16.840.1.113883.6.73 2017-01 C01EB15 trimetazidine Trimetazidin 2.16.840.1.113883.6.73 2017-01 C01EB16 Ibuprofen 2.16.840.1.113883.6.73 2017-01 C01EB17 ivabradine Ivabradin 2.16.840.1.113883.6.73 2017-01 C01EB18 Ranolazin 2.16.840.1.113883.6.73 2017-01 C01EB21 Regadenoson 2.16.840.1.113883.6.73 2017-01 C01EB22 meldonium Meldonium 2.16.840.1.113883.6.73 2017-01 C01EB23 tiazotic acid Tiazotinsyra 2.16.840.1.113883.6.73 2017-01 C01EX Other cardiac combination products Övriga kombinationspreparat vid hjärtsjukdomar 2.16.840.1.113883.6.73 2017-01 C02 ANTIHYPERTENSIVES Antihypertensiva medel 2.16.840.1.113883.6.73 2017-01 C02A ANTIADRENERGIC AGENTS, Antiadrenerga preparat med central CENTRALLY ACTING verkan 2.16.840.1.113883.6.73 2017-01 C02AA Rauwolfia alkaloids Rauwolfiaalkaloider 2.16.840.1.113883.6.73 2017-01 C02AA01 rescinnamine Rescinnamin 2.16.840.1.113883.6.73 2017-01 C02AA02 Reserpin 2.16.840.1.113883.6.73 2017-01 C02AA03 combinations of rauwolfia alkaloids Kombinationer av rauwolfiaalkaloider 2.16.840.1.113883.6.73 2017-01 C02AA04 rauwolfia alkaloids, whole root Rauwolfiaalkaloider, hela roten 2.16.840.1.113883.6.73 2017-01 C02AA05 deserpidine Deserpidin 2.16.840.1.113883.6.73 2017-01 C02AA06 methoserpidine Metoserpidin 2.16.840.1.113883.6.73 2017-01 C02AA07 bietaserpine Bietaserpin 2.16.840.1.113883.6.73 2017-01 C02AA52 reserpine, combinations Reserpin, kombinationer 2.16.840.1.113883.6.73 2017-01 C02AA53 combinations of rauwolfia alkoloids, Kombinationer av combinations rauwolfiaalkaloider, kombinationer 2.16.840.1.113883.6.73 2017-01 C02AA57 bietaserpine, combinations Bietaserpin, kombinationer 2.16.840.1.113883.6.73 2017-01 C02AB Metyldopa 2.16.840.1.113883.6.73 2017-01 C02AB01 methyldopa (levorotatory) Metyldopa (L-form) 2.16.840.1.113883.6.73 2017-01 C02AB02 methyldopa (racemic) Metyldopa (racemat) 2.16.840.1.113883.6.73 2017-01 C02AC Imidazoline receptor Imidazolinreceptoragonister 2.16.840.1.113883.6.73 2017-01 C02AC01 Klonidin 2.16.840.1.113883.6.73 2017-01 C02AC02 Guanfacin 2.16.840.1.113883.6.73 2017-01 C02AC04 tolonidine Tolonidin 2.16.840.1.113883.6.73 2017-01 C02AC05 moxonidine Moxonidin 2.16.840.1.113883.6.73 2017-01 C02AC06 rilmenidine Rilmenidin 2.16.840.1.113883.6.73 2017-01 C02B ANTIADRENERGIC AGENTS, Antiadrenerga preparat, GANGLION-BLOCKING ganglieblockerande 2.16.840.1.113883.6.73 2017-01 C02BA Sulfonium derivatives Sulfoniumderivat 2.16.840.1.113883.6.73 2017-01 C02BA01 trimetaphan Trimetafan 2.16.840.1.113883.6.73 2017-01 C02BB Secondary and tertiary amines Sekundära och tertiära aminer 2.16.840.1.113883.6.73 2017-01 C02BB01 Mekamylamin 2.16.840.1.113883.6.73 2017-01 C02BC Bisquaternary ammonium Biskvartära ammoniumföreningar compounds

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 40 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C02C ANTIADRENERGIC AGENTS, Antiadrenerga preparat med perifer PERIPHERALLY ACTING verkan 2.16.840.1.113883.6.73 2017-01 C02CA Alpha-adrenoreceptor antagonists Alfa-adrenoreceptorantagonister 2.16.840.1.113883.6.73 2017-01 C02CA01 Prazosin 2.16.840.1.113883.6.73 2017-01 C02CA02 indoramin Indoramin 2.16.840.1.113883.6.73 2017-01 C02CA03 trimazosin Trimazosin 2.16.840.1.113883.6.73 2017-01 C02CA04 Doxazosin 2.16.840.1.113883.6.73 2017-01 C02CA06 urapidil Urapidil 2.16.840.1.113883.6.73 2017-01 C02CC derivatives Guanidinderivat 2.16.840.1.113883.6.73 2017-01 C02CC01 betanidine Betanidin 2.16.840.1.113883.6.73 2017-01 C02CC02 guanethidine Guanetidin 2.16.840.1.113883.6.73 2017-01 C02CC03 guanoxan Guanoxan 2.16.840.1.113883.6.73 2017-01 C02CC04 debrisoquine Debrisokin 2.16.840.1.113883.6.73 2017-01 C02CC05 guanoclor Guanoklor 2.16.840.1.113883.6.73 2017-01 C02CC06 guanazodine Guanazodin 2.16.840.1.113883.6.73 2017-01 C02CC07 guanoxabenz Guanoxabens 2.16.840.1.113883.6.73 2017-01 C02D ARTERIOLAR SMOOTH MUSCLE, Medel som påverkar glatt AGENTS ACTING ON muskulatur i perifera kärl 2.16.840.1.113883.6.73 2017-01 C02DA derivatives Tiazidderivat 2.16.840.1.113883.6.73 2017-01 C02DA01 Diazoxid 2.16.840.1.113883.6.73 2017-01 C02DB Hydrazinophthalazine derivatives Hydrazinoftalazinderivat 2.16.840.1.113883.6.73 2017-01 C02DB01 dihydralazine Dihydralazin 2.16.840.1.113883.6.73 2017-01 C02DB02 hydralazine Hydralazin 2.16.840.1.113883.6.73 2017-01 C02DB03 endralazine Endralazin 2.16.840.1.113883.6.73 2017-01 C02DB04 cadralazine Kadralazin 2.16.840.1.113883.6.73 2017-01 C02DC derivatives Pyrimidinderivat 2.16.840.1.113883.6.73 2017-01 C02DC01 Minoxidil 2.16.840.1.113883.6.73 2017-01 C02DD Nitroferricyanide derivatives Nitrojärn(III)cyanidderivat 2.16.840.1.113883.6.73 2017-01 C02DD01 nitroprusside Nitroprussid 2.16.840.1.113883.6.73 2017-01 C02DG Guanidine derivatives Guanidinderivat 2.16.840.1.113883.6.73 2017-01 C02DG01 Pinacidil 2.16.840.1.113883.6.73 2017-01 C02K OTHER ANTIHYPERTENSIVES Övriga antihypertensiva medel 2.16.840.1.113883.6.73 2017-01 C02KA Alkaloids, excl. rauwolfia Alkaloider, exkl rauwolfia 2.16.840.1.113883.6.73 2017-01 C02KA01 veratrum Veratrum 2.16.840.1.113883.6.73 2017-01 C02KB Tyrosine hydroxylase inhibitors Tyrosinhydroxilashämmare 2.16.840.1.113883.6.73 2017-01 C02KB01 metirosine Metirosin 2.16.840.1.113883.6.73 2017-01 C02KC MAO inhibitors MAO-hämmare 2.16.840.1.113883.6.73 2017-01 C02KC01 Pargylin 2.16.840.1.113883.6.73 2017-01 C02KD Serotonin antagonists Serotoninantagonister 2.16.840.1.113883.6.73 2017-01 C02KD01 Ketanserin 2.16.840.1.113883.6.73 2017-01 C02KX Antihypertensives for pulmonary Antihypertensiva medel för arterial hypertension pulmonell arteriell hypertension 2.16.840.1.113883.6.73 2017-01 C02KX01 Bosentan 2.16.840.1.113883.6.73 2017-01 C02KX02 Ambrisentan

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 41 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C02KX03 Sitaxentan 2.16.840.1.113883.6.73 2017-01 C02KX04 Macitentan 2.16.840.1.113883.6.73 2017-01 C02KX05 Riociguat 2.16.840.1.113883.6.73 2017-01 C02L ANTIHYPERTENSIVES AND Antihypertensiva medel i IN COMBINATION kombination med diuretika 2.16.840.1.113883.6.73 2017-01 C02LA Rauwolfia alkaloids and diuretics in Rauwolfiaalkaloider i kombination combination med diuretika 2.16.840.1.113883.6.73 2017-01 C02LA01 reserpine and diuretics Reserpin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA02 rescinnamine and diuretics Rescinnamin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA03 deserpidine and diuretics Deserpidin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA04 methoserpidine and diuretics Metoserpidin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA07 bietaserpine and diuretics Bietaserpin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA08 rauwolfia alkaloids, whole root and Rauwolfiaalkaloider, hela roten och diuretics diuretika 2.16.840.1.113883.6.73 2017-01 C02LA09 syrosingopine and diuretics Syrosingopin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA50 combination of rauwolfia alkaloids Kombination av rauwolfiaalkaloider and diuretics incl. other och diuretika inkl. övriga combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C02LA51 reserpine and diuretics, Reserpin och diuretika, combinations with other drugs kombinationer med andra medel 2.16.840.1.113883.6.73 2017-01 C02LA52 rescinnamine and diuretics, Rescinnamin och diuretika, combinations with other drugs kombinationer med andra medel 2.16.840.1.113883.6.73 2017-01 C02LA71 reserpine and diuretics, Reserpin och diuretika, combinations with psycholeptics kombinationer med neuroleptika 2.16.840.1.113883.6.73 2017-01 C02LB Methyldopa and diuretics in Metyldopa i kombination med combination diuretika 2.16.840.1.113883.6.73 2017-01 C02LB01 methyldopa (levorotatory) and Metyldopa (L-form) och diuretika diuretics 2.16.840.1.113883.6.73 2017-01 C02LC Imidazoline receptor agonists in Imidazolinreceptoragonister i combination with diuretics kombination med diuretika 2.16.840.1.113883.6.73 2017-01 C02LC01 clonidine and diuretics Klonidin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LC05 moxonidine and diuretics Moxonidin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LC51 clonidine and diuretics, Klonidin och diuretika, combinations with other drugs kombinationer med andra medel 2.16.840.1.113883.6.73 2017-01 C02LE Alpha-adrenoreceptor antagonists Alfa-adrenoreceptorantagonister and diuretics och diuretika 2.16.840.1.113883.6.73 2017-01 C02LE01 prazosin and diuretics Prazosin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LF Guanidine derivatives and diuretics Guanidinderivat och diuretika 2.16.840.1.113883.6.73 2017-01 C02LF01 guanethidine and diuretics Guanetidin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LG Hydrazinophthalazine derivatives Hydrazinoftalazinderivat och and diuretics diuretika 2.16.840.1.113883.6.73 2017-01 C02LG01 dihydralazine and diuretics Dihydralazin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LG02 hydralazine and diuretics Hydralazin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LG03 picodralazine and diuretics Pikodralazin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LG51 dihydralazine and diuretics, Dihydralazin och diuretika, combinations with other drugs kombinationer med andra medel 2.16.840.1.113883.6.73 2017-01 C02LG73 picodralazine and diuretics, Pikodralazin och diuretika, combinations with psycholeptics kombinationer med neuroleptika

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 42 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C02LK Alkaloids, excl. rauwolfia, in Alkaloider, exkl rauwolfia, i combination with diuretics kombination med diuretika 2.16.840.1.113883.6.73 2017-01 C02LK01 veratrum and diuretics Veratrum och diuretika 2.16.840.1.113883.6.73 2017-01 C02LL MAO inhibitors and diuretics MAO-hämmare och diuretika 2.16.840.1.113883.6.73 2017-01 C02LL01 pargyline and diuretics Pargylin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LN Serotonin antagonists and diuretics Serotoninantagonister och diuretika 2.16.840.1.113883.6.73 2017-01 C02LX Other antihypertensives and Övriga antihypertensiva medel och diuretics diuretika 2.16.840.1.113883.6.73 2017-01 C02LX01 pinacidil and diuretics Pinacidil och diuretika 2.16.840.1.113883.6.73 2017-01 C02N COMBINATIONS OF Kombination av antihypertensiva ANTIHYPERTENSIVES IN ATC- medel i ATC-grupp C02 GR. C02 2.16.840.1.113883.6.73 2017-01 C03 DIURETICS Diuretika 2.16.840.1.113883.6.73 2017-01 C03A LOW-CEILING DIURETICS, Tiazider 2.16.840.1.113883.6.73 2017-01 C03AA Thiazides, plain Tiazider 2.16.840.1.113883.6.73 2017-01 C03AA01 Bendroflumetiazid 2.16.840.1.113883.6.73 2017-01 C03AA02 Hydroflumetiazid 2.16.840.1.113883.6.73 2017-01 C03AA03 Hydroklortiazid 2.16.840.1.113883.6.73 2017-01 C03AA04 Klortiazid 2.16.840.1.113883.6.73 2017-01 C03AA05 Polytiazid 2.16.840.1.113883.6.73 2017-01 C03AA06 Triklormetiazid 2.16.840.1.113883.6.73 2017-01 C03AA07 Cyklopentiazid 2.16.840.1.113883.6.73 2017-01 C03AA08 Metyklotiazid 2.16.840.1.113883.6.73 2017-01 C03AA09 Cyklotiazid 2.16.840.1.113883.6.73 2017-01 C03AA13 Mebutizid 2.16.840.1.113883.6.73 2017-01 C03AB Thiazides and potassium in Tiazider i kombination med kalium combination 2.16.840.1.113883.6.73 2017-01 C03AB01 bendroflumethiazide and potassium Bendroflumetiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB02 hydroflumethiazide and potassium Hydroflumetiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB03 hydrochlorothiazide and potassium Hydroklortiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB04 chlorothiazide and potassium Klortiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB05 polythiazide and potassium Polytiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB06 trichlormethiazide and potassium Triklormetiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB07 cyclopenthiazide and potassium Cyklopentiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB08 methyclothiazide and potassium Metylklotiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB09 cyclothiazide and potassium Cyklotiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AH Thiazides, combinations with Tiazider i komb med neuroleptika psycholeptics and/or analgesics och/eller analgetika 2.16.840.1.113883.6.73 2017-01 C03AH01 chlorothiazide, combinations Klortiazid, kombinationer 2.16.840.1.113883.6.73 2017-01 C03AH02 hydroflumethiazide, combinations Hydroflumetiazid, kombinationer 2.16.840.1.113883.6.73 2017-01 C03AX Thiazides, combinations with other Tiazider i kombination med andra drugs medel 2.16.840.1.113883.6.73 2017-01 C03AX01 hydrochlorothiazide, combinations Hydroklortiazid, kombinationer 2.16.840.1.113883.6.73 2017-01 C03B LOW-CEILING DIURETICS, EXCL. Tiazidbesläktade diuretika THIAZIDES

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 43 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C03BA Sulfonamides, plain Sulfonamidderivat 2.16.840.1.113883.6.73 2017-01 C03BA02 quinethazone Kinetazon 2.16.840.1.113883.6.73 2017-01 C03BA03 Klopamid 2.16.840.1.113883.6.73 2017-01 C03BA04 Klortalidon 2.16.840.1.113883.6.73 2017-01 C03BA05 Mefrusid 2.16.840.1.113883.6.73 2017-01 C03BA07 Klofenamid 2.16.840.1.113883.6.73 2017-01 C03BA08 Metolazon 2.16.840.1.113883.6.73 2017-01 C03BA09 Metikran 2.16.840.1.113883.6.73 2017-01 C03BA10 Xipamid 2.16.840.1.113883.6.73 2017-01 C03BA11 Indapamid 2.16.840.1.113883.6.73 2017-01 C03BA12 Klorexolon 2.16.840.1.113883.6.73 2017-01 C03BA13 Fenkizon 2.16.840.1.113883.6.73 2017-01 C03BA82 clorexolone, combinations with Klorexolon, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 C03BB Sulfonamides and potassium in Sulfonamider i kombination med combination kalium 2.16.840.1.113883.6.73 2017-01 C03BB02 quinethazone and potassium Kinetazon och kalium 2.16.840.1.113883.6.73 2017-01 C03BB03 clopamide and potassium Klopamid och kalium 2.16.840.1.113883.6.73 2017-01 C03BB04 chlortalidone and potassium Klortalidon och kalium 2.16.840.1.113883.6.73 2017-01 C03BB05 mefruside and potassium Mefrusid och kalium 2.16.840.1.113883.6.73 2017-01 C03BB07 clofenamide and potassium Klofenamid och kalium 2.16.840.1.113883.6.73 2017-01 C03BC Mercurial diuretics Kvicksilverdiuretika 2.16.840.1.113883.6.73 2017-01 C03BC01 Mersalyl 2.16.840.1.113883.6.73 2017-01 C03BD derivatives Xantinderivat 2.16.840.1.113883.6.73 2017-01 C03BD01 Teobromin 2.16.840.1.113883.6.73 2017-01 C03BK Sulfonamides, combinations with Sulfonamider i kombination med other drugs andra medel 2.16.840.1.113883.6.73 2017-01 C03BX Other low-ceiling diuretics Övriga tiazidbesläktade diuretika 2.16.840.1.113883.6.73 2017-01 C03BX03 Cikletanin 2.16.840.1.113883.6.73 2017-01 C03C HIGH-CEILING DIURETICS Loop-diuretika 2.16.840.1.113883.6.73 2017-01 C03CA Sulfonamides, plain Sulfonamider 2.16.840.1.113883.6.73 2017-01 C03CA01 Furosemid 2.16.840.1.113883.6.73 2017-01 C03CA02 Bumetanid 2.16.840.1.113883.6.73 2017-01 C03CA03 Piretanid 2.16.840.1.113883.6.73 2017-01 C03CA04 Torasemid 2.16.840.1.113883.6.73 2017-01 C03CB Sulfonamides and potassium in Sulfonamider i kombination med combination kalium 2.16.840.1.113883.6.73 2017-01 C03CB01 furosemide and potassium Furosemid och kalium 2.16.840.1.113883.6.73 2017-01 C03CB02 bumetanide and potassium Bumetanid och kalium 2.16.840.1.113883.6.73 2017-01 C03CC Aryloxyacetic acid derivatives Fenoxiättiksyraderivat 2.16.840.1.113883.6.73 2017-01 C03CC01 etacrynic acid Etakrynsyra 2.16.840.1.113883.6.73 2017-01 C03CC02 Tienilsyra 2.16.840.1.113883.6.73 2017-01 C03CD derivatives Pyrazolonderivat 2.16.840.1.113883.6.73 2017-01 C03CD01 Muzolimin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 44 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C03CX Other high-ceiling diuretics Övriga loop-diuretika 2.16.840.1.113883.6.73 2017-01 C03CX01 Etozolin 2.16.840.1.113883.6.73 2017-01 C03D POTASSIUM-SPARING AGENTS Kaliumsparande diuretika 2.16.840.1.113883.6.73 2017-01 C03DA antagonists Aldosteronantagonister 2.16.840.1.113883.6.73 2017-01 C03DA01 Spironolakton 2.16.840.1.113883.6.73 2017-01 C03DA02 Kaliumkanrenoat 2.16.840.1.113883.6.73 2017-01 C03DA03 Kanrenon 2.16.840.1.113883.6.73 2017-01 C03DA04 Eplerenon 2.16.840.1.113883.6.73 2017-01 C03DB Other potassium-sparing agents Övriga kaliumsparande medel 2.16.840.1.113883.6.73 2017-01 C03DB01 Amilorid 2.16.840.1.113883.6.73 2017-01 C03DB02 Triamteren 2.16.840.1.113883.6.73 2017-01 C03E DIURETICS AND POTASSIUM- Diuretika i kombination med SPARING AGENTS IN kaliumsparande medel COMBINATION 2.16.840.1.113883.6.73 2017-01 C03EA Low-ceiling diuretics and potassium- Tiazidbesläktad diuretika och sparing agents kaliumsparande medel 2.16.840.1.113883.6.73 2017-01 C03EA01 hydrochlorothiazide and potassium- Hydroklortiazid och kaliumsparande sparing agents medel 2.16.840.1.113883.6.73 2017-01 C03EA02 trichlormethiazide and potassium- Triklormetiazid och kaliumsparande sparing agents medel 2.16.840.1.113883.6.73 2017-01 C03EA03 and potassium-sparing Epitizid och kaliumsparande medel agents 2.16.840.1.113883.6.73 2017-01 C03EA04 and potassium-sparing Altizid och kaliumsparande medel agents 2.16.840.1.113883.6.73 2017-01 C03EA05 mebutizide and potassium-sparing Mebutizid och kaliumsparande agents medel 2.16.840.1.113883.6.73 2017-01 C03EA06 chlortalidone and potassium-sparing Klortalidon och kaliumsparande agents medel 2.16.840.1.113883.6.73 2017-01 C03EA07 cyclopenthiazide and potassium- Cyklopentiazid och kaliumsparande sparing agents medel 2.16.840.1.113883.6.73 2017-01 C03EA12 metolazone and potassium-sparing Metolazon och kaliumsparande agents medel 2.16.840.1.113883.6.73 2017-01 C03EA13 bendroflumethiazide and potassium- Bendroflumetiazid och sparing agents kaliumsparande medel 2.16.840.1.113883.6.73 2017-01 C03EA14 and potassium-sparing Butizid och kaliumsparande medel agents 2.16.840.1.113883.6.73 2017-01 C03EB High-ceiling diuretics and Loop-diuretika och kaliumsparande potassium-sparing agents medel 2.16.840.1.113883.6.73 2017-01 C03EB01 furosemide and potassium-sparing Furosemid och kaliumsparande agents diuretika 2.16.840.1.113883.6.73 2017-01 C03EB02 bumetanide and potassium-sparing Bumetanid och kaliumsparande agents medel 2.16.840.1.113883.6.73 2017-01 C03X OTHER DIURETICS Övriga diuretika 2.16.840.1.113883.6.73 2017-01 C03XA Vasopressin antagonists Vasopressinantagonister 2.16.840.1.113883.6.73 2017-01 C03XA01 Tolvaptan 2.16.840.1.113883.6.73 2017-01 C03XA02 Konivaptan 2.16.840.1.113883.6.73 2017-01 C04 PERIPHERAL VASODILATORS Perifera vasodilatorer 2.16.840.1.113883.6.73 2017-01 C04A PERIPHERAL VASODILATORS Perifera vasodilatorer 2.16.840.1.113883.6.73 2017-01 C04AA 2-amino-1-phenylethanol derivatives 2-Amino-1-fenyletanolderivat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 45 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C04AA01 Isoxsuprin 2.16.840.1.113883.6.73 2017-01 C04AA02 Bufenin 2.16.840.1.113883.6.73 2017-01 C04AA31 Bametan 2.16.840.1.113883.6.73 2017-01 C04AB Imidazoline derivatives Imidazolinderivat 2.16.840.1.113883.6.73 2017-01 C04AB01 Fentolamin 2.16.840.1.113883.6.73 2017-01 C04AB02 Tolazolin 2.16.840.1.113883.6.73 2017-01 C04AC Nicotinic acid and derivatives Nikotinsyra och derivat 2.16.840.1.113883.6.73 2017-01 C04AC01 nicotinic acid Nikotinsyra 2.16.840.1.113883.6.73 2017-01 C04AC02 nicotinyl (pyridylcarbinol) Nikotinylalkohol 2.16.840.1.113883.6.73 2017-01 C04AC03 Inositolnikotinat 2.16.840.1.113883.6.73 2017-01 C04AC07 Ciklonikat 2.16.840.1.113883.6.73 2017-01 C04AD derivatives Purinderivat 2.16.840.1.113883.6.73 2017-01 C04AD01 Pentifyllin 2.16.840.1.113883.6.73 2017-01 C04AD02 xantinol nicotinate Xantinolnikotinat 2.16.840.1.113883.6.73 2017-01 C04AD03 Pentoxifyllin 2.16.840.1.113883.6.73 2017-01 C04AD04 Etofyllinnikotinat 2.16.840.1.113883.6.73 2017-01 C04AE alkaloids Mjöldrygealkaloider 2.16.840.1.113883.6.73 2017-01 C04AE01 mesylates Ergoloidmesylat 2.16.840.1.113883.6.73 2017-01 C04AE02 Nicergolin 2.16.840.1.113883.6.73 2017-01 C04AE04 Dihydroergokristin 2.16.840.1.113883.6.73 2017-01 C04AE51 ergoloid mesylates, combinations Ergoloidmesylat, kombinationer 2.16.840.1.113883.6.73 2017-01 C04AE54 dihydroergocristine, combinations Dihydroergokristin, kombinationer 2.16.840.1.113883.6.73 2017-01 C04AF Enzymes Enzymer 2.16.840.1.113883.6.73 2017-01 C04AF01 kallidinogenase Kallidinogenas 2.16.840.1.113883.6.73 2017-01 C04AX Other peripheral vasodilators Övriga perifera vasodilatorer 2.16.840.1.113883.6.73 2017-01 C04AX01 Cyklandelat 2.16.840.1.113883.6.73 2017-01 C04AX02 Fenoxybensamin 2.16.840.1.113883.6.73 2017-01 C04AX07 Vinkamin 2.16.840.1.113883.6.73 2017-01 C04AX10 Moxisylyt 2.16.840.1.113883.6.73 2017-01 C04AX11 Bencyklan 2.16.840.1.113883.6.73 2017-01 C04AX17 Vinburnin 2.16.840.1.113883.6.73 2017-01 C04AX19 Suloktidil 2.16.840.1.113883.6.73 2017-01 C04AX20 Buflomedil 2.16.840.1.113883.6.73 2017-01 C04AX21 Naftidrofuryl 2.16.840.1.113883.6.73 2017-01 C04AX23 Butalmin 2.16.840.1.113883.6.73 2017-01 C04AX24 Visnadin 2.16.840.1.113883.6.73 2017-01 C04AX26 Cetiedil 2.16.840.1.113883.6.73 2017-01 C04AX27 Cinepazid 2.16.840.1.113883.6.73 2017-01 C04AX28 Ifenprodil 2.16.840.1.113883.6.73 2017-01 C04AX30 Azapetin 2.16.840.1.113883.6.73 2017-01 C04AX32 Fasudil 2.16.840.1.113883.6.73 2017-01 C05 Kärlskyddande medel

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 46 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C05A AGENTS FOR TREATMENT OF Utvärtes medel vid hemorrojder och AND ANAL analfissurer FISSURES FOR TOPICAL USE 2.16.840.1.113883.6.73 2017-01 C05AA Corticosteroids Kortikosteroider 2.16.840.1.113883.6.73 2017-01 C05AA01 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 C05AA04 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 C05AA05 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 C05AA06 Fluorometolon 2.16.840.1.113883.6.73 2017-01 C05AA08 Fluokortolon 2.16.840.1.113883.6.73 2017-01 C05AA09 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 C05AA10 acetonide Fluocinolonacetonid 2.16.840.1.113883.6.73 2017-01 C05AA11 Fluocinonid 2.16.840.1.113883.6.73 2017-01 C05AA12 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 C05AB Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 C05AD Local Lokalanestetika 2.16.840.1.113883.6.73 2017-01 C05AD01 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 C05AD02 Tetrakain 2.16.840.1.113883.6.73 2017-01 C05AD03 Bensokain 2.16.840.1.113883.6.73 2017-01 C05AD04 Cinkokain 2.16.840.1.113883.6.73 2017-01 C05AD05 Prokain 2.16.840.1.113883.6.73 2017-01 C05AD06 Oxetakain 2.16.840.1.113883.6.73 2017-01 C05AD07 Pramokain 2.16.840.1.113883.6.73 2017-01 C05AE Muscle relaxants Muskelavslappande medel 2.16.840.1.113883.6.73 2017-01 C05AE01 glyceryl trinitrate Glyceryltrinitrat 2.16.840.1.113883.6.73 2017-01 C05AE02 isosorbide dinitrate Isosorbiddinitrat 2.16.840.1.113883.6.73 2017-01 C05AE03 Diltiazem 2.16.840.1.113883.6.73 2017-01 C05AX Other agents for treatment of Övriga utvärtes medel vid hemorrhoids and anal fissures for hemorrojder och analfissurer topical use 2.16.840.1.113883.6.73 2017-01 C05AX01 aluminium preparations Aluminiumpreparat 2.16.840.1.113883.6.73 2017-01 C05AX02 bismuth preparations, combinations Vismutpreparat, kombinationer 2.16.840.1.113883.6.73 2017-01 C05AX03 other preparations, combinations Övriga medel, kombinationer 2.16.840.1.113883.6.73 2017-01 C05AX04 zinc preparations Zinkpreparat 2.16.840.1.113883.6.73 2017-01 C05AX05 Tribenosid 2.16.840.1.113883.6.73 2017-01 C05B ANTIVARICOSE THERAPY Medel för varixbehandling 2.16.840.1.113883.6.73 2017-01 C05BA or for topical Heparin eller heparinoida use substanser för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 C05BA01 organo- Organiska heparinföreningar 2.16.840.1.113883.6.73 2017-01 C05BA02 Natriumapolat 2.16.840.1.113883.6.73 2017-01 C05BA03 heparin Heparin 2.16.840.1.113883.6.73 2017-01 C05BA04 sodium Pentosanpolysulfatnatrium 2.16.840.1.113883.6.73 2017-01 C05BA51 heparinoid, combinations Heparinoid, kombinationer 2.16.840.1.113883.6.73 2017-01 C05BA53 heparin, combinations Heparin, kombinationer 2.16.840.1.113883.6.73 2017-01 C05BB Sclerosing agents for local injection Medel för sklerosering för lokal injektion

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 47 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C05BB01 Monoetanolaminoleat 2.16.840.1.113883.6.73 2017-01 C05BB02 Polidokanol 2.16.840.1.113883.6.73 2017-01 C05BB03 invert sugar Inverterat socker 2.16.840.1.113883.6.73 2017-01 C05BB04 sodium tetradecyl sulfate Natriumtetradecylsulfat 2.16.840.1.113883.6.73 2017-01 C05BB05 Fenol 2.16.840.1.113883.6.73 2017-01 C05BB56 glucose, combinations Glukos, kombinationer 2.16.840.1.113883.6.73 2017-01 C05BX Other sclerosing agents Övriga medel för sklerosering 2.16.840.1.113883.6.73 2017-01 C05BX01 Kalciumdobesilat 2.16.840.1.113883.6.73 2017-01 C05BX51 calcium dobesilate, combinations Kalciumdobesilat, kombinationer 2.16.840.1.113883.6.73 2017-01 C05C CAPILLARY STABILIZING Kapillärstabiliserande medel AGENTS 2.16.840.1.113883.6.73 2017-01 C05CA Bioflavonoids Bioflavonoider 2.16.840.1.113883.6.73 2017-01 C05CA01 rutoside Rutosid 2.16.840.1.113883.6.73 2017-01 C05CA02 Monoxerutin 2.16.840.1.113883.6.73 2017-01 C05CA03 Diosmin 2.16.840.1.113883.6.73 2017-01 C05CA04 Troxerutin 2.16.840.1.113883.6.73 2017-01 C05CA05 Hidrosmin 2.16.840.1.113883.6.73 2017-01 C05CA51 rutoside, combinations Rutosid, kombinationer 2.16.840.1.113883.6.73 2017-01 C05CA53 diosmin, combinations Diosmin, kombinationer 2.16.840.1.113883.6.73 2017-01 C05CA54 troxerutin, combinations Troxerutin, kombinationer 2.16.840.1.113883.6.73 2017-01 C05CX Other capillary stabilizing agents Övriga kapillärstabiliserande medel 2.16.840.1.113883.6.73 2017-01 C05CX01 tribenoside Tribenosid 2.16.840.1.113883.6.73 2017-01 C05CX02 naftazone Naftazon 2.16.840.1.113883.6.73 2017-01 C05CX03 Hippocastani semen Hippocastani semen 2.16.840.1.113883.6.73 2017-01 C07 BETA BLOCKING AGENTS Beta-receptorblockerande medel 2.16.840.1.113883.6.73 2017-01 C07A BETA BLOCKING AGENTS Beta-receptorblockerande medel 2.16.840.1.113883.6.73 2017-01 C07AA Beta blocking agents, non-selective Beta-receptorblockerande medel, icke-selektiva 2.16.840.1.113883.6.73 2017-01 C07AA01 alprenolol Alprenolol 2.16.840.1.113883.6.73 2017-01 C07AA02 oxprenolol Oxprenolol 2.16.840.1.113883.6.73 2017-01 C07AA03 Pindolol 2.16.840.1.113883.6.73 2017-01 C07AA05 Propranolol 2.16.840.1.113883.6.73 2017-01 C07AA06 Timolol 2.16.840.1.113883.6.73 2017-01 C07AA07 Sotalol 2.16.840.1.113883.6.73 2017-01 C07AA12 Nadolol 2.16.840.1.113883.6.73 2017-01 C07AA14 mepindolol Mepindolol 2.16.840.1.113883.6.73 2017-01 C07AA15 carteolol Karteolol 2.16.840.1.113883.6.73 2017-01 C07AA16 tertatolol Tertatolol 2.16.840.1.113883.6.73 2017-01 C07AA17 bopindolol Bopindolol 2.16.840.1.113883.6.73 2017-01 C07AA19 bupranolol Bupranolol 2.16.840.1.113883.6.73 2017-01 C07AA23 penbutolol Penbutolol 2.16.840.1.113883.6.73 2017-01 C07AA27 cloranolol Kloranolol 2.16.840.1.113883.6.73 2017-01 C07AB Beta blocking agents, selective Beta-receptorblockerande medel, selektiva

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 48 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C07AB01 practolol Praktolol 2.16.840.1.113883.6.73 2017-01 C07AB02 Metoprolol 2.16.840.1.113883.6.73 2017-01 C07AB03 Atenolol 2.16.840.1.113883.6.73 2017-01 C07AB04 Acebutolol 2.16.840.1.113883.6.73 2017-01 C07AB05 betaxolol Betaxolol 2.16.840.1.113883.6.73 2017-01 C07AB06 bevantolol Bevantolol 2.16.840.1.113883.6.73 2017-01 C07AB07 bisoprolol Bisoprolol 2.16.840.1.113883.6.73 2017-01 C07AB08 celiprolol Celiprolol 2.16.840.1.113883.6.73 2017-01 C07AB09 Esmolol 2.16.840.1.113883.6.73 2017-01 C07AB10 epanolol Epanolol 2.16.840.1.113883.6.73 2017-01 C07AB11 s-atenolol S-atenolol 2.16.840.1.113883.6.73 2017-01 C07AB12 nebivolol Nebivolol 2.16.840.1.113883.6.73 2017-01 C07AB13 talinolol Talinolol 2.16.840.1.113883.6.73 2017-01 C07AB14 landiolol Landiolol 2.16.840.1.113883.6.73 2017-01 C07AG Alpha and beta blocking agents Alfa- och beta-receptorblockerande medel 2.16.840.1.113883.6.73 2017-01 C07AG01 labetalol Labetalol 2.16.840.1.113883.6.73 2017-01 C07AG02 carvedilol Karvedilol 2.16.840.1.113883.6.73 2017-01 C07B BETA BLOCKING AGENTS AND Beta-receptorblockerande medel THIAZIDES och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA Beta blocking agents, non-selective, Icke-selektiva beta- and thiazides receptorblockerare och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA02 oxprenolol and thiazides Oxprenolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA05 propranolol and thiazides Propranolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA06 timolol and thiazides Timolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA07 sotalol and thiazides Sotalol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA12 nadolol and thiazides Nadolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA68 metipranolol and thiazides, Metipranolol och tiazider, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C07BB Beta blocking agents, selective, and Selektiva beta-receptorblockerare thiazides och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB02 metoprolol and thiazides Metoprolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB03 atenolol and thiazides Atenolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB04 acebutolol and thiazides Acebutolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB06 bevantolol and thiazides Bevantolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB07 bisoprolol and thiazides Bisoprolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB12 nebivolol and thiazides Nebivolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB52 metoprolol and thiazides, Metoprolol och tiazider, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C07BG Alpha and beta blocking agents and Alfa- och beta-receptorblockerande thiazides medel och tiazider 2.16.840.1.113883.6.73 2017-01 C07BG01 labetalol and thiazides Labetalol och tiazider 2.16.840.1.113883.6.73 2017-01 C07C BETA BLOCKING AGENTS AND Beta-receptorblockerande medel OTHER DIURETICS och övriga diuretika

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 49 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C07CA Beta blocking agents, non-selective, Icke-selektiva beta- and other diuretics receptorblockerare och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CA02 oxprenolol and other diuretics Oxprenolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CA03 pindolol and other diuretics Pindolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CA17 bopindolol and other diuretics Bopindolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CA23 penbutolol and other diuretics Penbutolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CB Beta blocking agents, selective, and Selektiva beta-receptorblockerare other diuretics och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CB02 metoprolol and other diuretics Metoprolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CB03 atenolol and other diuretics Atenolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CB53 atenolol and other diuretics, Atenolol och övriga diuretika, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C07CG Alpha and beta blocking agents and Alfa- och beta-receptorblockerande other diuretics medel och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CG01 labetalol and other diuretics Labetalol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07D BETA BLOCKING AGENTS, Beta-receptorblockerande medel, THIAZIDES AND OTHER tiazider och övriga diuretika DIURETICS 2.16.840.1.113883.6.73 2017-01 C07DA Beta blocking agents, non-selective, Icke-selektiva beta- thiazides and other diuretics receptorblockerare, tiazider och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07DA06 timolol, thiazides and other diuretics Timolol, tiazider och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07DB Beta blocking agents, selective, Selektiva beta-receptorblockerare, thiazides and other diuretics tiazider och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07DB01 atenolol, thiazides and other Atenolol, tiazider och övriga diuretics diuretika 2.16.840.1.113883.6.73 2017-01 C07E BETA BLOCKING AGENTS AND Beta-receptorblockerande medel VASODILATORS och kärlvidgande medel 2.16.840.1.113883.6.73 2017-01 C07EA Beta blocking agents, non-selective, Icke-selektiva beta- and vasodilators receptorblockerare och kärlvidgande medel 2.16.840.1.113883.6.73 2017-01 C07EB Beta blocking agents, selective, and Selektiva beta-receptorblockerare vasodilators och kärlvidgande medel 2.16.840.1.113883.6.73 2017-01 C07F BETA BLOCKING AGENTS, Beta-receptorblockerande medel, OTHER COMBINATIONS övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C07FB Beta blocking agents and calcium Beta-receptorblockerande medel channel blockers och kalciumantagonister 2.16.840.1.113883.6.73 2017-01 C07FB02 metoprolol and Metoprolol och felodipin 2.16.840.1.113883.6.73 2017-01 C07FB03 atenolol and Atenolol och nifedipin 2.16.840.1.113883.6.73 2017-01 C07FB07 bisoprolol and Bisoprolol och amlodipin 2.16.840.1.113883.6.73 2017-01 C07FB12 nevibolol and amlodipine Nevibolol och amlodipin 2.16.840.1.113883.6.73 2017-01 C07FB13 metoprolol and amlodipine Metoprolol och amlodipin 2.16.840.1.113883.6.73 2017-01 C07FX Beta blocking agents, other Beta-receptorblockerande medel, combinations övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C07FX01 propranolol and other combinations Propranolol och övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C07FX02 sotalol and acetylsalicylic acid Sotalol och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 C07FX03 metoprolol and acetylsalicylic acid Metoprolol och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 C07FX04 bisoprolol and acetylsalicylic acid Bisoprolol och acetylsalicylsyra © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 50 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C07FX05 metoprolol and ivabradine Metoprolol och ivabradin 2.16.840.1.113883.6.73 2017-01 C07FX06 carvedilol and ivabradine Karvedilol och ivabradin 2.16.840.1.113883.6.73 2017-01 C08 CALCIUM CHANNEL BLOCKERS Kalciumantagonister 2.16.840.1.113883.6.73 2017-01 C08C SELECTIVE CALCIUM CHANNEL Kalciumantagonister med BLOCKERS WITH MAINLY övervägande kärlselektiv effekt VASCULAR EFFECTS 2.16.840.1.113883.6.73 2017-01 C08CA Dihydropyridine derivatives Dihydropyridinderivat 2.16.840.1.113883.6.73 2017-01 C08CA01 amlodipine Amlodipin 2.16.840.1.113883.6.73 2017-01 C08CA02 felodipine Felodipin 2.16.840.1.113883.6.73 2017-01 C08CA03 Isradipin 2.16.840.1.113883.6.73 2017-01 C08CA04 Nikardipin 2.16.840.1.113883.6.73 2017-01 C08CA05 nifedipine Nifedipin 2.16.840.1.113883.6.73 2017-01 C08CA06 Nimodipin 2.16.840.1.113883.6.73 2017-01 C08CA07 Nisoldipin 2.16.840.1.113883.6.73 2017-01 C08CA08 Nitrendipin 2.16.840.1.113883.6.73 2017-01 C08CA09 Lacidipin 2.16.840.1.113883.6.73 2017-01 C08CA10 Nilvadipin 2.16.840.1.113883.6.73 2017-01 C08CA11 Manidipin 2.16.840.1.113883.6.73 2017-01 C08CA12 Barnidipin 2.16.840.1.113883.6.73 2017-01 C08CA13 Lerkanidipin 2.16.840.1.113883.6.73 2017-01 C08CA14 cilnidipine Cilnidipin 2.16.840.1.113883.6.73 2017-01 C08CA15 Benidipin 2.16.840.1.113883.6.73 2017-01 C08CA16 Klevidipin 2.16.840.1.113883.6.73 2017-01 C08CA55 nifedipine, combinations Nifedipin, kombinationer 2.16.840.1.113883.6.73 2017-01 C08CX Other selective calcium channel Övriga selektiva blockers with mainly vascular effects kalciumantagonister med främst vaskulär effekt 2.16.840.1.113883.6.73 2017-01 C08CX01 Mibefradil 2.16.840.1.113883.6.73 2017-01 C08D SELECTIVE CALCIUM CHANNEL Kalciumantagonister med direkt BLOCKERS WITH DIRECT hjärtselektiv effekt CARDIAC EFFECTS 2.16.840.1.113883.6.73 2017-01 C08DA Phenylalkylamine derivatives Fenylalkylaminderivat 2.16.840.1.113883.6.73 2017-01 C08DA01 Verapamil 2.16.840.1.113883.6.73 2017-01 C08DA02 Gallopamil 2.16.840.1.113883.6.73 2017-01 C08DA51 verapamil, combinations Verapamil, kombinationer 2.16.840.1.113883.6.73 2017-01 C08DB Benzothiazepine derivatives Bensotiazepinderivat 2.16.840.1.113883.6.73 2017-01 C08DB01 diltiazem Diltiazem 2.16.840.1.113883.6.73 2017-01 C08E NON-SELECTIVE CALCIUM Icke-selektiva kalciumantagonister CHANNEL BLOCKERS 2.16.840.1.113883.6.73 2017-01 C08EA Phenylalkylamine derivatives Fenylalkylaminderivat 2.16.840.1.113883.6.73 2017-01 C08EA01 Fendilin 2.16.840.1.113883.6.73 2017-01 C08EA02 Bepridil 2.16.840.1.113883.6.73 2017-01 C08EX Other non-selective calcium channel Övriga icke-selektiva blockers kalciumantagonister 2.16.840.1.113883.6.73 2017-01 C08EX01 Lidoflazin 2.16.840.1.113883.6.73 2017-01 C08EX02 Perhexilin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 51 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C08G CALCIUM CHANNEL BLOCKERS Kalciumantagonister och diuretika AND DIURETICS 2.16.840.1.113883.6.73 2017-01 C08GA Calcium channel blockers and Kalciumantagonister och diuretika diuretics 2.16.840.1.113883.6.73 2017-01 C08GA01 nifedipine and diuretics Nifedipin och diuretika 2.16.840.1.113883.6.73 2017-01 C08GA02 amlodipine and diuretics Amlodipin och diuretika 2.16.840.1.113883.6.73 2017-01 C09 AGENTS ACTING ON THE RENIN- Medel som påverkar renin- ANGIOTENSIN SYSTEM angiotensinsystemet 2.16.840.1.113883.6.73 2017-01 C09A ACE INHIBITORS, PLAIN ACE-hämmare 2.16.840.1.113883.6.73 2017-01 C09AA ACE inhibitors, plain ACE-hämmare 2.16.840.1.113883.6.73 2017-01 C09AA01 captopril Kaptopril 2.16.840.1.113883.6.73 2017-01 C09AA02 enalapril Enalapril 2.16.840.1.113883.6.73 2017-01 C09AA03 lisinopril Lisinopril 2.16.840.1.113883.6.73 2017-01 C09AA04 perindopril Perindopril 2.16.840.1.113883.6.73 2017-01 C09AA05 ramipril Ramipril 2.16.840.1.113883.6.73 2017-01 C09AA06 quinapril Kinapril 2.16.840.1.113883.6.73 2017-01 C09AA07 benazepril Benazepril 2.16.840.1.113883.6.73 2017-01 C09AA08 cilazapril Cilazapril 2.16.840.1.113883.6.73 2017-01 C09AA09 fosinopril Fosinopril 2.16.840.1.113883.6.73 2017-01 C09AA10 trandolapril Trandolapril 2.16.840.1.113883.6.73 2017-01 C09AA11 spirapril Spirapril 2.16.840.1.113883.6.73 2017-01 C09AA12 delapril Delapril 2.16.840.1.113883.6.73 2017-01 C09AA13 moexipril Moexipril 2.16.840.1.113883.6.73 2017-01 C09AA14 temocapril Temokapril 2.16.840.1.113883.6.73 2017-01 C09AA15 zofenopril Zofenopril 2.16.840.1.113883.6.73 2017-01 C09AA16 imidapril Imidapril 2.16.840.1.113883.6.73 2017-01 C09B ACE INHIBITORS, ACE-hämmare, kombinationer COMBINATIONS 2.16.840.1.113883.6.73 2017-01 C09BA ACE inhibitors and diuretics ACE-hämmare och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA01 captopril and diuretics Kaptopril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA02 enalapril and diuretics Enalapril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA03 lisinopril and diuretics Lisinopril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA04 perindopril and diuretics Perindopril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA05 ramipril and diuretics Ramipril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA06 quinapril and diuretics Kinapril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA07 benazepril and diuretics Benazepril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA08 cilazapril and diuretics Cilazapril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA09 fosinopril and diuretics Fosinopril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA12 delapril and diuretics Delapril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA13 moexipril and diuretics Moexipril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA15 zofenopril and diuretics Zofenopril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BB ACE inhibitors and calcium channel ACE-hämmare och blockers kalciumantagonister 2.16.840.1.113883.6.73 2017-01 C09BB02 enalapril and lercanidipine Enalapril och lerkanidipin 2.16.840.1.113883.6.73 2017-01 C09BB03 lisinopril and amlodipine Lisinopril och amlodipin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 52 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C09BB04 perindopril and amlodipine Perindopril och amlodipin 2.16.840.1.113883.6.73 2017-01 C09BB05 ramipril and felodipine Ramipril och felodipin 2.16.840.1.113883.6.73 2017-01 C09BB06 enalapril and nitrendipine Enalapril och nitrendipin 2.16.840.1.113883.6.73 2017-01 C09BB07 ramipril and amlodipine Ramipril och amlodipin 2.16.840.1.113883.6.73 2017-01 C09BB10 trandolapril and verapamil Trandolapril och verapamil 2.16.840.1.113883.6.73 2017-01 C09BB12 delapril and manidipine Delapril och manidipin 2.16.840.1.113883.6.73 2017-01 C09BX ACE inhibitors, other combinations ACE-hämmare, övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C09BX01 perindopril, amlodipine and Perindopril, amlodipin och indapamide indapamid 2.16.840.1.113883.6.73 2017-01 C09BX02 perindopril and bisoprolol Perindopril och bisoprolol 2.16.840.1.113883.6.73 2017-01 C09C ANGIOTENSIN II ANTAGONISTS, Angiotensin II receptorblockerare PLAIN (ARBs) 2.16.840.1.113883.6.73 2017-01 C09CA Angiotensin II antagonists, plain Angiotensin II receptorblockerare (ARBs) 2.16.840.1.113883.6.73 2017-01 C09CA01 Losartan 2.16.840.1.113883.6.73 2017-01 C09CA02 eprosartan Eprosartan 2.16.840.1.113883.6.73 2017-01 C09CA03 valsartan Valsartan 2.16.840.1.113883.6.73 2017-01 C09CA04 irbesartan Irbesartan 2.16.840.1.113883.6.73 2017-01 C09CA05 tasosartan Tasosartan 2.16.840.1.113883.6.73 2017-01 C09CA06 candesartan Kandesartan 2.16.840.1.113883.6.73 2017-01 C09CA07 telmisartan Telmisartan 2.16.840.1.113883.6.73 2017-01 C09CA08 olmesartan medoxomil Olmesartanmedoxomil 2.16.840.1.113883.6.73 2017-01 C09CA09 azilsartan medoxomil Azilsartanmedoxomil 2.16.840.1.113883.6.73 2017-01 C09CA10 fimasartan Fimasartan 2.16.840.1.113883.6.73 2017-01 C09D ANGIOTENSIN II ANTAGONISTS, Angiotensin II receptorblockerare COMBINATIONS (ARBs), kombinationer 2.16.840.1.113883.6.73 2017-01 C09DA Angiotensin II antagonists and Angiotensin II receptorblockerare diuretics (ARBs) och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA01 losartan and diuretics Losartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA02 eprosartan and diuretics Eprosartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA03 valsartan and diuretics Valsartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA04 irbesartan and diuretics Irbesartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA06 candesartan and diuretics Kandesartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA07 telmisartan and diuretics Telmisartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA08 olmesartan medoxomil and diuretics Olmesartanmedoxomil och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA09 azilsartan medoxomil and diuretics Azilsartanmedoxomil och diuretika 2.16.840.1.113883.6.73 2017-01 C09DB Angiotensin II antagonists and Angiotensin II receptorblockerare calcium channel blockers (ARBs) och kalciumantagonister 2.16.840.1.113883.6.73 2017-01 C09DB01 valsartan and amlodipine Valsartan och amlodipin 2.16.840.1.113883.6.73 2017-01 C09DB02 olmesartan medoxomil and Olmesartanmedoxomil och amlodipine amlodipin 2.16.840.1.113883.6.73 2017-01 C09DB04 telmisartan and amlodipine Telmisartan och amlodipin 2.16.840.1.113883.6.73 2017-01 C09DB05 irbesartan and amlodipine Irbesartan och amlodipin 2.16.840.1.113883.6.73 2017-01 C09DB06 losartan and amlodipine Losartan och amlodipin 2.16.840.1.113883.6.73 2017-01 C09DB07 candesartan and amlodipine Kandesartan och amlodipin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 53 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C09DB08 valsartan and lercanidipine Valsartan och lerkanidipin 2.16.840.1.113883.6.73 2017-01 C09DX Angiotensin II antagonists, other Angiotensin II receptorblockerare combinations (ARBs), övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C09DX01 valsartan, amlodipine and Valsartan, amlodipin och hydrochlorothiazide hydroklortiazid 2.16.840.1.113883.6.73 2017-01 C09DX02 valsartan and aliskiren Valsartan och aliskiren 2.16.840.1.113883.6.73 2017-01 C09DX03 olmesartan medoxomil, amlodipine Olmesartanmedoxomil, amlodipin and hydrochlorothiazide och hydroklortiazid 2.16.840.1.113883.6.73 2017-01 C09DX04 valsartan and sacubitril Valsartan och sakubitril 2.16.840.1.113883.6.73 2017-01 C09X OTHER AGENTS ACTING ON THE Övriga medel som påverkar renin- RENIN-ANGIOTENSIN SYSTEM angiotensinsystemet 2.16.840.1.113883.6.73 2017-01 C09XA Renin-inhibitors Renin-hämmare 2.16.840.1.113883.6.73 2017-01 C09XA01 remikiren Remikiren 2.16.840.1.113883.6.73 2017-01 C09XA02 aliskiren Aliskiren 2.16.840.1.113883.6.73 2017-01 C09XA52 aliskiren and hydrochlorothiazide Aliskiren och hydroklortiazid 2.16.840.1.113883.6.73 2017-01 C09XA53 aliskiren and amlodipine Aliskiren och amlodipin 2.16.840.1.113883.6.73 2017-01 C09XA54 aliskiren, amlodipine and Aliskiren, amlodipin och hydrochlorothiazide hydroklortiazid 2.16.840.1.113883.6.73 2017-01 C10 MODIFYING AGENTS Medel som påverkar serumlipidnivåerna 2.16.840.1.113883.6.73 2017-01 C10A LIPID MODIFYING AGENTS, Medel som påverkar PLAIN serumlipidnivåerna 2.16.840.1.113883.6.73 2017-01 C10AA HMG CoA reductase inhibitors HMG CoA reduktas-hämmare 2.16.840.1.113883.6.73 2017-01 C10AA01 simvastatin Simvastatin 2.16.840.1.113883.6.73 2017-01 C10AA02 Lovastatin 2.16.840.1.113883.6.73 2017-01 C10AA03 Pravastatin 2.16.840.1.113883.6.73 2017-01 C10AA04 Fluvastatin 2.16.840.1.113883.6.73 2017-01 C10AA05 Atorvastatin 2.16.840.1.113883.6.73 2017-01 C10AA06 Cerivastatin 2.16.840.1.113883.6.73 2017-01 C10AA07 Rosuvastatin 2.16.840.1.113883.6.73 2017-01 C10AA08 Pitavastatin 2.16.840.1.113883.6.73 2017-01 C10AB Fibrater 2.16.840.1.113883.6.73 2017-01 C10AB01 Klofibrat 2.16.840.1.113883.6.73 2017-01 C10AB02 Bezafibrat 2.16.840.1.113883.6.73 2017-01 C10AB03 Aluminiumklofibrat 2.16.840.1.113883.6.73 2017-01 C10AB04 Gemfibrozil 2.16.840.1.113883.6.73 2017-01 C10AB05 Fenofibrat 2.16.840.1.113883.6.73 2017-01 C10AB06 Simfibrat 2.16.840.1.113883.6.73 2017-01 C10AB07 Ronifibrat 2.16.840.1.113883.6.73 2017-01 C10AB08 Ciprofibrat 2.16.840.1.113883.6.73 2017-01 C10AB09 Etofibrat 2.16.840.1.113883.6.73 2017-01 C10AB10 Klofibrid 2.16.840.1.113883.6.73 2017-01 C10AB11 fenofibrate Kolinfenofibrat 2.16.840.1.113883.6.73 2017-01 C10AC Bile acid sequestrants Resiner 2.16.840.1.113883.6.73 2017-01 C10AC01 Kolestyramin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 54 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C10AC02 Kolestipol 2.16.840.1.113883.6.73 2017-01 C10AC03 Kolextran 2.16.840.1.113883.6.73 2017-01 C10AC04 Kolesevelam 2.16.840.1.113883.6.73 2017-01 C10AD Nicotinic acid and derivatives Nikotinsyra och derivat 2.16.840.1.113883.6.73 2017-01 C10AD01 Niceritrol 2.16.840.1.113883.6.73 2017-01 C10AD02 nicotinic acid Nikotinsyra 2.16.840.1.113883.6.73 2017-01 C10AD03 Nikofuranos 2.16.840.1.113883.6.73 2017-01 C10AD04 aluminium nicotinate Aluminiumnikotinat 2.16.840.1.113883.6.73 2017-01 C10AD05 (pyridylcarbinol) Nikotinylalkohol (pyridylkarbinol) 2.16.840.1.113883.6.73 2017-01 C10AD06 Acipimox 2.16.840.1.113883.6.73 2017-01 C10AD52 nicotinic acid, combinations Nikotinsyra, kombinationer 2.16.840.1.113883.6.73 2017-01 C10AX Other lipid modifying agents Övriga medel som påverkar serumlipidnivåerna 2.16.840.1.113883.6.73 2017-01 C10AX01 Dextrotyroxin 2.16.840.1.113883.6.73 2017-01 C10AX02 Probukol 2.16.840.1.113883.6.73 2017-01 C10AX03 Tiadenol 2.16.840.1.113883.6.73 2017-01 C10AX05 Meglutol 2.16.840.1.113883.6.73 2017-01 C10AX06 omega-3-triglycerides incl. other Omega-3-triglycerider inkl. övriga esters and acids estrar och syror 2.16.840.1.113883.6.73 2017-01 C10AX07 magnesium pyridoxal 5-phosphate Magnesium pyridoxal 5-fosfat glutamate glutamat 2.16.840.1.113883.6.73 2017-01 C10AX08 Polikosanol 2.16.840.1.113883.6.73 2017-01 C10AX09 Ezetimib 2.16.840.1.113883.6.73 2017-01 C10AX10 Alipogen-tiparvovek 2.16.840.1.113883.6.73 2017-01 C10AX11 Mipomersen 2.16.840.1.113883.6.73 2017-01 C10AX12 Lomitapid 2.16.840.1.113883.6.73 2017-01 C10AX13 Evolokumab 2.16.840.1.113883.6.73 2017-01 C10AX14 Alirokumab 2.16.840.1.113883.6.73 2017-01 C10B LIPID MODIFYING AGENTS, Medel som påverkar COMBINATIONS serumlipidnivåerna, kombinationer 2.16.840.1.113883.6.73 2017-01 C10BA HMG CoA reductase inhibitors in HMG CoA-reduktashämmare i combination with other lipid kombination med andra medel som modifying agents påverkar serumlipidnivåerna 2.16.840.1.113883.6.73 2017-01 C10BA01 lovastatin and nicotinic acid Lovastatin och nikotinsyra 2.16.840.1.113883.6.73 2017-01 C10BA02 simvastatin and ezetimibe Simvastatin och ezetimib 2.16.840.1.113883.6.73 2017-01 C10BA03 pravastatin and fenofibrate Pravastatin och fenofibrat 2.16.840.1.113883.6.73 2017-01 C10BA04 simvastatin and fenofibrate Simvastatin och fenofibrat 2.16.840.1.113883.6.73 2017-01 C10BA05 atorvastatin and ezetimibe Atorvastatin och ezetimib 2.16.840.1.113883.6.73 2017-01 C10BA06 rosuvastatin and ezetimibe Rosuvastatin och ezetimib 2.16.840.1.113883.6.73 2017-01 C10BX HMG CoA reductase inhibitors, HMG CoA-reduktashämmare, other combinations övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C10BX01 simvastatin and acetylsalicylic acid Simvastatin och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 C10BX02 pravastatin and acetylsalicylic acid Pravastatin och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 C10BX03 atorvastatin and amlodipine Atorvastatin och amlodipin 2.16.840.1.113883.6.73 2017-01 C10BX04 simvastatin, acetylsalicylic acid and Simvastatin, acetylsalicylsyra och ramipril ramipril © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 55 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C10BX05 rosuvastatin and acetylsalicylic acid Rosuvastatin och acetylsalisylsyra 2.16.840.1.113883.6.73 2017-01 C10BX06 atorvastatin, acetylsalicylic acid and Atorvastatin, acetylsalicylsyra och ramipril ramipril 2.16.840.1.113883.6.73 2017-01 C10BX07 rosuvastatin, amlodipine and Rosuvastatin, amlodipin och lisinopril lisinopril 2.16.840.1.113883.6.73 2017-01 C10BX08 atorvastatin and acetylsalicylic acid Atorvastatin och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 C10BX09 rosuvastatin and amlodipine Rosuvastatin och amlodipin 2.16.840.1.113883.6.73 2017-01 C10BX10 rosuvastatin and valsartan Rosuvastatin och valsartan 2.16.840.1.113883.6.73 2017-01 C10BX11 atorvastatin, amlodipine and Atorvastatin, amlodipin och perindopril perindopril 2.16.840.1.113883.6.73 2017-01 C10BX12 atorvastatin, acetylsalicylic acid and Atorvastatin, acetylsalicylsyra och perindopril perindopril 2.16.840.1.113883.6.73 2017-01 D DERMATOLOGICALS Hudpreparat 2.16.840.1.113883.6.73 2017-01 D01 FOR Svampmedel för utvärtes bruk DERMATOLOGICAL USE 2.16.840.1.113883.6.73 2017-01 D01A ANTIFUNGALS FOR TOPICAL Svampmedel för utvärtes bruk USE 2.16.840.1.113883.6.73 2017-01 D01AA Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 D01AA01 nystatin Nystatin 2.16.840.1.113883.6.73 2017-01 D01AA02 natamycin Natamycin 2.16.840.1.113883.6.73 2017-01 D01AA03 Hakimycin 2.16.840.1.113883.6.73 2017-01 D01AA04 pecilocin Pecilocin 2.16.840.1.113883.6.73 2017-01 D01AA06 mepartricin Mepartricin 2.16.840.1.113883.6.73 2017-01 D01AA07 pyrrolnitrin Pyrrolnitrin 2.16.840.1.113883.6.73 2017-01 D01AA08 Griseofulvin 2.16.840.1.113883.6.73 2017-01 D01AA20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 D01AC Imidazole and derivatives Imidazol- och triazolderivat 2.16.840.1.113883.6.73 2017-01 D01AC01 clotrimazole Klotrimazol 2.16.840.1.113883.6.73 2017-01 D01AC02 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 D01AC03 Ekonazol 2.16.840.1.113883.6.73 2017-01 D01AC04 Klormidazol 2.16.840.1.113883.6.73 2017-01 D01AC05 Isokonazol 2.16.840.1.113883.6.73 2017-01 D01AC06 Tiabendazol 2.16.840.1.113883.6.73 2017-01 D01AC07 Tiokonazol 2.16.840.1.113883.6.73 2017-01 D01AC08 Ketokonazol 2.16.840.1.113883.6.73 2017-01 D01AC09 Sulkonazol 2.16.840.1.113883.6.73 2017-01 D01AC10 Bifonazol 2.16.840.1.113883.6.73 2017-01 D01AC11 Oxikonazol 2.16.840.1.113883.6.73 2017-01 D01AC12 Fentikonazol 2.16.840.1.113883.6.73 2017-01 D01AC13 Omokonazol 2.16.840.1.113883.6.73 2017-01 D01AC14 Sertakonazol 2.16.840.1.113883.6.73 2017-01 D01AC15 Flukonazol 2.16.840.1.113883.6.73 2017-01 D01AC16 Flutrimazol 2.16.840.1.113883.6.73 2017-01 D01AC17 eberconazole Eberkonazol 2.16.840.1.113883.6.73 2017-01 D01AC18 Lulikonazol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 56 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D01AC19 Efinakonazol 2.16.840.1.113883.6.73 2017-01 D01AC20 / in combination Imidazoler/triazoler i kombination with corticosteroids med kortikosteroider 2.16.840.1.113883.6.73 2017-01 D01AC52 miconazole, combinations Mikonazol, kombinationer 2.16.840.1.113883.6.73 2017-01 D01AC60 bifonazole, combinations Bifonazol, kombinationer 2.16.840.1.113883.6.73 2017-01 D01AE Other antifungals for topical use Övriga utvärtes medel vid hudmykoser 2.16.840.1.113883.6.73 2017-01 D01AE01 bromochlorosalicylanilide Bromsalicylkloranilid 2.16.840.1.113883.6.73 2017-01 D01AE02 methylrosaniline Metylrosanilin 2.16.840.1.113883.6.73 2017-01 D01AE03 tribromometacresol Tribromometakresol 2.16.840.1.113883.6.73 2017-01 D01AE04 Undecylensyra 2.16.840.1.113883.6.73 2017-01 D01AE05 polynoxylin Polynoxylin 2.16.840.1.113883.6.73 2017-01 D01AE06 2-(4-chlorphenoxy)- Klorfenoxietanol 2.16.840.1.113883.6.73 2017-01 D01AE07 chlorphenesin Klorfenesin 2.16.840.1.113883.6.73 2017-01 D01AE08 Tiklaton 2.16.840.1.113883.6.73 2017-01 D01AE09 Sulbentin 2.16.840.1.113883.6.73 2017-01 D01AE10 ethyl hydroxybenzoate Etylhydroxibensoat 2.16.840.1.113883.6.73 2017-01 D01AE11 Haloprogin 2.16.840.1.113883.6.73 2017-01 D01AE12 Salicylsyra 2.16.840.1.113883.6.73 2017-01 D01AE13 selenium Selensulfid 2.16.840.1.113883.6.73 2017-01 D01AE14 Ciklopirox 2.16.840.1.113883.6.73 2017-01 D01AE15 Terbinafin 2.16.840.1.113883.6.73 2017-01 D01AE16 Amorolfin 2.16.840.1.113883.6.73 2017-01 D01AE17 Dimazol 2.16.840.1.113883.6.73 2017-01 D01AE18 Tolnaftat 2.16.840.1.113883.6.73 2017-01 D01AE19 Tolciklat 2.16.840.1.113883.6.73 2017-01 D01AE20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 D01AE21 Flucytosin 2.16.840.1.113883.6.73 2017-01 D01AE22 Naftifin 2.16.840.1.113883.6.73 2017-01 D01AE23 Butenafin 2.16.840.1.113883.6.73 2017-01 D01AE54 undecylenic acid, combinations Undecylensyra, kombinationer 2.16.840.1.113883.6.73 2017-01 D01B ANTIFUNGALS FOR SYSTEMIC Svampmedel för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 D01BA Antifungals for systemic use Svampmedel för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 D01BA01 griseofulvin Griseofulvin 2.16.840.1.113883.6.73 2017-01 D01BA02 terbinafine Terbinafin 2.16.840.1.113883.6.73 2017-01 D02 EMOLLIENTS AND PROTECTIVES Hudskyddande och uppmjukande medel 2.16.840.1.113883.6.73 2017-01 D02A EMOLLIENTS AND PROTECTIVES Hudskyddande och uppmjukande medel 2.16.840.1.113883.6.73 2017-01 D02AA Silicone products Silikonpreparat 2.16.840.1.113883.6.73 2017-01 D02AB Zinc products Zinkpreparat 2.16.840.1.113883.6.73 2017-01 D02AC Soft paraffin and fat products Mjukt paraffin och fettprodukter 2.16.840.1.113883.6.73 2017-01 D02AD Liquid plasters Flytande plåster 2.16.840.1.113883.6.73 2017-01 D02AE Carbamide products Karbamidpreparat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 57 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D02AE01 carbamide Karbamid 2.16.840.1.113883.6.73 2017-01 D02AE51 carbamide, combinations Karbamid, kombinationer 2.16.840.1.113883.6.73 2017-01 D02AF Salicylic acid preparations Salicylsyrapreparat 2.16.840.1.113883.6.73 2017-01 D02AX Other emollients and protectives Övriga hudskyddande och uppmjukande medel 2.16.840.1.113883.6.73 2017-01 D02B PROTECTIVES AGAINST UV- Medel som skyddar mot UV- RADIATION strålning 2.16.840.1.113883.6.73 2017-01 D02BA Protectives against UV-radiation for Medel som skyddar mot UV- topical use strålning, utvärtes 2.16.840.1.113883.6.73 2017-01 D02BA01 aminobenzoic acid Aminobensoesyra 2.16.840.1.113883.6.73 2017-01 D02BA02 octinoxate Oktinoxat 2.16.840.1.113883.6.73 2017-01 D02BB Protectives against UV-radiation for Medel som skyddar mot UV- systemic use strålning, systemiska 2.16.840.1.113883.6.73 2017-01 D02BB01 betacarotene Betakaroten 2.16.840.1.113883.6.73 2017-01 D02BB02 Afamelanotid 2.16.840.1.113883.6.73 2017-01 D03 PREPARATIONS FOR Medel vid sår- och brännskador TREATMENT OF WOUNDS AND ULCERS 2.16.840.1.113883.6.73 2017-01 D03A CICATRIZANTS Medel vid sår- och brännskador 2.16.840.1.113883.6.73 2017-01 D03AA Cod-liver oil ointments Torskleverolja, salva 2.16.840.1.113883.6.73 2017-01 D03AX Other cicatrizants Övriga medel vid sår-och brännskador 2.16.840.1.113883.6.73 2017-01 D03AX01 cadexomer iodine Kadexomerjod 2.16.840.1.113883.6.73 2017-01 D03AX02 dextranomer Dextranomer 2.16.840.1.113883.6.73 2017-01 D03AX03 dexpanthenol Dexapantenol 2.16.840.1.113883.6.73 2017-01 D03AX04 calcium pantothenate Kalciumpantotenat 2.16.840.1.113883.6.73 2017-01 D03AX05 Hyaluronsyra 2.16.840.1.113883.6.73 2017-01 D03AX06 becaplermin Bekaplermin 2.16.840.1.113883.6.73 2017-01 D03AX09 crilanomer Krilanomer 2.16.840.1.113883.6.73 2017-01 D03AX10 Enoxolon 2.16.840.1.113883.6.73 2017-01 D03AX11 sodium chlorite Natriumklorit 2.16.840.1.113883.6.73 2017-01 D03AX12 trolamine Trolamin 2.16.840.1.113883.6.73 2017-01 D03AX13 Betulae cortex Björk, bark 2.16.840.1.113883.6.73 2017-01 D03B ENZYMES Enzymer 2.16.840.1.113883.6.73 2017-01 D03BA Proteolytic enzymes Proteolytiska enzymer 2.16.840.1.113883.6.73 2017-01 D03BA01 trypsin Trypsin 2.16.840.1.113883.6.73 2017-01 D03BA02 collagenase Kollagenas 2.16.840.1.113883.6.73 2017-01 D03BA03 bromelains Bromelainer 2.16.840.1.113883.6.73 2017-01 D03BA52 collagenase, combinations Kollagenas, kombinationer 2.16.840.1.113883.6.73 2017-01 D04 , INCL. Klådstillande medel, inkl. , antihistaminer, anestetika etc. ANESTHETICS, ETC. 2.16.840.1.113883.6.73 2017-01 D04A ANTIPRURITICS, INCL. Klådstillande medel, inkl. ANTIHISTAMINES, antihistaminer, anestetika etc. ANESTHETICS, ETC. 2.16.840.1.113883.6.73 2017-01 D04AA Antihistamines for topical use Antihistaminer för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 D04AA01 Tonzylamin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 58 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D04AA02 Mepyramin 2.16.840.1.113883.6.73 2017-01 D04AA03 Tenalidin 2.16.840.1.113883.6.73 2017-01 D04AA04 Tripelenamin 2.16.840.1.113883.6.73 2017-01 D04AA09 Kloropyramin 2.16.840.1.113883.6.73 2017-01 D04AA10 Prometazin 2.16.840.1.113883.6.73 2017-01 D04AA12 Tolpropamin 2.16.840.1.113883.6.73 2017-01 D04AA13 Dimetinden 2.16.840.1.113883.6.73 2017-01 D04AA14 Klemastin 2.16.840.1.113883.6.73 2017-01 D04AA15 Bamipin 2.16.840.1.113883.6.73 2017-01 D04AA16 Feniramin 2.16.840.1.113883.6.73 2017-01 D04AA22 Isotipendyl 2.16.840.1.113883.6.73 2017-01 D04AA32 Difenhydramin 2.16.840.1.113883.6.73 2017-01 D04AA33 diphenhydramine methylbromide Difenhydraminmetylbromid 2.16.840.1.113883.6.73 2017-01 D04AA34 Klorfenoxamin 2.16.840.1.113883.6.73 2017-01 D04AB Anesthetics for topical use Lokalanestetika för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 D04AB01 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 D04AB02 cinchocaine Cinkain 2.16.840.1.113883.6.73 2017-01 D04AB03 Oxibuprokain 2.16.840.1.113883.6.73 2017-01 D04AB04 benzocaine Bensokain 2.16.840.1.113883.6.73 2017-01 D04AB05 Kinisokain 2.16.840.1.113883.6.73 2017-01 D04AB06 tetracaine Tetrakain 2.16.840.1.113883.6.73 2017-01 D04AB07 pramocaine Pramokain 2.16.840.1.113883.6.73 2017-01 D04AX Other antipruritics Övriga klådstillande medel 2.16.840.1.113883.6.73 2017-01 D05 ANTIPSORIATICS Medel vid 2.16.840.1.113883.6.73 2017-01 D05A ANTIPSORIATICS FOR TOPICAL Medel vid psoriasis för utvärtes bruk USE 2.16.840.1.113883.6.73 2017-01 D05AA Tars Tjäror 2.16.840.1.113883.6.73 2017-01 D05AC Antracen derivatives Antracenderivat 2.16.840.1.113883.6.73 2017-01 D05AC01 dithranol Ditranol 2.16.840.1.113883.6.73 2017-01 D05AC51 dithranol, combinations Ditranol, kombinationer 2.16.840.1.113883.6.73 2017-01 D05AD Psoralens for topical use Psoralener för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 D05AD01 trioxysalen Trioxisalen 2.16.840.1.113883.6.73 2017-01 D05AD02 Metoxsalen 2.16.840.1.113883.6.73 2017-01 D05AX Other antipsoriatics for topical use Övriga medel vid psoriasis för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 D05AX01 fumaric acid Fumarsyra 2.16.840.1.113883.6.73 2017-01 D05AX02 Kalcipotriol 2.16.840.1.113883.6.73 2017-01 D05AX03 calcitriol Kalcitriol 2.16.840.1.113883.6.73 2017-01 D05AX04 Takalcitol 2.16.840.1.113883.6.73 2017-01 D05AX05 tazarotene Tazaroten 2.16.840.1.113883.6.73 2017-01 D05AX52 calcipotriol, combinations Kalcipotriol, kombinationer 2.16.840.1.113883.6.73 2017-01 D05B ANTIPSORIATICS FOR SYSTEMIC Medel vid psoriasis för systemiskt USE bruk 2.16.840.1.113883.6.73 2017-01 D05BA Psoralens for systemic use Psoralener för systemiskt bruk

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 59 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D05BA01 trioxysalen Trioxisalen 2.16.840.1.113883.6.73 2017-01 D05BA02 methoxsalen Metoxsalen 2.16.840.1.113883.6.73 2017-01 D05BA03 bergapten Bergapten 2.16.840.1.113883.6.73 2017-01 D05BB Retinoids for treatment of psoriasis Retinoider för behandling av psoriasis 2.16.840.1.113883.6.73 2017-01 D05BB01 etretinate Etretinat 2.16.840.1.113883.6.73 2017-01 D05BB02 acitretin Acitretin 2.16.840.1.113883.6.73 2017-01 D05BX Other antipsoriatics for systemic use Övriga medel vid psoriasis för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 D05BX51 fumaric acid derivatives, Derivat av fumarsyra kombinationer combinations 2.16.840.1.113883.6.73 2017-01 D06 ANTIBIOTICS AND Antibiotika och kemoterapeutika för CHEMOTHERAPEUTICS FOR utvärtes bruk DERMATOLOGICAL USE 2.16.840.1.113883.6.73 2017-01 D06A ANTIBIOTICS FOR TOPICAL USE Antibiotika för topikal användning 2.16.840.1.113883.6.73 2017-01 D06AA Tetracycline and derivatives Tetracyklin och derivat 2.16.840.1.113883.6.73 2017-01 D06AA01 Demeklocyklin 2.16.840.1.113883.6.73 2017-01 D06AA02 chlortetracycline Klortetracyklin 2.16.840.1.113883.6.73 2017-01 D06AA03 Oxitetracyklin 2.16.840.1.113883.6.73 2017-01 D06AA04 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 D06AX Other antibiotics for topical use Övriga antibiotika för topikal användning 2.16.840.1.113883.6.73 2017-01 D06AX01 Fusidinsyra 2.16.840.1.113883.6.73 2017-01 D06AX02 Kloramfenikol 2.16.840.1.113883.6.73 2017-01 D06AX04 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 D06AX05 Bacitracin 2.16.840.1.113883.6.73 2017-01 D06AX07 Gentamicin 2.16.840.1.113883.6.73 2017-01 D06AX08 Tyrotricin 2.16.840.1.113883.6.73 2017-01 D06AX09 Mupirocin 2.16.840.1.113883.6.73 2017-01 D06AX10 Virginiamycin 2.16.840.1.113883.6.73 2017-01 D06AX11 rifaximin Rifaximin 2.16.840.1.113883.6.73 2017-01 D06AX12 Amikacin 2.16.840.1.113883.6.73 2017-01 D06AX13 Retapamulin 2.16.840.1.113883.6.73 2017-01 D06B CHEMOTHERAPEUTICS FOR Kemoterapeutika för topikal TOPICAL USE användning 2.16.840.1.113883.6.73 2017-01 D06BA Sulfonamides Sulfonamider 2.16.840.1.113883.6.73 2017-01 D06BA01 silver Silversulfadiazin 2.16.840.1.113883.6.73 2017-01 D06BA02 sulfathiazole Sulfatiazol 2.16.840.1.113883.6.73 2017-01 D06BA03 mafenide Mafenid 2.16.840.1.113883.6.73 2017-01 D06BA04 sulfamethizole Sulfametizol 2.16.840.1.113883.6.73 2017-01 D06BA05 sulfanilamide Sulfanilamid 2.16.840.1.113883.6.73 2017-01 D06BA06 sulfamerazine Sulfamerazin 2.16.840.1.113883.6.73 2017-01 D06BA51 silver sulfadiazine, combinations Silversulfadiazin, kombinationer 2.16.840.1.113883.6.73 2017-01 D06BB Antivirals Antivirala medel 2.16.840.1.113883.6.73 2017-01 D06BB01 idoxuridine Idoxuridin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 60 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D06BB02 tromantadine Tromantadin 2.16.840.1.113883.6.73 2017-01 D06BB03 aciclovir Aciklovir 2.16.840.1.113883.6.73 2017-01 D06BB04 podophyllotoxin Podofyllotoxin 2.16.840.1.113883.6.73 2017-01 D06BB05 Inosin 2.16.840.1.113883.6.73 2017-01 D06BB06 penciclovir Penciklovir 2.16.840.1.113883.6.73 2017-01 D06BB07 lysozyme Lysozym 2.16.840.1.113883.6.73 2017-01 D06BB08 ibacitabine Ibacitabin 2.16.840.1.113883.6.73 2017-01 D06BB09 edoxudine Edoxudin 2.16.840.1.113883.6.73 2017-01 D06BB10 imiquimod Imikvimod 2.16.840.1.113883.6.73 2017-01 D06BB11 docosanol Docosanol 2.16.840.1.113883.6.73 2017-01 D06BB12 sinecatechins Sinekatekiner 2.16.840.1.113883.6.73 2017-01 D06BB53 aciclovir, combinations Aciklovir, kombinationer 2.16.840.1.113883.6.73 2017-01 D06BX Other chemotherapeutics Övriga kemoterapeutika 2.16.840.1.113883.6.73 2017-01 D06BX01 metronidazole Metronidazol 2.16.840.1.113883.6.73 2017-01 D06BX02 ingenol mebutate Ingenolmebutat 2.16.840.1.113883.6.73 2017-01 D06C ANTIBIOTICS AND Antibiotika och kemoterapeutika i CHEMOTHERAPEUTICS, kombination COMBINATIONS 2.16.840.1.113883.6.73 2017-01 D07 CORTICOSTEROIDS, Kortikosteroider för utvärtes bruk DERMATOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 D07A CORTICOSTEROIDS, PLAIN Kortikosteroider 2.16.840.1.113883.6.73 2017-01 D07AA Corticosteroids, weak (group I) Kortikosteroider, milt verkande (grupp I) 2.16.840.1.113883.6.73 2017-01 D07AA01 Metylprednisolon 2.16.840.1.113883.6.73 2017-01 D07AA02 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 D07AA03 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 D07AB Corticosteroids, moderately potent Kortikosteroider, medelstarkt (group II) verkande (grupp II) 2.16.840.1.113883.6.73 2017-01 D07AB01 Klobetason 2.16.840.1.113883.6.73 2017-01 D07AB02 Hydrokortisonbutyrat 2.16.840.1.113883.6.73 2017-01 D07AB03 Flumetason 2.16.840.1.113883.6.73 2017-01 D07AB04 Fluokortin 2.16.840.1.113883.6.73 2017-01 D07AB05 Fluperolon 2.16.840.1.113883.6.73 2017-01 D07AB06 fluorometholone Fluorometolon 2.16.840.1.113883.6.73 2017-01 D07AB07 Flupredniden 2.16.840.1.113883.6.73 2017-01 D07AB08 Desonid 2.16.840.1.113883.6.73 2017-01 D07AB09 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 D07AB10 Alklometason 2.16.840.1.113883.6.73 2017-01 D07AB11 Hydrokortisonbuteprat 2.16.840.1.113883.6.73 2017-01 D07AB19 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 D07AB21 Klokortolone 2.16.840.1.113883.6.73 2017-01 D07AB30 combinations of corticosteroids Kombinationer av kortikosteroider 2.16.840.1.113883.6.73 2017-01 D07AC Corticosteroids, potent (group III) Kortikosteroider, starkt verkande (grupp III)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 61 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D07AC01 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 D07AC02 Fluklorolon 2.16.840.1.113883.6.73 2017-01 D07AC03 Desoximetason 2.16.840.1.113883.6.73 2017-01 D07AC04 Fluocinolonacetonid 2.16.840.1.113883.6.73 2017-01 D07AC05 fluocortolone Fluokortolon 2.16.840.1.113883.6.73 2017-01 D07AC06 Diflukortolon 2.16.840.1.113883.6.73 2017-01 D07AC07 Fludroxikortid 2.16.840.1.113883.6.73 2017-01 D07AC08 fluocinonide Fluocinonid 2.16.840.1.113883.6.73 2017-01 D07AC09 budesonide Budesonid 2.16.840.1.113883.6.73 2017-01 D07AC10 Diflorason 2.16.840.1.113883.6.73 2017-01 D07AC11 Amcinonid 2.16.840.1.113883.6.73 2017-01 D07AC12 Halometason 2.16.840.1.113883.6.73 2017-01 D07AC13 Mometason 2.16.840.1.113883.6.73 2017-01 D07AC14 methylprednisolone aceponate Metylprednisolonaceponat 2.16.840.1.113883.6.73 2017-01 D07AC15 beclometasone Beklometason 2.16.840.1.113883.6.73 2017-01 D07AC16 Hydrokortisonaceponat 2.16.840.1.113883.6.73 2017-01 D07AC17 Flutikason 2.16.840.1.113883.6.73 2017-01 D07AC18 Prednikarbat 2.16.840.1.113883.6.73 2017-01 D07AC19 Difluprednat 2.16.840.1.113883.6.73 2017-01 D07AC21 Ulobetasol 2.16.840.1.113883.6.73 2017-01 D07AD Corticosteroids, very potent (group Kortikosteroider, extra starkt IV) verkande (grupp IV) 2.16.840.1.113883.6.73 2017-01 D07AD01 Klobetasol 2.16.840.1.113883.6.73 2017-01 D07AD02 Halcinonid 2.16.840.1.113883.6.73 2017-01 D07B CORTICOSTEROIDS, Kortikosteroider i kombination med COMBINATIONS WITH antiseptika ANTISEPTICS 2.16.840.1.113883.6.73 2017-01 D07BA Corticosteroids, weak, combinations Kortikosteroider, milda, i with antiseptics kombination med antiseptika 2.16.840.1.113883.6.73 2017-01 D07BA01 prednisolone and antiseptics Prednisolon och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BA04 hydrocortisone and antiseptics Hydrokortison och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BB Corticosteroids, moderately potent, Kortikosteroider, medelstarka, i combinations with antiseptics kombination med antiseptika 2.16.840.1.113883.6.73 2017-01 D07BB01 flumetasone and antiseptics Flumetason och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BB02 desonide and antiseptics Desonid och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BB03 triamcinolone and antiseptics Triamcinolon och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BB04 hydrocortisone butyrate and Hydrokortisonbutyrat och antiseptika antiseptics 2.16.840.1.113883.6.73 2017-01 D07BC Corticosteroids, potent, Kortikosteroider, starka, i combinations with antiseptics kombination med antiseptika 2.16.840.1.113883.6.73 2017-01 D07BC01 betamethasone and antiseptics Betametason och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BC02 fluocinolone acetonide and Fluocinolonacetonid och antiseptika antiseptics 2.16.840.1.113883.6.73 2017-01 D07BC03 fluocortolone and antiseptics Fluokortolon och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BC04 diflucortolone and antiseptics Diflukortolon och antiseptika

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 62 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D07BD Corticosteroids, very potent, Kortikosteroider, mycket potenta i combinations with antiseptics kombination med antiseptika 2.16.840.1.113883.6.73 2017-01 D07C CORTICOSTEROIDS, Kortikosteroider i kombination med COMBINATIONS WITH antibiotika ANTIBIOTICS 2.16.840.1.113883.6.73 2017-01 D07CA Corticosteroids, weak, combinations Kortikosteroider, milda, i with antibiotics kombination med antibiotika 2.16.840.1.113883.6.73 2017-01 D07CA01 hydrocortisone and antibiotics Hydrokortison och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CA02 methylprednisolone and antibiotics Metylprednisolon och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CA03 prednisolone and antibiotics Prednisolon och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB Corticosteroids, moderately potent, Kortikosteroider, medelstarka, i combinations with antibiotics kombination med antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB01 triamcinolone and antibiotics Triamcinolon och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB02 fluprednidene and antibiotics Flupredniden och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB03 fluorometholone and antibiotics Fluorometolon och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB04 dexamethasone and antibiotics Dexametason och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB05 flumetasone and antibiotics Flumetason och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC Corticosteroids, potent, Kortikosteroider, starka, i combinations with antibiotics kombination med antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC01 betamethasone and antibiotics Betametason och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC02 fluocinolone acetonide and Fluocinolonacetonid och antibiotika antibiotics 2.16.840.1.113883.6.73 2017-01 D07CC03 fludroxycortide and antibiotics Fludroxikortid och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC04 beclometasone and antibiotics Beklometason och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC05 fluocinonide and antibiotics Fluocinonid och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC06 fluocortolone and antibiotics Fluokortolon och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CD Corticosteroids, very potent, Kortikosteroider, mycket potenta i combinations with antibiotics kombination med antibiotika 2.16.840.1.113883.6.73 2017-01 D07CD01 clobetasol and antibiotics Klobetasol och antibiotika 2.16.840.1.113883.6.73 2017-01 D07X CORTICOSTEROIDS, OTHER Kortikosteroider, övriga COMBINATIONS kombinationer 2.16.840.1.113883.6.73 2017-01 D07XA Corticosteroids, weak, other Milda kortikosteroider, övriga combinations kombinationer 2.16.840.1.113883.6.73 2017-01 D07XA01 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 D07XA02 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 D07XB Corticosteroids, moderately potent, Medelstarka kortikosteroider, övriga other combinations kombinationer 2.16.840.1.113883.6.73 2017-01 D07XB01 flumetasone Flumetason 2.16.840.1.113883.6.73 2017-01 D07XB02 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 D07XB03 fluprednidene Flupredniden 2.16.840.1.113883.6.73 2017-01 D07XB04 fluorometholone Fluorometolon 2.16.840.1.113883.6.73 2017-01 D07XB05 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 D07XB30 combinations of corticosteroids Kombinationer av kortikosteroider 2.16.840.1.113883.6.73 2017-01 D07XC Corticosteroids, potent, other Starka kortikosteroider, övriga combinations kombinationer 2.16.840.1.113883.6.73 2017-01 D07XC01 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 D07XC02 desoximetasone Desoximetason

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 63 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D07XC03 mometasone Mometason 2.16.840.1.113883.6.73 2017-01 D07XC04 diflucortolone Diflukortolon 2.16.840.1.113883.6.73 2017-01 D07XC05 fluocortolone Fluokortolon 2.16.840.1.113883.6.73 2017-01 D07XD Corticosteroids, very potent, other Mycket potenta kortikosteroider, combinations övriga kombinationer 2.16.840.1.113883.6.73 2017-01 D08 ANTISEPTICS AND Antiseptika och sårmedel DISINFECTANTS 2.16.840.1.113883.6.73 2017-01 D08A ANTISEPTICS AND Antiseptika och sårmedel DISINFECTANTS 2.16.840.1.113883.6.73 2017-01 D08AA Acridine derivatives Akridinderivat 2.16.840.1.113883.6.73 2017-01 D08AA01 ethacridine lactate Etakridinlaktat 2.16.840.1.113883.6.73 2017-01 D08AA02 aminoacridine Aminoakridin 2.16.840.1.113883.6.73 2017-01 D08AA03 euflavine Euflavin 2.16.840.1.113883.6.73 2017-01 D08AB Aluminium agents Aluminiumföreningar 2.16.840.1.113883.6.73 2017-01 D08AC Biguanides and amidines Biguanider och amidiner 2.16.840.1.113883.6.73 2017-01 D08AC01 dibrompropamidine Dibrompropamidin 2.16.840.1.113883.6.73 2017-01 D08AC02 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 D08AC03 Propamidin 2.16.840.1.113883.6.73 2017-01 D08AC04 Hexamidin 2.16.840.1.113883.6.73 2017-01 D08AC05 polihexanide Polihexanid 2.16.840.1.113883.6.73 2017-01 D08AC52 chlorhexidine, combinations Klorhexidin, kombinationer 2.16.840.1.113883.6.73 2017-01 D08AD products Borsyrapreparat 2.16.840.1.113883.6.73 2017-01 D08AE Phenol and derivatives Fenol och fenolderivat 2.16.840.1.113883.6.73 2017-01 D08AE01 hexachlorophene Hexaklorofen 2.16.840.1.113883.6.73 2017-01 D08AE02 Polikresulen 2.16.840.1.113883.6.73 2017-01 D08AE03 phenol Fenol 2.16.840.1.113883.6.73 2017-01 D08AE04 Triklosan 2.16.840.1.113883.6.73 2017-01 D08AE05 chloroxylenol Kloroxylenol 2.16.840.1.113883.6.73 2017-01 D08AE06 biphenylol Bifenylol 2.16.840.1.113883.6.73 2017-01 D08AF derivatives Nitrofuranderivat 2.16.840.1.113883.6.73 2017-01 D08AF01 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 D08AG Iodine products Jodpreparat 2.16.840.1.113883.6.73 2017-01 D08AG01 iodine/octylphenoxypolyglycolether Jod/oktylfenoxipolyglykoleter 2.16.840.1.113883.6.73 2017-01 D08AG02 povidone-iodine Povidon, joderad 2.16.840.1.113883.6.73 2017-01 D08AG03 iodine Jod 2.16.840.1.113883.6.73 2017-01 D08AG04 diiodohydroxypropane Dijodhydroxipropan 2.16.840.1.113883.6.73 2017-01 D08AH derivatives Kinolinderivat 2.16.840.1.113883.6.73 2017-01 D08AH01 Dekvalinium 2.16.840.1.113883.6.73 2017-01 D08AH02 Klorkinaldol 2.16.840.1.113883.6.73 2017-01 D08AH03 oxyquinoline Hydroxikinolin 2.16.840.1.113883.6.73 2017-01 D08AH30 Kliokinol 2.16.840.1.113883.6.73 2017-01 D08AJ Quaternary ammonium compounds Kvartära ammoniumföreningar 2.16.840.1.113883.6.73 2017-01 D08AJ01 benzalkonium Bensalkonium 2.16.840.1.113883.6.73 2017-01 D08AJ02 Cetrimonium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 64 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D08AJ03 cetylpyridinium Cetylpyridinium 2.16.840.1.113883.6.73 2017-01 D08AJ04 cetrimide Cetrimid 2.16.840.1.113883.6.73 2017-01 D08AJ05 benzoxonium chloride Bensoxoniumklorid 2.16.840.1.113883.6.73 2017-01 D08AJ06 didecyldimethylammonium chloride Didecyldimetylammoniumklorid 2.16.840.1.113883.6.73 2017-01 D08AJ08 Bensetoniumklorid 2.16.840.1.113883.6.73 2017-01 D08AJ10 decamethoxine Dekametoxin 2.16.840.1.113883.6.73 2017-01 D08AJ57 octenidine, combinations Oktenidin, kombinationer 2.16.840.1.113883.6.73 2017-01 D08AJ58 benzethonium chloride, Bensetoniumklorid, kombinationer combinations 2.16.840.1.113883.6.73 2017-01 D08AJ59 dodeclonium bromide, combinations Dodekloniumbromid, kombinationer 2.16.840.1.113883.6.73 2017-01 D08AK Mercurial products Kvicksilverföreningar 2.16.840.1.113883.6.73 2017-01 D08AK01 mercuric amidochloride Kvicksilveramidoklorid 2.16.840.1.113883.6.73 2017-01 D08AK02 phenylmercuric borate Fenylkvicksilverborat 2.16.840.1.113883.6.73 2017-01 D08AK03 mercuric chloride Kvicksilverdiklorid 2.16.840.1.113883.6.73 2017-01 D08AK04 mercurochrome Merbromin 2.16.840.1.113883.6.73 2017-01 D08AK05 mercury, metallic Kvicksilver, metallisk 2.16.840.1.113883.6.73 2017-01 D08AK06 thiomersal Tiomersal 2.16.840.1.113883.6.73 2017-01 D08AK30 mercuric iodide Kvicksilverdijodid 2.16.840.1.113883.6.73 2017-01 D08AL Silver compounds Silverpreparat 2.16.840.1.113883.6.73 2017-01 D08AL01 silver nitrate Silvernitrat 2.16.840.1.113883.6.73 2017-01 D08AL30 silver Silver 2.16.840.1.113883.6.73 2017-01 D08AX Other antiseptics and disinfectants Övriga antiseptika och sårmedel 2.16.840.1.113883.6.73 2017-01 D08AX01 hydrogen peroxide Väteperoxid 2.16.840.1.113883.6.73 2017-01 D08AX02 eosin Eosin 2.16.840.1.113883.6.73 2017-01 D08AX03 propanol Propanol 2.16.840.1.113883.6.73 2017-01 D08AX04 tosylchloramide sodium Tosylkloramidnatrium 2.16.840.1.113883.6.73 2017-01 D08AX05 isopropanol Isopropanol 2.16.840.1.113883.6.73 2017-01 D08AX06 potassium permanganate Kaliumpermanganat 2.16.840.1.113883.6.73 2017-01 D08AX07 sodium hypochlorite Natriumhypoklorit 2.16.840.1.113883.6.73 2017-01 D08AX08 ethanol Etanol 2.16.840.1.113883.6.73 2017-01 D08AX53 propanol, combinations Propanol, kombinationer 2.16.840.1.113883.6.73 2017-01 D09 MEDICATED DRESSINGS Medicinska förband 2.16.840.1.113883.6.73 2017-01 D09A MEDICATED DRESSINGS Medicinska förband 2.16.840.1.113883.6.73 2017-01 D09AA Medicated dressings with Medicinska förband med antiinfectives antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 D09AA01 framycetin Framycetin 2.16.840.1.113883.6.73 2017-01 D09AA02 fusidic acid Fusidinsyra 2.16.840.1.113883.6.73 2017-01 D09AA03 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 D09AA04 phenylmercuric nitrate Fenylmerkurinitrat 2.16.840.1.113883.6.73 2017-01 D09AA05 benzododecinium Bensododecinium 2.16.840.1.113883.6.73 2017-01 D09AA06 triclosan Triklosan 2.16.840.1.113883.6.73 2017-01 D09AA07 cetylpyridinium Cetylpyridinium 2.16.840.1.113883.6.73 2017-01 D09AA08 aluminium chlorohydrate Aluminiumklorhydrat 2.16.840.1.113883.6.73 2017-01 D09AA09 povidone-iodine Povidon, joderad © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 65 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D09AA10 clioquinol Kliokinol 2.16.840.1.113883.6.73 2017-01 D09AA11 benzalkonium Bensalkonium 2.16.840.1.113883.6.73 2017-01 D09AA12 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 D09AA13 Jodoform 2.16.840.1.113883.6.73 2017-01 D09AB Zinc bandages Zinkbandage 2.16.840.1.113883.6.73 2017-01 D09AB01 zinc bandage without supplements Zinkbandage utan tillägg 2.16.840.1.113883.6.73 2017-01 D09AB02 zinc bandage with supplements Zinkbandage med tillägg 2.16.840.1.113883.6.73 2017-01 D09AX Soft paraffin dressings Mjuka paraffinkompresser 2.16.840.1.113883.6.73 2017-01 D10 ANTI-ACNE PREPARATIONS Medel mot akne 2.16.840.1.113883.6.73 2017-01 D10A ANTI-ACNE PREPARATIONS FOR Medel mot akne för utvärtes bruk TOPICAL USE 2.16.840.1.113883.6.73 2017-01 D10AA Corticosteroids, combinations for Kortikosteroider, kombinationer för treatment of acne behandling av akne 2.16.840.1.113883.6.73 2017-01 D10AA01 fluorometholone Fluorometolon 2.16.840.1.113883.6.73 2017-01 D10AA02 methylprednisolone Metylprednisolon 2.16.840.1.113883.6.73 2017-01 D10AA03 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 D10AB Preparations containing Medel innehållande svavel 2.16.840.1.113883.6.73 2017-01 D10AB01 bithionol Bitionol 2.16.840.1.113883.6.73 2017-01 D10AB02 sulfur Svavel 2.16.840.1.113883.6.73 2017-01 D10AB03 tioxolone Tioxolon 2.16.840.1.113883.6.73 2017-01 D10AB05 Mesulfen 2.16.840.1.113883.6.73 2017-01 D10AD Retinoids for topical use in acne Retinoider för utvärtes behandling mot akne 2.16.840.1.113883.6.73 2017-01 D10AD01 Tretinoin 2.16.840.1.113883.6.73 2017-01 D10AD02 retinol Retinol (vitamin A) 2.16.840.1.113883.6.73 2017-01 D10AD03 adapalene Adapalen 2.16.840.1.113883.6.73 2017-01 D10AD04 Isotretinoin 2.16.840.1.113883.6.73 2017-01 D10AD05 motretinide Motretinid 2.16.840.1.113883.6.73 2017-01 D10AD51 tretinoin, combinations Tretinoin, kombinationer 2.16.840.1.113883.6.73 2017-01 D10AD53 adapalene, combinations Adapalen, kombinationer 2.16.840.1.113883.6.73 2017-01 D10AD54 isotretinoin, combinations Isotretinoin, kombinationer 2.16.840.1.113883.6.73 2017-01 D10AE Peroxides Peroxider 2.16.840.1.113883.6.73 2017-01 D10AE01 benzoyl peroxide Bensoylperoxid 2.16.840.1.113883.6.73 2017-01 D10AE51 benzoyl peroxide, combinations Bensoylperoxid, kombinationer 2.16.840.1.113883.6.73 2017-01 D10AF Antiinfectives for treatment of acne Antiinfektiva medel mot akne 2.16.840.1.113883.6.73 2017-01 D10AF01 Klindamycin 2.16.840.1.113883.6.73 2017-01 D10AF02 Erytromycin 2.16.840.1.113883.6.73 2017-01 D10AF03 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 D10AF04 Meklocyklin 2.16.840.1.113883.6.73 2017-01 D10AF05 nadifloxacin Nadifloxacin 2.16.840.1.113883.6.73 2017-01 D10AF06 sulfacetamide Sulfacetamid 2.16.840.1.113883.6.73 2017-01 D10AF51 clindamycin, combinations Klindamycin, kombinationer 2.16.840.1.113883.6.73 2017-01 D10AF52 erythromycin, combinations Erytromycin, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 66 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D10AX Other anti-acne preparations for Övriga medel mot akne för utvärtes topical use bruk 2.16.840.1.113883.6.73 2017-01 D10AX01 Aluminiumklorid 2.16.840.1.113883.6.73 2017-01 D10AX02 Resorcinol 2.16.840.1.113883.6.73 2017-01 D10AX03 azelaic acid Azelainsyra 2.16.840.1.113883.6.73 2017-01 D10AX04 Aluminiumoxid 2.16.840.1.113883.6.73 2017-01 D10AX05 Dapson 2.16.840.1.113883.6.73 2017-01 D10AX30 various combinations Övriga kombinationer 2.16.840.1.113883.6.73 2017-01 D10B ANTI-ACNE PREPARATIONS FOR Medel mot akne för systemiskt bruk SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 D10BA Retinoids for treatment of acne Retinoider mot akne 2.16.840.1.113883.6.73 2017-01 D10BA01 isotretinoin Isotretinoin 2.16.840.1.113883.6.73 2017-01 D10BX Other anti-acne preparations for Övriga medel mot akne för systemic use systemiskt bruk 2.16.840.1.113883.6.73 2017-01 D10BX01 ichtasol Ichtasol 2.16.840.1.113883.6.73 2017-01 D11 OTHER DERMATOLOGICAL Övriga dermatologiska medel PREPARATIONS 2.16.840.1.113883.6.73 2017-01 D11A OTHER DERMATOLOGICAL Övriga dermatologiska medel PREPARATIONS 2.16.840.1.113883.6.73 2017-01 D11AA Antihidrotics Antitranspirationsmedel 2.16.840.1.113883.6.73 2017-01 D11AC Medicated shampoos Medicinska schampon 2.16.840.1.113883.6.73 2017-01 D11AC01 cetrimide Cetrimid 2.16.840.1.113883.6.73 2017-01 D11AC02 cadmium compounds Kadmiumföreningar 2.16.840.1.113883.6.73 2017-01 D11AC03 selenium compounds Selensulfid 2.16.840.1.113883.6.73 2017-01 D11AC06 povidone-iodine Povidon, joderad 2.16.840.1.113883.6.73 2017-01 D11AC08 sulfur compounds Svavelkombinationer 2.16.840.1.113883.6.73 2017-01 D11AC09 xenysalate Xenysalat 2.16.840.1.113883.6.73 2017-01 D11AC30 others Övrigt 2.16.840.1.113883.6.73 2017-01 D11AE for topical use Anabola steroider 2.16.840.1.113883.6.73 2017-01 D11AE01 metandienone Metandienon 2.16.840.1.113883.6.73 2017-01 D11AF Wart and anti-corn preparations Vårtmedel 2.16.840.1.113883.6.73 2017-01 D11AH Agents for , excluding Medel vid dermatit, exkl. corticosteroids kortikosteroider 2.16.840.1.113883.6.73 2017-01 D11AH01 Takrolimus 2.16.840.1.113883.6.73 2017-01 D11AH02 Pimekrolimus 2.16.840.1.113883.6.73 2017-01 D11AH03 cromoglicic acid Natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 D11AH04 Alitretinoin 2.16.840.1.113883.6.73 2017-01 D11AX Other dermatologicals Övriga dermatologiska medel 2.16.840.1.113883.6.73 2017-01 D11AX01 minoxidil Minoxidil 2.16.840.1.113883.6.73 2017-01 D11AX02 gamolenic acid Gamolensyra 2.16.840.1.113883.6.73 2017-01 D11AX03 calcium gluconate Kalciumglukonat 2.16.840.1.113883.6.73 2017-01 D11AX04 succinate Litiumsuccinat 2.16.840.1.113883.6.73 2017-01 D11AX05 magnesium sulfate Magnesiumsulfat 2.16.840.1.113883.6.73 2017-01 D11AX06 Mekinol 2.16.840.1.113883.6.73 2017-01 D11AX08 Tiratrikol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 67 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D11AX09 Oxaceprol 2.16.840.1.113883.6.73 2017-01 D11AX10 Finasterid 2.16.840.1.113883.6.73 2017-01 D11AX11 Hydrokinon 2.16.840.1.113883.6.73 2017-01 D11AX12 pyrithione zinc Pyrithion zink 2.16.840.1.113883.6.73 2017-01 D11AX13 Monobenzon 2.16.840.1.113883.6.73 2017-01 D11AX16 Eflornitin 2.16.840.1.113883.6.73 2017-01 D11AX18 Diklofenak 2.16.840.1.113883.6.73 2017-01 D11AX21 Brimonidin 2.16.840.1.113883.6.73 2017-01 D11AX22 Ivermektin 2.16.840.1.113883.6.73 2017-01 D11AX23 aminobenzoate potassium Aminobensoatkalium 2.16.840.1.113883.6.73 2017-01 D11AX24 deoxycholic acid Deoxicholsyra 2.16.840.1.113883.6.73 2017-01 D11AX52 gamolenic acid, combinations Gamolensyra, kombinationer 2.16.840.1.113883.6.73 2017-01 D11AX57 collagen, combinations Kollagen, kombinationer 2.16.840.1.113883.6.73 2017-01 G GENITO AND Urin- och könsorgan samt SEX könshormoner 2.16.840.1.113883.6.73 2017-01 G01 GYNECOLOGICAL Antiinfektiva och antiseptiska medel ANTIINFECTIVES AND för gynekologiskt bruk ANTISEPTICS 2.16.840.1.113883.6.73 2017-01 G01A ANTIINFECTIVES AND Antiinfektiva och antiseptiska medel, ANTISEPTICS, EXCL. exkl. kombinationer med COMBINATIONS WITH kortikosteroider CORTICOSTEROIDS 2.16.840.1.113883.6.73 2017-01 G01AA Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 G01AA01 nystatin Nystatin 2.16.840.1.113883.6.73 2017-01 G01AA02 natamycin Natamycin 2.16.840.1.113883.6.73 2017-01 G01AA03 amphotericin B Amfotericin B 2.16.840.1.113883.6.73 2017-01 G01AA04 Kandicidin 2.16.840.1.113883.6.73 2017-01 G01AA05 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 G01AA06 hachimycin Hakimycin 2.16.840.1.113883.6.73 2017-01 G01AA07 oxytetracycline Oxitetracyklin 2.16.840.1.113883.6.73 2017-01 G01AA08 Karfecillin 2.16.840.1.113883.6.73 2017-01 G01AA09 mepartricin Mepartricin 2.16.840.1.113883.6.73 2017-01 G01AA10 clindamycin Klindamycin 2.16.840.1.113883.6.73 2017-01 G01AA11 Pentamycin 2.16.840.1.113883.6.73 2017-01 G01AA51 nystatin, combinations Nystatin, kombinationer 2.16.840.1.113883.6.73 2017-01 G01AB Arsenic compounds Arsenikföreningar 2.16.840.1.113883.6.73 2017-01 G01AB01 acetarsol Acetarsol 2.16.840.1.113883.6.73 2017-01 G01AC Quinoline derivatives Kinolinderivat 2.16.840.1.113883.6.73 2017-01 G01AC01 Dijodhydroxikinolin 2.16.840.1.113883.6.73 2017-01 G01AC02 clioquinol Kliokinol 2.16.840.1.113883.6.73 2017-01 G01AC03 chlorquinaldol Klorkinaldol 2.16.840.1.113883.6.73 2017-01 G01AC05 dequalinium Dekvalinium 2.16.840.1.113883.6.73 2017-01 G01AC06 broxyquinoline Broxikinolin 2.16.840.1.113883.6.73 2017-01 G01AC30 oxyquinoline Hydroxikinolin 2.16.840.1.113883.6.73 2017-01 G01AD Organic acids Organiska syror

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 68 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G01AD01 lactic acid Mjölksyra 2.16.840.1.113883.6.73 2017-01 G01AD02 Ättiksyra 2.16.840.1.113883.6.73 2017-01 G01AD03 ascorbic acid Askorbinsyra (vitamin C) 2.16.840.1.113883.6.73 2017-01 G01AE Sulfonamides Sulfonamider 2.16.840.1.113883.6.73 2017-01 G01AE01 Sulfatolamid 2.16.840.1.113883.6.73 2017-01 G01AE10 combinations of sulfonamides Kombinationer av sulfonamider 2.16.840.1.113883.6.73 2017-01 G01AF Imidazole derivatives Imidazolderivat 2.16.840.1.113883.6.73 2017-01 G01AF01 metronidazole Metronidazol 2.16.840.1.113883.6.73 2017-01 G01AF02 clotrimazole Klotrimazol 2.16.840.1.113883.6.73 2017-01 G01AF04 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 G01AF05 econazole Ekonazol 2.16.840.1.113883.6.73 2017-01 G01AF06 Ornidazol 2.16.840.1.113883.6.73 2017-01 G01AF07 isoconazole Isokonazol 2.16.840.1.113883.6.73 2017-01 G01AF08 tioconazole Tiokonazol 2.16.840.1.113883.6.73 2017-01 G01AF11 ketoconazole Ketokonazol 2.16.840.1.113883.6.73 2017-01 G01AF12 fenticonazole Fentikonazol 2.16.840.1.113883.6.73 2017-01 G01AF13 Azanidazol 2.16.840.1.113883.6.73 2017-01 G01AF14 Propenidazol 2.16.840.1.113883.6.73 2017-01 G01AF15 Butokonazol 2.16.840.1.113883.6.73 2017-01 G01AF16 omoconazole Omokonazol 2.16.840.1.113883.6.73 2017-01 G01AF17 oxiconazole Oxikonazol 2.16.840.1.113883.6.73 2017-01 G01AF18 flutrimazole Flutrimazol 2.16.840.1.113883.6.73 2017-01 G01AF19 sertaconazole Sertakonazol 2.16.840.1.113883.6.73 2017-01 G01AF20 combinations of imidazole Kombinationer av imidazolderivat derivatives 2.16.840.1.113883.6.73 2017-01 G01AG Triazole derivatives Triazolderivat 2.16.840.1.113883.6.73 2017-01 G01AG02 Terkonazol 2.16.840.1.113883.6.73 2017-01 G01AX Other antiinfectives and antiseptics Övriga antiinfektiva och antiseptiska medel 2.16.840.1.113883.6.73 2017-01 G01AX01 clodantoin Klodantoin 2.16.840.1.113883.6.73 2017-01 G01AX02 inosine Inosin 2.16.840.1.113883.6.73 2017-01 G01AX03 policresulen Polikresulen 2.16.840.1.113883.6.73 2017-01 G01AX05 Nifuratel 2.16.840.1.113883.6.73 2017-01 G01AX06 Furazolidon 2.16.840.1.113883.6.73 2017-01 G01AX09 methylrosaniline Metylrosanilin 2.16.840.1.113883.6.73 2017-01 G01AX11 povidone-iodine Povidon, joderad 2.16.840.1.113883.6.73 2017-01 G01AX12 ciclopirox Ciklopirox 2.16.840.1.113883.6.73 2017-01 G01AX13 Protiofat 2.16.840.1.113883.6.73 2017-01 G01AX14 fermentum Lactobacillus fermentum 2.16.840.1.113883.6.73 2017-01 G01AX15 usnate Kopparusnat 2.16.840.1.113883.6.73 2017-01 G01AX16 hexetidine Hexetidin 2.16.840.1.113883.6.73 2017-01 G01AX66 octenidine, combinations Oktenidin, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 69 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G01B ANTIINFECTIVES/ANTISEPTICS Antiinfektiva och antiseptiska medel IN COMBINATION WITH i kombination med kortikosteroider CORTICOSTEROIDS 2.16.840.1.113883.6.73 2017-01 G01BA Antibiotics and corticosteroids Antibiotika och kortikosteroider 2.16.840.1.113883.6.73 2017-01 G01BC Quinoline derivatives and Kinolinderivat och kortikosteroider corticosteroids 2.16.840.1.113883.6.73 2017-01 G01BD Antiseptics and corticosteroids Antiseptika och kortikosteroider 2.16.840.1.113883.6.73 2017-01 G01BE Sulfonamides and corticosteroids Sulfonamider och kortikosteroider 2.16.840.1.113883.6.73 2017-01 G01BF Imidazole derivatives and Imidazolderivat och kortikosteroider corticosteroids 2.16.840.1.113883.6.73 2017-01 G02 OTHER GYNECOLOGICALS Övriga medel för gynekologiskt bruk 2.16.840.1.113883.6.73 2017-01 G02A Uteruskontraherande medel 2.16.840.1.113883.6.73 2017-01 G02AB Ergot alkaloids Mjöldrygealkaloider 2.16.840.1.113883.6.73 2017-01 G02AB01 Metylergometrin 2.16.840.1.113883.6.73 2017-01 G02AB02 ergot alkaloids Mjöldrygealkaloider 2.16.840.1.113883.6.73 2017-01 G02AB03 ergometrine Ergometrin 2.16.840.1.113883.6.73 2017-01 G02AC Ergot alkaloids and oxytocin incl. Mjöldrygealkaloider och oxytocin, analogues, in combination inkl analoger, i kombination 2.16.840.1.113883.6.73 2017-01 G02AC01 methylergometrine and oxytocin Metylergometrin och oxytocin 2.16.840.1.113883.6.73 2017-01 G02AD Prostaglandins Prostaglandiner 2.16.840.1.113883.6.73 2017-01 G02AD01 dinoprost Dinoprost 2.16.840.1.113883.6.73 2017-01 G02AD02 dinoprostone Dinoproston 2.16.840.1.113883.6.73 2017-01 G02AD03 gemeprost Gemeprost 2.16.840.1.113883.6.73 2017-01 G02AD04 carboprost Karboprost 2.16.840.1.113883.6.73 2017-01 G02AD05 sulprostone Sulproston 2.16.840.1.113883.6.73 2017-01 G02AD06 misoprostol Misoprostol 2.16.840.1.113883.6.73 2017-01 G02AX Other uterotonics Övriga uteruskontraherande medel 2.16.840.1.113883.6.73 2017-01 G02B CONTRACEPTIVES FOR TOPICAL Antikonceptionella medel för lokal USE användning 2.16.840.1.113883.6.73 2017-01 G02BA Intrauterine contraceptives Intrauterina preventivmedel 2.16.840.1.113883.6.73 2017-01 G02BA01 plastic IUD Plastiskt intrauterint preventivmedel 2.16.840.1.113883.6.73 2017-01 G02BA02 plastic IUD with copper Plastiskt intrauterint preventivmedel med koppar 2.16.840.1.113883.6.73 2017-01 G02BA03 plastic IUD with Plastiskt intrauterint preventivmedel med gestagen 2.16.840.1.113883.6.73 2017-01 G02BB Intravaginal contraceptives Intravaginala preventivmedel 2.16.840.1.113883.6.73 2017-01 G02BB01 vaginal ring with progestogen and Vaginalring med progestogen och östrogen 2.16.840.1.113883.6.73 2017-01 G02C OTHER GYNECOLOGICALS Övriga medel för gynekologiskt bruk 2.16.840.1.113883.6.73 2017-01 G02CA Sympathomimetics, labour Sympatomimetika för repressants undertryckande av värkarbete 2.16.840.1.113883.6.73 2017-01 G02CA01 ritodrine Ritodrin 2.16.840.1.113883.6.73 2017-01 G02CA02 buphenine Bufenin 2.16.840.1.113883.6.73 2017-01 G02CA03 Fenoterol 2.16.840.1.113883.6.73 2017-01 G02CB Prolactine inhibitors Prolaktinhämmare 2.16.840.1.113883.6.73 2017-01 G02CB01 Bromokriptin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 70 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G02CB02 Lisurid 2.16.840.1.113883.6.73 2017-01 G02CB03 Kabergolin 2.16.840.1.113883.6.73 2017-01 G02CB04 Kinagolid 2.16.840.1.113883.6.73 2017-01 G02CB05 Metergolin 2.16.840.1.113883.6.73 2017-01 G02CB06 Tergurid 2.16.840.1.113883.6.73 2017-01 G02CC Antiinflammatory products for Antiinflammatoriska medel för vaginal administration vaginal administrering 2.16.840.1.113883.6.73 2017-01 G02CC01 ibuprofen Ibuprofen 2.16.840.1.113883.6.73 2017-01 G02CC02 Naproxen 2.16.840.1.113883.6.73 2017-01 G02CC03 benzydamine Bensydamin 2.16.840.1.113883.6.73 2017-01 G02CC04 Flunoxaprofen 2.16.840.1.113883.6.73 2017-01 G02CX Other gynecologicals Övriga medel för gynekologiskt bruk 2.16.840.1.113883.6.73 2017-01 G02CX01 atosiban Atosiban 2.16.840.1.113883.6.73 2017-01 G02CX02 Flibanserin 2.16.840.1.113883.6.73 2017-01 G02CX03 Agni casti fructus Munkpeppar, frukt 2.16.840.1.113883.6.73 2017-01 G02CX04 Cimicifugae rhizoma Läkesilverax, jordstam 2.16.840.1.113883.6.73 2017-01 G03 SEX HORMONES AND Könshormoner och modulatorer av MODULATORS OF THE GENITAL könsorgan SYSTEM 2.16.840.1.113883.6.73 2017-01 G03A HORMONAL CONTRACEPTIVES Hormonella antikonceptionella FOR SYSTEMIC USE medel för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 G03AA and , fixed Gestagener och östrogener i fasta combinations kombinationer 2.16.840.1.113883.6.73 2017-01 G03AA01 etynodiol and Etynodiol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA02 quingestanol and ethinylestradiol Kingestanol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA03 and ethinylestradiol Lynestrenol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA04 megestrol and ethinylestradiol Megestrol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA05 and ethinylestradiol Noretisteron och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA06 and ethinylestradiol Norgestrel och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA07 and ethinylestradiol Levonorgestrel och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA08 medroxyprogesterone and Medroxiprogesteron och ethinylestradiol etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA09 and ethinylestradiol Desogestrel och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA10 and ethinylestradiol Gestoden och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA11 and ethinylestradiol Norgestimat och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA12 and ethinylestradiol Drospirenon och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA13 and ethinylestradiol Norelgestromin och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA14 nomegestrol and Nomegestrol och estradiol 2.16.840.1.113883.6.73 2017-01 G03AA15 chlormadinone and ethinylestradiol Klormadinon och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA16 and ethinylestradiol Dienogest och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB Progestogens and estrogens, Gestagener och östrogener, sequential preparations sekvenspreparat 2.16.840.1.113883.6.73 2017-01 G03AB01 megestrol and ethinylestradiol Megestrol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB02 lynestrenol and ethinylestradiol Lynestrenol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB03 levonorgestrel and ethinylestradiol Levonorgestrel och etinylestradiol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 71 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03AB04 norethisterone and ethinylestradiol Noretisteron och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB05 desogestrel and ethinylestradiol Desogestrel och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB06 gestodene and ethinylestradiol Gestoden och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB07 chlormadinone and ethinylestradiol Klormadinon och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB08 dienogest and estradiol Dienogest och estradiol 2.16.840.1.113883.6.73 2017-01 G03AC Progestogens Gestagener 2.16.840.1.113883.6.73 2017-01 G03AC01 norethisterone Noretisteron 2.16.840.1.113883.6.73 2017-01 G03AC02 lynestrenol Lynestrenol 2.16.840.1.113883.6.73 2017-01 G03AC03 levonorgestrel Levonorgestrel 2.16.840.1.113883.6.73 2017-01 G03AC04 quingestanol Kvingestanol 2.16.840.1.113883.6.73 2017-01 G03AC05 megestrol Megestrol 2.16.840.1.113883.6.73 2017-01 G03AC06 medroxyprogesterone Medroxiprogesteron 2.16.840.1.113883.6.73 2017-01 G03AC07 Norgestrienon 2.16.840.1.113883.6.73 2017-01 G03AC08 Etonogestrel 2.16.840.1.113883.6.73 2017-01 G03AC09 desogestrel Desogestrel 2.16.840.1.113883.6.73 2017-01 G03AC10 drospirenone Drospirenon 2.16.840.1.113883.6.73 2017-01 G03AD Emergency contraceptives Akut preventivmedel 2.16.840.1.113883.6.73 2017-01 G03AD01 levonorgestrel Levonorgestrel 2.16.840.1.113883.6.73 2017-01 G03AD02 ulipristal Ulipristal 2.16.840.1.113883.6.73 2017-01 G03B ANDROGENS Androgener 2.16.840.1.113883.6.73 2017-01 G03BA 3-oxoandrosten (4) derivatives 3-Oxandrostenderivat 2.16.840.1.113883.6.73 2017-01 G03BA01 Fluoximesteron 2.16.840.1.113883.6.73 2017-01 G03BA02 Metyltestosteron 2.16.840.1.113883.6.73 2017-01 G03BA03 Testosteron 2.16.840.1.113883.6.73 2017-01 G03BB 5-androstanon (3) derivatives 5-Androstanonderivat 2.16.840.1.113883.6.73 2017-01 G03BB01 Mesterolon 2.16.840.1.113883.6.73 2017-01 G03BB02 androstanolone Androstanolon 2.16.840.1.113883.6.73 2017-01 G03C ESTROGENS Östrogener 2.16.840.1.113883.6.73 2017-01 G03CA Natural and semisynthetic Naturliga och halvsyntetiska estrogens, plain estrogener 2.16.840.1.113883.6.73 2017-01 G03CA01 ethinylestradiol Etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03CA03 estradiol Estradiol 2.16.840.1.113883.6.73 2017-01 G03CA04 Estriol 2.16.840.1.113883.6.73 2017-01 G03CA06 Klortrianisen 2.16.840.1.113883.6.73 2017-01 G03CA07 Estron 2.16.840.1.113883.6.73 2017-01 G03CA09 Promestrien 2.16.840.1.113883.6.73 2017-01 G03CA53 estradiol, combinations Estradiol, kombinationer 2.16.840.1.113883.6.73 2017-01 G03CA57 Konjugerade estrogener 2.16.840.1.113883.6.73 2017-01 G03CB Synthetic estrogens, plain Syntetiska östrogener 2.16.840.1.113883.6.73 2017-01 G03CB01 Dienestrol 2.16.840.1.113883.6.73 2017-01 G03CB02 Dietylstilbestrol 2.16.840.1.113883.6.73 2017-01 G03CB03 Metallenestril 2.16.840.1.113883.6.73 2017-01 G03CB04 Moxestrol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 72 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03CC Estrogens, combinations with other Östrogener i kombination med drugs andra medel 2.16.840.1.113883.6.73 2017-01 G03CC02 dienestrol Dienestrol 2.16.840.1.113883.6.73 2017-01 G03CC03 methallenestril Metallenestril 2.16.840.1.113883.6.73 2017-01 G03CC04 estrone Estron 2.16.840.1.113883.6.73 2017-01 G03CC05 diethylstilbestrol Dietylstilbestrol 2.16.840.1.113883.6.73 2017-01 G03CC06 estriol Estriol 2.16.840.1.113883.6.73 2017-01 G03CC07 conjugated estrogens and Konjugerade östrogener och bazedoxifen 2.16.840.1.113883.6.73 2017-01 G03CX Other estrogens Övriga estrogener 2.16.840.1.113883.6.73 2017-01 G03CX01 Tibolon 2.16.840.1.113883.6.73 2017-01 G03D PROGESTOGENS Gestagener 2.16.840.1.113883.6.73 2017-01 G03DA Pregnen (4) derivatives Pregnenderivat 2.16.840.1.113883.6.73 2017-01 G03DA01 gestonorone Gestonoron 2.16.840.1.113883.6.73 2017-01 G03DA02 medroxyprogesterone Medroxiprogesteron 2.16.840.1.113883.6.73 2017-01 G03DA03 hydroxyprogesterone Hydroxiprogesteron 2.16.840.1.113883.6.73 2017-01 G03DA04 Progesteron 2.16.840.1.113883.6.73 2017-01 G03DB Pregnadien derivatives Pregnadienderivat 2.16.840.1.113883.6.73 2017-01 G03DB01 Dydrogesteron 2.16.840.1.113883.6.73 2017-01 G03DB02 megestrol Megestrol 2.16.840.1.113883.6.73 2017-01 G03DB03 Medrogeston 2.16.840.1.113883.6.73 2017-01 G03DB04 nomegestrol Nomegestrol 2.16.840.1.113883.6.73 2017-01 G03DB05 Demegeston 2.16.840.1.113883.6.73 2017-01 G03DB06 chlormadinone Klormadinon 2.16.840.1.113883.6.73 2017-01 G03DB07 Promegeston 2.16.840.1.113883.6.73 2017-01 G03DB08 dienogest Dienogest 2.16.840.1.113883.6.73 2017-01 G03DC Estren derivatives Östrenderivat 2.16.840.1.113883.6.73 2017-01 G03DC01 Allylestrenol 2.16.840.1.113883.6.73 2017-01 G03DC02 norethisterone Noretisteron 2.16.840.1.113883.6.73 2017-01 G03DC03 lynestrenol Lynestrenol 2.16.840.1.113883.6.73 2017-01 G03DC04 Etisteron 2.16.840.1.113883.6.73 2017-01 G03DC06 etynodiol Etynodiol 2.16.840.1.113883.6.73 2017-01 G03DC31 methylestrenolone Metylestrenolon 2.16.840.1.113883.6.73 2017-01 G03E ANDROGENS AND FEMALE SEX Androgener och kvinnliga HORMONES IN COMBINATION könshormoner, kombinationer 2.16.840.1.113883.6.73 2017-01 G03EA Androgens and estrogens Androgener och östrogener 2.16.840.1.113883.6.73 2017-01 G03EA01 methyltestosterone and estrogen Metyltestosteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03EA02 testosterone and estrogen Testosteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03EA03 prasterone and estrogen Prasteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03EB , progestogen and Androgener, gestagener och estrogen in combination östrogener, kombinationer 2.16.840.1.113883.6.73 2017-01 G03EK Androgens and female sex Androgener och kvinnliga hormones in combination with other könshormoner i kombination med drugs andra medel 2.16.840.1.113883.6.73 2017-01 G03EK01 methyltestosterone Metyltestosteron

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 73 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03F PROGESTOGENS AND Gestagener i kombination med ESTROGENS IN COMBINATION östrogener 2.16.840.1.113883.6.73 2017-01 G03FA Progestogens and estrogens, fixed Gestagener och östrogener i fasta combinations kombinationer 2.16.840.1.113883.6.73 2017-01 G03FA01 norethisterone and estrogen Noretisteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA02 hydroxyprogesterone and estrogen Hydroxiprogesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA03 ethisterone and estrogen Etisteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA04 progesterone and estrogen Progesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA05 methylnortestosterone and estrogen Metylnortestosteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA06 etynodiol and estrogen Etynodiol och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA07 lynestrenol and estrogen Lynestrenol och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA08 megestrol and estrogen Megestrol och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA09 and estrogen Noretisteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA10 norgestrel and estrogen Norgestrel och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA11 levonorgestrel and estrogen Levonorgestrel och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA12 medroxyprogesterone and estrogen Medroxiprogesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA13 norgestimate and estrogen Norgestimat och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA14 dydrogesterone and estrogen Dydrogesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA15 dienogest and estrogen Dienogest och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA16 and estrogen Trimegeston och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA17 drospirenone and estrogen Drospirenon och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB Progestogens and estrogens, Gestagener och östrogener, sequential preparations sekvenspreparat 2.16.840.1.113883.6.73 2017-01 G03FB01 norgestrel and estrogen Norgestrel och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB02 lynestrenol and estrogen Lynestrenol och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB03 chlormadinone and estrogen Klormadinon och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB04 megestrol and estrogen Megestrol och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB05 norethisterone and estrogen Noretisteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB06 medroxyprogesterone and estrogen Medroxiprogesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB07 medrogestone and estrogen Medrogeston och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB08 dydrogesterone and estrogen Dydrogesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB09 levonorgestrel and estrogen Levonorgestrel och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB10 desogestrel and estrogen Desogestrel och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB11 trimegestone and estrogen Trimegeston och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB12 nomegestrol and estrogen Nomegestrol och östrogen 2.16.840.1.113883.6.73 2017-01 G03G AND OTHER Gonadotropiner och andra OVULATION STIMULANTS ovulationsstimulerande medel 2.16.840.1.113883.6.73 2017-01 G03GA Gonadotropins Gonadotropiner 2.16.840.1.113883.6.73 2017-01 G03GA01 chorionic gonadotrophin Koriongonadotropin 2.16.840.1.113883.6.73 2017-01 G03GA02 human menopausal gonadotrophin Menopausgonadotropin 2.16.840.1.113883.6.73 2017-01 G03GA03 serum gonadotrophin Serumgonadotropin 2.16.840.1.113883.6.73 2017-01 G03GA04 Urofollitropin 2.16.840.1.113883.6.73 2017-01 G03GA05 follitropin alfa Follitropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA06 follitropin beta Follitropin beta

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 74 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03GA07 lutropin alfa Lutropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA08 choriogonadotropin alfa Koriogonadotropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA09 corifollitropin alfa Korifollitropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA10 follitropin delta Follitropin delta 2.16.840.1.113883.6.73 2017-01 G03GA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 G03GB Ovulation stimulants, synthetic Syntetiska ovulationsstimulerande medel 2.16.840.1.113883.6.73 2017-01 G03GB01 Cyklofenil 2.16.840.1.113883.6.73 2017-01 G03GB02 Klomifen 2.16.840.1.113883.6.73 2017-01 G03GB03 Epimestrol 2.16.840.1.113883.6.73 2017-01 G03H Antiandrogener 2.16.840.1.113883.6.73 2017-01 G03HA Antiandrogens, plain Antiandrogener 2.16.840.1.113883.6.73 2017-01 G03HA01 Cyproteron 2.16.840.1.113883.6.73 2017-01 G03HB Antiandrogens and estrogens Antiandrogener och östrogener 2.16.840.1.113883.6.73 2017-01 G03HB01 cyproterone and estrogen Cyproteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03X OTHER SEX HORMONES AND Övriga könshormoner och MODULATORS OF THE GENITAL modulatorer av könsorgan SYSTEM 2.16.840.1.113883.6.73 2017-01 G03XA and similar Gonadotropinhämmare och liknande agents medel 2.16.840.1.113883.6.73 2017-01 G03XA01 Danazol 2.16.840.1.113883.6.73 2017-01 G03XA02 Gestrinon 2.16.840.1.113883.6.73 2017-01 G03XB Progesterone receptor modulators Progesteronreceptormodulatorer 2.16.840.1.113883.6.73 2017-01 G03XB01 Mifepriston 2.16.840.1.113883.6.73 2017-01 G03XB02 ulipristal Ulipristal 2.16.840.1.113883.6.73 2017-01 G03XB51 mifepristone, combinations Mifepriston, kombinationer 2.16.840.1.113883.6.73 2017-01 G03XC Selective estrogen receptor Selektiva modulators östrogenreceptormodulatorer 2.16.840.1.113883.6.73 2017-01 G03XC01 Raloxifen 2.16.840.1.113883.6.73 2017-01 G03XC02 bazedoxifene Bazedoxifen 2.16.840.1.113883.6.73 2017-01 G03XC03 Lasofoxifen 2.16.840.1.113883.6.73 2017-01 G03XC04 Ormeloxifen 2.16.840.1.113883.6.73 2017-01 G03XC05 Ospemifen 2.16.840.1.113883.6.73 2017-01 G04 UROLOGICALS Urologiska medel 2.16.840.1.113883.6.73 2017-01 G04B UROLOGICALS Urologiska medel 2.16.840.1.113883.6.73 2017-01 G04BA Surgörande medel 2.16.840.1.113883.6.73 2017-01 G04BA01 ammonium chloride Ammoniumklorid 2.16.840.1.113883.6.73 2017-01 G04BA03 calcium chloride Kalciumklorid 2.16.840.1.113883.6.73 2017-01 G04BC Urinary concrement solvents Medel för upplösning av urinsyrakonkrement 2.16.840.1.113883.6.73 2017-01 G04BD Drugs for urinary frequency and Medel mot inkontinens och för incontinence kontroll av miktionsfrekvens 2.16.840.1.113883.6.73 2017-01 G04BD01 emepronium Emepron 2.16.840.1.113883.6.73 2017-01 G04BD02 Flavoxat 2.16.840.1.113883.6.73 2017-01 G04BD03 Meladrazin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 75 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G04BD04 Oxybutynin 2.16.840.1.113883.6.73 2017-01 G04BD05 Terodilin 2.16.840.1.113883.6.73 2017-01 G04BD06 Propiverin 2.16.840.1.113883.6.73 2017-01 G04BD07 Tolterodin 2.16.840.1.113883.6.73 2017-01 G04BD08 Solifenacin 2.16.840.1.113883.6.73 2017-01 G04BD09 trospium Trospium 2.16.840.1.113883.6.73 2017-01 G04BD10 Darifenacin 2.16.840.1.113883.6.73 2017-01 G04BD11 Fesoterodin 2.16.840.1.113883.6.73 2017-01 G04BD12 Mirabegron 2.16.840.1.113883.6.73 2017-01 G04BD13 Desfesoterodin 2.16.840.1.113883.6.73 2017-01 G04BE Drugs used in Medel vid erektil dysfunktion 2.16.840.1.113883.6.73 2017-01 G04BE01 alprostadil Alprostadil 2.16.840.1.113883.6.73 2017-01 G04BE02 papaverine Papaverin 2.16.840.1.113883.6.73 2017-01 G04BE03 Sildenafil 2.16.840.1.113883.6.73 2017-01 G04BE04 Yohimbin 2.16.840.1.113883.6.73 2017-01 G04BE06 moxisylyte Moxisylyt 2.16.840.1.113883.6.73 2017-01 G04BE07 Apomorfin 2.16.840.1.113883.6.73 2017-01 G04BE08 Tadalafil 2.16.840.1.113883.6.73 2017-01 G04BE09 Vardenafil 2.16.840.1.113883.6.73 2017-01 G04BE10 Avanafil 2.16.840.1.113883.6.73 2017-01 G04BE11 Udenafil 2.16.840.1.113883.6.73 2017-01 G04BE30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 G04BE52 papaverine, combinations Papaverin, kombinationer 2.16.840.1.113883.6.73 2017-01 G04BX Other urologicals Övriga urologiska medel 2.16.840.1.113883.6.73 2017-01 G04BX01 Magnesiumhydroxid 2.16.840.1.113883.6.73 2017-01 G04BX03 Acetohydroxamsyra 2.16.840.1.113883.6.73 2017-01 G04BX06 Fenazopyridin 2.16.840.1.113883.6.73 2017-01 G04BX10 Succinimid 2.16.840.1.113883.6.73 2017-01 G04BX11 collagen Kollagen 2.16.840.1.113883.6.73 2017-01 G04BX12 Fenylsalicylat 2.16.840.1.113883.6.73 2017-01 G04BX13 Dimetylsulfoxid 2.16.840.1.113883.6.73 2017-01 G04BX14 Dapoxetin 2.16.840.1.113883.6.73 2017-01 G04BX15 pentosan polysulfate sodium Pentosanpolysulfatnatrium 2.16.840.1.113883.6.73 2017-01 G04BX16 Tiopronin 2.16.840.1.113883.6.73 2017-01 G04C DRUGS USED IN BENIGN Medel vid benign prostatahyperplasi PROSTATIC HYPERTROPHY 2.16.840.1.113883.6.73 2017-01 G04CA Alpha-adrenoreceptor antagonists Alfa-adrenoreceptorantagonister 2.16.840.1.113883.6.73 2017-01 G04CA01 Alfuzosin 2.16.840.1.113883.6.73 2017-01 G04CA02 Tamsulosin 2.16.840.1.113883.6.73 2017-01 G04CA03 Terazosin 2.16.840.1.113883.6.73 2017-01 G04CA04 Silodosin 2.16.840.1.113883.6.73 2017-01 G04CA51 alfuzosin and finasteride Alfuzosin och finasterid 2.16.840.1.113883.6.73 2017-01 G04CA52 tamsulosin and Tamsulosin och dutasterid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 76 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G04CA53 tamsulosin and solifenacin Tamsulosin och solifenacin 2.16.840.1.113883.6.73 2017-01 G04CB Testosterone-5-alpha reductase Testosteron-5-alfa- inhibitors reduktashämmare 2.16.840.1.113883.6.73 2017-01 G04CB01 finasteride Finasterid 2.16.840.1.113883.6.73 2017-01 G04CB02 dutasteride Dutasterid 2.16.840.1.113883.6.73 2017-01 G04CX Other drugs used in benign prostatic Övriga medel vid benign hypertrophy prostatahyperplasi 2.16.840.1.113883.6.73 2017-01 G04CX01 Prunus africanae cortex Pygeum africanum, bark 2.16.840.1.113883.6.73 2017-01 G04CX02 Sabalis serrulatae fructus Sågpalmetto, frukt 2.16.840.1.113883.6.73 2017-01 G04CX03 mepartricin Mepartricin 2.16.840.1.113883.6.73 2017-01 H SYSTEMIC HORMONAL Systemiska hormonpreparat, exkl. PREPARATIONS, EXCL. SEX könshormoner och insuliner HORMONES AND INSULINS 2.16.840.1.113883.6.73 2017-01 H01 PITUITARY AND HYPOTHALAMIC Hypofys- och hypotalamushormoner HORMONES AND ANALOGUES och analoger 2.16.840.1.113883.6.73 2017-01 H01A ANTERIOR PITUITARY LOBE Hypofysframlobens hormoner samt HORMONES AND ANALOGUES analoger 2.16.840.1.113883.6.73 2017-01 H01AA ACTH ACTH 2.16.840.1.113883.6.73 2017-01 H01AA01 corticotropin Kortikotropin 2.16.840.1.113883.6.73 2017-01 H01AA02 tetracosactide Tetrakosaktid 2.16.840.1.113883.6.73 2017-01 H01AB Thyrotropin Tyrotropin 2.16.840.1.113883.6.73 2017-01 H01AB01 thyrotropin alfa Tyrotropin alfa 2.16.840.1.113883.6.73 2017-01 H01AC Somatropin and somatropin Somatropin, samt agonists somatropinagonister 2.16.840.1.113883.6.73 2017-01 H01AC01 somatropin Somatropin 2.16.840.1.113883.6.73 2017-01 H01AC02 somatrem Somatrem 2.16.840.1.113883.6.73 2017-01 H01AC03 mecasermin Mekasermin 2.16.840.1.113883.6.73 2017-01 H01AC04 Sermorelin 2.16.840.1.113883.6.73 2017-01 H01AC05 mecasermin rinfabate Mekaserminrinfabat 2.16.840.1.113883.6.73 2017-01 H01AC06 tesamorelin Tesamorelin 2.16.840.1.113883.6.73 2017-01 H01AX Other anterior pituitary lobe Övriga hypofysframlobens hormoner hormones and analogues samt analoger 2.16.840.1.113883.6.73 2017-01 H01AX01 pegvisomant Pegvisomant 2.16.840.1.113883.6.73 2017-01 H01B POSTERIOR PITUITARY LOBE Hypofysbaklobens hormoner HORMONES 2.16.840.1.113883.6.73 2017-01 H01BA Vasopressin and analogues Vasopressin och analoger 2.16.840.1.113883.6.73 2017-01 H01BA01 vasopressin Vasopressin (argipressin) 2.16.840.1.113883.6.73 2017-01 H01BA02 desmopressin Desmopressin 2.16.840.1.113883.6.73 2017-01 H01BA03 lypressin Lypressin 2.16.840.1.113883.6.73 2017-01 H01BA04 terlipressin Terlipressin 2.16.840.1.113883.6.73 2017-01 H01BA05 ornipressin Ornipressin 2.16.840.1.113883.6.73 2017-01 H01BA06 argipressin Argipressin 2.16.840.1.113883.6.73 2017-01 H01BB Oxytocin and analogues Oxytocin och analoger 2.16.840.1.113883.6.73 2017-01 H01BB01 demoxytocin Demoxytocin 2.16.840.1.113883.6.73 2017-01 H01BB02 oxytocin Oxytocin 2.16.840.1.113883.6.73 2017-01 H01BB03 carbetocin Karbetocin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 77 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 H01C HYPOTHALAMIC HORMONES Hypotalamushormoner 2.16.840.1.113883.6.73 2017-01 H01CA -releasing hormones Gonadotropinfrisättande hormoner 2.16.840.1.113883.6.73 2017-01 H01CA01 Gonadorelin 2.16.840.1.113883.6.73 2017-01 H01CA02 Nafarelin 2.16.840.1.113883.6.73 2017-01 H01CB Somatostatin and analogues Somatostatin och analoger 2.16.840.1.113883.6.73 2017-01 H01CB01 somatostatin Somatostatin 2.16.840.1.113883.6.73 2017-01 H01CB02 Oktreotid 2.16.840.1.113883.6.73 2017-01 H01CB03 lanreotide Lanreotid 2.16.840.1.113883.6.73 2017-01 H01CB04 vapreotide Vapreotid 2.16.840.1.113883.6.73 2017-01 H01CB05 pasireotide Pasireotid 2.16.840.1.113883.6.73 2017-01 H01CC Anti-gonadotropin-releasing Gonadotropinantagonister hormones 2.16.840.1.113883.6.73 2017-01 H01CC01 Ganirelix 2.16.840.1.113883.6.73 2017-01 H01CC02 Cetrorelix 2.16.840.1.113883.6.73 2017-01 H02 CORTICOSTEROIDS FOR Kortikosteroider för systemiskt bruk SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 H02A CORTICOSTEROIDS FOR Kortikosteroider för systemiskt bruk SYSTEMIC USE, PLAIN 2.16.840.1.113883.6.73 2017-01 H02AA Mineralkortikoider 2.16.840.1.113883.6.73 2017-01 H02AA01 aldosterone Aldosteron 2.16.840.1.113883.6.73 2017-01 H02AA02 Fludrokortison 2.16.840.1.113883.6.73 2017-01 H02AA03 desoxycortone Desoxikorton 2.16.840.1.113883.6.73 2017-01 H02AB Glukokortikoider 2.16.840.1.113883.6.73 2017-01 H02AB01 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 H02AB02 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 H02AB03 fluocortolone Fluokortolon 2.16.840.1.113883.6.73 2017-01 H02AB04 methylprednisolone Metylprednisolon 2.16.840.1.113883.6.73 2017-01 H02AB05 Parametason 2.16.840.1.113883.6.73 2017-01 H02AB06 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 H02AB07 prednisone Prednison 2.16.840.1.113883.6.73 2017-01 H02AB08 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 H02AB09 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 H02AB10 Kortison 2.16.840.1.113883.6.73 2017-01 H02AB11 Prednyliden 2.16.840.1.113883.6.73 2017-01 H02AB12 Rimexolon 2.16.840.1.113883.6.73 2017-01 H02AB13 Deflazakort 2.16.840.1.113883.6.73 2017-01 H02AB14 Kloprednol 2.16.840.1.113883.6.73 2017-01 H02AB15 Meprednison 2.16.840.1.113883.6.73 2017-01 H02AB17 Kortivazol 2.16.840.1.113883.6.73 2017-01 H02B CORTICOSTEROIDS FOR Kortikosteroider för systemiskt bruk, SYSTEMIC USE, COMBINATIONS kombinationer 2.16.840.1.113883.6.73 2017-01 H02BX Corticosteroids for systemic use, Kortikosteroider för systemiskt bruk, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 H02BX01 methylprednisolone, combinations Metylprednisolon, kombinationer 2.16.840.1.113883.6.73 2017-01 H02C ANTIADRENAL PREPARATIONS Antiadrenerga preparat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 78 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 H02CA Anticorticosteroids Antikortikosteroider 2.16.840.1.113883.6.73 2017-01 H02CA01 Trilostan 2.16.840.1.113883.6.73 2017-01 H03 THERAPY Tyreoideabehandling 2.16.840.1.113883.6.73 2017-01 H03A THYROID PREPARATIONS Tyreoideapreparat 2.16.840.1.113883.6.73 2017-01 H03AA Thyroid hormones Tyreoideahormoner 2.16.840.1.113883.6.73 2017-01 H03AA01 levothyroxine sodium Levotyroxinnatrium 2.16.840.1.113883.6.73 2017-01 H03AA02 liothyronine sodium Liotyroninnatrium 2.16.840.1.113883.6.73 2017-01 H03AA03 combinations of levothyroxine and Kombinationer av levotyroxin och liothyronine liotyronin 2.16.840.1.113883.6.73 2017-01 H03AA04 tiratricol Tiratrikol 2.16.840.1.113883.6.73 2017-01 H03AA05 thyroid gland preparations Sköldkörtelpreparat 2.16.840.1.113883.6.73 2017-01 H03B ANTITHYROID PREPARATIONS Antityreoida substanser, tyreostatika 2.16.840.1.113883.6.73 2017-01 H03BA Thiouracils Tiouraciler 2.16.840.1.113883.6.73 2017-01 H03BA01 methylthiouracil Metyltiouracil 2.16.840.1.113883.6.73 2017-01 H03BA02 propylthiouracil Propyltiouracil 2.16.840.1.113883.6.73 2017-01 H03BA03 benzylthiouracil Bensyltiouracil 2.16.840.1.113883.6.73 2017-01 H03BB Sulfur-containing imidazole Svavelhaltiga imidazolderivat derivatives 2.16.840.1.113883.6.73 2017-01 H03BB01 carbimazole Karbimazol 2.16.840.1.113883.6.73 2017-01 H03BB02 thiamazole Tiamazol 2.16.840.1.113883.6.73 2017-01 H03BB52 thiamazole, combinations Tiamazol, kombinationer 2.16.840.1.113883.6.73 2017-01 H03BC Perchlorates Perklorater 2.16.840.1.113883.6.73 2017-01 H03BC01 potassium perchlorate Kaliumperklorat 2.16.840.1.113883.6.73 2017-01 H03BX Other antithyroid preparations Övriga antityreoida substanser 2.16.840.1.113883.6.73 2017-01 H03BX01 diiodotyrosine Dijodtyrosin 2.16.840.1.113883.6.73 2017-01 H03BX02 dibromotyrosine Dibromotyrosin 2.16.840.1.113883.6.73 2017-01 H03C IODINE THERAPY Jodterapi 2.16.840.1.113883.6.73 2017-01 H03CA Iodine therapy Jodterapi 2.16.840.1.113883.6.73 2017-01 H04 PANCREATIC HORMONES Pankreashormoner 2.16.840.1.113883.6.73 2017-01 H04A GLYCOGENOLYTIC HORMONES Glukogenolytiskt hormon 2.16.840.1.113883.6.73 2017-01 H04AA Glycogenolytic hormones Glukogenolytiskt hormon 2.16.840.1.113883.6.73 2017-01 H04AA01 glucagon Glukagon 2.16.840.1.113883.6.73 2017-01 H05 CALCIUM Medel som reglerar kalciumomsättningen 2.16.840.1.113883.6.73 2017-01 H05A PARATHYROID HORMONES AND Paratyreoideahormoner och ANALOGUES analoger 2.16.840.1.113883.6.73 2017-01 H05AA Parathyroid hormones and Paratyreoideahormoner och analogues analoger 2.16.840.1.113883.6.73 2017-01 H05AA01 extract Paratyreoideaextrakt 2.16.840.1.113883.6.73 2017-01 H05AA02 Teriparatid 2.16.840.1.113883.6.73 2017-01 H05AA03 parathyroid Paratyroidhormon 2.16.840.1.113883.6.73 2017-01 H05B ANTI-PARATHYROID AGENTS Antiparatyreoideamedel 2.16.840.1.113883.6.73 2017-01 H05BA preparations Kalcitoninpreparat 2.16.840.1.113883.6.73 2017-01 H05BA01 calcitonin (salmon synthetic) Kalcitonin, lax, syntetisk 2.16.840.1.113883.6.73 2017-01 H05BA02 calcitonin (pork natural) Kalcitonin (naturligt från gris) © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 79 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 H05BA03 calcitonin (human synthetic) Kalcitonin, human, syntetisk 2.16.840.1.113883.6.73 2017-01 H05BA04 Elkatonin 2.16.840.1.113883.6.73 2017-01 H05BX Other anti-parathyroid agents Övriga antiparatyreoideamedel 2.16.840.1.113883.6.73 2017-01 H05BX01 Cinakalcet 2.16.840.1.113883.6.73 2017-01 H05BX02 Parikalcitol 2.16.840.1.113883.6.73 2017-01 H05BX03 Doxerkalciferol 2.16.840.1.113883.6.73 2017-01 H05BX04 Etelkalcetid 2.16.840.1.113883.6.73 2017-01 J ANTIINFECTIVES FOR SYSTEMIC Antiinfektiva medel för systemiskt USE bruk 2.16.840.1.113883.6.73 2017-01 J01 ANTIBACTERIALS FOR Antibakteriella medel för systemiskt SYSTEMIC USE bruk 2.16.840.1.113883.6.73 2017-01 J01A Tetracykliner 2.16.840.1.113883.6.73 2017-01 J01AA Tetracyclines Tetracykliner 2.16.840.1.113883.6.73 2017-01 J01AA01 demeclocycline Demeklocyklin 2.16.840.1.113883.6.73 2017-01 J01AA02 doxycycline Doxycyklin 2.16.840.1.113883.6.73 2017-01 J01AA03 chlortetracycline Klortetracyklin 2.16.840.1.113883.6.73 2017-01 J01AA04 Lymecyklin 2.16.840.1.113883.6.73 2017-01 J01AA05 Metacyklin 2.16.840.1.113883.6.73 2017-01 J01AA06 oxytetracycline Oxitetracyklin 2.16.840.1.113883.6.73 2017-01 J01AA07 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 J01AA08 minocycline Minocyklin 2.16.840.1.113883.6.73 2017-01 J01AA09 Rolitetracyklin 2.16.840.1.113883.6.73 2017-01 J01AA10 Penimepicyklin 2.16.840.1.113883.6.73 2017-01 J01AA11 Klomocyklin 2.16.840.1.113883.6.73 2017-01 J01AA12 Tigecyklin 2.16.840.1.113883.6.73 2017-01 J01AA20 combinations of tetracyclines Kombinationer av tetracykliner 2.16.840.1.113883.6.73 2017-01 J01AA56 oxytetracycline, combinations Oxitetracyklin, kombinationer 2.16.840.1.113883.6.73 2017-01 J01B Amfenikoler 2.16.840.1.113883.6.73 2017-01 J01BA Amphenicols Amfenikoler 2.16.840.1.113883.6.73 2017-01 J01BA01 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 J01BA02 Tiamfenikol 2.16.840.1.113883.6.73 2017-01 J01BA52 thiamphenicol, combinations Tiamfenikol, kombinationer 2.16.840.1.113883.6.73 2017-01 J01C BETA-LACTAM ANTIBACTERIALS, Antibakteriella betalaktamer, PENICILLINS penicilliner 2.16.840.1.113883.6.73 2017-01 J01CA Penicillins with extended spectrum Penicilliner med utvidgat spektrum 2.16.840.1.113883.6.73 2017-01 J01CA01 ampicillin Ampicillin 2.16.840.1.113883.6.73 2017-01 J01CA02 pivampicillin Pivampicillin 2.16.840.1.113883.6.73 2017-01 J01CA03 carbenicillin Karbenicillin 2.16.840.1.113883.6.73 2017-01 J01CA04 amoxicillin Amoxicillin 2.16.840.1.113883.6.73 2017-01 J01CA05 carindacillin Karindacillin 2.16.840.1.113883.6.73 2017-01 J01CA06 bacampicillin Bakampicillin 2.16.840.1.113883.6.73 2017-01 J01CA07 epicillin Epicillin 2.16.840.1.113883.6.73 2017-01 J01CA08 pivmecillinam Pivmecillinam 2.16.840.1.113883.6.73 2017-01 J01CA09 azlocillin Azlocillin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 80 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01CA10 mezlocillin Mezlocillin 2.16.840.1.113883.6.73 2017-01 J01CA11 mecillinam Mecillinam 2.16.840.1.113883.6.73 2017-01 J01CA12 piperacillin Piperacillin 2.16.840.1.113883.6.73 2017-01 J01CA13 ticarcillin Tikarcillin 2.16.840.1.113883.6.73 2017-01 J01CA14 metampicillin Metampicillin 2.16.840.1.113883.6.73 2017-01 J01CA15 talampicillin Talampicillin 2.16.840.1.113883.6.73 2017-01 J01CA16 sulbenicillin Sulbenicillin 2.16.840.1.113883.6.73 2017-01 J01CA17 temocillin Temocillin 2.16.840.1.113883.6.73 2017-01 J01CA18 hetacillin Hetacillin 2.16.840.1.113883.6.73 2017-01 J01CA19 aspoxicillin Aspoxicillin 2.16.840.1.113883.6.73 2017-01 J01CA20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J01CA51 ampicillin, combinations Ampicillin, kombinationer 2.16.840.1.113883.6.73 2017-01 J01CE Beta-lactamase sensitive penicillins Betalaktamaskänsliga penicilliner 2.16.840.1.113883.6.73 2017-01 J01CE01 benzylpenicillin Bensylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE02 phenoxymethylpenicillin Fenoximetylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE03 propicillin Propicillin 2.16.840.1.113883.6.73 2017-01 J01CE04 azidocillin Azidocillin 2.16.840.1.113883.6.73 2017-01 J01CE05 pheneticillin Feneticillin 2.16.840.1.113883.6.73 2017-01 J01CE06 penamecillin Penamecillin 2.16.840.1.113883.6.73 2017-01 J01CE07 clometocillin Klometocillin 2.16.840.1.113883.6.73 2017-01 J01CE08 benzathine benzylpenicillin Bensatin bensylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE09 procaine benzylpenicillin Bensylpenicillinprokain 2.16.840.1.113883.6.73 2017-01 J01CE10 benzathine phenoxymethylpenicillin Bensatin fenoximetylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J01CF Beta-lactamase resistant penicillins Betalaktamasresistenta penicilliner 2.16.840.1.113883.6.73 2017-01 J01CF01 dicloxacillin Dikloxacillin 2.16.840.1.113883.6.73 2017-01 J01CF02 cloxacillin Kloxacillin 2.16.840.1.113883.6.73 2017-01 J01CF03 meticillin Meticillin 2.16.840.1.113883.6.73 2017-01 J01CF04 oxacillin Oxacillin 2.16.840.1.113883.6.73 2017-01 J01CF05 flucloxacillin Flukloxacillin 2.16.840.1.113883.6.73 2017-01 J01CF06 nafcillin Nafcillin 2.16.840.1.113883.6.73 2017-01 J01CG Beta-lactamase inhibitors Betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01CG01 sulbactam Sulbaktam 2.16.840.1.113883.6.73 2017-01 J01CG02 tazobactam Tazobaktam 2.16.840.1.113883.6.73 2017-01 J01CR Combinations of penicillins, incl. Kombinationer av penicilliner, inkl. beta-lactamase inhibitors betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01CR01 ampicillin and Ampicillin och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01CR02 amoxicillin and enzyme inhibitor Amoxicillin och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01CR03 ticarcillin and enzyme inhibitor Tikarcillin och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01CR04 sultamicillin Sultamicillin 2.16.840.1.113883.6.73 2017-01 J01CR05 piperacillin and enzyme inhibitor Piperacillin och betalaktamashämmare © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 81 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01CR50 combinations of penicillins Kombinationer av penicilliner 2.16.840.1.113883.6.73 2017-01 J01D OTHER BETA-LACTAM Övriga antibakteriella betalaktamer ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01DB First-generation cephalosporins Cefalosporiner, första generationen 2.16.840.1.113883.6.73 2017-01 J01DB01 cefalexin Cefalexin 2.16.840.1.113883.6.73 2017-01 J01DB02 cefaloridine Cefaloridin 2.16.840.1.113883.6.73 2017-01 J01DB03 cefalotin Cefalotin 2.16.840.1.113883.6.73 2017-01 J01DB04 cefazolin Cefazolin 2.16.840.1.113883.6.73 2017-01 J01DB05 cefadroxil Cefadroxil 2.16.840.1.113883.6.73 2017-01 J01DB06 cefazedone Cefazedon 2.16.840.1.113883.6.73 2017-01 J01DB07 cefatrizine Cefatrizin 2.16.840.1.113883.6.73 2017-01 J01DB08 cefapirin Cefapirin 2.16.840.1.113883.6.73 2017-01 J01DB09 cefradine Cefradin 2.16.840.1.113883.6.73 2017-01 J01DB10 cefacetrile Cefacetril 2.16.840.1.113883.6.73 2017-01 J01DB11 cefroxadine Cefroxadin 2.16.840.1.113883.6.73 2017-01 J01DB12 ceftezole Ceftezol 2.16.840.1.113883.6.73 2017-01 J01DC Second-generation cephalosporins Cefalosporiner, andra generationen 2.16.840.1.113883.6.73 2017-01 J01DC01 cefoxitin Cefoxitin 2.16.840.1.113883.6.73 2017-01 J01DC02 cefuroxime Cefuroxim 2.16.840.1.113883.6.73 2017-01 J01DC03 cefamandole Cefamandol 2.16.840.1.113883.6.73 2017-01 J01DC04 cefaclor Cefaklor 2.16.840.1.113883.6.73 2017-01 J01DC05 cefotetan Cefotetan 2.16.840.1.113883.6.73 2017-01 J01DC06 cefonicid Cefonicid 2.16.840.1.113883.6.73 2017-01 J01DC07 cefotiam Cefotiam 2.16.840.1.113883.6.73 2017-01 J01DC08 loracarbef Lorakarbef 2.16.840.1.113883.6.73 2017-01 J01DC09 cefmetazole Cefmetazol 2.16.840.1.113883.6.73 2017-01 J01DC10 cefprozil Cefprozil 2.16.840.1.113883.6.73 2017-01 J01DC11 ceforanide Ceforanid 2.16.840.1.113883.6.73 2017-01 J01DC12 cefminox Cefminox 2.16.840.1.113883.6.73 2017-01 J01DC13 cefbuperazone Cefbuperazon 2.16.840.1.113883.6.73 2017-01 J01DC14 flomoxef Flomoxef 2.16.840.1.113883.6.73 2017-01 J01DD Third-generation cephalosporins Cefalosporiner, tredje generationen 2.16.840.1.113883.6.73 2017-01 J01DD01 cefotaxime Cefotaxim 2.16.840.1.113883.6.73 2017-01 J01DD02 ceftazidime Ceftazidim 2.16.840.1.113883.6.73 2017-01 J01DD03 cefsulodin Cefsulodin 2.16.840.1.113883.6.73 2017-01 J01DD04 ceftriaxone Ceftriaxon 2.16.840.1.113883.6.73 2017-01 J01DD05 cefmenoxime Cefmenoxim 2.16.840.1.113883.6.73 2017-01 J01DD06 latamoxef Latamoxef 2.16.840.1.113883.6.73 2017-01 J01DD07 ceftizoxime Ceftizoxim 2.16.840.1.113883.6.73 2017-01 J01DD08 cefixime Cefixim 2.16.840.1.113883.6.73 2017-01 J01DD09 cefodizime Cefodizim 2.16.840.1.113883.6.73 2017-01 J01DD10 cefetamet Cefetamet 2.16.840.1.113883.6.73 2017-01 J01DD11 cefpiramide Cefpiramid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 82 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01DD12 cefoperazone Cefoperazon 2.16.840.1.113883.6.73 2017-01 J01DD13 cefpodoxime Cefpodoxim 2.16.840.1.113883.6.73 2017-01 J01DD14 ceftibuten Ceftibuten 2.16.840.1.113883.6.73 2017-01 J01DD15 cefdinir Cefdinir 2.16.840.1.113883.6.73 2017-01 J01DD16 cefditoren Cefditoren 2.16.840.1.113883.6.73 2017-01 J01DD17 cefcapene Cefkapen 2.16.840.1.113883.6.73 2017-01 J01DD51 cefotaxime, combinations Cefotaxim och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01DD52 ceftazidime, combinations Ceftazidim och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01DD54 ceftriaxone, combinations Ceftriaxon, kombinationer 2.16.840.1.113883.6.73 2017-01 J01DD62 cefoperazone, combinations Cefoperazon och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01DE Fourth-generation cephalosporins Cefalosporiner, fjärde generationen 2.16.840.1.113883.6.73 2017-01 J01DE01 cefepime Cefepim 2.16.840.1.113883.6.73 2017-01 J01DE02 cefpirome Cefpirom 2.16.840.1.113883.6.73 2017-01 J01DE03 cefozopran Cefozopran 2.16.840.1.113883.6.73 2017-01 J01DF Monobactams Monobaktamer 2.16.840.1.113883.6.73 2017-01 J01DF01 aztreonam Aztreonam 2.16.840.1.113883.6.73 2017-01 J01DF02 carumonam Karumonam 2.16.840.1.113883.6.73 2017-01 J01DH Carbapenems Karbapenemer 2.16.840.1.113883.6.73 2017-01 J01DH02 meropenem Meropenem 2.16.840.1.113883.6.73 2017-01 J01DH03 ertapenem Ertapenem 2.16.840.1.113883.6.73 2017-01 J01DH04 doripenem Doripenem 2.16.840.1.113883.6.73 2017-01 J01DH05 biapenem Biapenem 2.16.840.1.113883.6.73 2017-01 J01DH51 imipenem and enzyme inhibitor Imipenem och cilastatin 2.16.840.1.113883.6.73 2017-01 J01DH55 panipenem and betamipron Panipenem och betamipron 2.16.840.1.113883.6.73 2017-01 J01DI Other cephalosporins and penems Övriga cefalosporiner och penemer 2.16.840.1.113883.6.73 2017-01 J01DI01 ceftobiprole medocaril Ceftobiprolmedokaril 2.16.840.1.113883.6.73 2017-01 J01DI02 ceftaroline fosamil Ceftarolinfosamil 2.16.840.1.113883.6.73 2017-01 J01DI03 faropenem Faropenem 2.16.840.1.113883.6.73 2017-01 J01DI54 ceftolozane and enzyme inhibitor Ceftolozan och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01E SULFONAMIDES AND Sulfonamider och trimetoprim TRIMETHOPRIM 2.16.840.1.113883.6.73 2017-01 J01EA Trimethoprim and derivatives Trimetoprim och derivat 2.16.840.1.113883.6.73 2017-01 J01EA01 trimethoprim Trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EA02 brodimoprim Brodimoprim 2.16.840.1.113883.6.73 2017-01 J01EA03 iclaprim Iklaprim 2.16.840.1.113883.6.73 2017-01 J01EB Short-acting sulfonamides Kortverkande sulfonamider 2.16.840.1.113883.6.73 2017-01 J01EB01 sulfaisodimidine Sulfaisodimidin 2.16.840.1.113883.6.73 2017-01 J01EB02 sulfamethizole Sulfametizol 2.16.840.1.113883.6.73 2017-01 J01EB03 sulfadimidine Sulfadimidin 2.16.840.1.113883.6.73 2017-01 J01EB04 sulfapyridine Sulfapyridin 2.16.840.1.113883.6.73 2017-01 J01EB05 sulfafurazole Sulfafurazol © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 83 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01EB06 sulfanilamide Sulfanilamid 2.16.840.1.113883.6.73 2017-01 J01EB07 sulfathiazole Sulfatiazol 2.16.840.1.113883.6.73 2017-01 J01EB08 sulfathiourea Sulfatiourea 2.16.840.1.113883.6.73 2017-01 J01EB20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J01EC Intermediate-acting sulfonamides Medellångverkande sulfonamider 2.16.840.1.113883.6.73 2017-01 J01EC01 sulfamethoxazole Sulfametoxazol 2.16.840.1.113883.6.73 2017-01 J01EC02 sulfadiazine Sulfadiazin 2.16.840.1.113883.6.73 2017-01 J01EC03 sulfamoxole Sulfamoxol 2.16.840.1.113883.6.73 2017-01 J01EC20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J01ED Long-acting sulfonamides Långverkande sulfonamider 2.16.840.1.113883.6.73 2017-01 J01ED01 sulfadimethoxine Sulfadimetoxin 2.16.840.1.113883.6.73 2017-01 J01ED02 Sulfalen 2.16.840.1.113883.6.73 2017-01 J01ED03 sulfametomidine Sulfametomidin 2.16.840.1.113883.6.73 2017-01 J01ED04 sulfametoxydiazine Sulfametoxidiazin 2.16.840.1.113883.6.73 2017-01 J01ED05 sulfamethoxypyridazine Sulfametoxipyridazin 2.16.840.1.113883.6.73 2017-01 J01ED06 sulfaperin Sulfaperin 2.16.840.1.113883.6.73 2017-01 J01ED07 sulfamerazine Sulfamerazin 2.16.840.1.113883.6.73 2017-01 J01ED08 sulfaphenazole Sulfafenazol 2.16.840.1.113883.6.73 2017-01 J01ED09 sulfamazone Sulfamazon 2.16.840.1.113883.6.73 2017-01 J01ED20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J01EE Combinations of sulfonamides and Kombinationer av sulfonamider och trimethoprim, incl. derivatives trimetoprim, inkl derivat 2.16.840.1.113883.6.73 2017-01 J01EE01 sulfamethoxazole and trimethoprim Sulfametoxazol och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EE02 sulfadiazine and trimethoprim Sulfadiazin och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EE03 sulfametrole and trimethoprim Sulfametrol och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EE04 sulfamoxole and trimethoprim Sulfamoxol och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EE05 sulfadimidine and trimethoprim Sulfadimidin och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EE06 sulfadiazine and tetroxoprim Sulfadiazin och tetroxoprim 2.16.840.1.113883.6.73 2017-01 J01EE07 sulfamerazine and trimethoprim Sulfamerazin och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01F , Makrolider, linkosamider och AND streptograminer 2.16.840.1.113883.6.73 2017-01 J01FA Macrolides Makrolider 2.16.840.1.113883.6.73 2017-01 J01FA01 erythromycin Erytromycin 2.16.840.1.113883.6.73 2017-01 J01FA02 Spiramycin 2.16.840.1.113883.6.73 2017-01 J01FA03 Midekamycin 2.16.840.1.113883.6.73 2017-01 J01FA05 Oleandomycin 2.16.840.1.113883.6.73 2017-01 J01FA06 Roxitromycin 2.16.840.1.113883.6.73 2017-01 J01FA07 Josamycin 2.16.840.1.113883.6.73 2017-01 J01FA08 Troleandomycin 2.16.840.1.113883.6.73 2017-01 J01FA09 clarithromycin Klaritromycin 2.16.840.1.113883.6.73 2017-01 J01FA10 Azitromycin 2.16.840.1.113883.6.73 2017-01 J01FA11 Miocamycin 2.16.840.1.113883.6.73 2017-01 J01FA12 Rokitamycin 2.16.840.1.113883.6.73 2017-01 J01FA13 Diritromycin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 84 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01FA14 Fluritromycin 2.16.840.1.113883.6.73 2017-01 J01FA15 Telitromycin 2.16.840.1.113883.6.73 2017-01 J01FA16 Solitromycin 2.16.840.1.113883.6.73 2017-01 J01FF Lincosamides Linkosamider 2.16.840.1.113883.6.73 2017-01 J01FF01 clindamycin Klindamycin 2.16.840.1.113883.6.73 2017-01 J01FF02 Linkomycin 2.16.840.1.113883.6.73 2017-01 J01FG Streptogramins Streptograminer 2.16.840.1.113883.6.73 2017-01 J01FG01 Pristinamycin 2.16.840.1.113883.6.73 2017-01 J01FG02 quinupristin/dalfopristin Kinupristin och dalfopristin 2.16.840.1.113883.6.73 2017-01 J01G Antibakteriella aminoglykosider ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01GA Streptomyciner 2.16.840.1.113883.6.73 2017-01 J01GA01 streptomycin Streptomycin 2.16.840.1.113883.6.73 2017-01 J01GA02 Streptoduocin 2.16.840.1.113883.6.73 2017-01 J01GB Other Övriga aminoglykosider 2.16.840.1.113883.6.73 2017-01 J01GB01 Tobramycin 2.16.840.1.113883.6.73 2017-01 J01GB03 gentamicin Gentamicin 2.16.840.1.113883.6.73 2017-01 J01GB04 kanamycin Kanamycin 2.16.840.1.113883.6.73 2017-01 J01GB05 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 J01GB06 amikacin Amikacin 2.16.840.1.113883.6.73 2017-01 J01GB07 Netilmicin 2.16.840.1.113883.6.73 2017-01 J01GB08 Sisomicin 2.16.840.1.113883.6.73 2017-01 J01GB09 Dibekacin 2.16.840.1.113883.6.73 2017-01 J01GB10 Ribostamycin 2.16.840.1.113883.6.73 2017-01 J01GB11 Isepamicin 2.16.840.1.113883.6.73 2017-01 J01GB12 Arbekacin 2.16.840.1.113883.6.73 2017-01 J01GB13 Bekanamycin 2.16.840.1.113883.6.73 2017-01 J01M QUINOLONE ANTIBACTERIALS Antibakteriella kinolonderivat 2.16.840.1.113883.6.73 2017-01 J01MA Fluoroquinolones Fluorokinoloner 2.16.840.1.113883.6.73 2017-01 J01MA01 Ofloxacin 2.16.840.1.113883.6.73 2017-01 J01MA02 Ciprofloxacin 2.16.840.1.113883.6.73 2017-01 J01MA03 pefloxacin Pefloxacin 2.16.840.1.113883.6.73 2017-01 J01MA04 enoxacin Enoxacin 2.16.840.1.113883.6.73 2017-01 J01MA05 temafloxacin Temafloxacin 2.16.840.1.113883.6.73 2017-01 J01MA06 norfloxacin Norfloxacin 2.16.840.1.113883.6.73 2017-01 J01MA07 lomefloxacin Lomefloxacin 2.16.840.1.113883.6.73 2017-01 J01MA08 fleroxacin Fleroxacin 2.16.840.1.113883.6.73 2017-01 J01MA09 sparfloxacin Sparfloxacin 2.16.840.1.113883.6.73 2017-01 J01MA10 rufloxacin Rufloxacin 2.16.840.1.113883.6.73 2017-01 J01MA11 grepafloxacin Grepafloxacin 2.16.840.1.113883.6.73 2017-01 J01MA12 levofloxacin Levofloxacin 2.16.840.1.113883.6.73 2017-01 J01MA13 trovafloxacin Trovafloxacin 2.16.840.1.113883.6.73 2017-01 J01MA14 moxifloxacin Moxifloxacin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 85 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01MA15 gemifloxacin Gemifloxacin 2.16.840.1.113883.6.73 2017-01 J01MA16 gatifloxacin Gatifloxacin 2.16.840.1.113883.6.73 2017-01 J01MA17 prulifloxacin Prulifloxacin 2.16.840.1.113883.6.73 2017-01 J01MA18 pazufloxacin Pazufloxacin 2.16.840.1.113883.6.73 2017-01 J01MA19 garenoxacin Garenoxacin 2.16.840.1.113883.6.73 2017-01 J01MA21 sitafloxacin Sitafloxacin 2.16.840.1.113883.6.73 2017-01 J01MB Other quinolones Övriga kinoloner 2.16.840.1.113883.6.73 2017-01 J01MB01 rosoxacin Rosoxacin 2.16.840.1.113883.6.73 2017-01 J01MB02 nalidixic acid Nalidixinsyra 2.16.840.1.113883.6.73 2017-01 J01MB03 piromidic acid Piromidinsyra 2.16.840.1.113883.6.73 2017-01 J01MB04 pipemidic acid Pipemidinsyra 2.16.840.1.113883.6.73 2017-01 J01MB05 oxolinic acid Oxolininsyra 2.16.840.1.113883.6.73 2017-01 J01MB06 cinoxacin Cinoxacin 2.16.840.1.113883.6.73 2017-01 J01MB07 flumequine Flumekin 2.16.840.1.113883.6.73 2017-01 J01MB08 nemonoxacin Nemonoxacin 2.16.840.1.113883.6.73 2017-01 J01R COMBINATIONS OF Antibakteriella medel, kombinationer ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01RA Combinations of antibacterials Antibakteriella medel, kombinationer 2.16.840.1.113883.6.73 2017-01 J01RA01 penicillins, combinations with other Penicilliner, kombinationer med antibacterials andra antibakteriella medel 2.16.840.1.113883.6.73 2017-01 J01RA02 sulfonamides, combinations with Sulfonamider, kombinationer med other antibacterials (excl. andra antibakteriella medel (exkl. trimethoprim) trimetoprim) 2.16.840.1.113883.6.73 2017-01 J01RA03 cefuroxime and metronidazole Cefuroxim och metronidazol 2.16.840.1.113883.6.73 2017-01 J01RA04 spiramycin and metronidazole Spiramycin och metronidazol 2.16.840.1.113883.6.73 2017-01 J01RA05 levofloxacin and ornidazole Levofloxacin och ornidazol 2.16.840.1.113883.6.73 2017-01 J01RA06 cefepime and amikacin Cefepim och amikacin 2.16.840.1.113883.6.73 2017-01 J01RA07 azithromycin, fluconazole and Azitromycin, flukonazol och seknidazol 2.16.840.1.113883.6.73 2017-01 J01RA08 tetracycline and oleandomycin Tetracyklin och oleandomycin 2.16.840.1.113883.6.73 2017-01 J01RA09 ofloxacin and ornidazole Ofloxacin och ornidazol 2.16.840.1.113883.6.73 2017-01 J01RA10 ciprofloxacin and metronidazole Ciprofloxacin och metronidazol 2.16.840.1.113883.6.73 2017-01 J01RA11 ciprofloxacin and tinidazole Ciprofloxacin och tinidazol 2.16.840.1.113883.6.73 2017-01 J01RA12 ciprofloxacin and ornidazole Ciprofloxacin och ornidazol 2.16.840.1.113883.6.73 2017-01 J01RA13 norfloxacin and tinidazole Norfloxacin och tinidazol 2.16.840.1.113883.6.73 2017-01 J01X OTHER ANTIBACTERIALS Övriga antibakteriella medel 2.16.840.1.113883.6.73 2017-01 J01XA Glycopeptide antibacterials Antibakteriella glykopeptider 2.16.840.1.113883.6.73 2017-01 J01XA01 vancomycin Vankomycin 2.16.840.1.113883.6.73 2017-01 J01XA02 teicoplanin Teikoplanin 2.16.840.1.113883.6.73 2017-01 J01XA03 telavancin Telavancin 2.16.840.1.113883.6.73 2017-01 J01XA04 dalbavancin Dalbavancin 2.16.840.1.113883.6.73 2017-01 J01XA05 oritavancin Oritavancin 2.16.840.1.113883.6.73 2017-01 J01XB Polymyxins Polymyxiner 2.16.840.1.113883.6.73 2017-01 J01XB01 colistin Kolistin 2.16.840.1.113883.6.73 2017-01 J01XB02 polymyxin B Polymyxin B © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 86 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01XC Steroid antibacterials Antibakteriella steroider 2.16.840.1.113883.6.73 2017-01 J01XC01 fusidic acid Fusidinsyra 2.16.840.1.113883.6.73 2017-01 J01XD Imidazole derivatives Imidazolderivat 2.16.840.1.113883.6.73 2017-01 J01XD01 metronidazole Metronidazol 2.16.840.1.113883.6.73 2017-01 J01XD02 tinidazole Tinidazol 2.16.840.1.113883.6.73 2017-01 J01XD03 ornidazole Ornidazol 2.16.840.1.113883.6.73 2017-01 J01XE Nitrofuran derivatives Nitrofuranderivat 2.16.840.1.113883.6.73 2017-01 J01XE01 nitrofurantoin Nitrofurantoin 2.16.840.1.113883.6.73 2017-01 J01XE02 nifurtoinol Nifurtoinol 2.16.840.1.113883.6.73 2017-01 J01XE03 furazidin Furazidin 2.16.840.1.113883.6.73 2017-01 J01XE51 nitrofurantoin, combinations Nitrofurantoin, kombinationer 2.16.840.1.113883.6.73 2017-01 J01XX Other antibacterials Övriga antibakteriella medel 2.16.840.1.113883.6.73 2017-01 J01XX01 fosfomycin Fosfomycin 2.16.840.1.113883.6.73 2017-01 J01XX02 xibornol Xibornol 2.16.840.1.113883.6.73 2017-01 J01XX03 clofoctol Klofoktol 2.16.840.1.113883.6.73 2017-01 J01XX04 Spektinomycin 2.16.840.1.113883.6.73 2017-01 J01XX05 methenamine Metenamin 2.16.840.1.113883.6.73 2017-01 J01XX06 mandelic acid Mandelinsyra 2.16.840.1.113883.6.73 2017-01 J01XX07 nitroxoline Nitroxolin 2.16.840.1.113883.6.73 2017-01 J01XX08 Linezolid 2.16.840.1.113883.6.73 2017-01 J01XX09 daptomycin Daptomycin 2.16.840.1.113883.6.73 2017-01 J01XX10 bacitracin Bacitracin 2.16.840.1.113883.6.73 2017-01 J01XX11 Tedizolid 2.16.840.1.113883.6.73 2017-01 J02 ANTIMYCOTICS FOR SYSTEMIC Antimykotika för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 J02A ANTIMYCOTICS FOR SYSTEMIC Antimykotika för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 J02AA Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 J02AA01 amphotericin B Amfotericin B 2.16.840.1.113883.6.73 2017-01 J02AA02 hachimycin Hakimycin 2.16.840.1.113883.6.73 2017-01 J02AB Imidazole derivatives Imidazolderivat 2.16.840.1.113883.6.73 2017-01 J02AB01 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 J02AB02 ketoconazole Ketokonazol 2.16.840.1.113883.6.73 2017-01 J02AC Triazole derivatives Triazolderivat 2.16.840.1.113883.6.73 2017-01 J02AC01 fluconazole Flukonazol 2.16.840.1.113883.6.73 2017-01 J02AC02 Itrakonazol 2.16.840.1.113883.6.73 2017-01 J02AC03 Vorikonazol 2.16.840.1.113883.6.73 2017-01 J02AC04 Posakonazol 2.16.840.1.113883.6.73 2017-01 J02AC05 isavuconazole Isavukonazol 2.16.840.1.113883.6.73 2017-01 J02AX Other antimycotics for systemic use Övriga antimykotika för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 J02AX01 flucytosine Flucytosin 2.16.840.1.113883.6.73 2017-01 J02AX04 Kaspofungin 2.16.840.1.113883.6.73 2017-01 J02AX05 Mikafungin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 87 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J02AX06 Anidulafungin 2.16.840.1.113883.6.73 2017-01 J04 Medel mot mykobakterier 2.16.840.1.113883.6.73 2017-01 J04A DRUGS FOR TREATMENT OF Medel för behandling av tuberkulos 2.16.840.1.113883.6.73 2017-01 J04AA Aminosalicylic acid and derivatives Aminosalicylsyra och derivat 2.16.840.1.113883.6.73 2017-01 J04AA01 4-aminosalicylic acid 4-Aminosalicylsyra 2.16.840.1.113883.6.73 2017-01 J04AA02 sodium Natriumaminosalicylat 2.16.840.1.113883.6.73 2017-01 J04AA03 calcium aminosalicylate Kalciumaminosalicylat 2.16.840.1.113883.6.73 2017-01 J04AB Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 J04AB01 Cykloserin 2.16.840.1.113883.6.73 2017-01 J04AB02 rifampicin Rifampicin 2.16.840.1.113883.6.73 2017-01 J04AB03 Rifamycin 2.16.840.1.113883.6.73 2017-01 J04AB04 rifabutin Rifabutin 2.16.840.1.113883.6.73 2017-01 J04AB05 rifapentine Rifapentin 2.16.840.1.113883.6.73 2017-01 J04AB30 capreomycin Kapreomycin 2.16.840.1.113883.6.73 2017-01 J04AC Hydrazides Hydrazider 2.16.840.1.113883.6.73 2017-01 J04AC01 isoniazid Isoniazid 2.16.840.1.113883.6.73 2017-01 J04AC51 isoniazid, combinations Isoniazid, kombinationer 2.16.840.1.113883.6.73 2017-01 J04AD Thiocarbamide derivatives Tiokarbamidderivat 2.16.840.1.113883.6.73 2017-01 J04AD01 protionamide Protionamid 2.16.840.1.113883.6.73 2017-01 J04AD02 tiocarlide Tiokarlid 2.16.840.1.113883.6.73 2017-01 J04AD03 ethionamide Etionamid 2.16.840.1.113883.6.73 2017-01 J04AK Other drugs for treatment of Övriga medel för behandling av tuberculosis tuberkulos 2.16.840.1.113883.6.73 2017-01 J04AK01 Pyrazinamid 2.16.840.1.113883.6.73 2017-01 J04AK02 ethambutol Etambutol 2.16.840.1.113883.6.73 2017-01 J04AK03 terizidone Terizidon 2.16.840.1.113883.6.73 2017-01 J04AK04 morinamide Morinamid 2.16.840.1.113883.6.73 2017-01 J04AK05 bedaquiline Bedakilin 2.16.840.1.113883.6.73 2017-01 J04AK06 delamanid Delamanid 2.16.840.1.113883.6.73 2017-01 J04AK07 Tioacetazon 2.16.840.1.113883.6.73 2017-01 J04AM Combinations of drugs for treatment Medel mot tuberkulos, of tuberculosis kombinationer 2.16.840.1.113883.6.73 2017-01 J04AM01 streptomycin and isoniazid Streptomycin och isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM02 rifampicin and isoniazid Rifampicin och isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM03 ethambutol and isoniazid Etambutol och isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM04 thioacetazone and isoniazid Tioacetazon och isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM05 rifampicin, pyrazinamide and Rifampicin, pyrazinamid och isoniazid isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM06 rifampicin, pyrazinamide, Rifampicin, pyrazinamid, etambutol ethambutol and isoniazid och isoniazid 2.16.840.1.113883.6.73 2017-01 J04B DRUGS FOR TREATMENT OF Medel för behandling av lepra LEPRA 2.16.840.1.113883.6.73 2017-01 J04BA Drugs for treatment of lepra Medel för behandling av lepra 2.16.840.1.113883.6.73 2017-01 J04BA01 clofazimine Klofazimin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 88 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J04BA02 dapsone Dapson 2.16.840.1.113883.6.73 2017-01 J04BA03 aldesulfone sodium Aldesulfonnatrium 2.16.840.1.113883.6.73 2017-01 J05 ANTIVIRALS FOR SYSTEMIC USE Virushämmande medel för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 J05A DIRECT ACTING ANTIVIRALS Virushämmande medel, direktverkande 2.16.840.1.113883.6.73 2017-01 J05AA Thiosemicarbazones Tiosemikarbazoner 2.16.840.1.113883.6.73 2017-01 J05AA01 metisazone Metisazon 2.16.840.1.113883.6.73 2017-01 J05AB and excl. Nukleosider och nukleotider, exkl. reverse transcriptase inhibitors hämmare av omvänt transkriptas 2.16.840.1.113883.6.73 2017-01 J05AB01 aciclovir Aciklovir 2.16.840.1.113883.6.73 2017-01 J05AB02 idoxuridine Idoxuridin 2.16.840.1.113883.6.73 2017-01 J05AB03 vidarabine Vidarabin 2.16.840.1.113883.6.73 2017-01 J05AB04 ribavirin Ribavirin 2.16.840.1.113883.6.73 2017-01 J05AB06 ganciclovir Ganciklovir 2.16.840.1.113883.6.73 2017-01 J05AB09 famciclovir Famciklovir 2.16.840.1.113883.6.73 2017-01 J05AB11 valaciclovir Valaciklovir 2.16.840.1.113883.6.73 2017-01 J05AB12 cidofovir Cidofovir 2.16.840.1.113883.6.73 2017-01 J05AB13 penciclovir Penciklovir 2.16.840.1.113883.6.73 2017-01 J05AB14 valganciclovir Valganciklovir 2.16.840.1.113883.6.73 2017-01 J05AB15 brivudine Brivudin 2.16.840.1.113883.6.73 2017-01 J05AC Cyclic amines Cykliska aminer 2.16.840.1.113883.6.73 2017-01 J05AC02 Rimantadin 2.16.840.1.113883.6.73 2017-01 J05AC03 tromantadine Tromantadin 2.16.840.1.113883.6.73 2017-01 J05AD Phosphonic acid derivatives Fosfonsyraderivat 2.16.840.1.113883.6.73 2017-01 J05AD01 foscarnet Foskarnet 2.16.840.1.113883.6.73 2017-01 J05AD02 fosfonet Fosfonet 2.16.840.1.113883.6.73 2017-01 J05AE Protease inhibitors Proteashämmare 2.16.840.1.113883.6.73 2017-01 J05AE01 saquinavir Sakvinavir 2.16.840.1.113883.6.73 2017-01 J05AE02 indinavir Indinavir 2.16.840.1.113883.6.73 2017-01 J05AE03 ritonavir Ritonavir 2.16.840.1.113883.6.73 2017-01 J05AE04 nelfinavir Nelfinavir 2.16.840.1.113883.6.73 2017-01 J05AE05 amprenavir Amprenavir 2.16.840.1.113883.6.73 2017-01 J05AE07 fosamprenavir Fosamprenavir 2.16.840.1.113883.6.73 2017-01 J05AE08 atazanavir Atazanavir 2.16.840.1.113883.6.73 2017-01 J05AE09 tipranavir Tipranavir 2.16.840.1.113883.6.73 2017-01 J05AE10 darunavir Darunavir 2.16.840.1.113883.6.73 2017-01 J05AE11 telaprevir Telaprevir 2.16.840.1.113883.6.73 2017-01 J05AE12 boceprevir Boceprevir 2.16.840.1.113883.6.73 2017-01 J05AE13 faldaprevir Faldaprevir 2.16.840.1.113883.6.73 2017-01 J05AE14 simeprevir Simeprevir 2.16.840.1.113883.6.73 2017-01 J05AE15 asunaprevir Asunaprevir 2.16.840.1.113883.6.73 2017-01 J05AF and reverse Nukleosider och nukleotider, transcriptase inhibitors hämmare av omvänt transkriptas

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 89 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J05AF01 zidovudine Zidovudin 2.16.840.1.113883.6.73 2017-01 J05AF02 didanosine Didanosin 2.16.840.1.113883.6.73 2017-01 J05AF03 zalcitabine Zalcitabin 2.16.840.1.113883.6.73 2017-01 J05AF04 stavudine Stavudin 2.16.840.1.113883.6.73 2017-01 J05AF05 lamivudine Lamivudin 2.16.840.1.113883.6.73 2017-01 J05AF06 abacavir Abakavir 2.16.840.1.113883.6.73 2017-01 J05AF07 tenofovir disoproxil Tenofovirdisoproxil 2.16.840.1.113883.6.73 2017-01 J05AF08 adefovir dipivoxil Adefovir dipivoxil 2.16.840.1.113883.6.73 2017-01 J05AF09 emtricitabine Emtricitabin 2.16.840.1.113883.6.73 2017-01 J05AF10 entecavir Entekavir 2.16.840.1.113883.6.73 2017-01 J05AF11 telbivudine Telbivudin 2.16.840.1.113883.6.73 2017-01 J05AF12 clevudine Klevudin 2.16.840.1.113883.6.73 2017-01 J05AF13 tenofovir alafenamide Tenofoviralafenamid 2.16.840.1.113883.6.73 2017-01 J05AG Non-nucleoside reverse Ickenukleosider, hämmare av transcriptase inhibitors omvänt transkriptas 2.16.840.1.113883.6.73 2017-01 J05AG01 nevirapine Nevirapin 2.16.840.1.113883.6.73 2017-01 J05AG02 delavirdine Delavirdin 2.16.840.1.113883.6.73 2017-01 J05AG03 Efavirenz 2.16.840.1.113883.6.73 2017-01 J05AG04 etravirine Etravirin 2.16.840.1.113883.6.73 2017-01 J05AG05 rilpivirine Rilpivirin 2.16.840.1.113883.6.73 2017-01 J05AH Neuraminidase inhibitors Neuraminidashämmare 2.16.840.1.113883.6.73 2017-01 J05AH01 zanamivir Zanamivir 2.16.840.1.113883.6.73 2017-01 J05AH02 oseltamivir Oseltamivir 2.16.840.1.113883.6.73 2017-01 J05AR Antivirals for treatment of HIV Virushämmande medel mot , combinations hivinfektioner, kombinationer 2.16.840.1.113883.6.73 2017-01 J05AR01 zidovudine and lamivudine Zidovudin och lamivudin 2.16.840.1.113883.6.73 2017-01 J05AR02 lamivudine and abacavir Lamivudin och abakavir 2.16.840.1.113883.6.73 2017-01 J05AR03 tenofovir disoproxil and Tenofovirdisoproxil och emtricitabin emtricitabine 2.16.840.1.113883.6.73 2017-01 J05AR04 zidovudine, lamivudine and abacavir Zidovudin, lamivudin och abakavir 2.16.840.1.113883.6.73 2017-01 J05AR05 zidovudine, lamivudine and Zidovudin, lamivudin och nevirapin nevirapine 2.16.840.1.113883.6.73 2017-01 J05AR06 emtricitabine, tenofovir disoproxil Emtricitabin, tenofovirdisoproxil och and efavirenz efavirenz 2.16.840.1.113883.6.73 2017-01 J05AR07 stavudine, lamivudine and Stavudin, lamivudin och nevirapin nevirapine 2.16.840.1.113883.6.73 2017-01 J05AR08 emtricitabine, tenofovir disoproxil Emtricitabin, tenofovirdisoproxil och and rilpivirine rilpivirin 2.16.840.1.113883.6.73 2017-01 J05AR09 emtricitabine, tenofovir disoproxil, Emtricitabin, tenofovirdisoproxil, elvitegravir and cobicistat elvitegravir och kobicistat 2.16.840.1.113883.6.73 2017-01 J05AR10 lopinavir and ritonavir Lopinavir och ritonavir 2.16.840.1.113883.6.73 2017-01 J05AR11 lamivudine, tenofovir disoproxil and Lamivudin, tenofovirdisoproxil och efavirenz efavirenz 2.16.840.1.113883.6.73 2017-01 J05AR12 lamivudine and tenofovir disoproxil Lamivudin och tenofovirdisoproxil 2.16.840.1.113883.6.73 2017-01 J05AR13 lamivudine, abacavir and Lamivudin, abakavir och dolutegravir dolutegravir

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 90 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J05AR14 darunavir and cobicistat Darunavir och kobicistat 2.16.840.1.113883.6.73 2017-01 J05AR15 atazanavir and cobicistat Atazanavir och kobicistat 2.16.840.1.113883.6.73 2017-01 J05AR16 lamivudine and raltegravir Lamivudin och raltegravir 2.16.840.1.113883.6.73 2017-01 J05AR17 emtricitabine and tenofovir Emtricitabin och tenofoviralafenamid alafenamide 2.16.840.1.113883.6.73 2017-01 J05AR18 emtricitabine, tenofovir alafenamide, Emtricitabin, tenofoviralafenamid, elvitegravir and cobicistat elvitegravir och kobicistat 2.16.840.1.113883.6.73 2017-01 J05AR19 emtricitabine, tenofovir alafenamide Emtricitabin, tenofoviralafenamid and rilpivirine och rilpivirin 2.16.840.1.113883.6.73 2017-01 J05AX Other antivirals Övriga virushämmande medel 2.16.840.1.113883.6.73 2017-01 J05AX01 moroxydine Moroxydin 2.16.840.1.113883.6.73 2017-01 J05AX02 lysozyme Lysozym 2.16.840.1.113883.6.73 2017-01 J05AX05 inosine pranobex Inosin pranobex 2.16.840.1.113883.6.73 2017-01 J05AX06 pleconaril Plekonaril 2.16.840.1.113883.6.73 2017-01 J05AX07 enfuvirtide Enfuvirtid 2.16.840.1.113883.6.73 2017-01 J05AX08 raltegravir Raltegravir 2.16.840.1.113883.6.73 2017-01 J05AX09 maraviroc Maravirok 2.16.840.1.113883.6.73 2017-01 J05AX10 maribavir Maribavir 2.16.840.1.113883.6.73 2017-01 J05AX11 elvitegravir Elvitegravir 2.16.840.1.113883.6.73 2017-01 J05AX12 dolutegravir Dolutegravir 2.16.840.1.113883.6.73 2017-01 J05AX13 umifenovir Umifenovir 2.16.840.1.113883.6.73 2017-01 J05AX14 daclatasvir Daklatasvir 2.16.840.1.113883.6.73 2017-01 J05AX15 sofosbuvir Sofosbuvir 2.16.840.1.113883.6.73 2017-01 J05AX16 dasabuvir Dasabuvir 2.16.840.1.113883.6.73 2017-01 J05AX65 sofosbuvir and ledipasvir Sofosbuvir och ledipasvir 2.16.840.1.113883.6.73 2017-01 J05AX66 dasabuvir, ombitasvir, paritaprevir Dasabuvir, ombitasvir, paritaprevir and ritonavir och ritonavir 2.16.840.1.113883.6.73 2017-01 J05AX67 ombitasvir, paritaprevir and ritonavir Ombitasvir, paritaprevir och ritonavir 2.16.840.1.113883.6.73 2017-01 J05AX68 elbasvir and grazoprevir Elbasvir och grazoprevir 2.16.840.1.113883.6.73 2017-01 J06 IMMUNE SERA AND Immunsera och immunglobuliner IMMUNOGLOBULINS 2.16.840.1.113883.6.73 2017-01 J06A IMMUNE SERA Immunsera 2.16.840.1.113883.6.73 2017-01 J06AA Immune sera Immunsera 2.16.840.1.113883.6.73 2017-01 J06AA01 Difteriantitoxin 2.16.840.1.113883.6.73 2017-01 J06AA02 antitoxin Stelkrampsantitoxin 2.16.840.1.113883.6.73 2017-01 J06AA03 Serum mot ormgift 2.16.840.1.113883.6.73 2017-01 J06AA04 botulinum antitoxin Antitoxin mot 2.16.840.1.113883.6.73 2017-01 J06AA05 gas-gangrene sera Serum mot gasgangrän 2.16.840.1.113883.6.73 2017-01 J06AA06 serum Serum mot rabies 2.16.840.1.113883.6.73 2017-01 J06B IMMUNOGLOBULINS Immunglobuliner 2.16.840.1.113883.6.73 2017-01 J06BA Immunoglobulins, normal human Humant, normalt immunglobulin 2.16.840.1.113883.6.73 2017-01 J06BA01 immunoglobulins, normal human, for Humant, normalt immunglobulin för extravascular adm. extravaskulärt bruk 2.16.840.1.113883.6.73 2017-01 J06BA02 immunoglobulins, normal human, for Humant, normalt immunglobulin för intravascular adm. intravaskulärt bruk

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 91 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J06BB Specific immunoglobulins Specifika immunglobuliner 2.16.840.1.113883.6.73 2017-01 J06BB01 anti-D (rh) immunoglobulin Immunglobulin mot Rh- immunisering 2.16.840.1.113883.6.73 2017-01 J06BB02 tetanus immunoglobulin Immunglobulin mot stelkramp 2.16.840.1.113883.6.73 2017-01 J06BB03 varicella/zoster immunoglobulin Immunglobulin mot varicella/zoster 2.16.840.1.113883.6.73 2017-01 J06BB04 immunoglobulin Immunglobulin mot hepatit B 2.16.840.1.113883.6.73 2017-01 J06BB05 rabies immunoglobulin Immunglobulin mot rabies 2.16.840.1.113883.6.73 2017-01 J06BB06 immunoglobulin Immunglobulin mot röda hund 2.16.840.1.113883.6.73 2017-01 J06BB07 immunoglobulin Immunglobulinvaccin 2.16.840.1.113883.6.73 2017-01 J06BB08 staphylococcus immunoglobulin Immunglobulin mot stafylokocker 2.16.840.1.113883.6.73 2017-01 J06BB09 immunoglobulin Immunglobulin mot cytomegalovirus-infektion 2.16.840.1.113883.6.73 2017-01 J06BB10 diphtheria immunoglobulin Immunglobulin mot difteri 2.16.840.1.113883.6.73 2017-01 J06BB11 hepatitis A immunoglobulin Immunglobulin mot hepatit A 2.16.840.1.113883.6.73 2017-01 J06BB12 encephalitis, tick borne Immunglobulin mot encefalit, immunoglobulin fästingburet 2.16.840.1.113883.6.73 2017-01 J06BB13 pertussis immunoglobulin Immunglobulin mot kikhosta 2.16.840.1.113883.6.73 2017-01 J06BB14 immunoglobulin Immunglobulin mot mässling 2.16.840.1.113883.6.73 2017-01 J06BB15 mumps immunoglobulin Immunglobulin mot påssjuka 2.16.840.1.113883.6.73 2017-01 J06BB16 Palivizumab 2.16.840.1.113883.6.73 2017-01 J06BB17 Motavizumab 2.16.840.1.113883.6.73 2017-01 J06BB18 Raxibakumab 2.16.840.1.113883.6.73 2017-01 J06BB19 immunoglobulin Immunglobulin mot mjältbrand 2.16.840.1.113883.6.73 2017-01 J06BB21 Bezlotoxumab 2.16.840.1.113883.6.73 2017-01 J06BB30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J06BC Other immunoglobulins Övriga immunglobuliner 2.16.840.1.113883.6.73 2017-01 J06BC01 Nebakumab 2.16.840.1.113883.6.73 2017-01 J07 Vacciner 2.16.840.1.113883.6.73 2017-01 J07A BACTERIAL VACCINES Vacciner mot bakteriella infektioner 2.16.840.1.113883.6.73 2017-01 J07AC Anthrax vaccines Vaccin mot mjältbrand 2.16.840.1.113883.6.73 2017-01 J07AC01 anthrax Antigen mot mjältbrand 2.16.840.1.113883.6.73 2017-01 J07AD Brucellosis vaccines Vaccin mot brucella 2.16.840.1.113883.6.73 2017-01 J07AD01 brucella antigen Antigen mot brucella 2.16.840.1.113883.6.73 2017-01 J07AE Cholera vaccines Vaccin mot kolera 2.16.840.1.113883.6.73 2017-01 J07AE01 cholera, inactivated, whole cell Vaccin mot kolera, inaktiverat helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AE02 cholera, live attenuated Vaccin mot kolera, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07AE51 cholera, combinations with typhoid Vaccin mot kolera, kombinationer , inactivated, whole cell med vaccin mot tyfoid, inaktiverat helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AF Diphtheria vaccines Vaccin mot difteri 2.16.840.1.113883.6.73 2017-01 J07AF01 diphtheria toxoid Difteritoxoid 2.16.840.1.113883.6.73 2017-01 J07AG Hemophilus influenzae B vaccines Vaccin mot haemophilus influenzae B

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 92 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07AG01 hemophilus influenzae B, purified Vaccin mot haemophilus influenzae antigen conjugated B, konjugerat renat antigen 2.16.840.1.113883.6.73 2017-01 J07AG51 hemophilus influenzae B, Vaccin mot haemophilus influenzae combinations with toxoids B i kombination med toxoider 2.16.840.1.113883.6.73 2017-01 J07AG52 hemophilus influenzae B, Vaccin mot haemophilus influenzae combinations with pertussis and B, i kombination med kikhosta och toxoids toxoider 2.16.840.1.113883.6.73 2017-01 J07AG53 hemophilus influenzae B, Vaccin mot haemophilus influenzae combinations with meningococcus B, i kombination med C, conjugated meningococcus C, konjugerad 2.16.840.1.113883.6.73 2017-01 J07AH Meningococcal vaccines Vaccin mot meningokockinfektioner 2.16.840.1.113883.6.73 2017-01 J07AH01 meningococcus A, purified Vaccin mot meningokockinfektion polysaccharides antigen typ A, renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH02 other meningococcal monovalent Vaccin mot meningokockinfektioner, purified polysaccharides antigen övriga monovalenta renade polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH03 meningococcus A,C, bivalent Vaccin mot meningokockinfektioner purified polysaccharides antigen A,C, bivalent renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH04 meningococcus A,C,Y,W-135, Vaccin mot meningokockinfektioner tetravalent purified polysaccharides A,C,Y,W-135, tetravalent renat antigen polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH05 other meningococcal polyvalent Vaccin mot meningokockinfektioner, purified polysaccharides antigen övriga polyvalenta renade polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH06 meningococcus B, outer membrane Vaccin mot meningokockinfektion vesicle vaccine typ B, yttermembranvesikel 2.16.840.1.113883.6.73 2017-01 J07AH07 meningococcus C, purified Vaccin mot meningokockinfektion polysaccharides antigen conjugated typ C, konjugerat renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH08 meningococcus A,C,Y,W-135, Vaccin mot meningokockinfektioner tetravalent purified polysaccharides A,C,Y,W-135, tetravalent konjugerat antigen conjugated renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH09 meningococcus B, multicomponent Vaccin mot meningokockinfektion vaccine typ B, multikomponent vaccin 2.16.840.1.113883.6.73 2017-01 J07AH10 meningococcus A, purified Vaccin mot meningokockinfektion polysaccharides antigen conjugated typ A, konjugerat renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AJ Pertussis vaccines Vaccin mot kikhosta 2.16.840.1.113883.6.73 2017-01 J07AJ01 pertussis, inactivated, whole cell Vaccin mot kikhosta, inaktiverat helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AJ02 pertussis, purified antigen Vaccin mot kikhosta, renat antigen 2.16.840.1.113883.6.73 2017-01 J07AJ51 pertussis, inactivated, whole cell, Vaccin mot kikhosta, inaktiverat combinations with toxoids helcellsvaccin, kombinationer med toxoider 2.16.840.1.113883.6.73 2017-01 J07AJ52 pertussis, purified antigen, Vaccin mot kikhosta, renat antigen, combinations with toxoids kombinationer med toxoider 2.16.840.1.113883.6.73 2017-01 J07AK Plague vaccines Vaccin mot pest 2.16.840.1.113883.6.73 2017-01 J07AK01 plague, inactivated, whole cell Vaccin mot pest, inaktiverat helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AL Pneumococcal vaccines Vaccin mot pneumokockinfektioner 2.16.840.1.113883.6.73 2017-01 J07AL01 pneumococcus, purified Vaccin mot pneumokockinfektioner, polysaccharides antigen renade polysackaridantigener

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 93 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07AL02 pneumococcus, purified Vaccin mot pneumokockinfektioner, polysaccharides antigen conjugated konjugerat renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AL52 pneumococcus purified Vaccin mot pneumokockinfektioner, polysaccharides antigen and renade polysackaridantigener och haemophilus influenzae, conjugated Haemophilus influenzae, konjugerat 2.16.840.1.113883.6.73 2017-01 J07AM Tetanus vaccines Vaccin mot stelkramp 2.16.840.1.113883.6.73 2017-01 J07AM01 tetanus toxoid Stelkrampstoxoid 2.16.840.1.113883.6.73 2017-01 J07AM51 tetanus toxoid, combinations with Stelkrampstoxoid, kombinationer diphtheria toxoid med difteritoxoid 2.16.840.1.113883.6.73 2017-01 J07AM52 tetanus toxoid, combinations with Stelkrampstoxoid, kombinationer tetanus immunoglobulin med stelkrampsimmunglobulin 2.16.840.1.113883.6.73 2017-01 J07AN Tuberculosis vaccines Vaccin mot tuberkulos 2.16.840.1.113883.6.73 2017-01 J07AN01 tuberculosis, live attenuated Vaccin mot tuberkulos, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07AP Typhoid vaccines Vaccin mot tyfoid 2.16.840.1.113883.6.73 2017-01 J07AP01 typhoid, oral, live attenuated Vaccin mot tyfoid, oralt, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07AP02 typhoid, inactivated, whole cell Vaccin mot tyfoid, inaktiverat helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AP03 typhoid, purified polysaccharide Vaccin mot tyfoid, renat antigen polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AP10 typhoid, combinations with paratyphi Vaccin mot tyfoid, kombinationer types med paratyfityper 2.16.840.1.113883.6.73 2017-01 J07AR Typhus (exanthematicus) vaccines Vaccin mot fläcktyfus 2.16.840.1.113883.6.73 2017-01 J07AR01 typhus exanthematicus, inactivated, Vaccin mot fläcktyfus, inaktiverat whole cell helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AX Other bacterial vaccines Övriga bakteriella vacciner 2.16.840.1.113883.6.73 2017-01 J07B VIRAL VACCINES Vacciner mot virusinfektioner 2.16.840.1.113883.6.73 2017-01 J07BA Encephalitis vaccines Vaccin mot encefalit 2.16.840.1.113883.6.73 2017-01 J07BA01 encephalitis, tick borne, inactivated, Vaccin mot fästingburen encefalit, whole inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BA02 encephalitis, Japanese, inactivated, Vaccin mot japansk encefalit, whole virus inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BA03 encephalitis, Japanese, live Vaccin mot japansk encefalit, attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BB Influenza vaccines Vaccin mot influensa 2.16.840.1.113883.6.73 2017-01 J07BB01 influenza, inactivated, whole virus Vaccin mot influensa, inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BB02 influenza, inactivated, split virus or Vaccin mot influensa, inaktiverat, surface antigen spjälkat virus eller ytantigen 2.16.840.1.113883.6.73 2017-01 J07BB03 influenza, live attenuated Vaccin mot influensa, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BC Hepatitis vaccines Vaccin mot hepatit 2.16.840.1.113883.6.73 2017-01 J07BC01 hepatitis B, purified antigen Vaccin mot hepatit B, renat antigen 2.16.840.1.113883.6.73 2017-01 J07BC02 hepatitis A, inactivated, whole virus Vaccin mot hepatit A, inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BC20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J07BD Measles vaccines Vaccin mot mässling

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 94 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07BD01 measles, live attenuated Vaccin mot mässling, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BD51 measles, combinations with mumps, Vaccin mot mässling och påssjuka, live attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BD52 measles, combinations with mumps Vaccin mot mässling, påssjuka och and rubella, live attenuated röda hund, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BD53 measles, combinations with rubella, Vaccin mot mässling och röda hund, live attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BD54 measles, combinations with mumps, Vaccin mot mässling, påssjuka, rubella and varicella, live attenuated röda hund och vattkoppor, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BE Mumps vaccines Vaccin mot påssjuka 2.16.840.1.113883.6.73 2017-01 J07BE01 mumps, live attenuated Vaccin mot påssjuka, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BF Poliomyelitis vaccines Vaccin mot 2.16.840.1.113883.6.73 2017-01 J07BF01 poliomyelitis oral, monovalent, live Vaccin mot polio, oralt, monovalent, attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BF02 poliomyelitis oral, trivalent, live Vaccin mot polio, oralt, trivalent, attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BF03 poliomyelitis, trivalent, inactivated, Vaccin mot polio, trivalent, whole virus inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BF04 poliomyelitis oral, bivalent, live Vaccin mot polio, oralt, bivalent, attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BG Rabies vaccines Vaccin mot rabies 2.16.840.1.113883.6.73 2017-01 J07BG01 rabies, inactivated, whole virus Vaccin mot rabies, inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BH Rota virus vaccines Vaccin mot rotavirusdiarré 2.16.840.1.113883.6.73 2017-01 J07BH01 rota virus, live attenuated Vaccin mot rotavirus, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BH02 rota virus, pentavalent, live, Vaccin mot rotavirus, pentavalent, reassorted levande, reassortant 2.16.840.1.113883.6.73 2017-01 J07BJ Rubella vaccines Vaccin mot röda hund 2.16.840.1.113883.6.73 2017-01 J07BJ01 rubella, live attenuated Vaccin mot röda hund, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BJ51 rubella, combinations with mumps, Vaccin mot röda hund och påssjuka, live attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BK Varicella zoster vaccines Varicella zoster vacciner 2.16.840.1.113883.6.73 2017-01 J07BK01 varicella, live attenuated Vaccin mot vattkoppor, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BK02 zoster, live attenuated Vaccin mot bältros, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BL Yellow vaccines Vaccin mot gula febern 2.16.840.1.113883.6.73 2017-01 J07BL01 yellow fever, live attenuated Vaccin mot gula febern, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BM Papillomavirus vaccines Papillomvirusvacciner 2.16.840.1.113883.6.73 2017-01 J07BM01 papillomavirus (human types 6, 11, Papillomvirus (humant, typ 6, 11, 16, 18) 16, 18) 2.16.840.1.113883.6.73 2017-01 J07BM02 papillomavirus (human types 16, 18) Papillomvirus (humant, typ 16, 18) 2.16.840.1.113883.6.73 2017-01 J07BM03 papillomavirus (human types 6, 11, Papillomvirus (humant, typ 6, 11, 16, 18, 31, 33, 45, 52, 58) 16, 18, 31, 33, 45, 52, 58)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 95 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07BX Other viral vaccines Övriga vacciner mot virusinfektioner 2.16.840.1.113883.6.73 2017-01 J07BX01 smallpox, live attenuated Vaccin mot smittkoppor, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07C BACTERIAL AND VIRAL Vacciner mot bakteriella infektioner i VACCINES, COMBINED kombination med vacciner mot virusinfektioner 2.16.840.1.113883.6.73 2017-01 J07CA Bacterial and viral vaccines, Vacciner mot bakteriella infektioner i combined kombination med vacciner mot virusinfektioner 2.16.840.1.113883.6.73 2017-01 J07CA01 diphtheria-poliomyelitis-tetanus Vaccin mot difteri, polio och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA02 diphtheria-pertussis-poliomyelitis- Vaccin mot difteri, kikhosta, polio tetanus och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA03 diphtheria-rubella-tetanus Vaccin mot difteri, röda hund och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA04 hemophilus influenzae B and Vaccin mot haemophilus influenzae poliomyelitis B och polio 2.16.840.1.113883.6.73 2017-01 J07CA05 diphtheria-hepatitis B-pertussis- Vaccin mot difteri, hepatit B, tetanus kikhosta och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA06 diphtheria-hemophilus influenzae B- Vaccin mot difteri, haemophilus pertussis-poliomyelitis-tetanus influenzae B, kikhosta, polio och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA07 diphtheria-hepatitis B-tetanus Vaccin mot difteri, hepatit B och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA08 hemophilus influenzae B and Vaccin mot haemophilus influenzae hepatitis B B och hepatit B 2.16.840.1.113883.6.73 2017-01 J07CA09 diphtheria-hemophilus influenzae B- Vaccin mot difteri, haemophilus pertussis-poliomyelitis-tetanus- influenzae B, kikhosta, polio, hepatitis B stelkramp och hepatit B 2.16.840.1.113883.6.73 2017-01 J07CA10 typhoid-hepatitis A Vaccin mot tyfoid och hepatit A 2.16.840.1.113883.6.73 2017-01 J07CA11 diphtheria-hemophilus influenzae B- Vaccin mot difteri, haemophilus pertussis-tetanus-hepatitis B influnzae B, kikhosta, stelkramp och hepatit B 2.16.840.1.113883.6.73 2017-01 J07CA12 diphtheria-pertussis-poliomyelitis- Vaccin mot difteri, kikhosta, polio, tetanus-hepatitis B stelkramp och hepatit B 2.16.840.1.113883.6.73 2017-01 J07CA13 diphtheria-hemophilus influenzae B- Vaccin mot difteri, haemophilus pertussis-tetanus-hepatitis B- influenzae B, kikhosta, stelkramp, meningococcus A + C hepatit B och meningococcus A + C 2.16.840.1.113883.6.73 2017-01 J07X OTHER VACCINES Övriga vacciner 2.16.840.1.113883.6.73 2017-01 L ANTINEOPLASTIC AND Tumörer och rubbningar i IMMUNOMODULATING AGENTS immunsystemet 2.16.840.1.113883.6.73 2017-01 L01 ANTINEOPLASTIC AGENTS Antineoplastiska medel 2.16.840.1.113883.6.73 2017-01 L01A ALKYLATING AGENTS Alkylerande medel 2.16.840.1.113883.6.73 2017-01 L01AA mustard analogues Kvävesenapsgasanaloger 2.16.840.1.113883.6.73 2017-01 L01AA01 Cyklofosfamid 2.16.840.1.113883.6.73 2017-01 L01AA02 chlorambucil Klorambucil 2.16.840.1.113883.6.73 2017-01 L01AA03 melphalan Melfalan 2.16.840.1.113883.6.73 2017-01 L01AA05 chlormethine Klormetin 2.16.840.1.113883.6.73 2017-01 L01AA06 ifosfamide Ifosfamid 2.16.840.1.113883.6.73 2017-01 L01AA07 trofosfamide Trofosfamid 2.16.840.1.113883.6.73 2017-01 L01AA08 Prednimustin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 96 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01AA09 bendamustine Bendamustin 2.16.840.1.113883.6.73 2017-01 L01AB Alkyl sulfonates Alkylsulfonater 2.16.840.1.113883.6.73 2017-01 L01AB01 busulfan Busulfan 2.16.840.1.113883.6.73 2017-01 L01AB02 treosulfan Treosulfan 2.16.840.1.113883.6.73 2017-01 L01AB03 mannosulfan Mannosulfan 2.16.840.1.113883.6.73 2017-01 L01AC imines Aziridiner 2.16.840.1.113883.6.73 2017-01 L01AC01 thiotepa Tiotepa 2.16.840.1.113883.6.73 2017-01 L01AC02 triaziquone Triazikvon 2.16.840.1.113883.6.73 2017-01 L01AC03 carboquone Karbokvon 2.16.840.1.113883.6.73 2017-01 L01AD Nitrosoureas Nitrosureaföreningar 2.16.840.1.113883.6.73 2017-01 L01AD01 carmustine Karmustin 2.16.840.1.113883.6.73 2017-01 L01AD02 lomustine Lomustin 2.16.840.1.113883.6.73 2017-01 L01AD03 semustine Semustin 2.16.840.1.113883.6.73 2017-01 L01AD04 streptozocin Streptozocin 2.16.840.1.113883.6.73 2017-01 L01AD05 fotemustine Fotemustin 2.16.840.1.113883.6.73 2017-01 L01AD06 nimustine Nimustin 2.16.840.1.113883.6.73 2017-01 L01AD07 ranimustine Ranimustin 2.16.840.1.113883.6.73 2017-01 L01AG Epoxides Epoxider 2.16.840.1.113883.6.73 2017-01 L01AG01 etoglucid Etoglucid 2.16.840.1.113883.6.73 2017-01 L01AX Other alkylating agents Övriga alkylerande medel 2.16.840.1.113883.6.73 2017-01 L01AX01 mitobronitol Mitobronitol 2.16.840.1.113883.6.73 2017-01 L01AX02 pipobroman Pipobroman 2.16.840.1.113883.6.73 2017-01 L01AX03 temozolomide Temozolomid 2.16.840.1.113883.6.73 2017-01 L01AX04 dacarbazine Dakarbazin 2.16.840.1.113883.6.73 2017-01 L01B Antimetaboliter 2.16.840.1.113883.6.73 2017-01 L01BA Folic acid analogues Folsyraanaloger 2.16.840.1.113883.6.73 2017-01 L01BA01 Metotrexat 2.16.840.1.113883.6.73 2017-01 L01BA03 raltitrexed Raltitrexed 2.16.840.1.113883.6.73 2017-01 L01BA04 Pemetrexed 2.16.840.1.113883.6.73 2017-01 L01BA05 Pralatrexat 2.16.840.1.113883.6.73 2017-01 L01BB Purine analogues Purinanaloger 2.16.840.1.113883.6.73 2017-01 L01BB02 mercaptopurine Merkaptopurin 2.16.840.1.113883.6.73 2017-01 L01BB03 tioguanine Tioguanin 2.16.840.1.113883.6.73 2017-01 L01BB04 Kladribin 2.16.840.1.113883.6.73 2017-01 L01BB05 fludarabine Fludarabin 2.16.840.1.113883.6.73 2017-01 L01BB06 clofarabine Klofarabin 2.16.840.1.113883.6.73 2017-01 L01BB07 nelarabine Nelarabin 2.16.840.1.113883.6.73 2017-01 L01BC Pyrimidine analogues Pyrimidinanaloger 2.16.840.1.113883.6.73 2017-01 L01BC01 cytarabine Cytarabin 2.16.840.1.113883.6.73 2017-01 L01BC02 fluorouracil Fluorouracil 2.16.840.1.113883.6.73 2017-01 L01BC03 tegafur Tegafur 2.16.840.1.113883.6.73 2017-01 L01BC04 carmofur Karmofur 2.16.840.1.113883.6.73 2017-01 L01BC05 gemcitabine Gemcitabin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 97 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01BC06 capecitabine Kapecitabin 2.16.840.1.113883.6.73 2017-01 L01BC07 azacitidine Azacitidin 2.16.840.1.113883.6.73 2017-01 L01BC08 decitabine Decitabin 2.16.840.1.113883.6.73 2017-01 L01BC52 fluorouracil, combinations Fluorouracil, kombinationer 2.16.840.1.113883.6.73 2017-01 L01BC53 tegafur, combinations Tegafur, kombinationer 2.16.840.1.113883.6.73 2017-01 L01BC59 trifluridine, combinations Trifluridin, kombinationer 2.16.840.1.113883.6.73 2017-01 L01C PLANT ALKALOIDS AND OTHER Växtalkaloider och andra NATURAL PRODUCTS naturprodukter 2.16.840.1.113883.6.73 2017-01 L01CA Vinca alkaloids and analogues Vinca-alkaloider och analoger 2.16.840.1.113883.6.73 2017-01 L01CA01 vinblastine Vinblastin 2.16.840.1.113883.6.73 2017-01 L01CA02 vincristine Vinkristin 2.16.840.1.113883.6.73 2017-01 L01CA03 vindesine Vindesin 2.16.840.1.113883.6.73 2017-01 L01CA04 vinorelbine Vinorelbin 2.16.840.1.113883.6.73 2017-01 L01CA05 vinflunine Vinflunin 2.16.840.1.113883.6.73 2017-01 L01CA06 vintafolide Vintafolid 2.16.840.1.113883.6.73 2017-01 L01CB Podophyllotoxin derivatives Podofyllotoxinderivat 2.16.840.1.113883.6.73 2017-01 L01CB01 etoposide Etoposid 2.16.840.1.113883.6.73 2017-01 L01CB02 teniposide Teniposid 2.16.840.1.113883.6.73 2017-01 L01CC derivatives Kolkicinderivat 2.16.840.1.113883.6.73 2017-01 L01CC01 demecolcine Demekolcin 2.16.840.1.113883.6.73 2017-01 L01CD Taxaner 2.16.840.1.113883.6.73 2017-01 L01CD01 Paklitaxel 2.16.840.1.113883.6.73 2017-01 L01CD02 docetaxel Docetaxel 2.16.840.1.113883.6.73 2017-01 L01CD03 paclitaxel poliglumex Paklitaxelpoliglumex 2.16.840.1.113883.6.73 2017-01 L01CD04 cabazitaxel Kabazitaxel 2.16.840.1.113883.6.73 2017-01 L01CX Other plant alkaloids and natural Övriga växtalkaloider och products naturprodukter 2.16.840.1.113883.6.73 2017-01 L01CX01 trabectedin Trabektedin 2.16.840.1.113883.6.73 2017-01 L01D CYTOTOXIC ANTIBIOTICS AND Cytotoxiska antibiotika och RELATED SUBSTANCES närbesläktade substanser 2.16.840.1.113883.6.73 2017-01 L01DA Actinomycines Aktinomyciner 2.16.840.1.113883.6.73 2017-01 L01DA01 dactinomycin Daktinomycin 2.16.840.1.113883.6.73 2017-01 L01DB and related Antracykliner och närbesläktade substances substanser 2.16.840.1.113883.6.73 2017-01 L01DB01 doxorubicin Doxorubicin 2.16.840.1.113883.6.73 2017-01 L01DB02 daunorubicin Daunorubicin 2.16.840.1.113883.6.73 2017-01 L01DB03 epirubicin Epirubicin 2.16.840.1.113883.6.73 2017-01 L01DB04 aclarubicin Aklarubicin 2.16.840.1.113883.6.73 2017-01 L01DB05 zorubicin Zorubicin 2.16.840.1.113883.6.73 2017-01 L01DB06 idarubicin Idarubicin 2.16.840.1.113883.6.73 2017-01 L01DB07 mitoxantrone Mitoxantron 2.16.840.1.113883.6.73 2017-01 L01DB08 pirarubicin Pirarubicin 2.16.840.1.113883.6.73 2017-01 L01DB09 valrubicin Valrubicin 2.16.840.1.113883.6.73 2017-01 L01DB10 amrubicin Amrubicin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 98 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01DB11 pixantrone Pixantron 2.16.840.1.113883.6.73 2017-01 L01DC Other cytotoxic antibiotics Övriga cytotoxiska antibiotika 2.16.840.1.113883.6.73 2017-01 L01DC01 bleomycin Bleomycin 2.16.840.1.113883.6.73 2017-01 L01DC02 plicamycin Plikamycin 2.16.840.1.113883.6.73 2017-01 L01DC03 mitomycin Mitomycin 2.16.840.1.113883.6.73 2017-01 L01DC04 ixabepilone Ixabepilon 2.16.840.1.113883.6.73 2017-01 L01X OTHER ANTINEOPLASTIC Övriga antineoplastiska medel AGENTS 2.16.840.1.113883.6.73 2017-01 L01XA Platinum compounds Platinaföreningar 2.16.840.1.113883.6.73 2017-01 L01XA01 Cisplatin 2.16.840.1.113883.6.73 2017-01 L01XA02 carboplatin Karboplatin 2.16.840.1.113883.6.73 2017-01 L01XA03 oxaliplatin Oxaliplatin 2.16.840.1.113883.6.73 2017-01 L01XA04 satraplatin Satraplatin 2.16.840.1.113883.6.73 2017-01 L01XA05 polyplatillen Polyplatillen 2.16.840.1.113883.6.73 2017-01 L01XB Methylhydrazines Metylhydraziner 2.16.840.1.113883.6.73 2017-01 L01XB01 procarbazine Prokarbazin 2.16.840.1.113883.6.73 2017-01 L01XC Monoclonal Monoklonala antikroppar 2.16.840.1.113883.6.73 2017-01 L01XC01 edrecolomab Edrekolomab 2.16.840.1.113883.6.73 2017-01 L01XC02 Rituximab 2.16.840.1.113883.6.73 2017-01 L01XC03 trastuzumab Trastuzumab 2.16.840.1.113883.6.73 2017-01 L01XC05 gemtuzumab Gemtuzumabozogamicin 2.16.840.1.113883.6.73 2017-01 L01XC06 cetuximab Cetuximab 2.16.840.1.113883.6.73 2017-01 L01XC07 Bevacizumab 2.16.840.1.113883.6.73 2017-01 L01XC08 panitumumab Panitumumab 2.16.840.1.113883.6.73 2017-01 L01XC09 catumaxomab Katumaxomab 2.16.840.1.113883.6.73 2017-01 L01XC10 ofatumumab Ofatumumab 2.16.840.1.113883.6.73 2017-01 L01XC11 Ipilimumab 2.16.840.1.113883.6.73 2017-01 L01XC12 brentuximab vedotin Brentuximab vedotin 2.16.840.1.113883.6.73 2017-01 L01XC13 pertuzumab Pertuzumab 2.16.840.1.113883.6.73 2017-01 L01XC14 trastuzumab emtansine Trastuzumabemtansin 2.16.840.1.113883.6.73 2017-01 L01XC15 Obinutuzumab 2.16.840.1.113883.6.73 2017-01 L01XC16 dinutuximab Dinutuximab beta 2.16.840.1.113883.6.73 2017-01 L01XC17 nivolumab Nivolumab 2.16.840.1.113883.6.73 2017-01 L01XC18 pembrolizumab Pembrolizumab 2.16.840.1.113883.6.73 2017-01 L01XC19 blinatumomab Blinatumomab 2.16.840.1.113883.6.73 2017-01 L01XC21 ramucirumab Ramucirumab 2.16.840.1.113883.6.73 2017-01 L01XC22 necitumumab Necitumumab 2.16.840.1.113883.6.73 2017-01 L01XC23 elotuzumab Elotuzumab 2.16.840.1.113883.6.73 2017-01 L01XC24 daratumumab Daratumumab 2.16.840.1.113883.6.73 2017-01 L01XC25 mogamulizumab Mogamulizumab 2.16.840.1.113883.6.73 2017-01 L01XC26 inotuzumab ozogamicin Inotuzumabozogamicin 2.16.840.1.113883.6.73 2017-01 L01XD Sensitizers used in Sensibiliserande ämnen för photodynamic/ strålning/fotodynamisk behandling 2.16.840.1.113883.6.73 2017-01 L01XD01 porfimer sodium Porfimernatrium © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 99 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01XD03 methyl aminolevulinate Metylaminolevulinat 2.16.840.1.113883.6.73 2017-01 L01XD04 aminolevulinic acid Aminolevulinsyra 2.16.840.1.113883.6.73 2017-01 L01XD05 temoporfin Temoporfin 2.16.840.1.113883.6.73 2017-01 L01XD06 efaproxiral Efaproxiral 2.16.840.1.113883.6.73 2017-01 L01XE Protein kinase inhibitors Proteinkinashämmare 2.16.840.1.113883.6.73 2017-01 L01XE01 imatinib Imatinib 2.16.840.1.113883.6.73 2017-01 L01XE02 gefitinib Gefitinib 2.16.840.1.113883.6.73 2017-01 L01XE03 erlotinib Erlotinib 2.16.840.1.113883.6.73 2017-01 L01XE04 sunitinib Sunitinib 2.16.840.1.113883.6.73 2017-01 L01XE05 sorafenib Sorafenib 2.16.840.1.113883.6.73 2017-01 L01XE06 dasatinib Dasatinib 2.16.840.1.113883.6.73 2017-01 L01XE07 lapatinib Lapatinib 2.16.840.1.113883.6.73 2017-01 L01XE08 nilotinib Nilotinib 2.16.840.1.113883.6.73 2017-01 L01XE09 Temsirolimus 2.16.840.1.113883.6.73 2017-01 L01XE10 Everolimus 2.16.840.1.113883.6.73 2017-01 L01XE11 pazopanib Pazopanib 2.16.840.1.113883.6.73 2017-01 L01XE12 vandetanib Vandetanib 2.16.840.1.113883.6.73 2017-01 L01XE13 afatinib Afatinib 2.16.840.1.113883.6.73 2017-01 L01XE14 bosutinib Bosutinib 2.16.840.1.113883.6.73 2017-01 L01XE15 vemurafenib Vemurafenib 2.16.840.1.113883.6.73 2017-01 L01XE16 crizotinib Krizotinib 2.16.840.1.113883.6.73 2017-01 L01XE17 axitinib Axitinib 2.16.840.1.113883.6.73 2017-01 L01XE18 ruxolitinib Ruxolitinib 2.16.840.1.113883.6.73 2017-01 L01XE19 Ridaforolimus 2.16.840.1.113883.6.73 2017-01 L01XE21 regorafenib Regorafenib 2.16.840.1.113883.6.73 2017-01 L01XE22 masitinib Masitinib 2.16.840.1.113883.6.73 2017-01 L01XE23 dabrafenib Dabrafenib 2.16.840.1.113883.6.73 2017-01 L01XE24 ponatinib Ponatinib 2.16.840.1.113883.6.73 2017-01 L01XE25 trametinib Trametinib 2.16.840.1.113883.6.73 2017-01 L01XE26 cabozantinib Kabozantinib 2.16.840.1.113883.6.73 2017-01 L01XE27 ibrutinib Ibrutinib 2.16.840.1.113883.6.73 2017-01 L01XE28 ceritinib Ceritinib 2.16.840.1.113883.6.73 2017-01 L01XE29 lenvatinib Lenvatinib 2.16.840.1.113883.6.73 2017-01 L01XE31 nintedanib Nintedanib 2.16.840.1.113883.6.73 2017-01 L01XE32 cediranib Cediranib 2.16.840.1.113883.6.73 2017-01 L01XE33 palbociclib Palbociklib 2.16.840.1.113883.6.73 2017-01 L01XE34 tivozanib Tivozanib 2.16.840.1.113883.6.73 2017-01 L01XE35 osimertinib Osimertinib 2.16.840.1.113883.6.73 2017-01 L01XE36 alectinib Alektinib 2.16.840.1.113883.6.73 2017-01 L01XE37 rociletinib Rociletinib 2.16.840.1.113883.6.73 2017-01 L01XE38 cobimetinib Kobimetinib 2.16.840.1.113883.6.73 2017-01 L01XE39 midostaurin Midostaurin 2.16.840.1.113883.6.73 2017-01 L01XE40 olmutinib Olmutinib © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 100 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01XX Other antineoplastic agents Övriga antineoplastiska medel 2.16.840.1.113883.6.73 2017-01 L01XX01 amsacrine Amsakrin 2.16.840.1.113883.6.73 2017-01 L01XX02 asparaginase Asparginas 2.16.840.1.113883.6.73 2017-01 L01XX03 altretamine Altretamin 2.16.840.1.113883.6.73 2017-01 L01XX05 hydroxycarbamide Hydroxikarbamid 2.16.840.1.113883.6.73 2017-01 L01XX07 lonidamine Lonidamin 2.16.840.1.113883.6.73 2017-01 L01XX08 pentostatin Pentostatin 2.16.840.1.113883.6.73 2017-01 L01XX09 Miltefosin 2.16.840.1.113883.6.73 2017-01 L01XX10 masoprocol Masoprokol 2.16.840.1.113883.6.73 2017-01 L01XX11 estramustine Estramustin 2.16.840.1.113883.6.73 2017-01 L01XX14 tretinoin Tretinoin 2.16.840.1.113883.6.73 2017-01 L01XX16 mitoguazone Mitoguazon 2.16.840.1.113883.6.73 2017-01 L01XX17 topotecan Topotekan 2.16.840.1.113883.6.73 2017-01 L01XX18 tiazofurine Tiazofurin 2.16.840.1.113883.6.73 2017-01 L01XX19 irinotecan Irinotekan 2.16.840.1.113883.6.73 2017-01 L01XX22 alitretinoin Alitretinoin 2.16.840.1.113883.6.73 2017-01 L01XX23 Mitotan 2.16.840.1.113883.6.73 2017-01 L01XX24 pegaspargase Pegaspargas 2.16.840.1.113883.6.73 2017-01 L01XX25 bexarotene Bexaroten 2.16.840.1.113883.6.73 2017-01 L01XX27 arsenic trioxide Arseniktrioxid 2.16.840.1.113883.6.73 2017-01 L01XX29 denileukin diftitox Denileukin diftitox 2.16.840.1.113883.6.73 2017-01 L01XX32 bortezomib Bortezomib 2.16.840.1.113883.6.73 2017-01 L01XX33 Celecoxib 2.16.840.1.113883.6.73 2017-01 L01XX35 anagrelide Anagrelid 2.16.840.1.113883.6.73 2017-01 L01XX36 oblimersen Oblimersen 2.16.840.1.113883.6.73 2017-01 L01XX37 sitimagene ceradenovec Sitimagen-ceradenovek 2.16.840.1.113883.6.73 2017-01 L01XX38 vorinostat Vorinostat 2.16.840.1.113883.6.73 2017-01 L01XX39 romidepsin Romidepsin 2.16.840.1.113883.6.73 2017-01 L01XX40 omacetaxine mepesuccinate Omacetaxinmepesuccinat 2.16.840.1.113883.6.73 2017-01 L01XX41 eribulin Eribulin 2.16.840.1.113883.6.73 2017-01 L01XX42 panobinostat Panobinostat 2.16.840.1.113883.6.73 2017-01 L01XX43 vismodegib Vismodegib 2.16.840.1.113883.6.73 2017-01 L01XX44 Aflibercept 2.16.840.1.113883.6.73 2017-01 L01XX45 carfilzomib Karfilzomib 2.16.840.1.113883.6.73 2017-01 L01XX46 olaparib Olaparib 2.16.840.1.113883.6.73 2017-01 L01XX47 idelalisib Idelalisib 2.16.840.1.113883.6.73 2017-01 L01XX48 sonidegib Sonidegib 2.16.840.1.113883.6.73 2017-01 L01XX49 belinostat Belinostat 2.16.840.1.113883.6.73 2017-01 L01XX50 ixazomib Ixazomib 2.16.840.1.113883.6.73 2017-01 L01XX51 talimogene laherparepvec Talimogen-laherparepvek 2.16.840.1.113883.6.73 2017-01 L01XX52 venetoclax Venetoklax 2.16.840.1.113883.6.73 2017-01 L01XX53 vosaroxin Vosaroxin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 101 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01XY Combinations of antineoplastic Kombinationer av antineoplastiska agents medel 2.16.840.1.113883.6.73 2017-01 L02 ENDOCRINE THERAPY Endokrinterapi 2.16.840.1.113883.6.73 2017-01 L02A HORMONES AND RELATED Hormoner AGENTS 2.16.840.1.113883.6.73 2017-01 L02AA Estrogens Östrogener 2.16.840.1.113883.6.73 2017-01 L02AA01 diethylstilbestrol Dietylstilbestrol 2.16.840.1.113883.6.73 2017-01 L02AA02 Polyöstradiolfosfat 2.16.840.1.113883.6.73 2017-01 L02AA03 ethinylestradiol Etinylestradiol 2.16.840.1.113883.6.73 2017-01 L02AA04 Fosfestrol 2.16.840.1.113883.6.73 2017-01 L02AB Progestogens Gestagener 2.16.840.1.113883.6.73 2017-01 L02AB01 megestrol Megestrol 2.16.840.1.113883.6.73 2017-01 L02AB02 medroxyprogesterone Medroxiprogesteron 2.16.840.1.113883.6.73 2017-01 L02AB03 gestonorone Gestonoron 2.16.840.1.113883.6.73 2017-01 L02AE Gonadotropin releasing hormone Gonadotropinfrisättande analogues hormonanaloger 2.16.840.1.113883.6.73 2017-01 L02AE01 Buserelin 2.16.840.1.113883.6.73 2017-01 L02AE02 Leuprorelin 2.16.840.1.113883.6.73 2017-01 L02AE03 Goserelin 2.16.840.1.113883.6.73 2017-01 L02AE04 Triptorelin 2.16.840.1.113883.6.73 2017-01 L02AE05 Histrelin 2.16.840.1.113883.6.73 2017-01 L02AX Other hormones Övriga hormoner 2.16.840.1.113883.6.73 2017-01 L02B HORMONE ANTAGONISTS AND Antihormoner och relaterade medel RELATED AGENTS 2.16.840.1.113883.6.73 2017-01 L02BA Anti-estrogens Antiöstrogener 2.16.840.1.113883.6.73 2017-01 L02BA01 Tamoxifen 2.16.840.1.113883.6.73 2017-01 L02BA02 Toremifen 2.16.840.1.113883.6.73 2017-01 L02BA03 Fulvestrant 2.16.840.1.113883.6.73 2017-01 L02BB Anti-androgens Antiandrogener 2.16.840.1.113883.6.73 2017-01 L02BB01 Flutamid 2.16.840.1.113883.6.73 2017-01 L02BB02 Nilutamid 2.16.840.1.113883.6.73 2017-01 L02BB03 Bikalutamid 2.16.840.1.113883.6.73 2017-01 L02BB04 Enzalutamid 2.16.840.1.113883.6.73 2017-01 L02BG Aromatase inhibitors Aromatashämmare 2.16.840.1.113883.6.73 2017-01 L02BG01 Aminoglutetimid 2.16.840.1.113883.6.73 2017-01 L02BG02 Formestan 2.16.840.1.113883.6.73 2017-01 L02BG03 Anastrozol 2.16.840.1.113883.6.73 2017-01 L02BG04 Letrozol 2.16.840.1.113883.6.73 2017-01 L02BG05 Vorozol 2.16.840.1.113883.6.73 2017-01 L02BG06 Exemestan 2.16.840.1.113883.6.73 2017-01 L02BX Other hormone antagonists and Övriga antihormoner och relaterade related agents medel 2.16.840.1.113883.6.73 2017-01 L02BX01 Abarelix 2.16.840.1.113883.6.73 2017-01 L02BX02 Degarelix 2.16.840.1.113883.6.73 2017-01 L02BX03 abiraterone Abirateron © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 102 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L03 Immunstimulerande medel 2.16.840.1.113883.6.73 2017-01 L03A IMMUNOSTIMULANTS Immunstimulerande medel 2.16.840.1.113883.6.73 2017-01 L03AA Colony stimulating factors Hematopoetiska tillväxtfaktorer 2.16.840.1.113883.6.73 2017-01 L03AA02 Filgrastim 2.16.840.1.113883.6.73 2017-01 L03AA03 Molgramostim 2.16.840.1.113883.6.73 2017-01 L03AA09 Sargramostim 2.16.840.1.113883.6.73 2017-01 L03AA10 Lenograstim 2.16.840.1.113883.6.73 2017-01 L03AA12 Ancestim 2.16.840.1.113883.6.73 2017-01 L03AA13 Pegfilgrastim 2.16.840.1.113883.6.73 2017-01 L03AA14 Lipegfilgrastim 2.16.840.1.113883.6.73 2017-01 L03AA15 balugrastim Balugrastim 2.16.840.1.113883.6.73 2017-01 L03AA16 empegfilgrastim Empegfilgrastim 2.16.840.1.113883.6.73 2017-01 L03AB Interferoner 2.16.840.1.113883.6.73 2017-01 L03AB01 alfa natural , naturlig 2.16.840.1.113883.6.73 2017-01 L03AB02 interferon beta natural Interferon beta, naturlig 2.16.840.1.113883.6.73 2017-01 L03AB03 Interferon gamma 2.16.840.1.113883.6.73 2017-01 L03AB04 interferon alfa-2a Interferon alfa-2a 2.16.840.1.113883.6.73 2017-01 L03AB05 interferon alfa-2b Interferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB06 interferon alfa-n1 Interferon alfa-n1 2.16.840.1.113883.6.73 2017-01 L03AB07 interferon beta-1a Interferon beta-1a 2.16.840.1.113883.6.73 2017-01 L03AB08 interferon beta-1b Interferon beta-1b 2.16.840.1.113883.6.73 2017-01 L03AB09 interferon alfacon-1 Interferon alfacon-1 2.16.840.1.113883.6.73 2017-01 L03AB10 peginterferon alfa-2b Peginterferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB11 peginterferon alfa-2a Peginterferon alfa-2a 2.16.840.1.113883.6.73 2017-01 L03AB12 alfa-2b Albinterferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB13 peginterferon beta-1a Peginterferon beta-1a 2.16.840.1.113883.6.73 2017-01 L03AB14 cepeginterferon alfa-2b Cepeginterferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB60 peginterferon alfa-2b, combinations Peginterferon alfa-2b, kombinationer 2.16.840.1.113883.6.73 2017-01 L03AB61 peginterferon alfa-2a, combinations Peginterferon alfa-2a, kombinationer 2.16.840.1.113883.6.73 2017-01 L03AC Interleukiner 2.16.840.1.113883.6.73 2017-01 L03AC01 aldesleukin Aldesleukin 2.16.840.1.113883.6.73 2017-01 L03AC02 Oprelvekin 2.16.840.1.113883.6.73 2017-01 L03AX Other immunostimulants Övriga immunstimulerande medel 2.16.840.1.113883.6.73 2017-01 L03AX01 Lentinan 2.16.840.1.113883.6.73 2017-01 L03AX02 Rokinimex 2.16.840.1.113883.6.73 2017-01 L03AX03 BCG vaccine Vaccin mot Bacillus Calmette- Guerin (BCG) 2.16.840.1.113883.6.73 2017-01 L03AX04 pegademase Pegademas 2.16.840.1.113883.6.73 2017-01 L03AX05 Pidotimod 2.16.840.1.113883.6.73 2017-01 L03AX07 poly I:C Poly I:C 2.16.840.1.113883.6.73 2017-01 L03AX08 poly ICLC Poly ICLC 2.16.840.1.113883.6.73 2017-01 L03AX09 Tymopentin 2.16.840.1.113883.6.73 2017-01 L03AX10 immunocyanin Immunocyanin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 103 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L03AX11 tasonermin Tasonermin 2.16.840.1.113883.6.73 2017-01 L03AX12 melanoma vaccine Melanomvaccin 2.16.840.1.113883.6.73 2017-01 L03AX13 Glatirameracetat 2.16.840.1.113883.6.73 2017-01 L03AX14 dihydrochloride Histamindihydroklorid 2.16.840.1.113883.6.73 2017-01 L03AX15 Mifamurtid 2.16.840.1.113883.6.73 2017-01 L03AX16 Plerixafor 2.16.840.1.113883.6.73 2017-01 L03AX17 sipuleucel-T Sipuleucel-T 2.16.840.1.113883.6.73 2017-01 L03AX18 cridanimod Kridanimod 2.16.840.1.113883.6.73 2017-01 L03AX19 dasiprotimut-T Dasiprotimut-T 2.16.840.1.113883.6.73 2017-01 L04 IMMUNOSUPPRESSANTS Immunsuppressiva medel 2.16.840.1.113883.6.73 2017-01 L04A IMMUNOSUPPRESSANTS Immunsuppressiva medel 2.16.840.1.113883.6.73 2017-01 L04AA Selective immunosuppressants Selektiva immunsuppressiva medel 2.16.840.1.113883.6.73 2017-01 L04AA02 muromonab-CD3 Muromonab CD3 2.16.840.1.113883.6.73 2017-01 L04AA03 antilymphocyte immunoglobulin Anti-lymfoocyt-immunoglobulin (horse) (häst) 2.16.840.1.113883.6.73 2017-01 L04AA04 antithymocyte immunoglobulin Anti-tymocyt-immunoglobulin (kanin) (rabbit) 2.16.840.1.113883.6.73 2017-01 L04AA06 Mykofenolsyra 2.16.840.1.113883.6.73 2017-01 L04AA10 Sirolimus 2.16.840.1.113883.6.73 2017-01 L04AA13 Leflunomid 2.16.840.1.113883.6.73 2017-01 L04AA15 Alefacept 2.16.840.1.113883.6.73 2017-01 L04AA18 everolimus Everolimus 2.16.840.1.113883.6.73 2017-01 L04AA19 Gusperimus 2.16.840.1.113883.6.73 2017-01 L04AA21 Efalizumab 2.16.840.1.113883.6.73 2017-01 L04AA22 abetimus Abetimus 2.16.840.1.113883.6.73 2017-01 L04AA23 Natalizumab 2.16.840.1.113883.6.73 2017-01 L04AA24 Abatacept 2.16.840.1.113883.6.73 2017-01 L04AA25 Ekulizumab 2.16.840.1.113883.6.73 2017-01 L04AA26 Belimumab 2.16.840.1.113883.6.73 2017-01 L04AA27 Fingolimod 2.16.840.1.113883.6.73 2017-01 L04AA28 Belatacept 2.16.840.1.113883.6.73 2017-01 L04AA29 Tofacitinib 2.16.840.1.113883.6.73 2017-01 L04AA31 Teriflunomid 2.16.840.1.113883.6.73 2017-01 L04AA32 Apremilast 2.16.840.1.113883.6.73 2017-01 L04AA33 Vedolizumab 2.16.840.1.113883.6.73 2017-01 L04AA34 Alemtuzumab 2.16.840.1.113883.6.73 2017-01 L04AA35 begelomab Begelomab 2.16.840.1.113883.6.73 2017-01 L04AA36 Okrelizumab 2.16.840.1.113883.6.73 2017-01 L04AA37 Baricitinib 2.16.840.1.113883.6.73 2017-01 L04AB alpha (TNF-) Tumörnekrosfaktor alfa (TNF-) inhibitors hämmare 2.16.840.1.113883.6.73 2017-01 L04AB01 Etanercept 2.16.840.1.113883.6.73 2017-01 L04AB02 Infliximab 2.16.840.1.113883.6.73 2017-01 L04AB03 Afelimomab

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 104 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L04AB04 Adalimumab 2.16.840.1.113883.6.73 2017-01 L04AB05 Certolizumabpegol 2.16.840.1.113883.6.73 2017-01 L04AB06 Golimumab 2.16.840.1.113883.6.73 2017-01 L04AC inhibitors Interleukinhämmare 2.16.840.1.113883.6.73 2017-01 L04AC01 Daklizumab 2.16.840.1.113883.6.73 2017-01 L04AC02 Basiliximab 2.16.840.1.113883.6.73 2017-01 L04AC03 Anakinra 2.16.840.1.113883.6.73 2017-01 L04AC04 Rilonacept 2.16.840.1.113883.6.73 2017-01 L04AC05 Ustekinumab 2.16.840.1.113883.6.73 2017-01 L04AC07 Tocilizumab 2.16.840.1.113883.6.73 2017-01 L04AC08 canakinumab Kanakinumab 2.16.840.1.113883.6.73 2017-01 L04AC09 briakinumab Briakinumab 2.16.840.1.113883.6.73 2017-01 L04AC10 Sekukinumab 2.16.840.1.113883.6.73 2017-01 L04AC11 siltuximab Siltuximab 2.16.840.1.113883.6.73 2017-01 L04AC12 brodalumab Brodalumab 2.16.840.1.113883.6.73 2017-01 L04AC13 ixekizumab Ixekizumab 2.16.840.1.113883.6.73 2017-01 L04AC14 sarilumab Sarilumab 2.16.840.1.113883.6.73 2017-01 L04AD inhibitors Kalcineurinhämmare 2.16.840.1.113883.6.73 2017-01 L04AD01 Ciklosporin 2.16.840.1.113883.6.73 2017-01 L04AD02 tacrolimus Takrolimus 2.16.840.1.113883.6.73 2017-01 L04AD03 Voklosporin 2.16.840.1.113883.6.73 2017-01 L04AX Other immunosuppressants Övriga immunsuppressiva medel 2.16.840.1.113883.6.73 2017-01 L04AX01 Azatioprin 2.16.840.1.113883.6.73 2017-01 L04AX02 Talidomid 2.16.840.1.113883.6.73 2017-01 L04AX03 methotrexate Metotrexat 2.16.840.1.113883.6.73 2017-01 L04AX04 Lenalidomid 2.16.840.1.113883.6.73 2017-01 L04AX05 Pirfenidon 2.16.840.1.113883.6.73 2017-01 L04AX06 Pomalidomid 2.16.840.1.113883.6.73 2017-01 M MUSCULO-SKELETAL SYSTEM Rörelseapparaten 2.16.840.1.113883.6.73 2017-01 M01 ANTIINFLAMMATORY AND Antiinflammatoriska och ANTIRHEUMATIC PRODUCTS antireumatiska medel 2.16.840.1.113883.6.73 2017-01 M01A ANTIINFLAMMATORY AND Antiinflammatoriska och ANTIRHEUMATIC PRODUCTS, antireumatiska medel, icke-steroida NON-STEROIDS 2.16.840.1.113883.6.73 2017-01 M01AA Butylpyrazolidines Butylpyrazolidiner 2.16.840.1.113883.6.73 2017-01 M01AA01 Fenylbutazon 2.16.840.1.113883.6.73 2017-01 M01AA02 Mofebutazon 2.16.840.1.113883.6.73 2017-01 M01AA03 Oxifenbutazon 2.16.840.1.113883.6.73 2017-01 M01AA05 Klofezon 2.16.840.1.113883.6.73 2017-01 M01AA06 Kebuzon 2.16.840.1.113883.6.73 2017-01 M01AB Acetic acid derivatives and related Ättiksyraderivat och närbesläktade substances substanser 2.16.840.1.113883.6.73 2017-01 M01AB01 indometacin Indometacin 2.16.840.1.113883.6.73 2017-01 M01AB02 Sulindak

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 105 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M01AB03 Tolmetin 2.16.840.1.113883.6.73 2017-01 M01AB04 Zomepirak 2.16.840.1.113883.6.73 2017-01 M01AB05 diclofenac Diklofenak 2.16.840.1.113883.6.73 2017-01 M01AB06 Alklofenak 2.16.840.1.113883.6.73 2017-01 M01AB07 Bumadizon 2.16.840.1.113883.6.73 2017-01 M01AB08 Etodolak 2.16.840.1.113883.6.73 2017-01 M01AB09 Lonazolak 2.16.840.1.113883.6.73 2017-01 M01AB10 Fentiazak 2.16.840.1.113883.6.73 2017-01 M01AB11 Acemetacin 2.16.840.1.113883.6.73 2017-01 M01AB12 Difenpiramid 2.16.840.1.113883.6.73 2017-01 M01AB13 Oxametacin 2.16.840.1.113883.6.73 2017-01 M01AB14 Proglumetacin 2.16.840.1.113883.6.73 2017-01 M01AB15 Ketorolak 2.16.840.1.113883.6.73 2017-01 M01AB16 Aceklofenak 2.16.840.1.113883.6.73 2017-01 M01AB17 Bufexamak 2.16.840.1.113883.6.73 2017-01 M01AB51 indometacin, combinations Indometacin, kombinationer 2.16.840.1.113883.6.73 2017-01 M01AB55 diclofenac, combinations Diklofenak, kombinationer 2.16.840.1.113883.6.73 2017-01 M01AC Oxikamer 2.16.840.1.113883.6.73 2017-01 M01AC01 Piroxikam 2.16.840.1.113883.6.73 2017-01 M01AC02 Tenoxikam 2.16.840.1.113883.6.73 2017-01 M01AC04 Droxikam 2.16.840.1.113883.6.73 2017-01 M01AC05 Lornoxikam 2.16.840.1.113883.6.73 2017-01 M01AC06 Meloxikam 2.16.840.1.113883.6.73 2017-01 M01AC56 meloxicam, combinations Meloxikam, kombinationer 2.16.840.1.113883.6.73 2017-01 M01AE Propionic acid derivatives Propionsyraderivat 2.16.840.1.113883.6.73 2017-01 M01AE01 ibuprofen Ibuprofen 2.16.840.1.113883.6.73 2017-01 M01AE02 naproxen Naproxen 2.16.840.1.113883.6.73 2017-01 M01AE03 Ketoprofen 2.16.840.1.113883.6.73 2017-01 M01AE04 Fenoprofen 2.16.840.1.113883.6.73 2017-01 M01AE05 Fenbufen 2.16.840.1.113883.6.73 2017-01 M01AE06 Benoxaprofen 2.16.840.1.113883.6.73 2017-01 M01AE07 Suprofen 2.16.840.1.113883.6.73 2017-01 M01AE08 Pirprofen 2.16.840.1.113883.6.73 2017-01 M01AE09 Flurbiprofen 2.16.840.1.113883.6.73 2017-01 M01AE10 Indoprofen 2.16.840.1.113883.6.73 2017-01 M01AE11 Tiaprofensyra 2.16.840.1.113883.6.73 2017-01 M01AE12 Oxaprozin 2.16.840.1.113883.6.73 2017-01 M01AE13 Ibuproxam 2.16.840.1.113883.6.73 2017-01 M01AE14 Dexibuprofen 2.16.840.1.113883.6.73 2017-01 M01AE15 flunoxaprofen Flunoxaprofen 2.16.840.1.113883.6.73 2017-01 M01AE16 Alminoprofen 2.16.840.1.113883.6.73 2017-01 M01AE17 Dexketoprofen 2.16.840.1.113883.6.73 2017-01 M01AE18 Naproxcinod © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 106 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M01AE51 ibuprofen, combinations Ibuprofen, kombinationer 2.16.840.1.113883.6.73 2017-01 M01AE52 naproxen and esomeprazole Naproxen och esomeprazol 2.16.840.1.113883.6.73 2017-01 M01AE53 ketoprofen, combinations Ketoprofen, kombinationer 2.16.840.1.113883.6.73 2017-01 M01AE56 naproxen and misoprostol Naproxen och misoprostol 2.16.840.1.113883.6.73 2017-01 M01AG Fenamates Fenamater 2.16.840.1.113883.6.73 2017-01 M01AG01 Mefenamsyra 2.16.840.1.113883.6.73 2017-01 M01AG02 Tolfenamsyra 2.16.840.1.113883.6.73 2017-01 M01AG03 Flufenamsyra 2.16.840.1.113883.6.73 2017-01 M01AG04 Meklofenamsyra 2.16.840.1.113883.6.73 2017-01 M01AH Coxibs Coxiber 2.16.840.1.113883.6.73 2017-01 M01AH01 celecoxib Celecoxib 2.16.840.1.113883.6.73 2017-01 M01AH02 Rofecoxib 2.16.840.1.113883.6.73 2017-01 M01AH03 Valdecoxib 2.16.840.1.113883.6.73 2017-01 M01AH04 Parecoxib 2.16.840.1.113883.6.73 2017-01 M01AH05 Etoricoxib 2.16.840.1.113883.6.73 2017-01 M01AH06 Lumiracoxib 2.16.840.1.113883.6.73 2017-01 M01AX Other antiinflammatory and Övriga icke-steroida antirheumatic agents, non-steroids antiinflammatoriska och antireumatiska medel 2.16.840.1.113883.6.73 2017-01 M01AX01 Nabumeton 2.16.840.1.113883.6.73 2017-01 M01AX02 Nifluminsyra 2.16.840.1.113883.6.73 2017-01 M01AX04 Azapropazon 2.16.840.1.113883.6.73 2017-01 M01AX05 Glukosamin 2.16.840.1.113883.6.73 2017-01 M01AX07 benzydamine Bensydamin 2.16.840.1.113883.6.73 2017-01 M01AX12 glucosaminoglycan polysulfate Glukosaminoglykanpolysulfat 2.16.840.1.113883.6.73 2017-01 M01AX13 Prokvazon 2.16.840.1.113883.6.73 2017-01 M01AX14 orgotein Orgotein 2.16.840.1.113883.6.73 2017-01 M01AX17 Nimesulid 2.16.840.1.113883.6.73 2017-01 M01AX18 Feprazon 2.16.840.1.113883.6.73 2017-01 M01AX21 Diacerein 2.16.840.1.113883.6.73 2017-01 M01AX22 Morniflumat 2.16.840.1.113883.6.73 2017-01 M01AX23 Tenidap 2.16.840.1.113883.6.73 2017-01 M01AX24 oxaceprol Oxaceprol 2.16.840.1.113883.6.73 2017-01 M01AX25 chondroitin sulfate Kondroitinsulfat 2.16.840.1.113883.6.73 2017-01 M01AX26 avocado and soyabean oil, Avokado- och sojaolja, ej förtvålbara unsaponifiables 2.16.840.1.113883.6.73 2017-01 M01AX68 feprazone, combinations Feprazon, kombinationer 2.16.840.1.113883.6.73 2017-01 M01B ANTIINFLAMMATORY/ANTIRHEU Antiinflammatoriska/antireumatiska MATIC AGENTS IN COMBINATION medel i kombination 2.16.840.1.113883.6.73 2017-01 M01BA Antiinflammatory/antirheumatic Antiinflammatoriska/antireumatiska agents in combination with medel i kombination med corticosteroids kortikosteroider 2.16.840.1.113883.6.73 2017-01 M01BA01 phenylbutazone and corticosteroids Fenylbutazon och kortikosteroider 2.16.840.1.113883.6.73 2017-01 M01BA02 and corticosteroids Dipyrocetyl och kortikosteroider

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 107 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M01BA03 acetylsalicylic acid and Acetylsalicylsyra och corticosteroids kortikosteroider 2.16.840.1.113883.6.73 2017-01 M01BX Other Övriga kombinationer med antiinflammatory/antirheumatic antiinflammatoriska/antireumatiska agents in combination with other medel drugs 2.16.840.1.113883.6.73 2017-01 M01C SPECIFIC ANTIRHEUMATIC Specifika antireumatiska medel AGENTS 2.16.840.1.113883.6.73 2017-01 M01CA Kinolinderivat 2.16.840.1.113883.6.73 2017-01 M01CA03 Oxycinkofen 2.16.840.1.113883.6.73 2017-01 M01CB preparations Guldpreparat 2.16.840.1.113883.6.73 2017-01 M01CB01 Natriumaurotiomalat 2.16.840.1.113883.6.73 2017-01 M01CB02 sodium aurotiosulfate Natriumaurotiosulfat 2.16.840.1.113883.6.73 2017-01 M01CB03 Auranofin 2.16.840.1.113883.6.73 2017-01 M01CB04 Aurotioglukos 2.16.840.1.113883.6.73 2017-01 M01CB05 aurotioprol Aurotioprol 2.16.840.1.113883.6.73 2017-01 M01CC and similar agents Penicillamin och liknande medel 2.16.840.1.113883.6.73 2017-01 M01CC01 penicillamine Penicillamin 2.16.840.1.113883.6.73 2017-01 M01CC02 Bucillamin 2.16.840.1.113883.6.73 2017-01 M01CX Other specific antirheumatic agents Övriga specifika antireumatiska medel 2.16.840.1.113883.6.73 2017-01 M02 TOPICAL PRODUCTS FOR JOINT Utvärtes medel vid led- och AND MUSCULAR PAIN muskelsmärtor 2.16.840.1.113883.6.73 2017-01 M02A TOPICAL PRODUCTS FOR JOINT Utvärtes medel vid led- och AND MUSCULAR PAIN muskelsmärtor 2.16.840.1.113883.6.73 2017-01 M02AA Antiinflammatory preparations, non- Antiinflammatoriska medel, icke- steroids for topical use steroider för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 M02AA01 phenylbutazone Fenylbutazon 2.16.840.1.113883.6.73 2017-01 M02AA02 mofebutazone Mofebutazon 2.16.840.1.113883.6.73 2017-01 M02AA03 clofezone Klofezon 2.16.840.1.113883.6.73 2017-01 M02AA04 oxyphenbutazone Oxyfenbutazon 2.16.840.1.113883.6.73 2017-01 M02AA05 benzydamine Bensydamin 2.16.840.1.113883.6.73 2017-01 M02AA06 Etofenamat 2.16.840.1.113883.6.73 2017-01 M02AA07 piroxicam Piroxikam 2.16.840.1.113883.6.73 2017-01 M02AA08 Felbinak 2.16.840.1.113883.6.73 2017-01 M02AA09 bufexamac Bufexamak 2.16.840.1.113883.6.73 2017-01 M02AA10 ketoprofen Ketoprofen 2.16.840.1.113883.6.73 2017-01 M02AA11 Bendazak 2.16.840.1.113883.6.73 2017-01 M02AA12 naproxen Naproxen 2.16.840.1.113883.6.73 2017-01 M02AA13 ibuprofen Ibuprofen 2.16.840.1.113883.6.73 2017-01 M02AA14 fentiazac Fentiazak 2.16.840.1.113883.6.73 2017-01 M02AA15 diclofenac Diklofenak 2.16.840.1.113883.6.73 2017-01 M02AA16 feprazone Feprazon 2.16.840.1.113883.6.73 2017-01 M02AA17 niflumic acid Nifluminsyra 2.16.840.1.113883.6.73 2017-01 M02AA18 meclofenamic acid Meklofenamsyra 2.16.840.1.113883.6.73 2017-01 M02AA19 flurbiprofen Flurbiprofen

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 108 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M02AA21 tolmetin Tolmetin 2.16.840.1.113883.6.73 2017-01 M02AA22 Suxibuzon 2.16.840.1.113883.6.73 2017-01 M02AA23 indometacin Indometacin 2.16.840.1.113883.6.73 2017-01 M02AA24 Nifenazon 2.16.840.1.113883.6.73 2017-01 M02AA25 aceclofenac Aceklofenak 2.16.840.1.113883.6.73 2017-01 M02AA26 nimesulide Nimesulid 2.16.840.1.113883.6.73 2017-01 M02AA27 dexketoprofen Dexketoprofen 2.16.840.1.113883.6.73 2017-01 M02AA28 piketoprofen Piketoprofen 2.16.840.1.113883.6.73 2017-01 M02AB and similar agents Kapsaicin och liknande medel 2.16.840.1.113883.6.73 2017-01 M02AB01 capsaicin Kapsaicin 2.16.840.1.113883.6.73 2017-01 M02AB02 zucapsaicin Zukapsaicin 2.16.840.1.113883.6.73 2017-01 M02AC Preparations with salicylic acid Salicylsyraderivat derivatives 2.16.840.1.113883.6.73 2017-01 M02AX Other topical products for joint and Övriga utvärtes medel för led- och muscular pain muskelsmärtor 2.16.840.1.113883.6.73 2017-01 M02AX02 tolazoline Tolazolin 2.16.840.1.113883.6.73 2017-01 M02AX03 dimethyl sulfoxide Dimetylsulfoxid 2.16.840.1.113883.6.73 2017-01 M02AX05 idrocilamide Idrocilamid 2.16.840.1.113883.6.73 2017-01 M02AX06 Tolperison 2.16.840.1.113883.6.73 2017-01 M02AX10 various Övrigt 2.16.840.1.113883.6.73 2017-01 M03 MUSCLE RELAXANTS Muskelavslappande medel 2.16.840.1.113883.6.73 2017-01 M03A MUSCLE RELAXANTS, Muskelavslappande medel, perifert PERIPHERALLY ACTING AGENTS verkande 2.16.840.1.113883.6.73 2017-01 M03AA alkaloids Kurarealkaloider 2.16.840.1.113883.6.73 2017-01 M03AA01 alcuronium Alkuron 2.16.840.1.113883.6.73 2017-01 M03AA02 tubocurarine Tubokurarin 2.16.840.1.113883.6.73 2017-01 M03AA04 dimethyltubocurarine Dimetyltubokurarin 2.16.840.1.113883.6.73 2017-01 M03AB Choline derivatives Kolinderivat 2.16.840.1.113883.6.73 2017-01 M03AB01 suxamethonium Suxametonium 2.16.840.1.113883.6.73 2017-01 M03AC Other quaternary ammonium Övriga kvartära compounds ammoniumföreningar 2.16.840.1.113883.6.73 2017-01 M03AC01 pancuronium Pankuronium 2.16.840.1.113883.6.73 2017-01 M03AC02 gallamine Gallamin 2.16.840.1.113883.6.73 2017-01 M03AC03 vecuronium Vekuronium 2.16.840.1.113883.6.73 2017-01 M03AC04 atracurium Atrakurium 2.16.840.1.113883.6.73 2017-01 M03AC05 hexafluronium Hexafluronium 2.16.840.1.113883.6.73 2017-01 M03AC06 Pipekuronbromid 2.16.840.1.113883.6.73 2017-01 M03AC07 Doxakuriumklorid 2.16.840.1.113883.6.73 2017-01 M03AC08 Fazadiniumbromid 2.16.840.1.113883.6.73 2017-01 M03AC09 Rokuroniumbromid 2.16.840.1.113883.6.73 2017-01 M03AC10 Mivakuriumklorid 2.16.840.1.113883.6.73 2017-01 M03AC11 cisatracurium Cisatrakurium 2.16.840.1.113883.6.73 2017-01 M03AX Other muscle relaxants, peripherally Övriga muskelavslappande medel, acting agents perifert verkande 2.16.840.1.113883.6.73 2017-01 M03AX01 Botulinum toxin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 109 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M03B MUSCLE RELAXANTS, Muskelavslappande medel, centralt CENTRALLY ACTING AGENTS verkande 2.16.840.1.113883.6.73 2017-01 M03BA Carbamic acid esters Karbaminsyraestrar 2.16.840.1.113883.6.73 2017-01 M03BA01 Fenprobamat 2.16.840.1.113883.6.73 2017-01 M03BA02 Karisoprodol 2.16.840.1.113883.6.73 2017-01 M03BA03 Metokarbamol 2.16.840.1.113883.6.73 2017-01 M03BA04 Styramat 2.16.840.1.113883.6.73 2017-01 M03BA05 Febarbamat 2.16.840.1.113883.6.73 2017-01 M03BA51 phenprobamate, combinations excl. Fenprobamat, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BA52 carisoprodol, combinations excl. Karisoprodol, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BA53 methocarbamol, combinations excl. Metokarbamol, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BA71 phenprobamate, combinations with Fenprobamat i kombination med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BA72 carisoprodol, combinations with Karisoprodol, kombinationer med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BA73 methocarbamol, combinations with Metokarbamol i kombination med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BB Oxazol, thiazine, and triazine Oxazol-, tiazin- och triazinderivat derivatives 2.16.840.1.113883.6.73 2017-01 M03BB02 Klormezanon 2.16.840.1.113883.6.73 2017-01 M03BB03 Klorzoxazon 2.16.840.1.113883.6.73 2017-01 M03BB52 chlormezanone, combinations excl. Klormezanon, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BB53 chlorzoxazone, combinations excl. Klorzoxazon, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BB72 chlormezanone, combinations with Klormezanon i kombination med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BB73 chlorzoxazone, combinations with Klorzoxazon, kombinationer med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BC Ethers, chemically close to Etrar, kemiskt besläktade med antihistamines antihistaminer 2.16.840.1.113883.6.73 2017-01 M03BC01 (citrate) Orfenadrin 2.16.840.1.113883.6.73 2017-01 M03BC51 orphenadrine, combinations Orfenadrin, kombinationer 2.16.840.1.113883.6.73 2017-01 M03BX Other centrally acting agents Övriga muskelavslappande medel, centralt verkande 2.16.840.1.113883.6.73 2017-01 M03BX01 Baklofen 2.16.840.1.113883.6.73 2017-01 M03BX02 Tizanidin 2.16.840.1.113883.6.73 2017-01 M03BX03 Pridinol 2.16.840.1.113883.6.73 2017-01 M03BX04 tolperisone Tolperison 2.16.840.1.113883.6.73 2017-01 M03BX05 Tiokolkikosid 2.16.840.1.113883.6.73 2017-01 M03BX06 Mefenesin 2.16.840.1.113883.6.73 2017-01 M03BX07 Tetrazepam 2.16.840.1.113883.6.73 2017-01 M03BX08 Cyklobenzaprin 2.16.840.1.113883.6.73 2017-01 M03BX09 eperisone Eperison 2.16.840.1.113883.6.73 2017-01 M03BX30 fenyramidol Feniramidol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 110 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M03BX55 thiocolchicoside, combinations Tiokolkikosid, kombinationer 2.16.840.1.113883.6.73 2017-01 M03C MUSCLE RELAXANTS, DIRECTLY Muskelavslappande medel, ACTING AGENTS direktverkande 2.16.840.1.113883.6.73 2017-01 M03CA Dantrolene and derivatives Dantrolen och derivat 2.16.840.1.113883.6.73 2017-01 M03CA01 dantrolene Dantrolen 2.16.840.1.113883.6.73 2017-01 M04 ANTIGOUT PREPARATIONS Giktmedel 2.16.840.1.113883.6.73 2017-01 M04A ANTIGOUT PREPARATIONS Giktmedel 2.16.840.1.113883.6.73 2017-01 M04AA Preparations inhibiting Medel som hämmar produktionen production av urinsyra 2.16.840.1.113883.6.73 2017-01 M04AA01 Allopurinol 2.16.840.1.113883.6.73 2017-01 M04AA02 Tisopurin 2.16.840.1.113883.6.73 2017-01 M04AA03 Febuxostat 2.16.840.1.113883.6.73 2017-01 M04AA51 allopurinol, combinations Allopurinol, kombinationer 2.16.840.1.113883.6.73 2017-01 M04AB Preparations increasing uric acid Medel som ökar utsöndringen av excretion urinsyra 2.16.840.1.113883.6.73 2017-01 M04AB01 Probenecid 2.16.840.1.113883.6.73 2017-01 M04AB02 Sulfinpyrazon 2.16.840.1.113883.6.73 2017-01 M04AB03 Bensbromaron 2.16.840.1.113883.6.73 2017-01 M04AB04 Isobromindion 2.16.840.1.113883.6.73 2017-01 M04AB05 Lesinurad 2.16.840.1.113883.6.73 2017-01 M04AC Preparations with no effect on uric Medel utan effekt på acid metabolism urinsyrametabolismen 2.16.840.1.113883.6.73 2017-01 M04AC01 colchicine Kolkicin 2.16.840.1.113883.6.73 2017-01 M04AC02 Cinkofen 2.16.840.1.113883.6.73 2017-01 M04AX Other antigout preparations Övriga giktmedel 2.16.840.1.113883.6.73 2017-01 M04AX01 urate oxidase Uratoxidas 2.16.840.1.113883.6.73 2017-01 M04AX02 Peglotikas 2.16.840.1.113883.6.73 2017-01 M05 DRUGS FOR TREATMENT OF Medel för behandling av BONE DISEASES skelettsjukdomar 2.16.840.1.113883.6.73 2017-01 M05B DRUGS AFFECTING BONE Medel som påverkar benvävnad och STRUCTURE AND mineralisering MINERALIZATION 2.16.840.1.113883.6.73 2017-01 M05BA Bisfosfonater 2.16.840.1.113883.6.73 2017-01 M05BA01 Etidronat 2.16.840.1.113883.6.73 2017-01 M05BA02 Klodronat 2.16.840.1.113883.6.73 2017-01 M05BA03 Pamidronat 2.16.840.1.113883.6.73 2017-01 M05BA04 Alendronsyra 2.16.840.1.113883.6.73 2017-01 M05BA05 Tiludronsyra 2.16.840.1.113883.6.73 2017-01 M05BA06 Ibandronsyra 2.16.840.1.113883.6.73 2017-01 M05BA07 Risedronsyra 2.16.840.1.113883.6.73 2017-01 M05BA08 Zoledronsyra 2.16.840.1.113883.6.73 2017-01 M05BB Bisphosphonates, combinations Bisfosfonater, kombinationer 2.16.840.1.113883.6.73 2017-01 M05BB01 etidronic acid and calcium, Etidronsyra och kalcium, sequential sekvenspreparat 2.16.840.1.113883.6.73 2017-01 M05BB02 risedronic acid and calcium, Risedronsyra och kalcium, sequential sekvenspreparat

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 111 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M05BB03 alendronic acid and colecalciferol Alendronsyra och kolekalciferol 2.16.840.1.113883.6.73 2017-01 M05BB04 risedronic acid, calcium and Risedronsyra, kalcium och colecalciferol, sequential kolekalciferol, sekvenspreparat 2.16.840.1.113883.6.73 2017-01 M05BB05 alendronic acid, calcium and Alendronsyra, kalcium och colecalciferol, sequential kolekalciferol sekvenspreparat 2.16.840.1.113883.6.73 2017-01 M05BB06 alendronic acid and alfacalcidol, Alendronsyra och alfakalcidol, sequential sekvenspreparat 2.16.840.1.113883.6.73 2017-01 M05BB07 risedronic acid and colecalciferol Risedronsyra och kolekalciferol 2.16.840.1.113883.6.73 2017-01 M05BB08 zoledronic acid, calcium and Zoledronsyra, kalcium och colecalciferol, sequential kolekalciferol, sekvenspreparat 2.16.840.1.113883.6.73 2017-01 M05BC Bone morphogenetic proteins Benmorfogenetiska proteiner 2.16.840.1.113883.6.73 2017-01 M05BC01 dibotermin alfa Dibotermin alfa 2.16.840.1.113883.6.73 2017-01 M05BC02 eptotermin alfa Eptotermin alfa 2.16.840.1.113883.6.73 2017-01 M05BX Other drugs affecting bone structure Övriga medel som påverkar and mineralization benstruktur och mineralisering 2.16.840.1.113883.6.73 2017-01 M05BX01 Ipriflavon 2.16.840.1.113883.6.73 2017-01 M05BX02 aluminium chlorohydrate Aluminiumklorhydrat 2.16.840.1.113883.6.73 2017-01 M05BX03 Strontiumranelat 2.16.840.1.113883.6.73 2017-01 M05BX04 Denosumab 2.16.840.1.113883.6.73 2017-01 M05BX05 burosumab Burosumab 2.16.840.1.113883.6.73 2017-01 M05BX53 strontium ranelate and colecalciferol Strontiumranelat och kolekalciferol 2.16.840.1.113883.6.73 2017-01 M09 OTHER DRUGS FOR DISORDERS Övriga medel för sjukdomar i OF THE MUSCULO-SKELETAL rörelseapparaten SYSTEM 2.16.840.1.113883.6.73 2017-01 M09A OTHER DRUGS FOR DISORDERS Övriga medel för sjukdomar i OF THE MUSCULO-SKELETAL rörelseapparaten SYSTEM 2.16.840.1.113883.6.73 2017-01 M09AA and derivatives Kinin och derivat 2.16.840.1.113883.6.73 2017-01 M09AA01 hydroquinine Hydrokinin 2.16.840.1.113883.6.73 2017-01 M09AA72 quinine, combinations with Kinin i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 M09AB Enzymes Enzymer 2.16.840.1.113883.6.73 2017-01 M09AB01 chymopapain Kymopapain 2.16.840.1.113883.6.73 2017-01 M09AB02 collagenase clostridium histolyticum Kollagenas, Clostridium histolyticum 2.16.840.1.113883.6.73 2017-01 M09AB03 bromelains Bromelainer 2.16.840.1.113883.6.73 2017-01 M09AB52 trypsin, combinations Trypsin, kombinationer 2.16.840.1.113883.6.73 2017-01 M09AX Other drugs for disorders of the Övriga medel för sjukdomar i musculo-skeletal system rörelseapparaten 2.16.840.1.113883.6.73 2017-01 M09AX01 hyaluronic acid Hyaluronsyra 2.16.840.1.113883.6.73 2017-01 M09AX02 chondrocytes, autologous Kondrocyter, autologa 2.16.840.1.113883.6.73 2017-01 M09AX03 ataluren Ataluren 2.16.840.1.113883.6.73 2017-01 M09AX04 drisapersen Drisapersen 2.16.840.1.113883.6.73 2017-01 M09AX05 aceneuramic acid Aceneuraminsyra 2.16.840.1.113883.6.73 2017-01 N NERVOUS SYSTEM Nervsystemet 2.16.840.1.113883.6.73 2017-01 N01 ANESTHETICS Anestetika 2.16.840.1.113883.6.73 2017-01 N01A ANESTHETICS, GENERAL Allmänanestetika 2.16.840.1.113883.6.73 2017-01 N01AA Ethers Etrar © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 112 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N01AA01 Dietyleter 2.16.840.1.113883.6.73 2017-01 N01AA02 vinyl ether Vinyleter 2.16.840.1.113883.6.73 2017-01 N01AB Halogenated hydrocarbons Halogenerade kolväten 2.16.840.1.113883.6.73 2017-01 N01AB01 Halotan 2.16.840.1.113883.6.73 2017-01 N01AB02 Kloroform 2.16.840.1.113883.6.73 2017-01 N01AB04 Enfluran 2.16.840.1.113883.6.73 2017-01 N01AB05 Trikloretylen 2.16.840.1.113883.6.73 2017-01 N01AB06 Isofluran 2.16.840.1.113883.6.73 2017-01 N01AB07 Desfluran 2.16.840.1.113883.6.73 2017-01 N01AB08 Sevofluran 2.16.840.1.113883.6.73 2017-01 N01AF , plain Barbiturater 2.16.840.1.113883.6.73 2017-01 N01AF01 Metohexital 2.16.840.1.113883.6.73 2017-01 N01AF02 Hexobarbital 2.16.840.1.113883.6.73 2017-01 N01AF03 thiopental Tiopental 2.16.840.1.113883.6.73 2017-01 N01AG Barbiturates in combination with Barbitursyraderivat i kombination other drugs med andra medel 2.16.840.1.113883.6.73 2017-01 N01AG01 Narkobarbital 2.16.840.1.113883.6.73 2017-01 N01AH Opioid anesthetics Opioidanestetika 2.16.840.1.113883.6.73 2017-01 N01AH01 Fentanyl 2.16.840.1.113883.6.73 2017-01 N01AH02 Alfentanil 2.16.840.1.113883.6.73 2017-01 N01AH03 Sufentanil 2.16.840.1.113883.6.73 2017-01 N01AH04 Fenoperidin 2.16.840.1.113883.6.73 2017-01 N01AH05 Anileridin 2.16.840.1.113883.6.73 2017-01 N01AH06 Remifentanil 2.16.840.1.113883.6.73 2017-01 N01AH51 fentanyl, combinations Fentanyl, kombinationer 2.16.840.1.113883.6.73 2017-01 N01AX Other general anesthetics Övriga allmänanestetika 2.16.840.1.113883.6.73 2017-01 N01AX03 Ketamin 2.16.840.1.113883.6.73 2017-01 N01AX04 Propanidid 2.16.840.1.113883.6.73 2017-01 N01AX05 Alfaxalon 2.16.840.1.113883.6.73 2017-01 N01AX07 Etomidat 2.16.840.1.113883.6.73 2017-01 N01AX10 Propofol 2.16.840.1.113883.6.73 2017-01 N01AX11 Natriumoxibat 2.16.840.1.113883.6.73 2017-01 N01AX13 Dikväveoxid 2.16.840.1.113883.6.73 2017-01 N01AX14 Esketamin 2.16.840.1.113883.6.73 2017-01 N01AX15 xenon Xenon 2.16.840.1.113883.6.73 2017-01 N01AX63 nitrous oxide, combinations Dikväveoxid, kombinationer 2.16.840.1.113883.6.73 2017-01 N01B ANESTHETICS, LOCAL Lokalanestetika 2.16.840.1.113883.6.73 2017-01 N01BA Esters of aminobenzoic acid Aminosyrabensoestrar 2.16.840.1.113883.6.73 2017-01 N01BA01 metabutethamine Metabuteamin 2.16.840.1.113883.6.73 2017-01 N01BA02 procaine Prokain 2.16.840.1.113883.6.73 2017-01 N01BA03 tetracaine Tetrakain 2.16.840.1.113883.6.73 2017-01 N01BA04 chloroprocaine Kloroprokain 2.16.840.1.113883.6.73 2017-01 N01BA05 benzocaine Bensokain

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 113 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N01BA52 procaine, combinations Prokain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB Amides Amider 2.16.840.1.113883.6.73 2017-01 N01BB01 bupivacaine Bupivakain 2.16.840.1.113883.6.73 2017-01 N01BB02 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 N01BB03 mepivacaine Mepivakain 2.16.840.1.113883.6.73 2017-01 N01BB04 prilocaine Prilokain 2.16.840.1.113883.6.73 2017-01 N01BB05 butanilicaine Butanilikain 2.16.840.1.113883.6.73 2017-01 N01BB06 cinchocaine Cinkain 2.16.840.1.113883.6.73 2017-01 N01BB07 etidocaine Etidokain 2.16.840.1.113883.6.73 2017-01 N01BB08 articaine Artikain 2.16.840.1.113883.6.73 2017-01 N01BB09 ropivacaine Ropivakain 2.16.840.1.113883.6.73 2017-01 N01BB10 levobupivacaine Levobupivakain 2.16.840.1.113883.6.73 2017-01 N01BB20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB51 bupivacaine, combinations Bupivakain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB52 lidocaine, combinations Lidokain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB53 mepivacaine, combinations Mepivakain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB54 prilocaine, combinations Prilokain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB57 etidocaine, combinations Etidokain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB58 articaine, combinations Artikain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BC Esters of Estrar av bensoesyra 2.16.840.1.113883.6.73 2017-01 N01BC01 Kokain 2.16.840.1.113883.6.73 2017-01 N01BX Other local anesthetics Övriga lokalanestetika 2.16.840.1.113883.6.73 2017-01 N01BX01 ethyl chloride Etylklorid 2.16.840.1.113883.6.73 2017-01 N01BX02 Dyklonin 2.16.840.1.113883.6.73 2017-01 N01BX03 phenol Fenol 2.16.840.1.113883.6.73 2017-01 N01BX04 capsaicin Kapsaicin 2.16.840.1.113883.6.73 2017-01 N02 ANALGESICS Analgetika 2.16.840.1.113883.6.73 2017-01 N02A Opioider 2.16.840.1.113883.6.73 2017-01 N02AA Natural opium alkaloids Naturliga opiumalkaloider, opiater 2.16.840.1.113883.6.73 2017-01 N02AA01 morphine Morfin 2.16.840.1.113883.6.73 2017-01 N02AA02 opium Opium 2.16.840.1.113883.6.73 2017-01 N02AA03 Hydromorfon 2.16.840.1.113883.6.73 2017-01 N02AA04 Nikomorfin 2.16.840.1.113883.6.73 2017-01 N02AA05 Oxikodon 2.16.840.1.113883.6.73 2017-01 N02AA08 Dihydrokodein 2.16.840.1.113883.6.73 2017-01 N02AA10 Papaveretum 2.16.840.1.113883.6.73 2017-01 N02AA51 morphine, combinations Morfin, kombinationer 2.16.840.1.113883.6.73 2017-01 N02AA55 oxycodone and naloxone Oxikodon och naloxon 2.16.840.1.113883.6.73 2017-01 N02AA58 dihydrocodeine, combinations Dihydrokodein, kombinationer 2.16.840.1.113883.6.73 2017-01 N02AA59 , combinations excl. Kodein, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AA79 codeine, combinations with Kodein, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AB Phenylpiperidine derivatives Fenylpiperidinderivat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 114 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02AB01 Ketobemidon 2.16.840.1.113883.6.73 2017-01 N02AB02 Petidin 2.16.840.1.113883.6.73 2017-01 N02AB03 fentanyl Fentanyl 2.16.840.1.113883.6.73 2017-01 N02AB52 pethidine, combinations excl. Petidin, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AB72 pethidine, combinations with Petidin, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AC Diphenylpropylamine derivatives Difenylpropylaminderivat 2.16.840.1.113883.6.73 2017-01 N02AC01 Dextromoramid 2.16.840.1.113883.6.73 2017-01 N02AC03 Piritramid 2.16.840.1.113883.6.73 2017-01 N02AC04 Dextropropoxifen 2.16.840.1.113883.6.73 2017-01 N02AC05 Bezitramid 2.16.840.1.113883.6.73 2017-01 N02AC52 , combinations excl. Metadon, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AC54 dextropropoxyphene, combinations Dextropropoxifen, kombinationer excl. psycholeptics exkl. neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AC74 dextropropoxyphene, combinations Dextropropoxifen, kombinationer with psycholeptics med neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AD derivatives Bensomorfanderivat 2.16.840.1.113883.6.73 2017-01 N02AD01 Pentazocin 2.16.840.1.113883.6.73 2017-01 N02AD02 Fenazocin 2.16.840.1.113883.6.73 2017-01 N02AE derivatives Oripavinderivat 2.16.840.1.113883.6.73 2017-01 N02AE01 Buprenorfin 2.16.840.1.113883.6.73 2017-01 N02AF derivatives Morfinderivat 2.16.840.1.113883.6.73 2017-01 N02AF01 Butorfanol 2.16.840.1.113883.6.73 2017-01 N02AF02 Nalbufin 2.16.840.1.113883.6.73 2017-01 N02AG Opioids in combination with Opiater och opioider i kombination antispasmodics med spasmolytika 2.16.840.1.113883.6.73 2017-01 N02AG01 morphine and antispasmodics Morfin och spasmolytika 2.16.840.1.113883.6.73 2017-01 N02AG02 ketobemidone and antispasmodics Ketobemidon och spasmolytika 2.16.840.1.113883.6.73 2017-01 N02AG03 pethidine and antispasmodics Petidin och spasmolytika 2.16.840.1.113883.6.73 2017-01 N02AG04 hydromorphone and antispasmodics Hydromorfon och spasmolytika 2.16.840.1.113883.6.73 2017-01 N02AJ Opioids in combination with non- Opioider i kombination med icke- opioid analgesics opioida analgetika 2.16.840.1.113883.6.73 2017-01 N02AJ01 dihydrocodeine and Dihydrokodein och paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ02 dihydrocodeine and acetylsalicylic Dihydrokodein och acetylsalicylsyra acid 2.16.840.1.113883.6.73 2017-01 N02AJ03 dihydrocodeine and other non- Dihydrokodein och övriga icke- opioid analgesics opioida analgetika 2.16.840.1.113883.6.73 2017-01 N02AJ06 codeine and paracetamol Kodein och paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ07 codeine and acetylsalicylic acid Kodein och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 N02AJ08 codeine and ibuprofen Kodein och ibuprofen 2.16.840.1.113883.6.73 2017-01 N02AJ09 codeine and other non-opioid Kodein och övriga icke-opioida analgesics analgetika 2.16.840.1.113883.6.73 2017-01 N02AJ13 and paracetamol Tramadol och paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ14 tramadol and dexketoprofen Tramadol och dexketoprofen

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 115 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02AJ15 tramadol and other non-opioid Tramadol och övriga icke-opioida analgesics analgetika 2.16.840.1.113883.6.73 2017-01 N02AJ17 oxycodone and paracetamol Oxikodon och paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ18 oxycodone and acetylsalicylic acid Oxikodon och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 N02AJ19 oxycodone and ibuprofen Oxikodon och ibuprofen 2.16.840.1.113883.6.73 2017-01 N02AX Other opioids Övriga opioider 2.16.840.1.113883.6.73 2017-01 N02AX01 Tilidin 2.16.840.1.113883.6.73 2017-01 N02AX02 tramadol Tramadol 2.16.840.1.113883.6.73 2017-01 N02AX03 Dezocin 2.16.840.1.113883.6.73 2017-01 N02AX05 Meptazinol 2.16.840.1.113883.6.73 2017-01 N02AX06 Tapentadol 2.16.840.1.113883.6.73 2017-01 N02B OTHER ANALGESICS AND Övriga analgetika och antipyretika 2.16.840.1.113883.6.73 2017-01 N02BA Salicylic acid and derivatives Salicylsyra och derivat 2.16.840.1.113883.6.73 2017-01 N02BA01 acetylsalicylic acid Acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 N02BA02 aloxiprin Aloxiprin 2.16.840.1.113883.6.73 2017-01 N02BA03 choline salicylate Kolinsalicylat 2.16.840.1.113883.6.73 2017-01 N02BA04 Natriumsalicylat 2.16.840.1.113883.6.73 2017-01 N02BA05 Salicylamid 2.16.840.1.113883.6.73 2017-01 N02BA06 Salsalat 2.16.840.1.113883.6.73 2017-01 N02BA07 Etenzamid 2.16.840.1.113883.6.73 2017-01 N02BA08 morpholine salicylate Morfolinsalicylat 2.16.840.1.113883.6.73 2017-01 N02BA09 dipyrocetyl Dipyricetyl 2.16.840.1.113883.6.73 2017-01 N02BA10 Benorilat 2.16.840.1.113883.6.73 2017-01 N02BA11 Diflunisal 2.16.840.1.113883.6.73 2017-01 N02BA12 Kaliumsalicylat 2.16.840.1.113883.6.73 2017-01 N02BA14 Guacetisal 2.16.840.1.113883.6.73 2017-01 N02BA15 carbasalate calcium Karbasalatkalcium 2.16.840.1.113883.6.73 2017-01 N02BA16 Imidazolsalicylat 2.16.840.1.113883.6.73 2017-01 N02BA51 acetylsalicylic acid, combinations Acetylsalicylsyra, kombinationer excl. psycholeptics exkl. neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA55 salicylamide, combinations excl. Salicylamid, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA57 ethenzamide, combinations excl. Etenzamid, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA59 dipyrocetyl, combinations excl. Dipyricetyl, kombinationer exkl psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA65 carbasalate calcium combinations Karbasalatkalciumkombinationer excl. psycholeptics exkl. neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA71 acetylsalicylic acid, combinations Acetylsalicylsyra, kombinationer with psycholeptics med neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA75 salicylamide, combinations with Salicylamid i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA77 ethenzamide, combinations with Etenzamid i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA79 dipyrocetyl, combinations with Dipyricetyl i kombination med psycholeptics neuroleptika © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 116 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02BB Pyrazolonderivat 2.16.840.1.113883.6.73 2017-01 N02BB01 Fenazon 2.16.840.1.113883.6.73 2017-01 N02BB02 sodium Metamizolnatrium 2.16.840.1.113883.6.73 2017-01 N02BB03 Aminofenazon 2.16.840.1.113883.6.73 2017-01 N02BB04 Propyfenazon 2.16.840.1.113883.6.73 2017-01 N02BB05 nifenazone Nifenazon 2.16.840.1.113883.6.73 2017-01 N02BB51 phenazone, combinations excl. Fenazon, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB52 metamizole sodium, combinations Metamizolnatrium, kombinationer excl. psycholeptics exkl. neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB53 aminophenazone, combinations Aminofenazon, kombinationer exkl excl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB54 propyphenazone, combinations Propyfenazon, kombinationer exkl. excl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB71 phenazone, combinations with Fenazon i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB72 metamizole sodium, combinations Metamizolnatrium i kombination with psycholeptics med neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB73 aminophenazone, combinations with Aminofenazon i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB74 propyphenazone, combinations with Propyfenazon, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE Anilides Anilider, inkl kombinationer 2.16.840.1.113883.6.73 2017-01 N02BE01 paracetamol Paracetamol 2.16.840.1.113883.6.73 2017-01 N02BE03 Fenacetin 2.16.840.1.113883.6.73 2017-01 N02BE04 Bucetin 2.16.840.1.113883.6.73 2017-01 N02BE05 Propacetamol 2.16.840.1.113883.6.73 2017-01 N02BE51 paracetamol, combinations excl. Paracetamol, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE53 phenacetin, combinations excl. Fenacetin, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE54 bucetin, combinations excl. Bucetin, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE71 paracetamol, combinations with Paracetamol, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE73 phenacetin, combinations with Fenacetin, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE74 bucetin, combinations with Bucetin i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BG Other analgesics and antipyretics Övriga analgetika och antipyretika 2.16.840.1.113883.6.73 2017-01 N02BG02 Rimazolium 2.16.840.1.113883.6.73 2017-01 N02BG03 Glafenin 2.16.840.1.113883.6.73 2017-01 N02BG04 Floktafenin 2.16.840.1.113883.6.73 2017-01 N02BG05 Viminol 2.16.840.1.113883.6.73 2017-01 N02BG06 Nefopam 2.16.840.1.113883.6.73 2017-01 N02BG07 Flupirtin 2.16.840.1.113883.6.73 2017-01 N02BG08 Zikonotid 2.16.840.1.113883.6.73 2017-01 N02BG09 Metoxyfluran

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 117 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02BG10 Kannabinoider 2.16.840.1.113883.6.73 2017-01 N02C ANTIMIGRAINE PREPARATIONS Medel vid migrän 2.16.840.1.113883.6.73 2017-01 N02CA Ergot alkaloids Mjöldrygealkaloider 2.16.840.1.113883.6.73 2017-01 N02CA01 Dihydroergotamin 2.16.840.1.113883.6.73 2017-01 N02CA02 Ergotamin 2.16.840.1.113883.6.73 2017-01 N02CA04 Metysergid 2.16.840.1.113883.6.73 2017-01 N02CA07 lisuride Lisurid 2.16.840.1.113883.6.73 2017-01 N02CA51 dihydroergotamine, combinations Dihydroergotamin, kombinationer 2.16.840.1.113883.6.73 2017-01 N02CA52 ergotamine, combinations excl. Ergotamin, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02CA72 ergotamine, combinations with Ergotamin, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02CB derivatives Progesteronderivat 2.16.840.1.113883.6.73 2017-01 N02CB01 flumedroxone Flumedroxon 2.16.840.1.113883.6.73 2017-01 N02CC Selective serotonin (5HT1) agonists Selektiva serotonin(5HT1)agonister 2.16.840.1.113883.6.73 2017-01 N02CC01 Sumatriptan 2.16.840.1.113883.6.73 2017-01 N02CC02 Naratriptan 2.16.840.1.113883.6.73 2017-01 N02CC03 Zolmitriptan 2.16.840.1.113883.6.73 2017-01 N02CC04 Rizatriptan 2.16.840.1.113883.6.73 2017-01 N02CC05 Almotriptan 2.16.840.1.113883.6.73 2017-01 N02CC06 Eletriptan 2.16.840.1.113883.6.73 2017-01 N02CC07 Frovatriptan 2.16.840.1.113883.6.73 2017-01 N02CX Other antimigraine preparations Övriga migränmedel 2.16.840.1.113883.6.73 2017-01 N02CX01 Pizotifen 2.16.840.1.113883.6.73 2017-01 N02CX02 clonidine Klonidin 2.16.840.1.113883.6.73 2017-01 N02CX03 Iprazokrom 2.16.840.1.113883.6.73 2017-01 N02CX05 Dimetotiazin 2.16.840.1.113883.6.73 2017-01 N02CX06 Oxetoron 2.16.840.1.113883.6.73 2017-01 N03 ANTIEPILEPTICS Antiepileptika 2.16.840.1.113883.6.73 2017-01 N03A ANTIEPILEPTICS Antiepileptika 2.16.840.1.113883.6.73 2017-01 N03AA Barbiturates and derivatives Barbitursyraderivat 2.16.840.1.113883.6.73 2017-01 N03AA01 Metylfenobarbital 2.16.840.1.113883.6.73 2017-01 N03AA02 Fenobarbital 2.16.840.1.113883.6.73 2017-01 N03AA03 Primidon 2.16.840.1.113883.6.73 2017-01 N03AA04 Barbexaklon 2.16.840.1.113883.6.73 2017-01 N03AA30 Metarbital 2.16.840.1.113883.6.73 2017-01 N03AB derivatives Hydantoinderivat 2.16.840.1.113883.6.73 2017-01 N03AB01 Etotoin 2.16.840.1.113883.6.73 2017-01 N03AB02 Fenytoin 2.16.840.1.113883.6.73 2017-01 N03AB03 amino(diphenylhydantoin) valeric Aminovaleriansyra acid 2.16.840.1.113883.6.73 2017-01 N03AB04 Mefenytoin 2.16.840.1.113883.6.73 2017-01 N03AB05 Fosfenytoin 2.16.840.1.113883.6.73 2017-01 N03AB52 phenytoin, combinations Fenytoin, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 118 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N03AB54 mephenytoin, combinations Mefenytoin, kombinationer 2.16.840.1.113883.6.73 2017-01 N03AC Oxazolidine derivatives Oxazolidindionderivat 2.16.840.1.113883.6.73 2017-01 N03AC01 Parametadion 2.16.840.1.113883.6.73 2017-01 N03AC02 Trimetadion 2.16.840.1.113883.6.73 2017-01 N03AC03 Etadion 2.16.840.1.113883.6.73 2017-01 N03AD Succinimide derivatives Succinimidderivat 2.16.840.1.113883.6.73 2017-01 N03AD01 Etosuximid 2.16.840.1.113883.6.73 2017-01 N03AD02 Fensuximid 2.16.840.1.113883.6.73 2017-01 N03AD03 Mesuximid 2.16.840.1.113883.6.73 2017-01 N03AD51 ethosuximide, combinations Etosuximid, kombinationer 2.16.840.1.113883.6.73 2017-01 N03AE derivatives Bensodiazepinderivat 2.16.840.1.113883.6.73 2017-01 N03AE01 Klonazepam 2.16.840.1.113883.6.73 2017-01 N03AF Carboxamide derivatives Karboxamidderivat 2.16.840.1.113883.6.73 2017-01 N03AF01 Karbamazepin 2.16.840.1.113883.6.73 2017-01 N03AF02 Oxkarbazepin 2.16.840.1.113883.6.73 2017-01 N03AF03 Rufinamid 2.16.840.1.113883.6.73 2017-01 N03AF04 eslicarbazepine Eslikarbazepin 2.16.840.1.113883.6.73 2017-01 N03AG derivatives Fettsyraderivat 2.16.840.1.113883.6.73 2017-01 N03AG01 valproic acid Valproinsyra 2.16.840.1.113883.6.73 2017-01 N03AG02 Valpromid 2.16.840.1.113883.6.73 2017-01 N03AG03 aminobutyric acid Aminosmörsyra 2.16.840.1.113883.6.73 2017-01 N03AG04 Vigabatrin 2.16.840.1.113883.6.73 2017-01 N03AG05 Progabid 2.16.840.1.113883.6.73 2017-01 N03AG06 Tiagabin 2.16.840.1.113883.6.73 2017-01 N03AX Other antiepileptics Övriga antiepileptika 2.16.840.1.113883.6.73 2017-01 N03AX03 Sultiam 2.16.840.1.113883.6.73 2017-01 N03AX07 Fenacemid 2.16.840.1.113883.6.73 2017-01 N03AX09 Lamotrigin 2.16.840.1.113883.6.73 2017-01 N03AX10 Felbamat 2.16.840.1.113883.6.73 2017-01 N03AX11 Topiramat 2.16.840.1.113883.6.73 2017-01 N03AX12 Gabapentin 2.16.840.1.113883.6.73 2017-01 N03AX13 Feneturid 2.16.840.1.113883.6.73 2017-01 N03AX14 Levetiracetam 2.16.840.1.113883.6.73 2017-01 N03AX15 Zonisamid 2.16.840.1.113883.6.73 2017-01 N03AX16 Pregabalin 2.16.840.1.113883.6.73 2017-01 N03AX17 Stiripentol 2.16.840.1.113883.6.73 2017-01 N03AX18 Lakosamid 2.16.840.1.113883.6.73 2017-01 N03AX19 Karisbamat 2.16.840.1.113883.6.73 2017-01 N03AX21 Retigabin 2.16.840.1.113883.6.73 2017-01 N03AX22 Perampanel 2.16.840.1.113883.6.73 2017-01 N03AX23 Brivaracetam 2.16.840.1.113883.6.73 2017-01 N03AX30 beclamide Beklamid 2.16.840.1.113883.6.73 2017-01 N04 ANTI-PARKINSON DRUGS Medel vid © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 119 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N04A ANTICHOLINERGIC AGENTS Antikolinergika 2.16.840.1.113883.6.73 2017-01 N04AA Tertiary amines Antikolinergika, tertiära aminer 2.16.840.1.113883.6.73 2017-01 N04AA01 Trihexyfenidyl 2.16.840.1.113883.6.73 2017-01 N04AA02 Biperiden 2.16.840.1.113883.6.73 2017-01 N04AA03 Metixen 2.16.840.1.113883.6.73 2017-01 N04AA04 Procyklidin 2.16.840.1.113883.6.73 2017-01 N04AA05 Profenamin 2.16.840.1.113883.6.73 2017-01 N04AA08 Dexetimid 2.16.840.1.113883.6.73 2017-01 N04AA09 Fenglutarimid 2.16.840.1.113883.6.73 2017-01 N04AA10 Mazatikol 2.16.840.1.113883.6.73 2017-01 N04AA11 Bornaprin 2.16.840.1.113883.6.73 2017-01 N04AA12 Tropatepin 2.16.840.1.113883.6.73 2017-01 N04AB Ethers chemically close to Antikolinergika, kemiskt närstående antihistamines antihistaminer 2.16.840.1.113883.6.73 2017-01 N04AB01 Etanautin 2.16.840.1.113883.6.73 2017-01 N04AB02 orphenadrine (chloride) Orfenadrin 2.16.840.1.113883.6.73 2017-01 N04AC Ethers of tropine or tropine Antikolinergika, etrar av tropin derivatives 2.16.840.1.113883.6.73 2017-01 N04AC01 Bensatropin 2.16.840.1.113883.6.73 2017-01 N04AC30 Etybensatropin 2.16.840.1.113883.6.73 2017-01 N04B DOPAMINERGIC AGENTS Dopaminerga medel 2.16.840.1.113883.6.73 2017-01 N04BA Dopa and dopa derivatives Dopa och dopaderivat 2.16.840.1.113883.6.73 2017-01 N04BA01 levodopa Levodopa 2.16.840.1.113883.6.73 2017-01 N04BA02 levodopa and decarboxylase Levodopa och inhibitor dekarboxylashämmare 2.16.840.1.113883.6.73 2017-01 N04BA03 levodopa, decarboxylase inhibitor Levodopa, dekarboxylashämmare and COMT inhibitor och COMT-hämmare 2.16.840.1.113883.6.73 2017-01 N04BA04 Melevodopa 2.16.840.1.113883.6.73 2017-01 N04BA05 melevodopa and decarboxylase Melevodopa och inhibitor dekarboxylashämmare 2.16.840.1.113883.6.73 2017-01 N04BA06 and decarboxylase Etilevodopa och inhibitor dekarboxylashämmare 2.16.840.1.113883.6.73 2017-01 N04BB Adamantane derivatives Adamantanderivat 2.16.840.1.113883.6.73 2017-01 N04BB01 Amantadin 2.16.840.1.113883.6.73 2017-01 N04BC Dopamine agonists Dopaminagonister 2.16.840.1.113883.6.73 2017-01 N04BC01 bromocriptine Bromokriptin 2.16.840.1.113883.6.73 2017-01 N04BC02 Pergolid 2.16.840.1.113883.6.73 2017-01 N04BC03 mesylate Dihydroergokryptinmesylat 2.16.840.1.113883.6.73 2017-01 N04BC04 Ropinirol 2.16.840.1.113883.6.73 2017-01 N04BC05 Pramipexol 2.16.840.1.113883.6.73 2017-01 N04BC06 cabergoline Kabergolin 2.16.840.1.113883.6.73 2017-01 N04BC07 apomorphine Apomorfin 2.16.840.1.113883.6.73 2017-01 N04BC08 Piribedil 2.16.840.1.113883.6.73 2017-01 N04BC09 Rotigotin 2.16.840.1.113883.6.73 2017-01 N04BD Monoamine oxidase B inhibitors MAO-B hämmare

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 120 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N04BD01 Selegilin 2.16.840.1.113883.6.73 2017-01 N04BD02 Rasagilin 2.16.840.1.113883.6.73 2017-01 N04BD03 Safinamid 2.16.840.1.113883.6.73 2017-01 N04BX Other dopaminergic agents Övriga dopaminerga medel 2.16.840.1.113883.6.73 2017-01 N04BX01 Tolkapon 2.16.840.1.113883.6.73 2017-01 N04BX02 Entakapon 2.16.840.1.113883.6.73 2017-01 N04BX03 Budipin 2.16.840.1.113883.6.73 2017-01 N05 PSYCHOLEPTICS Neuroleptika, lugnande medel och sömnmedel 2.16.840.1.113883.6.73 2017-01 N05A Neuroleptika 2.16.840.1.113883.6.73 2017-01 N05AA with aliphatic side- Fentiazinderivat med alifatisk chain sidokedja 2.16.840.1.113883.6.73 2017-01 N05AA01 Klorpromazin 2.16.840.1.113883.6.73 2017-01 N05AA02 Levomepromazin 2.16.840.1.113883.6.73 2017-01 N05AA03 Promazin 2.16.840.1.113883.6.73 2017-01 N05AA04 Acepromazin 2.16.840.1.113883.6.73 2017-01 N05AA05 Triflupromazin 2.16.840.1.113883.6.73 2017-01 N05AA06 Cyamemazin 2.16.840.1.113883.6.73 2017-01 N05AA07 Klorproetazin 2.16.840.1.113883.6.73 2017-01 N05AB Phenothiazines with Fentiazinderivat med piperazinring structure 2.16.840.1.113883.6.73 2017-01 N05AB01 Dixyrazin 2.16.840.1.113883.6.73 2017-01 N05AB02 Flufenazin 2.16.840.1.113883.6.73 2017-01 N05AB03 Perfenazin 2.16.840.1.113883.6.73 2017-01 N05AB04 Proklorperazin 2.16.840.1.113883.6.73 2017-01 N05AB05 Tiopropazat 2.16.840.1.113883.6.73 2017-01 N05AB06 Trifluoperazin 2.16.840.1.113883.6.73 2017-01 N05AB07 Acetofenazin 2.16.840.1.113883.6.73 2017-01 N05AB08 Tioproperazin 2.16.840.1.113883.6.73 2017-01 N05AB09 Butaperazin 2.16.840.1.113883.6.73 2017-01 N05AB10 Perazin 2.16.840.1.113883.6.73 2017-01 N05AC Phenothiazines with Fentiazinderivat med piperidinring structure 2.16.840.1.113883.6.73 2017-01 N05AC01 Periciazin 2.16.840.1.113883.6.73 2017-01 N05AC02 Tioridazin 2.16.840.1.113883.6.73 2017-01 N05AC03 Mesoridazin 2.16.840.1.113883.6.73 2017-01 N05AC04 Pipotiazin 2.16.840.1.113883.6.73 2017-01 N05AD derivatives Butyrofenonderivat 2.16.840.1.113883.6.73 2017-01 N05AD01 Haloperidol 2.16.840.1.113883.6.73 2017-01 N05AD02 Trifluperidol 2.16.840.1.113883.6.73 2017-01 N05AD03 Melperon 2.16.840.1.113883.6.73 2017-01 N05AD04 Moperon 2.16.840.1.113883.6.73 2017-01 N05AD05 Pipamperon 2.16.840.1.113883.6.73 2017-01 N05AD06 Bromperidol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 121 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05AD07 Benperidol 2.16.840.1.113883.6.73 2017-01 N05AD08 Droperidol 2.16.840.1.113883.6.73 2017-01 N05AD09 Fluanison 2.16.840.1.113883.6.73 2017-01 N05AE derivatives Indolderivat 2.16.840.1.113883.6.73 2017-01 N05AE01 Oxipertin 2.16.840.1.113883.6.73 2017-01 N05AE02 Molindon 2.16.840.1.113883.6.73 2017-01 N05AE03 Sertindol 2.16.840.1.113883.6.73 2017-01 N05AE04 Ziprasidon 2.16.840.1.113883.6.73 2017-01 N05AE05 Lurasidon 2.16.840.1.113883.6.73 2017-01 N05AF derivatives Tioxantenderivat 2.16.840.1.113883.6.73 2017-01 N05AF01 Flupentixol 2.16.840.1.113883.6.73 2017-01 N05AF02 Klopentixol 2.16.840.1.113883.6.73 2017-01 N05AF03 Klorprotixen 2.16.840.1.113883.6.73 2017-01 N05AF04 Tiotixen 2.16.840.1.113883.6.73 2017-01 N05AF05 Zuklopentixol 2.16.840.1.113883.6.73 2017-01 N05AG derivatives Difenylbutylpiperidinderivat 2.16.840.1.113883.6.73 2017-01 N05AG01 Fluspirilen 2.16.840.1.113883.6.73 2017-01 N05AG02 Pimozid 2.16.840.1.113883.6.73 2017-01 N05AG03 Penfluridol 2.16.840.1.113883.6.73 2017-01 N05AH Diazepines, oxazepines, thiazepines Diazepiner, oxazepiner, tiazepiner and oxepines och oxepiner 2.16.840.1.113883.6.73 2017-01 N05AH01 Loxapin 2.16.840.1.113883.6.73 2017-01 N05AH02 Klozapin 2.16.840.1.113883.6.73 2017-01 N05AH03 Olanzapin 2.16.840.1.113883.6.73 2017-01 N05AH04 Kvetiapin 2.16.840.1.113883.6.73 2017-01 N05AH05 Asenapin 2.16.840.1.113883.6.73 2017-01 N05AH06 Klotiapin 2.16.840.1.113883.6.73 2017-01 N05AL Bensamider 2.16.840.1.113883.6.73 2017-01 N05AL01 Sulpirid 2.16.840.1.113883.6.73 2017-01 N05AL02 Sultoprid 2.16.840.1.113883.6.73 2017-01 N05AL03 Tiaprid 2.16.840.1.113883.6.73 2017-01 N05AL04 Remoxiprid 2.16.840.1.113883.6.73 2017-01 N05AL05 Amisulprid 2.16.840.1.113883.6.73 2017-01 N05AL06 Veraliprid 2.16.840.1.113883.6.73 2017-01 N05AL07 Levosulpirid 2.16.840.1.113883.6.73 2017-01 N05AN Lithium Litium 2.16.840.1.113883.6.73 2017-01 N05AN01 lithium Litium 2.16.840.1.113883.6.73 2017-01 N05AX Other antipsychotics Övriga neuroleptika 2.16.840.1.113883.6.73 2017-01 N05AX07 Protipendyl 2.16.840.1.113883.6.73 2017-01 N05AX08 Risperidon 2.16.840.1.113883.6.73 2017-01 N05AX10 Mosapramin 2.16.840.1.113883.6.73 2017-01 N05AX11 Zotepin 2.16.840.1.113883.6.73 2017-01 N05AX12 Aripiprazol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 122 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05AX13 Paliperidon 2.16.840.1.113883.6.73 2017-01 N05AX14 Iloperidon 2.16.840.1.113883.6.73 2017-01 N05AX15 Kariprazin 2.16.840.1.113883.6.73 2017-01 N05AX16 Brexpiprazol 2.16.840.1.113883.6.73 2017-01 N05AX17 Pimavanserin 2.16.840.1.113883.6.73 2017-01 N05B Lugnande medel, ataraktika 2.16.840.1.113883.6.73 2017-01 N05BA Benzodiazepine derivatives Bensodiazepinderivat 2.16.840.1.113883.6.73 2017-01 N05BA01 Diazepam 2.16.840.1.113883.6.73 2017-01 N05BA02 Klordiazepoxid 2.16.840.1.113883.6.73 2017-01 N05BA03 Medazepam 2.16.840.1.113883.6.73 2017-01 N05BA04 Oxazepam 2.16.840.1.113883.6.73 2017-01 N05BA05 potassium Dikaliumklorazepat 2.16.840.1.113883.6.73 2017-01 N05BA06 Lorazepam 2.16.840.1.113883.6.73 2017-01 N05BA07 Adinazolam 2.16.840.1.113883.6.73 2017-01 N05BA08 Bromazepam 2.16.840.1.113883.6.73 2017-01 N05BA09 Klobazam 2.16.840.1.113883.6.73 2017-01 N05BA10 Ketazolam 2.16.840.1.113883.6.73 2017-01 N05BA11 Prazepam 2.16.840.1.113883.6.73 2017-01 N05BA12 Alprazolam 2.16.840.1.113883.6.73 2017-01 N05BA13 Halazepam 2.16.840.1.113883.6.73 2017-01 N05BA14 Pinazepam 2.16.840.1.113883.6.73 2017-01 N05BA15 Kamazepam 2.16.840.1.113883.6.73 2017-01 N05BA16 Nordazepam 2.16.840.1.113883.6.73 2017-01 N05BA17 Fludiazepam 2.16.840.1.113883.6.73 2017-01 N05BA18 Etylloflazepat 2.16.840.1.113883.6.73 2017-01 N05BA19 Etizolam 2.16.840.1.113883.6.73 2017-01 N05BA21 Klotiazepam 2.16.840.1.113883.6.73 2017-01 N05BA22 Kloxazolam 2.16.840.1.113883.6.73 2017-01 N05BA23 Tofisopam 2.16.840.1.113883.6.73 2017-01 N05BA24 Bentazepam 2.16.840.1.113883.6.73 2017-01 N05BA56 lorazepam, combinations Lorazepam, kombinationer 2.16.840.1.113883.6.73 2017-01 N05BB derivatives Difenylmetylpiperazinderivat 2.16.840.1.113883.6.73 2017-01 N05BB01 Hydroxizin 2.16.840.1.113883.6.73 2017-01 N05BB02 Kaptodiam 2.16.840.1.113883.6.73 2017-01 N05BB51 hydroxyzine, combinations Hydroxizin, kombinationer 2.16.840.1.113883.6.73 2017-01 N05BC Propandiolderivat 2.16.840.1.113883.6.73 2017-01 N05BC01 Meprobamat 2.16.840.1.113883.6.73 2017-01 N05BC03 Emylkamat 2.16.840.1.113883.6.73 2017-01 N05BC04 Mebutamat 2.16.840.1.113883.6.73 2017-01 N05BC51 meprobamate, combinations Meprobamat, kombinationer 2.16.840.1.113883.6.73 2017-01 N05BD Dibenzo-bicyclo-octadiene Dibenso-bicyklo-oktadienderivat derivatives 2.16.840.1.113883.6.73 2017-01 N05BD01 Bensoktamin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 123 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05BE Azaspirodecanedione derivatives Azaspironderivat 2.16.840.1.113883.6.73 2017-01 N05BE01 Buspiron 2.16.840.1.113883.6.73 2017-01 N05BX Other anxiolytics Övriga lugnande medel 2.16.840.1.113883.6.73 2017-01 N05BX01 Mefenoxalon 2.16.840.1.113883.6.73 2017-01 N05BX02 Gedocarnil 2.16.840.1.113883.6.73 2017-01 N05BX03 Etifoxin 2.16.840.1.113883.6.73 2017-01 N05BX04 Fabomotizol 2.16.840.1.113883.6.73 2017-01 N05C AND Sömnmedel och lugnande medel 2.16.840.1.113883.6.73 2017-01 N05CA Barbiturates, plain Barbiturater 2.16.840.1.113883.6.73 2017-01 N05CA01 Pentobarbital 2.16.840.1.113883.6.73 2017-01 N05CA02 Amobarbital 2.16.840.1.113883.6.73 2017-01 N05CA03 Butobarbital 2.16.840.1.113883.6.73 2017-01 N05CA04 Barbital 2.16.840.1.113883.6.73 2017-01 N05CA05 Allpropymal 2.16.840.1.113883.6.73 2017-01 N05CA06 Secobarbital 2.16.840.1.113883.6.73 2017-01 N05CA07 Talbumal 2.16.840.1.113883.6.73 2017-01 N05CA08 Vinylbital 2.16.840.1.113883.6.73 2017-01 N05CA09 Vinbarbital 2.16.840.1.113883.6.73 2017-01 N05CA10 Cyklobarbital 2.16.840.1.113883.6.73 2017-01 N05CA11 heptabarbital Heptabarbital 2.16.840.1.113883.6.73 2017-01 N05CA12 Reposal 2.16.840.1.113883.6.73 2017-01 N05CA15 methohexital Metohexital 2.16.840.1.113883.6.73 2017-01 N05CA16 hexobarbital Hexobarbital 2.16.840.1.113883.6.73 2017-01 N05CA19 thiopental Tiopental 2.16.840.1.113883.6.73 2017-01 N05CA20 etallobarbital Etallobarbital 2.16.840.1.113883.6.73 2017-01 N05CA21 Allobarbital 2.16.840.1.113883.6.73 2017-01 N05CA22 proxibarbal Proxibarbal 2.16.840.1.113883.6.73 2017-01 N05CB Barbiturates, combinations Barbitursyraderivat, kombinationer 2.16.840.1.113883.6.73 2017-01 N05CB01 combinations of barbiturates Kombinationer av barbitursyraderivat 2.16.840.1.113883.6.73 2017-01 N05CB02 barbiturates in combination with Barbitursyraderivat i kombination other drugs med andra medel 2.16.840.1.113883.6.73 2017-01 N05CC Aldehydes and derivatives Aldehyder, inkl derivat 2.16.840.1.113883.6.73 2017-01 N05CC01 hydrate Kloralhydrat 2.16.840.1.113883.6.73 2017-01 N05CC02 Kloralodol 2.16.840.1.113883.6.73 2017-01 N05CC03 acetylglycinamide Acetylglycinamidkloralhydrat 2.16.840.1.113883.6.73 2017-01 N05CC04 Dikloralfenazon 2.16.840.1.113883.6.73 2017-01 N05CC05 Paraldehyd 2.16.840.1.113883.6.73 2017-01 N05CD Benzodiazepine derivatives Bensodiazepinderivat 2.16.840.1.113883.6.73 2017-01 N05CD01 Flurazepam 2.16.840.1.113883.6.73 2017-01 N05CD02 Nitrazepam 2.16.840.1.113883.6.73 2017-01 N05CD03 Flunitrazepam 2.16.840.1.113883.6.73 2017-01 N05CD04 Estazolam 2.16.840.1.113883.6.73 2017-01 N05CD05 Triazolam © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 124 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05CD06 Lormetazepam 2.16.840.1.113883.6.73 2017-01 N05CD07 Temazepam 2.16.840.1.113883.6.73 2017-01 N05CD08 Midazolam 2.16.840.1.113883.6.73 2017-01 N05CD09 Brotizolam 2.16.840.1.113883.6.73 2017-01 N05CD10 Kvazepam 2.16.840.1.113883.6.73 2017-01 N05CD11 Loprazolam 2.16.840.1.113883.6.73 2017-01 N05CD12 Doxefazepam 2.16.840.1.113883.6.73 2017-01 N05CD13 Cinolazepam 2.16.840.1.113883.6.73 2017-01 N05CE Piperidinedione derivatives Piperidindionderivat 2.16.840.1.113883.6.73 2017-01 N05CE01 Glutetimid 2.16.840.1.113883.6.73 2017-01 N05CE02 Metyprylon 2.16.840.1.113883.6.73 2017-01 N05CE03 Pyrityldion 2.16.840.1.113883.6.73 2017-01 N05CF Benzodiazepine related drugs Bensodiazepinbesläktade medel 2.16.840.1.113883.6.73 2017-01 N05CF01 Zopiklon 2.16.840.1.113883.6.73 2017-01 N05CF02 Zolpidem 2.16.840.1.113883.6.73 2017-01 N05CF03 Zaleplon 2.16.840.1.113883.6.73 2017-01 N05CF04 Eszopiklon 2.16.840.1.113883.6.73 2017-01 N05CH receptor agonists Melatoninreceptor agonister 2.16.840.1.113883.6.73 2017-01 N05CH01 melatonin Melatonin 2.16.840.1.113883.6.73 2017-01 N05CH02 Ramelteon 2.16.840.1.113883.6.73 2017-01 N05CH03 Tasimelteon 2.16.840.1.113883.6.73 2017-01 N05CM Other hypnotics and sedatives Övriga sömnmedel och lugnande medel 2.16.840.1.113883.6.73 2017-01 N05CM01 Metakvalon 2.16.840.1.113883.6.73 2017-01 N05CM02 Klometiazol 2.16.840.1.113883.6.73 2017-01 N05CM03 Bromisoval 2.16.840.1.113883.6.73 2017-01 N05CM04 Karbromal 2.16.840.1.113883.6.73 2017-01 N05CM05 scopolamine Skopolamin 2.16.840.1.113883.6.73 2017-01 N05CM06 Propiomazin 2.16.840.1.113883.6.73 2017-01 N05CM07 Triklofos 2.16.840.1.113883.6.73 2017-01 N05CM08 Klorvinylpentinol 2.16.840.1.113883.6.73 2017-01 N05CM09 Valerianae radix Vänderot, rot 2.16.840.1.113883.6.73 2017-01 N05CM10 Hexapropymat 2.16.840.1.113883.6.73 2017-01 N05CM11 Bromider 2.16.840.1.113883.6.73 2017-01 N05CM12 Apronal 2.16.840.1.113883.6.73 2017-01 N05CM13 Valnoktamid 2.16.840.1.113883.6.73 2017-01 N05CM15 Metylpentynol 2.16.840.1.113883.6.73 2017-01 N05CM16 Niaprazin 2.16.840.1.113883.6.73 2017-01 N05CM18 Dexmedetomidin 2.16.840.1.113883.6.73 2017-01 N05CX Hypnotics and sedatives in Kombinationer, exkl. combination, excl. barbiturates barbitursyraderivat 2.16.840.1.113883.6.73 2017-01 N05CX01 meprobamate, combinations Meprobamat, kombinationer 2.16.840.1.113883.6.73 2017-01 N05CX02 methaqualone, combinations Metkvalon, kombinationer 2.16.840.1.113883.6.73 2017-01 N05CX03 methylpentynol, combinations Metylpentynol, kombinationer © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 125 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05CX04 clomethiazole, combinations Klometiazol, kombinationer 2.16.840.1.113883.6.73 2017-01 N05CX05 emepronium, combinations Emepron, kombinationer 2.16.840.1.113883.6.73 2017-01 N05CX06 dipiperonylaminoethanol, Dipiperonylaminoetanol, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 N06 PSYCHOANALEPTICS Psykoanaleptika 2.16.840.1.113883.6.73 2017-01 N06A Antidepressiva medel 2.16.840.1.113883.6.73 2017-01 N06AA Non-selective monoamine reuptake Icke-selektiva inhibitors monoaminåterupptagshämmare 2.16.840.1.113883.6.73 2017-01 N06AA01 Desipramin 2.16.840.1.113883.6.73 2017-01 N06AA02 Imipramin 2.16.840.1.113883.6.73 2017-01 N06AA03 imipramine oxide Imipraminoxid 2.16.840.1.113883.6.73 2017-01 N06AA04 Klomipramin 2.16.840.1.113883.6.73 2017-01 N06AA05 Opipramol 2.16.840.1.113883.6.73 2017-01 N06AA06 Trimipramin 2.16.840.1.113883.6.73 2017-01 N06AA07 Lofepramin 2.16.840.1.113883.6.73 2017-01 N06AA08 Dibensepin 2.16.840.1.113883.6.73 2017-01 N06AA09 Amitriptylin 2.16.840.1.113883.6.73 2017-01 N06AA10 Nortriptylin 2.16.840.1.113883.6.73 2017-01 N06AA11 Protriptylin 2.16.840.1.113883.6.73 2017-01 N06AA12 Doxepin 2.16.840.1.113883.6.73 2017-01 N06AA13 Iprindol 2.16.840.1.113883.6.73 2017-01 N06AA14 Melitracen 2.16.840.1.113883.6.73 2017-01 N06AA15 Butriptylin 2.16.840.1.113883.6.73 2017-01 N06AA16 Dosulepin 2.16.840.1.113883.6.73 2017-01 N06AA17 Amoxapin 2.16.840.1.113883.6.73 2017-01 N06AA18 Dimetakrin 2.16.840.1.113883.6.73 2017-01 N06AA19 amineptine Amineptin 2.16.840.1.113883.6.73 2017-01 N06AA21 Maprotilin 2.16.840.1.113883.6.73 2017-01 N06AA23 Kinupramin 2.16.840.1.113883.6.73 2017-01 N06AB Selective serotonin reuptake Selektiva inhibitors serotoninåterupptagshämmare 2.16.840.1.113883.6.73 2017-01 N06AB02 zimeldine Zimelidin 2.16.840.1.113883.6.73 2017-01 N06AB03 Fluoxetin 2.16.840.1.113883.6.73 2017-01 N06AB04 Citalopram 2.16.840.1.113883.6.73 2017-01 N06AB05 Paroxetin 2.16.840.1.113883.6.73 2017-01 N06AB06 Sertralin 2.16.840.1.113883.6.73 2017-01 N06AB07 alaproclate Alaproklat 2.16.840.1.113883.6.73 2017-01 N06AB08 Fluvoxamin 2.16.840.1.113883.6.73 2017-01 N06AB09 Etoperidon 2.16.840.1.113883.6.73 2017-01 N06AB10 Escitalopram 2.16.840.1.113883.6.73 2017-01 N06AF Monoamine oxidase inhibitors, non- MAO-hämmare, ickeselektiva selective 2.16.840.1.113883.6.73 2017-01 N06AF01 isocarboxazid Isokarboxazid 2.16.840.1.113883.6.73 2017-01 N06AF02 nialamide Nialamid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 126 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N06AF03 Fenelzin 2.16.840.1.113883.6.73 2017-01 N06AF04 tranylcypromine Tranylcypromin 2.16.840.1.113883.6.73 2017-01 N06AF05 iproniazide Iproniazid 2.16.840.1.113883.6.73 2017-01 N06AF06 Iproklozid 2.16.840.1.113883.6.73 2017-01 N06AG Monoamine oxidase A inhibitors MAO-hämmare, selektiva typ A hämmare 2.16.840.1.113883.6.73 2017-01 N06AG02 moclobemide Moklobemid 2.16.840.1.113883.6.73 2017-01 N06AG03 Toloxaton 2.16.840.1.113883.6.73 2017-01 N06AX Other antidepressants Övriga antidepressiva medel 2.16.840.1.113883.6.73 2017-01 N06AX01 oxitriptan Oxitriptan 2.16.840.1.113883.6.73 2017-01 N06AX02 tryptophan Tryptofan 2.16.840.1.113883.6.73 2017-01 N06AX03 Mianserin 2.16.840.1.113883.6.73 2017-01 N06AX04 nomifensine Nomifensin 2.16.840.1.113883.6.73 2017-01 N06AX05 Trazodon 2.16.840.1.113883.6.73 2017-01 N06AX06 Nefazodon 2.16.840.1.113883.6.73 2017-01 N06AX07 minaprine Minaprin 2.16.840.1.113883.6.73 2017-01 N06AX08 bifemelane Bifemelan 2.16.840.1.113883.6.73 2017-01 N06AX09 viloxazine Viloxazin 2.16.840.1.113883.6.73 2017-01 N06AX10 Oxaflozan 2.16.840.1.113883.6.73 2017-01 N06AX11 Mirtazapin 2.16.840.1.113883.6.73 2017-01 N06AX12 bupropion Bupropion 2.16.840.1.113883.6.73 2017-01 N06AX13 medifoxamine Medifoxamin 2.16.840.1.113883.6.73 2017-01 N06AX14 Tianeptin 2.16.840.1.113883.6.73 2017-01 N06AX15 Pivagabin 2.16.840.1.113883.6.73 2017-01 N06AX16 Venlafaxin 2.16.840.1.113883.6.73 2017-01 N06AX17 Milnacipran 2.16.840.1.113883.6.73 2017-01 N06AX18 Reboxetin 2.16.840.1.113883.6.73 2017-01 N06AX19 Gepiron 2.16.840.1.113883.6.73 2017-01 N06AX21 Duloxetin 2.16.840.1.113883.6.73 2017-01 N06AX22 Agomelatin 2.16.840.1.113883.6.73 2017-01 N06AX23 desvenlafaxine Desvenlafaxin 2.16.840.1.113883.6.73 2017-01 N06AX24 Vilazodon 2.16.840.1.113883.6.73 2017-01 N06AX25 Hyperici herba Hyperici herba 2.16.840.1.113883.6.73 2017-01 N06AX26 Vortioxetin 2.16.840.1.113883.6.73 2017-01 N06B PSYCHOSTIMULANTS, AGENTS Psykostimulantia, medel vid ADHD USED FOR ADHD AND och nootropika NOOTROPICS 2.16.840.1.113883.6.73 2017-01 N06BA Centrally acting sympathomimetics Centralt verkande sympatomimetika 2.16.840.1.113883.6.73 2017-01 N06BA01 amfetamine Amfetamin 2.16.840.1.113883.6.73 2017-01 N06BA02 dexamfetamine Dexamfetamin 2.16.840.1.113883.6.73 2017-01 N06BA03 metamfetamine Metamfetamin 2.16.840.1.113883.6.73 2017-01 N06BA04 Metylfenidat 2.16.840.1.113883.6.73 2017-01 N06BA05 pemoline Pemolin 2.16.840.1.113883.6.73 2017-01 N06BA06 fencamfamin Fenkamfamin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 127 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N06BA07 Modafinil 2.16.840.1.113883.6.73 2017-01 N06BA08 fenozolone Fenozolon 2.16.840.1.113883.6.73 2017-01 N06BA09 Atomoxetin 2.16.840.1.113883.6.73 2017-01 N06BA10 fenetylline Fenetyllin 2.16.840.1.113883.6.73 2017-01 N06BA11 dexmethylphenidate Dexmetylfenidat 2.16.840.1.113883.6.73 2017-01 N06BA12 lisdexamfetamine Lisdexamfetamin 2.16.840.1.113883.6.73 2017-01 N06BA13 Armodafinil 2.16.840.1.113883.6.73 2017-01 N06BC Xanthine derivatives Xantinderivat 2.16.840.1.113883.6.73 2017-01 N06BC01 Koffein 2.16.840.1.113883.6.73 2017-01 N06BC02 Propentofyllin 2.16.840.1.113883.6.73 2017-01 N06BX Other psychostimulants and Övriga psykostimulantia och nootropics nootropika 2.16.840.1.113883.6.73 2017-01 N06BX01 Meklofenoxat 2.16.840.1.113883.6.73 2017-01 N06BX02 Pyritinol 2.16.840.1.113883.6.73 2017-01 N06BX03 Piracetam 2.16.840.1.113883.6.73 2017-01 N06BX04 deanol Deanol 2.16.840.1.113883.6.73 2017-01 N06BX05 fipexide Fipexid 2.16.840.1.113883.6.73 2017-01 N06BX06 Citikolin 2.16.840.1.113883.6.73 2017-01 N06BX07 oxiracetam Oxiracetam 2.16.840.1.113883.6.73 2017-01 N06BX08 Pirisudanol 2.16.840.1.113883.6.73 2017-01 N06BX09 Linopirdin 2.16.840.1.113883.6.73 2017-01 N06BX10 nizofenone Nizofenon 2.16.840.1.113883.6.73 2017-01 N06BX11 aniracetam Aniracetam 2.16.840.1.113883.6.73 2017-01 N06BX12 Acetylcarnitin 2.16.840.1.113883.6.73 2017-01 N06BX13 idebenone Idebenon 2.16.840.1.113883.6.73 2017-01 N06BX14 prolintane Prolintan 2.16.840.1.113883.6.73 2017-01 N06BX15 pipradrol Pipradol 2.16.840.1.113883.6.73 2017-01 N06BX16 pramiracetam Pramiracetam 2.16.840.1.113883.6.73 2017-01 N06BX17 Adrafinil 2.16.840.1.113883.6.73 2017-01 N06BX18 Vinpocetin 2.16.840.1.113883.6.73 2017-01 N06BX21 Mebikar 2.16.840.1.113883.6.73 2017-01 N06BX22 Fenibut 2.16.840.1.113883.6.73 2017-01 N06C PSYCHOLEPTICS AND Psykoleptika-psykoanaleptika, PSYCHOANALEPTICS IN kombinationer COMBINATION 2.16.840.1.113883.6.73 2017-01 N06CA Antidepressants in combination with Antidepressiva i kombination med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 N06CA01 amitriptyline and psycholeptics Amitriptylin och neuroleptika 2.16.840.1.113883.6.73 2017-01 N06CA02 melitracen and psycholeptics Melitracen och psykoleptika 2.16.840.1.113883.6.73 2017-01 N06CA03 fluoxetine and psycholeptics Fluoxetin och psykoleptika 2.16.840.1.113883.6.73 2017-01 N06CB Psychostimulants in combination Psykostimulantia i kombination med with psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N06D ANTI-DEMENTIA DRUGS Medel vid demenssjukdomar 2.16.840.1.113883.6.73 2017-01 N06DA Anticholinesterases Kolinesterashämmare 2.16.840.1.113883.6.73 2017-01 N06DA01 tacrine Takrin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 128 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N06DA02 donepezil Donepezil 2.16.840.1.113883.6.73 2017-01 N06DA03 rivastigmine Rivastigmin 2.16.840.1.113883.6.73 2017-01 N06DA04 Galantamin 2.16.840.1.113883.6.73 2017-01 N06DA05 ipidacrine Ipidakrin 2.16.840.1.113883.6.73 2017-01 N06DA52 donepezil and Donepezil och memantin 2.16.840.1.113883.6.73 2017-01 N06DA53 donepezil, memantine and Ginkgo Donepezil, memantin och Ginkgo, folium blad 2.16.840.1.113883.6.73 2017-01 N06DX Other anti-dementia drugs Övriga medel vid demenssjukdomar 2.16.840.1.113883.6.73 2017-01 N06DX01 memantine Memantin 2.16.840.1.113883.6.73 2017-01 N06DX02 Ginkgo folium Ginkgo, blad 2.16.840.1.113883.6.73 2017-01 N06DX30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 N07 OTHER NERVOUS SYSTEM Övriga medel med verkan på DRUGS nervsystemet 2.16.840.1.113883.6.73 2017-01 N07A PARASYMPATHOMIMETICS Parasympatomimetika 2.16.840.1.113883.6.73 2017-01 N07AA Anticholinesterases Kolinesterashämmare 2.16.840.1.113883.6.73 2017-01 N07AA01 neostigmine Neostigmin 2.16.840.1.113883.6.73 2017-01 N07AA02 pyridostigmine Pyridostigmin 2.16.840.1.113883.6.73 2017-01 N07AA03 distigmine Distigmin 2.16.840.1.113883.6.73 2017-01 N07AA30 ambenonium Ambenonium 2.16.840.1.113883.6.73 2017-01 N07AA51 neostigmine, combinations Neostigmin, kombinationer 2.16.840.1.113883.6.73 2017-01 N07AB Choline esters Kolinestrar 2.16.840.1.113883.6.73 2017-01 N07AB01 Karbakol 2.16.840.1.113883.6.73 2017-01 N07AB02 Betanekol 2.16.840.1.113883.6.73 2017-01 N07AX Other parasympathomimetics Övriga parasympatomimetika 2.16.840.1.113883.6.73 2017-01 N07AX01 Pilokarpin 2.16.840.1.113883.6.73 2017-01 N07AX02 choline alfoscerate Kolinalfoscerat 2.16.840.1.113883.6.73 2017-01 N07AX03 Cevimelin 2.16.840.1.113883.6.73 2017-01 N07B DRUGS USED IN ADDICTIVE Medel vid behandling av DISORDERS beroendetillstånd 2.16.840.1.113883.6.73 2017-01 N07BA Drugs used in dependence Medel vid nikotinberoende 2.16.840.1.113883.6.73 2017-01 N07BA01 nicotine Nikotin 2.16.840.1.113883.6.73 2017-01 N07BA03 Vareniklin 2.16.840.1.113883.6.73 2017-01 N07BB Drugs used in alcohol dependence Medel vid alkoholberoende 2.16.840.1.113883.6.73 2017-01 N07BB01 Disulfiram 2.16.840.1.113883.6.73 2017-01 N07BB02 calcium carbimide Kalciumkarbimid 2.16.840.1.113883.6.73 2017-01 N07BB03 acamprosate Akamprosat 2.16.840.1.113883.6.73 2017-01 N07BB04 naltrexone Naltrexon 2.16.840.1.113883.6.73 2017-01 N07BB05 nalmefene Nalmefen 2.16.840.1.113883.6.73 2017-01 N07BC Drugs used in opioid dependence Medel vid opioidberoende 2.16.840.1.113883.6.73 2017-01 N07BC01 buprenorphine Buprenorfin 2.16.840.1.113883.6.73 2017-01 N07BC02 methadone Metadon 2.16.840.1.113883.6.73 2017-01 N07BC03 Levacetylmetadol 2.16.840.1.113883.6.73 2017-01 N07BC04 Lofexidin 2.16.840.1.113883.6.73 2017-01 N07BC05 Levometadon

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 129 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N07BC06 diamorphine Diamorfin 2.16.840.1.113883.6.73 2017-01 N07BC51 buprenorphine, combinations Buprenorfin, kombinationer 2.16.840.1.113883.6.73 2017-01 N07C ANTIVERTIGO PREPARATIONS Medel mot yrsel 2.16.840.1.113883.6.73 2017-01 N07CA Antivertigo preparations Medel mot yrsel 2.16.840.1.113883.6.73 2017-01 N07CA01 Betahistin 2.16.840.1.113883.6.73 2017-01 N07CA02 Cinnarizin 2.16.840.1.113883.6.73 2017-01 N07CA03 Flunarizin 2.16.840.1.113883.6.73 2017-01 N07CA04 acetylleucine Acetylleucin 2.16.840.1.113883.6.73 2017-01 N07CA52 cinnarizine, combinations Cinnarizin kombinationer 2.16.840.1.113883.6.73 2017-01 N07X OTHER NERVOUS SYSTEM Övriga läkemedel med verkan på DRUGS nervsystemet 2.16.840.1.113883.6.73 2017-01 N07XA Gangliosides and ganglioside Gangliosider och gangliosidderivat derivatives 2.16.840.1.113883.6.73 2017-01 N07XX Other nervous system drugs Övriga medel med verkan på nervsystemet 2.16.840.1.113883.6.73 2017-01 N07XX01 tirilazad Tirilazad 2.16.840.1.113883.6.73 2017-01 N07XX02 Riluzol 2.16.840.1.113883.6.73 2017-01 N07XX03 xaliproden Xaliproden 2.16.840.1.113883.6.73 2017-01 N07XX04 sodium oxybate Natriumoxibat 2.16.840.1.113883.6.73 2017-01 N07XX05 Amifampridin 2.16.840.1.113883.6.73 2017-01 N07XX06 Tetrabenazin 2.16.840.1.113883.6.73 2017-01 N07XX07 fampridine Fampridin 2.16.840.1.113883.6.73 2017-01 N07XX08 tafamidis Tafamidis 2.16.840.1.113883.6.73 2017-01 N07XX09 Dimetylfumarat 2.16.840.1.113883.6.73 2017-01 N07XX10 Lakinimod 2.16.840.1.113883.6.73 2017-01 N07XX11 Pitolisant 2.16.840.1.113883.6.73 2017-01 N07XX59 , combinations Dextrometorfan, kombinationer 2.16.840.1.113883.6.73 2017-01 P PRODUCTS, Antiparasitära, insektsdödande och AND REPELLENTS repellerande medel 2.16.840.1.113883.6.73 2017-01 P01 Medel mot protozoer 2.16.840.1.113883.6.73 2017-01 P01A AGENTS AGAINST Medel mot protozoer AND OTHER PROTOZOAL DISEASES 2.16.840.1.113883.6.73 2017-01 P01AA Hydroxyquinoline derivatives Hydroxikinolinderivat 2.16.840.1.113883.6.73 2017-01 P01AA01 broxyquinoline Broxikinolin 2.16.840.1.113883.6.73 2017-01 P01AA02 clioquinol Kliokinol 2.16.840.1.113883.6.73 2017-01 P01AA04 chlorquinaldol Klorkinaldol 2.16.840.1.113883.6.73 2017-01 P01AA05 Tilbrokinol 2.16.840.1.113883.6.73 2017-01 P01AA52 clioquinol, combinations Kliokinol, kombinationer 2.16.840.1.113883.6.73 2017-01 P01AB derivatives Nitroimidazolderivat 2.16.840.1.113883.6.73 2017-01 P01AB01 metronidazole Metronidazol 2.16.840.1.113883.6.73 2017-01 P01AB02 tinidazole Tinidazol 2.16.840.1.113883.6.73 2017-01 P01AB03 ornidazole Ornidazol 2.16.840.1.113883.6.73 2017-01 P01AB04 azanidazole Azanidazol 2.16.840.1.113883.6.73 2017-01 P01AB05 propenidazole Propenidazol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 130 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P01AB06 Nimorazol 2.16.840.1.113883.6.73 2017-01 P01AB07 secnidazole Seknidazol 2.16.840.1.113883.6.73 2017-01 P01AB51 metronidazole, combinations Metronidazol, kombinationer 2.16.840.1.113883.6.73 2017-01 P01AC derivatives Dikloracetamid derivat 2.16.840.1.113883.6.73 2017-01 P01AC01 Diloxanid 2.16.840.1.113883.6.73 2017-01 P01AC02 Klefamid 2.16.840.1.113883.6.73 2017-01 P01AC03 Etofamid 2.16.840.1.113883.6.73 2017-01 P01AC04 Teklozan 2.16.840.1.113883.6.73 2017-01 P01AR Arsenic compounds Arsenikföreningar 2.16.840.1.113883.6.73 2017-01 P01AR01 Arstinol 2.16.840.1.113883.6.73 2017-01 P01AR02 Difetarson 2.16.840.1.113883.6.73 2017-01 P01AR03 Glykobiarsol 2.16.840.1.113883.6.73 2017-01 P01AR53 glycobiarsol, combinations Glykobiarsol, kombinationer 2.16.840.1.113883.6.73 2017-01 P01AX Other agents against amoebiasis Övriga medel mot protozoer and other protozoal diseases 2.16.840.1.113883.6.73 2017-01 P01AX01 Kiniofon 2.16.840.1.113883.6.73 2017-01 P01AX02 Emetin 2.16.840.1.113883.6.73 2017-01 P01AX04 Fankinon 2.16.840.1.113883.6.73 2017-01 P01AX05 Mepakrin 2.16.840.1.113883.6.73 2017-01 P01AX06 Atovakvon 2.16.840.1.113883.6.73 2017-01 P01AX07 Trimetrexat 2.16.840.1.113883.6.73 2017-01 P01AX08 Tenonitrozol 2.16.840.1.113883.6.73 2017-01 P01AX09 Dihydroemetin 2.16.840.1.113883.6.73 2017-01 P01AX10 Fumagillin 2.16.840.1.113883.6.73 2017-01 P01AX11 Nitazoxanid 2.16.840.1.113883.6.73 2017-01 P01AX52 emetine, combinations Emetin, kombinationer 2.16.840.1.113883.6.73 2017-01 P01B ANTIMALARIALS Malariamedel 2.16.840.1.113883.6.73 2017-01 P01BA Aminoquinolines Aminokinoliner 2.16.840.1.113883.6.73 2017-01 P01BA01 Klorokin 2.16.840.1.113883.6.73 2017-01 P01BA02 Hydroxiklorokin 2.16.840.1.113883.6.73 2017-01 P01BA03 Primakin 2.16.840.1.113883.6.73 2017-01 P01BA06 Amodiakin 2.16.840.1.113883.6.73 2017-01 P01BB Biguanides Biguanider 2.16.840.1.113883.6.73 2017-01 P01BB01 Proguanil 2.16.840.1.113883.6.73 2017-01 P01BB02 embonate Cykloguanilembonat 2.16.840.1.113883.6.73 2017-01 P01BB51 proguanil, combinations Proguanil, kombinationer 2.16.840.1.113883.6.73 2017-01 P01BC Methanolquinolines Metanolkinoliner 2.16.840.1.113883.6.73 2017-01 P01BC01 quinine Kinin 2.16.840.1.113883.6.73 2017-01 P01BC02 Meflokin 2.16.840.1.113883.6.73 2017-01 P01BD Diaminopyrimidines Diaminopyrimidiner 2.16.840.1.113883.6.73 2017-01 P01BD01 Pyrimetamin 2.16.840.1.113883.6.73 2017-01 P01BD51 pyrimethamine, combinations Pyrimetamin, kombinationer 2.16.840.1.113883.6.73 2017-01 P01BE and derivatives, plain Artemisinin och derivat

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 131 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P01BE01 artemisinin Artemisinin 2.16.840.1.113883.6.73 2017-01 P01BE02 Artemeter 2.16.840.1.113883.6.73 2017-01 P01BE03 Artesunat 2.16.840.1.113883.6.73 2017-01 P01BE04 Artemotil 2.16.840.1.113883.6.73 2017-01 P01BE05 artenimol Artenimol 2.16.840.1.113883.6.73 2017-01 P01BF Artemisinin and derivatives, Artemisinin och derivat, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 P01BF01 artemether and Artemeter och lumefantrin 2.16.840.1.113883.6.73 2017-01 P01BF02 artesunate and mefloquine Artesunat och meflokin 2.16.840.1.113883.6.73 2017-01 P01BF03 artesunate and amodiaquine Artesunat och amodiakin 2.16.840.1.113883.6.73 2017-01 P01BF04 artesunate, sulphamethopyrazine Artesunat, sulfametopyrazin och and pyrimethamine pyrimetamin 2.16.840.1.113883.6.73 2017-01 P01BF05 artenimol and Artenimol och piperakin 2.16.840.1.113883.6.73 2017-01 P01BF06 artesunate and Artesunat och pyronaridin 2.16.840.1.113883.6.73 2017-01 P01BX Other antimalarials Övriga malariamedel 2.16.840.1.113883.6.73 2017-01 P01BX01 Halofantrin 2.16.840.1.113883.6.73 2017-01 P01BX02 and piperaquine Arterolan och piperakin 2.16.840.1.113883.6.73 2017-01 P01C AGENTS AGAINST Medel mot leishmaniasis och LEISHMANIASIS AND trypanosomiasis TRYPANOSOMIASIS 2.16.840.1.113883.6.73 2017-01 P01CA Nitroimidazole derivatives Nitroimidazolderivat 2.16.840.1.113883.6.73 2017-01 P01CA02 benznidazole Bensnidazol 2.16.840.1.113883.6.73 2017-01 P01CB compounds Antimonföreningar 2.16.840.1.113883.6.73 2017-01 P01CB01 antimonate Meglumin 2.16.840.1.113883.6.73 2017-01 P01CB02 sodium stibogluconate Natrium stiboglukonat 2.16.840.1.113883.6.73 2017-01 P01CC Nitrofuran derivatives Nitrofuranderivat 2.16.840.1.113883.6.73 2017-01 P01CC01 nifurtimox Nifurtimox 2.16.840.1.113883.6.73 2017-01 P01CC02 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 P01CD Arsenic compounds Arsenikföreningar 2.16.840.1.113883.6.73 2017-01 P01CD01 melarsoprol Melarsoprol 2.16.840.1.113883.6.73 2017-01 P01CD02 acetarsol Acetarsol 2.16.840.1.113883.6.73 2017-01 P01CX Other agents against leishmaniasis Övriga medel mot leishmaniasis och and trypanosomiasis trypanosomiasis 2.16.840.1.113883.6.73 2017-01 P01CX01 isethionate Pentamidin 2.16.840.1.113883.6.73 2017-01 P01CX02 sodium Suraminnatrium 2.16.840.1.113883.6.73 2017-01 P01CX03 eflornithine Eflornitin 2.16.840.1.113883.6.73 2017-01 P02 Medel vid maskinfektion 2.16.840.1.113883.6.73 2017-01 P02B ANTITREMATODALS Medel mot trematoder 2.16.840.1.113883.6.73 2017-01 P02BA Quinoline derivatives and related Kinolinderivat och närbesläktade substances substanser 2.16.840.1.113883.6.73 2017-01 P02BA01 praziquantel Prazikvantel 2.16.840.1.113883.6.73 2017-01 P02BA02 oxamniquine Oxamnikin 2.16.840.1.113883.6.73 2017-01 P02BB Organophosphorous compounds Organiska fosforföreningar 2.16.840.1.113883.6.73 2017-01 P02BB01 Metrifonat 2.16.840.1.113883.6.73 2017-01 P02BX Other antitrematodal agents Övriga medel mot trematoder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 132 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P02BX01 bithionol Bitionol 2.16.840.1.113883.6.73 2017-01 P02BX02 niridazole Niridazol 2.16.840.1.113883.6.73 2017-01 P02BX03 stibophen Stibofen 2.16.840.1.113883.6.73 2017-01 P02BX04 triclabendazole Triklabendazol 2.16.840.1.113883.6.73 2017-01 P02C ANTINEMATODAL AGENTS Medel mot nematoder 2.16.840.1.113883.6.73 2017-01 P02CA derivatives Bensimidazolderivat 2.16.840.1.113883.6.73 2017-01 P02CA01 mebendazole Mebendazol 2.16.840.1.113883.6.73 2017-01 P02CA02 tiabendazole Tiabendazol 2.16.840.1.113883.6.73 2017-01 P02CA03 albendazole Albendazol 2.16.840.1.113883.6.73 2017-01 P02CA04 ciclobendazole Ciclobendazol 2.16.840.1.113883.6.73 2017-01 P02CA05 flubendazole Flubendazol 2.16.840.1.113883.6.73 2017-01 P02CA06 fenbendazole Fenbendazol 2.16.840.1.113883.6.73 2017-01 P02CA51 mebendazole, combinations Mebendazol, kombinationer 2.16.840.1.113883.6.73 2017-01 P02CB Piperazine and derivatives Piperazin och derivat 2.16.840.1.113883.6.73 2017-01 P02CB01 piperazine Piperazin 2.16.840.1.113883.6.73 2017-01 P02CB02 diethylcarbamazine Dietylkarbamazin 2.16.840.1.113883.6.73 2017-01 P02CC Tetrahydropyrimidine derivatives Tetrahydropyrimidinderivat 2.16.840.1.113883.6.73 2017-01 P02CC01 Pyrantel 2.16.840.1.113883.6.73 2017-01 P02CC02 oxantel Oxantel 2.16.840.1.113883.6.73 2017-01 P02CE Imidazothiazole derivatives Imidazotiazolderivat 2.16.840.1.113883.6.73 2017-01 P02CE01 Levamisol 2.16.840.1.113883.6.73 2017-01 P02CF Avermectines Avermektiner 2.16.840.1.113883.6.73 2017-01 P02CF01 ivermectin Ivermektin 2.16.840.1.113883.6.73 2017-01 P02CX Other antinematodals Övriga medel mot nematoder 2.16.840.1.113883.6.73 2017-01 P02CX01 pyrvinium Pyrvin 2.16.840.1.113883.6.73 2017-01 P02CX02 bephenium Befen 2.16.840.1.113883.6.73 2017-01 P02D ANTICESTODALS Medel mot cestoder 2.16.840.1.113883.6.73 2017-01 P02DA Salicylic acid derivatives Salicylsyraderivat 2.16.840.1.113883.6.73 2017-01 P02DA01 niclosamide Niklosamid 2.16.840.1.113883.6.73 2017-01 P02DX Other anticestodals Övriga medel mot cestoder 2.16.840.1.113883.6.73 2017-01 P02DX01 desaspidin Desaspidin 2.16.840.1.113883.6.73 2017-01 P02DX02 dichlorophen Diklorofen 2.16.840.1.113883.6.73 2017-01 P03 , INCL. Medel mot ektoparasiter, inkl. SCABICIDES, INSECTICIDES AND skabb-, insektsdödande och REPELLENTS repellerande medel 2.16.840.1.113883.6.73 2017-01 P03A ECTOPARASITICIDES, INCL. Medel mot ektoparasiter, inkl. SCABICIDES skabbmedel 2.16.840.1.113883.6.73 2017-01 P03AA Sulfur containing products Svavelhaltiga preparat 2.16.840.1.113883.6.73 2017-01 P03AA01 Dixantogen 2.16.840.1.113883.6.73 2017-01 P03AA02 potassium polysulfide Kaliumpolysulfid 2.16.840.1.113883.6.73 2017-01 P03AA03 mesulfen Mesulfen 2.16.840.1.113883.6.73 2017-01 P03AA04 disulfiram Disulfiram 2.16.840.1.113883.6.73 2017-01 P03AA05 Tiram 2.16.840.1.113883.6.73 2017-01 P03AA54 disulfiram, combinations Disulfiram, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 133 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P03AB containing products Klorhaltiga preparat 2.16.840.1.113883.6.73 2017-01 P03AB01 clofenotane Klofenotan 2.16.840.1.113883.6.73 2017-01 P03AB02 Lindan 2.16.840.1.113883.6.73 2017-01 P03AB51 clofenotane, combinations Klofenotan, kombinationer 2.16.840.1.113883.6.73 2017-01 P03AC Pyrethrines, incl. synthetic Pyretriner, inkl. syntetiska föreningar compounds 2.16.840.1.113883.6.73 2017-01 P03AC01 Pyretrum 2.16.840.1.113883.6.73 2017-01 P03AC02 Bioalletrin 2.16.840.1.113883.6.73 2017-01 P03AC03 Fenotrin 2.16.840.1.113883.6.73 2017-01 P03AC04 Permetrin 2.16.840.1.113883.6.73 2017-01 P03AC51 pyrethrum, combinations Pyretrum, kombinationer 2.16.840.1.113883.6.73 2017-01 P03AC52 bioallethrin, combinations Bioalletrin, kombinationer 2.16.840.1.113883.6.73 2017-01 P03AC53 phenothrin, combinations Fenotrin, kombinationer 2.16.840.1.113883.6.73 2017-01 P03AC54 permethrin, combinations Permetrin, kombinationer 2.16.840.1.113883.6.73 2017-01 P03AX Other ectoparasiticides, incl. Övriga medel mot ektoparasiter, scabicides inkl. skabbmedel 2.16.840.1.113883.6.73 2017-01 P03AX01 Bensylbensoat 2.16.840.1.113883.6.73 2017-01 P03AX02 copper oleinate Kopparoleinat 2.16.840.1.113883.6.73 2017-01 P03AX03 Malation 2.16.840.1.113883.6.73 2017-01 P03AX04 quassia Kvassia 2.16.840.1.113883.6.73 2017-01 P03AX05 dimeticone Dimetikon 2.16.840.1.113883.6.73 2017-01 P03AX06 benzyl alcohol Bensylalkohol 2.16.840.1.113883.6.73 2017-01 P03B INSECTICIDES AND REPELLENTS Insektsdödande och repellerande medel 2.16.840.1.113883.6.73 2017-01 P03BA Pyrethrines Pyretriner 2.16.840.1.113883.6.73 2017-01 P03BA01 Cyflutrin 2.16.840.1.113883.6.73 2017-01 P03BA02 Cypermetrin 2.16.840.1.113883.6.73 2017-01 P03BA03 decamethrin Dekametrin 2.16.840.1.113883.6.73 2017-01 P03BA04 Tetrametrin 2.16.840.1.113883.6.73 2017-01 P03BX Other insecticides and repellents Övriga insektsdödande och repellerande medel 2.16.840.1.113883.6.73 2017-01 P03BX01 diethyltoluamide Dietyltoluamid 2.16.840.1.113883.6.73 2017-01 P03BX02 dimethylphthalate Dimetylftalat 2.16.840.1.113883.6.73 2017-01 P03BX03 dibutylphthalate Dibutylftalat 2.16.840.1.113883.6.73 2017-01 P03BX04 dibutylsuccinate Dibutylsuccinat 2.16.840.1.113883.6.73 2017-01 P03BX05 dimethylcarbate Dimetylkarbat 2.16.840.1.113883.6.73 2017-01 P03BX06 etohexadiol Etohexadiol 2.16.840.1.113883.6.73 2017-01 R RESPIRATORY SYSTEM Andningsorgan 2.16.840.1.113883.6.73 2017-01 R01 NASAL PREPARATIONS Medel vid nässjukdomar 2.16.840.1.113883.6.73 2017-01 R01A AND OTHER Avsvällande och övriga medel för NASAL PREPARATIONS FOR lokal behandling vid nässjukdomar TOPICAL USE 2.16.840.1.113883.6.73 2017-01 R01AA Sympathomimetics, plain Sympatomimetika 2.16.840.1.113883.6.73 2017-01 R01AA02 Cyklopentamin 2.16.840.1.113883.6.73 2017-01 R01AA03 ephedrine Efedrin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 134 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R01AA04 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 R01AA05 Oximetazolin 2.16.840.1.113883.6.73 2017-01 R01AA06 Tetryzolin 2.16.840.1.113883.6.73 2017-01 R01AA07 Xylometazolin 2.16.840.1.113883.6.73 2017-01 R01AA08 Nafazolin 2.16.840.1.113883.6.73 2017-01 R01AA09 Tramazolin 2.16.840.1.113883.6.73 2017-01 R01AA10 Metizolin 2.16.840.1.113883.6.73 2017-01 R01AA11 Tuaminoheptan 2.16.840.1.113883.6.73 2017-01 R01AA12 Fenoxazolin 2.16.840.1.113883.6.73 2017-01 R01AA13 Tymazolin 2.16.840.1.113883.6.73 2017-01 R01AA14 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 R01AA15 indanazoline Indanazolin 2.16.840.1.113883.6.73 2017-01 R01AB Sympathomimetics, combinations Sympatomimetika, kombinationer excl. corticosteroids exkl. kortikosteroider 2.16.840.1.113883.6.73 2017-01 R01AB01 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 R01AB02 naphazoline Nafazolin 2.16.840.1.113883.6.73 2017-01 R01AB03 tetryzoline Tetryzolin 2.16.840.1.113883.6.73 2017-01 R01AB05 ephedrine Efedrin 2.16.840.1.113883.6.73 2017-01 R01AB06 xylometazoline Xylometazolin 2.16.840.1.113883.6.73 2017-01 R01AB07 oxymetazoline Oximetazolin 2.16.840.1.113883.6.73 2017-01 R01AB08 tuaminoheptane Tuaminoheptan 2.16.840.1.113883.6.73 2017-01 R01AC Antiallergic agents, excl. Antiallergika, exkl. kortikosteroider corticosteroids 2.16.840.1.113883.6.73 2017-01 R01AC01 cromoglicic acid Natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 R01AC02 Levokabastin 2.16.840.1.113883.6.73 2017-01 R01AC03 Azelastin 2.16.840.1.113883.6.73 2017-01 R01AC04 Antazolin 2.16.840.1.113883.6.73 2017-01 R01AC05 spaglumic acid Spagluminsyra 2.16.840.1.113883.6.73 2017-01 R01AC06 thonzylamine Tonzylamin 2.16.840.1.113883.6.73 2017-01 R01AC07 Nedokromil 2.16.840.1.113883.6.73 2017-01 R01AC08 Olopatadin 2.16.840.1.113883.6.73 2017-01 R01AC51 cromoglicic acid, combinations Natriumkromoglikat, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AD Corticosteroids Kortikosteroider 2.16.840.1.113883.6.73 2017-01 R01AD01 beclometasone Beklometason 2.16.840.1.113883.6.73 2017-01 R01AD02 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 R01AD03 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 R01AD04 Flunisolid 2.16.840.1.113883.6.73 2017-01 R01AD05 budesonide Budesonid 2.16.840.1.113883.6.73 2017-01 R01AD06 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 R01AD07 tixocortol Tixokortol 2.16.840.1.113883.6.73 2017-01 R01AD08 fluticasone Flutikason 2.16.840.1.113883.6.73 2017-01 R01AD09 mometasone Mometason 2.16.840.1.113883.6.73 2017-01 R01AD11 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 R01AD12 Flutikasonfuroat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 135 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R01AD13 Ciklesonid 2.16.840.1.113883.6.73 2017-01 R01AD52 prednisolone, combinations Prednisolon, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AD53 dexamethasone, combinations Dexametason, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AD57 tixocortol, combinations Tixokortol, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AD58 fluticasone, combinations Flutikason, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AD60 hydrocortisone, combinations Hydrokortison, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AX Other nasal preparations Övriga medel vid nässjukdomar 2.16.840.1.113883.6.73 2017-01 R01AX01 calcium hexamine thiocyanate Kalciumhexamintiocyanat 2.16.840.1.113883.6.73 2017-01 R01AX02 retinol Retinol (vitamin A) 2.16.840.1.113883.6.73 2017-01 R01AX03 Ipratropiumbromid 2.16.840.1.113883.6.73 2017-01 R01AX05 Ritiometan 2.16.840.1.113883.6.73 2017-01 R01AX06 mupirocin Mupirocin 2.16.840.1.113883.6.73 2017-01 R01AX07 hexamidine Hexamidin 2.16.840.1.113883.6.73 2017-01 R01AX08 framycetin Framycetin 2.16.840.1.113883.6.73 2017-01 R01AX09 hyaluronic acid Hyaluronsyra 2.16.840.1.113883.6.73 2017-01 R01AX10 various Övrigt 2.16.840.1.113883.6.73 2017-01 R01AX30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R01B NASAL DECONGESTANTS FOR Avsvällande medel, perorala SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 R01BA Sympathomimetics Sympatomimetika 2.16.840.1.113883.6.73 2017-01 R01BA01 Fenylpropanolamin 2.16.840.1.113883.6.73 2017-01 R01BA02 Pseudoefedrin 2.16.840.1.113883.6.73 2017-01 R01BA03 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 R01BA51 phenylpropanolamine, combinations Fenylpropanolamin, kombinationer 2.16.840.1.113883.6.73 2017-01 R01BA52 pseudoephedrine, combinations Pseudoefedrin, kombinationer 2.16.840.1.113883.6.73 2017-01 R01BA53 phenylephrine, combinations Fenylefrin, kombinationer 2.16.840.1.113883.6.73 2017-01 R02 THROAT PREPARATIONS Medel vid sjukdomar i strupe och svalg 2.16.840.1.113883.6.73 2017-01 R02A THROAT PREPARATIONS Medel vid sjukdomar i strupe och svalg 2.16.840.1.113883.6.73 2017-01 R02AA Antiseptics Antiseptika 2.16.840.1.113883.6.73 2017-01 R02AA01 Ambazon 2.16.840.1.113883.6.73 2017-01 R02AA02 dequalinium Dekvalinium 2.16.840.1.113883.6.73 2017-01 R02AA03 dichlorobenzyl alcohol 2,4-Diklorobensylalkohol 2.16.840.1.113883.6.73 2017-01 R02AA05 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 R02AA06 cetylpyridinium Cetylpyridinium 2.16.840.1.113883.6.73 2017-01 R02AA09 benzethonium Bensetonium 2.16.840.1.113883.6.73 2017-01 R02AA10 myristyl-benzalkonium Myristylbensalkon 2.16.840.1.113883.6.73 2017-01 R02AA11 chlorquinaldol Klorkinaldol 2.16.840.1.113883.6.73 2017-01 R02AA12 Hexylresorcinol 2.16.840.1.113883.6.73 2017-01 R02AA13 acriflavinium chloride Akriflaviniumklorid 2.16.840.1.113883.6.73 2017-01 R02AA14 oxyquinoline Hydroxikinolin 2.16.840.1.113883.6.73 2017-01 R02AA15 povidone-iodine Povidon, joderad 2.16.840.1.113883.6.73 2017-01 R02AA16 benzalkonium Bensalkonium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 136 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R02AA17 cetrimonium Cetrimonium 2.16.840.1.113883.6.73 2017-01 R02AA18 hexamidine Hexamidin 2.16.840.1.113883.6.73 2017-01 R02AA19 phenol Fenol 2.16.840.1.113883.6.73 2017-01 R02AA20 various Övrigt 2.16.840.1.113883.6.73 2017-01 R02AA21 octenidine Oktenidin 2.16.840.1.113883.6.73 2017-01 R02AB Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 R02AB01 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 R02AB02 tyrothricin Tyrotricin 2.16.840.1.113883.6.73 2017-01 R02AB03 Fusafungin 2.16.840.1.113883.6.73 2017-01 R02AB04 bacitracin Bacitracin 2.16.840.1.113883.6.73 2017-01 R02AB30 Gramicidin 2.16.840.1.113883.6.73 2017-01 R02AD Anesthetics, local Lokalanestetika 2.16.840.1.113883.6.73 2017-01 R02AD01 benzocaine Bensokain 2.16.840.1.113883.6.73 2017-01 R02AD02 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 R02AD03 cocaine Kokain 2.16.840.1.113883.6.73 2017-01 R02AD04 dyclonine Dyklonin 2.16.840.1.113883.6.73 2017-01 R02AX Other throat preparations Övriga medel vid sjukdomar i strupe och svalg 2.16.840.1.113883.6.73 2017-01 R02AX01 flurbiprofen Flurbiprofen 2.16.840.1.113883.6.73 2017-01 R02AX02 ibuprofen Ibuprofen 2.16.840.1.113883.6.73 2017-01 R03 DRUGS FOR OBSTRUCTIVE Medel vid obstruktiva AIRWAY DISEASES luftvägssjukdomar 2.16.840.1.113883.6.73 2017-01 R03A ADRENERGICS, Adrenergika, inhalationer 2.16.840.1.113883.6.73 2017-01 R03AA Alpha- and beta-adrenoreceptor Alfa- och beta- agonists adrenoreceptoragonister 2.16.840.1.113883.6.73 2017-01 R03AA01 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 R03AB Non-selective beta-adrenoreceptor Icke-selektiva beta-adrenoceptor agonists agonister 2.16.840.1.113883.6.73 2017-01 R03AB02 isoprenaline Isoprenalin 2.16.840.1.113883.6.73 2017-01 R03AB03 Orkiprenalin 2.16.840.1.113883.6.73 2017-01 R03AC Selective beta-2-adrenoreceptor Selektiva beta-2-stimulerande agonists medel 2.16.840.1.113883.6.73 2017-01 R03AC02 Salbutamol 2.16.840.1.113883.6.73 2017-01 R03AC03 Terbutalin 2.16.840.1.113883.6.73 2017-01 R03AC04 fenoterol Fenoterol 2.16.840.1.113883.6.73 2017-01 R03AC05 Rimiterol 2.16.840.1.113883.6.73 2017-01 R03AC06 Hexoprenalin 2.16.840.1.113883.6.73 2017-01 R03AC07 Isoetarin 2.16.840.1.113883.6.73 2017-01 R03AC08 Pirbuterol 2.16.840.1.113883.6.73 2017-01 R03AC09 Tretokinol 2.16.840.1.113883.6.73 2017-01 R03AC10 Karbuterol 2.16.840.1.113883.6.73 2017-01 R03AC11 Tulobuterol 2.16.840.1.113883.6.73 2017-01 R03AC12 Salmeterol 2.16.840.1.113883.6.73 2017-01 R03AC13 Formoterol 2.16.840.1.113883.6.73 2017-01 R03AC14 Klenbuterol © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 137 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03AC15 Reproterol 2.16.840.1.113883.6.73 2017-01 R03AC16 Prokaterol 2.16.840.1.113883.6.73 2017-01 R03AC17 Bitolterol 2.16.840.1.113883.6.73 2017-01 R03AC18 Indakaterol 2.16.840.1.113883.6.73 2017-01 R03AC19 Olodaterol 2.16.840.1.113883.6.73 2017-01 R03AH Combinations of adrenergics Kombinationer av adrenergika 2.16.840.1.113883.6.73 2017-01 R03AK Adrenergics in combination with Adrenergika i kombination med corticosteroids or other drugs, excl. kortikosteroider eller övriga medel, anticholinergics exkl. antikolinergika 2.16.840.1.113883.6.73 2017-01 R03AK01 epinephrine and other drugs for Adrenalin och övriga medel vid obstructive airway diseases obstruktiva luftvägssjukdomar 2.16.840.1.113883.6.73 2017-01 R03AK02 isoprenaline and other drugs for Isoprenalin och övriga medel vid obstructive airway diseases obstruktiva luftvägssjukdomar 2.16.840.1.113883.6.73 2017-01 R03AK04 salbutamol and sodium Salbutamol och natriumkromoglikat cromoglicate 2.16.840.1.113883.6.73 2017-01 R03AK05 reproterol and sodium cromoglicate Reproterol och natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 R03AK06 salmeterol and fluticasone Salmeterol och flutikason 2.16.840.1.113883.6.73 2017-01 R03AK07 formoterol and budesonide Formoterol och budesonid 2.16.840.1.113883.6.73 2017-01 R03AK08 formoterol and beclometasone Formoterol och beklometason 2.16.840.1.113883.6.73 2017-01 R03AK09 formoterol and mometasone Formoterol och mometason 2.16.840.1.113883.6.73 2017-01 R03AK10 and fluticasone furoate Vilanterol och flutikasonfuroat 2.16.840.1.113883.6.73 2017-01 R03AK11 formoterol and fluticasone Formoterol och flutikason 2.16.840.1.113883.6.73 2017-01 R03AK12 salmeterol and budesonide Salmeterol och budesonid 2.16.840.1.113883.6.73 2017-01 R03AK13 salbutamol and beclometasone Salbutamol och beklometason 2.16.840.1.113883.6.73 2017-01 R03AL Adrenergics in combination with Adrenergika i kombination med anticholinergics antikolinergika inkl. trippelkombinationer med kortikosteroider 2.16.840.1.113883.6.73 2017-01 R03AL01 fenoterol and ipratropium bromide Fenoterol och ipratropiumbromid 2.16.840.1.113883.6.73 2017-01 R03AL02 salbutamol and ipratropium bromide Salbutamol och ipratropiumbromid 2.16.840.1.113883.6.73 2017-01 R03AL03 vilanterol and Vilanterol och umeklidiniumbromid 2.16.840.1.113883.6.73 2017-01 R03AL04 indacaterol and glycopyrronium Indakaterol och bromide glykopyrroniumbromid 2.16.840.1.113883.6.73 2017-01 R03AL05 formoterol and Formoterol och aklidiniumbromid 2.16.840.1.113883.6.73 2017-01 R03AL06 olodaterol and Olodaterol och tiotropiumbromid 2.16.840.1.113883.6.73 2017-01 R03AL07 formoterol and glycopyrronium Formoterol och bromide glykopyrroniumbromid 2.16.840.1.113883.6.73 2017-01 R03B OTHER DRUGS FOR Övriga medel vid obstruktiva OBSTRUCTIVE AIRWAY luftvägssjukdomar, inhalationer DISEASES, INHALANTS 2.16.840.1.113883.6.73 2017-01 R03BA Glucocorticoids Glukokortikoider 2.16.840.1.113883.6.73 2017-01 R03BA01 beclometasone Beklometason 2.16.840.1.113883.6.73 2017-01 R03BA02 budesonide Budesonid 2.16.840.1.113883.6.73 2017-01 R03BA03 flunisolide Flunisolid 2.16.840.1.113883.6.73 2017-01 R03BA04 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 R03BA05 fluticasone Flutikason 2.16.840.1.113883.6.73 2017-01 R03BA06 triamcinolone Triamcinolon

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 138 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03BA07 mometasone Mometason 2.16.840.1.113883.6.73 2017-01 R03BA08 ciclesonide Ciklesonid 2.16.840.1.113883.6.73 2017-01 R03BA09 fluticasone furoate Flutikasonfuroat 2.16.840.1.113883.6.73 2017-01 R03BB Anticholinergics Antikolinergika 2.16.840.1.113883.6.73 2017-01 R03BB01 ipratropium bromide Ipratropiumbromid 2.16.840.1.113883.6.73 2017-01 R03BB02 Oxitropiumbromid 2.16.840.1.113883.6.73 2017-01 R03BB03 stramoni preparations Stramonimedel 2.16.840.1.113883.6.73 2017-01 R03BB04 tiotropium bromide Tiotropiumbromid 2.16.840.1.113883.6.73 2017-01 R03BB05 aclidinium bromide Aklidiniumbromid 2.16.840.1.113883.6.73 2017-01 R03BB06 glycopyrronium bromide Glykopyrroniumbromid 2.16.840.1.113883.6.73 2017-01 R03BB07 umeclidinium bromide Umeklidiniumbromid 2.16.840.1.113883.6.73 2017-01 R03BB54 tiotropium bromide, combinations Tiotropiumbromid, kombinationer 2.16.840.1.113883.6.73 2017-01 R03BC Antiallergic agents, excl. Antiallergika, exkl. kortikosteroider corticosteroids 2.16.840.1.113883.6.73 2017-01 R03BC01 cromoglicic acid Natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 R03BC03 nedocromil Nedokromil 2.16.840.1.113883.6.73 2017-01 R03BX Other drugs for obstructive airway Övriga medel vid obstruktiva diseases, inhalants luftvägssjukdomar, inhalationer 2.16.840.1.113883.6.73 2017-01 R03BX01 Fenspirid 2.16.840.1.113883.6.73 2017-01 R03C ADRENERGICS FOR SYSTEMIC Adrenergika för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 R03CA Alpha- and beta-adrenoreceptor Alfa- och beta- agonists adrenoreceptoragonister 2.16.840.1.113883.6.73 2017-01 R03CA02 ephedrine Efedrin 2.16.840.1.113883.6.73 2017-01 R03CB Non-selective beta-adrenoreceptor Icke-selektiva beta-adrenoceptor agonists agonister 2.16.840.1.113883.6.73 2017-01 R03CB01 isoprenaline Isoprenalin 2.16.840.1.113883.6.73 2017-01 R03CB02 Metoxifenamin 2.16.840.1.113883.6.73 2017-01 R03CB03 orciprenaline Orkiprenalin 2.16.840.1.113883.6.73 2017-01 R03CB51 isoprenaline, combinations Isoprenalin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03CB53 orciprenaline, combinations Orkiprenalin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03CC Selective beta-2-adrenoreceptor Selektiva beta-2-stimulerande agonists medel 2.16.840.1.113883.6.73 2017-01 R03CC02 salbutamol Salbutamol 2.16.840.1.113883.6.73 2017-01 R03CC03 terbutaline Terbutalin 2.16.840.1.113883.6.73 2017-01 R03CC04 fenoterol Fenoterol 2.16.840.1.113883.6.73 2017-01 R03CC05 hexoprenaline Hexoprenalin 2.16.840.1.113883.6.73 2017-01 R03CC06 isoetarine Isoetarin 2.16.840.1.113883.6.73 2017-01 R03CC07 pirbuterol Pirbuterol 2.16.840.1.113883.6.73 2017-01 R03CC08 procaterol Prokaterol 2.16.840.1.113883.6.73 2017-01 R03CC09 tretoquinol Tretokinol 2.16.840.1.113883.6.73 2017-01 R03CC10 carbuterol Karbuterol 2.16.840.1.113883.6.73 2017-01 R03CC11 tulobuterol Tulobuterol 2.16.840.1.113883.6.73 2017-01 R03CC12 Bambuterol 2.16.840.1.113883.6.73 2017-01 R03CC13 clenbuterol Klenbuterol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 139 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03CC14 reproterol Reproterol 2.16.840.1.113883.6.73 2017-01 R03CC53 terbutaline, combinations Terbutalin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03CK Adrenergics and other drugs for Adrenergika och andra medel vid obstructive airway diseases obstruktiva luftvägssjukdomar 2.16.840.1.113883.6.73 2017-01 R03D OTHER SYSTEMIC DRUGS FOR Övriga systemiska medel för OBSTRUCTIVE AIRWAY obstruktiva lungsjukdomar DISEASES 2.16.840.1.113883.6.73 2017-01 R03DA Xantiner 2.16.840.1.113883.6.73 2017-01 R03DA01 Diprofyllin 2.16.840.1.113883.6.73 2017-01 R03DA02 Kolinteofyllinat 2.16.840.1.113883.6.73 2017-01 R03DA03 Proxifyllin 2.16.840.1.113883.6.73 2017-01 R03DA04 Teofyllin 2.16.840.1.113883.6.73 2017-01 R03DA05 Aminofyllin 2.16.840.1.113883.6.73 2017-01 R03DA06 Etamifyllin 2.16.840.1.113883.6.73 2017-01 R03DA07 theobromine Teobromin 2.16.840.1.113883.6.73 2017-01 R03DA08 Bamifyllin 2.16.840.1.113883.6.73 2017-01 R03DA09 piperazine Acefyllinpiperazin 2.16.840.1.113883.6.73 2017-01 R03DA10 bufylline Bufyllin 2.16.840.1.113883.6.73 2017-01 R03DA11 Doxofyllin 2.16.840.1.113883.6.73 2017-01 R03DA20 combinations of xanthines Kombinationer av xantinderivat 2.16.840.1.113883.6.73 2017-01 R03DA51 diprophylline, combinations Diprofyllin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03DA54 theophylline, combinations excl. Teofyllin, kombinationer, exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 R03DA55 aminophylline, combinations Aminofyllin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03DA57 theobromine, combinations Teobromin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03DA74 theophylline, combinations with Teofyllin, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 R03DB Xanthines and adrenergics Xantiner och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DB01 diprophylline and adrenergics Diprofyllin och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DB02 choline theophyllinate and Kolinteofyllinat och adrenergika adrenergics 2.16.840.1.113883.6.73 2017-01 R03DB03 proxyphylline and adrenergics Proxyfyllin och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DB04 theophylline and adrenergics Teofyllin och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DB05 aminophylline and adrenergics Aminofyllin och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DB06 etamiphylline and adrenergics Etamifyllin och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DC receptor antagonists Leukotrienreceptorantagonister 2.16.840.1.113883.6.73 2017-01 R03DC01 Zafirlukast 2.16.840.1.113883.6.73 2017-01 R03DC02 Pranlukast 2.16.840.1.113883.6.73 2017-01 R03DC03 Montelukast 2.16.840.1.113883.6.73 2017-01 R03DC04 Ibudilast 2.16.840.1.113883.6.73 2017-01 R03DC53 montelukast, combinations Montelukast, kombinationer 2.16.840.1.113883.6.73 2017-01 R03DX Other systemic drugs for obstructive Övriga systemiska medel för airway diseases obstruktiva lungsjukdomar 2.16.840.1.113883.6.73 2017-01 R03DX01 amlexanox Amlexanox 2.16.840.1.113883.6.73 2017-01 R03DX02 Eprozinol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 140 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03DX03 fenspiride Fenspirid 2.16.840.1.113883.6.73 2017-01 R03DX05 Omalizumab 2.16.840.1.113883.6.73 2017-01 R03DX06 Seratrodast 2.16.840.1.113883.6.73 2017-01 R03DX07 Roflumilast 2.16.840.1.113883.6.73 2017-01 R03DX08 Reslizumab 2.16.840.1.113883.6.73 2017-01 R03DX09 Mepolizumab 2.16.840.1.113883.6.73 2017-01 R05 COUGH AND COLD Medel mot hosta och förkylning PREPARATIONS 2.16.840.1.113883.6.73 2017-01 R05C EXPECTORANTS, EXCL. Expektorantia, exkl. kombinationer COMBINATIONS WITH COUGH med hostdämpande medel SUPPRESSANTS 2.16.840.1.113883.6.73 2017-01 R05CA Expectorants Expektorantia, exkl. mukolytika 2.16.840.1.113883.6.73 2017-01 R05CA01 Tyloxapol 2.16.840.1.113883.6.73 2017-01 R05CA02 Kaliumjodid 2.16.840.1.113883.6.73 2017-01 R05CA03 Guajfenesin 2.16.840.1.113883.6.73 2017-01 R05CA04 ipecacuanha Ipekakuanharot 2.16.840.1.113883.6.73 2017-01 R05CA05 althea root Altearot 2.16.840.1.113883.6.73 2017-01 R05CA06 senega Senega 2.16.840.1.113883.6.73 2017-01 R05CA07 Antimonpentasulfid 2.16.840.1.113883.6.73 2017-01 R05CA08 creosote Kreosot 2.16.840.1.113883.6.73 2017-01 R05CA09 Guajakolsulfonat 2.16.840.1.113883.6.73 2017-01 R05CA10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R05CA11 levoverbenone Levoverbenon 2.16.840.1.113883.6.73 2017-01 R05CA12 Hederae helicis folium Murgröna, blad 2.16.840.1.113883.6.73 2017-01 R05CA13 cineole Cineol 2.16.840.1.113883.6.73 2017-01 R05CB Mucolytics Mukolytika 2.16.840.1.113883.6.73 2017-01 R05CB01 Acetylcystein 2.16.840.1.113883.6.73 2017-01 R05CB02 Bromhexin 2.16.840.1.113883.6.73 2017-01 R05CB03 Karbocystein 2.16.840.1.113883.6.73 2017-01 R05CB04 Eprazinon 2.16.840.1.113883.6.73 2017-01 R05CB05 Mesna 2.16.840.1.113883.6.73 2017-01 R05CB06 Ambroxol 2.16.840.1.113883.6.73 2017-01 R05CB07 Sobrerol 2.16.840.1.113883.6.73 2017-01 R05CB08 Domiodol 2.16.840.1.113883.6.73 2017-01 R05CB09 Letostein 2.16.840.1.113883.6.73 2017-01 R05CB10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R05CB11 Stepronin 2.16.840.1.113883.6.73 2017-01 R05CB13 (desoxyribonuclease) Dornas alfa (deoxiribonukleas) 2.16.840.1.113883.6.73 2017-01 R05CB14 Neltenexin 2.16.840.1.113883.6.73 2017-01 R05CB15 Erdostein 2.16.840.1.113883.6.73 2017-01 R05CB16 mannitol Mannitol 2.16.840.1.113883.6.73 2017-01 R05D COUGH SUPPRESSANTS, EXCL. Hosthämmande medel, exkl COMBINATIONS WITH kombinationer med expektorantia EXPECTORANTS 2.16.840.1.113883.6.73 2017-01 R05DA Opium alkaloids and derivatives Opiumalkaloider och derivat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 141 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R05DA01 Etylmorfin 2.16.840.1.113883.6.73 2017-01 R05DA03 Hydrokodon 2.16.840.1.113883.6.73 2017-01 R05DA04 codeine Kodein 2.16.840.1.113883.6.73 2017-01 R05DA05 opium alkaloids with morphine Opiumalkaloider med morfin 2.16.840.1.113883.6.73 2017-01 R05DA06 Normetadon 2.16.840.1.113883.6.73 2017-01 R05DA07 Noskapin 2.16.840.1.113883.6.73 2017-01 R05DA08 Folkodin 2.16.840.1.113883.6.73 2017-01 R05DA09 dextromethorphan Dextrometorfan 2.16.840.1.113883.6.73 2017-01 R05DA10 Tebakon 2.16.840.1.113883.6.73 2017-01 R05DA11 Dimemorfan 2.16.840.1.113883.6.73 2017-01 R05DA12 Acetyldihydrokodein 2.16.840.1.113883.6.73 2017-01 R05DA20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R05DB Other cough suppressants Övriga hostdämpande medel 2.16.840.1.113883.6.73 2017-01 R05DB01 Bensonatat 2.16.840.1.113883.6.73 2017-01 R05DB02 Benproperin 2.16.840.1.113883.6.73 2017-01 R05DB03 Klobutinol 2.16.840.1.113883.6.73 2017-01 R05DB04 Isoaminil 2.16.840.1.113883.6.73 2017-01 R05DB05 Pentoxiverin 2.16.840.1.113883.6.73 2017-01 R05DB07 Oxolamin 2.16.840.1.113883.6.73 2017-01 R05DB09 Oxeladin 2.16.840.1.113883.6.73 2017-01 R05DB10 Klofedanol 2.16.840.1.113883.6.73 2017-01 R05DB11 Pipazetat 2.16.840.1.113883.6.73 2017-01 R05DB12 Bibenzoniumbromid 2.16.840.1.113883.6.73 2017-01 R05DB13 Butamirat 2.16.840.1.113883.6.73 2017-01 R05DB14 Fedrilat 2.16.840.1.113883.6.73 2017-01 R05DB15 Zipeprol 2.16.840.1.113883.6.73 2017-01 R05DB16 Dibunat 2.16.840.1.113883.6.73 2017-01 R05DB17 Droxypropin 2.16.840.1.113883.6.73 2017-01 R05DB18 Prenoxdiazin 2.16.840.1.113883.6.73 2017-01 R05DB19 Dropropizin 2.16.840.1.113883.6.73 2017-01 R05DB20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R05DB21 Kloperastin 2.16.840.1.113883.6.73 2017-01 R05DB22 Meprotixol 2.16.840.1.113883.6.73 2017-01 R05DB23 Piperidion 2.16.840.1.113883.6.73 2017-01 R05DB24 Tipepidin 2.16.840.1.113883.6.73 2017-01 R05DB25 Morklofon 2.16.840.1.113883.6.73 2017-01 R05DB26 Nepinalon 2.16.840.1.113883.6.73 2017-01 R05DB27 Levodropropizin 2.16.840.1.113883.6.73 2017-01 R05DB28 Dimetoxanat 2.16.840.1.113883.6.73 2017-01 R05F COUGH SUPPRESSANTS AND Hosthämmande medel i EXPECTORANTS, kombination med expektorantia COMBINATIONS 2.16.840.1.113883.6.73 2017-01 R05FA Opium derivatives and expectorants Opiumderivat och expektorantia 2.16.840.1.113883.6.73 2017-01 R05FA01 opium derivatives and mucolytics Opiumderivat och mukolytika © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 142 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R05FA02 opium derivatives and expectorants Opiumderivat och expektorantia 2.16.840.1.113883.6.73 2017-01 R05FB Other cough suppressants and Övriga hosthämmande medel i expectorants kombination med expektorantia 2.16.840.1.113883.6.73 2017-01 R05FB01 cough suppressants and mucolytics Hosthämmande medel och mukolytika 2.16.840.1.113883.6.73 2017-01 R05FB02 cough suppressants and Hosthämmande medel i expectorants kombination med expektorantia, exkl mukolytika 2.16.840.1.113883.6.73 2017-01 R05X OTHER COLD PREPARATIONS Övriga medel mot förkylning 2.16.840.1.113883.6.73 2017-01 R06 ANTIHISTAMINES FOR SYSTEMIC Antihistaminer för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 R06A ANTIHISTAMINES FOR SYSTEMIC Antihistaminer för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 R06AA Aminoalkyl ethers Aminoalkyletrar 2.16.840.1.113883.6.73 2017-01 R06AA01 Bromdifenhydramin 2.16.840.1.113883.6.73 2017-01 R06AA02 diphenhydramine Dimenhydrinat 2.16.840.1.113883.6.73 2017-01 R06AA04 clemastine Klemastin 2.16.840.1.113883.6.73 2017-01 R06AA06 chlorphenoxamine Klorfenoxamin 2.16.840.1.113883.6.73 2017-01 R06AA07 Difenylpyralin 2.16.840.1.113883.6.73 2017-01 R06AA08 Karbinoxamin 2.16.840.1.113883.6.73 2017-01 R06AA09 Doxylamin 2.16.840.1.113883.6.73 2017-01 R06AA10 Trimetobenzamid 2.16.840.1.113883.6.73 2017-01 R06AA52 diphenhydramine, combinations Difenhydramin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AA54 clemastine, combinations Klemastin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AA56 chlorphenoxamine, combinations Klorfenoxamin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AA57 diphenylpyraline, combinations Difenylpyralin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AA59 doxylamine, combinations Doxylamin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AB Substituted alkylamines Alkylaminer, substituerade 2.16.840.1.113883.6.73 2017-01 R06AB01 Bromfeniramin 2.16.840.1.113883.6.73 2017-01 R06AB02 Dexklorfeniramin 2.16.840.1.113883.6.73 2017-01 R06AB03 dimetindene Dimetinden 2.16.840.1.113883.6.73 2017-01 R06AB04 Klorfenamin 2.16.840.1.113883.6.73 2017-01 R06AB05 pheniramine Feniramin 2.16.840.1.113883.6.73 2017-01 R06AB06 Dexbromfeniramin 2.16.840.1.113883.6.73 2017-01 R06AB07 Talastin 2.16.840.1.113883.6.73 2017-01 R06AB51 brompheniramine, combinations Bromfeniramin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AB52 dexchlorpheniramine, combinations Dexklorfeniramin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AB54 chlorphenamine, combinations Klorfenamin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AB56 dexbrompheniramine, combinations Dexbromfeniramin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AC Substituted ethylene diamines Etylendiaminer, substituerade 2.16.840.1.113883.6.73 2017-01 R06AC01 mepyramine Mepyramin 2.16.840.1.113883.6.73 2017-01 R06AC02 Histapyrrodin 2.16.840.1.113883.6.73 2017-01 R06AC03 chloropyramine Kloropyramin 2.16.840.1.113883.6.73 2017-01 R06AC04 tripelennamine Tripelennamin 2.16.840.1.113883.6.73 2017-01 R06AC05 Metapyrilen

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 143 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R06AC06 thonzylamine Tonzylamin 2.16.840.1.113883.6.73 2017-01 R06AC52 histapyrrodine, combinations Histapyrrodin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AC53 chloropyramine, combinations Kloropyramin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AD derivatives Fentiazinderivat 2.16.840.1.113883.6.73 2017-01 R06AD01 Alimemazin 2.16.840.1.113883.6.73 2017-01 R06AD02 promethazine Prometazin 2.16.840.1.113883.6.73 2017-01 R06AD03 Tietylperazin 2.16.840.1.113883.6.73 2017-01 R06AD04 Metdilazin 2.16.840.1.113883.6.73 2017-01 R06AD05 Hydroxietylprometazin 2.16.840.1.113883.6.73 2017-01 R06AD06 thiazinam Tiazinam 2.16.840.1.113883.6.73 2017-01 R06AD07 Mekitazin 2.16.840.1.113883.6.73 2017-01 R06AD08 Oxomemazin 2.16.840.1.113883.6.73 2017-01 R06AD09 isothipendyl Isotipendyl 2.16.840.1.113883.6.73 2017-01 R06AD52 promethazine, combinations Prometazin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AD55 hydroxyethylpromethazine, Hydroxietylprometazin, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 R06AE Piperazine derivatives Piperazinderivat 2.16.840.1.113883.6.73 2017-01 R06AE01 Buklizin 2.16.840.1.113883.6.73 2017-01 R06AE03 Cyklizin 2.16.840.1.113883.6.73 2017-01 R06AE04 Klorcyklizin 2.16.840.1.113883.6.73 2017-01 R06AE05 meclozine Meklozin 2.16.840.1.113883.6.73 2017-01 R06AE06 Oxatomid 2.16.840.1.113883.6.73 2017-01 R06AE07 Cetirizin 2.16.840.1.113883.6.73 2017-01 R06AE09 Levocetirizin 2.16.840.1.113883.6.73 2017-01 R06AE51 buclizine, combinations Buklizin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AE53 cyclizine, combinations Cyklizin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AE55 meclozine, combinations Meklozin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AK Combinations of antihistamines Kombinationer av antihistaminer 2.16.840.1.113883.6.73 2017-01 R06AX Other antihistamines for systemic Övriga antihistaminer för systemiskt use bruk 2.16.840.1.113883.6.73 2017-01 R06AX01 bamipine Bamipin 2.16.840.1.113883.6.73 2017-01 R06AX02 Cyproheptadin 2.16.840.1.113883.6.73 2017-01 R06AX03 thenalidine Tenalidin 2.16.840.1.113883.6.73 2017-01 R06AX04 Fenindamin 2.16.840.1.113883.6.73 2017-01 R06AX05 antazoline Antazolin 2.16.840.1.113883.6.73 2017-01 R06AX07 Triprolidin 2.16.840.1.113883.6.73 2017-01 R06AX08 Pyrrobutamin 2.16.840.1.113883.6.73 2017-01 R06AX09 Azatadin 2.16.840.1.113883.6.73 2017-01 R06AX11 Astemizol 2.16.840.1.113883.6.73 2017-01 R06AX12 Terfenadin 2.16.840.1.113883.6.73 2017-01 R06AX13 Loratadin 2.16.840.1.113883.6.73 2017-01 R06AX15 Mebhydrolin 2.16.840.1.113883.6.73 2017-01 R06AX16 Deptropin 2.16.840.1.113883.6.73 2017-01 R06AX17 Ketotifen © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 144 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R06AX18 Akrivastin 2.16.840.1.113883.6.73 2017-01 R06AX19 azelastine Azelastin 2.16.840.1.113883.6.73 2017-01 R06AX21 Tritokvalin 2.16.840.1.113883.6.73 2017-01 R06AX22 Ebastin 2.16.840.1.113883.6.73 2017-01 R06AX23 Pimetixen 2.16.840.1.113883.6.73 2017-01 R06AX24 Epinastin 2.16.840.1.113883.6.73 2017-01 R06AX25 Mizolastin 2.16.840.1.113883.6.73 2017-01 R06AX26 Fexofenadin 2.16.840.1.113883.6.73 2017-01 R06AX27 Desloratadin 2.16.840.1.113883.6.73 2017-01 R06AX28 Rupatadin 2.16.840.1.113883.6.73 2017-01 R06AX29 Bilastin 2.16.840.1.113883.6.73 2017-01 R06AX31 Kifenadin 2.16.840.1.113883.6.73 2017-01 R06AX32 sequifenadine Sekifenadin 2.16.840.1.113883.6.73 2017-01 R06AX53 thenalidine, combinations Tenalidin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AX58 pyrrobutamine, combinations Pyrrobutamin, kombinationer 2.16.840.1.113883.6.73 2017-01 R07 OTHER RESPIRATORY SYSTEM Övriga medel vid sjukdomar i PRODUCTS andningsorganen 2.16.840.1.113883.6.73 2017-01 R07A OTHER RESPIRATORY SYSTEM Övriga medel vid sjukdomar i PRODUCTS andningsorganen 2.16.840.1.113883.6.73 2017-01 R07AA Lung surfactants Ytaktiva medel (lunga) 2.16.840.1.113883.6.73 2017-01 R07AA01 colfosceril palmitate Kolfoskeril 2.16.840.1.113883.6.73 2017-01 R07AA02 natural phospholipids Naturliga fosfolipider 2.16.840.1.113883.6.73 2017-01 R07AA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R07AB Respiratory stimulants Andningsstimulerande medel 2.16.840.1.113883.6.73 2017-01 R07AB01 doxapram Doxapram 2.16.840.1.113883.6.73 2017-01 R07AB02 nikethamide Niketamid 2.16.840.1.113883.6.73 2017-01 R07AB03 pentetrazol Pentetrazol 2.16.840.1.113883.6.73 2017-01 R07AB04 etamivan Etamivan 2.16.840.1.113883.6.73 2017-01 R07AB05 bemegride Bemegrid 2.16.840.1.113883.6.73 2017-01 R07AB06 prethcamide Pretkamid 2.16.840.1.113883.6.73 2017-01 R07AB07 almitrine Almitrin 2.16.840.1.113883.6.73 2017-01 R07AB08 dimefline Dimeflin 2.16.840.1.113883.6.73 2017-01 R07AB09 mepixanox Mepixanox 2.16.840.1.113883.6.73 2017-01 R07AB52 nikethamide, combinations Niketamid, kombinationer 2.16.840.1.113883.6.73 2017-01 R07AB53 pentetrazol, combinations Pentetrazol, kombinationer 2.16.840.1.113883.6.73 2017-01 R07AX Other respiratory system products Övriga medel vid sjukdomar i andningsorganen 2.16.840.1.113883.6.73 2017-01 R07AX01 Kväveoxid 2.16.840.1.113883.6.73 2017-01 R07AX02 ivacaftor Ivakaftor 2.16.840.1.113883.6.73 2017-01 R07AX30 ivacaftor and lumacaftor Ivakaftor och lumakaftor 2.16.840.1.113883.6.73 2017-01 S SENSORY ORGANS Ögon och öron 2.16.840.1.113883.6.73 2017-01 S01 OPHTHALMOLOGICALS Medel vid ögonsjukdomar 2.16.840.1.113883.6.73 2017-01 S01A ANTIINFECTIVES Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01AA Antibiotics Antibiotika

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 145 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01AA01 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 S01AA02 chlortetracycline Klortetracyklin 2.16.840.1.113883.6.73 2017-01 S01AA03 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 S01AA04 oxytetracycline Oxitetracyklin 2.16.840.1.113883.6.73 2017-01 S01AA05 tyrothricin Tyrotricin 2.16.840.1.113883.6.73 2017-01 S01AA07 framycetin Framycetin 2.16.840.1.113883.6.73 2017-01 S01AA09 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 S01AA10 natamycin Natamycin 2.16.840.1.113883.6.73 2017-01 S01AA11 gentamicin Gentamicin 2.16.840.1.113883.6.73 2017-01 S01AA12 tobramycin Tobramycin 2.16.840.1.113883.6.73 2017-01 S01AA13 fusidic acid Fusidinsyra 2.16.840.1.113883.6.73 2017-01 S01AA14 benzylpenicillin Bensylpenicillin 2.16.840.1.113883.6.73 2017-01 S01AA15 Dihydrostreptomycin 2.16.840.1.113883.6.73 2017-01 S01AA16 rifamycin Rifamycin 2.16.840.1.113883.6.73 2017-01 S01AA17 erythromycin Erytromycin 2.16.840.1.113883.6.73 2017-01 S01AA18 polymyxin B Polymyxin B 2.16.840.1.113883.6.73 2017-01 S01AA19 ampicillin Ampicillin 2.16.840.1.113883.6.73 2017-01 S01AA20 antibiotics in combination with other Antibiotika i kombination med andra drugs läkemedel 2.16.840.1.113883.6.73 2017-01 S01AA21 amikacin Amikacin 2.16.840.1.113883.6.73 2017-01 S01AA22 Mikronomicin 2.16.840.1.113883.6.73 2017-01 S01AA23 netilmicin Netilmicin 2.16.840.1.113883.6.73 2017-01 S01AA24 kanamycin Kanamycin 2.16.840.1.113883.6.73 2017-01 S01AA25 azidamfenicol Azidamfenikol 2.16.840.1.113883.6.73 2017-01 S01AA26 azithromycin Azitromycin 2.16.840.1.113883.6.73 2017-01 S01AA27 cefuroxime Cefuroxim 2.16.840.1.113883.6.73 2017-01 S01AA30 combinations of different antibiotics Kombinationer av olika antibiotika 2.16.840.1.113883.6.73 2017-01 S01AB Sulfonamides Sulfonamider 2.16.840.1.113883.6.73 2017-01 S01AB01 sulfamethizole Sulfametizol 2.16.840.1.113883.6.73 2017-01 S01AB02 sulfafurazole Sulfafurazol 2.16.840.1.113883.6.73 2017-01 S01AB03 sulfadicramide Sulfadikramid 2.16.840.1.113883.6.73 2017-01 S01AB04 sulfacetamide Sulfacetamid 2.16.840.1.113883.6.73 2017-01 S01AB05 sulfafenazol Sulfafenazol 2.16.840.1.113883.6.73 2017-01 S01AD Antivirals Antivirala medel 2.16.840.1.113883.6.73 2017-01 S01AD01 idoxuridine Idoxuridin 2.16.840.1.113883.6.73 2017-01 S01AD02 trifluridine Trifluridin 2.16.840.1.113883.6.73 2017-01 S01AD03 aciclovir Aciklovir 2.16.840.1.113883.6.73 2017-01 S01AD05 interferon Interferon 2.16.840.1.113883.6.73 2017-01 S01AD06 vidarabine Vidarabin 2.16.840.1.113883.6.73 2017-01 S01AD07 famciclovir Famciklovir 2.16.840.1.113883.6.73 2017-01 S01AD08 fomivirsen Fomiversen 2.16.840.1.113883.6.73 2017-01 S01AD09 ganciclovir Ganciklovir 2.16.840.1.113883.6.73 2017-01 S01AE Fluoroquinolones Fluorokinoloner

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 146 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01AE01 ofloxacin Ofloxacin 2.16.840.1.113883.6.73 2017-01 S01AE02 norfloxacin Norfloxacin 2.16.840.1.113883.6.73 2017-01 S01AE03 ciprofloxacin Ciprofloxacin 2.16.840.1.113883.6.73 2017-01 S01AE04 lomefloxacin Lomefloxacin 2.16.840.1.113883.6.73 2017-01 S01AE05 levofloxacin Levofloxacin 2.16.840.1.113883.6.73 2017-01 S01AE06 gatifloxacin Gatifloxacin 2.16.840.1.113883.6.73 2017-01 S01AE07 moxifloxacin Moxifloxacin 2.16.840.1.113883.6.73 2017-01 S01AE08 besifloxacin Besifloxacin 2.16.840.1.113883.6.73 2017-01 S01AX Other antiinfectives Övriga antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01AX01 mercury compounds Kvicksilverföreningar 2.16.840.1.113883.6.73 2017-01 S01AX02 silver compounds Silverföreningar 2.16.840.1.113883.6.73 2017-01 S01AX03 zinc compounds Zinkföreningar 2.16.840.1.113883.6.73 2017-01 S01AX04 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 S01AX05 bibrocathol Bibrokatol 2.16.840.1.113883.6.73 2017-01 S01AX06 resorcinol Resorcinol 2.16.840.1.113883.6.73 2017-01 S01AX07 sodium borate Natriumborat 2.16.840.1.113883.6.73 2017-01 S01AX08 hexamidine Hexamidin 2.16.840.1.113883.6.73 2017-01 S01AX09 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 S01AX10 Natriumpropionat 2.16.840.1.113883.6.73 2017-01 S01AX14 dibrompropamidine Dibrompropamidin 2.16.840.1.113883.6.73 2017-01 S01AX15 propamidine Propamidin 2.16.840.1.113883.6.73 2017-01 S01AX16 Pikloxydin 2.16.840.1.113883.6.73 2017-01 S01AX18 povidone-iodine Povidon, joderad 2.16.840.1.113883.6.73 2017-01 S01B ANTIINFLAMMATORY AGENTS Antiinflammatoriska medel 2.16.840.1.113883.6.73 2017-01 S01BA Corticosteroids, plain Kortikosteroider 2.16.840.1.113883.6.73 2017-01 S01BA01 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 S01BA02 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 S01BA03 cortisone Kortison 2.16.840.1.113883.6.73 2017-01 S01BA04 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 S01BA05 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 S01BA06 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 S01BA07 fluorometholone Fluorometolon 2.16.840.1.113883.6.73 2017-01 S01BA08 Medryson 2.16.840.1.113883.6.73 2017-01 S01BA09 clobetasone Klobetason 2.16.840.1.113883.6.73 2017-01 S01BA10 alclometasone Alklometason 2.16.840.1.113883.6.73 2017-01 S01BA11 desonide Desonid 2.16.840.1.113883.6.73 2017-01 S01BA12 Formokortal 2.16.840.1.113883.6.73 2017-01 S01BA13 rimexolone Rimexolon 2.16.840.1.113883.6.73 2017-01 S01BA14 Loteprednol 2.16.840.1.113883.6.73 2017-01 S01BA15 fluocinolone acetonide Fluocinolonacetonid 2.16.840.1.113883.6.73 2017-01 S01BB Corticosteroids and mydriatics in Kortikosteroider och mydriatika i combination kombination 2.16.840.1.113883.6.73 2017-01 S01BB01 hydrocortisone and mydriatics Hydrokortison och mydratikum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 147 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01BB02 prednisolone and mydriatics Prednisolon och mydriaktika 2.16.840.1.113883.6.73 2017-01 S01BB03 fluorometholone and mydriatics Fluorometolon och mydriatika 2.16.840.1.113883.6.73 2017-01 S01BB04 betamethasone and mydriatics Betametason och mydriatika 2.16.840.1.113883.6.73 2017-01 S01BC Antiinflammatory agents, non- Icke-steroida antiinflammatoriska steroids medel 2.16.840.1.113883.6.73 2017-01 S01BC01 indometacin Indometacin 2.16.840.1.113883.6.73 2017-01 S01BC02 oxyphenbutazone Oxifenbutazon 2.16.840.1.113883.6.73 2017-01 S01BC03 diclofenac Diklofenak 2.16.840.1.113883.6.73 2017-01 S01BC04 flurbiprofen Flurbiprofen 2.16.840.1.113883.6.73 2017-01 S01BC05 ketorolac Ketorolak 2.16.840.1.113883.6.73 2017-01 S01BC06 piroxicam Piroxikam 2.16.840.1.113883.6.73 2017-01 S01BC07 bendazac Bendazak 2.16.840.1.113883.6.73 2017-01 S01BC08 salicylic acid Salicylsyra 2.16.840.1.113883.6.73 2017-01 S01BC09 Pranoprofen 2.16.840.1.113883.6.73 2017-01 S01BC10 Nepafenak 2.16.840.1.113883.6.73 2017-01 S01BC11 Bromfenak 2.16.840.1.113883.6.73 2017-01 S01C ANTIINFLAMMATORY AGENTS Antiinflammatoriska och antiinfektiva AND ANTIINFECTIVES IN medel i kombination COMBINATION 2.16.840.1.113883.6.73 2017-01 S01CA Corticosteroids and antiinfectives in Kortikosteroider i kombination med combination antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA01 dexamethasone and antiinfectives Dexametason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA02 prednisolone and antiinfectives Prednisolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA03 hydrocortisone and antiinfectives Hydrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA04 fluocortolone and antiinfectives Fluokortolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA05 betamethasone and antiinfectives Betametason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA06 fludrocortisone and antiinfectives Fludrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA07 fluorometholone and antiinfectives Fluorometolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA08 methylprednisolone and Metylprednisolon och antiinfektiva antiinfectives medel 2.16.840.1.113883.6.73 2017-01 S01CA09 and antiinfectives Klorprednison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA10 fluocinolone acetonide and Fluocinolonacetonid och antiinfectives antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA11 clobetasone and antiinfectives Klobetason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CB Corticosteroids/antiinfectives/mydria Kortikosteroider/antiinfektiva/mydriat tics in combination ika i kombination 2.16.840.1.113883.6.73 2017-01 S01CB01 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 S01CB02 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 S01CB03 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 S01CB04 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 S01CB05 fluorometholone Fluorometolon

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 148 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01CC Antiinflammatory agents, non- Icke-steroida antiinflammatoriska steroids and antiinfectives in medel och antiinfektiva medel i combination kombination 2.16.840.1.113883.6.73 2017-01 S01CC01 diclofenac and antiinfectives Diklofenak och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CC02 indometacin and antiinfectives Indometacin och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01E ANTIGLAUCOMA PREPARATIONS Medel vid glaukom samt miotika AND MIOTICS 2.16.840.1.113883.6.73 2017-01 S01EA Sympathomimetics in glaucoma Sympatomimetika vid glaukom therapy1) 2.16.840.1.113883.6.73 2017-01 S01EA01 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 S01EA02 dipivefrine Dipivefrin 2.16.840.1.113883.6.73 2017-01 S01EA03 apraclonidine Apraklonidin 2.16.840.1.113883.6.73 2017-01 S01EA04 clonidine Klonidin 2.16.840.1.113883.6.73 2017-01 S01EA05 brimonidine Brimonidin 2.16.840.1.113883.6.73 2017-01 S01EA51 epinephrine, combinations Adrenalin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01EB Parasympathomimetics Parasympatomimetika 2.16.840.1.113883.6.73 2017-01 S01EB01 pilocarpine Pilokarpin 2.16.840.1.113883.6.73 2017-01 S01EB02 carbachol Karbakol 2.16.840.1.113883.6.73 2017-01 S01EB03 ecothiopate Ekotiopat 2.16.840.1.113883.6.73 2017-01 S01EB04 demecarium Demekar 2.16.840.1.113883.6.73 2017-01 S01EB05 physostigmine Fysostigmin 2.16.840.1.113883.6.73 2017-01 S01EB06 neostigmine Neostigmin 2.16.840.1.113883.6.73 2017-01 S01EB07 fluostigmine Fluostigmin 2.16.840.1.113883.6.73 2017-01 S01EB08 Aceklidin 2.16.840.1.113883.6.73 2017-01 S01EB09 Acetylkolin 2.16.840.1.113883.6.73 2017-01 S01EB10 Paraoxon 2.16.840.1.113883.6.73 2017-01 S01EB51 pilocarpine, combinations Pilokarpin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01EB58 aceclidine, combinations Aceklidin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01EC Carbonic anhydrase inhibitors Karbanhydrashämmare 2.16.840.1.113883.6.73 2017-01 S01EC01 Acetazolamid 2.16.840.1.113883.6.73 2017-01 S01EC02 diclofenamide Diklofenamid 2.16.840.1.113883.6.73 2017-01 S01EC03 dorzolamide Dorzolamid 2.16.840.1.113883.6.73 2017-01 S01EC04 brinzolamide Brinzolamid 2.16.840.1.113883.6.73 2017-01 S01EC05 methazolamide Metazolamid 2.16.840.1.113883.6.73 2017-01 S01EC54 brinzolamide, combinations Brinzolamid, kombinationer 2.16.840.1.113883.6.73 2017-01 S01ED Beta blocking agents1) Beta-receptorblockerande medel 2.16.840.1.113883.6.73 2017-01 S01ED01 timolol Timolol 2.16.840.1.113883.6.73 2017-01 S01ED02 betaxolol Betaxolol 2.16.840.1.113883.6.73 2017-01 S01ED03 levobunolol Levobunolol 2.16.840.1.113883.6.73 2017-01 S01ED04 metipranolol Metipranolol 2.16.840.1.113883.6.73 2017-01 S01ED05 carteolol Karteolol 2.16.840.1.113883.6.73 2017-01 S01ED06 befunolol Befunolol 2.16.840.1.113883.6.73 2017-01 S01ED51 timolol, combinations Timolol, kombinationer 2.16.840.1.113883.6.73 2017-01 S01ED52 betaxolol, combinations Betoxalol, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 149 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01ED54 metipranolol, combinations Metipranolol, kombinationer 2.16.840.1.113883.6.73 2017-01 S01ED55 carteolol, combinations Karteolol, kombinationer 2.16.840.1.113883.6.73 2017-01 S01EE analogues1) Prostaglandinanaloger 2.16.840.1.113883.6.73 2017-01 S01EE01 latanoprost Latanoprost 2.16.840.1.113883.6.73 2017-01 S01EE02 unoprostone Unoproston 2.16.840.1.113883.6.73 2017-01 S01EE03 bimatoprost Bimatoprost 2.16.840.1.113883.6.73 2017-01 S01EE04 travoprost Travoprost 2.16.840.1.113883.6.73 2017-01 S01EE05 tafluprost Tafluprost 2.16.840.1.113883.6.73 2017-01 S01EX Other antiglaucoma preparations Övriga medel vid glaukom samt miotika 2.16.840.1.113883.6.73 2017-01 S01EX01 guanethidine Guanetidin 2.16.840.1.113883.6.73 2017-01 S01EX02 dapiprazole Dapiprazol 2.16.840.1.113883.6.73 2017-01 S01F MYDRIATICS AND Mydriatika och cykloplegika CYCLOPLEGICS 2.16.840.1.113883.6.73 2017-01 S01FA Anticholinergics Antikolinergika 2.16.840.1.113883.6.73 2017-01 S01FA01 atropine Atropin 2.16.840.1.113883.6.73 2017-01 S01FA02 scopolamine Skopolamin 2.16.840.1.113883.6.73 2017-01 S01FA03 methylscopolamine Metylskopolamin 2.16.840.1.113883.6.73 2017-01 S01FA04 Cyklopentolat 2.16.840.1.113883.6.73 2017-01 S01FA05 Homatropin 2.16.840.1.113883.6.73 2017-01 S01FA06 Tropikamid 2.16.840.1.113883.6.73 2017-01 S01FA54 cyclopentolate, combinations Cyklopentolat, kombinationer 2.16.840.1.113883.6.73 2017-01 S01FA56 tropicamide, combinations Tropikamid, kombinationer 2.16.840.1.113883.6.73 2017-01 S01FB Sympathomimetics excl. Sympatomimetika, exkl. medel vid antiglaucoma preparations glaukom 2.16.840.1.113883.6.73 2017-01 S01FB01 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 S01FB02 ephedrine Efedrin 2.16.840.1.113883.6.73 2017-01 S01FB03 ibopamine Ibopamin 2.16.840.1.113883.6.73 2017-01 S01FB51 phenylephrine and ketorolac Fenylefrin och ketorolak 2.16.840.1.113883.6.73 2017-01 S01G DECONGESTANTS AND Avsvällande medel och antiallergika ANTIALLERGICS 2.16.840.1.113883.6.73 2017-01 S01GA Sympathomimetics used as Sympatomimetika som avsvällande decongestants medel 2.16.840.1.113883.6.73 2017-01 S01GA01 naphazoline Nafazolin 2.16.840.1.113883.6.73 2017-01 S01GA02 tetryzoline Tetryzolin 2.16.840.1.113883.6.73 2017-01 S01GA03 xylometazoline Xylometazolin 2.16.840.1.113883.6.73 2017-01 S01GA04 oxymetazoline Oximetazolin 2.16.840.1.113883.6.73 2017-01 S01GA05 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 S01GA06 oxedrine Oxedrin 2.16.840.1.113883.6.73 2017-01 S01GA51 naphazoline, combinations Nafazolin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01GA52 tetryzoline, combinations Tetryzolin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01GA53 xylometazoline, combinations Xylometazolin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01GA55 phenylephrine, combinations Fenylefrin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01GA56 oxedrine, combinations Oxedrin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01GX Other antiallergics Övriga antiallergika © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 150 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01GX01 cromoglicic acid Natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 S01GX02 levocabastine Levokabastin 2.16.840.1.113883.6.73 2017-01 S01GX03 spaglumic acid Spagluminsyra 2.16.840.1.113883.6.73 2017-01 S01GX04 nedocromil Nedokromil 2.16.840.1.113883.6.73 2017-01 S01GX05 Lodoxamid 2.16.840.1.113883.6.73 2017-01 S01GX06 Emedastin 2.16.840.1.113883.6.73 2017-01 S01GX07 azelastine Azelastin 2.16.840.1.113883.6.73 2017-01 S01GX08 ketotifen Ketotifen 2.16.840.1.113883.6.73 2017-01 S01GX09 olopatadine Olopatadin 2.16.840.1.113883.6.73 2017-01 S01GX10 epinastine Epinastin 2.16.840.1.113883.6.73 2017-01 S01GX11 Alkaftadin 2.16.840.1.113883.6.73 2017-01 S01GX51 cromoglicic acid, combinations Natriumkromoglikat, kombinationer 2.16.840.1.113883.6.73 2017-01 S01H LOCAL ANESTHETICS Lokalanestetika 2.16.840.1.113883.6.73 2017-01 S01HA Local anesthetics Lokalanestetika 2.16.840.1.113883.6.73 2017-01 S01HA01 cocaine Kokain 2.16.840.1.113883.6.73 2017-01 S01HA02 oxybuprocaine Oxibuprokain 2.16.840.1.113883.6.73 2017-01 S01HA03 tetracaine Tetrakain 2.16.840.1.113883.6.73 2017-01 S01HA04 proxymetacaine Proximetakain 2.16.840.1.113883.6.73 2017-01 S01HA05 procaine Prokain 2.16.840.1.113883.6.73 2017-01 S01HA06 cinchocaine Cinkokain 2.16.840.1.113883.6.73 2017-01 S01HA07 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 S01HA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 S01J DIAGNOSTIC AGENTS Diagnostiska medel 2.16.840.1.113883.6.73 2017-01 S01JA Colouring agents Färgämnen 2.16.840.1.113883.6.73 2017-01 S01JA01 fluorescein Fluorescein 2.16.840.1.113883.6.73 2017-01 S01JA02 rose bengal sodium Bengalrosanatrium 2.16.840.1.113883.6.73 2017-01 S01JA51 fluorescein, combinations Fluorescein, kombinationer 2.16.840.1.113883.6.73 2017-01 S01JX Other ophthalmological diagnostic Övriga diagnostiska medel vid agents ögonsjukdomar 2.16.840.1.113883.6.73 2017-01 S01K SURGICAL AIDS Hjälpmedel vid operationer 2.16.840.1.113883.6.73 2017-01 S01KA Viscoelastic substances Viskoelastiska substanser 2.16.840.1.113883.6.73 2017-01 S01KA01 hyaluronic acid Hyaluronsyra 2.16.840.1.113883.6.73 2017-01 S01KA02 hypromellose Hypromellos 2.16.840.1.113883.6.73 2017-01 S01KA51 hyaluronic acid, combinations Hyaluronsyra, kombinationer 2.16.840.1.113883.6.73 2017-01 S01KX Other surgical aids Övriga hjälpmedel vid operationer 2.16.840.1.113883.6.73 2017-01 S01KX01 chymotrypsin Kymotrypsin 2.16.840.1.113883.6.73 2017-01 S01L OCULAR VASCULAR DISORDER Medel vid kärlsjukdomar i ögat AGENTS 2.16.840.1.113883.6.73 2017-01 S01LA Antineovascularisation agents Medel mot kärlnybildning 2.16.840.1.113883.6.73 2017-01 S01LA01 Verteporfin 2.16.840.1.113883.6.73 2017-01 S01LA02 anecortave Anekortav 2.16.840.1.113883.6.73 2017-01 S01LA03 Pegaptanib 2.16.840.1.113883.6.73 2017-01 S01LA04 Ranibizumab 2.16.840.1.113883.6.73 2017-01 S01LA05 aflibercept Aflibercept © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 151 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01X OTHER OPHTHALMOLOGICALS Övriga medel vid ögonsjukdomar 2.16.840.1.113883.6.73 2017-01 S01XA Other ophthalmologicals Övriga medel vid ögonsjukdomar 2.16.840.1.113883.6.73 2017-01 S01XA01 guaiazulen Guajazulen 2.16.840.1.113883.6.73 2017-01 S01XA02 retinol Retinol (vitamin A) 2.16.840.1.113883.6.73 2017-01 S01XA03 sodium chloride, hypertonic Natriumklorid, hyperton 2.16.840.1.113883.6.73 2017-01 S01XA04 potassium iodide Kaliumjodid 2.16.840.1.113883.6.73 2017-01 S01XA05 sodium edetate Natriumedetat 2.16.840.1.113883.6.73 2017-01 S01XA06 ethylmorphine Etylmorfin 2.16.840.1.113883.6.73 2017-01 S01XA07 Alum 2.16.840.1.113883.6.73 2017-01 S01XA08 acetylcysteine Acetylcystein 2.16.840.1.113883.6.73 2017-01 S01XA09 iodoheparinate Jodoheparinat 2.16.840.1.113883.6.73 2017-01 S01XA10 inosine Inosin 2.16.840.1.113883.6.73 2017-01 S01XA11 nandrolone Nandrolon 2.16.840.1.113883.6.73 2017-01 S01XA12 dexpanthenol Dexpantenol 2.16.840.1.113883.6.73 2017-01 S01XA13 alteplase Alteplas 2.16.840.1.113883.6.73 2017-01 S01XA14 heparin Heparin 2.16.840.1.113883.6.73 2017-01 S01XA15 ascorbic acid Askorbinsyra (vitamin C) 2.16.840.1.113883.6.73 2017-01 S01XA18 ciclosporin Ciklosporin 2.16.840.1.113883.6.73 2017-01 S01XA19 limbal stems cells, autologous Autologa limbala stamceller 2.16.840.1.113883.6.73 2017-01 S01XA20 artificial tears and other indifferent Tårsubstitut och övriga indifferenta preparations medel 2.16.840.1.113883.6.73 2017-01 S01XA21 mercaptamine Merkaptamin 2.16.840.1.113883.6.73 2017-01 S01XA22 ocriplasmin Okriplasmin 2.16.840.1.113883.6.73 2017-01 S01XA23 sirolimus Sirolimus 2.16.840.1.113883.6.73 2017-01 S02 OTOLOGICALS Medel vid öronsjukdomar 2.16.840.1.113883.6.73 2017-01 S02A ANTIINFECTIVES Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02AA Antiinfectives Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02AA01 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 S02AA02 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 S02AA03 boric acid Borsyra 2.16.840.1.113883.6.73 2017-01 S02AA04 Aluminiumacetotartrat 2.16.840.1.113883.6.73 2017-01 S02AA05 clioquinol Kliokinol 2.16.840.1.113883.6.73 2017-01 S02AA06 hydrogen peroxide Väteperoxid 2.16.840.1.113883.6.73 2017-01 S02AA07 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 S02AA08 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 S02AA09 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 S02AA10 acetic acid Ättiksyra 2.16.840.1.113883.6.73 2017-01 S02AA11 polymyxin B Polymyxin B 2.16.840.1.113883.6.73 2017-01 S02AA12 rifamycin Rifamycin 2.16.840.1.113883.6.73 2017-01 S02AA13 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 S02AA14 gentamicin Gentamicin 2.16.840.1.113883.6.73 2017-01 S02AA15 ciprofloxacin Ciprofloxacin 2.16.840.1.113883.6.73 2017-01 S02AA16 ofloxacin Ofloxacin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 152 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S02AA30 antiinfectives, combinations Antiinfektiva medel, kombinationer 2.16.840.1.113883.6.73 2017-01 S02B CORTICOSTEROIDS Kortikosteroider 2.16.840.1.113883.6.73 2017-01 S02BA Corticosteroids Kortikosteroider 2.16.840.1.113883.6.73 2017-01 S02BA01 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 S02BA03 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 S02BA06 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 S02BA07 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 S02BA08 fluocinolone acetonide Fluocinolonacetonid 2.16.840.1.113883.6.73 2017-01 S02C CORTICOSTEROIDS AND Kortikosteroider i kombination med ANTIINFECTIVES IN antiinfektiva medel COMBINATION 2.16.840.1.113883.6.73 2017-01 S02CA Corticosteroids and antiinfectives in Kortikosteroider i kombination med combination antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA01 prednisolone and antiinfectives Prednisolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA02 flumetasone and antiinfectives Flumetason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA03 hydrocortisone and antiinfectives Hydrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA04 triamcinolone and antiinfectives Triamcinolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA05 fluocinolone acetonide and Fluocinolonacetonid och antiinfectives antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA06 dexamethasone and antiinfectives Dexametason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA07 fludrocortisone and antiinfectives Fludrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02D OTHER OTOLOGICALS Övriga medel vid öronsjukdomar 2.16.840.1.113883.6.73 2017-01 S02DA Analgesics and anesthetics Analgetika och anestetika 2.16.840.1.113883.6.73 2017-01 S02DA01 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 S02DA02 cocaine Kokain 2.16.840.1.113883.6.73 2017-01 S02DA03 phenazone Fenazon 2.16.840.1.113883.6.73 2017-01 S02DA04 cinchocaine Cinkokain 2.16.840.1.113883.6.73 2017-01 S02DA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 S02DC Indifferent preparations Indifferenta medel 2.16.840.1.113883.6.73 2017-01 S03 OPHTHALMOLOGICAL AND Medel vid ögon- och öronsjukdomar OTOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 S03A ANTIINFECTIVES Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03AA Antiinfectives Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03AA01 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 S03AA02 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 S03AA03 polymyxin B Polymyxin B 2.16.840.1.113883.6.73 2017-01 S03AA04 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 S03AA05 hexamidine Hexamidin 2.16.840.1.113883.6.73 2017-01 S03AA06 gentamicin Gentamicin 2.16.840.1.113883.6.73 2017-01 S03AA07 ciprofloxacin Ciprofloxacin 2.16.840.1.113883.6.73 2017-01 S03AA08 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 S03AA30 antiinfectives, combinations Antiinfektiva, kombinationer 2.16.840.1.113883.6.73 2017-01 S03B CORTICOSTEROIDS Kortikosteroider © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 153 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S03BA Corticosteroids Kortikosteroider 2.16.840.1.113883.6.73 2017-01 S03BA01 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 S03BA02 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 S03BA03 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 S03C CORTICOSTEROIDS AND Kortikosteroider i kombination med ANTIINFECTIVES IN antiinfektiva medel COMBINATION 2.16.840.1.113883.6.73 2017-01 S03CA Corticosteroids and antiinfectives in Kortikosteroider i kombination med combination antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03CA01 dexamethasone and antiinfectives Dexametason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03CA02 prednisolone and antiinfectives Prednisolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03CA04 hydrocortisone and antiinfectives Hydrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03CA05 fludrocortisone and antiinfectives Fludrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03CA06 betamethasone and antiinfectives Betametason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03D OTHER OPHTHALMOLOGICAL Övriga medel vid ögon- och AND OTOLOGICAL öronsjukdomar PREPARATIONS 2.16.840.1.113883.6.73 2017-01 V VARIOUS Övrigt 2.16.840.1.113883.6.73 2017-01 V01 Allergener 2.16.840.1.113883.6.73 2017-01 V01A ALLERGENS Allergener 2.16.840.1.113883.6.73 2017-01 V01AA extracts Allergenextrakt 2.16.840.1.113883.6.73 2017-01 V01AA01 feather Fjädrar 2.16.840.1.113883.6.73 2017-01 V01AA02 grass pollen Gräspollen 2.16.840.1.113883.6.73 2017-01 V01AA03 house dust mites Husdammskvalster 2.16.840.1.113883.6.73 2017-01 V01AA04 mould fungus and yeast fungus Mögelsvampar och jästsvampar 2.16.840.1.113883.6.73 2017-01 V01AA05 tree pollen Pollen från träd 2.16.840.1.113883.6.73 2017-01 V01AA07 insects Insekter 2.16.840.1.113883.6.73 2017-01 V01AA08 food Födoämnen 2.16.840.1.113883.6.73 2017-01 V01AA09 textiles Textilier 2.16.840.1.113883.6.73 2017-01 V01AA10 flowers Örter 2.16.840.1.113883.6.73 2017-01 V01AA11 animals Djur 2.16.840.1.113883.6.73 2017-01 V01AA20 various Övrigt 2.16.840.1.113883.6.73 2017-01 V03 ALL OTHER THERAPEUTIC Medel vid förgiftningar, PRODUCTS överdoseringar m.m. 2.16.840.1.113883.6.73 2017-01 V03A ALL OTHER THERAPEUTIC Medel vid förgiftningar, PRODUCTS överdoseringar m.m. 2.16.840.1.113883.6.73 2017-01 V03AB Antidotes Medel vid förgiftningar 2.16.840.1.113883.6.73 2017-01 V03AB01 ipecacuanha Ipekakuanharot 2.16.840.1.113883.6.73 2017-01 V03AB02 nalorphine Nalorfin 2.16.840.1.113883.6.73 2017-01 V03AB03 edetates Edetat 2.16.840.1.113883.6.73 2017-01 V03AB04 pralidoxime Pralidoxim 2.16.840.1.113883.6.73 2017-01 V03AB05 prednisolone and promethazine Prednisolon och prometazin 2.16.840.1.113883.6.73 2017-01 V03AB06 thiosulfate Tiosulfat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 154 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V03AB08 sodium nitrite Natriumnitrit 2.16.840.1.113883.6.73 2017-01 V03AB09 Dimerkaprol 2.16.840.1.113883.6.73 2017-01 V03AB13 obidoxime Obidoxim 2.16.840.1.113883.6.73 2017-01 V03AB14 protamine Protamin 2.16.840.1.113883.6.73 2017-01 V03AB15 naloxone Naloxon 2.16.840.1.113883.6.73 2017-01 V03AB16 ethanol Etanol 2.16.840.1.113883.6.73 2017-01 V03AB17 methylthioninium chloride Metyltioninklorid 2.16.840.1.113883.6.73 2017-01 V03AB18 potassium permanganate Kaliumpermanganat 2.16.840.1.113883.6.73 2017-01 V03AB19 physostigmine Fysostigmin 2.16.840.1.113883.6.73 2017-01 V03AB20 copper sulfate Kopparsulfat 2.16.840.1.113883.6.73 2017-01 V03AB21 potassium iodide Kaliumjodid 2.16.840.1.113883.6.73 2017-01 V03AB22 amyl nitrite Amylnitrit 2.16.840.1.113883.6.73 2017-01 V03AB23 acetylcysteine Acetylcystein 2.16.840.1.113883.6.73 2017-01 V03AB24 digitalis antitoxin Digitalisantitoxin 2.16.840.1.113883.6.73 2017-01 V03AB25 flumazenil Flumazenil 2.16.840.1.113883.6.73 2017-01 V03AB26 methionine Metionin 2.16.840.1.113883.6.73 2017-01 V03AB27 4-dimethylaminophenol 4-Dimetylaminofenol 2.16.840.1.113883.6.73 2017-01 V03AB29 Kolinesteras 2.16.840.1.113883.6.73 2017-01 V03AB31 prussian blue Järn(III)ferrocyanid 2.16.840.1.113883.6.73 2017-01 V03AB32 Glutation 2.16.840.1.113883.6.73 2017-01 V03AB33 hydroxocobalamin Hydroxokobalamin 2.16.840.1.113883.6.73 2017-01 V03AB34 fomepizole Fomepizol 2.16.840.1.113883.6.73 2017-01 V03AB35 Sugammadex 2.16.840.1.113883.6.73 2017-01 V03AB36 phentolamine Fentolamin 2.16.840.1.113883.6.73 2017-01 V03AB37 idarucizumab Idarucizumab 2.16.840.1.113883.6.73 2017-01 V03AC Iron chelating agents Medel vid järnförgiftning 2.16.840.1.113883.6.73 2017-01 V03AC01 deferoxamine Deferoxamin 2.16.840.1.113883.6.73 2017-01 V03AC02 deferiprone Deferipron 2.16.840.1.113883.6.73 2017-01 V03AC03 deferasirox Deferasirox 2.16.840.1.113883.6.73 2017-01 V03AE Drugs for treatment of hyperkalemia Medel för behandling av and hyperphosphatemia hyperkalemi och hyperfosfatemi 2.16.840.1.113883.6.73 2017-01 V03AE01 polystyrene sulfonate Polystyrensulfonat 2.16.840.1.113883.6.73 2017-01 V03AE02 sevelamer Sevelamer 2.16.840.1.113883.6.73 2017-01 V03AE03 lanthanum carbonate Lantankarbonat 2.16.840.1.113883.6.73 2017-01 V03AE04 and magnesium Kalciumacetat och carbonate magnesiumkarbonat 2.16.840.1.113883.6.73 2017-01 V03AE05 sucroferric oxyhydroxide Sukrojärn(III)oxihydroxid 2.16.840.1.113883.6.73 2017-01 V03AE06 Kolestilan 2.16.840.1.113883.6.73 2017-01 V03AE07 calcium acetate Kalciumacetat 2.16.840.1.113883.6.73 2017-01 V03AE08 ferric citrate Järn(III)citrat 2.16.840.1.113883.6.73 2017-01 V03AE09 patiromer calcium Patiromerkalcium 2.16.840.1.113883.6.73 2017-01 V03AF Detoxifying agents for antineoplastic Medel mot toxicitet vid treatment cytostatikabehandling 2.16.840.1.113883.6.73 2017-01 V03AF01 mesna Mesna

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 155 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V03AF02 Dexrazoxan 2.16.840.1.113883.6.73 2017-01 V03AF03 calcium folinate Kalciumfolinat 2.16.840.1.113883.6.73 2017-01 V03AF04 calcium levofolinate Kalciumlevofolinat 2.16.840.1.113883.6.73 2017-01 V03AF05 amifostine Amifostin 2.16.840.1.113883.6.73 2017-01 V03AF06 sodium folinate Natriumfolinat 2.16.840.1.113883.6.73 2017-01 V03AF07 Rasburikas 2.16.840.1.113883.6.73 2017-01 V03AF08 Palifermin 2.16.840.1.113883.6.73 2017-01 V03AF09 glucarpidase Glukarpidas 2.16.840.1.113883.6.73 2017-01 V03AF10 sodium levofolinate Natriumlevofolinat 2.16.840.1.113883.6.73 2017-01 V03AG Drugs for treatment of Medel för behandling av hypercalcemia hyperkalcemi 2.16.840.1.113883.6.73 2017-01 V03AG01 sodium cellulose phosphate Natriumcellulosafosfater 2.16.840.1.113883.6.73 2017-01 V03AH Drugs for treatment of hypoglycemia Medel för behandling av hypoglykemi 2.16.840.1.113883.6.73 2017-01 V03AH01 diazoxide Diazoxid 2.16.840.1.113883.6.73 2017-01 V03AK Tissue adhesives Vävnadslim 2.16.840.1.113883.6.73 2017-01 V03AM Drugs for embolisation Medel för embolisering 2.16.840.1.113883.6.73 2017-01 V03AN Medical gases Medicinska gaser 2.16.840.1.113883.6.73 2017-01 V03AN01 oxygen Syre 2.16.840.1.113883.6.73 2017-01 V03AN02 carbon dioxide Koldioxid 2.16.840.1.113883.6.73 2017-01 V03AN03 helium Helium 2.16.840.1.113883.6.73 2017-01 V03AN04 nitrogen Kväve 2.16.840.1.113883.6.73 2017-01 V03AN05 medical air Medicinsk luft 2.16.840.1.113883.6.73 2017-01 V03AX Other therapeutic products Övriga terapeutiska produkter 2.16.840.1.113883.6.73 2017-01 V03AX02 Nalfurafin 2.16.840.1.113883.6.73 2017-01 V03AX03 cobicistat Kobicistat 2.16.840.1.113883.6.73 2017-01 V03AZ Nerve Nervdepressiva 2.16.840.1.113883.6.73 2017-01 V03AZ01 ethanol Etanol 2.16.840.1.113883.6.73 2017-01 V04 DIAGNOSTIC AGENTS Diagnostiska medel 2.16.840.1.113883.6.73 2017-01 V04B URINE TESTS Medel för urintest 2.16.840.1.113883.6.73 2017-01 V04C OTHER DIAGNOSTIC AGENTS Övriga diagnostiska medel 2.16.840.1.113883.6.73 2017-01 V04CA Tests for diabetes Medel för diabetestest 2.16.840.1.113883.6.73 2017-01 V04CA01 tolbutamide Tolbutamid 2.16.840.1.113883.6.73 2017-01 V04CA02 glucose Glukos 2.16.840.1.113883.6.73 2017-01 V04CB Tests for fat absorption Tester för fettabsorption 2.16.840.1.113883.6.73 2017-01 V04CB01 vitamin A concentrates Vitamin A koncentrat 2.16.840.1.113883.6.73 2017-01 V04CC Tests for bile duct patency Medel för tömning av gallblåsan 2.16.840.1.113883.6.73 2017-01 V04CC01 sorbitol Sorbitol 2.16.840.1.113883.6.73 2017-01 V04CC02 magnesium sulfate Magnesiumsulfat 2.16.840.1.113883.6.73 2017-01 V04CC03 Sinkalid 2.16.840.1.113883.6.73 2017-01 V04CC04 Ceruletid 2.16.840.1.113883.6.73 2017-01 V04CD Tests for pituitary function Medel för hypofysfunktionsprov 2.16.840.1.113883.6.73 2017-01 V04CD01 Metyrapon 2.16.840.1.113883.6.73 2017-01 V04CD03 sermorelin Sermorelin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 156 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V04CD04 Kortikorelin 2.16.840.1.113883.6.73 2017-01 V04CD05 Somatorelin 2.16.840.1.113883.6.73 2017-01 V04CD06 macimorelin Macimorelin 2.16.840.1.113883.6.73 2017-01 V04CE Tests for liver functional capacity Medel för leverfunktionstest 2.16.840.1.113883.6.73 2017-01 V04CE01 Galaktos 2.16.840.1.113883.6.73 2017-01 V04CE02 sulfobromophthalein Sulfobromoftalein 2.16.840.1.113883.6.73 2017-01 V04CE03 methacetin (13C) Metacetin (C-13) 2.16.840.1.113883.6.73 2017-01 V04CF Tuberculosis diagnostics Tuberkulosdiagnostikum 2.16.840.1.113883.6.73 2017-01 V04CF01 tuberculin Tuberkulin 2.16.840.1.113883.6.73 2017-01 V04CG Tests for gastric secretion Ventrikelsekretionstest 2.16.840.1.113883.6.73 2017-01 V04CG01 cation exchange resins Katjonbytarhartser 2.16.840.1.113883.6.73 2017-01 V04CG02 Betazol 2.16.840.1.113883.6.73 2017-01 V04CG03 histamine phosphate Histaminfosfat 2.16.840.1.113883.6.73 2017-01 V04CG04 Pentagastrin 2.16.840.1.113883.6.73 2017-01 V04CG05 methylthioninium chloride Metyltioninklorid 2.16.840.1.113883.6.73 2017-01 V04CG30 caffeine and sodium benzoate Koffein och natriumbensoat 2.16.840.1.113883.6.73 2017-01 V04CH Tests for renal function and ureteral Test för njurfunktion och uretära injuries sjukdomar 2.16.840.1.113883.6.73 2017-01 V04CH01 and other polyfructosans Inulin och andra polyfruktosaner 2.16.840.1.113883.6.73 2017-01 V04CH02 Indigokarmin 2.16.840.1.113883.6.73 2017-01 V04CH03 phenolsulfonphthalein Fenolrött 2.16.840.1.113883.6.73 2017-01 V04CH04 Alsaktid 2.16.840.1.113883.6.73 2017-01 V04CH30 Aminohippursyra 2.16.840.1.113883.6.73 2017-01 V04CJ Tests for thyreoidea function Tyreoideafunktionstest 2.16.840.1.113883.6.73 2017-01 V04CJ01 thyrotropin Tyrotropin 2.16.840.1.113883.6.73 2017-01 V04CJ02 protirelin Protirelin 2.16.840.1.113883.6.73 2017-01 V04CK Tests for pancreatic function Pankreasfunktionstest 2.16.840.1.113883.6.73 2017-01 V04CK01 Sekretin 2.16.840.1.113883.6.73 2017-01 V04CK02 pancreozymin () Kolecystokinin 2.16.840.1.113883.6.73 2017-01 V04CK03 Bentiromid 2.16.840.1.113883.6.73 2017-01 V04CL Tests for allergic diseases Allergitest 2.16.840.1.113883.6.73 2017-01 V04CM Tests for fertility disturbances Tester för fertilitetsstörningar 2.16.840.1.113883.6.73 2017-01 V04CM01 gonadorelin Gonadorelin 2.16.840.1.113883.6.73 2017-01 V04CX Other diagnostic agents Övriga diagnostiska medel 2.16.840.1.113883.6.73 2017-01 V06 GENERAL Näringspreparat 2.16.840.1.113883.6.73 2017-01 V06A DIET FORMULATIONS FOR Dietpreparat för bantning TREATMENT OF OBESITY 2.16.840.1.113883.6.73 2017-01 V06AA Low-energy diets Lågenergidieter 2.16.840.1.113883.6.73 2017-01 V06B PROTEIN SUPPLEMENTS Proteinsupplement 2.16.840.1.113883.6.73 2017-01 V06C INFANT FORMULAS Näringspreparat för barn 2.16.840.1.113883.6.73 2017-01 V06CA Nutrients without phenylalanine Medel vid fenylketonuri 2.16.840.1.113883.6.73 2017-01 V06D OTHER NUTRIENTS Övriga näringspreparat 2.16.840.1.113883.6.73 2017-01 V06DA Carbohydrates/proteins/minerals/vit Kolhydrat-, protein-, mineral- och amins, combinations vitamintillskott, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 157 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V06DB Fat/carbohydrates/proteins/minerals Fett-, kolhydrat-, protein-, mineral /vitamins, combinations och vitamintillskott 2.16.840.1.113883.6.73 2017-01 V06DC Carbohydrates Kolhydrater 2.16.840.1.113883.6.73 2017-01 V06DC01 glucose Glukos 2.16.840.1.113883.6.73 2017-01 V06DC02 fructose Fruktos 2.16.840.1.113883.6.73 2017-01 V06DD Amino acids, incl. combinations with Aminosyror, inkl kombinationer med polypeptides polypeptider 2.16.840.1.113883.6.73 2017-01 V06DE Amino Aminosyror-, kolhydrat-, mineral och acids/carbohydrates/minerals/vitami vitamintillskott, kombinationer ns, combinations 2.16.840.1.113883.6.73 2017-01 V06DF Milk substitutes Mjölksubstitut 2.16.840.1.113883.6.73 2017-01 V06DX Other combinations of nutrients Övriga kombinationer av näringsämnen 2.16.840.1.113883.6.73 2017-01 V07 ALL OTHER NON-THERAPEUTIC Tekniska hjälpmedel PRODUCTS 2.16.840.1.113883.6.73 2017-01 V07A ALL OTHER NON-THERAPEUTIC Tekniska hjälpmedel PRODUCTS 2.16.840.1.113883.6.73 2017-01 V07AA Plasters Plåster 2.16.840.1.113883.6.73 2017-01 V07AB Solvents and diluting agents, incl. Lösningar, spädningsvätskor och irrigating solutions spolvätskor 2.16.840.1.113883.6.73 2017-01 V07AC Blood transfusion, auxiliary products Hjälpmedel vid transfusioner, infusioner m m 2.16.840.1.113883.6.73 2017-01 V07AD Blood tests, auxiliary products Hjälpmedel vid blodprov 2.16.840.1.113883.6.73 2017-01 V07AN Incontinence equipment Inkontinenstillbehör 2.16.840.1.113883.6.73 2017-01 V07AR Sensitivity tests, discs and tablets Känslighetstester, -disker och tabletter 2.16.840.1.113883.6.73 2017-01 V07AS Stomi equipment Stomitillbehör 2.16.840.1.113883.6.73 2017-01 V07AT Cosmetics Kosmetika 2.16.840.1.113883.6.73 2017-01 V07AV Technical disinfectants Tekniska desinfektionsmedel 2.16.840.1.113883.6.73 2017-01 V07AX Washing agents etc. Tvättmedel m.m. 2.16.840.1.113883.6.73 2017-01 V07AY Other non-therapeutic auxiliary Övriga icke terapeutiska hjälpmedel products 2.16.840.1.113883.6.73 2017-01 V07AZ Chemicals and reagents for analysis Kemikalier och reagenser för analyser 2.16.840.1.113883.6.73 2017-01 V08 CONTRAST MEDIA Kontrastmedel 2.16.840.1.113883.6.73 2017-01 V08A X-RAY CONTRAST MEDIA, Joderade röntgenkontrastmedel IODINATED 2.16.840.1.113883.6.73 2017-01 V08AA Watersoluble, nephrotropic, high Vattenlösliga, högosmolära osmolar X-ray contrast media röntgenkontrastmedel med njuraffinitet 2.16.840.1.113883.6.73 2017-01 V08AA01 diatrizoic acid Amidotrizoinsyra 2.16.840.1.113883.6.73 2017-01 V08AA02 Metrizoinsyra 2.16.840.1.113883.6.73 2017-01 V08AA03 Jodamid 2.16.840.1.113883.6.73 2017-01 V08AA04 Jotalamsyra 2.16.840.1.113883.6.73 2017-01 V08AA05 Joxitalamsyra 2.16.840.1.113883.6.73 2017-01 V08AA06 ioglicic acid Jogliksyra 2.16.840.1.113883.6.73 2017-01 V08AA07 Acetrizoinsyra 2.16.840.1.113883.6.73 2017-01 V08AA08 Jokarmsyra

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 158 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V08AA09 Metiodal 2.16.840.1.113883.6.73 2017-01 V08AA10 Diodon 2.16.840.1.113883.6.73 2017-01 V08AB Watersoluble, nephrotropic, low Vattenlösliga, lågosmolära osmolar X-ray contrast media röntgenkontrastmedel med njuraffinitet 2.16.840.1.113883.6.73 2017-01 V08AB01 Metrizamid 2.16.840.1.113883.6.73 2017-01 V08AB02 Johexol 2.16.840.1.113883.6.73 2017-01 V08AB03 Joxaglinsyra 2.16.840.1.113883.6.73 2017-01 V08AB04 Jopamidol 2.16.840.1.113883.6.73 2017-01 V08AB05 Jopromid 2.16.840.1.113883.6.73 2017-01 V08AB06 Jotrolan 2.16.840.1.113883.6.73 2017-01 V08AB07 Joversol 2.16.840.1.113883.6.73 2017-01 V08AB08 Jopentol 2.16.840.1.113883.6.73 2017-01 V08AB09 Jodixanol 2.16.840.1.113883.6.73 2017-01 V08AB10 Jomeprol 2.16.840.1.113883.6.73 2017-01 V08AB11 Jobitridol 2.16.840.1.113883.6.73 2017-01 V08AB12 Joxilan 2.16.840.1.113883.6.73 2017-01 V08AC Watersoluble, hepatotropic X-ray Vattenlösliga röntgenkontrastmedel contrast media med leveraffinitet 2.16.840.1.113883.6.73 2017-01 V08AC01 Jodoxamsyra 2.16.840.1.113883.6.73 2017-01 V08AC02 Jotroxinsyra 2.16.840.1.113883.6.73 2017-01 V08AC03 ioglycamic acid Joglykamsyra 2.16.840.1.113883.6.73 2017-01 V08AC04 Adipiodon 2.16.840.1.113883.6.73 2017-01 V08AC05 Jobensamsyra 2.16.840.1.113883.6.73 2017-01 V08AC06 Jopansyra 2.16.840.1.113883.6.73 2017-01 V08AC07 Jocetamsyra 2.16.840.1.113883.6.73 2017-01 V08AC08 sodium iopodate Natriumjopodat 2.16.840.1.113883.6.73 2017-01 V08AC09 tyropanoic acid Tyropanoinsyra 2.16.840.1.113883.6.73 2017-01 V08AC10 calcium iopodate Kalciumjopodat 2.16.840.1.113883.6.73 2017-01 V08AD Non-watersoluble X-ray contrast Vattenolösliga media röntgenkontrastmedel 2.16.840.1.113883.6.73 2017-01 V08AD01 ethyl esters of iodised fatty acids Etylestrar av jodiserade fettsyror 2.16.840.1.113883.6.73 2017-01 V08AD02 Jopydol 2.16.840.1.113883.6.73 2017-01 V08AD03 Propyljodon 2.16.840.1.113883.6.73 2017-01 V08AD04 Jofendylat 2.16.840.1.113883.6.73 2017-01 V08B X-RAY CONTRAST MEDIA, NON- Röntgenkontrastmedel utan jod IODINATED 2.16.840.1.113883.6.73 2017-01 V08BA containing X-ray Bariumsulfat contrast media 2.16.840.1.113883.6.73 2017-01 V08BA01 barium sulfate with suspending Bariumsulfat agents 2.16.840.1.113883.6.73 2017-01 V08BA02 barium sulfate without suspending Bariumsulfat agents 2.16.840.1.113883.6.73 2017-01 V08C MAGNETIC RESONANCE Kontrastmedel för magnetisk IMAGING CONTRAST MEDIA resonanstomografi 2.16.840.1.113883.6.73 2017-01 V08CA Paramagnetic contrast media Paramagnetiska kontrastmedel

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 159 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V08CA01 Gadopentetat 2.16.840.1.113883.6.73 2017-01 V08CA02 Gadoterinsyra 2.16.840.1.113883.6.73 2017-01 V08CA03 Gadodiamid 2.16.840.1.113883.6.73 2017-01 V08CA04 Gadoteridol 2.16.840.1.113883.6.73 2017-01 V08CA05 Mangafodipir 2.16.840.1.113883.6.73 2017-01 V08CA06 Gadoversetamid 2.16.840.1.113883.6.73 2017-01 V08CA07 ferric ammonium citrate Järn(III)ammoniumcitrat 2.16.840.1.113883.6.73 2017-01 V08CA08 Gadobenat 2.16.840.1.113883.6.73 2017-01 V08CA09 Gadobutrol 2.16.840.1.113883.6.73 2017-01 V08CA10 Gadoxetinsyra 2.16.840.1.113883.6.73 2017-01 V08CA11 Gadofosveset 2.16.840.1.113883.6.73 2017-01 V08CB Superparamagnetic contrast media Superparamagnetiska kontrastmedel 2.16.840.1.113883.6.73 2017-01 V08CB01 ferumoxsil Ferumoxsil 2.16.840.1.113883.6.73 2017-01 V08CB02 ferristene Järnferrit med bärarpartiklar 2.16.840.1.113883.6.73 2017-01 V08CB03 iron oxide, Järnoxid, nanopartiklar 2.16.840.1.113883.6.73 2017-01 V08CX Other magnetic resonance imaging Övriga kontrastmedel för magnetisk contrast media resonanstomografi 2.16.840.1.113883.6.73 2017-01 V08CX01 Perflubron 2.16.840.1.113883.6.73 2017-01 V08D ULTRASOUND CONTRAST MEDIA Kontrastmedel för ultraljudsundersökningar 2.16.840.1.113883.6.73 2017-01 V08DA Ultrasound contrast media Kontrastmedel för ultraljudsundersökningar 2.16.840.1.113883.6.73 2017-01 V08DA01 microspheres of human albumin Mikrosfärer av humant albumin 2.16.840.1.113883.6.73 2017-01 V08DA02 microparticles of galactose Mikropartiklar av galaktos 2.16.840.1.113883.6.73 2017-01 V08DA03 Perflenapent 2.16.840.1.113883.6.73 2017-01 V08DA04 microspheres of phospholipids Mikrosfärer av fosfolipider 2.16.840.1.113883.6.73 2017-01 V08DA05 Svavelhexafluorid 2.16.840.1.113883.6.73 2017-01 V08DA06 perflubutane polymer microspheres Perflubutanpolymermikrosfärer 2.16.840.1.113883.6.73 2017-01 V09 DIAGNOSTIC Diagnostiska radiofarmaka RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V09A CENTRAL NERVOUS SYSTEM Centrala nervsystemet 2.16.840.1.113883.6.73 2017-01 V09AA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09AA01 technetium (99mTc) exametazime Teknetium(Tc-99m)exametazim 2.16.840.1.113883.6.73 2017-01 V09AA02 technetium (99mTc) bicisate Teknetium(Tc- 99m)bicisatdihydroklorid 2.16.840.1.113883.6.73 2017-01 V09AB Iodine (123I) compounds Jod(I-123)föreningar 2.16.840.1.113883.6.73 2017-01 V09AB01 iodine iofetamine (123I) Jodjofetamin(I-123) 2.16.840.1.113883.6.73 2017-01 V09AB02 iodine iolopride (123I) Jodjoloprid(I-123) 2.16.840.1.113883.6.73 2017-01 V09AB03 iodine ioflupane (123I) Jodjoflupan(I-123) 2.16.840.1.113883.6.73 2017-01 V09AX Other central nervous system Övriga diagnostiska radiofarmaka diagnostic radiopharmaceuticals för det centrala nervsystemet 2.16.840.1.113883.6.73 2017-01 V09AX01 indium (111In) pentetic acid Indium(In-111)pentetat 2.16.840.1.113883.6.73 2017-01 V09AX03 iodine (124I) 2beta-carbomethoxy- Jod (I-124) 2beta-karbometoxi- 3beta-(4 iodophenyl)-tropane 3beta-(4 jodofenyl)-tropan 2.16.840.1.113883.6.73 2017-01 V09AX04 flutemetamol (18F) Flutemetamol(F-18) © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 160 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09AX05 florbetapir (18F) Florbetapir(F-18) 2.16.840.1.113883.6.73 2017-01 V09AX06 florbetaben (18F) Florbetaben(F-18) 2.16.840.1.113883.6.73 2017-01 V09B SKELETON Skelett 2.16.840.1.113883.6.73 2017-01 V09BA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09BA01 technetium (99mTc) oxidronic acid Teknetium(Tc-99m)oxidronsyra 2.16.840.1.113883.6.73 2017-01 V09BA02 technetium (99mTc) medronic acid Teknetium(Tc-99m)medronat 2.16.840.1.113883.6.73 2017-01 V09BA03 technetium (99mTc) pyrophosphate Teknetium(Tc-99m)pyrofosfat 2.16.840.1.113883.6.73 2017-01 V09BA04 technetium (99mTc) butedronic acid Teknetium(Tc-99m)butedronsyra 2.16.840.1.113883.6.73 2017-01 V09C RENAL SYSTEM Renala systemet 2.16.840.1.113883.6.73 2017-01 V09CA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09CA01 technetium (99mTc) pentetic acid Teknetium(Tc-99m)pentetsyra 2.16.840.1.113883.6.73 2017-01 V09CA02 technetium (99mTc) succimer Teknetium(Tc-99m)succimer 2.16.840.1.113883.6.73 2017-01 V09CA03 technetium (99mTc) mertiatide Teknetium(Tc-99m)mertiatid 2.16.840.1.113883.6.73 2017-01 V09CA04 technetium (99mTc) gluceptate Teknetium(Tc-99m)gluceptat 2.16.840.1.113883.6.73 2017-01 V09CA05 technetium (99mTc) gluconate Teknetium(Tc-99m)glukonat 2.16.840.1.113883.6.73 2017-01 V09CA06 technetium (99mTc) Teknetium(Tc-99m)etylendicystein ethylenedicysteine 2.16.840.1.113883.6.73 2017-01 V09CX Other renal system diagnostic Övriga diagnostiska radiofarmaka radiopharmaceuticals för det renala systemet 2.16.840.1.113883.6.73 2017-01 V09CX01 sodium iodohippurate (123I) Natriumjodhippurat(I-123) 2.16.840.1.113883.6.73 2017-01 V09CX02 sodium iodohippurate (131I) Natriumjodhippurat(I-131) 2.16.840.1.113883.6.73 2017-01 V09CX03 sodium iothalamate (125I) Natriumjotalamat(I-125) 2.16.840.1.113883.6.73 2017-01 V09CX04 (51Cr) edetate Krom(Cr-51)edetat 2.16.840.1.113883.6.73 2017-01 V09D HEPATIC AND RETICULO Hepatiska och retikuloendoteliala ENDOTHELIAL SYSTEM systemet 2.16.840.1.113883.6.73 2017-01 V09DA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09DA01 technetium (99mTc) disofenin Teknetium(Tc-99m)disofenin 2.16.840.1.113883.6.73 2017-01 V09DA02 technetium (99mTc) etifenin Teknetium(Tc-99m)etifenin 2.16.840.1.113883.6.73 2017-01 V09DA03 technetium (99mTc) lidofenin Teknetium(Tc-99m)lidofenin 2.16.840.1.113883.6.73 2017-01 V09DA04 technetium (99mTc) mebrofenin Teknetium(Tc-99m)mebrofenin 2.16.840.1.113883.6.73 2017-01 V09DA05 technetium (99mTc) galtifenin Teknetium(Tc-99m)galtifenin 2.16.840.1.113883.6.73 2017-01 V09DB Technetium (99mTc), particles and Teknetium(Tc-99m), partiklar och colloids kolloider 2.16.840.1.113883.6.73 2017-01 V09DB01 technetium (99mTc) nanocolloid Teknetium(Tc-99m)nanokolloid 2.16.840.1.113883.6.73 2017-01 V09DB02 technetium (99mTc) microcolloid Teknetium(Tc-99m)mikrokolloid 2.16.840.1.113883.6.73 2017-01 V09DB03 technetium (99mTc) Teknetium(Tc-99m)millimikrosfärer millimicrospheres 2.16.840.1.113883.6.73 2017-01 V09DB04 technetium (99mTc) tin colloid Teknetium(Tc-99m)tennkolloid 2.16.840.1.113883.6.73 2017-01 V09DB05 technetium (99mTc) sulfur colloid Teknetium(Tc-99m)svavelkolloid 2.16.840.1.113883.6.73 2017-01 V09DB06 technetium (99mTc) rheniumsulfide Teknetium(Tc- colloid 99m)rheniumsulfidkolloid 2.16.840.1.113883.6.73 2017-01 V09DB07 technetium (99mTc) phytate Teknetium(Tc-99m)fytat 2.16.840.1.113883.6.73 2017-01 V09DX Other hepatic and reticulo Övriga radiofarmaka för diagnostik endothelial system diagnostic av det hepatiska och radiopharmaceuticals retikuloendoteliala systemet 2.16.840.1.113883.6.73 2017-01 V09DX01 selenium (75Se) tauroselcholic acid Selenium(Se-75)tauroselcholsyra © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 161 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09E RESPIRATORY SYSTEM Andningsorganen 2.16.840.1.113883.6.73 2017-01 V09EA Technetium (99mTc), inhalants Teknetium(Tc-99m), inhalationer 2.16.840.1.113883.6.73 2017-01 V09EA01 technetium (99mTc) pentetic acid Teknetium(Tc-99m)pentetsyra 2.16.840.1.113883.6.73 2017-01 V09EA02 technetium (99mTc) technegas Teknetium(Tc-99m)teknegas 2.16.840.1.113883.6.73 2017-01 V09EA03 technetium (99mTc) nanocolloid Teknetium(Tc-99m)nanokolloid 2.16.840.1.113883.6.73 2017-01 V09EB Technetium (99mTc), particles for Teknetium(Tc-99m), partiklar för injection injektion 2.16.840.1.113883.6.73 2017-01 V09EB01 technetium (99mTc) macrosalb Teknetium(Tc-99m)makrosalb 2.16.840.1.113883.6.73 2017-01 V09EB02 technetium (99mTc) microspheres Teknetium(Tc-99m)mikrosfärer 2.16.840.1.113883.6.73 2017-01 V09EX Other respiratory system diagnostic Övriga diagnostiska radiofarmaka radiopharmaceuticals för andningsorganen 2.16.840.1.113883.6.73 2017-01 V09EX01 krypton (81mKr) gas Krypton (Kr-81m) gas 2.16.840.1.113883.6.73 2017-01 V09EX02 xenon (127Xe) gas Xenon(Xe-127)gas 2.16.840.1.113883.6.73 2017-01 V09EX03 xenon (133Xe) gas Xenon(Xe-133)gas 2.16.840.1.113883.6.73 2017-01 V09F THYROID Tyreoidea 2.16.840.1.113883.6.73 2017-01 V09FX Various thyroid diagnostic Övriga diagnostiska radiofarmaka radiopharmaceuticals för tyreoidea 2.16.840.1.113883.6.73 2017-01 V09FX01 technetium (99mTc) pertechnetate Teknetium(Tc-99m)perteknetat 2.16.840.1.113883.6.73 2017-01 V09FX02 sodium iodide (123I) Natriumjodid(I-123) 2.16.840.1.113883.6.73 2017-01 V09FX03 sodium iodide (131I) Natriumjodid(I-131) 2.16.840.1.113883.6.73 2017-01 V09FX04 sodium iodide (124I) Natriumjodid(I-124) 2.16.840.1.113883.6.73 2017-01 V09G CARDIOVASCULAR SYSTEM Hjärta och kretslopp 2.16.840.1.113883.6.73 2017-01 V09GA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09GA01 technetium (99mTc) sestamibi Teknetium(Tc-99m)sestamibi 2.16.840.1.113883.6.73 2017-01 V09GA02 technetium (99mTc) tetrofosmin Teknetium(Tc-99m)tetrofosmin 2.16.840.1.113883.6.73 2017-01 V09GA03 technetium (99mTc) teboroxime Teknetium(Tc-99m)teboroxim 2.16.840.1.113883.6.73 2017-01 V09GA04 technetium (99mTc) human albumin Teknetium(Tc-99m)albumin, humant 2.16.840.1.113883.6.73 2017-01 V09GA05 technetium (99mTc) furifosmin Teknetium(Tc-99m)furifosmin 2.16.840.1.113883.6.73 2017-01 V09GA06 technetium (99mTc) stannous agent Teknetium(Tc-99m)tennmärkta labelled cells celler 2.16.840.1.113883.6.73 2017-01 V09GA07 technetium (99mTc) apcitide Teknetium(Tc-99m)apcitid 2.16.840.1.113883.6.73 2017-01 V09GB Iodine (125I) compounds Jod(I-125)föreningar 2.16.840.1.113883.6.73 2017-01 V09GB01 fibrinogen (125I) Fibrinogen(I-125) 2.16.840.1.113883.6.73 2017-01 V09GB02 iodine (125I) human albumin Humant jod(I-125)albumin 2.16.840.1.113883.6.73 2017-01 V09GX Other cardiovascular system Övriga diagnostiska radiofarmaka diagnostic radiopharmaceuticals för det kardiovaskulära systemet 2.16.840.1.113883.6.73 2017-01 V09GX01 thallium (201Tl) chloride Tallium(Tl-201)klorid 2.16.840.1.113883.6.73 2017-01 V09GX02 indium (111In) imciromab Indium(In-111)imikromab 2.16.840.1.113883.6.73 2017-01 V09GX03 chromium (51Cr) chromate labelled Natriumkromat(Cr-51) cells 2.16.840.1.113883.6.73 2017-01 V09GX04 rubidium (82Rb) chloride Rubidium(Rb-82)klorid 2.16.840.1.113883.6.73 2017-01 V09H AND - och DETECTION infektionsdetektion 2.16.840.1.113883.6.73 2017-01 V09HA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09HA01 technetium (99mTc) human Teknetium(Tc-99m)immunglobulin, immunoglobulin humant © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 162 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09HA02 technetium (99mTc) exametazime Teknetium(Tc- labelled cells 99m)exametazimmärkta celler 2.16.840.1.113883.6.73 2017-01 V09HA03 technetium (99mTc) antigranulocyte Teknetium(Tc-99m)antigranulocyt antikropp 2.16.840.1.113883.6.73 2017-01 V09HA04 technetium (99mTc) sulesomab Teknetium(Tc-99m)sulesomab 2.16.840.1.113883.6.73 2017-01 V09HB Indium (111In) compounds Indium(In-111)föreningar 2.16.840.1.113883.6.73 2017-01 V09HB01 indium (111In) oxinate labelled cells Indium(In-111)oxin 2.16.840.1.113883.6.73 2017-01 V09HB02 indium (111In) tropolonate labelled Indium(In-111)tropolonatmärkta cells celler 2.16.840.1.113883.6.73 2017-01 V09HX Other diagnostic Övriga diagnostiska radiofarmaka radiopharmaceuticals for för inflammations- och inflammation and infection detection infektionsdetektion 2.16.840.1.113883.6.73 2017-01 V09HX01 gallium (67Ga) citrate Gallium(Ga-67)citrat 2.16.840.1.113883.6.73 2017-01 V09I TUMOUR DETECTION Tumördetektion 2.16.840.1.113883.6.73 2017-01 V09IA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09IA01 technetium (99mTc) Teknetium(Tc- antiCarcinoEmbryonicAntigen 99m)antiCarcinoEmbryoAntigen antibody antikropp 2.16.840.1.113883.6.73 2017-01 V09IA02 technetium (99mTc) antimelanoma Teknetium(Tc-99m)antimelanom antibody antikropp 2.16.840.1.113883.6.73 2017-01 V09IA03 technetium (99mTc) pentavalent Teknetium(Tc-99m)pentavalent succimer succimer 2.16.840.1.113883.6.73 2017-01 V09IA04 technetium (99mTc) votumumab Teknetium(Tc-99m)votumumab 2.16.840.1.113883.6.73 2017-01 V09IA05 technetium (99mTc) depreotide Teknetium(Tc-99m)depreotid 2.16.840.1.113883.6.73 2017-01 V09IA06 technetium (99mTc) arcitumomab Teknetium(Tc-99m)arcitumomab 2.16.840.1.113883.6.73 2017-01 V09IA07 technetium (99mTc) hynic- Teknetium(Tc-99m)hynik-oktreotid octreotide 2.16.840.1.113883.6.73 2017-01 V09IA08 technetium (99mTc) etarfolatide Teknetium(Tc-99m)etarfolatid 2.16.840.1.113883.6.73 2017-01 V09IA09 technetium (99mTc) tilmanocept Teknetium(Tc-99m)tilmanocept 2.16.840.1.113883.6.73 2017-01 V09IB Indium (111In) compounds Indium(In-111)föreningar 2.16.840.1.113883.6.73 2017-01 V09IB01 indium (111In) pentetreotide Indium(In-111)pentetreotid 2.16.840.1.113883.6.73 2017-01 V09IB02 indium (111In) satumomab Indium(In-111)satumomabpendetid pendetide 2.16.840.1.113883.6.73 2017-01 V09IB03 indium (111In) Indium(In-111)antiovariumkarcinom antiovariumcarcinoma antibody antikropp 2.16.840.1.113883.6.73 2017-01 V09IB04 indium (111In) capromab pendetide Indium(In-111)kapromabpentid 2.16.840.1.113883.6.73 2017-01 V09IX Other diagnostic Övriga diagnostiska radiofarmaka radiopharmaceuticals for tumour för tumördetektion detection 2.16.840.1.113883.6.73 2017-01 V09IX01 iobenguane (123I) Jobenguan(I-123) 2.16.840.1.113883.6.73 2017-01 V09IX02 iobenguane (131I) Jobenguan(I-131) 2.16.840.1.113883.6.73 2017-01 V09IX03 iodine (125I) CC49-monoclonal Jod (I-125) CC49-monoklonal antibody antikropp 2.16.840.1.113883.6.73 2017-01 V09IX04 fludeoxyglucose (18F) Fludeoxiglukos(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX05 fluorodopa (18F) Fluorodopa(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX06 sodium fluoride (18F) Natriumfluorid(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX07 fluoromethylcholine (18F) Fluorokolin(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX08 fluoroethylcholine (18F) Fluoroetylkolin(F-18)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 163 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09IX09 gallium (68Ga) edotreotide Gallium(Ga-68)edotreotid 2.16.840.1.113883.6.73 2017-01 V09IX10 fluoroethyl-L-tyrosine (18F) Fluoroetyl-L-tyrosin(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX11 fluoroestradiol (18F) Fluoroestradiol(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX12 fluciclovine (18F) Fluciklovin(F-18) 2.16.840.1.113883.6.73 2017-01 V09X OTHER DIAGNOSTIC Övriga diagnostiska radiofarmaka RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V09XA Iodine (131I) compounds Jod(I-131) föreningar 2.16.840.1.113883.6.73 2017-01 V09XA01 iodine (131I) norcholesterol Jod(I-131)norkolesterol 2.16.840.1.113883.6.73 2017-01 V09XA02 iodocholesterol (131I) Jodokolesterol(I-131) 2.16.840.1.113883.6.73 2017-01 V09XA03 iodine (131I) human albumin Jod(I-131)humanalbumin 2.16.840.1.113883.6.73 2017-01 V09XX Various diagnostic Diverse diagnostiska radiofarmaka radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V09XX01 (57Co) cyanocobalamine Cyanokobalamin(Co-57) 2.16.840.1.113883.6.73 2017-01 V09XX02 cobalt (58Co) cyanocobalamine Cyanokobalamin(Co-58) 2.16.840.1.113883.6.73 2017-01 V09XX03 selenium (75Se) norcholesterol Selen(Se-75)norkolesterol 2.16.840.1.113883.6.73 2017-01 V09XX04 ferric (59Fe) citrate Järn(Fe-59)citrat 2.16.840.1.113883.6.73 2017-01 V10 THERAPEUTIC Terapeutiska radiofarmaka RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V10A ANTIINFLAMMATORY AGENTS Antiinflammatoriska medel 2.16.840.1.113883.6.73 2017-01 V10AA Yttrium (90Y) compounds Yttrium(Y-90)föreningar 2.16.840.1.113883.6.73 2017-01 V10AA01 yttrium (90Y) citrate colloid Yttrium(Y-90)citratkolloid 2.16.840.1.113883.6.73 2017-01 V10AA02 yttrium (90Y) ferrihydroxide colloid Yttrium(Y-90)ferrihydroxidkolloid 2.16.840.1.113883.6.73 2017-01 V10AA03 yttrium (90Y) silicate colloid Yttrium(Y-90)silikatkolloid 2.16.840.1.113883.6.73 2017-01 V10AX Other antiinflammatory therapeutic Övriga antiinflammatoriska radiopharmaceuticals terapeutiska radiofarmaka 2.16.840.1.113883.6.73 2017-01 V10AX01 phosphorous (32P) Fosfor(P-32)kromfosfatkolloid chromicphosphate colloid 2.16.840.1.113883.6.73 2017-01 V10AX02 samarium (153Sm) hydroxyapatite Samarium(Sm- colloid 153)hydroxiapatitkolloid 2.16.840.1.113883.6.73 2017-01 V10AX03 dysprosium (165Dy) colloid Dysprosium(Dy-165)kolloid 2.16.840.1.113883.6.73 2017-01 V10AX04 erbium (169Er) citrate colloid Erbium(Er-169)citratkolloid 2.16.840.1.113883.6.73 2017-01 V10AX05 rhenium (186Re) sulfide colloid Rhenium(Re-186)sulfidkolloid 2.16.840.1.113883.6.73 2017-01 V10AX06 gold (198Au) colloidal Guld(Au-198), kolloidalt 2.16.840.1.113883.6.73 2017-01 V10B PAIN PALLIATION (BONE Smärtlindring (ben-sökande ämnen) SEEKING AGENTS) 2.16.840.1.113883.6.73 2017-01 V10BX Various pain palliation Diverse smärtlindrande radiopharmaceuticals radiofarmaka 2.16.840.1.113883.6.73 2017-01 V10BX01 strontium (89Sr) chloride Strontium(Sr-89)klorid 2.16.840.1.113883.6.73 2017-01 V10BX02 samarium (153Sm) lexidronam Samarium(Sm-153)lexidronam 2.16.840.1.113883.6.73 2017-01 V10BX03 rhenium (186Re) etidronic acid Rhenium(Re-186)etidronsyra 2.16.840.1.113883.6.73 2017-01 V10X OTHER THERAPEUTIC Övriga terapeutiska radiofarmaka RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V10XA Iodine (131I) compounds Jod(I-131) föreningar 2.16.840.1.113883.6.73 2017-01 V10XA01 sodium iodide (131I) Natriumjodid(I-131) 2.16.840.1.113883.6.73 2017-01 V10XA02 iobenguane (131I) Jobenguan(I-131)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 164 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V10XA53 tositumomab/iodine (131I) Tositumomab/jod(I- tositumomab 131)tositumomab 2.16.840.1.113883.6.73 2017-01 V10XX Various therapeutic Diverse terapeutiska radiofarmaka radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V10XX01 sodium phosphate (32P) Natriumfosfat(P-32) 2.16.840.1.113883.6.73 2017-01 V10XX02 ibritumomab tiuxetan (90Y) Ibritumomabtiuxetan(Y-90) 2.16.840.1.113883.6.73 2017-01 V10XX03 radium (223Ra) dichloride Radium(Ra-223)diklorid 2.16.840.1.113883.6.73 2017-01 V20 SURGICAL DRESSINGS Kirurgiska förband

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 165 of 624 Service Provider MTC epSOSAdministrativeGender

epSOSAdministrativeGender

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.34

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1 913-20091020 F Female Femme kvinna Femme 2.16.840.1.113883.5.1 913-20091020 M Male Male man Homme 2.16.840.1.113883.5.1 913-20091020 UN Undifferentiated Indifférencié odifferentierad Indifférencié

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 166 of 624 Service Provider MTC epSOSAdverseEventType

epSOSAdverseEventType

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.18

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 235719002 Food intolerance Intolérance alimentaire 2.16.840.1.113883.6.96 2016-07 29544009 Intolerance Intolérance 2.16.840.1.113883.6.96 2016-07 414285001 Food allergy Allergie alimentaire 2.16.840.1.113883.6.96 2016-07 416098002 allergy Allergie à un médicament 2.16.840.1.113883.6.96 2016-07 418038007 Propensity to adverse reactions to substance 2.16.840.1.113883.6.96 2016-07 418471000 Propensity to adverse reactions to food 2.16.840.1.113883.6.96 2016-07 419199007 Allergy to substance Allergie à une substance 2.16.840.1.113883.6.96 2016-07 419511003 Propensity to adverse reactions to drug 2.16.840.1.113883.6.96 2016-07 420134006 Propensity to adverse reactions 2.16.840.1.113883.6.96 2016-07 59037007 Drug intolerance Intolérance à un médicament

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 167 of 624 Service Provider MTC epSOSAllergenNoDrugs

epSOSAllergenNoDrugs

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.19

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 102259006 Citrus fruit 2.16.840.1.113883.6.96 2016-07 102261002 Strawberry 2.16.840.1.113883.6.96 2016-07 102262009 Chocolate 2.16.840.1.113883.6.96 2016-07 102263004 Eggs (edible) 2.16.840.1.113883.6.96 2016-07 102264005 Cheese 2.16.840.1.113883.6.96 2016-07 111088007 Latex 2.16.840.1.113883.6.96 2016-07 11526002 Aspartame 2.16.840.1.113883.6.96 2016-07 115589000 Ethanolamine 2.16.840.1.113883.6.96 2016-07 116273005 Dietary substance 2.16.840.1.113883.6.96 2016-07 116549003 Organochlorine pesticide 2.16.840.1.113883.6.96 2016-07 116637007 Fungal antigen 2.16.840.1.113883.6.96 2016-07 11894001 Clostridium botulinum toxin 2.16.840.1.113883.6.96 2016-07 119417004 2.16.840.1.113883.6.96 2016-07 12503006 Aluminium 2.16.840.1.113883.6.96 2016-07 12510000 Eucalyptus oil 2.16.840.1.113883.6.96 2016-07 128488006 House dust 2.16.840.1.113883.6.96 2016-07 128489003 Sand 2.16.840.1.113883.6.96 2016-07 13577000 Nut 2.16.840.1.113883.6.96 2016-07 13652007 Silicone 2.16.840.1.113883.6.96 2016-07 14402002 Wood 2.16.840.1.113883.6.96 2016-07 14423008 Adhesive bandage 2.16.840.1.113883.6.96 2016-07 226359003 - dietary 2.16.840.1.113883.6.96 2016-07 226491003 Apple juice 2.16.840.1.113883.6.96 2016-07 226760005 Dairy foods 2.16.840.1.113883.6.96 2016-07 226915003 Red meat 2.16.840.1.113883.6.96 2016-07 226934003 Pork 2.16.840.1.113883.6.96 2016-07 227037002 Fish - dietary 2.16.840.1.113883.6.96 2016-07 227144008 Tuna fish 2.16.840.1.113883.6.96 2016-07 227146005 Shellfish - dietary 2.16.840.1.113883.6.96 2016-07 227161006 Octopus - dietary 2.16.840.1.113883.6.96 2016-07 227163009 Squid - dietary 2.16.840.1.113883.6.96 2016-07 227252000 Mushroom - dietary

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 168 of 624 Service Provider MTC epSOSAllergenNoDrugs

2.16.840.1.113883.6.96 2016-07 227313005 Pulse vegetables 2.16.840.1.113883.6.96 2016-07 227344001 Broad bean - dietary 2.16.840.1.113883.6.96 2016-07 227374009 Herbs and spices 2.16.840.1.113883.6.96 2016-07 227388008 Cinnamon 2.16.840.1.113883.6.96 2016-07 227425007 Figs 2.16.840.1.113883.6.96 2016-07 227444000 Raspberries 2.16.840.1.113883.6.96 2016-07 230031005 Lobster - dietary 2.16.840.1.113883.6.96 2016-07 230032003 Oyster - dietary 2.16.840.1.113883.6.96 2016-07 230034002 Nuts and seeds 2.16.840.1.113883.6.96 2016-07 2309006 Gold 2.16.840.1.113883.6.96 2016-07 23182003 Cereal 2.16.840.1.113883.6.96 2016-07 255640000 Biocide 2.16.840.1.113883.6.96 2016-07 255667006 Paraffin 2.16.840.1.113883.6.96 2016-07 256259004 Pollen 2.16.840.1.113883.6.96 2016-07 256260009 Tree and shrub pollen 2.16.840.1.113883.6.96 2016-07 256277009 Grass pollen 2.16.840.1.113883.6.96 2016-07 256292005 Flower and weed pollen 2.16.840.1.113883.6.96 2016-07 256303006 Ragweed pollen 2.16.840.1.113883.6.96 2016-07 256305004 Tree resin 2.16.840.1.113883.6.96 2016-07 256307007 Banana 2.16.840.1.113883.6.96 2016-07 256309005 Peach - dietary 2.16.840.1.113883.6.96 2016-07 256310000 Cherry - dietary 2.16.840.1.113883.6.96 2016-07 256311001 Apple - dietary 2.16.840.1.113883.6.96 2016-07 256319004 Carrot 2.16.840.1.113883.6.96 2016-07 256323007 Onion - dietary 2.16.840.1.113883.6.96 2016-07 256326004 Celery 2.16.840.1.113883.6.96 2016-07 256327008 Tomato - dietary 2.16.840.1.113883.6.96 2016-07 256349002 Peanut - dietary 2.16.840.1.113883.6.96 2016-07 256352005 Walnut - nut 2.16.840.1.113883.6.96 2016-07 256355007 Soya bean 2.16.840.1.113883.6.96 2016-07 256417003 Horse dander 2.16.840.1.113883.6.96 2016-07 256419000 Mouse epithelium 2.16.840.1.113883.6.96 2016-07 256435007 Feathers 2.16.840.1.113883.6.96 2016-07 256440004 Wasp venom 2.16.840.1.113883.6.96 2016-07 256443002 Egg white 2.16.840.1.113883.6.96 2016-07 256504004 Polycarbonate dental material 2.16.840.1.113883.6.96 2016-07 260118006 Wall pellitory pollen 2.16.840.1.113883.6.96 2016-07 260126003 Olive pollen 2.16.840.1.113883.6.96 2016-07 260152009 Cat dander 2.16.840.1.113883.6.96 2016-07 260153004 Cow dander 2.16.840.1.113883.6.96 2016-07 260154005 Dog dander 2.16.840.1.113883.6.96 2016-07 260156007 Mouse urine proteins 2.16.840.1.113883.6.96 2016-07 260167008 Sesame seed © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 169 of 624 Service Provider MTC epSOSAllergenNoDrugs

2.16.840.1.113883.6.96 2016-07 260170007 Potato - dietary 2.16.840.1.113883.6.96 2016-07 260172004 Garlic - dietary 2.16.840.1.113883.6.96 2016-07 260176001 Kiwi fruit 2.16.840.1.113883.6.96 2016-07 260177005 Melon 2.16.840.1.113883.6.96 2016-07 261243003 Brass 2.16.840.1.113883.6.96 2016-07 264287008 Animal dander 2.16.840.1.113883.6.96 2016-07 264295007 Cow's milk protein 2.16.840.1.113883.6.96 2016-07 264337003 Seed 2.16.840.1.113883.6.96 2016-07 276310004 Animal hair 2.16.840.1.113883.6.96 2016-07 278840001 Shrimp product 2.16.840.1.113883.6.96 2016-07 2799001 Methylbenzethonium chloride 2.16.840.1.113883.6.96 2016-07 280939008 Insect venom 2.16.840.1.113883.6.96 2016-07 28230009 Poultry 2.16.840.1.113883.6.96 2016-07 28647000 Meat 2.16.840.1.113883.6.96 2016-07 288328004 Bee venom 2.16.840.1.113883.6.96 2016-07 289122001 Cosmetic material 2.16.840.1.113883.6.96 2016-07 289949002 Cypress pollen 2.16.840.1.113883.6.96 2016-07 303300008 Egg protein 2.16.840.1.113883.6.96 2016-07 303314008 Scorpion venom 2.16.840.1.113883.6.96 2016-07 303315009 Spider venom 2.16.840.1.113883.6.96 2016-07 31006001 Kingdom Plantae 2.16.840.1.113883.6.96 2016-07 311846002 insecticide 2.16.840.1.113883.6.96 2016-07 311984009 Chemical or external agent 2.16.840.1.113883.6.96 2016-07 33008008 Dust 2.16.840.1.113883.6.96 2016-07 33396006 Nickel 2.16.840.1.113883.6.96 2016-07 37017009 Helminth 2.16.840.1.113883.6.96 2016-07 3829006 Iron 2.16.840.1.113883.6.96 2016-07 386936005 Azelaic acid 2.16.840.1.113883.6.96 2016-07 387293003 Dithranol 2.16.840.1.113883.6.96 2016-07 387398009 Podophyllum resin 2.16.840.1.113883.6.96 2016-07 391737006 Almond oil 2.16.840.1.113883.6.96 2016-07 395922006 Wool 2.16.840.1.113883.6.96 2016-07 396031000 Dimeticone 2.16.840.1.113883.6.96 2016-07 406466009 House dust allergen 2.16.840.1.113883.6.96 2016-07 406470001 Insect allergen 2.16.840.1.113883.6.96 2016-07 406472009 Animal protein and epidermal allergen 2.16.840.1.113883.6.96 2016-07 406473004 Contact allergen 2.16.840.1.113883.6.96 2016-07 406771001 Sulphite and/or sulphite derivative 2.16.840.1.113883.6.96 2016-07 406774009 Fish derived omega 3 fatty acid 2.16.840.1.113883.6.96 2016-07 410853002 Perfluorochemical 2.16.840.1.113883.6.96 2016-07 412061001 Blueberries 2.16.840.1.113883.6.96 2016-07 412068007 Rye

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 170 of 624 Service Provider MTC epSOSAllergenNoDrugs

2.16.840.1.113883.6.96 2016-07 412069004 Flavouring agent 2.16.840.1.113883.6.96 2016-07 412071004 Wheat 2.16.840.1.113883.6.96 2016-07 412145001 Hair 2.16.840.1.113883.6.96 2016-07 412153009 Rabbit dander 2.16.840.1.113883.6.96 2016-07 412156001 2.16.840.1.113883.6.96 2016-07 412160003 Suture allergen 2.16.840.1.113883.6.96 2016-07 412161004 Wool 2.16.840.1.113883.6.96 2016-07 412357001 Corn 2.16.840.1.113883.6.96 2016-07 415710007 Terpene 2.16.840.1.113883.6.96 2016-07 418266005 Yellow paraffin 2.16.840.1.113883.6.96 2016-07 418504009 Oats 2.16.840.1.113883.6.96 2016-07 418785009 Perfume 2.16.840.1.113883.6.96 2016-07 418920007 Adhesive agent 2.16.840.1.113883.6.96 2016-07 419420009 Watermelon 2.16.840.1.113883.6.96 2016-07 419604006 Weed pollen 2.16.840.1.113883.6.96 2016-07 419633007 White paraffin 2.16.840.1.113883.6.96 2016-07 41967008 Silver 2.16.840.1.113883.6.96 2016-07 420111002 Contact agent 2.16.840.1.113883.6.96 2016-07 42416001 Lanolin 2.16.840.1.113883.6.96 2016-07 430503006 Glutamate 2.16.840.1.113883.6.96 2016-07 43230003 Rubber 2.16.840.1.113883.6.96 2016-07 43735007 Sulphur 2.16.840.1.113883.6.96 2016-07 44027008 Seafood 2.16.840.1.113883.6.96 2016-07 47703008 Lactose 2.16.840.1.113883.6.96 2016-07 51905005 Mustard 2.16.840.1.113883.6.96 2016-07 52454007 Albumin 2.16.840.1.113883.6.96 2016-07 57126000 Glue 2.16.840.1.113883.6.96 2016-07 59351004 Citrate 2.16.840.1.113883.6.96 2016-07 59533004 Food additive 2.16.840.1.113883.6.96 2016-07 59545008 Pesticide 2.16.840.1.113883.6.96 2016-07 61789006 Dye 2.16.840.1.113883.6.96 2016-07 66925006 Copper 2.16.840.1.113883.6.96 2016-07 67324005 Rice 2.16.840.1.113883.6.96 2016-07 72511004 Fruit 2.16.840.1.113883.6.96 2016-07 7791007 Soy protein 2.16.840.1.113883.6.96 2016-07 80237000 Cocoa butter 2.16.840.1.113883.6.96 2016-07 83619009 Polyvinyl alcohol 2.16.840.1.113883.6.96 2016-07 89811004 Gluten 2.16.840.1.113883.6.96 2016-07 89889006 fibre 2.16.840.1.113883.6.96 2016-07 9021002 2.16.840.1.113883.6.96 2016-07 91598004 Benzoyl peroxide

TRANSCODINGS © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 171 of 624 Service Provider MTC epSOSAllergenNoDrugs

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 172 of 624 Service Provider MTC epSOSBloodGroup

epSOSBloodGroup

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.20

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 112144000 Blood group A 2.16.840.1.113883.6.96 2016-07 112149005 Blood group B 2.16.840.1.113883.6.96 2016-07 165743006 Blood group AB 2.16.840.1.113883.6.96 2016-07 278147001 Blood group O Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278148006 Blood group O Rh(D) negative 2.16.840.1.113883.6.96 2016-07 278149003 Blood group A Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278150003 Blood group B Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278151004 Blood group AB Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278152006 Blood group A Rh(D) negative 2.16.840.1.113883.6.96 2016-07 278153001 Blood group B Rh(D) negative 2.16.840.1.113883.6.96 2016-07 278154007 Blood group AB Rh(D) negative 2.16.840.1.113883.6.96 2016-07 58460004 Blood group O

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 173 of 624 Service Provider MTC epSOSBloodPressure

epSOSBloodPressure

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.21

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.1 2.59 8462-4 Diastolic blood pressure 2.16.840.1.113883.6.1 2.59 8480-6 Systolic blood pressure

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 174 of 624 Service Provider MTC epSOSCodeProb

epSOSCodeProb

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.23

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 248536006 Finding of functional performance and activity 2.16.840.1.113883.6.96 2016-07 282291009 Diagnosis interpretation 2.16.840.1.113883.6.96 2016-07 404684003 Clinical finding 2.16.840.1.113883.6.96 2016-07 409586006 Complaint 2.16.840.1.113883.6.96 2016-07 418799008 Finding reported by subject or history provider 2.16.840.1.113883.6.96 2016-07 55607006 Problem 2.16.840.1.113883.6.96 2016-07 64572001 Disease

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 175 of 624 Service Provider MTC epSOSConfidentiality

epSOSConfidentiality

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.31

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.25 913-20091020 N normal Normal 2.16.840.1.113883.5.25 913-20091020 R restricted restreint Restreint 2.16.840.1.113883.5.25 913-20091020 V very restricted très restreint Confidentiel

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 176 of 624 Service Provider MTC epSOSCountry

epSOSCountry

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.4

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 1.0.3166.1 2006-2nd AD ANDORRA 1.0.3166.1 2006-2nd AE UNITED ARAB EMIRATES 1.0.3166.1 2006-2nd AF AFGHANISTAN 1.0.3166.1 2006-2nd AG ANTIGUA AND BARBUDA 1.0.3166.1 2006-2nd AI ANGUILLA 1.0.3166.1 2006-2nd AL ALBANIA 1.0.3166.1 2006-2nd AM ARMENIA 1.0.3166.1 2006-2nd AO ANGOLA 1.0.3166.1 2006-2nd AQ ANTARCTICA 1.0.3166.1 2006-2nd AR ARGENTINA 1.0.3166.1 2006-2nd AS AMERICAN SAMOA 1.0.3166.1 2006-2nd AT AUSTRIA 1.0.3166.1 2006-2nd AU AUSTRALIA 1.0.3166.1 2006-2nd AW ARUBA 1.0.3166.1 2006-2nd AX ÅLAND ISLANDS 1.0.3166.1 2006-2nd AZ AZERBAIJAN 1.0.3166.1 2006-2nd BA BOSNIA AND HERZEGOVINA 1.0.3166.1 2006-2nd BB BARBADOS 1.0.3166.1 2006-2nd BD BANGLADESH 1.0.3166.1 2006-2nd BE BELGIUM 1.0.3166.1 2006-2nd BF BURKINA FASO 1.0.3166.1 2006-2nd BG BULGARIA 1.0.3166.1 2006-2nd BH BAHRAIN 1.0.3166.1 2006-2nd BI BURUNDI 1.0.3166.1 2006-2nd BJ BENIN 1.0.3166.1 2006-2nd BL SAINT BARTHÉLEMY 1.0.3166.1 2006-2nd BM BERMUDA 1.0.3166.1 2006-2nd BN BRUNEI DARUSSALAM 1.0.3166.1 2006-2nd BO BOLIVIA (PLURINATIONAL STATE OF) 1.0.3166.1 2006-2nd BQ BONAIRE, SINT EUSTATIUS AND SABA 1.0.3166.1 2006-2nd BR BRAZIL © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 177 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd BS BAHAMAS 1.0.3166.1 2006-2nd BT BHUTAN 1.0.3166.1 2006-2nd BV BOUVET ISLAND 1.0.3166.1 2006-2nd BW BOTSWANA 1.0.3166.1 2006-2nd BY BELARUS 1.0.3166.1 2006-2nd BZ BELIZE 1.0.3166.1 2006-2nd CA CANADA 1.0.3166.1 2006-2nd CC COCOS (KEELING) ISLANDS 1.0.3166.1 2006-2nd CD CONGO, DEMOCRATIC REPUBLIC OF 1.0.3166.1 2006-2nd CF CENTRAL AFRICAN REPUBLIC 1.0.3166.1 2006-2nd CG CONGO 1.0.3166.1 2006-2nd CH SWITZERLAND 1.0.3166.1 2006-2nd CI COTE D'IVOIRE 1.0.3166.1 2006-2nd CK COOK ISLANDS 1.0.3166.1 2006-2nd CL CHILE 1.0.3166.1 2006-2nd CM CAMEROON 1.0.3166.1 2006-2nd CN CHINA 1.0.3166.1 2006-2nd CO COLOMBIA 1.0.3166.1 2006-2nd CR COSTA RICA 1.0.3166.1 2006-2nd CU CUBA 1.0.3166.1 2006-2nd CV CAPE VERDE 1.0.3166.1 2006-2nd CW CURACAO 1.0.3166.1 2006-2nd CX CHRISTMAS ISLAND 1.0.3166.1 2006-2nd CY CYPRUS 1.0.3166.1 2006-2nd CZ CZECH REPUBLIC 1.0.3166.1 2006-2nd DE GERMANY 1.0.3166.1 2006-2nd DJ DJIBOUTI 1.0.3166.1 2006-2nd DK DENMARK 1.0.3166.1 2006-2nd DM DOMINICA 1.0.3166.1 2006-2nd DO DOMINICAN REPUBLIC 1.0.3166.1 2006-2nd DZ ALGERIA 1.0.3166.1 2006-2nd EC ECUADOR 1.0.3166.1 2006-2nd EE ESTONIA 1.0.3166.1 2006-2nd EG EGYPT 1.0.3166.1 2006-2nd EH WESTERN SAHARA 1.0.3166.1 2006-2nd ER ERITREA 1.0.3166.1 2006-2nd ES SPAIN 1.0.3166.1 2006-2nd ET ETHIOPIA 1.0.3166.1 2006-2nd FI FINLAND 1.0.3166.1 2006-2nd FJ FIJI 1.0.3166.1 2006-2nd FK FALKLAND ISLANDS (MALVINAS) 1.0.3166.1 2006-2nd FM MICRONESIA (FEDERATED STATES OF) © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 178 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd FO FAROE ISLANDS 1.0.3166.1 2006-2nd FR FRANCE 1.0.3166.1 2006-2nd GA GABON 1.0.3166.1 2006-2nd GB UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND 1.0.3166.1 2006-2nd GD GRENADA 1.0.3166.1 2006-2nd GE GEORGIA 1.0.3166.1 2006-2nd GF FRENCH GUIANA 1.0.3166.1 2006-2nd GG GUERNSEY 1.0.3166.1 2006-2nd GH GHANA 1.0.3166.1 2006-2nd GI GIBRALTAR 1.0.3166.1 2006-2nd GL GREENLAND 1.0.3166.1 2006-2nd GM GAMBIA 1.0.3166.1 2006-2nd GN GUINEA 1.0.3166.1 2006-2nd GP GUADELOUPE 1.0.3166.1 2006-2nd GQ EQUATORIAL GUINEA 1.0.3166.1 2006-2nd GR GREECE 1.0.3166.1 2006-2nd GS SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS 1.0.3166.1 2006-2nd GT GUATEMALA 1.0.3166.1 2006-2nd GU GUAM 1.0.3166.1 2006-2nd GW GUINEA-BISSAU 1.0.3166.1 2006-2nd GY GUYANA 1.0.3166.1 2006-2nd HK HONG KONG 1.0.3166.1 2006-2nd HM HEARD ISLAND AND MCDONALD ISLANDS 1.0.3166.1 2006-2nd HN HONDURAS 1.0.3166.1 2006-2nd HR CROATIA 1.0.3166.1 2006-2nd HT HAITI 1.0.3166.1 2006-2nd HU HUNGARY 1.0.3166.1 2006-2nd ID INDONESIA 1.0.3166.1 2006-2nd IE IRELAND 1.0.3166.1 2006-2nd IL ISRAEL 1.0.3166.1 2006-2nd IM ISLE OF MAN 1.0.3166.1 2006-2nd IN INDIA 1.0.3166.1 2006-2nd IO BRITISH INDIAN OCEAN TERRITORY 1.0.3166.1 2006-2nd IQ IRAQ 1.0.3166.1 2006-2nd IR IRAN (ISLAMIC REPUBLIC OF) 1.0.3166.1 2006-2nd IS ICELAND 1.0.3166.1 2006-2nd IT ITALY 1.0.3166.1 2006-2nd JE JERSEY 1.0.3166.1 2006-2nd JM JAMAICA 1.0.3166.1 2006-2nd JO JORDAN © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 179 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd JP JAPAN 1.0.3166.1 2006-2nd KE KENYA 1.0.3166.1 2006-2nd KG KYRGYZSTAN 1.0.3166.1 2006-2nd KH CAMBODIA 1.0.3166.1 2006-2nd KI KIRIBATI 1.0.3166.1 2006-2nd KM COMOROS 1.0.3166.1 2006-2nd KN SAINT KITTS AND NEVIS 1.0.3166.1 2006-2nd KP KOREA (DEMOCRATIC PEOPLE'S REPUBLIC OF) 1.0.3166.1 2006-2nd KR KOREA, REPUBLIC OF 1.0.3166.1 2006-2nd KW KUWAIT 1.0.3166.1 2006-2nd KY CAYMAN ISLANDS 1.0.3166.1 2006-2nd KZ KAZAKHSTAN 1.0.3166.1 2006-2nd LA LAO PEOPLE'S DEMOCRATIC REPUBLIC 1.0.3166.1 2006-2nd LB LEBANON 1.0.3166.1 2006-2nd LC SAINT LUCIA 1.0.3166.1 2006-2nd LI LIECHTENSTEIN 1.0.3166.1 2006-2nd LK SRI LANKA 1.0.3166.1 2006-2nd LR LIBERIA 1.0.3166.1 2006-2nd LS LESOTHO 1.0.3166.1 2006-2nd LT LITHUANIA 1.0.3166.1 2006-2nd LU LUXEMBOURG 1.0.3166.1 2006-2nd LV LATVIA 1.0.3166.1 2006-2nd LY LIBYA 1.0.3166.1 2006-2nd MA MOROCCO 1.0.3166.1 2006-2nd MC MONACO 1.0.3166.1 2006-2nd MD MOLDOVA, REPUBLIC OF 1.0.3166.1 2006-2nd ME MONTENEGRO 1.0.3166.1 2006-2nd MF SAINT MARTIN (FRENCH PART) 1.0.3166.1 2006-2nd MG MADAGASCAR 1.0.3166.1 2006-2nd MH MARSHALL ISLANDS 1.0.3166.1 2006-2nd MK MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF 1.0.3166.1 2006-2nd ML MALI 1.0.3166.1 2006-2nd MM MYANMAR 1.0.3166.1 2006-2nd MN MONGOLIA 1.0.3166.1 2006-2nd MO MACAO 1.0.3166.1 2006-2nd MP NORTHERN MARIANA ISLANDS 1.0.3166.1 2006-2nd MQ MARTINIQUE 1.0.3166.1 2006-2nd MR MAURITANIA 1.0.3166.1 2006-2nd MS MONTSERRAT 1.0.3166.1 2006-2nd MT MALTA 1.0.3166.1 2006-2nd MU MAURITIUS

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 180 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd MV MALDIVES 1.0.3166.1 2006-2nd MW MALAWI 1.0.3166.1 2006-2nd MX MEXICO 1.0.3166.1 2006-2nd MY MALAYSIA 1.0.3166.1 2006-2nd MZ MOZAMBIQUE 1.0.3166.1 2006-2nd NA NAMIBIA 1.0.3166.1 2006-2nd NC NEW CALEDONIA 1.0.3166.1 2006-2nd NE NIGER 1.0.3166.1 2006-2nd NF NORFOLK ISLAND 1.0.3166.1 2006-2nd NG NIGERIA 1.0.3166.1 2006-2nd NI NICARAGUA 1.0.3166.1 2006-2nd NL NETHERLANDS 1.0.3166.1 2006-2nd NO NORWAY 1.0.3166.1 2006-2nd NP NEPAL 1.0.3166.1 2006-2nd NR NAURU 1.0.3166.1 2006-2nd NU NIUE 1.0.3166.1 2006-2nd NZ NEW ZEALAND 1.0.3166.1 2006-2nd OM OMAN 1.0.3166.1 2006-2nd PA PANAMA 1.0.3166.1 2006-2nd PE PERU 1.0.3166.1 2006-2nd PF FRENCH POLYNESIA 1.0.3166.1 2006-2nd PG PAPUA NEW GUINEA 1.0.3166.1 2006-2nd PH PHILIPPINES 1.0.3166.1 2006-2nd PK PAKISTAN 1.0.3166.1 2006-2nd PL POLAND 1.0.3166.1 2006-2nd PM SAINT PIERRE AND MIQUELON 1.0.3166.1 2006-2nd PN PITCAIRN 1.0.3166.1 2006-2nd PR PUERTO RICO 1.0.3166.1 2006-2nd PS PALESTINE, STATE OF 1.0.3166.1 2006-2nd PT PORTUGAL 1.0.3166.1 2006-2nd PW PALAU 1.0.3166.1 2006-2nd PY PARAGUAY 1.0.3166.1 2006-2nd QA QATAR 1.0.3166.1 2006-2nd RE REUNION 1.0.3166.1 2006-2nd RO ROMANIA 1.0.3166.1 2006-2nd RS SERBIA 1.0.3166.1 2006-2nd RU RUSSIAN FEDERATION 1.0.3166.1 2006-2nd RW RWANDA 1.0.3166.1 2006-2nd SA SAUDI ARABIA 1.0.3166.1 2006-2nd SB SOLOMON ISLANDS 1.0.3166.1 2006-2nd SC SEYCHELLES 1.0.3166.1 2006-2nd SD SUDAN 1.0.3166.1 2006-2nd SE SWEDEN © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 181 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd SG SINGAPORE 1.0.3166.1 2006-2nd SH SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA 1.0.3166.1 2006-2nd SI SLOVENIA 1.0.3166.1 2006-2nd SJ SVALBARD AND JAN MAYEN 1.0.3166.1 2006-2nd SK SLOVAKIA 1.0.3166.1 2006-2nd SL SIERRA LEONE 1.0.3166.1 2006-2nd SM SAN MARINO 1.0.3166.1 2006-2nd SN SENEGAL 1.0.3166.1 2006-2nd SO SOMALIA 1.0.3166.1 2006-2nd SR SURINAME 1.0.3166.1 2006-2nd SS SOUTH SUDAN 1.0.3166.1 2006-2nd ST SAO TOME AND PRINCIPE 1.0.3166.1 2006-2nd SV EL SALVADOR 1.0.3166.1 2006-2nd SX SINT MAARTEN (DUTCH PART) 1.0.3166.1 2006-2nd SY SYRIAN ARAB REPUBLIC 1.0.3166.1 2006-2nd SZ SWAZILAND 1.0.3166.1 2006-2nd TC TURKS AND CAICOS ISLANDS 1.0.3166.1 2006-2nd TD CHAD 1.0.3166.1 2006-2nd TF FRENCH SOUTHERN TERRITORIES 1.0.3166.1 2006-2nd TG TOGO 1.0.3166.1 2006-2nd TH THAILAND 1.0.3166.1 2006-2nd TJ TAJIKISTAN 1.0.3166.1 2006-2nd TK TOKELAU 1.0.3166.1 2006-2nd TL TIMOR-LESTE 1.0.3166.1 2006-2nd TM TURKMENISTAN 1.0.3166.1 2006-2nd TN TUNISIA 1.0.3166.1 2006-2nd TO TONGA 1.0.3166.1 2006-2nd TR TURKEY 1.0.3166.1 2006-2nd TT TRINIDAD AND TOBAGO 1.0.3166.1 2006-2nd TV TUVALU 1.0.3166.1 2006-2nd TW TAIWAN, PROVINCE OF CHINA 1.0.3166.1 2006-2nd TZ TANZANIA, UNITED REPUBLIC OF 1.0.3166.1 2006-2nd UA UKRAINE 1.0.3166.1 2006-2nd UG UGANDA 1.0.3166.1 2006-2nd UM UNITED STATES MINOR OUTLYING ISLANDS 1.0.3166.1 2006-2nd US UNITED STATES OF AMERICA 1.0.3166.1 2006-2nd UY URUGUAY 1.0.3166.1 2006-2nd UZ UZBEKISTAN 1.0.3166.1 2006-2nd VA HOLY SEE 1.0.3166.1 2006-2nd VC SAINT VINCENT AND THE GRENADINES

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 182 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd VE VENEZUELA (BOLIVARIAN REPUBLIC OF) 1.0.3166.1 2006-2nd VG VIRGIN ISLANDS, BRITISH 1.0.3166.1 2006-2nd VI VIRGIN ISLANDS, U.S. 1.0.3166.1 2006-2nd VN VIET NAM 1.0.3166.1 2006-2nd VU VANUATU 1.0.3166.1 2006-2nd WF WALLIS AND FUTUNA 1.0.3166.1 2006-2nd WS SAMOA 1.0.3166.1 2006-2nd YE YEMEN 1.0.3166.1 2006-2nd YT MAYOTTE 1.0.3166.1 2006-2nd ZA SOUTH AFRICA 1.0.3166.1 2006-2nd ZM ZAMBIA 1.0.3166.1 2006-2nd ZW ZIMBABWE

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 183 of 624 Service Provider MTC epSOSDisplayLabel

epSOSDisplayLabel

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.46

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 1 Active Ingredient 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 10 Clinical Manifestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 108 Original narrative 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 109 Translated coded 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 11 Closed/Inactive Problem 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 110 Clinical sections 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 111 Prescription and Dispensation details 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 112 Code System 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 113 Code 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 114 Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 115 Dispensed Number of packages 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 116 If substitution of brand name is marked as not allowed, pharmacists may still consider dispensing the national equivalent even though the brand name might be slightly different. This is a known situation: the same pharmaceutical company is marketing the same medicinal product in different countries with slightly different names due to marketing reasons. If the pharmacist is certain that this is the case, the systems allows the input of the new brand name. 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 117 Original Document Language 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 118 Diagnostic Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 119 Blood Group 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 12 Contact Information 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 120 Min 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 121 Max 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 122 Administered 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 123 Severity 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 13 Country 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 15 Creation Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 16 Custodian

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 184 of 624 Service Provider MTC epSOSDisplayLabel

1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 17 Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 18 Date To 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 19 Date of Birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 2 Active Problem 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 20 Date of Prescription 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 202 Mark the checkbox if brand name (when allowed) has been substituted or package size has been changed 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 21 Device/Implant 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 22 Dispense 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 23 Dispensed Package Size 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 24 Dispensed Product 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 25 Dose Form 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 26 End Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 27 Every 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 28 Facility ID 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 29 Facility Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 3 Address 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 30 Family Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 31 for 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 32 Frequency of Intakes 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 33 Gender 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 34 Given Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 35 Guardian 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 36 Implant Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 37 Instructions to patient 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 38 Is substitution of brand name allowed? 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 39 Last Update 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 4 Advise to the dispenser 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 40 Legal Authenticator 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 41 National Insurance Number 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 42 No 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 43 Number of packages 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 44 Observation Type 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 45 Onset Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 46 Organisation Identifier 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 47 Organisation Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 48 Other Active Ingredients 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 49 Other Contacts 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 5 Agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 50 Package Size 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 51 Patient

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 185 of 624 Service Provider MTC epSOSDisplayLabel

1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 52 Patient IDs 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 53 per unit 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 54 Preferred HCP/Legal organization to contact 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 55 Prefix 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 56 Prescriber 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 58 Prescription ID 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 6 at 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 62 Procedure 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 63 Procedure Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 64 Profession 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 65 Reaction Type 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 66 Regional/National Health ID 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 67 Route of Administration 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 68 See details 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 69 Specialty 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 7 Author (HCP) 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 70 Strength 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 71 Substitute 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 72 The Active Problem section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 73 The Allergies, adverse reactions, alerts section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 74 The Medical Devices and implants section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 75 The Medication Summary section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 76 The History of Procedures section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 77 unit(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 78 Units per intake 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 79 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 8 Authoring Device 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 80 Vaccination Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 81 Yes 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 84 Observation Value 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 85 Date From 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 9 Brand Name

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 186 of 624 Service Provider MTC epSOSDocumentCode

epSOSDocumentCode

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.32

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.1 2.59 34133-9 Summary of episode note Synthèse des notes épisodiques 2.16.840.1.113883.6.1 2.59 56445-0 Medication summary Document Synthèse médicamenteuse 2.16.840.1.113883.6.1 2.59 57016-8 Privacy policy acknowledgment Accord sur les politiques privées Document 2.16.840.1.113883.6.1 2.59 57833-6 Prescription for medication Prescription 2.16.840.1.113883.6.1 2.59 60591-5 Patient summary Document Volet de synthèse médicale Dossier Patient 2.16.840.1.113883.6.1 2.59 60593-1 Medication dispensed.extended Dispensation médicamenteuse Document

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 187 of 624 Service Provider MTC epSOSDoseForm

epSOSDoseForm

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.2

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 0.4.0.127.0.16.1.1.2.1 2017-04-14 10100500 Concentrate for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10101000 Oral drops, solution Orala droppar, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10102000 Oral drops, suspension Orala droppar, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10103000 Oral drops, emulsion Orala droppar, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10104000 Oral liquid Oral vätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10105000 Oral solution Oral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10106000 Oral suspension Oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10107000 Oral emulsion Oral emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10108000 Oral gel Oral gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10109000 Oral paste Oral pasta 0.4.0.127.0.16.1.1.2.1 2017-04-14 10110000 Powder for oral solution Pulver till oral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10111000 Powder for oral suspension Pulver till oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10112000 Granules for oral solution Granulat till oral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10113000 Granules for oral suspension Granulat till oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10114000 Powder and solvent for oral solution Pulver och vätska till oral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10115000 Powder and solvent for oral Pulver och vätska till oral suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10115500 Powder and solvent for syrup 0.4.0.127.0.16.1.1.2.1 2017-04-14 10117000 Syrup Sirap 0.4.0.127.0.16.1.1.2.1 2017-04-14 10118000 Powder for syrup Pulver till sirap 0.4.0.127.0.16.1.1.2.1 2017-04-14 10119000 Granules for syrup Granulat till sirap 0.4.0.127.0.16.1.1.2.1 2017-04-14 10120000 Soluble tablet Löslig tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10121000 Dispersible tablet Dispergerbar tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10121500 Dispersible tablets for dose dispenser 0.4.0.127.0.16.1.1.2.1 2017-04-14 10122000 Örtte 0.4.0.127.0.16.1.1.2.1 2017-04-14 10201000 Oral powder Oralt pulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10202000 Instant herbal tea Örtte, lösligt 0.4.0.127.0.16.1.1.2.1 2017-04-14 10203000 Effervescent powder Bruspulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10204000 Granules Granulat 0.4.0.127.0.16.1.1.2.1 2017-04-14 10205000 Effervescent granules Brusgranulat 0.4.0.127.0.16.1.1.2.1 2017-04-14 10206000 Gastro-resistant granules Enterogranulat 0.4.0.127.0.16.1.1.2.1 2017-04-14 10207000 Prolonged-release granules Depotgranulat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 188 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10208000 Modified-release granules Granulat med modifierad frisättning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10209000 Cachet Oblatkapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10210000 Capsule, hard Kapsel, hård 0.4.0.127.0.16.1.1.2.1 2017-04-14 10211000 Capsule, soft Kapsel, mjuk 0.4.0.127.0.16.1.1.2.1 2017-04-14 10212000 Gastro-resistant capsule, hard Enterokapsel, hård 0.4.0.127.0.16.1.1.2.1 2017-04-14 10213000 Gastro-resistant capsule, soft Enterokapsel, mjuk 0.4.0.127.0.16.1.1.2.1 2017-04-14 10214000 Chewable capsule, soft Tuggkapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10215000 Prolonged-release capsule, hard Depotkapsel, hård 0.4.0.127.0.16.1.1.2.1 2017-04-14 10216000 Prolonged-release capsule, soft Depotkapsel, mjuk 0.4.0.127.0.16.1.1.2.1 2017-04-14 10217000 Modified-release capsule, hard Kapsel med modifierad frisättning, hård 0.4.0.127.0.16.1.1.2.1 2017-04-14 10218000 Modified-release capsule, soft 0.4.0.127.0.16.1.1.2.1 2017-04-14 10219000 Tablet Tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10220000 Coated tablet Dragerad tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10221000 Film-coated tablet Filmdragerad tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10222000 Effervescent tablet Brustablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10223000 Orodispersible tablet Munsönderfallande tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10224000 Oral lyophilisate Frystorkad tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10225000 Gastro-resistant tablet Enterotablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10226000 Prolonged-release tablet Depottablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10227000 Modified-release tablet Tablett med modifierad frisättning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10228000 Chewable tablet Tuggtablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10229000 Medicated chewing-gum Medicinskt tuggummi 0.4.0.127.0.16.1.1.2.1 2017-04-14 10230000 Oral gum 0.4.0.127.0.16.1.1.2.1 2017-04-14 10231000 Pillules Granuler 0.4.0.127.0.16.1.1.2.1 2017-04-14 10236100 Orodispersible film 0.4.0.127.0.16.1.1.2.1 2017-04-14 10301000 Gargle Gurgelvatten 0.4.0.127.0.16.1.1.2.1 2017-04-14 10302000 Concentrate for gargle Koncentrat till gurgelvatten 0.4.0.127.0.16.1.1.2.1 2017-04-14 10303000 Gargle, powder for solution Gurgelvatten, pulver till lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10304000 Gargle, tablet for solution Gurgelvatten, tablett till lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10305000 Oromucosal solution Munhålelösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10306000 Oromucosal suspension Munhålesuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10307000 Oromucosal drops Munhåledroppar 0.4.0.127.0.16.1.1.2.1 2017-04-14 10308100 Oromucosal spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10308200 Oromucosal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10308300 Oromucosal spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10309100 Sublingual spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10309200 Sublingual spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10309300 Sublingual spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10310000 Munsköljvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10311000 Mouthwash, tablet for solution Munsköljvätska, tablett till lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10312000 Gingival solution Tandköttslösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10313000 Oromucosal gel Munhålegel

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 189 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10314000 Oromucosal paste Munhålepasta 0.4.0.127.0.16.1.1.2.1 2017-04-14 10314005 Oromucosal ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 10314010 Oromucosal cream Munhålekräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10314011 Buccal film 0.4.0.127.0.16.1.1.2.1 2017-04-14 10315000 Gingival gel Tandköttsgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10316000 Gingival paste Tandköttspasta 0.4.0.127.0.16.1.1.2.1 2017-04-14 10317000 Oromucosal capsule Munhålekapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10317500 Sublingual film 0.4.0.127.0.16.1.1.2.1 2017-04-14 10318000 Sublingual tablet Resoriblett, sublingual 0.4.0.127.0.16.1.1.2.1 2017-04-14 10319000 Muco-adhesive buccal tablet Buckaltablett, häftande 0.4.0.127.0.16.1.1.2.1 2017-04-14 10320000 Buccal tablet Buckaltablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10321000 Lozenge Sugtablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10322000 Compressed lozenge Komprimerad sugtablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10323000 Pastille Pastill 0.4.0.127.0.16.1.1.2.1 2017-04-14 10401000 Periodontal powder Periodontalpulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10401500 Dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10402000 Dental gel Dentalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10403000 Dental stick Dentalstift 0.4.0.127.0.16.1.1.2.1 2017-04-14 10405000 Dental powder Dentalpulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10406000 Dental solution Dentallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10407000 Dental suspension Dentalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10408000 Dental emulsion Dentalemulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10409000 Toothpaste Tandkräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10410000 Periodontal gel Periodontalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10411000 Periodontal insert 0.4.0.127.0.16.1.1.2.1 2017-04-14 10412000 Powder and solution for dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10413000 Powder for dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10414000 Solution for dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10501000 Bath additive Badtillsats 0.4.0.127.0.16.1.1.2.1 2017-04-14 10502000 Cream Kräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10503000 Gel Gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10504000 Ointment Salva 0.4.0.127.0.16.1.1.2.1 2017-04-14 10505000 Cutaneous paste Kutan pasta 0.4.0.127.0.16.1.1.2.1 2017-04-14 10506000 Medicated plaster Medicinskt plåster 0.4.0.127.0.16.1.1.2.1 2017-04-14 10507000 Cutaneous foam Kutant skum 0.4.0.127.0.16.1.1.2.1 2017-04-14 10508000 Shampoo Schampo 0.4.0.127.0.16.1.1.2.1 2017-04-14 10509000 Cutaneous spray, solution Kutan spray, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10510000 Cutaneous spray, suspension Kutan spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10511000 Cutaneous spray, powder Kutan spray, pulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10512000 Cutaneous liquid Kutan vätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10513000 Cutaneous solution Kutan lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10514000 Concentrate for cutaneous solution Koncentrat till kutan lösning

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 190 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10514500 Powder for cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10515000 Cutaneous suspension Kutan suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10516000 Cutaneous emulsion Kutan emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10517000 Cutaneous powder Puder 0.4.0.127.0.16.1.1.2.1 2017-04-14 10517500 Cutaneous patch Kutant plåster 0.4.0.127.0.16.1.1.2.1 2017-04-14 10518000 Solution for iontophoresis Lösning för jontofores 0.4.0.127.0.16.1.1.2.1 2017-04-14 10518500 Powder for solution for iontophoresis 0.4.0.127.0.16.1.1.2.1 2017-04-14 10519000 Transdermal patch Depotplåster 0.4.0.127.0.16.1.1.2.1 2017-04-14 10520000 Collodion Kollodium 0.4.0.127.0.16.1.1.2.1 2017-04-14 10521000 Medicated nail lacquer Medicinskt nagellack 0.4.0.127.0.16.1.1.2.1 2017-04-14 10522000 Poultice Medicinskt omslag 0.4.0.127.0.16.1.1.2.1 2017-04-14 10523000 Cutaneous stick Kutant stift 0.4.0.127.0.16.1.1.2.1 2017-04-14 10525000 Impregnated Salvkompress 0.4.0.127.0.16.1.1.2.1 2017-04-14 10546250 Transdermal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10546400 Transdermal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10546500 Transdermal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10547000 Transdermal system 0.4.0.127.0.16.1.1.2.1 2017-04-14 10548000 Solution for skin-prick test Lösning för pricktest 0.4.0.127.0.16.1.1.2.1 2017-04-14 10549000 Solution for skin-scratch test Lösning för risttest 0.4.0.127.0.16.1.1.2.1 2017-04-14 10550000 Plaster for provocation test Plåster för provokationstest 0.4.0.127.0.16.1.1.2.1 2017-04-14 10600500 Concentrate for solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 10601000 Eye cream Ögonkräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10602000 Eye gel Ögongel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10603000 Eye ointment Ögonsalva 0.4.0.127.0.16.1.1.2.1 2017-04-14 10604000 Eye drops, solution Ögondroppar, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10604500 Eye drops, emulsion Ögondroppar, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10605000 Eye drops, suspension Ögondroppar, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10606000 Eye drops, powder and solvent for Ögondroppar, pulver och vätska till solution lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10607000 Eye drops, powder and solvent for Ögondroppar, pulver och vätska till suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10608000 Eye drops, solvent for reconstitution Vätska för beredning av ögondroppar 0.4.0.127.0.16.1.1.2.1 2017-04-14 10609000 Eye drops, prolonged-release Depotögondroppar 0.4.0.127.0.16.1.1.2.1 2017-04-14 10610000 Eye lotion Ögonsköljvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10611000 Eye lotion, solvent for reconstitution Vätska för beredning av ögonsköljvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10612000 Ophthalmic insert Ögonlamell 0.4.0.127.0.16.1.1.2.1 2017-04-14 10613000 Ophthalmic strip 0.4.0.127.0.16.1.1.2.1 2017-04-14 10701000 Ear cream Öronkräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10702000 Ear gel Örongel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10703000 Ear ointment Öronsalva 0.4.0.127.0.16.1.1.2.1 2017-04-14 10704000 Ear drops, solution Örondroppar, lösning

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 191 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10705000 Ear drops, suspension Örondroppar, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10706000 Ear drops, emulsion Örondroppar, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10707000 Ear drops, powder and solvent for Örondroppar, pulver och vätska till suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10708000 Ear powder Öronpulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10709000 Ear spray, solution Öronspray, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10710000 Ear spray, suspension Öronspray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10711000 Ear spray, emulsion Öronspray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10712000 Ear wash, solution Öronsköljvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10713000 Ear wash, emulsion Öronsköljvätska, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10714000 Ear tampon Örontampong 0.4.0.127.0.16.1.1.2.1 2017-04-14 10715000 Ear stick Öronstift 0.4.0.127.0.16.1.1.2.1 2017-04-14 10801000 Nasal cream Näskräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10802000 Nasal gel Näsgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10803000 Nasal ointment Nässalva 0.4.0.127.0.16.1.1.2.1 2017-04-14 10804000 Nasal drops, solution Näsdroppar, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10805000 Nasal drops, suspension Näsdroppar, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10806000 Nasal drops, emulsion Näsdroppar, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10807000 Nasal powder Näspulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10808000 Nasal spray, solution Nässpray, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10809000 Nasal spray, suspension Nässpray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10810000 Nasal spray, emulsion Nässpray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10811000 Nasal wash Nässköljvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10812000 Nasal stick Nässtift 0.4.0.127.0.16.1.1.2.1 2017-04-14 10901000 Vaginal cream Vaginalkräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10902000 Vaginal gel Vaginalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10903000 Vaginal ointment Vaginalsalva 0.4.0.127.0.16.1.1.2.1 2017-04-14 10904000 Vaginal foam Vaginalskum 0.4.0.127.0.16.1.1.2.1 2017-04-14 10905000 Vaginal solution Vaginallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10906000 Vaginal suspension Vaginalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10907000 Vaginal emulsion Vaginalemulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10908000 Tablet for vaginal solution Tablett till vaginallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10909000 Pessary Vagitorium 0.4.0.127.0.16.1.1.2.1 2017-04-14 10910000 Vaginal capsule, hard Vaginalkapsel, hård 0.4.0.127.0.16.1.1.2.1 2017-04-14 10911000 Vaginal capsule, soft Vaginalkapsel, mjuk 0.4.0.127.0.16.1.1.2.1 2017-04-14 10912000 Vaginal tablet Vaginaltablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10913000 Effervescent vaginal tablet Vaginal brustablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10914000 Medicated vaginal tampon Vaginaltampong 0.4.0.127.0.16.1.1.2.1 2017-04-14 10915000 Vaginal delivery system Vaginalinlägg 0.4.0.127.0.16.1.1.2.1 2017-04-14 11001000 Rectal cream Rektalkräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 11002000 Rectal gel Rektalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11003000 Rectal ointment Rektalsalva 0.4.0.127.0.16.1.1.2.1 2017-04-14 11004000 Rectal foam Rektalskum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 192 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 11005000 Rectal solution Rektallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11006000 Rectal suspension Rektalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11007000 Rectal emulsion Rektalemulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11008000 Concentrate for rectal solution Koncentrat till rektallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11009000 Powder for rectal solution Pulver till rektallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11010 Oral drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 11010000 Powder for rectal suspension Pulver till rektalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11011000 Tablet for rectal solution Tablett till rektallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11012000 Tablet for rectal suspension Tablett till rektalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11013000 Suppository Suppositorium 0.4.0.127.0.16.1.1.2.1 2017-04-14 11014000 Rectal capsule Rektalkapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11015000 Rectal tampon Rektaltampong 0.4.0.127.0.16.1.1.2.1 2017-04-14 11101000 Nebuliser solution Lösning för nebulisator 0.4.0.127.0.16.1.1.2.1 2017-04-14 11102000 Nebuliser suspension Suspension för nebulisator 0.4.0.127.0.16.1.1.2.1 2017-04-14 11103000 Powder for nebuliser suspension Pulver till suspension för nebulisator 0.4.0.127.0.16.1.1.2.1 2017-04-14 11104000 Powder for nebuliser solution Pulver till lösning för nebulisator 0.4.0.127.0.16.1.1.2.1 2017-04-14 11105000 Nebuliser emulsion Emulsion för nebulisator 0.4.0.127.0.16.1.1.2.1 2017-04-14 11106000 Pressurised inhalation, solution Inhalationsspray, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11107000 Pressurised inhalation, suspension Inhalationsspray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11108000 Pressurised inhalation, emulsion Inhalationsspray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11109000 Inhalation powder Inhalationspulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 11110000 Inhalation powder, hard capsule Inhalationspulver, hård kapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11111000 Inhalation powder, pre-dispensed Inhalationspulver, avdelad dos 0.4.0.127.0.16.1.1.2.1 2017-04-14 11112000 Inhalation vapour, powder Inhalationsånga, pulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 11113000 Inhalation vapour, capsule Inhalationsånga, kapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11114000 Inhalation vapour, solution Inhalationsånga, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11115000 Inhalation vapour, tablet Inhalationsånga, tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 11116000 Inhalation vapour, ointment Inhalationsånga, salva 0.4.0.127.0.16.1.1.2.1 2017-04-14 11117000 Inhalation vapour, liquid Inhalationsånga, vätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 11201000 Solution for injection Injektionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11202000 Suspension for injection Injektionsvätska, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11203000 Emulsion for injection Injektionsvätska, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11204000 Gel for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11205000 Powder for solution for injection Pulver till injektionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11206000 Powder for suspension for injection Pulver till injektionsvätska, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11207000 Powder and solvent for solution for Pulver och vätska till injection injektionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11208000 Powder and solvent for suspension Pulver och vätska till for injection injektionsvätska, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11208400 Powder for prolonged-release suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11208500 Prolonged-release suspension for injection

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 193 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 11209000 Concentrate for solution for injection Koncentrat till injektionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11209500 Solution for cardioplegia 0.4.0.127.0.16.1.1.2.1 2017-04-14 11210000 Solution for infusion Infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11210500 Solution for infusion in Infusionsvätska, lösning i administration system administreringssats 0.4.0.127.0.16.1.1.2.1 2017-04-14 11211000 Emulsion for infusion Infusionsvätska, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11211500 Powder for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11212000 Powder for solution for infusion Pulver till infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11213000 Concentrate for solution for infusion Koncentrat till infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11214000 Powder and solvent for solution for Pulver och vätska till infusion infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11216000 Solvent for parenteral use Spädningsvätska för parenteral användning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11301000 Implant Implantat 0.4.0.127.0.16.1.1.2.1 2017-04-14 11302000 Implantation tablet Tablett för implantation 0.4.0.127.0.16.1.1.2.1 2017-04-14 11303000 Implantation chain Kedja för implantation 0.4.0.127.0.16.1.1.2.1 2017-04-14 11303300 Implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 11303500 Implantation suspension Suspension för implantation 0.4.0.127.0.16.1.1.2.1 2017-04-14 11304000 Powder and solvent for implantation paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 11401000 Solution for peritoneal dialysis Peritonealdialysvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 11402000 Solution for haemofiltration Hemofiltrationsvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 11403000 Solution for haemodiafiltration Hemodiafiltrationsvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 11404000 Solution for haemodialysis Hemodialysvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 11405000 Concentrate for solution for Hemodialyskoncentrat haemodialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 11502000 Bladder irrigation Spolvätska för urinblåsan 0.4.0.127.0.16.1.1.2.1 2017-04-14 11502500 Intravesical solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11503000 Powder for bladder irrigation Pulver till spolvätska för urinblåsan 0.4.0.127.0.16.1.1.2.1 2017-04-14 11504000 Urethral gel Uretralgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11505000 Urethral stick Uretralstift 0.4.0.127.0.16.1.1.2.1 2017-04-14 11601000 Endotracheopulmonary instillation, Instillationsvätska för luftvägarna, solution lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11602000 Endotracheopulmonary instillation, Instillationsvätska för luftvägarna, powder for solution pulver till lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11603000 Endotracheopulmonary instillation, Instillationsvätska för luftvägarna, suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11604000 Endotracheopulmonary instillation, powder and solvent for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11605000 Endotracheopulmonary instillation, powder and solvent for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11701000 Endocervical gel Endocervikalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11702000 Powder and solvent for endocervical Pulver och vätska till gel endocervikalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11901000 Intrauterine delivery system Intrauterint inlägg 0.4.0.127.0.16.1.1.2.1 2017-04-14 12100 Capsule © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 194 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 12101000 Denture lacquer 0.4.0.127.0.16.1.1.2.1 2017-04-14 12102000 and preservative solution for blood 0.4.0.127.0.16.1.1.2.1 2017-04-14 12103000 Solution for blood fraction Lösning för modifiering av modification blodfraktion 0.4.0.127.0.16.1.1.2.1 2017-04-14 12104000 Wound stick Sårstift 0.4.0.127.0.16.1.1.2.1 2017-04-14 12105000 Radiopharmaceutical precursor Stamlösning till radioaktiva läkemedel 0.4.0.127.0.16.1.1.2.1 2017-04-14 12106000 Radionuclide generator Radionuklidgenerator 0.4.0.127.0.16.1.1.2.1 2017-04-14 12107000 Kit for radiopharmaceutical Beredningssats för radioaktiva preparation läkemedel 0.4.0.127.0.16.1.1.2.1 2017-04-14 12108000 Gastroenteral solution Gastroenteral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 12110000 Gastroenteral suspension Gastroenteral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 12111000 Gastroenteral emulsion Gastroenteral emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 12111500 Intraperitoneal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 12112000 Solution for organ preservation Vätska för organförvaring 0.4.0.127.0.16.1.1.2.1 2017-04-14 12113000 Irrigation solution Spolvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 12114000 irrigation Magspolvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 12115000 Sealant Vävnadslim 0.4.0.127.0.16.1.1.2.1 2017-04-14 12115100 Sealant matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 12115200 Sealant powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 12116000 Powder and solvent for sealant Pulver och vätska till vävnadslim 0.4.0.127.0.16.1.1.2.1 2017-04-14 12117000 Impregnated pad Impregnerad kudde 0.4.0.127.0.16.1.1.2.1 2017-04-14 12117500 Impregnated plug 0.4.0.127.0.16.1.1.2.1 2017-04-14 12118000 Living tissue equivalent 0.4.0.127.0.16.1.1.2.1 2017-04-14 12119000 Medicated sponge Medicinerad svamp 0.4.0.127.0.16.1.1.2.1 2017-04-14 12120 Gastro-resistant capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 12120000 Intestinal gel Intestinal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 12130000 Medicated thread 0.4.0.127.0.16.1.1.2.1 2017-04-14 12131000 Solution for provocation test Lösning för provokationstest 0.4.0.127.0.16.1.1.2.1 2017-04-14 12150 Prolonged-release capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 12301000 Medicinal gas, compressed Medicinsk gas, komprimerad 0.4.0.127.0.16.1.1.2.1 2017-04-14 12302000 Medicinal gas, cryogenic Medicinsk gas, kryogen 0.4.0.127.0.16.1.1.2.1 2017-04-14 12303000 Medicinal gas, liquefied Medicinsk gas, flytande 0.4.0.127.0.16.1.1.2.1 2017-04-14 13001000 Concentrate for concentrate for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13002000 Concentrate for nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13003000 Concentrate for oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13004000 Concentrate for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13005000 Dispersion for concentrate for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13006000 Ear drops, powder for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13007000 Effervescent granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13008000 Emulsion for emulsion for injection © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 195 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 13009000 Endotracheopulmonary instillation, powder for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13010000 Eye drops, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13011000 Eye drops, powder for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13012000 Gas for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13013000 Gas for dispersion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13014000 Gel for gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13015000 Granules for rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13016000 Laryngopharyngeal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13017000 Laryngopharyngeal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13018000 Matrix for implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 13020000 Nasal drops, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13021000 Powder for gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13022000 Powder for dental gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13023000 Powder for dispersion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13024000 Powder for endocervical gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13025000 Powder for endosinusial solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13026000 Powder for gingival gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13027000 Powder for implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 13028000 Powder for implantation paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 13029000 Powder for intraocular instillation solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13031000 Powder for sealant 0.4.0.127.0.16.1.1.2.1 2017-04-14 13032000 Powder for solution for skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 13033000 Solution for solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13035000 Solvent for... 0.4.0.127.0.16.1.1.2.1 2017-04-14 13036000 Suspension for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13037000 Suspension for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13039000 Suspension for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13040000 Powder for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13041000 Endosinusial solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13042000 Epilesional solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13043000 Implantation paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 13044000 Intraocular instillation solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13045000 Intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13046000 Coated granules 0.4.0.127.0.16.1.1.2.1 2017-04-14 13047000 Solution for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13048000 Granules for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13049000 Dispersion for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13050 Oromucosal liquid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 196 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 13050000 Gas for dispersion for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13051000 Solution for injection/skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 13052000 Powder for solution for injection/skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 13053000 Solution for injection in administration system 0.4.0.127.0.16.1.1.2.1 2017-04-14 13057000 Powder and solvent for prolonged- release suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 13060000 Powder for oral/rectal suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 14050 Dental liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 15090 Cutaneous spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 16040 Eye drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 17040 Ear drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 17090 Ear spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 17120 Ear wash 0.4.0.127.0.16.1.1.2.1 2017-04-14 18040 Nasal drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 18080 Nasal spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 19050 Vaginal liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 19100 Vaginal capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 20050 Enema 0.4.0.127.0.16.1.1.2.1 2017-04-14 21010 Nebuliser liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 21060 Pressurised inhalation 0.4.0.127.0.16.1.1.2.1 2017-04-14 21140 Inhalation vapour 0.4.0.127.0.16.1.1.2.1 2017-04-14 22010 Injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 22030 Powder for concentrate 0.4.0.127.0.16.1.1.2.1 2017-04-14 22050 Powder for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 22060 Powder for prolonged-release injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 22090 Sterile concentrate 0.4.0.127.0.16.1.1.2.1 2017-04-14 22100 Infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 22120 Powder for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 26010 Endotracheopulmonary instillation 0.4.0.127.0.16.1.1.2.1 2017-04-14 30047500 Pouch 0.4.0.127.0.16.1.1.2.1 2017-04-14 31030 Blood fraction modifier 0.4.0.127.0.16.1.1.2.1 2017-04-14 31080 Gastroenteral liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 50001000 Chewable/dispersible tablet Tuggtablett/dispergerbar tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 50001250 Coated granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50002000 Concentrate and solvent for Koncentrat och vätska till koncentrat concentrate for solution for infusion till infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50003000 Concentrate and solvent for cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50006000 Concentrate and solvent for solution Koncentrat och vätska till for infusion infusionsvätska, lösning

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 197 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50007000 Concentrate and solvent for solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50007500 Concentrate and solvent for solution for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50008000 Concentrate and solvent for Koncentrat och vätska till suspension for injection injektionsvätska, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009000 Concentrate for cutaneous spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009300 Concentrate for dispersion for Koncentrat till infusionsvätska, infusion dispersion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009500 Concentrate for emulsion for Koncentrat till infusionsvätska, infusion emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009750 Concentrate for intravesical solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50010000 Concentrate for oral solution Koncentrat till oral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50011000 Concentrate for oral/rectal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50013250 Concentrate for solution for peritoneal dialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 50015200 Cutaneous/nasal ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 50015450 Cutaneous solution/concentrate for oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50015500 Cutaneous spray, emulsion Kutan spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50016000 Cutaneous spray, ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017000 Dental paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017200 Ear drops, solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017500 Dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017550 Ear drops, suspension in single- dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50018000 Ear/eye drops, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50018500 Ear/eye drops, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50019000 Ear/eye ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 50019500 Ear/eye/nasal drops, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50020200 Ear/nasal drops, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50021000 Emulsion for injection/infusion Injektionsvätska/infusionsvätska, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50021250 Emulsion for injection/infusion in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50021500 Emulsion and suspension for Emulsion och suspension till emulsion for injection injektionsvätska, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50022000 Endosinusial wash, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50022500 Eye drops, prolonged-release solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023000 Eye drops, solution in single-dose Ögondroppar, lösning i container endosbehållare 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023100 Eye drops, suspension in single- dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023300 Eye gel in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023400 Eye ointment in single-dose container

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 198 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50023700 Film-coated tablet and gastro- resistant granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50024000 Gargle/mouthwash 0.4.0.127.0.16.1.1.2.1 2017-04-14 50024500 Gargle/nasal wash 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026000 Gastro-resistant granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026150 Gastro-resistant granules for oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026400 Gel in pressurised container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026500 Granules and solvent for oral Granulat och vätska till oral suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50027000 Granules and solvent for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029150 Granules for oral/rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029170 Granules for oral solution in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029200 Granules for oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029500 Granules for vaginal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029550 Granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029700 Herbal tea in bag Örtte i påse 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029750 Implant in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50030000 Inhalation powder, tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50031000 Inhalation vapour, effervescent tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50032000 Inhalation vapour, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033000 Inhalation vapour, impregnated pad 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033100 Inhalation vapour, impregnated plug 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033400 Intravesical solution/solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033500 Intravitreal implant in applicator Intravitrealt implantat i applikator 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036000 Modified-release granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036050 Mouthwash, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036200 Nasal drops, solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036500 Nasal/oromucosal solution Näs-/munhålelösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036700 Nasal/oromucosal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037100 Nasal spray, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037250 Nasal spray, solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037400 Nasal spray, solution/oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037500 Oral drops, granules for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037600 Oral emulsion in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037700 Oral paste in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037750 Oral drops, liquid Orala droppar, vätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037800 Oral powder in sachet

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 199 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50037900 Oral/rectal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038000 Oral/rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038500 Oral solution/concentrate for nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038600 Oral solution in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038650 Oral solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038700 Oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50039000 Oromucosal patch 0.4.0.127.0.16.1.1.2.1 2017-04-14 50039300 Oromucosal powder in pouch Munhålepulver i portionspåse 0.4.0.127.0.16.1.1.2.1 2017-04-14 50039500 Oromucosal/laryngopharyngeal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50040500 Oromucosal/laryngopharyngeal solution/spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50041000 Pillules in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50041200 Powder and gel for gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 50041500 Powder and solution for solution for Pulver och lösning till injection injektionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50042000 Powder and solvent for concentrate Pulver och vätska till koncentrat till for solution for infusion infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50043000 Powder for concentrate for solution Pulver till koncentrat till for infusion infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50044000 Powder and solvent for cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50044500 Powder and solvent for dispersion Pulver och vätska till for injection injektionsvätska, dispersion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50044700 Powder and solvent for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50045000 Powder and solvent for endosinusial solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50045500 Powder and solvent for epilesional solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50046000 Powder and solvent for gingival gel Pulver och vätska till tandköttsgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047000 Powder and solvent for intraocular Pulver och vätska till instillation solution instillationsvätska, lösning för intraokulär användning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047500 Powder and solvent for intravesical Pulver och vätska till intravesikal solution lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047600 Powder and solvent for intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047650 Nasal drops, powder and solvent for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047700 Powder and solvent for nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048000 Powder and solvent for prolonged- Pulver och vätska till release suspension for injection injektionsvätska, depotsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048010 Powder and solvent for prolonged- release suspension for injection in pre-filled pen 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048050 Powder and solvent for solution for injection in cartridge © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 200 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50048150 Powder and solvent for solution for injection in pre-filled pen 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048250 Powder and solvent for solution for Pulver och vätska till injection in pre-filled syringe injektionsvätska, lösning i förfylld spruta 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048270 Powder and solvent for solution for injection/skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048300 Powder and solvent for suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048500 Powder and suspension for Pulver och suspension till suspension for injection injektionsvätska, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048600 Powder, dispersion and solvent for concentrate for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048750 Powder for concentrate for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049100 Powder for concentrate for intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049200 Powder for concentrate for solution for haemodialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049250 Powder for concentrate for solution for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049270 Powder for dental solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049300 Powder for epilesional solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049500 Powder for implantation suspension Pulver till suspension för implantation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50050000 Powder for intravesical solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50050500 Powder for intravesical solution/solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50051000 Powder for intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50052000 Powder for oral/rectal suspension Pulver till oral / rektalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50052500 Powder for oral solution in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50053500 Powder for solution for Pulver till injektions- injection/infusion /infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50055350 Powder, solvent and matrix for implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056000 Prolonged-release granules for oral Depotgranulat för oral suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056150 Prolonged-release granules for oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056200 Prolonged-release granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056250 Prolonged-release suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056500 Radiopharmaceutical precursor, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056600 Solution and suspension for suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50057000 Solution for haemodialysis/haemofiltration

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 201 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50058500 Solution for infusion in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060000 Solution for injection/infusion Injektionsvätska, lösning / infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060100 Solution for injection in cartridge Injektionsvätska, lösning i cylinderampull 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060150 Solution for injection in needle-free injector 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060200 Solution for injection in pre-filled pen Injektionsvätska, lösning i förfylld injektionspenna 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060300 Solution for injection in pre-filled Injektionsvätska, lösning i förfylld syringe spruta 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060500 Solution for injection/infusion in pre- Injektions- / infusionsvätska, lösning filled syringe i förfylld spruta 0.4.0.127.0.16.1.1.2.1 2017-04-14 50061500 Solution for sealant Lösningar till vävnadslim 0.4.0.127.0.16.1.1.2.1 2017-04-14 50062000 Suspension and effervescent Suspension och brusgranulat för granules for oral suspension oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50062500 Suspension and solution for spray Suspension och lösning till spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 50063100 Suspension for injection in cartridge Injektionsvätska, suspension i cylinderampull 0.4.0.127.0.16.1.1.2.1 2017-04-14 50063200 Suspension for injection in pre-filled Injektionsvätska, suspension i pen förfylld injektionspenna 0.4.0.127.0.16.1.1.2.1 2017-04-14 50063300 Suspension for injection in pre-filled Injektionsvätska, suspension i syringe förfylld spruta 0.4.0.127.0.16.1.1.2.1 2017-04-14 50064000 Tablet and solvent for rectal Tablett och vätska till suspension rektalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50065000 Tablet and powder for oral solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50071000 Powder and solvent for dental gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 50073000 Powder for solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50073500 Solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50074000 Solvent for solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50076000 Solvent for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50077000 Dispersion for injection Injektionsvätska, dispersion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50078000 Gas and solvent for dispersion for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50079000 Concentrate for solution for Koncentrat till injektions- injection/infusion /infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50080000 Powder and solvent for solution for Pulver och vätska till injektions- injection/infusion /infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50081000 Inhalation solution Inhalationsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50082000 Oral drops, powder for suspension

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 202 of 624 Service Provider MTC epSOSDoseForm

Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 203 of 624 Service Provider MTC epSOSHealthcareProfessionalRoles

epSOSHealthcareProfessionalRoles

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.1

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.2.9.6.2.7 2008 22 Health professionals Professionnels de Santé 2.16.840.1.113883.2.9.6.2.7 2008 221 Medical doctors Docteurs Läkare 2.16.840.1.113883.2.9.6.2.7 2008 2211 Generalist medical practitioners Médecins Généraliste 2.16.840.1.113883.2.9.6.2.7 2008 2212 Specialist medical practitioners Médecin Spécialisé 2.16.840.1.113883.2.9.6.2.7 2008 222 Nursing and midwifery professionals Infirmières et Auxiliaires de Santé 2.16.840.1.113883.2.9.6.2.7 2008 2221 Nursing professionals Infirmières Sjuksköterska 2.16.840.1.113883.2.9.6.2.7 2008 2222 Midwifery professionals Auxiliaires de Santé Barnmorska 2.16.840.1.113883.2.9.6.2.7 2008 223 Traditional and complementary Médecins Traditionnel et medicine professionals Complémentaire 2.16.840.1.113883.2.9.6.2.7 2008 224 Paramedical practitioners Médecins Paramédical 2.16.840.1.113883.2.9.6.2.7 2008 225 Veterinarians Vétérinaires 2.16.840.1.113883.2.9.6.2.7 2008 226 Other health professionals Autres Professionnels de Santé 2.16.840.1.113883.2.9.6.2.7 2008 2261 Dentists Dentiste Tandläkare 2.16.840.1.113883.2.9.6.2.7 2008 2262 Pharmacists Pharmaciens Farmaceut 2.16.840.1.113883.2.9.6.2.7 2008 2263 Environmental and occupational Professionnels Environnement et health and hygiene professionals Hygiène et Santé Public 2.16.840.1.113883.2.9.6.2.7 2008 2264 Physiotherapists Physiothérapeutes 2.16.840.1.113883.2.9.6.2.7 2008 2265 Dieticians and nutritionists Diététiciens et Nutritionnistes 2.16.840.1.113883.2.9.6.2.7 2008 2266 Audiologists and speech therapists Audio-logistes et Orthophonistes 2.16.840.1.113883.2.9.6.2.7 2008 2267 Optometrists and ophthalmic Opticiens opticians 2.16.840.1.113883.2.9.6.2.7 2008 2269 Health professionals not elsewhere classified 2.16.840.1.113883.2.9.6.2.7 2008 32 Health associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 321 Medical and pharmaceutical technicians 2.16.840.1.113883.2.9.6.2.7 2008 3211 Medical imaging and therapeutic equipment technicians 2.16.840.1.113883.2.9.6.2.7 2008 3212 Medical and pathology laboratory technicians 2.16.840.1.113883.2.9.6.2.7 2008 3213 Pharmaceutical technicians and assistants 2.16.840.1.113883.2.9.6.2.7 2008 3214 Medical and dental prosthetic technicians 2.16.840.1.113883.2.9.6.2.7 2008 322 Nursing and midwifery associate professionals © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 204 of 624 Service Provider MTC epSOSHealthcareProfessionalRoles

2.16.840.1.113883.2.9.6.2.7 2008 3221 Nursing associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 3222 Midwifery associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 323 Traditional and complementary medicine associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 325 Other health associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 3251 Dental assistants and therapists tandhygienist 2.16.840.1.113883.2.9.6.2.7 2008 3252 Medical records and health information technicians 2.16.840.1.113883.2.9.6.2.7 2008 3253 Community health workers 2.16.840.1.113883.2.9.6.2.7 2008 3254 Dispensing opticians 2.16.840.1.113883.2.9.6.2.7 2008 3255 Physiotherapy technicians and assistants 2.16.840.1.113883.2.9.6.2.7 2008 3256 Medical assistants 2.16.840.1.113883.2.9.6.2.7 2008 3257 Environmental and occupational health inspectors and associates 2.16.840.1.113883.2.9.6.2.7 2008 3258 Ambulance workers Ambulanciers 2.16.840.1.113883.2.9.6.2.7 2008 3259 Health associate professionals not elsewhere classified

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 205 of 624 Service Provider MTC epSOSIllnessesandDisorders

epSOSIllnessesandDisorders

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.5

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00 Cholera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00.1 Cholera due to Vibrio cholerae 01, biovar eltor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00.9 Cholera, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01 Typhoid and paratyphoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.0 Typhoid fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.1 Paratyphoid fever A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.2 Paratyphoid fever B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.3 Paratyphoid fever C 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.4 Paratyphoid fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02 Other salmonella infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.0 Salmonella enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.1 Salmonella sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.2 Localized salmonella infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.8 Other specified salmonella infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.9 Salmonella infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03 Shigellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.0 Shigellosis due to Shigella dysenteriae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.1 Shigellosis due to Shigella flexneri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.2 Shigellosis due to Shigella boydii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.3 Shigellosis due to Shigella sonnei 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.8 Other shigellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.9 Shigellosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04 Other bacterial intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.0 Enteropathogenic Escherichia coli infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.1 Enterotoxigenic Escherichia coli infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.2 Enteroinvasive Escherichia coli infection

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 206 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.3 Enterohaemorrhagic Escherichia coli infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.4 Other intestinal Escherichia coli infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.5 Campylobacter enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.6 Enteritis due to Yersinia enterocolitica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.7 Enterocolitis due to Clostridium difficile 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.8 Other specified bacterial intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.9 Bacterial intestinal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05 Other bacterial foodborne intoxications, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.0 Foodborne staphylococcal intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.1 Botulism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.2 Foodborne Clostridium perfringens [Clostridium welchii] intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.3 Foodborne Vibrio parahaemolyticus intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.4 Foodborne Bacillus cereus intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.8 Other specified bacterial foodborne intoxications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.9 Bacterial foodborne intoxication, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06 Amoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.0 Acute amoebic dysentery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.1 Chronic intestinal amoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.2 Amoebic nondysenteric colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.3 Amoeboma of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.4 Amoebic liver abscessK77.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.5 Amoebic lung abscessJ99.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.6 Amoebic brain abscessG07 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.7 Cutaneous amoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.8 Amoebic infection of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.9 Amoebiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07 Other protozoal intestinal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.1 Giardiasis [lambliasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.8 Other specified protozoal intestinal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.9 Protozoal intestinal disease, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 207 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08 Viral and other specified intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.0 Rotaviral enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.1 Acute gastroenteropathy due to Norwalk agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.2 Adenoviral enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.3 Other viral enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.4 Viral intestinal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.5 Other specified intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A09 Other gastroenteritis and colitis of infectious and unspecified origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A09.0 Other and unspecified gastroenteritis and colitis of infectious origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A09.9 Gastroenteritis and colitis of unspecified origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15 Respiratory tuberculosis, bacteriologically and histologically confirmed 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.0 Tuberculosis of lung, confirmed by sputum microscopy with or without culture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.1 Tuberculosis of lung, confirmed by culture only 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.2 Tuberculosis of lung, confirmed histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.3 Tuberculosis of lung, confirmed by unspecified means 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.4 Tuberculosis of intrathoracic lymph nodes, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.5 Tuberculosis of larynx, trachea and bronchus, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.6 Tuberculous pleurisy, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.7 Primary respiratory tuberculosis, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.8 Other respiratory tuberculosis, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.9 Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.0 Tuberculosis of lung, bacteriologically and histologically negative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.1 Tuberculosis of lung, bacteriological and histological examination not done © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 208 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.2 Tuberculosis of lung, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.3 Tuberculosis of intrathoracic lymph nodes, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.4 Tuberculosis of larynx, trachea and bronchus, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.5 Tuberculous pleurisy, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.7 Primary respiratory tuberculosis without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.8 Other respiratory tuberculosis, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.9 Respiratory tuberculosis unspecified, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17 Tuberculosis of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.0 Tuberculous meningitisG01 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.1 Meningeal tuberculomaG07 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.8 Other tuberculosis of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.9 Tuberculosis of nervous system, unspecifiedG99.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18 Tuberculosis of other organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.0 Tuberculosis of bones and joints 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.1 Tuberculosis of genitourinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.2 Tuberculous peripheral lymphadenopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.3 Tuberculosis of intestines, peritoneum and mesenteric glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.4 Tuberculosis of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.5 Tuberculosis of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.6 Tuberculosis of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.7 Tuberculosis of adrenal glandsE35.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.8 Tuberculosis of other specified organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19 Miliary tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.0 Acute miliary tuberculosis of a single specified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.1 Acute miliary tuberculosis of multiple sites

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 209 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.2 Acute miliary tuberculosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.8 Other miliary tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.9 Miliary tuberculosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20 Plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.0 Bubonic plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.1 Cellulocutaneous plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.2 Pneumonic plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.3 Plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.7 Septicaemic plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.8 Other forms of plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.9 Plague, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21 Tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.0 Ulceroglandular tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.1 Oculoglandular tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.2 Pulmonary tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.3 Gastrointestinal tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.7 Generalized tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.8 Other forms of tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.9 Tularaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22 Anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.0 Cutaneous anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.1 Pulmonary anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.2 Gastrointestinal anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.7 Anthrax sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.8 Other forms of anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.9 Anthrax, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23 Brucellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.0 Brucellosis due to Brucella melitensis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.1 Brucellosis due to Brucella abortus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.2 Brucellosis due to Brucella suis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.3 Brucellosis due to Brucella canis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.8 Other brucellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.9 Brucellosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24 Glanders and melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.0 Glanders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.1 Acute and fulminating melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.2 Subacute and chronic melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.3 Other melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.4 Melioidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25 Rat-bite fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25.0 Spirillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25.1 Streptobacillosis © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 210 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25.9 Rat-bite fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26 Erysipeloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.0 Cutaneous erysipeloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.7 Erysipelothrix sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.8 Other forms of erysipeloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.9 Erysipeloid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27 Leptospirosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27.0 Leptospirosis icterohaemorrhagica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27.8 Other forms of leptospirosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27.9 Leptospirosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28 Other zoonotic bacterial diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.0 Pasteurellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.1 Cat-scratch disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.2 Extraintestinal yersiniosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.8 Other specified zoonotic bacterial diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.9 Zoonotic bacterial disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30 Leprosy [Hansen disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.0 Indeterminate leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.1 Tuberculoid leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.2 Borderline tuberculoid leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.3 Borderline leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.4 Borderline lepromatous leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.5 Lepromatous leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.8 Other forms of leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.9 Leprosy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31 Infection due to other mycobacteria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.0 Pulmonary mycobacterial infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.1 Cutaneous mycobacterial infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.8 Other mycobacterial infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.9 Mycobacterial infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32 Listeriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.0 Cutaneous listeriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.1 Listerial meningitis and meningoencephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.7 Listerial sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.8 Other forms of listeriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.9 Listeriosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A33 Tetanus neonatorum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A34 Obstetrical tetanus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A35 Other tetanus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36 Diphtheria

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 211 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.0 Pharyngeal diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.1 Nasopharyngeal diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.2 Laryngeal diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.3 Cutaneous diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.8 Other diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.9 Diphtheria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37 Whooping cough 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.0 Whooping cough due to Bordetella pertussis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.1 Whooping cough due to Bordetella parapertussis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.8 Whooping cough due to other Bordetella species 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.9 Whooping cough, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A38 Scarlet fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39 Meningococcal infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.0 Meningococcal meningitisG01 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.1 Waterhouse-Friderichsen syndromeE35.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.2 Acute meningococcaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.3 Chronic meningococcaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.4 Meningococcaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.5 Meningococcal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.8 Other meningococcal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.9 Meningococcal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40 Streptococcal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.0 Sepsis due to , group A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.1 Sepsis due to streptococcus, group B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.2 Sepsis due to streptococcus, group D 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.3 Sepsis due to 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.8 Other streptococcal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.9 Streptococcal sepsis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41 Other sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.0 Sepsis due to Staphylococcus aureus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.1 Sepsis due to other specified staphylococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.2 Sepsis due to unspecified staphylococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.3 Sepsis due to Haemophilus influenzae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.4 Sepsis due to anaerobes

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 212 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.5 Sepsis due to other Gram-negative organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.8 Other specified sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.9 Sepsis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42 Actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.0 Pulmonary actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.1 Abdominal actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.2 Cervicofacial actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.7 Actinomycotic sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.8 Other forms of actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.9 Actinomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43 Nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.0 Pulmonary nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.1 Cutaneous nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.8 Other forms of nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.9 Nocardiosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44 Bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.0 Systemic bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.1 Cutaneous and mucocutaneous bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.8 Other forms of bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.9 Bartonellosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A46 Erysipelas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48 Other bacterial diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.0 Gas gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.1 Legionnaires disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.2 Nonpneumonic Legionnaires disease [Pontiac fever] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.3 Toxic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.4 Brazilian purpuric fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.8 Other specified bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49 Bacterial infection of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.0 Staphylococcal infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.1 Streptococcal and enterococcal infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.2 Haemophilus influenzae infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.3 Mycoplasma infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.8 Other bacterial infections of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.9 Bacterial infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50 Congenital syphilis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 213 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.0 Early congenital syphilis, symptomatic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.1 Early congenital syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.2 Early congenital syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.3 Late congenital syphilitic oculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.4 Late congenital neurosyphilis [juvenile neurosyphilis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.5 Other late congenital syphilis, symptomatic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.6 Late congenital syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.7 Late congenital syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.9 Congenital syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51 Early syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.0 Primary genital syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.1 Primary anal syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.2 Primary syphilis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.3 Secondary syphilis of skin and mucous membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.4 Other secondary syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.5 Early syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.9 Early syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52 Late syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.0 Cardiovascular syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.1 Symptomatic neurosyphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.2 Asymptomatic neurosyphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.3 Neurosyphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.7 Other symptomatic late syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.8 Late syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.9 Late syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A53 Other and unspecified syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A53.0 Latent syphilis, unspecified as early or late 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A53.9 Syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54 Gonococcal infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.0 Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.1 Gonococcal infection of lower genitourinary tract with periurethral and accessory gland abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.2 Gonococcal pelviperitonitis and other gonococcal genitourinary infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.3 Gonococcal infection of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.4 Gonococcal infection of musculoskeletal system

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 214 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.5 Gonococcal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.6 Gonococcal infection of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.8 Other gonococcal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.9 Gonococcal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A55 Chlamydial lymphogranuloma (venereum) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56 Other sexually transmitted chlamydial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.0 Chlamydial infection of lower genitourinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.1 Chlamydial infection of pelviperitoneum and other genitourinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.2 Chlamydial infection of genitourinary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.3 Chlamydial infection of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.4 Chlamydial infection of pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.8 Sexually transmitted chlamydial infection of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A57 Chancroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A58 Granuloma inguinale 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59 Trichomoniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59.0 Urogenital trichomoniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59.8 Trichomoniasis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59.9 Trichomoniasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60 Anogenital herpesviral [herpes simplex] infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60.0 Herpesviral infection of genitalia and urogenital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60.1 Herpesviral infection of perianal skin and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60.9 Anogenital herpesviral infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A63 Other predominantly sexually transmitted diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A63.0 Anogenital (venereal) warts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A63.8 Other specified predominantly sexually transmitted diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A64 Unspecified sexually transmitted disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A65 Nonvenereal syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66 Yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.0 Initial lesions of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.1 Multiple papillomata and wet crab yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.2 Other early skin lesions of yaws

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 215 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.3 Hyperkeratosis of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.4 Gummata and ulcers of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.5 Gangosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.6 Bone and joint lesions of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.7 Other manifestations of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.8 Latent yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.9 Yaws, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67 Pinta [carate] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.0 Primary lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.1 Intermediate lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.2 Late lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.3 Mixed lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.9 Pinta, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68 Relapsing fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68.0 Louse-borne relapsing fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68.1 Tick-borne relapsing fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68.9 Relapsing fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69 Other spirochaetal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.0 Necrotizing ulcerative stomatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.1 Other Vincent infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.2 Lyme disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.8 Other specified spirochaetal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.9 Spirochaetal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A70 Chlamydia psittaci infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71 Trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71.0 Initial stage of trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71.1 Active stage of trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71.9 Trachoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74 Other diseases caused by chlamydiae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74.0 Chlamydial conjunctivitisH13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74.8 Other chlamydial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74.9 Chlamydial infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75 Typhus fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.0 Epidemic louse-borne typhus fever due to Rickettsia prowazekii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.1 Recrudescent typhus [Brill disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.2 Typhus fever due to Rickettsia typhi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.3 Typhus fever due to Rickettsia tsutsugamushi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.9 Typhus fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77 Spotted fever [tick-borne rickettsioses]

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 216 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.0 Spotted fever due to Rickettsia rickettsii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.1 Spotted fever due to Rickettsia conorii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.2 Spotted fever due to Rickettsia sibirica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.3 Spotted fever due to Rickettsia australis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.8 Other spotted fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.9 Spotted fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A78 Q fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79 Other rickettsioses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.0 Trench fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.1 Rickettsialpox due to Rickettsia akari 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.8 Other specified rickettsioses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.9 Rickettsiosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80 Acute poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.0 Acute paralytic poliomyelitis, vaccine-associated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.1 Acute paralytic poliomyelitis, wild virus, imported 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.2 Acute paralytic poliomyelitis, wild virus, indigenous 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.3 Acute paralytic poliomyelitis, other and unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.4 Acute nonparalytic poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.9 Acute poliomyelitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81 Atypical virus infections of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.0 Creutzfeldt-Jakob disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.1 Subacute sclerosing panencephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.2 Progressive multifocal leukoencephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.8 Other atypical virus infections of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.9 Atypical virus infection of central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82 Rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82.0 Sylvatic rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82.1 Urban rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82.9 Rabies, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83 Mosquito-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.0 Japanese encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.1 Western equine encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.2 Eastern equine encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.3 St Louis encephalitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 217 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.4 Australian encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.5 California encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.6 Rocio virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.8 Other mosquito-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.9 Mosquito-borne viral encephalitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84 Tick-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.0 Far Eastern tick-borne encephalitis [Russian spring-summer encephalitis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.1 Central European tick-borne encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.8 Other tick-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.9 Tick-borne viral encephalitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85 Other viral encephalitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.0 Enteroviral encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.1 Adenoviral encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.2 Arthropod-borne viral encephalitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.8 Other specified viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A86 Unspecified viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87 Viral meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.0 Enteroviral meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.1 Adenoviral meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.2 Lymphocytic choriomeningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.8 Other viral meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.9 Viral meningitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88 Other viral infections of central nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88.0 Enteroviral exanthematous fever [Boston exanthem] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88.1 Epidemic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88.8 Other specified viral infections of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A89 Unspecified viral infection of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92 Other mosquito-borne viral fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.0 Chikungunya virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.1 O'nyong-nyong fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.2 Venezuelan equine fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.3 West Nile virus infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.4 Rift Valley fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.8 Other specified mosquito-borne viral fevers

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 218 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.9 Mosquito-borne viral fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93 Other arthropod-borne viral fevers, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.0 Oropouche virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.1 Sandfly fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.2 Colorado tick fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.8 Other specified arthropod-borne viral fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A94 Unspecified arthropod-borne viral fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95 Yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95.0 Sylvatic yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95.1 Urban yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95.9 Yellow fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96 Arenaviral haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.0 Junin haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.1 Machupo haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.2 Lassa fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.8 Other arenaviral haemorrhagic fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.9 Arenaviral haemorrhagic fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97 Dengue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.0 Dengue without warning signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.1 Dengue with warning signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.2 Severe Dengue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.9 Dengue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98 Other viral haemorrhagic fevers, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.0 Crimean-Congo haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.1 Omsk haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.2 Kyasanur Forest disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.3 Marburg virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.4 virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.5 Haemorrhagic fever with renal syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.8 Other specified viral haemorrhagic fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A99 Unspecified viral haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00 Herpesviral [herpes simplex] infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.0 Eczema herpeticum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.1 Herpesviral vesicular dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 219 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.3 Herpesviral meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.4 Herpesviral encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.5 Herpesviral ocular disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.7 Disseminated herpesviral disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.8 Other forms of herpesviral infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.9 Herpesviral infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01 Varicella [chickenpox] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.0 Varicella meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.1 Varicella encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.2 Varicella pneumoniaJ17.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.8 Varicella with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.9 Varicella without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02 Zoster [herpes zoster] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.0 Zoster encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.1 Zoster meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.2 Zoster with other nervous system involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.3 Zoster ocular disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.7 Disseminated zoster 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.8 Zoster with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.9 Zoster without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B03 Smallpox 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B04 Monkeypox 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05 Measles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.0 Measles complicated by encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.1 Measles complicated by meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.2 Measles complicated by pneumoniaJ17.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.3 Measles complicated by otitis mediaH67.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.4 Measles with intestinal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.8 Measles with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.9 Measles without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06 Rubella [German measles] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06.0 Rubella with neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06.8 Rubella with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06.9 Rubella without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B07 Viral warts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08 Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.0 Other orthopoxvirus infections

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 220 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.1 Molluscum contagiosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.2 Exanthema subitum [sixth disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.3 Erythema infectiosum [fifth disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.4 Enteroviral vesicular stomatitis with exanthem 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.5 Enteroviral vesicular pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.8 Other specified viral infections characterized by skin and mucous membrane lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B09 Unspecified viral infection characterized by skin and mucous membrane lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B15 Acute hepatitis A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B15.0 Hepatitis A with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B15.9 Hepatitis A without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16 Acute hepatitis B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.2 Acute hepatitis B without delta- agent with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.9 Acute hepatitis B without delta- agent and without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17 Other acute viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.0 Acute delta-(super)infection of hepatitis B carrier 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.1 Acute hepatitis C 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.2 Acute hepatitis E 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.8 Other specified acute viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.9 Acute viral hepatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18 Chronic viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.0 Chronic viral hepatitis B with delta- agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.1 Chronic viral hepatitis B without delta-agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.2 Chronic viral hepatitis C 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.8 Other chronic viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.9 Chronic viral hepatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B19 Unspecified viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B19.0 Unspecified viral hepatitis with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B19.9 Unspecified viral hepatitis without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.0 HIV disease resulting in mycobacterial infection

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 221 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.1 HIV disease resulting in other bacterial infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.2 HIV disease resulting in cytomegaloviral disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.3 HIV disease resulting in other viral infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.4 HIV disease resulting in candidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.5 HIV disease resulting in other mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.6 HIV disease resulting in Pneumocystis jirovecii pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.7 HIV disease resulting in multiple infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.8 HIV disease resulting in other infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.9 HIV disease resulting in unspecified infectious or parasitic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.0 HIV disease resulting in Kaposi sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.1 HIV disease resulting in Burkitt lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.2 HIV disease resulting in other types of non-Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.3 HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.7 HIV disease resulting in multiple malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.8 HIV disease resulting in other malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.9 HIV disease resulting in unspecified malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.0 HIV disease resulting in encephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.1 HIV disease resulting in lymphoid interstitial pneumonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.2 HIV disease resulting in wasting syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.7 HIV disease resulting in multiple diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23 Human immunodeficiency virus [HIV] disease resulting in other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.0 Acute HIV infection syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.1 HIV disease resulting in (persistent) generalized lymphadenopathy

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 222 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.2 HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.8 HIV disease resulting in other specified conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B24 Unspecified human immunodeficiency virus [HIV] disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25 Cytomegaloviral disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.0 Cytomegaloviral pneumonitisJ17.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.1 Cytomegaloviral hepatitisK77.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.2 Cytomegaloviral pancreatitisK87.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.8 Other cytomegaloviral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.9 Cytomegaloviral disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26 Mumps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.0 Mumps orchitisN51.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.1 Mumps meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.2 Mumps encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.3 Mumps pancreatitisK87.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.8 Mumps with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.9 Mumps without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27 Infectious mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.0 Gammaherpesviral mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.1 Cytomegaloviral mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.8 Other infectious mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.9 Infectious mononucleosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30 Viral conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.0 Keratoconjunctivitis due to adenovirusH19.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.1 Conjunctivitis due to adenovirusH13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.2 Viral pharyngoconjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)H13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.8 Other viral conjunctivitisH13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.9 Viral conjunctivitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33 Other viral diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.0 Epidemic myalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.1 Ross River disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.2 Viral carditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.3 Retrovirus infections, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]J17.1

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 223 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.8 Other specified viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34 Viral infection of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.0 Adenovirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.1 Enterovirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.2 Coronavirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.3 Parvovirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.4 Papovavirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.8 Other viral infections of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.9 Viral infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35 Dermatophytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.0 Tinea barbae and tinea capitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.1 Tinea unguium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.2 Tinea manuum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.3 Tinea pedis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.4 Tinea corporis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.5 Tinea imbricata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.6 Tinea inguinalis [Tinea cruris] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.8 Other dermatophytoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.9 Dermatophytosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36 Other superficial mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.0 Pityriasis versicolor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.1 Tinea nigra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.2 White piedra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.3 Black piedra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.8 Other specified superficial mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.9 Superficial mycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37 Candidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.0 Candidal stomatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.1 Pulmonary candidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.2 Candidiasis of skin and nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.3 Candidiasis of vulva and vaginaN77.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.4 Candidiasis of other urogenital sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.5 Candidal meningitisG02.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.6 Candidal endocarditisI39.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.7 Candidal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.8 Candidiasis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.9 Candidiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38 Coccidioidomycosis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 224 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.0 Acute pulmonary coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.1 Chronic pulmonary coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.2 Pulmonary coccidioidomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.3 Cutaneous coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.4 Coccidioidomycosis meningitisG02.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.7 Disseminated coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.8 Other forms of coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.9 Coccidioidomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39 Histoplasmosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.0 Acute pulmonary histoplasmosis capsulati 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.1 Chronic pulmonary histoplasmosis capsulati 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.2 Pulmonary histoplasmosis capsulati, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.3 Disseminated histoplasmosis capsulati 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.4 Histoplasmosis capsulati, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.5 Histoplasmosis duboisii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.9 Histoplasmosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40 Blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.0 Acute pulmonary blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.1 Chronic pulmonary blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.2 Pulmonary blastomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.3 Cutaneous blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.7 Disseminated blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.8 Other forms of blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.9 Blastomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41 Paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.0 Pulmonary paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.7 Disseminated paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.8 Other forms of paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.9 Paracoccidioidomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42 Sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.0 Pulmonary sporotrichosisJ99.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.1 Lymphocutaneous sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.7 Disseminated sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.8 Other forms of sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.9 Sporotrichosis, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 225 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43 Chromomycosis and phaeomycotic abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.0 Cutaneous chromomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.1 Phaeomycotic brain abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.2 Subcutaneous phaeomycotic abscess and cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.8 Other forms of chromomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.9 Chromomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44 Aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.0 Invasive pulmonary aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.1 Other pulmonary aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.2 Tonsillar aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.7 Disseminated aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.8 Other forms of aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.9 Aspergillosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45 Cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.0 Pulmonary cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.1 Cerebral cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.2 Cutaneous cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.3 Osseous cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.7 Disseminated cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.8 Other forms of cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.9 Cryptococcosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46 Zygomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.0 Pulmonary mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.1 Rhinocerebral mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.2 Gastrointestinal mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.3 Cutaneous mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.4 Disseminated mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.5 Mucormycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.8 Other zygomycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.9 Zygomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47 Mycetoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47.0 Eumycetoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47.1 Actinomycetoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47.9 Mycetoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48 Other mycoses, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.0 Lobomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.1 Rhinosporidiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.2 Allescheriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.3 Geotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.4 Penicillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.7 Opportunistic mycoses

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 226 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.8 Other specified mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B49 Unspecified mycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50 Plasmodium falciparum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50.0 Plasmodium falciparum malaria with cerebral complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50.8 Other severe and complicated Plasmodium falciparum malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50.9 Plasmodium falciparum malaria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51 Plasmodium vivax malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51.0 Plasmodium vivax malaria with rupture of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51.8 Plasmodium vivax malaria with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51.9 Plasmodium vivax malaria without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52 Plasmodium malariae malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52.0 Plasmodium malariae malaria with nephropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52.8 Plasmodium malariae malaria with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52.9 Plasmodium malariae malaria without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53 Other parasitologically confirmed malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53.0 Plasmodium ovale malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53.1 Malaria due to simian plasmodia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53.8 Other parasitologically confirmed malaria, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B54 Unspecified malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55 Leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.0 Visceral leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.1 Cutaneous leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.2 Mucocutaneous leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.9 Leishmaniasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56 African trypanosomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56.0 Gambiense trypanosomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56.1 Rhodesiense trypanosomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56.9 African trypanosomiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57 Chagas disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.0 Acute Chagas disease with heart involvementI41.2I98.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.1 Acute Chagas disease without heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.2 Chagas disease (chronic) with heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.3 Chagas disease (chronic) with digestive system involvement © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 227 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.4 Chagas disease (chronic) with nervous system involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.5 Chagas disease (chronic) with other organ involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.0 Toxoplasma oculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.1 Toxoplasma hepatitisK77.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.2 Toxoplasma meningoencephalitisG05.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.3 Pulmonary toxoplasmosisJ17.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.8 Toxoplasmosis with other organ involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.9 Toxoplasmosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B59 PneumocystosisJ17.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60 Other protozoal diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.1 Acanthamoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.2 Naegleriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.8 Other specified protozoal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B64 Unspecified protozoal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65 Schistosomiasis [bilharziasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.0 Schistosomiasis due to Schistosoma haematobium [urinary schistosomiasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.1 Schistosomiasis due to Schistosoma mansoni [intestinal schistosomiasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.2 Schistosomiasis due to Schistosoma japonicum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.3 Cercarial dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.8 Other schistosomiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.9 Schistosomiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66 Other fluke infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.0 Opisthorchiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.1 Clonorchiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.2 Dicrocoeliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.3 Fascioliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.4 Paragonimiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.5 Fasciolopsiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.8 Other specified fluke infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.9 Fluke infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67 Echinococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.0 Echinococcus granulosus infection of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.1 Echinococcus granulosus infection of lung

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 228 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.2 Echinococcus granulosus infection of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.3 Echinococcus granulosus infection, other and multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.4 Echinococcus granulosus infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.5 Echinococcus multilocularis infection of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.6 Echinococcus multilocularis infection, other and multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.7 Echinococcus multilocularis infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.8 Echinococcosis, unspecified, of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.9 Echinococcosis, other and unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68 Taeniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68.0 Taenia solium taeniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68.1 Taenia saginata taeniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68.9 Taeniasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69 Cysticercosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.0 Cysticercosis of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.1 Cysticercosis of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.8 Cysticercosis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.9 Cysticercosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B70 Diphyllobothriasis and sparganosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B70.0 Diphyllobothriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B70.1 Sparganosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71 Other cestode infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.0 Hymenolepiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.1 Dipylidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.8 Other specified cestode infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.9 Cestode infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B72 Dracunculiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B73 Onchocerciasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74 Filariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.0 Filariasis due to Wuchereria bancrofti 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.1 Filariasis due to Brugia malayi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.2 Filariasis due to Brugia timori 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.3 Loiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.4 Mansonelliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.8 Other filariases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.9 Filariasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B75 Trichinellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76 Hookworm diseases

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 229 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.0 Ancylostomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.1 Necatoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.8 Other hookworm diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.9 Hookworm disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77 Ascariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77.0 Ascariasis with intestinal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77.8 Ascariasis with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77.9 Ascariasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78 Strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.0 Intestinal strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.1 Cutaneous strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.7 Disseminated strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.9 Strongyloidiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B79 Trichuriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B80 Enterobiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81 Other intestinal helminthiases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.0 Anisakiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.1 Intestinal capillariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.2 Trichostrongyliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.3 Intestinal angiostrongyliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.4 Mixed intestinal helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.8 Other specified intestinal helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B82 Unspecified intestinal parasitism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B82.0 Intestinal helminthiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B82.9 Intestinal parasitism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83 Other helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.0 Visceral larva migrans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.1 Gnathostomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.2 Angiostrongyliasis due to Parastrongylus cantonensis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.3 Syngamiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.4 Internal hirudiniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.8 Other specified helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.9 Helminthiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85 Pediculosis and phthiriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.0 Pediculosis due to Pediculus humanus capitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.1 Pediculosis due to Pediculus humanus corporis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.2 Pediculosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.3 Phthiriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.4 Mixed pediculosis and phthiriasis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 230 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B86 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87 Myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.0 Cutaneous myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.1 Wound myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.2 Ocular myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.3 Nasopharyngeal myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.4 Aural myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.8 Myiasis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.9 Myiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88 Other infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.0 Other acariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.1 Tungiasis [sandflea infestation] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.2 Other arthropod infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.3 External hirudiniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.8 Other specified infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.9 Infestation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B89 Unspecified parasitic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90 Sequelae of tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.0 Sequelae of central nervous system tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.1 Sequelae of genitourinary tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.2 Sequelae of tuberculosis of bones and joints 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.8 Sequelae of tuberculosis of other organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.9 Sequelae of respiratory and unspecified tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B91 Sequelae of poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B92 Sequelae of leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94 Sequelae of other and unspecified infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.0 Sequelae of trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.1 Sequelae of viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.2 Sequelae of viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.8 Sequelae of other specified infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.9 Sequelae of unspecified infectious or parasitic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 231 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.2 Streptococcus group D and enterococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.4 Other streptococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.7 Other staphylococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96 Other specified bacterial agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.5 Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.6 Bacillus fragilis [B. fragilis] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.8 Other specified bacterial agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97 Viral agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.0 Adenovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.1 Enterovirus as the cause of diseases classified to other chapters

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 232 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.2 Coronavirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.3 Retrovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.4 Respiratory syncytial virus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.5 Reovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.6 Parvovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.7 Papillomavirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.8 Other viral agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B98 Other specified infectious agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B98.1 Vibrio vulnificus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B99 Other and unspecified infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00 Malignant neoplasm of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.0 Malignant neoplasm: External upper lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.1 Malignant neoplasm: External lower lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.2 Malignant neoplasm: External lip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.3 Malignant neoplasm: Upper lip, inner aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.4 Malignant neoplasm: Lower lip, inner aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.5 Malignant neoplasm: Lip, unspecified, inner aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.6 Malignant neoplasm: Commissure of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.8 Malignant neoplasm: Overlapping lesion of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.9 Malignant neoplasm: Lip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C01 Malignant neoplasm of base of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02 Malignant neoplasm of other and unspecified parts of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.0 Malignant neoplasm: Dorsal surface of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.1 Malignant neoplasm: Border of tongue

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 233 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.2 Malignant neoplasm: Ventral surface of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.3 Malignant neoplasm: Anterior two- thirds of tongue, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.4 Malignant neoplasm: Lingual tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.8 Malignant neoplasm: Overlapping lesion of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.9 Malignant neoplasm: Tongue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03 Malignant neoplasm of gum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03.0 Malignant neoplasm: Upper gum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03.1 Malignant neoplasm: Lower gum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03.9 Malignant neoplasm: Gum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04 Malignant neoplasm of floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.0 Malignant neoplasm: Anterior floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.1 Malignant neoplasm: Lateral floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.8 Malignant neoplasm: Overlapping lesion of floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.9 Malignant neoplasm: Floor of mouth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05 Malignant neoplasm of palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.0 Malignant neoplasm: Hard palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.1 Malignant neoplasm: Soft palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.2 Malignant neoplasm: Uvula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.8 Malignant neoplasm: Overlapping lesion of palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.9 Malignant neoplasm: Palate, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06 Malignant neoplasm of other and unspecified parts of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.0 Malignant neoplasm: Cheek mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.1 Malignant neoplasm: Vestibule of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.2 Malignant neoplasm: Retromolar area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.8 Malignant neoplasm: Overlapping lesion of other and unspecified parts of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.9 Malignant neoplasm: Mouth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C07 Malignant neoplasm of parotid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08 Malignant neoplasm of other and unspecified major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.0 Malignant neoplasm: Submandibular gland

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 234 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.1 Malignant neoplasm: Sublingual gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.8 Malignant neoplasm: Overlapping lesion of major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.9 Malignant neoplasm: Major salivary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09 Malignant neoplasm of tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.0 Malignant neoplasm: Tonsillar fossa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.1 Malignant neoplasm: Tonsillar pillar (anterior)(posterior) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.8 Malignant neoplasm: Overlapping lesion of tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.9 Malignant neoplasm: Tonsil, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10 Malignant neoplasm of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.0 Malignant neoplasm: Vallecula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.1 Malignant neoplasm: Anterior surface of epiglottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.2 Malignant neoplasm: Lateral wall of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.3 Malignant neoplasm: Posterior wall of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.4 Malignant neoplasm: Branchial cleft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.8 Malignant neoplasm: Overlapping lesion of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.9 Malignant neoplasm: Oropharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11 Malignant neoplasm of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.0 Malignant neoplasm: Superior wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.1 Malignant neoplasm: Posterior wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.2 Malignant neoplasm: Lateral wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.3 Malignant neoplasm: Anterior wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.8 Malignant neoplasm: Overlapping lesion of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.9 Malignant neoplasm: Nasopharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C12 Malignant neoplasm of piriform sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13 Malignant neoplasm of hypopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.0 Malignant neoplasm: Postcricoid region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.1 Malignant neoplasm: Aryepiglottic fold, hypopharyngeal aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.2 Malignant neoplasm: Posterior wall of hypopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.8 Malignant neoplasm: Overlapping lesion of hypopharynx © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 235 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.9 Malignant neoplasm: Hypopharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14 Malignant neoplasm of other and ill- defined sites in the lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14.0 Malignant neoplasm: Pharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14.2 Malignant neoplasm: Waldeyer ring 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14.8 Malignant neoplasm: Overlapping lesion of lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15 Malignant neoplasm of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.0 Malignant neoplasm: Cervical part of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.1 Malignant neoplasm: Thoracic part of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.2 Malignant neoplasm: Abdominal part of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.3 Malignant neoplasm: Upper third of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.4 Malignant neoplasm: Middle third of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.5 Malignant neoplasm: Lower third of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.8 Malignant neoplasm: Overlapping lesion of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.9 Malignant neoplasm: Oesophagus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16 Malignant neoplasm of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.0 Malignant neoplasm: Cardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.1 Malignant neoplasm: Fundus of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.2 Malignant neoplasm: Body of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.3 Malignant neoplasm: Pyloric antrum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.4 Malignant neoplasm: Pylorus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.5 Malignant neoplasm: Lesser curvature of stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.6 Malignant neoplasm: Greater curvature of stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.8 Malignant neoplasm: Overlapping lesion of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.9 Malignant neoplasm: Stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17 Malignant neoplasm of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.0 Malignant neoplasm: Duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.1 Malignant neoplasm: Jejunum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.2 Malignant neoplasm: Ileum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.3 Malignant neoplasm: Meckel diverticulum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 236 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.8 Malignant neoplasm: Overlapping lesion of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.9 Malignant neoplasm: Small intestine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18 Malignant neoplasm of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.0 Malignant neoplasm: Caecum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.1 Malignant neoplasm: Appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.2 Malignant neoplasm: Ascending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.3 Malignant neoplasm: Hepatic flexure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.4 Malignant neoplasm: Transverse colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.5 Malignant neoplasm: Splenic flexure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.6 Malignant neoplasm: Descending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.7 Malignant neoplasm: Sigmoid colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.8 Malignant neoplasm: Overlapping lesion of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.9 Malignant neoplasm: Colon, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C19 Malignant neoplasm of rectosigmoid junction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C20 Malignant neoplasm of rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21 Malignant neoplasm of anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.0 Malignant neoplasm: Anus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.1 Malignant neoplasm: Anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.2 Malignant neoplasm: Cloacogenic zone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.8 Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22 Malignant neoplasm of liver and intrahepatic bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.0 Malignant neoplasm: Liver cell carcinoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.1 Malignant neoplasm: Intrahepatic bile duct carcinoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.2 Malignant neoplasm: Hepatoblastoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.3 Malignant neoplasm: Angiosarcoma of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.4 Malignant neoplasm: Other sarcomas of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.7 Malignant neoplasm: Other specified carcinomas of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.9 Malignant neoplasm: Liver, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C23 Malignant neoplasm of gallbladder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 237 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24 Malignant neoplasm of other and unspecified parts of biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.0 Malignant neoplasm: Extrahepatic bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.1 Malignant neoplasm: Ampulla of Vater 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.8 Malignant neoplasm: Overlapping lesion of biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.9 Malignant neoplasm: Biliary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25 Malignant neoplasm of 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.0 Malignant neoplasm: Head of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.1 Malignant neoplasm: Body of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.2 Malignant neoplasm: Tail of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.3 Malignant neoplasm: Pancreatic duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.4 Malignant neoplasm: Endocrine pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.7 Malignant neoplasm: Other parts of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.8 Malignant neoplasm: Overlapping lesion of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.9 Malignant neoplasm: Pancreas, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26 Malignant neoplasm of other and ill- defined digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.0 Malignant neoplasm: Intestinal tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.1 Malignant neoplasm: Spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.8 Malignant neoplasm: Overlapping lesion of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.9 Malignant neoplasm: Ill-defined sites within the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C30 Malignant neoplasm of nasal cavity and middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C30.0 Malignant neoplasm: Nasal cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C30.1 Malignant neoplasm: Middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31 Malignant neoplasm of accessory sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.0 Malignant neoplasm: Maxillary sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.1 Malignant neoplasm: Ethmoidal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.2 Malignant neoplasm: Frontal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.3 Malignant neoplasm: Sphenoidal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.8 Malignant neoplasm: Overlapping lesion of accessory sinuses

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 238 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.9 Malignant neoplasm: Accessory sinus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32 Malignant neoplasm of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.0 Malignant neoplasm: Glottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.1 Malignant neoplasm: Supraglottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.2 Malignant neoplasm: Subglottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.3 Malignant neoplasm: Laryngeal cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.8 Malignant neoplasm: Overlapping lesion of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.9 Malignant neoplasm: Larynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C33 Malignant neoplasm of trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34 Malignant neoplasm of bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.0 Malignant neoplasm: Main bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.1 Malignant neoplasm: Upper lobe, bronchus or lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.2 Malignant neoplasm: Middle lobe, bronchus or lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.3 Malignant neoplasm: Lower lobe, bronchus or lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.8 Malignant neoplasm: Overlapping lesion of bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.9 Malignant neoplasm: Bronchus or lung, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C37 Malignant neoplasm of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38 Malignant neoplasm of heart, mediastinum and pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.0 Malignant neoplasm: Heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.1 Malignant neoplasm: Anterior mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.2 Malignant neoplasm: Posterior mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.3 Malignant neoplasm: Mediastinum, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.4 Malignant neoplasm: Pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.8 Malignant neoplasm: Overlapping lesion of heart, mediastinum and pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39 Malignant neoplasm of other and ill- defined sites in the respiratory system and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39.0 Malignant neoplasm: Upper respiratory tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39.8 Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39.9 Malignant neoplasm: Ill-defined sites within the respiratory system

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 239 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40 Malignant neoplasm of bone and articular cartilage of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.0 Malignant neoplasm: Scapula and long bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.1 Malignant neoplasm: Short bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.2 Malignant neoplasm: Long bones of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.3 Malignant neoplasm: Short bones of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.8 Malignant neoplasm: Overlapping lesion of bone and articular cartilage of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.9 Malignant neoplasm: Bone and articular cartilage of limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.0 Malignant neoplasm: Bones of skull and face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.1 Malignant neoplasm: Mandible 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.2 Malignant neoplasm: Vertebral column 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.3 Malignant neoplasm: Ribs, sternum and clavicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.4 Malignant neoplasm: Pelvic bones, sacrum and coccyx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.8 Malignant neoplasm: Overlapping lesion of bone and articular cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.9 Malignant neoplasm: Bone and articular cartilage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43 Malignant melanoma of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.0 Malignant neoplasm: Malignant melanoma of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.1 Malignant neoplasm: Malignant melanoma of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.2 Malignant neoplasm: Malignant melanoma of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.3 Malignant neoplasm: Malignant melanoma of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.4 Malignant neoplasm: Malignant melanoma of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.5 Malignant neoplasm: Malignant melanoma of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.6 Malignant neoplasm: Malignant melanoma of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.7 Malignant neoplasm: Malignant melanoma of lower limb, including hip © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 240 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.8 Malignant neoplasm: Overlapping malignant melanoma of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.9 Malignant neoplasm: Malignant melanoma of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44 Other malignant neoplasms of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.0 Malignant neoplasm: Skin of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.1 Malignant neoplasm: Skin of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.2 Malignant neoplasm: Skin of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.3 Malignant neoplasm: Skin of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.4 Malignant neoplasm: Skin of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.5 Malignant neoplasm: Skin of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.6 Malignant neoplasm: Skin of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.7 Malignant neoplasm: Skin of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.8 Malignant neoplasm: Overlapping lesion of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.9 Malignant neoplasm: Malignant neoplasm of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45 Mesothelioma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.0 Mesothelioma of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.1 Mesothelioma of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.2 Mesothelioma of pericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.7 Mesothelioma of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.9 Mesothelioma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46 Kaposi sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.0 Kaposi sarcoma of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.1 Kaposi sarcoma of soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.2 Kaposi sarcoma of palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.3 Kaposi sarcoma of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.7 Kaposi sarcoma of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.8 Kaposi sarcoma of multiple organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.9 Kaposi sarcoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47 Malignant neoplasm of peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.0 Malignant neoplasm: Peripheral nerves of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.1 Malignant neoplasm: Peripheral nerves of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.2 Malignant neoplasm: Peripheral nerves of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.3 Malignant neoplasm: Peripheral nerves of thorax

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 241 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.4 Malignant neoplasm: Peripheral nerves of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.5 Malignant neoplasm: Peripheral nerves of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.6 Malignant neoplasm: Peripheral nerves of trunk, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.8 Malignant neoplasm: Overlapping lesion of peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.9 Malignant neoplasm: Peripheral nerves and autonomic nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48 Malignant neoplasm of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.0 Malignant neoplasm: Retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.1 Malignant neoplasm: Specified parts of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.2 Malignant neoplasm: Peritoneum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.8 Malignant neoplasm: Overlapping lesion of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49 Malignant neoplasm of other connective and soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.0 Malignant neoplasm: Connective and soft tissue of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.1 Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.2 Malignant neoplasm: Connective and soft tissue of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.3 Malignant neoplasm: Connective and soft tissue of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.4 Malignant neoplasm: Connective and soft tissue of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.5 Malignant neoplasm: Connective and soft tissue of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.6 Malignant neoplasm: Connective and soft tissue of trunk, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.8 Malignant neoplasm: Overlapping lesion of connective and soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.9 Malignant neoplasm: Connective and soft tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50 Malignant neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.0 Malignant neoplasm: Nipple and areola 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.1 Malignant neoplasm: Central portion of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.2 Malignant neoplasm: Upper-inner quadrant of breast

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 242 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.3 Malignant neoplasm: Lower-inner quadrant of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.4 Malignant neoplasm: Upper-outer quadrant of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.5 Malignant neoplasm: Lower-outer quadrant of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.6 Malignant neoplasm: Axillary tail of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.8 Malignant neoplasm: Overlapping lesion of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.9 Malignant neoplasm: Breast, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51 Malignant neoplasm of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.0 Malignant neoplasm: Labium majus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.1 Malignant neoplasm: Labium minus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.2 Malignant neoplasm: Clitoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.8 Malignant neoplasm: Overlapping lesion of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.9 Malignant neoplasm: Vulva, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C52 Malignant neoplasm of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53 Malignant neoplasm of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.0 Malignant neoplasm: Endocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.1 Malignant neoplasm: Exocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.8 Malignant neoplasm: Overlapping lesion of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.9 Malignant neoplasm: Cervix uteri, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54 Malignant neoplasm of corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.0 Malignant neoplasm: Isthmus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.1 Malignant neoplasm: Endometrium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.2 Malignant neoplasm: Myometrium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.3 Malignant neoplasm: Fundus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.8 Malignant neoplasm: Overlapping lesion of corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.9 Malignant neoplasm: Corpus uteri, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C55 Malignant neoplasm of uterus, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C56 Malignant neoplasm of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57 Malignant neoplasm of other and unspecified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.0 Malignant neoplasm: Fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.1 Malignant neoplasm: Broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.2 Malignant neoplasm: Round ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.3 Malignant neoplasm: Parametrium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 243 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.4 Malignant neoplasm: Uterine adnexa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.7 Malignant neoplasm: Other specified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.8 Malignant neoplasm: Overlapping lesion of female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.9 Malignant neoplasm: Female genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C58 Malignant neoplasm of placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60 Malignant neoplasm of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.0 Malignant neoplasm: Prepuce 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.1 Malignant neoplasm: Glans penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.2 Malignant neoplasm: Body of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.8 Malignant neoplasm: Overlapping lesion of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.9 Malignant neoplasm: Penis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C61 Malignant neoplasm of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62 Malignant neoplasm of testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62.0 Malignant neoplasm: Undescended testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62.1 Malignant neoplasm: Descended testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62.9 Malignant neoplasm: Testis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63 Malignant neoplasm of other and unspecified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.0 Malignant neoplasm: Epididymis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.1 Malignant neoplasm: Spermatic cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.2 Malignant neoplasm: Scrotum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.7 Malignant neoplasm: Other specified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.8 Malignant neoplasm: Overlapping lesion of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.9 Malignant neoplasm: Male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C64 Malignant neoplasm of kidney, except renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C65 Malignant neoplasm of renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C66 Malignant neoplasm of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67 Malignant neoplasm of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.0 Malignant neoplasm: Trigone of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.1 Malignant neoplasm: Dome of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.2 Malignant neoplasm: Lateral wall of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.3 Malignant neoplasm: Anterior wall of bladder © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 244 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.4 Malignant neoplasm: Posterior wall of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.5 Malignant neoplasm: Bladder neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.6 Malignant neoplasm: Ureteric orifice 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.7 Malignant neoplasm: Urachus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.8 Malignant neoplasm: Overlapping lesion of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.9 Malignant neoplasm: Bladder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68 Malignant neoplasm of other and unspecified urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.0 Malignant neoplasm: Urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.1 Malignant neoplasm: Paraurethral gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.8 Malignant neoplasm: Overlapping lesion of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.9 Malignant neoplasm: Urinary organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69 Malignant neoplasm of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.0 Malignant neoplasm: Conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.1 Malignant neoplasm: Cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.2 Malignant neoplasm: Retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.3 Malignant neoplasm: Choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.4 Malignant neoplasm: Ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.5 Malignant neoplasm: Lacrimal gland and duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.6 Malignant neoplasm: Orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.8 Malignant neoplasm: Overlapping lesion of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.9 Malignant neoplasm: Eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70 Malignant neoplasm of meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70.0 Malignant neoplasm: Cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70.1 Malignant neoplasm: Spinal meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70.9 Malignant neoplasm: Meninges, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71 Malignant neoplasm of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.0 Malignant neoplasm: Cerebrum, except lobes and ventricles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.1 Malignant neoplasm: Frontal lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.2 Malignant neoplasm: Temporal lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.3 Malignant neoplasm: Parietal lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.4 Malignant neoplasm: Occipital lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.5 Malignant neoplasm: Cerebral ventricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.6 Malignant neoplasm: Cerebellum © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 245 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.7 Malignant neoplasm: Brain stem 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.8 Malignant neoplasm: Overlapping lesion of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.9 Malignant neoplasm: Brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.0 Malignant neoplasm: Spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.1 Malignant neoplasm: Cauda equina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.2 Malignant neoplasm: Olfactory nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.3 Malignant neoplasm: Optic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.4 Malignant neoplasm: Acoustic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.5 Malignant neoplasm: Other and unspecified cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.8 Malignant neoplasm: Overlapping lesion of brain and other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.9 Malignant neoplasm: Central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C73 Malignant neoplasm of thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74 Malignant neoplasm of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74.0 Malignant neoplasm: Cortex of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74.1 Malignant neoplasm: Medulla of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74.9 Malignant neoplasm: Adrenal gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75 Malignant neoplasm of other endocrine glands and related structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.0 Malignant neoplasm: Parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.1 Malignant neoplasm: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.2 Malignant neoplasm: Craniopharyngeal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.3 Malignant neoplasm: Pineal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.4 Malignant neoplasm: Carotid body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.5 Malignant neoplasm: Aortic body and other paraganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.8 Malignant neoplasm: Pluriglandular involvement, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.9 Malignant neoplasm: Endocrine gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76 Malignant neoplasm of other and ill- defined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.0 Malignant neoplasm of other and ill- defined sites: Head, face and neck

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 246 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.1 Malignant neoplasm of other and ill- defined sites: Thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.2 Malignant neoplasm of other and ill- defined sites: Abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.3 Malignant neoplasm of other and ill- defined sites: Pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.4 Malignant neoplasm of other and ill- defined sites: Upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.5 Malignant neoplasm of other and ill- defined sites: Lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.7 Malignant neoplasm of other and ill- defined sites: Other ill-defined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.8 Malignant neoplasm of other and ill- defined sites: Overlapping lesion of other and ill-defined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77 Secondary and unspecified malignant neoplasm of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.0 Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.1 Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.2 Secondary and unspecified malignant neoplasm: Intra- abdominal lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.3 Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.4 Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.5 Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.8 Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.9 Secondary and unspecified malignant neoplasm: Lymph node, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78 Secondary malignant neoplasm of respiratory and digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.0 Secondary malignant neoplasm of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.1 Secondary malignant neoplasm of mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.2 Secondary malignant neoplasm of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.4 Secondary malignant neoplasm of small intestine

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 247 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.5 Secondary malignant neoplasm of large intestine and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.8 Secondary malignant neoplasm of other and unspecified digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79 Secondary malignant neoplasm of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.0 Secondary malignant neoplasm of kidney and renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.2 Secondary malignant neoplasm of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.3 Secondary malignant neoplasm of brain and cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.5 Secondary malignant neoplasm of bone and bone marrow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.6 Secondary malignant neoplasm of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.7 Secondary malignant neoplasm of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.8 Secondary malignant neoplasm of other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.9 Secondary malignant neoplasm, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C80 Malignant neoplasm, without specification of site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C80.0 Malignant neoplasm, primary site unknown, so stated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C80.9 Malignant neoplasm, primary site unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81 Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.0 Nodular lymphocyte predominant Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.1 Nodular sclerosis classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.2 Mixed cellularity classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.3 Lymphocyte depleted classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.4 Lymphocyte-rich (classical) Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.7 Other classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.9 Hodgkin lymphoma, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 248 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82 Follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.0 Follicular lymphoma grade I 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.1 Follicular lymphoma grade II 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.2 Follicular lymphoma grade III, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.3 Follicular lymphoma grade IIIa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.4 Follicular lymphoma grade IIIb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.5 Diffuse follicle centre lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.6 Cutaneous follicle centre lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.7 Other types of follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.9 Follicular lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83 Non-follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.0 Small cell B-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.1 Mantle cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.3 Diffuse large B-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.5 Lymphoblastic (diffuse) lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.7 Burkitt lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.8 Other non-follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.9 Non-follicular (diffuse) lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84 Mature T/NK-cell lymphomas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.0 Mycosis fungoides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.1 Sézary disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.4 Peripheral T-cell lymphoma, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.5 Other mature T/NK-cell lymphomas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.6 Anaplastic large cell lymphoma, ALK-positive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.7 Anaplastic large cell lymphoma, ALK-negative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.8 Cutaneous T-cell lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.9 Mature T/NK-cell lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85 Other and unspecified types of non- Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.1 B-cell lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.2 Mediastinal (thymic) large B-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.7 Other specified types of non- Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.9 Non-Hodgkin lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86 Other specified types of T/NK-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.0 Extranodal NK/T-cell lymphoma, nasal type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.1 Hepatosplenic T-cell lymphoma © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 249 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.2 Enteropathy-type (intestinal) T-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.3 Subcutaneous panniculitis-like T-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.4 Blastic NK-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.5 Angioimmunoblastic T-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.6 Primary cutaneous CD30-positive T- cell proliferations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88 Malignant immunoproliferative diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.0 Waldenström macroglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.2 Other heavy chain disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.3 Immunoproliferative small intestinal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.7 Other malignant immunoproliferative diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.9 Malignant immunoproliferative disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90 Multiple myeloma and malignant plasma cell neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.0 Multiple myeloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.1 Plasma cell leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.2 Extramedullary plasmacytoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.3 Solitary plasmacytoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91 Lymphoid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.0 Acute lymphoblastic leukaemia [ALL] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.1 Chronic lymphocytic leukaemia of B- cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.3 Prolymphocytic leukaemia of B-cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.4 Hairy-cell leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.5 Adult T-cell lymphoma/leukaemia [HTLV-1-associated] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.6 Prolymphocytic leukaemia of T-cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.7 Other lymphoid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.8 Mature B-cell leukaemia Burkitt-type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.9 Lymphoid leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92 Myeloid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.0 Acute myeloblastic leukaemia [AML] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.1 Chronic myeloid leukaemia [CML], BCR/ABL-positive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.2 Atypical chronic myeloid leukaemia, BCR/ABL- negative

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 250 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.3 Myeloid sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.4 Acute promyelocytic leukaemia [PML] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.5 Acute myelomonocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.6 Acute myeloid leukaemia with 11q23-abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.7 Other myeloid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.8 Acute myeloid leukaemia with multilineage dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.9 Myeloid leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93 Monocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.0 Acute monoblastic/monocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.1 Chronic myelomonocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.3 Juvenile myelomonocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.7 Other monocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.9 Monocytic leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94 Other leukaemias of specified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.0 Acute erythroid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.2 Acute megakaryoblastic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.3 Mast cell leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.4 Acute panmyelosis with myelofibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.7 Other specified leukaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95 Leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.0 Acute leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.1 Chronic leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.7 Other leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.9 Leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.0 Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis [Letterer-Siwe disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.2 Malignant mast cell tumour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.4 Sarcoma of dendritic cells (accessory cells) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.6 Unifocal Langerhans-cell histiocytosis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 251 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.8 Histiocytic sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.9 Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C97 Malignant neoplasms of independent (primary) multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00 Carcinoma of oral cavity, oesophagus and stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00.0 Carcinoma in situ: Lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00.1 Carcinoma in situ: Oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00.2 Carcinoma in situ: Stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01 Carcinoma in situ of other and unspecified digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.0 Carcinoma in situ: Colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.1 Carcinoma in situ: Rectosigmoid junction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.2 Carcinoma in situ: Rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.3 Carcinoma in situ: Anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.4 Carcinoma in situ: Other and unspecified parts of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.5 Carcinoma in situ: Liver, gallbladder and bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.7 Carcinoma in situ: Other specified digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.9 Carcinoma in situ: Digestive organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02 Carcinoma in situ of middle ear and respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.0 Carcinoma in situ: Larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.1 Carcinoma in situ: Trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.2 Carcinoma in situ: Bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.3 Carcinoma in situ: Other parts of respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.4 Carcinoma in situ: Respiratory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03 Melanoma in situ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.0 Melanoma in situ of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.1 Melanoma in situ of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.2 Melanoma in situ of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.3 Melanoma in situ of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.4 Melanoma in situ of scalp and neck

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 252 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.5 Melanoma in situ of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.6 Melanoma in situ of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.7 Melanoma in situ of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.8 Melanoma in situ of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.9 Melanoma in situ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04 Carcinoma in situ of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.0 Carcinoma in situ: Skin of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.1 Carcinoma in situ: Skin of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.2 Carcinoma in situ: Skin of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.3 Carcinoma in situ: Skin of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.4 Carcinoma in situ: Skin of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.5 Carcinoma in situ: Skin of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.6 Carcinoma in situ: Skin of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.7 Carcinoma in situ: Skin of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.8 Carcinoma in situ: Skin of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.9 Carcinoma in situ: Skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05 Carcinoma in situ of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.0 Lobular carcinoma in situ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.1 Intraductal carcinoma in situ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.7 Other carcinoma in situ of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.9 Carcinoma in situ of breast, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06 Carcinoma in situ of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.0 Carcinoma in situ: Endocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.1 Carcinoma in situ: Exocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.7 Carcinoma in situ: Other parts of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.9 Carcinoma in situ: Cervix, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07 Carcinoma in situ of other and unspecified genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.0 Carcinoma in situ: Endometrium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.1 Carcinoma in situ: Vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.2 Carcinoma in situ: Vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.3 Carcinoma in situ: Other and unspecified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.4 Carcinoma in situ: Penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.5 Carcinoma in situ: Prostate

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 253 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.6 Carcinoma in situ: Other and unspecified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09 Carcinoma in situ of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.0 Carcinoma in situ: Bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.1 Carcinoma in situ: Other and unspecified urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.2 Carcinoma in situ: Eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.3 Carcinoma in situ: Thyroid and other endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.7 Carcinoma in situ of other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.9 Carcinoma in situ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10 Benign neoplasm of mouth and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.0 Benign neoplasm: Lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.1 Benign neoplasm: Tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.2 Benign neoplasm: Floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.3 Benign neoplasm: Other and unspecified parts of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.4 Benign neoplasm: Tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.5 Benign neoplasm: Other parts of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.6 Benign neoplasm: Nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.7 Benign neoplasm: Hypopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.9 Benign neoplasm: Pharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11 Benign neoplasm of major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11.0 Benign neoplasm: Parotid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11.7 Benign neoplasm: Other major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11.9 Benign neoplasm: Major salivary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12 Benign neoplasm of colon, rectum, anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.0 Benign neoplasm: Caecum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.1 Benign neoplasm: Appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.2 Benign neoplasm: Ascending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.3 Benign neoplasm: Transverse colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.4 Benign neoplasm: Descending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.5 Benign neoplasm: Sigmoid colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.6 Benign neoplasm: Colon, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.7 Benign neoplasm: Rectosigmoid junction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.8 Benign neoplasm: Rectum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 254 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.9 Benign neoplasm: Anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13 Benign neoplasm of other and ill- defined parts of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.0 Benign neoplasm: Oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.1 Benign neoplasm: Stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.2 Benign neoplasm: Duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.3 Benign neoplasm: Other and unspecified parts of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.4 Benign neoplasm: Liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.5 Benign neoplasm: Extrahepatic bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.6 Benign neoplasm: Pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.7 Benign neoplasm: Endocrine pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.9 Benign neoplasm: Ill-defined sites within the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14 Benign neoplasm of middle ear and respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.0 Benign neoplasm: Middle ear, nasal cavity and accessory sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.1 Benign neoplasm: Larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.2 Benign neoplasm: Trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.3 Benign neoplasm: Bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.4 Benign neoplasm: Respiratory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15 Benign neoplasm of other and unspecified intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.0 Benign neoplasm: Thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.1 Benign neoplasm: Heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.2 Benign neoplasm: Mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.7 Benign neoplasm: Other specified intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.9 Benign neoplasm: Intrathoracic organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16 Benign neoplasm of bone and articular cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.0 Benign neoplasm: Scapula and long bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.1 Benign neoplasm: Short bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.2 Benign neoplasm: Long bones of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.3 Benign neoplasm: Short bones of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.4 Benign neoplasm: Bones of skull and face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.5 Benign neoplasm: Lower jaw bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.6 Benign neoplasm: Vertebral column © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 255 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.7 Benign neoplasm: Ribs, sternum and clavicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.8 Benign neoplasm: Pelvic bones, sacrum and coccyx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.9 Benign neoplasm: Bone and articular cartilage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17 Benign lipomatous neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.4 Benign lipomatous neoplasm of intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.5 Benign lipomatous neoplasm of intra-abdominal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.6 Benign lipomatous neoplasm of spermatic cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.7 Benign lipomatous neoplasm of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.9 Benign lipomatous neoplasm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D18 Haemangioma and lymphangioma, any site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D18.0 Haemangioma, any site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D18.1 Lymphangioma, any site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19 Benign neoplasm of mesothelial tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.0 Benign neoplasm: Mesothelial tissue of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.1 Benign neoplasm: Mesothelial tissue of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.7 Benign neoplasm: Mesothelial tissue of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.9 Benign neoplasm: Mesothelial tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D20.0 Benign neoplasm: Retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D20.1 Benign neoplasm: Peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21 Other benign neoplasms of connective and other soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.0 Benign neoplasm: Connective and other soft tissue of head, face and neck

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 256 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.1 Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.2 Benign neoplasm: Connective and other soft tissue of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.3 Benign neoplasm: Connective and other soft tissue of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.4 Benign neoplasm: Connective and other soft tissue of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.5 Benign neoplasm: Connective and other soft tissue of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.6 Benign neoplasm: Connective and other soft tissue of trunk, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.9 Benign neoplasm: Connective and other soft tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22 Melanocytic naevi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.0 Melanocytic naevi of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.1 Melanocytic naevi of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.2 Melanocytic naevi of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.3 Melanocytic naevi of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.4 Melanocytic naevi of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.5 Melanocytic naevi of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.6 Melanocytic naevi of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.7 Melanocytic naevi of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.9 Melanocytic naevi, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23 Other benign neoplasms of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.0 Benign neoplasm: Skin of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.1 Benign neoplasm: Skin of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.2 Benign neoplasm: Skin of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.3 Benign neoplasm: Skin of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.4 Benign neoplasm: Skin of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.5 Benign neoplasm: Skin of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.6 Benign neoplasm: Skin of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.7 Benign neoplasm: Skin of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.9 Benign neoplasm: Skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D24 Benign neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25 Leiomyoma of uterus

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 257 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.0 Submucous leiomyoma of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.1 Intramural leiomyoma of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.2 Subserosal leiomyoma of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.9 Leiomyoma of uterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26 Other benign neoplasms of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.0 Other benign neoplasm: Cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.1 Other benign neoplasm: Corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.7 Other benign neoplasm: Other parts of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.9 Other benign neoplasm: Uterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D27 Benign neoplasm of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28 Benign neoplasm of other and unspecified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.0 Benign neoplasm: Vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.1 Benign neoplasm: Vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.2 Benign neoplasm: Uterine tubes and ligaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.7 Benign neoplasm: Other specified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.9 Benign neoplasm: Female genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29 Benign neoplasm of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.0 Benign neoplasm: Penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.1 Benign neoplasm: Prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.2 Benign neoplasm: Testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.3 Benign neoplasm: Epididymis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.4 Benign neoplasm: Scrotum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.7 Benign neoplasm: Other male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.9 Benign neoplasm: Male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30 Benign neoplasm of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.0 Benign neoplasm: Kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.1 Benign neoplasm: Renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.2 Benign neoplasm: Ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.3 Benign neoplasm: Bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.4 Benign neoplasm: Urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.7 Benign neoplasm: Other urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.9 Benign neoplasm: Urinary organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31 Benign neoplasm of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.0 Benign neoplasm: Conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.1 Benign neoplasm: Cornea © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 258 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.2 Benign neoplasm: Retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.3 Benign neoplasm: Choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.4 Benign neoplasm: Ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.5 Benign neoplasm: Lacrimal gland and duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.6 Benign neoplasm: Orbit, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.9 Benign neoplasm: Eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32 Benign neoplasm of meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32.0 Benign neoplasm: Cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32.1 Benign neoplasm: Spinal meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32.9 Benign neoplasm: Meninges, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33 Benign neoplasm of brain and other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.0 Benign neoplasm: Brain, supratentorial 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.1 Benign neoplasm: Brain, infratentorial 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.2 Benign neoplasm: Brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.3 Benign neoplasm: Cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.4 Benign neoplasm: Spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.7 Benign neoplasm: Other specified parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.9 Benign neoplasm: Central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D34 Benign neoplasm of thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35 Benign neoplasm of other and unspecified endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.0 Benign neoplasm: Adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.1 Benign neoplasm: Parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.2 Benign neoplasm: Pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.3 Benign neoplasm: Craniopharyngeal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.4 Benign neoplasm: Pineal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.5 Benign neoplasm: Carotid body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.6 Benign neoplasm: Aortic body and other paraganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.7 Benign neoplasm: Other specified endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.8 Benign neoplasm: Pluriglandular involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.9 Benign neoplasm: Endocrine gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36 Benign neoplasm of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.0 Benign neoplasm: Lymph nodes

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 259 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.1 Benign neoplasm: Peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.7 Benign neoplasm: Other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.9 Benign neoplasm: Benign neoplasm of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.0 Neoplasm of uncertain or unknown behaviour: Lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.1 Neoplasm of uncertain or unknown behaviour: Stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.2 Neoplasm of uncertain or unknown behaviour: Small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.3 Neoplasm of uncertain or unknown behaviour: Appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.4 Neoplasm of uncertain or unknown behaviour: Colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.5 Neoplasm of uncertain or unknown behaviour: Rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.6 Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.7 Neoplasm of uncertain or unknown behaviour: Other digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.9 Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.0 Neoplasm of uncertain or unknown behaviour: Larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.1 Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.2 Neoplasm of uncertain or unknown behaviour: Pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.3 Neoplasm of uncertain or unknown behaviour: Mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.4 Neoplasm of uncertain or unknown behaviour: Thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.5 Neoplasm of uncertain or unknown behaviour: Other respiratory organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.6 Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39 Neoplasm of uncertain or unknown behaviour of female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.0 Neoplasm of uncertain or unknown behaviour: Uterus

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 260 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.1 Neoplasm of uncertain or unknown behaviour: Ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.2 Neoplasm of uncertain or unknown behaviour: Placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.7 Neoplasm of uncertain or unknown behaviour: Other female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.9 Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40 Neoplasm of uncertain or unknown behaviour of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.0 Neoplasm of uncertain or unknown behaviour: Prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.1 Neoplasm of uncertain or unknown behaviour: Testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.7 Neoplasm of uncertain or unknown behaviour: Other male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.9 Neoplasm of uncertain or unknown behaviour: Male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41 Neoplasm of uncertain or unknown behaviour of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.0 Neoplasm of uncertain or unknown behaviour: Kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.1 Neoplasm of uncertain or unknown behaviour: Renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.2 Neoplasm of uncertain or unknown behaviour: Ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.3 Neoplasm of uncertain or unknown behaviour: Urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.4 Neoplasm of uncertain or unknown behaviour: Bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.7 Neoplasm of uncertain or unknown behaviour: Other urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.9 Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42 Neoplasm of uncertain or unknown behaviour of meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42.0 Neoplasm of uncertain or unknown behaviour: Cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42.1 Neoplasm of uncertain or unknown behaviour: Spinal meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42.9 Neoplasm of uncertain or unknown behaviour: Meninges, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.0 Neoplasm of uncertain or unknown behaviour: Brain, supratentorial 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.1 Neoplasm of uncertain or unknown behaviour: Brain, infratentorial © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 261 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.2 Neoplasm of uncertain or unknown behaviour: Brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.3 Neoplasm of uncertain or unknown behaviour: Cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.4 Neoplasm of uncertain or unknown behaviour: Spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.7 Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.9 Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44 Neoplasm of uncertain or unknown behaviour of endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.0 Neoplasm of uncertain or unknown behaviour: Thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.1 Neoplasm of uncertain or unknown behaviour: Adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.2 Neoplasm of uncertain or unknown behaviour: Parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.3 Neoplasm of uncertain or unknown behaviour: Pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.4 Neoplasm of uncertain or unknown behaviour: Craniopharyngeal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.5 Neoplasm of uncertain or unknown behaviour: Pineal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.6 Neoplasm of uncertain or unknown behaviour: Carotid body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.7 Neoplasm of uncertain or unknown behaviour: Aortic body and other paraganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.8 Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.9 Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D45 Polycythaemia vera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46 Myelodysplastic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.0 anaemia without ring sideroblasts, so stated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.1 Refractory anaemia with ring sideroblasts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.2 Refractory anaemia with excess of blasts [RAEB] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.4 Refractory anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.5 Refractory anaemia with multi- lineage dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.7 Other myelodysplastic syndromes

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 262 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.9 Myelodysplastic syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.1 Chronic myeloproliferative disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.2 Monoclonal gammopathy of undetermined significance (MGUS) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.3 Essential (haemorrhagic) thrombocythaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.4 Osteomyelofibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.0 Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.1 Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.2 Neoplasm of uncertain or unknown behaviour: Peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.3 Neoplasm of uncertain or unknown behaviour: Retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.4 Neoplasm of uncertain or unknown behaviour: Peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.5 Neoplasm of uncertain or unknown behaviour: Skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.6 Neoplasm of uncertain or unknown behaviour: Breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.7 Neoplasm of uncertain or unknown behaviour: Other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.9 Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50 Iron deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.0 Iron deficiency anaemia secondary to blood loss (chronic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.1 Sideropenic dysphagia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.8 Other iron deficiency anaemias

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 263 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.9 Iron deficiency anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51 Vitamin B12deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.0 Vitamin B12deficiency anaemia due to intrinsic factor deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.1 Vitamin B12deficiency anaemia due to selective vitamin B12malabsorption with proteinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.2 Transcobalamin II deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.3 Other dietary vitamin B12deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.8 Other vitamin B12deficiency anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.9 Vitamin B12deficiency anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52 deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.0 Dietary folate deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.1 Drug-induced folate deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.8 Other folate deficiency anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.9 Folate deficiency anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53 Other nutritional anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.0 Protein deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.1 Other megaloblastic anaemias, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.2 Scorbutic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.8 Other specified nutritional anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.9 Nutritional anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55 Anaemia due to enzyme disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.0 Anaemia due to glucose-6- phosphate dehydrogenase [G6PD] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.1 Anaemia due to other disorders of glutathione metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.2 Anaemia due to disorders of glycolytic enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.3 Anaemia due to disorders of nucleotide metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.8 Other anaemias due to enzyme disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.9 Anaemia due to enzyme disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56 Thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.0 Alpha thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.1 Beta thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.2 Delta-beta thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.3 Thalassaemia trait 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.4 Hereditary persistence of fetal haemoglobin [HPFH]

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 264 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.8 Other thalassaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.9 Thalassaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57 Sickle-cell disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.0 Sickle-cell anaemia with crisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.1 Sickle-cell anaemia without crisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.2 Double heterozygous sickling disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.3 Sickle-cell trait 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.8 Other sickle-cell disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58 Other hereditary haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.0 Hereditary spherocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.1 Hereditary elliptocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.2 Other haemoglobinopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.8 Other specified hereditary haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.9 Hereditary haemolytic anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59 Acquired haemolytic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.0 Drug-induced autoimmune haemolytic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.1 Other autoimmune haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.2 Drug-induced nonautoimmune haemolytic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.3 Haemolytic-uraemic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.4 Other nonautoimmune haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava- Micheli] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.6 Haemoglobinuria due to haemolysis from other external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.8 Other acquired haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.9 Acquired haemolytic anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60 Acquired pure red cell aplasia [erythroblastopenia] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.0 Chronic acquired pure red cell aplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.1 Transient acquired pure red cell aplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.8 Other acquired pure red cell aplasias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.9 Acquired pure red cell aplasia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61 Other aplastic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.0 Constitutional aplastic anaemia

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 265 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.1 Drug-induced aplastic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.2 Aplastic anaemia due to other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.3 Idiopathic aplastic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.8 Other specified aplastic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.9 Aplastic anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D62 Acute posthaemorrhagic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D63 Anaemia in chronic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D63.0 Anaemia in neoplastic diseaseC00- D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D63.8 Anaemia in other chronic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64 Other anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.0 Hereditary sideroblastic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.1 Secondary sideroblastic anaemia due to disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.2 Secondary sideroblastic anaemia due to drugs and toxins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.3 Other sideroblastic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.4 Congenital dyserythropoietic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.8 Other specified anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.9 Anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D65 Disseminated intravascular coagulation [defibrination syndrome] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D66 Hereditary factor VIII deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D67 Hereditary factor IX deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68 Other coagulation defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.0 Von Willebrand disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.1 Hereditary factor XI deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.2 Hereditary deficiency of other clotting factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.3 Haemorrhagic disorder due to circulating 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.4 Acquired coagulation factor deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.5 Primary thrombophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.6 Other thrombophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.8 Other specified coagulation defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.9 Coagulation defect, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69 Purpura and other haemorrhagic conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.0 Allergic purpura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.1 Qualitative platelet defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.2 Other nonthrombocytopenic purpura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.3 Idiopathic thrombocytopenic purpura

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 266 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.4 Other primary thrombocytopenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.5 Secondary thrombocytopenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.6 Thrombocytopenia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.8 Other specified haemorrhagic conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.9 Haemorrhagic condition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D70 Agranulocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D71 Functional disorders of polymorphonuclear neutrophils 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72 Other disorders of white blood cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.0 Genetic anomalies of leukocytes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.1 Eosinophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.8 Other specified disorders of white blood cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.9 Disorder of white blood cells, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73 Diseases of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.0 Hyposplenism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.1 Hypersplenism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.2 Chronic congestive splenomegaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.3 Abscess of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.4 Cyst of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.5 Infarction of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.8 Other diseases of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.9 Disease of spleen, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74 Methaemoglobinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74.0 Congenital methaemoglobinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74.8 Other methaemoglobinaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74.9 Methaemoglobinaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75 Other diseases of blood and blood- forming organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.0 Familial erythrocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.1 Secondary polycythaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.8 Other specified diseases of blood and blood-forming organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.9 Disease of blood and blood-forming organs, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76 Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76.1 Haemophagocytic lymphohistiocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76.2 Haemophagocytic syndrome, infection-associated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76.3 Other histiocytosis syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D77 Other disorders of blood and blood- forming organs in diseases classified elsewhere © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 267 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80 Immunodeficiency with predominantly antibody defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.0 Hereditary hypogammaglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.1 Nonfamilial hypogammaglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.2 Selective deficiency of immunoglobulin A [IgA] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.4 Selective deficiency of immunoglobulin M [IgM] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.5 Immunodeficiency with increased immunoglobulin M [IgM] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.6 Antibody deficiency with near- normal immunoglobulins or with hyperimmunoglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.7 Transient hypogammaglobulinaemia of infancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.8 Other immunodeficiencies with predominantly antibody defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.9 Immunodeficiency with predominantly antibody defects, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81 Combined immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.3 Adenosine deaminase [ADA] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.4 Nezelof syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.5 Purine nucleoside phosphorylase [PNP] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.6 Major histocompatibility complex class I deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.7 Major histocompatibility complex class II deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.8 Other combined immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.9 Combined immunodeficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82 Immunodeficiency associated with other major defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.0 Wiskott-Aldrich syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.1 Di George syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.2 Immunodeficiency with short-limbed stature

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 268 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.4 Hyperimmunoglobulin E [IgE] syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.8 Immunodeficiency associated with other specified major defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.9 Immunodeficiency associated with major defect, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83 Common variable immunodeficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.8 Other common variable immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.9 Common variable immunodeficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84 Other immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.0 Lymphocyte function antigen-1 [LFA-1] defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.1 Defects in the complement system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.8 Other specified immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.9 Immunodeficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86 Sarcoidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.0 Sarcoidosis of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.1 Sarcoidosis of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.3 Sarcoidosis of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.8 Sarcoidosis of other and combined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.9 Sarcoidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89 Other disorders involving the immune mechanism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.0 Polyclonal hypergammaglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.1 Cryoglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.2 Hypergammaglobulinaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.3 Immune reconstitution syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.9 Disorder involving the immune mechanism, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 269 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00 Congenital iodine-deficiency syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.0 Congenital iodine-deficiency syndrome, neurological type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.1 Congenital iodine-deficiency syndrome, myxoedematous type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.2 Congenital iodine-deficiency syndrome, mixed type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.9 Congenital iodine-deficiency syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01 Iodine-deficiency-related thyroid disorders and allied conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.0 Iodine-deficiency-related diffuse (endemic) goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.1 Iodine-deficiency-related multinodular (endemic) goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.2 Iodine-deficiency-related (endemic) goitre, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E02 Subclinical iodine-deficiency hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03 Other hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.0 Congenital hypothyroidism with diffuse goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.1 Congenital hypothyroidism without goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.2 Hypothyroidism due to medicaments and other exogenous substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.3 Postinfectious hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.4 Atrophy of thyroid (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.5 Myxoedema coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.8 Other specified hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.9 Hypothyroidism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04 Other nontoxic goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.0 Nontoxic diffuse goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.1 Nontoxic single thyroid nodule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.2 Nontoxic multinodular goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.8 Other specified nontoxic goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.9 Nontoxic goitre, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05 Thyrotoxicosis [hyperthyroidism] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.0 Thyrotoxicosis with diffuse goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.1 Thyrotoxicosis with toxic single thyroid nodule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.2 Thyrotoxicosis with toxic multinodular goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.3 Thyrotoxicosis from ectopic thyroid tissue

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 270 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.4 Thyrotoxicosis factitia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.5 Thyroid crisis or storm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.8 Other thyrotoxicosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.9 Thyrotoxicosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06 Thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.0 Acute thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.1 Subacute thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.2 Chronic thyroiditis with transient thyrotoxicosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.3 Autoimmune thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.4 Drug-induced thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.5 Other chronic thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.9 Thyroiditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07 Other disorders of thyroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.0 Hypersecretion of calcitonin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.1 Dyshormogenetic goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.8 Other specified disorders of thyroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.9 Disorder of thyroid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10 Type 1 diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.0 Type 1 diabetes mellitus; With coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.1 Type 1 diabetes mellitus; With ketoacidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.2 Type 1 diabetes mellitus; With renal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.3 Type 1 diabetes mellitus; With ophthalmic complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.4 Type 1 diabetes mellitus; With neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.5 Type 1 diabetes mellitus; With peripheral circulatory complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.6 Type 1 diabetes mellitus; With other specified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.7 Type 1 diabetes mellitus; With multiple complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.8 Type 1 diabetes mellitus; With unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.9 Type 1 diabetes mellitus; Without complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11 Type 2 diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.0 Type 2 diabetes mellitus; With coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.1 Type 2 diabetes mellitus; With ketoacidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.2 Type 2 diabetes mellitus; With renal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.3 Type 2 diabetes mellitus; With ophthalmic complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.4 Type 2 diabetes mellitus; With neurological complications

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 271 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.5 Type 2 diabetes mellitus; With peripheral circulatory complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.6 Type 2 diabetes mellitus; With other specified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.7 Type 2 diabetes mellitus; With multiple complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.8 Type 2 diabetes mellitus; With unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.9 Type 2 diabetes mellitus; Without complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12 Malnutrition-related diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.0 Malnutrition-related diabetes mellitus; With coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.1 Malnutrition-related diabetes mellitus; With ketoacidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.2 Malnutrition-related diabetes mellitus; With renal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.3 Malnutrition-related diabetes mellitus; With ophthalmic complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.4 Malnutrition-related diabetes mellitus; With neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.5 Malnutrition-related diabetes mellitus; With peripheral circulatory complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.6 Malnutrition-related diabetes mellitus; With other specified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.7 Malnutrition-related diabetes mellitus; With multiple complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.8 Malnutrition-related diabetes mellitus; With unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.9 Malnutrition-related diabetes mellitus; Without complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13 Other specified diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.0 Other specified diabetes mellitus; With coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.1 Other specified diabetes mellitus; With ketoacidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.2 Other specified diabetes mellitus; With renal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.3 Other specified diabetes mellitus; With ophthalmic complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.4 Other specified diabetes mellitus; With neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.5 Other specified diabetes mellitus; With peripheral circulatory complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.6 Other specified diabetes mellitus; With other specified complications

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 272 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.7 Other specified diabetes mellitus; With multiple complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.8 Other specified diabetes mellitus; With unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.9 Other specified diabetes mellitus; Without complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14 Unspecified diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.0 Unspecified diabetes mellitus; With coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.1 Unspecified diabetes mellitus; With ketoacidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.2 Unspecified diabetes mellitus; With renal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.3 Unspecified diabetes mellitus; With ophthalmic complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.4 Unspecified diabetes mellitus; With neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.5 Unspecified diabetes mellitus; With peripheral circulatory complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.6 Unspecified diabetes mellitus; With other specified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.7 Unspecified diabetes mellitus; With multiple complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.8 Unspecified diabetes mellitus; With unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.9 Unspecified diabetes mellitus; Without complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E15 Nondiabetic hypoglycaemic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16 Other disorders of pancreatic internal secretion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.0 Drug-induced hypoglycaemia without coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.1 Other hypoglycaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.2 Hypoglycaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.3 Increased secretion of glucagon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.4 Abnormal secretion of gastrin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.8 Other specified disorders of pancreatic internal secretion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.9 Disorder of pancreatic internal secretion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20 Hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.0 Idiopathic hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.1 Pseudohypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.8 Other hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.9 Hypoparathyroidism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21 Hyperparathyroidism and other disorders of parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.0 Primary hyperparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.1 Secondary hyperparathyroidism, not elsewhere classified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 273 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.2 Other hyperparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.3 Hyperparathyroidism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.4 Other specified disorders of parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.5 Disorder of parathyroid gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22 Hyperfunction of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.0 Acromegaly and pituitary gigantism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.1 Hyperprolactinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.2 Syndrome of inappropriate secretion of antidiuretic hormone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.8 Other hyperfunction of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.9 Hyperfunction of pituitary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23 Hypofunction and other disorders of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.0 Hypopituitarism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.1 Drug-induced hypopituitarism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.2 Diabetes insipidus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.3 Hypothalamic dysfunction, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.6 Other disorders of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.7 Disorder of pituitary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24 Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.0 Pituitary-dependent Cushing disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.1 Nelson syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.2 Drug-induced Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.3 Ectopic ACTH syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.4 Alcohol-induced pseudo-Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.8 Other Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.9 Cushing syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25 Adrenogenital disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25.0 Congenital adrenogenital disorders associated with enzyme deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25.8 Other adrenogenital disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25.9 Adrenogenital disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26 Hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.0 Primary hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.1 Secondary hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.8 Other hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.9 Hyperaldosteronism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27 Other disorders of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.0 Other adrenocortical overactivity © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 274 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.1 Primary adrenocortical insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.2 Addisonian crisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.3 Drug-induced adrenocortical insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.4 Other and unspecified adrenocortical insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.5 Adrenomedullary hyperfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.8 Other specified disorders of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.9 Disorder of adrenal gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28 Ovarian dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.0 Ovarian dysfunction: Estrogen excess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.1 Ovarian dysfunction: Androgen excess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.2 Polycystic ovarian syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.3 Primary ovarian failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.8 Other ovarian dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.9 Ovarian dysfunction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29 Testicular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.0 Testicular hyperfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.1 Testicular hypofunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.8 Other testicular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.9 Testicular dysfunction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30 Disorders of puberty, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.0 Delayed puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.1 Precocious puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.8 Other disorders of puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.9 Disorder of puberty, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31 Polyglandular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.0 Autoimmune polyglandular failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.1 Polyglandular hyperfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.8 Other polyglandular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.9 Polyglandular dysfunction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32 Diseases of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.0 Persistent hyperplasia of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.1 Abscess of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.8 Other diseases of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.9 Disease of thymus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34 Other endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.0 Carcinoid syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.1 Other hypersecretion of intestinal hormones

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 275 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.2 Ectopic hormone secretion, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.3 Short stature, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.4 Constitutional tall stature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.5 Androgen resistance syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.8 Other specified endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.9 Endocrine disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35 Disorders of endocrine glands in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35.0 Disorders of thyroid gland in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35.1 Disorders of adrenal glands in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35.8 Disorders of other endocrine glands in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E40 Kwashiorkor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E41 Nutritional marasmus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E42 Marasmic kwashiorkor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E43 Unspecified severe protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E44 Protein-energy malnutrition of moderate and mild degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E44.0 Moderate protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E44.1 Mild protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E45 Retarded development following protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E46 Unspecified protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50 Vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.0 Vitamin A deficiency with conjunctival xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.1 Vitamin A deficiency with Bitot spot and conjunctival xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.2 Vitamin A deficiency with corneal xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.3 Vitamin A deficiency with corneal ulceration and xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.4 Vitamin A deficiency with keratomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.5 Vitamin A deficiency with night blindness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.6 Vitamin A deficiency with xerophthalmic scars of cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.7 Other ocular manifestations of vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.8 Other manifestations of vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.9 Vitamin A deficiency, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 276 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51 Thiamine deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.1 Beriberi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.2 Wernicke encephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.8 Other manifestations of thiamine deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.9 Thiamine deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E52 deficiency [pellagra] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53 Deficiency of other B group vitamins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.0 Riboflavin deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.1 Pyridoxine deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.8 Deficiency of other specified B group vitamins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.9 Vitamin B deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E54 Ascorbic acid deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E55 Vitamin D deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E55.0 Rickets, active 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E55.9 Vitamin D deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56 Other vitamin deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.0 Deficiency of vitamin E 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.1 Deficiency of vitamin K 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.8 Deficiency of other vitamins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.9 Vitamin deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E58 Dietary calcium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E59 Dietary selenium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E60 Dietary zinc deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61 Deficiency of other elements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.0 Copper deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.1 Iron deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.2 Magnesium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.3 deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.4 Chromium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.5 deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.6 Vanadium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.7 Deficiency of multiple nutrient elements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.8 Deficiency of other specified nutrient elements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.9 Deficiency of nutrient element, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63 Other nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.0 [EFA] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.1 Imbalance of constituents of food intake 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.8 Other specified nutritional deficiencies © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 277 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.9 Nutritional deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64 Sequelae of malnutrition and other nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.0 Sequelae of protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.1 Sequelae of vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.2 Sequelae of vitamin C deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.3 Sequelae of rickets 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.8 Sequelae of other nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.9 Sequelae of unspecified nutritional deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E65 Localized adiposity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66 Obesity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.0 Obesity due to excess calories 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.1 Drug-induced obesity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.2 Extreme obesity with alveolar hypoventilation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.8 Other obesity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.9 Obesity, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67 Other hyperalimentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.0 Hypervitaminosis A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.1 Hypercarotenaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.2 Megavitamin-B6syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.3 Hypervitaminosis D 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.8 Other specified hyperalimentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E68 Sequelae of hyperalimentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70 Disorders of aromatic amino-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.0 Classical phenylketonuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.1 Other hyperphenylalaninaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.2 Disorders of tyrosine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.3 Albinism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.8 Other disorders of aromatic amino- acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.9 Disorder of aromatic amino-acid metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71 Disorders of branched-chain amino- acid metabolism and fatty-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.0 Maple-syrup-urine disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.1 Other disorders of branched-chain amino-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.2 Disorder of branched-chain amino- acid metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.3 Disorders of fatty-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72 Other disorders of amino-acid metabolism © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 278 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.0 Disorders of amino-acid transport 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.1 Disorders of sulfur-bearing amino- acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.2 Disorders of cycle metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.3 Disorders of lysine and hydroxylysine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.4 Disorders of ornithine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.5 Disorders of glycine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.8 Other specified disorders of amino- acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.9 Disorder of amino-acid metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73 Lactose intolerance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.0 Congenital lactase deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.1 Secondary lactase deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.8 Other lactose intolerance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.9 Lactose intolerance, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74 Other disorders of metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.0 Glycogen storage disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.1 Disorders of fructose metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.2 Disorders of galactose metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.3 Other disorders of intestinal carbohydrate absorption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.4 Disorders of pyruvate metabolism and gluconeogenesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.8 Other specified disorders of 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.9 Disorder of carbohydrate metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75 Disorders of metabolism and other lipid storage disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.0 GM2gangliosidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.1 Other gangliosidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.2 Other sphingolipidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.3 Sphingolipidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.4 Neuronal ceroid lipofuscinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.5 Other lipid storage disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.6 Lipid storage disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76 Disorders of glycosaminoglycan metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.0 Mucopolysaccharidosis, type I 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.1 Mucopolysaccharidosis, type II 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.2 Other mucopolysaccharidoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.3 Mucopolysaccharidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.8 Other disorders of glucosaminoglycan metabolism © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 279 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.9 Disorder of glucosaminoglycan metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77 Disorders of glycoprotein metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.0 Defects in post-translational modification of lysosomal enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.1 Defects in glycoprotein degradation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.8 Other disorders of glycoprotein metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.9 Disorder of glycoprotein metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78 Disorders of lipoprotein metabolism and other lipidaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.0 Pure hypercholesterolaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.1 Pure hyperglyceridaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.2 Mixed hyperlipidaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.3 Hyperchylomicronaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.4 Other hyperlipidaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.5 Hyperlipidaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.6 Lipoprotein deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.8 Other disorders of lipoprotein metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.9 Disorder of lipoprotein metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79 Disorders of purine and pyrimidine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.1 Lesch-Nyhan syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.8 Other disorders of purine and pyrimidine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.9 Disorder of purine and pyrimidine metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80 Disorders of porphyrin and bilirubin metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.0 Hereditary erythropoietic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.1 Porphyria cutanea tarda 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.2 Other porphyria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.3 Defects of catalase and peroxidase 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.4 Gilbert syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.5 Crigler-Najjar syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.6 Other disorders of bilirubin metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.7 Disorder of bilirubin metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83 Disorders of mineral metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.0 Disorders of copper metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.1 Disorders of iron metabolism © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 280 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.2 Disorders of zinc metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.3 Disorders of metabolism and phosphatases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.4 Disorders of magnesium metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.5 Disorders of 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.8 Other disorders of mineral metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.9 Disorder of mineral metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84 Cystic fibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.0 Cystic fibrosis with pulmonary manifestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.1 Cystic fibrosis with intestinal manifestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.8 Cystic fibrosis with other manifestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.9 Cystic fibrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85 Amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.0 Non-neuropathic heredofamilial amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.1 Neuropathic heredofamilial amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.2 Heredofamilial amyloidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.3 Secondary systemic amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.4 Organ-limited amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.8 Other amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.9 Amyloidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E86 Volume depletion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87 Other disorders of fluid, electrolyte and acid-base balance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.0 Hyperosmolality and hypernatraemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.1 Hypo-osmolality and hyponatraemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.2 Acidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.3 Alkalosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.4 Mixed disorder of acid-base balance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.5 Hyperkalaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.6 Hypokalaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.7 Fluid overload 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88 Other metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.0 Disorders of plasma-protein metabolism, not elsewhere classified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 281 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.1 Lipodystrophy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.2 Lipomatosis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.3 Tumour lysis syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.8 Other specified metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.9 Metabolic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.0 Postprocedural hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.1 Postprocedural hypoinsulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.2 Postprocedural hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.3 Postprocedural hypopituitarism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.4 Postprocedural ovarian failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.5 Postprocedural testicular hypofunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.6 Postprocedural adrenocortical(- medullary) hypofunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.8 Other postprocedural endocrine and metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.9 Postprocedural endocrine and metabolic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E90 Nutritional and metabolic disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00 Dementia in Alzheimer diseaseG30.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.0 Dementia in Alzheimer disease with early onsetG30.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.1 Dementia in Alzheimer disease with late onsetG30.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.2 Dementia in Alzheimer disease, atypical or mixed typeG30.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.9 Dementia in Alzheimer disease, unspecifiedG30.9 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01 Vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.0 Vascular dementia of acute onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.1 Multi-infarct dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.2 Subcortical vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.3 Mixed cortical and subcortical vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.8 Other vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.9 Vascular dementia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02 Dementia in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.0 Dementia in Pick diseaseG31.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.1 Dementia in Creutzfeldt-Jakob diseaseA81.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.2 Dementia in Huntington diseaseG10

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 282 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.3 Dementia in Parkinson diseaseG20 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.4 Dementia in human immunodeficiency virus [HIV] diseaseB22.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.8 Dementia in other specified diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F03 Unspecified dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05 Delirium, not induced by alcohol and other psychoactive substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.0 Delirium not superimposed on dementia, so described 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.1 Delirium superimposed on dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.8 Other delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.9 Delirium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06 Other mental disorders due to brain damage and dysfunction and to physical disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.0 Organic hallucinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.1 Organic catatonic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.2 Organic delusional [schizophrenia- like] disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.3 Organic mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.4 Organic anxiety disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.5 Organic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.6 Organic emotionally labile [asthenic] disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.7 Mild cognitive disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07 Personality and behavioural disorders due to brain disease, damage and dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.0 Organic personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.1 Postencephalitic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.2 Postconcussional syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F09 Unspecified organic or symptomatic mental disorder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 283 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10 Mental and behavioural disorders due to use of alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.0 Mental and behavioural disorders due to use of alcohol; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.1 Mental and behavioural disorders due to use of alcohol; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.2 Mental and behavioural disorders due to use of alcohol; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.3 Mental and behavioural disorders due to use of alcohol; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.4 Mental and behavioural disorders due to use of alcohol; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.5 Mental and behavioural disorders due to use of alcohol; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.6 Mental and behavioural disorders due to use of alcohol; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.7 Mental and behavioural disorders due to use of alcohol; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.8 Mental and behavioural disorders due to use of alcohol; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.9 Mental and behavioural disorders due to use of alcohol; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11 Mental and behavioural disorders due to use of opioids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.0 Mental and behavioural disorders due to use of opioids; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.1 Mental and behavioural disorders due to use of opioids; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.2 Mental and behavioural disorders due to use of opioids; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.3 Mental and behavioural disorders due to use of opioids; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.4 Mental and behavioural disorders due to use of opioids; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.5 Mental and behavioural disorders due to use of opioids; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.6 Mental and behavioural disorders due to use of opioids; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.7 Mental and behavioural disorders due to use of opioids; Residual and late-onset psychotic disorder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 284 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.8 Mental and behavioural disorders due to use of opioids; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.9 Mental and behavioural disorders due to use of opioids; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12 Mental and behavioural disorders due to use of cannabinoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.0 Mental and behavioural disorders due to use of cannabinoids; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.1 Mental and behavioural disorders due to use of cannabinoids; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.2 Mental and behavioural disorders due to use of cannabinoids; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.3 Mental and behavioural disorders due to use of cannabinoids; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.4 Mental and behavioural disorders due to use of cannabinoids; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.5 Mental and behavioural disorders due to use of cannabinoids; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.6 Mental and behavioural disorders due to use of cannabinoids; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.7 Mental and behavioural disorders due to use of cannabinoids; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.8 Mental and behavioural disorders due to use of cannabinoids; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.9 Mental and behavioural disorders due to use of cannabinoids; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13 Mental and behavioural disorders due to use of sedatives or hypnotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.0 Mental and behavioural disorders due to use of sedatives or hypnotics; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.1 Mental and behavioural disorders due to use of sedatives or hypnotics; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.2 Mental and behavioural disorders due to use of sedatives or hypnotics; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.3 Mental and behavioural disorders due to use of sedatives or hypnotics; Withdrawal state

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 285 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.4 Mental and behavioural disorders due to use of sedatives or hypnotics; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.5 Mental and behavioural disorders due to use of sedatives or hypnotics; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.6 Mental and behavioural disorders due to use of sedatives or hypnotics; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.7 Mental and behavioural disorders due to use of sedatives or hypnotics; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.8 Mental and behavioural disorders due to use of sedatives or hypnotics; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.9 Mental and behavioural disorders due to use of sedatives or hypnotics; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14 Mental and behavioural disorders due to use of cocaine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.0 Mental and behavioural disorders due to use of cocaine; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.1 Mental and behavioural disorders due to use of cocaine; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.2 Mental and behavioural disorders due to use of cocaine; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.3 Mental and behavioural disorders due to use of cocaine; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.4 Mental and behavioural disorders due to use of cocaine; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.5 Mental and behavioural disorders due to use of cocaine; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.6 Mental and behavioural disorders due to use of cocaine; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.7 Mental and behavioural disorders due to use of cocaine; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.8 Mental and behavioural disorders due to use of cocaine; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.9 Mental and behavioural disorders due to use of cocaine; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15 Mental and behavioural disorders due to use of other stimulants, including caffeine

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 286 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.0 Mental and behavioural disorders due to use of other stimulants, including caffeine; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.1 Mental and behavioural disorders due to use of other stimulants, including caffeine; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.2 Mental and behavioural disorders due to use of other stimulants, including caffeine; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.3 Mental and behavioural disorders due to use of other stimulants, including caffeine; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.4 Mental and behavioural disorders due to use of other stimulants, including caffeine; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.5 Mental and behavioural disorders due to use of other stimulants, including caffeine; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.6 Mental and behavioural disorders due to use of other stimulants, including caffeine; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.7 Mental and behavioural disorders due to use of other stimulants, including caffeine; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.8 Mental and behavioural disorders due to use of other stimulants, including caffeine; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.9 Mental and behavioural disorders due to use of other stimulants, including caffeine; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16 Mental and behavioural disorders due to use of hallucinogens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.0 Mental and behavioural disorders due to use of hallucinogens; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.1 Mental and behavioural disorders due to use of hallucinogens; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.2 Mental and behavioural disorders due to use of hallucinogens; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.3 Mental and behavioural disorders due to use of hallucinogens; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.4 Mental and behavioural disorders due to use of hallucinogens; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.5 Mental and behavioural disorders due to use of hallucinogens; Psychotic disorder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 287 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.6 Mental and behavioural disorders due to use of hallucinogens; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.7 Mental and behavioural disorders due to use of hallucinogens; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.8 Mental and behavioural disorders due to use of hallucinogens; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.9 Mental and behavioural disorders due to use of hallucinogens; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17 Mental and behavioural disorders due to use of 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.0 Mental and behavioural disorders due to use of tobacco; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.1 Mental and behavioural disorders due to use of tobacco; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.2 Mental and behavioural disorders due to use of tobacco; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.3 Mental and behavioural disorders due to use of tobacco; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.4 Mental and behavioural disorders due to use of tobacco; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.5 Mental and behavioural disorders due to use of tobacco; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.6 Mental and behavioural disorders due to use of tobacco; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.7 Mental and behavioural disorders due to use of tobacco; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.8 Mental and behavioural disorders due to use of tobacco; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.9 Mental and behavioural disorders due to use of tobacco; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18 Mental and behavioural disorders due to use of volatile solvents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.0 Mental and behavioural disorders due to use of volatile solvents; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.1 Mental and behavioural disorders due to use of volatile solvents; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.2 Mental and behavioural disorders due to use of volatile solvents; Dependence syndrome

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 288 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.3 Mental and behavioural disorders due to use of volatile solvents; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.4 Mental and behavioural disorders due to use of volatile solvents; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.5 Mental and behavioural disorders due to use of volatile solvents; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.6 Mental and behavioural disorders due to use of volatile solvents; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.7 Mental and behavioural disorders due to use of volatile solvents; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.8 Mental and behavioural disorders due to use of volatile solvents; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.9 Mental and behavioural disorders due to use of volatile solvents; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.0 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.1 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.2 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.3 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.4 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.5 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.6 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Amnesic syndrome

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 289 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.7 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.8 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.9 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20 Schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.0 Paranoid schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.1 Hebephrenic schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.2 Catatonic schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.3 Undifferentiated schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.4 Post-schizophrenic depression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.5 Residual schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.6 Simple schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.8 Other schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.9 Schizophrenia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F21 Schizotypal disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22 Persistent delusional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22.0 Delusional disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22.8 Other persistent delusional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22.9 Persistent delusional disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23 Acute and transient psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.2 Acute schizophrenia-like psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.3 Other acute predominantly delusional psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.8 Other acute and transient psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.9 Acute and transient psychotic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F24 Induced delusional disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25 Schizoaffective disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.0 Schizoaffective disorder, manic type

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 290 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.1 Schizoaffective disorder, depressive type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.2 Schizoaffective disorder, mixed type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.8 Other schizoaffective disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.9 Schizoaffective disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F28 Other nonorganic psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F29 Unspecified nonorganic psychosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30 Manic episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.0 Hypomania 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.1 Mania without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.2 Mania with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.8 Other manic episodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.9 Manic episode, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31 Bipolar affective disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.0 Bipolar affective disorder, current episode hypomanic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.3 Bipolar affective disorder, current episode mild or moderate depression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.6 Bipolar affective disorder, current episode mixed 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.7 Bipolar affective disorder, currently in remission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.8 Other bipolar affective disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.9 Bipolar affective disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32 Depressive episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.0 Mild depressive episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.1 Moderate depressive episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.2 Severe depressive episode without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.3 Severe depressive episode with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.8 Other depressive episodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.9 Depressive episode, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33 Recurrent depressive disorder © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 291 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.0 Recurrent depressive disorder, current episode mild 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.1 Recurrent depressive disorder, current episode moderate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.4 Recurrent depressive disorder, currently in remission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.8 Other recurrent depressive disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.9 Recurrent depressive disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34 Persistent mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.0 Cyclothymia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.1 Dysthymia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.8 Other persistent mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.9 Persistent mood [affective] disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38 Other mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38.0 Other single mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38.1 Other recurrent mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38.8 Other specified mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F39 Unspecified mood [affective] disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40 Phobic anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.0 Agoraphobia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.1 Social phobias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.2 Specific (isolated) phobias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.8 Other phobic anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.9 Phobic anxiety disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41 Other anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.0 Panic disorder [episodic paroxysmal anxiety] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.1 Generalized anxiety disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.2 Mixed anxiety and depressive disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.3 Other mixed anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.8 Other specified anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.9 Anxiety disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42 Obsessive-compulsive disorder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 292 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.0 Predominantly obsessional thoughts or ruminations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.1 Predominantly compulsive acts [obsessional rituals] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.2 Mixed obsessional thoughts and acts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.8 Other obsessive-compulsive disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.9 Obsessive-compulsive disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43 Reaction to severe stress, and adjustment disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.0 Acute stress reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.1 Post-traumatic stress disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.2 Adjustment disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.8 Other reactions to severe stress 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.9 Reaction to severe stress, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44 Dissociative [conversion] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.0 Dissociative amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.1 Dissociative fugue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.2 Dissociative stupor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.3 Trance and possession disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.4 Dissociative motor disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.5 Dissociative convulsions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.6 Dissociative anaesthesia and sensory loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.7 Mixed dissociative [conversion] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.8 Other dissociative [conversion] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.9 Dissociative [conversion] disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45 Somatoform disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.0 Somatization disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.1 Undifferentiated somatoform disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.2 Hypochondriacal disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.3 Somatoform autonomic dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.4 Persistent somatoform pain disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.8 Other somatoform disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.9 Somatoform disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48 Other neurotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.0 Neurasthenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.1 Depersonalization-derealization syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.8 Other specified neurotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.9 Neurotic disorder, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 293 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50 Eating disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.0 Anorexia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.1 Atypical anorexia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.2 Bulimia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.3 Atypical bulimia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.4 Overeating associated with other psychological disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.5 associated with other psychological disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.8 Other eating disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.9 Eating disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51 Nonorganic sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.0 Nonorganic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.1 Nonorganic hypersomnia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.2 Nonorganic disorder of the sleep- wake schedule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.3 Sleepwalking [somnambulism] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.4 Sleep terrors [night terrors] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.5 Nightmares 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.8 Other nonorganic sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.9 Nonorganic sleep disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52 Sexual dysfunction, not caused by organic disorder or disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.0 Lack or loss of sexual desire 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.1 Sexual aversion and lack of sexual enjoyment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.2 Failure of genital response 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.3 Orgasmic dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.5 Nonorganic vaginismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.6 Nonorganic dyspareunia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.7 Excessive sexual drive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.8 Other sexual dysfunction, not caused by organic disorder or disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 294 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.1 Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.8 Other mental and behavioural disorders associated with the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.9 Puerperal mental disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F55 Abuse of non-dependence- producing substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60 Specific personality disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.0 Paranoid personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.1 Schizoid personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.2 Dissocial personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.3 Emotionally unstable personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.4 Histrionic personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.5 Anankastic personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.6 Anxious [avoidant] personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.7 Dependent personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.8 Other specific personality disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.9 Personality disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F61 Mixed and other personality disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62 Enduring personality changes, not attributable to brain damage and disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.0 Enduring personality change after catastrophic experience 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.1 Enduring personality change after psychiatric illness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.8 Other enduring personality changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.9 Enduring personality change, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63 Habit and impulse disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.0 Pathological gambling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.1 Pathological fire-setting [pyromania] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.2 Pathological stealing [kleptomania] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.3 Trichotillomania 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.8 Other habit and impulse disorders

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 295 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.9 Habit and impulse disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64 Gender identity disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.0 Transsexualism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.1 Dual-role transvestism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.2 Gender identity disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.8 Other gender identity disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.9 Gender identity disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65 Disorders of sexual preference 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.0 Fetishism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.1 Fetishistic transvestism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.2 Exhibitionism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.3 Voyeurism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.4 Paedophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.5 Sadomasochism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.6 Multiple disorders of sexual preference 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.8 Other disorders of sexual preference 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.9 Disorder of sexual preference, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66 Psychological and behavioural disorders associated with sexual development and orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.0 Sexual maturation disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.1 Egodystonic sexual orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.2 Sexual relationship disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.8 Other psychosexual development disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.9 Psychosexual development disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68 Other disorders of adult personality and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68.0 Elaboration of physical symptoms for psychological reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68.8 Other specified disorders of adult personality and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F69 Unspecified disorder of adult personality and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70 Mild mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70.0 Mild mental retardation; With the statement of no, or minimal, impairment of behaviour

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 296 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70.1 Mild mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70.8 Mild mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70.9 Mild mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71 Moderate mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71.0 Moderate mental retardation; With the statement of no, or minimal, impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71.1 Moderate mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71.8 Moderate mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71.9 Moderate mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72 Severe mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72.0 Severe mental retardation; With the statement of no, or minimal, impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72.1 Severe mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72.8 Severe mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72.9 Severe mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73 Profound mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73.0 Profound mental retardation; With the statement of no, or minimal, impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73.1 Profound mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73.8 Profound mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73.9 Profound mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78 Other mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78.0 Other mental retardation; With the statement of no, or minimal, impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78.1 Other mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78.8 Other mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78.9 Other mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79 Unspecified mental retardation © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 297 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79.0 Unspecified mental retardation; With the statement of no, or minimal, impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79.1 Unspecified mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79.8 Unspecified mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79.9 Unspecified mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80 Specific developmental disorders of speech and language 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.0 Specific speech articulation disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.1 Expressive language disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.2 Receptive language disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.3 Acquired aphasia with epilepsy [Landau-Kleffner] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.8 Other developmental disorders of speech and language 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.9 Developmental disorder of speech and language, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81 Specific developmental disorders of scholastic skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.0 Specific reading disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.1 Specific spelling disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.2 Specific disorder of arithmetical skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.3 Mixed disorder of scholastic skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.8 Other developmental disorders of scholastic skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.9 Developmental disorder of scholastic skills, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F82 Specific developmental disorder of motor function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F83 Mixed specific developmental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84 Pervasive developmental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.0 Childhood autism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.1 Atypical autism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.2 Rett syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.3 Other childhood disintegrative disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.4 Overactive disorder associated with mental retardation and stereotyped movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.5 Asperger syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.8 Other pervasive developmental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.9 Pervasive developmental disorder, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 298 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F88 Other disorders of psychological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F89 Unspecified disorder of psychological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90 Hyperkinetic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.0 Disturbance of activity and attention 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.1 Hyperkinetic conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.8 Other hyperkinetic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.9 Hyperkinetic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91 Conduct disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.0 Conduct disorder confined to the family context 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.1 Unsocialized conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.2 Socialized conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.3 Oppositional defiant disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.8 Other conduct disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.9 Conduct disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92 Mixed disorders of conduct and emotions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92.0 Depressive conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92.8 Other mixed disorders of conduct and emotions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92.9 Mixed disorder of conduct and emotions, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93 Emotional disorders with onset specific to childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.0 Separation anxiety disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.1 Phobic anxiety disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.2 Social anxiety disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.3 Sibling rivalry disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.8 Other childhood emotional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.9 Childhood emotional disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94 Disorders of social functioning with onset specific to childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.0 Elective mutism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.1 Reactive attachment disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.2 Disinhibited attachment disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.8 Other childhood disorders of social functioning 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.9 Childhood disorder of social functioning, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95 Tic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.0 Transient tic disorder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 299 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.1 Chronic motor or vocal tic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.2 Combined vocal and multiple motor tic disorder [de la Tourette] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.8 Other tic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.9 Tic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.0 Nonorganic enuresis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.1 Nonorganic encopresis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.2 Feeding disorder of infancy and childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.3 Pica of infancy and childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.4 Stereotyped movement disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.5 Stuttering [stammering] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.6 Cluttering 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.8 Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.9 Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F99 Mental disorder, not otherwise specified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00 Bacterial meningitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.0 Haemophilus meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.1 Pneumococcal meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.2 Streptococcal meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.3 Staphylococcal meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.8 Other bacterial meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.9 Bacterial meningitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G01 Meningitis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02 Meningitis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02.0 Meningitis in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02.1 Meningitis in mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03 Meningitis due to other and unspecified causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.0 Nonpyogenic meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.1 Chronic meningitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 300 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.2 Benign recurrent meningitis [Mollaret] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.8 Meningitis due to other specified causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.9 Meningitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04 Encephalitis, myelitis and encephalomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.0 Acute disseminated encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.1 Tropical spastic paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.8 Other encephalitis, myelitis and encephalomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06 Intracranial and intraspinal abscess and granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06.0 Intracranial abscess and granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06.1 Intraspinal abscess and granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06.2 Extradural and subdural abscess, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G08 Intracranial and intraspinal phlebitis and thrombophlebitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G09 Sequelae of inflammatory diseases of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G10 Huntington disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11 Hereditary ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.0 Congenital nonprogressive ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.1 Early-onset cerebellar ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.2 Late-onset cerebellar ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.3 Cerebellar ataxia with defective DNA repair

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 301 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.4 Hereditary spastic paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.8 Other hereditary ataxias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.9 Hereditary ataxia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12 Spinal muscular atrophy and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.1 Other inherited spinal muscular atrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.2 Motor neuron disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.8 Other spinal muscular atrophies and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.9 Spinal muscular atrophy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.0 Paraneoplastic neuromyopathy and neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.2 Systemic atrophy primarily affecting central nervous system in myxoedemaE00.1E03.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G14 Postpolio syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G20 Parkinson disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21 Secondary parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.0 Malignant neuroleptic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.1 Other drug-induced secondary parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.2 Secondary parkinsonism due to other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.3 Postencephalitic parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.4 Vascular parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.8 Other secondary parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.9 Secondary parkinsonism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G22 Parkinsonism in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23 Other degenerative diseases of basal ganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.0 Hallervorden-Spatz disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.1 Progressive supranuclear ophthalmoplegia [Steele- Richardson-Olszewski] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.2 Multiple system atrophy, parkinsonian type [MSA-P] © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 302 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.3 Multiple system atrophy, cerebellar type [MSA-C] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.8 Other specified degenerative diseases of basal ganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.9 Degenerative disease of basal ganglia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24 Dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.0 Drug-induced dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.1 Idiopathic familial dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.2 Idiopathic nonfamilial dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.3 Spasmodic torticollis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.4 Idiopathic orofacial dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.5 Blepharospasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.8 Other dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.9 Dystonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25 Other extrapyramidal and movement disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.0 Essential tremor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.1 Drug-induced tremor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.2 Other specified forms of tremor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.3 Myoclonus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.4 Drug-induced chorea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.5 Other chorea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.6 Drug-induced tics and other tics of organic origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.8 Other specified extrapyramidal and movement disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.9 Extrapyramidal and movement disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G26 Extrapyramidal and movement disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30 Alzheimer disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.0 Alzheimer disease with early onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.1 Alzheimer disease with late onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.8 Other Alzheimer disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.9 Alzheimer disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31 Other degenerative diseases of nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.0 Circumscribed brain atrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.1 Senile degeneration of brain, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.2 Degeneration of nervous system due to alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.8 Other specified degenerative diseases of nervous system

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 303 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.9 Degenerative disease of nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G32 Other degenerative disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G35 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36 Other acute disseminated demyelination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.0 Neuromyelitis optica [Devic] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.8 Other specified acute disseminated demyelination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.9 Acute disseminated demyelination, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37 Other demyelinating diseases of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.0 Diffuse sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.1 Central demyelination of corpus callosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.2 Central pontine myelinolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.3 Acute transverse myelitis in demyelinating disease of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.4 Subacute necrotizing myelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.5 Concentric sclerosis [Baló] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.8 Other specified demyelinating diseases of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.9 Demyelinating disease of central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40 Epilepsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.0 Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with of localized onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.1 Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.2 Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.3 Generalized idiopathic epilepsy and epileptic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.4 Other generalized epilepsy and epileptic syndromes

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 304 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.5 Special epileptic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.6 Grand mal seizures, unspecified (with or without petit mal) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.7 Petit mal, unspecified, without grand mal seizures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.8 Other epilepsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.9 Epilepsy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41 Status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.0 Grand mal status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.1 Petit mal status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.2 Complex partial status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.8 Other status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.9 Status epilepticus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.0 Migraine without aura [common migraine] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.1 Migraine with aura [classical migraine] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.2 Status migrainosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.3 Complicated migraine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.8 Other migraine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.9 Migraine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44 Other headache syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.0 Cluster headache syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.1 Vascular headache, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.2 Tension-type headache 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.3 Chronic post-traumatic headache 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.4 Drug-induced headache, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.8 Other specified headache syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45 Transient cerebral ischaemic attacks and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.0 Vertebro-basilar artery syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.1 Carotid artery syndrome (hemispheric) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.2 Multiple and bilateral precerebral artery syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.3 Amaurosis fugax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.4 Transient global amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.8 Other transient cerebral ischaemic attacks and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.9 Transient cerebral ischaemic attack, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46 Vascular syndromes of brain in cerebrovascular diseasesI60-I67

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 305 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.0 Middle cerebral artery syndromeI66.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.1 Anterior cerebral artery syndromeI66.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.2 Posterior cerebral artery syndromeI66.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.3 Brain stem stroke syndromeI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.4 Cerebellar stroke syndromeI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.5 Pure motor lacunar syndromeI60- I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.6 Pure sensory lacunar syndromeI60- I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.7 Other lacunar syndromesI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.8 Other vascular syndromes of brain in cerebrovascular diseasesI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47 Sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.0 Disorders of initiating and maintaining sleep [insomnias] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.1 Disorders of excessive somnolence [hypersomnias] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.2 Disorders of the sleep-wake schedule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.3 Sleep apnoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.4 and cataplexy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.8 Other sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.9 Sleep disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50 Disorders of trigeminal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.0 Trigeminal neuralgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.1 Atypical facial pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.8 Other disorders of trigeminal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.9 Disorder of trigeminal nerve, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51 Facial nerve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.0 Bell palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.1 Geniculate ganglionitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.2 Melkersson syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.3 Clonic hemifacial spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.4 Facial myokymia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.8 Other disorders of facial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.9 Disorder of facial nerve, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52 Disorders of other cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.0 Disorders of olfactory nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.1 Disorders of glossopharyngeal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.2 Disorders of vagus nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.3 Disorders of hypoglossal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.7 Disorders of multiple cranial nerves © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 306 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.8 Disorders of other specified cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.9 Cranial nerve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53 Cranial nerve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.0 Postzoster neuralgiaB02.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.1 Multiple cranial nerve palsies in infectious and parasitic diseases classified elsewhereA00-B99 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.2 Multiple cranial nerve palsies in sarcoidosisD86.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.3 Multiple cranial nerve palsies in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.8 Other cranial nerve disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54 Nerve root and plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.0 Brachial plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.1 Lumbosacral plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.2 Cervical root disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.3 Thoracic root disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.4 Lumbosacral root disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.5 Neuralgic amyotrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.6 Phantom limb syndrome with pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.7 Phantom limb syndrome without pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.8 Other nerve root and plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.9 Nerve root and plexus disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55 Nerve root and plexus compressions in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.0 Nerve root and plexus compressions in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.1 Nerve root and plexus compressions in intervertebral disc disordersM50-M51 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.2 Nerve root and plexus compressions in spondylosisM47.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.3 Nerve root and plexus compressions in other dorsopathiesM45-M46M48.-M53- M54 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.8 Nerve root and plexus compressions in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56 Mononeuropathies of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.0 Carpal tunnel syndrome

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 307 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.1 Other lesions of median nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.2 Lesion of ulnar nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.3 Lesion of radial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.4 Causalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.8 Other mononeuropathies of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.9 Mononeuropathy of upper limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57 Mononeuropathies of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.0 Lesion of sciatic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.1 Meralgia paraesthetica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.2 Lesion of femoral nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.3 Lesion of lateral popliteal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.4 Lesion of medial popliteal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.5 Tarsal tunnel syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.6 Lesion of plantar nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.8 Other mononeuropathies of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.9 Mononeuropathy of lower limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58 Other mononeuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.0 Intercostal neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.7 Mononeuritis multiplex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.8 Other specified mononeuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.9 Mononeuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G59 Mononeuropathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G59.0 Diabetic mononeuropathyE10-E14 with common fourth character .4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G59.8 Other mononeuropathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60 Hereditary and idiopathic neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.0 Hereditary motor and sensory neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.1 Refsum disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.2 Neuropathy in association with hereditary ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.3 Idiopathic progressive neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.8 Other hereditary and idiopathic neuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.9 Hereditary and idiopathic neuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61 Inflammatory polyneuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.0 Guillain-Barré syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.1 Serum neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.8 Other inflammatory polyneuropathies © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 308 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.9 Inflammatory polyneuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62 Other polyneuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.0 Drug-induced polyneuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.2 Polyneuropathy due to other toxic agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.8 Other specified polyneuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.9 Polyneuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63 Polyneuropathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.1 Polyneuropathy in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.2 Diabetic polyneuropathyE10-E14 with common fourth character .4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.3 Polyneuropathy in other endocrine and metabolic diseasesE00- E07E15-E16E20-E34E70-E89 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.4 Polyneuropathy in nutritional deficiencyE40-E64 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.5 Polyneuropathy in systemic connective tissue disordersM30- M35 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.6 Polyneuropathy in other musculoskeletal disordersM00- M25M40-M96 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.8 Polyneuropathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G64 Other disorders of peripheral nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70 Myasthenia gravis and other myoneural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.0 Myasthenia gravis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.1 Toxic myoneural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.2 Congenital and developmental myasthenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.8 Other specified myoneural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.9 Myoneural disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71 Primary disorders of muscles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.0 Muscular dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.1 Myotonic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.2 Congenital myopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.3 Mitochondrial myopathy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.8 Other primary disorders of muscles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.9 Primary disorder of muscle, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 309 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72 Other myopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.0 Drug-induced myopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.1 Alcoholic myopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.2 Myopathy due to other toxic agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.3 Periodic paralysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.4 Inflammatory myopathy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.8 Other specified myopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.9 Myopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73 Disorders of myoneural junction and muscle in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.0 Myasthenic syndromes in endocrine diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.1 Lambert-Eaton syndromeC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.2 Other myasthenic syndromes in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.3 Myasthenic syndromes in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.4 Myopathy in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.5 Myopathy in endocrine diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.6 Myopathy in metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.7 Myopathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80 Cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.0 Spastic quadriplegic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.1 Spastic diplegic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.2 Spastic hemiplegic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.3 Dyskinetic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.4 Ataxic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.8 Other cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.9 Cerebral palsy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81 Hemiplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81.0 Flaccid hemiplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81.1 Spastic hemiplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81.9 Hemiplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82 Paraplegia and tetraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.0 Flaccid paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.1 Spastic paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.2 Paraplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.3 Flaccid tetraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.4 Spastic tetraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.5 Tetraplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83 Other paralytic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.0 Diplegia of upper limbs © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 310 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.1 Monoplegia of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.2 Monoplegia of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.3 Monoplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.4 Cauda equina syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.5 Locked-in syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.8 Other specified paralytic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.9 Paralytic syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90 Disorders of autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.0 Idiopathic peripheral autonomic neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.1 Familial dysautonomia [Riley-Day] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.2 Horner syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.4 Autonomic dysreflexia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.8 Other disorders of autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.9 Disorder of autonomic nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91 Hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.0 Communicating hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.1 Obstructive hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.2 Normal-pressure hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.3 Post-traumatic hydrocephalus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.8 Other hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.9 Hydrocephalus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G92 Toxic encephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93 Other disorders of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.0 Cerebral cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.1 Anoxic brain damage, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.2 Benign intracranial hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.3 Postviral fatigue syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.4 Encephalopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.5 Compression of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.6 Cerebral oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.7 Reye syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.8 Other specified disorders of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.9 Disorder of brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94 Other disorders of brain in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhereA00-B99 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.1 Hydrocephalus in neoplastic diseaseC00-D48

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 311 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.2 Hydrocephalus in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.8 Other specified disorders of brain in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95 Other diseases of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.0 Syringomyelia and syringobulbia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.1 Vascular myelopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.2 Cord compression, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.8 Other specified diseases of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.9 Disease of spinal cord, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96 Other disorders of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.0 Cerebrospinal fluid leak 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.1 Disorders of meninges, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.8 Other specified disorders of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.9 Disorder of central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97 Postprocedural disorders of nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.0 Cerebrospinal fluid leak from spinal puncture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.1 Other reaction to spinal and lumbar puncture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.2 Intracranial hypotension following ventricular shunting 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.8 Other postprocedural disorders of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.9 Postprocedural disorder of nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G98 Other disorders of nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99 Other disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.0 Autonomic neuropathy in endocrine and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.2 Myelopathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.8 Other specified disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H00 Hordeolum and chalazion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H00.0 Hordeolum and other deep inflammation of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H00.1 Chalazion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01 Other inflammation of eyelid © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 312 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.0 Blepharitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.1 Noninfectious dermatoses of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.8 Other specified inflammation of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.9 Inflammation of eyelid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02 Other disorders of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.0 Entropion and trichiasis of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.1 Ectropion of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.2 Lagophthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.3 Blepharochalasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.4 Ptosis of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.5 Other disorders affecting eyelid function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.6 Xanthelasma of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.7 Other degenerative disorders of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.8 Other specified disorders of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.9 Disorder of eyelid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03 Disorders of eyelid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03.0 Parasitic infestation of eyelid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03.1 Involvement of eyelid in other infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03.8 Involvement of eyelid in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04 Disorders of lacrimal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.0 Dacryoadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.1 Other disorders of lacrimal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.2 Epiphora 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.3 Acute and unspecified inflammation of lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.4 Chronic inflammation of lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.5 Stenosis and insufficiency of lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.6 Other changes in lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.8 Other disorders of lacrimal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.9 Disorder of lacrimal system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05 Disorders of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.0 Acute inflammation of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.1 Chronic inflammatory disorders of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.2 Exophthalmic conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.3 Deformity of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.4 Enophthalmos © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 313 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.5 Retained (old) foreign body following penetrating wound of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.8 Other disorders of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.9 Disorder of orbit, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06 Disorders of lacrimal system and orbit in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.0 Disorders of lacrimal system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.1 Parasitic infestation of orbit in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.2 Dysthyroid exophthalmosE05.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.3 Other disorders of orbit in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10 Conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.0 Mucopurulent conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.1 Acute atopic conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.2 Other acute conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.3 Acute conjunctivitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.4 Chronic conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.5 Blepharoconjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.8 Other conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.9 Conjunctivitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11 Other disorders of conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.0 Pterygium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.1 Conjunctival degenerations and deposits 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.2 Conjunctival scars 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.3 Conjunctival haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.4 Other conjunctival vascular disorders and cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.8 Other specified disorders of conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.9 Disorder of conjunctiva, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13 Disorders of conjunctiva in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.0 Filarial infection of conjunctivaB74.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.2 Conjunctivitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.3 Ocular pemphigoidL12.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.8 Other disorders of conjunctiva in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15 Disorders of sclera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.0 Scleritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.1 Episcleritis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 314 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.8 Other disorders of sclera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.9 Disorder of sclera, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16 Keratitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.0 Corneal ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.1 Other superficial keratitis without conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.2 Keratoconjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.3 Interstitial and deep keratitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.4 Corneal neovascularization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.8 Other keratitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.9 Keratitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17 Corneal scars and opacities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.0 Adherent leukoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.1 Other central corneal opacity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.8 Other corneal scars and opacities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.9 Corneal scar and opacity, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18 Other disorders of cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.0 Corneal pigmentations and deposits 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.1 Bullous keratopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.2 Other corneal oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.3 Changes in corneal membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.4 Corneal degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.5 Hereditary corneal dystrophies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.6 Keratoconus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.7 Other corneal deformities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.8 Other specified disorders of cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.9 Disorder of cornea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19 Disorders of sclera and cornea in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.0 Scleritis and episcleritis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.1 Herpesviral keratitis and keratoconjunctivitisB00.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.8 Other disorders of sclera and cornea in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20 Iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.0 Acute and subacute iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.1 Chronic iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.2 Lens-induced iridocyclitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 315 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.8 Other iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.9 Iridocyclitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21 Other disorders of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.0 Hyphaema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.1 Other vascular disorders of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.2 Degeneration of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.3 Cyst of iris, ciliary body and anterior chamber 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.4 Pupillary membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.5 Other adhesions and disruptions of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.8 Other specified disorders of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.9 Disorder of iris and ciliary body, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22 Disorders of iris and ciliary body in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22.1 Iridocyclitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25 Senile cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.0 Senile incipient cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.1 Senile nuclear cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.2 Senile cataract, morgagnian type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.8 Other senile cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.9 Senile cataract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26 Other cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.0 Infantile, juvenile and presenile cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.1 Traumatic cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.2 Complicated cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.3 Drug-induced cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.4 After-cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.8 Other specified cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.9 Cataract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27 Other disorders of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.0 Aphakia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.1 Dislocation of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.8 Other specified disorders of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.9 Disorder of lens, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 316 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28 Cataract and other disorders of lens in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.0 Diabetic cataractE10-E14 with common fourth character .3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.1 Cataract in other endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.2 Cataract in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.8 Other disorders of lens in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30 Chorioretinal inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.0 Focal chorioretinal inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.1 Disseminated chorioretinal inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.2 Posterior cyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.8 Other chorioretinal inflammations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.9 Chorioretinal inflammation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31 Other disorders of choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.0 Chorioretinal scars 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.1 Choroidal degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.2 Hereditary choroidal dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.3 Choroidal haemorrhage and rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.4 Choroidal detachment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.8 Other specified disorders of choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.9 Disorder of choroid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H32 Chorioretinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H32.8 Other chorioretinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33 Retinal detachments and breaks 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.0 Retinal detachment with retinal break 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.1 Retinoschisis and retinal cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.2 Serous retinal detachment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.3 Retinal breaks without detachment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.4 Traction detachment of retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.5 Other retinal detachments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34 Retinal vascular occlusions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.0 Transient retinal artery occlusion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.1 Central retinal artery occlusion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.2 Other retinal artery occlusions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.8 Other retinal vascular occlusions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.9 Retinal vascular occlusion, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 317 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35 Other retinal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.0 Background retinopathy and retinal vascular changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.1 Retinopathy of prematurity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.2 Other proliferative retinopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.3 Degeneration of macula and posterior pole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.4 Peripheral retinal degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.5 Hereditary retinal dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.6 Retinal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.7 Separation of retinal layers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.8 Other specified retinal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.9 Retinal disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H36 Retinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H36.0 Diabetic retinopathyE10-E14 with common fourth character .3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H36.8 Other retinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40 Glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.0 Glaucoma suspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.1 Primary open-angle glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.2 Primary angle-closure glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.3 Glaucoma secondary to eye trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.4 Glaucoma secondary to eye inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.5 Glaucoma secondary to other eye disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.6 Glaucoma secondary to drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.8 Other glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.9 Glaucoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H42 Glaucoma in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H42.0 Glaucoma in endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H42.8 Glaucoma in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43 Disorders of vitreous body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.0 Vitreous prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.1 Vitreous haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.2 Crystalline deposits in vitreous body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.3 Other vitreous opacities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.8 Other disorders of vitreous body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.9 Disorder of vitreous body, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44 Disorders of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.0 Purulent endophthalmitis © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 318 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.1 Other endophthalmitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.2 Degenerative myopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.3 Other degenerative disorders of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.4 Hypotony of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.5 Degenerated conditions of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.6 Retained (old) intraocular foreign body, magnetic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.7 Retained (old) intraocular foreign body, nonmagnetic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.8 Other disorders of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.9 Disorder of globe, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45 Disorders of vitreous body and globe in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45.0 Vitreous haemorrhage in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45.1 Endophthalmitis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H46 Optic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47 Other disorders of optic [2nd] nerve and visual pathways 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.0 Disorders of optic nerve, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.1 Papilloedema, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.2 Optic atrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.3 Other disorders of optic disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.4 Disorders of optic chiasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.5 Disorders of other visual pathways 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.6 Disorders of visual cortex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.7 Disorder of visual pathways, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48.0 Optic atrophy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48.1 Retrobulbar neuritis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49 Paralytic strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.0 Third [oculomotor] nerve palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.1 Fourth [trochlear] nerve palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.2 Sixth [abducent] nerve palsy

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 319 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.3 Total (external) ophthalmoplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.4 Progressive external ophthalmoplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.8 Other paralytic strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.9 Paralytic strabismus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50 Other strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.0 Convergent concomitant strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.1 Divergent concomitant strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.2 Vertical strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.3 Intermittent heterotropia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.4 Other and unspecified heterotropia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.5 Heterophoria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.6 Mechanical strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.8 Other specified strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.9 Strabismus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51 Other disorders of binocular movement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.0 Palsy of conjugate gaze 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.1 Convergence insufficiency and excess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.2 Internuclear ophthalmoplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.8 Other specified disorders of binocular movement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.9 Disorder of binocular movement, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52 Disorders of refraction and accommodation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.0 Hypermetropia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.1 Myopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.2 Astigmatism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.3 Anisometropia and aniseikonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.4 Presbyopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.5 Disorders of accommodation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.6 Other disorders of refraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.7 Disorder of refraction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53 Visual disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.0 Amblyopia ex anopsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.1 Subjective visual disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.2 Diplopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.3 Other disorders of binocular vision 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.4 Visual field defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.5 Colour vision deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.6 Night blindness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.8 Other visual disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.9 Visual disturbance, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 320 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54 Visual impairment including blindness (binocular or monocular) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.0 Blindness, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.1 Severe visual impairment, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.2 Moderate visual impairment, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.3 Mild or no visual impairment, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.4 Blindness, monocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.5 Severe visual impairment, monocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.6 Moderate visual impairment, monocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.9 Unspecified visual impairment (binocular) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H55 Nystagmus and other irregular eye movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57 Other disorders of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.0 Anomalies of pupillary function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.1 Ocular pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.8 Other specified disorders of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.9 Disorder of eye and adnexa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58 Other disorders of eye and adnexa in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58.0 Anomalies of pupillary function in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58.1 Visual disturbances in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58.8 Other specified disorders of eye and adnexa in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59 Postprocedural disorders of eye and adnexa, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59.0 Keratopathy (bullous aphakic) following cataract surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59.8 Other postprocedural disorders of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59.9 Postprocedural disorder of eye and adnexa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60 Otitis externa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.0 Abscess of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.1 Cellulitis of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.2 Malignant otitis externa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.3 Other infective otitis externa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.4 Cholesteatoma of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.5 Acute otitis externa, noninfective 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.8 Other otitis externa

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 321 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.9 Otitis externa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61 Other disorders of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.0 Perichondritis of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.1 Noninfective disorders of pinna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.2 Impacted cerumen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.3 Acquired stenosis of external ear canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.8 Other specified disorders of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.9 Disorder of external ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62 Disorders of external ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.0 Otitis externa in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.1 Otitis externa in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.2 Otitis externa in mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.4 Otitis externa in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.8 Other disorders of external ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65 Nonsuppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.0 Acute serous otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.1 Other acute nonsuppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.2 Chronic serous otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.3 Chronic mucoid otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.4 Other chronic nonsuppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.9 Nonsuppurative otitis media, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66 Suppurative and unspecified otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.0 Acute suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.1 Chronic tubotympanic suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.2 Chronic atticoantral suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.3 Other chronic suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.4 Suppurative otitis media, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.9 Otitis media, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67 Otitis media in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67.0 Otitis media in bacterial diseases classified elsewhere © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 322 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67.1 Otitis media in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67.8 Otitis media in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H68 Eustachian salpingitis and obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H68.0 Eustachian salpingitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H68.1 Obstruction of Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69 Other disorders of Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69.0 Patulous Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69.8 Other specified disorders of Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69.9 Eustachian tube disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70 Mastoiditis and related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.0 Acute mastoiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.1 Chronic mastoiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.2 Petrositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.8 Other mastoiditis and related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.9 Mastoiditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H71 Cholesteatoma of middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72 Perforation of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.0 Central perforation of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.1 Attic perforation of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.2 Other marginal perforations of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.8 Other perforations of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.9 Perforation of tympanic membrane, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73 Other disorders of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.0 Acute myringitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.1 Chronic myringitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.8 Other specified disorders of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.9 Disorder of tympanic membrane, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74 Other disorders of middle ear and mastoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.0 Tympanosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.1 Adhesive middle ear disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.2 Discontinuity and dislocation of ear ossicles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.3 Other acquired abnormalities of ear ossicles

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 323 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.4 Polyp of middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.8 Other specified disorders of middle ear and mastoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.9 Disorder of middle ear and mastoid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H75 Other disorders of middle ear and mastoid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80 Otosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.0 Otosclerosis involving oval window, nonobliterative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.1 Otosclerosis involving oval window, obliterative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.2 Cochlear otosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.8 Other otosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.9 Otosclerosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81 Disorders of vestibular function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.0 Ménière disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.1 Benign paroxysmal vertigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.2 Vestibular neuronitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.3 Other peripheral vertigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.4 Vertigo of central origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.8 Other disorders of vestibular function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.9 Disorder of vestibular function, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H82 Vertiginous syndromes in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83 Other diseases of inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.0 Labyrinthitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.1 Labyrinthine fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.2 Labyrinthine dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.3 Noise effects on inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.8 Other specified diseases of inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.9 Disease of inner ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90 Conductive and sensorineural hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.0 Conductive hearing loss, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 324 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.2 Conductive hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.3 Sensorineural hearing loss, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.5 Sensorineural hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.6 Mixed conductive and sensorineural hearing loss, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.8 Mixed conductive and sensorineural hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91 Other hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.0 Ototoxic hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.1 Presbycusis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.2 Sudden idiopathic hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.3 Deaf mutism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.8 Other specified hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.9 Hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92 Otalgia and effusion of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92.0 Otalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92.1 Otorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92.2 Otorrhagia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93 Other disorders of ear, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.0 Degenerative and vascular disorders of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.1 Tinnitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.2 Other abnormal auditory perceptions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.3 Disorders of acoustic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.8 Other specified disorders of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.9 Disorder of ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H94 Other disorders of ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H94.8 Other specified disorders of ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.0 Recurrent cholesteatoma of postmastoidectomy cavity

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 325 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.1 Other disorders following mastoidectomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.8 Other postprocedural disorders of ear and mastoid process 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.9 Postprocedural disorder of ear and mastoid process, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I00 Rheumatic fever without mention of heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01 Rheumatic fever with heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.0 Acute rheumatic pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.1 Acute rheumatic endocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.2 Acute rheumatic myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.8 Other acute rheumatic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.9 Acute rheumatic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I02 Rheumatic chorea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I02.0 Rheumatic chorea with heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I02.9 Rheumatic chorea without heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05 Rheumatic mitral valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.0 Mitral stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.1 Rheumatic mitral insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.2 Mitral stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.8 Other mitral valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.9 Mitral valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06 Rheumatic aortic valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.0 Rheumatic aortic stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.1 Rheumatic aortic insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.2 Rheumatic aortic stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.8 Other rheumatic aortic valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.9 Rheumatic aortic valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07 Rheumatic tricuspid valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.0 Tricuspid stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.1 Tricuspid insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.2 Tricuspid stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.8 Other tricuspid valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.9 Tricuspid valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08 Multiple valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.0 Disorders of both mitral and aortic valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.1 Disorders of both mitral and tricuspid valves

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 326 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.2 Disorders of both aortic and tricuspid valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.3 Combined disorders of mitral, aortic and tricuspid valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.8 Other multiple valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.9 Multiple valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09 Other rheumatic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.0 Rheumatic myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.1 Rheumatic diseases of endocardium, valve unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.2 Chronic rheumatic pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.8 Other specified rheumatic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.9 Rheumatic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I10 Essential (primary) hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I11 Hypertensive heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I11.0 Hypertensive heart disease with (congestive) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I11.9 Hypertensive heart disease without (congestive) heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I12 Hypertensive renal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I12.0 Hypertensive renal disease with renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I12.9 Hypertensive renal disease without renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13 Hypertensive heart and renal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.0 Hypertensive heart and renal disease with (congestive) heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.1 Hypertensive heart and renal disease with renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.9 Hypertensive heart and renal disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15 Secondary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.0 Renovascular hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.1 Hypertension secondary to other renal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.2 Hypertension secondary to endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.8 Other secondary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.9 Secondary hypertension, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20 Angina pectoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.0 Unstable angina

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 327 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.1 Angina pectoris with documented spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.8 Other forms of angina pectoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.9 Angina pectoris, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21 Acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.0 Acute transmural myocardial infarction of anterior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.1 Acute transmural myocardial infarction of inferior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.2 Acute transmural myocardial infarction of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.3 Acute transmural myocardial infarction of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.4 Acute subendocardial myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.9 Acute myocardial infarction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22 Subsequent myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.0 Subsequent myocardial infarction of anterior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.1 Subsequent myocardial infarction of inferior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.8 Subsequent myocardial infarction of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.9 Subsequent myocardial infarction of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23 Certain current complications following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.0 Haemopericardium as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.1 Atrial septal defect as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.2 Ventricular septal defect as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.6 Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.8 Other current complications following acute myocardial infarction

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 328 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24 Other acute ischaemic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.0 Coronary thrombosis not resulting in myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.1 Dressler syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.8 Other forms of acute ischaemic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.9 Acute ischaemic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25 Chronic ischaemic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.0 Atherosclerotic cardiovascular disease, so described 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.1 Atherosclerotic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.2 Old myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.3 Aneurysm of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.4 Coronary artery aneurysm and dissection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.5 Ischaemic cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.6 Silent myocardial ischaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.8 Other forms of chronic ischaemic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.9 Chronic ischaemic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I26 Pulmonary embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I26.0 Pulmonary embolism with mention of acute cor pulmonale 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I26.9 Pulmonary embolism without mention of acute cor pulmonale 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27 Other pulmonary heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.0 Primary pulmonary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.1 Kyphoscoliotic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.2 Other secondary pulmonary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.8 Other specified pulmonary heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.9 Pulmonary heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28 Other diseases of pulmonary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.0 Arteriovenous fistula of pulmonary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.1 Aneurysm of pulmonary artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.8 Other specified diseases of pulmonary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.9 Disease of pulmonary vessels, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30 Acute pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.0 Acute nonspecific idiopathic pericarditis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 329 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.1 Infective pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.8 Other forms of acute pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.9 Acute pericarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31 Other diseases of pericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.0 Chronic adhesive pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.1 Chronic constrictive pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.2 Haemopericardium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.3 Pericardial effusion (noninflammatory) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.8 Other specified diseases of pericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.9 Disease of pericardium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32 Pericarditis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32.0 Pericarditis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32.1 Pericarditis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32.8 Pericarditis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I33 Acute and subacute endocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I33.0 Acute and subacute infective endocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I33.9 Acute endocarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34 Nonrheumatic mitral valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.0 Mitral (valve) insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.1 Mitral (valve) prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.2 Nonrheumatic mitral (valve) stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.8 Other nonrheumatic mitral valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.9 Nonrheumatic mitral valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35 Nonrheumatic aortic valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.0 Aortic (valve) stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.1 Aortic (valve) insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.2 Aortic (valve) stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.8 Other aortic valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.9 Aortic valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36 Nonrheumatic tricuspid valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.0 Nonrheumatic tricuspid (valve) stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.1 Nonrheumatic tricuspid (valve) insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.2 Nonrheumatic tricuspid (valve) stenosis with insufficiency © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 330 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.8 Other nonrheumatic tricuspid valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.9 Nonrheumatic tricuspid valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37 Pulmonary valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.0 Pulmonary valve stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.1 Pulmonary valve insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.2 Pulmonary valve stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.8 Other pulmonary valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.9 Pulmonary valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I38 Endocarditis, valve unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39 Endocarditis and heart valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.0 Mitral valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.1 Aortic valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.2 Tricuspid valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.3 Pulmonary valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.4 Multiple valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.8 Endocarditis, valve unspecified, in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40 Acute myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.0 Infective myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.1 Isolated myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.8 Other acute myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.9 Acute myocarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41 Myocarditis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.0 Myocarditis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.1 Myocarditis in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.2 Myocarditis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.8 Myocarditis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42 Cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.0 Dilated cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.1 Obstructive hypertrophic cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.2 Other hypertrophic cardiomyopathy

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 331 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.3 Endomyocardial (eosinophilic) disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.4 Endocardial fibroelastosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.5 Other restrictive cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.6 Alcoholic cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.7 Cardiomyopathy due to drugs and other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.8 Other cardiomyopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.9 Cardiomyopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43 Cardiomyopathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.0 Cardiomyopathy in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.1 Cardiomyopathy in metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.2 Cardiomyopathy in nutritional diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.8 Cardiomyopathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44 Atrioventricular and left bundle- branch block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.0 Atrioventricular block, first degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.1 Atrioventricular block, second degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.2 Atrioventricular block, complete 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.3 Other and unspecified atrioventricular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.4 Left anterior fascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.5 Left posterior fascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.6 Other and unspecified fascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.7 Left bundle-branch block, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45 Other conduction disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.0 Right fascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.1 Other and unspecified right bundle- branch block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.2 Bifascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.3 Trifascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.4 Nonspecific intraventricular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.5 Other specified heart block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.6 Pre-excitation syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.8 Other specified conduction disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.9 Conduction disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I46 Cardiac arrest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I46.0 Cardiac arrest with successful resuscitation © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 332 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I46.1 Sudden cardiac death, so described 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I46.9 Cardiac arrest, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I47 Paroxysmal tachycardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I47.0 Re-entry ventricular arrhythmia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I47.1 Supraventricular tachycardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I47.2 Ventricular tachycardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I47.9 Paroxysmal tachycardia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48 Atrial fibrillation and flutter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.0 Paroxysmal atrial fibrillation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.1 Persistent atrial fibrillation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.2 Chronic atrial fibrillation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.3 Typical atrial flutter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.4 Atypical atrial flutter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.9 Atrial fibrillation and atrial flutter, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49 Other cardiac arrhythmias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.0 Ventricular fibrillation and flutter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.1 Atrial premature depolarization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.2 Junctional premature depolarization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.3 Ventricular premature depolarization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.4 Other and unspecified premature depolarization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.5 Sick sinus syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.8 Other specified cardiac arrhythmias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.9 Cardiac arrhythmia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I50 Heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I50.0 Congestive heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I50.1 Left ventricular failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I50.9 Heart failure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51 Complications and ill-defined descriptions of heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.0 Cardiac septal defect, acquired 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.1 Rupture of chordae tendineae, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.2 Rupture of papillary muscle, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.3 Intracardiac thrombosis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.4 Myocarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.5 Myocardial degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.6 Cardiovascular disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.7 Cardiomegaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.8 Other ill-defined heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.9 Heart disease, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 333 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I52 Other heart disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I52.0 Other heart disorders in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I52.1 Other heart disorders in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I52.8 Other heart disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60 Subarachnoid haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.1 Subarachnoid haemorrhage from middle cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.2 Subarachnoid haemorrhage from anterior communicating artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.3 Subarachnoid haemorrhage from posterior communicating artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.4 Subarachnoid haemorrhage from basilar artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.5 Subarachnoid haemorrhage from vertebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.6 Subarachnoid haemorrhage from other intracranial arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.8 Other subarachnoid haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.9 Subarachnoid haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61 Intracerebral haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.0 Intracerebral haemorrhage in hemisphere, subcortical 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.1 Intracerebral haemorrhage in hemisphere, cortical 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.2 Intracerebral haemorrhage in hemisphere, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.3 Intracerebral haemorrhage in brain stem 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.4 Intracerebral haemorrhage in cerebellum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.5 Intracerebral haemorrhage, intraventricular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.6 Intracerebral haemorrhage, multiple localized 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.8 Other intracerebral haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.9 Intracerebral haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I62 Other nontraumatic intracranial haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I62.0 Subdural haemorrhage (acute)(nontraumatic)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 334 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I62.1 Nontraumatic extradural haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I62.9 Intracranial haemorrhage (nontraumatic), unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63 Cerebral infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.0 Cerebral infarction due to thrombosis of precerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.1 Cerebral infarction due to embolism of precerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.3 Cerebral infarction due to thrombosis of cerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.4 Cerebral infarction due to embolism of cerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.8 Other cerebral infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.9 Cerebral infarction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I64 Stroke, not specified as haemorrhage or infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.0 Occlusion and stenosis of vertebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.1 Occlusion and stenosis of basilar artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.2 Occlusion and stenosis of carotid artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.8 Occlusion and stenosis of other precerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.9 Occlusion and stenosis of unspecified precerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.0 Occlusion and stenosis of middle cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.1 Occlusion and stenosis of anterior cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.2 Occlusion and stenosis of posterior cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.3 Occlusion and stenosis of cerebellar arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 335 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.8 Occlusion and stenosis of other cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.9 Occlusion and stenosis of unspecified cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67 Other cerebrovascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.0 Dissection of cerebral arteries, nonruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.1 Cerebral aneurysm, nonruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.2 Cerebral atherosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.3 Progressive vascular leukoencephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.4 Hypertensive encephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.5 Moyamoya disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.6 Nonpyogenic thrombosis of intracranial venous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.7 Cerebral arteritis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.8 Other specified cerebrovascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.9 Cerebrovascular disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I68 Cerebrovascular disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I68.0 Cerebral amyloid angiopathyE85.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I68.2 Cerebral arteritis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I68.8 Other cerebrovascular disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69 Sequelae of cerebrovascular disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.0 Sequelae of subarachnoid haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.1 Sequelae of intracerebral haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.2 Sequelae of other nontraumatic intracranial haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.3 Sequelae of cerebral infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.4 Sequelae of stroke, not specified as haemorrhage or infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.8 Sequelae of other and unspecified cerebrovascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70 Atherosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70.0 Atherosclerosis of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70.1 Atherosclerosis of renal artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70.2 Atherosclerosis of arteries of extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70.8 Atherosclerosis of other arteries

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 336 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70.9 Generalized and unspecified atherosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71 Aortic aneurysm and dissection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.0 Dissection of aorta [any part] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.1 Thoracic aortic aneurysm, ruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.2 Thoracic aortic aneurysm, without mention of rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.3 Abdominal aortic aneurysm, ruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.4 Abdominal aortic aneurysm, without mention of rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.5 Thoracoabdominal aortic aneurysm, ruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.8 Aortic aneurysm of unspecified site, ruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.9 Aortic aneurysm of unspecified site, without mention of rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72 Other aneurysm and dissection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.0 Aneurysm and dissection of carotid artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.1 Aneurysm and dissection of artery of upper extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.2 Aneurysm and dissection of renal artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.3 Aneurysm and dissection of iliac artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.4 Aneurysm and dissection of artery of lower extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.5 Aneurysm and dissection of other precerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.6 Aneurysm and dissection of vertebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.8 Aneurysm and dissection of other specified arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.9 Aneurysm and dissection of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I73 Other peripheral vascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I73.0 Raynaud syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I73.1 Thromboangiitis obliterans [Buerger] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I73.8 Other specified peripheral vascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I73.9 Peripheral vascular disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74 Arterial embolism and thrombosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.0 Embolism and thrombosis of abdominal aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.1 Embolism and thrombosis of other and unspecified parts of aorta

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 337 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.2 Embolism and thrombosis of arteries of upper extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.3 Embolism and thrombosis of arteries of lower extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.4 Embolism and thrombosis of arteries of extremities, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.5 Embolism and thrombosis of iliac artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.8 Embolism and thrombosis of other arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.9 Embolism and thrombosis of unspecified artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77 Other disorders of arteries and arterioles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.0 Arteriovenous fistula, acquired 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.1 Stricture of artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.2 Rupture of artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.3 Arterial fibromuscular dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.4 Coeliac artery compression syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.5 Necrosis of artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.6 Arteritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.8 Other specified disorders of arteries and arterioles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.9 Disorder of arteries and arterioles, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I78 Diseases of capillaries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I78.0 Hereditary haemorrhagic telangiectasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I78.1 Naevus, non-neoplastic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I78.8 Other diseases of capillaries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I78.9 Disease of capillaries, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I79.0 Aneurysm of aorta in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I79.1 Aortitis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I79.2 Peripheral angiopathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80 Phlebitis and thrombophlebitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.1 Phlebitis and thrombophlebitis of femoral vein

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 338 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.8 Phlebitis and thrombophlebitis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.9 Phlebitis and thrombophlebitis of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I81 Portal vein thrombosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82 Other venous embolism and thrombosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.0 Budd-Chiari syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.1 Thrombophlebitis migrans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.2 Embolism and thrombosis of vena cava 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.3 Embolism and thrombosis of renal vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.8 Embolism and thrombosis of other specified veins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.9 Embolism and thrombosis of unspecified vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I83 of lower extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I83.0 Varicose veins of lower extremities with ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I83.1 Varicose veins of lower extremities with inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I83.2 Varicose veins of lower extremities with both ulcer and inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I83.9 Varicose veins of lower extremities without ulcer or inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I85 Oesophageal varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I85.0 Oesophageal varices with bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I85.9 Oesophageal varices without bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86 Varicose veins of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.0 Sublingual varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.1 Scrotal varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.2 Pelvic varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.3 Vulval varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.4 Gastric varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.8 Varicose veins of other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87 Other disorders of veins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87.0 Postthrombotic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87.1 Compression of vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87.2 Venous insufficiency (chronic)(peripheral) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87.8 Other specified disorders of veins

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 339 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87.9 Disorder of vein, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I88 Nonspecific lymphadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I88.0 Nonspecific mesenteric lymphadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I88.1 Chronic lymphadenitis, except mesenteric 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I88.8 Other nonspecific lymphadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I88.9 Nonspecific lymphadenitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I89 Other noninfective disorders of lymphatic vessels and lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I89.0 Lymphoedema, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I89.1 Lymphangitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I89.8 Other specified noninfective disorders of lymphatic vessels and lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I89.9 Noninfective disorder of lymphatic vessels and lymph nodes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95 Hypotension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95.0 Idiopathic hypotension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95.1 Orthostatic hypotension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95.2 Hypotension due to drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95.8 Other hypotension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95.9 Hypotension, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97 Postprocedural disorders of , not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97.0 Postcardiotomy syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97.1 Other functional disturbances following cardiac surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97.2 Postmastectomy lymphoedema syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97.9 Postprocedural disorder of circulatory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98 Other disorders of circulatory system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98.0 Cardiovascular syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98.2 Oesophageal varices without bleeding in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98.3 Oesophageal varices with bleeding in diseases classified elsewhere

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 340 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98.8 Other specified disorders of circulatory system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I99 Other and unspecified disorders of circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J00 Acute nasopharyngitis [common cold] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01 Acute sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.0 Acute maxillary sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.1 Acute frontal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.2 Acute ethmoidal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.3 Acute sphenoidal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.4 Acute pansinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.8 Other acute sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.9 Acute sinusitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J02 Acute pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J02.0 Streptococcal pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J02.8 Acute pharyngitis due to other specified organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J02.9 Acute pharyngitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J03 Acute tonsillitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J03.0 Streptococcal tonsillitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J03.8 Acute tonsillitis due to other specified organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J03.9 Acute tonsillitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J04 Acute laryngitis and tracheitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J04.0 Acute laryngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J04.1 Acute tracheitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J04.2 Acute laryngotracheitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J05 Acute obstructive laryngitis [croup] and epiglottitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J05.0 Acute obstructive laryngitis [croup] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J05.1 Acute epiglottitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J06 Acute upper respiratory infections of multiple and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J06.0 Acute laryngopharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J06.8 Other acute upper respiratory infections of multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J06.9 Acute upper respiratory infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J09 Influenza due to identified zoonotic or pandemic influenza virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J10 influenza due to identified seasonal influenza virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J10.0 Influenza with pneumonia, seasonal influenza virus identified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 341 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J10.1 Influenza with other respiratory manifestations, seasonal influenza virus identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J10.8 Influenza with other manifestations, seasonal influenza virus identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J11 Influenza, virus not identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J11.0 Influenza with pneumonia, virus not identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J11.1 Influenza with other respiratory manifestations, virus not identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J11.8 Influenza with other manifestations, virus not identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12 Viral pneumonia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.0 Adenoviral pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.1 Respiratory syncytial virus pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.2 Parainfluenza virus pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.3 Human metapneumovirus pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.8 Other viral pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.9 Viral pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J13 Pneumonia due to Streptococcus pneumoniae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J14 Pneumonia due to Haemophilus influenzae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15 Bacterial pneumonia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.0 Pneumonia due to Klebsiella pneumoniae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.1 Pneumonia due to Pseudomonas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.2 Pneumonia due to staphylococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.3 Pneumonia due to streptococcus, group B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.4 Pneumonia due to other streptococci 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.5 Pneumonia due to Escherichia coli 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.6 Pneumonia due to other Gram- negative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.7 Pneumonia due to Mycoplasma pneumoniae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.8 Other bacterial pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.9 Bacterial pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J16 Pneumonia due to other infectious organisms, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J16.0 Chlamydial pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J16.8 Pneumonia due to other specified infectious organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17 Pneumonia in diseases classified elsewhere

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 342 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17.0 Pneumonia in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17.1 Pneumonia in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17.2 Pneumonia in mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17.3 Pneumonia in parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17.8 Pneumonia in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18 Pneumonia, organism unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18.0 Bronchopneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18.1 Lobar pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18.2 Hypostatic pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18.8 Other pneumonia, organism unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18.9 Pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20 Acute bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.0 Acute bronchitis due to Mycoplasma pneumoniae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.1 Acute bronchitis due to Haemophilus influenzae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.2 Acute bronchitis due to streptococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.3 Acute bronchitis due to coxsackievirus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.4 Acute bronchitis due to parainfluenza virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.5 Acute bronchitis due to respiratory syncytial virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.6 Acute bronchitis due to rhinovirus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.7 Acute bronchitis due to echovirus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.8 Acute bronchitis due to other specified organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.9 Acute bronchitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J21 Acute bronchiolitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J21.0 Acute bronchiolitis due to respiratory syncytial virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J21.1 Acute bronchiolitis due to human metapneumovirus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J21.8 Acute bronchiolitis due to other specified organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J21.9 Acute bronchiolitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J22 Unspecified acute lower respiratory infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30 Vasomotor and allergic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30.0 Vasomotor rhinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30.1 due to pollen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30.2 Other seasonal allergic rhinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30.3 Other allergic rhinitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 343 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30.4 Allergic rhinitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J31 Chronic rhinitis, nasopharyngitis and pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J31.0 Chronic rhinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J31.1 Chronic nasopharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J31.2 Chronic pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32 Chronic sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.0 Chronic maxillary sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.1 Chronic frontal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.2 Chronic ethmoidal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.3 Chronic sphenoidal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.4 Chronic pansinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.8 Other chronic sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.9 Chronic sinusitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J33 Nasal polyp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J33.0 Polyp of nasal cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J33.1 Polypoid sinus degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J33.8 Other polyp of sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J33.9 Nasal polyp, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34 Other disorders of nose and nasal sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34.0 Abscess, furuncle and carbuncle of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34.1 Cyst and mucocele of nose and nasal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34.2 Deviated nasal septum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34.3 Hypertrophy of nasal turbinates 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34.8 Other specified disorders of nose and nasal sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35 Chronic diseases of tonsils and adenoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.0 Chronic tonsillitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.1 Hypertrophy of tonsils 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.2 Hypertrophy of adenoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.3 Hypertrophy of tonsils with hypertrophy of adenoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.8 Other chronic diseases of tonsils and adenoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.9 Chronic disease of tonsils and adenoids, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J36 Peritonsillar abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J37 Chronic laryngitis and laryngotracheitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J37.0 Chronic laryngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J37.1 Chronic laryngotracheitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38 Diseases of vocal cords and larynx, not elsewhere classified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 344 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.0 Paralysis of vocal cords and larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.1 Polyp of vocal cord and larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.2 Nodules of vocal cords 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.3 Other diseases of vocal cords 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.4 Oedema of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.5 Laryngeal spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.6 Stenosis of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.7 Other diseases of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39 Other diseases of upper respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.0 Retropharyngeal and parapharyngeal abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.1 Other abscess of pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.2 Other diseases of pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.8 Other specified diseases of upper respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.9 Disease of upper respiratory tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J40 Bronchitis, not specified as acute or chronic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J41 Simple and mucopurulent chronic bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J41.0 Simple chronic bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J41.1 Mucopurulent chronic bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J41.8 Mixed simple and mucopurulent chronic bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J42 Unspecified chronic bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43 Emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43.0 MacLeod syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43.1 Panlobular emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43.2 Centrilobular emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43.8 Other emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43.9 Emphysema, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J44 Other chronic obstructive pulmonary disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J44.8 Other specified chronic obstructive pulmonary disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J44.9 Chronic obstructive pulmonary disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J45 © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 345 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J45.0 Predominantly allergic asthma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J45.1 Nonallergic asthma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J45.8 Mixed asthma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J45.9 Asthma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J46 Status asthmaticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J47 Bronchiectasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J60 Coalworker pneumoconiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J61 Pneumoconiosis due to asbestos and other mineral fibres 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J62 Pneumoconiosis due to dust containing silica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J62.0 Pneumoconiosis due to dust 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J62.8 Pneumoconiosis due to other dust containing silica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63 Pneumoconiosis due to other inorganic dusts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.0 Aluminosis (of lung) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.1 Bauxite fibrosis (of lung) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.2 Berylliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.3 Graphite fibrosis (of lung) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.4 Siderosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.5 Stannosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.8 Pneumoconiosis due to other specified inorganic dusts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J64 Unspecified pneumoconiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J65 Pneumoconiosis associated with tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J66 Airway disease due to specific organic dust 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J66.0 Byssinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J66.1 Flax-dresser disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J66.2 Cannabinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J66.8 Airway disease due to other specific organic dusts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67 Hypersensitivity pneumonitis due to organic dust 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.0 Farmer lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.1 Bagassosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.2 Bird fancier lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.3 Suberosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.4 Maltworker lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.5 Mushroom-worker lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.6 Maple-bark-stripper lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.7 Air-conditioner and humidifier lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.8 Hypersensitivity pneumonitis due to other organic dusts

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 346 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.9 Hypersensitivity pneumonitis due to unspecified organic dust 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.1 Pulmonary oedema due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J69 Pneumonitis due to solids and liquids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J69.0 Pneumonitis due to food and vomit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J69.1 Pneumonitis due to oils and essences 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J69.8 Pneumonitis due to other solids and liquids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70 Respiratory conditions due to other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.0 Acute pulmonary manifestations due to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.1 Chronic and other pulmonary manifestations due to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.2 Acute drug-induced interstitial lung disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.3 Chronic drug-induced interstitial lung disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.4 Drug-induced interstitial lung disorders, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.8 Respiratory conditions due to other specified external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.9 Respiratory conditions due to unspecified external agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J80 Adult respiratory distress syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J81 Pulmonary oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J82 Pulmonary eosinophilia, not elsewhere classified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 347 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J84 Other interstitial pulmonary diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J84.0 Alveolar and parietoalveolar conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J84.1 Other interstitial pulmonary diseases with fibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J84.8 Other specified interstitial pulmonary diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J84.9 Interstitial pulmonary disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85 Abscess of lung and mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85.0 Gangrene and necrosis of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85.1 Abscess of lung with pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85.2 Abscess of lung without pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85.3 Abscess of mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J86 Pyothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J86.0 Pyothorax with fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J86.9 Pyothorax without fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J90 Pleural effusion, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J91 Pleural effusion in conditions classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J92 Pleural plaque 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J92.0 Pleural plaque with presence of asbestos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J92.9 Pleural plaque without asbestos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J93 Pneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J93.0 Spontaneous tension pneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J93.1 Other spontaneous pneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J93.8 Other pneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J93.9 Pneumothorax, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94 Other pleural conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94.0 Chylous effusion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94.1 Fibrothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94.2 Haemothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94.8 Other specified pleural conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94.9 Pleural condition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95 Postprocedural respiratory disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.0 Tracheostomy malfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.1 Acute pulmonary insufficiency following thoracic surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.2 Acute pulmonary insufficiency following nonthoracic surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.3 Chronic pulmonary insufficiency following surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.4 Mendelson syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.5 Postprocedural subglottic stenosis © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 348 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.8 Other postprocedural respiratory disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.9 Postprocedural respiratory disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J96 Respiratory failure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J96.0 Acute respiratory failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J96.1 Chronic respiratory failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J96.9 Respiratory failure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98 Other respiratory disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.0 Diseases of bronchus, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.1 Pulmonary collapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.2 Interstitial emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.3 Compensatory emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.4 Other disorders of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.5 Diseases of mediastinum, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.6 Disorders of diaphragm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.8 Other specified respiratory disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.9 Respiratory disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J99 Respiratory disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J99.0 Rheumatoid lung diseaseM05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J99.1 Respiratory disorders in other diffuse connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J99.8 Respiratory disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00 Disorders of tooth development and eruption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.0 Anodontia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.1 Supernumerary teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.2 Abnormalities of size and form of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.3 Mottled teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.4 Disturbances in tooth formation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.5 Hereditary disturbances in tooth structure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.6 Disturbances in tooth eruption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.7 Teething syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.8 Other disorders of tooth development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.9 Disorder of tooth development, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K01 Embedded and impacted teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K01.0 Embedded teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K01.1 Impacted teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02 Dental caries © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 349 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.0 Caries limited to enamel 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.1 Caries of dentine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.2 Caries of cementum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.3 Arrested dental caries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.4 Odontoclasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.5 Caries with pulp exposure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.8 Other dental caries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.9 Dental caries, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03 Other diseases of hard tissues of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.0 Excessive attrition of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.1 Abrasion of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.2 Erosion of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.3 Pathological resorption of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.4 Hypercementosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.5 Ankylosis of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.6 Deposits [accretions] on teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.7 Posteruptive colour changes of dental hard tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.8 Other specified diseases of hard tissues of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.9 Disease of hard tissues of teeth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04 Diseases of pulp and periapical tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.0 Pulpitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.1 Necrosis of pulp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.2 Pulp degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.3 Abnormal hard tissue formation in pulp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.4 Acute apical periodontitis of pulpal origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.5 Chronic apical periodontitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.6 Periapical abscess with sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.7 Periapical abscess without sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.8 Radicular cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.9 Other and unspecified diseases of pulp and periapical tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05 Gingivitis and periodontal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.0 Acute gingivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.1 Chronic gingivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.2 Acute periodontitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.3 Chronic periodontitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.4 Periodontosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.5 Other periodontal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.6 Periodontal disease, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 350 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06 Other disorders of gingiva and edentulous alveolar ridge 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06.0 Gingival recession 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06.1 Gingival enlargement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06.2 Gingival and edentulous alveolar ridge lesions associated with trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06.8 Other specified disorders of gingiva and edentulous alveolar ridge 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06.9 Disorder of gingiva and edentulous alveolar ridge, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07 Dentofacial anomalies [including malocclusion] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.0 Major anomalies of jaw size 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.1 Anomalies of jaw-cranial base relationship 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.2 Anomalies of dental arch relationship 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.3 Anomalies of tooth position 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.4 Malocclusion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.5 Dentofacial functional abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.6 Temporomandibular joint disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.8 Other dentofacial anomalies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.9 Dentofacial anomaly, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08 Other disorders of teeth and supporting structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.0 Exfoliation of teeth due to systemic causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.1 Loss of teeth due to accident, extraction or local periodontal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.2 Atrophy of edentulous alveolar ridge 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.3 Retained dental root 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.8 Other specified disorders of teeth and supporting structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.9 Disorder of teeth and supporting structures, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09 Cysts of oral region, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09.0 Developmental odontogenic cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09.1 Developmental (nonodontogenic) cysts of oral region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09.2 Other cysts of jaw 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09.8 Other cysts of oral region, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09.9 Cyst of oral region, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10 Other diseases of jaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.0 Developmental disorders of jaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.1 Giant cell granuloma, central 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.2 Inflammatory conditions of jaws © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 351 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.3 Alveolitis of jaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.8 Other specified diseases of jaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.9 Disease of jaws, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11 Diseases of salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.0 Atrophy of salivary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.1 Hypertrophy of salivary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.2 Sialoadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.3 Abscess of salivary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.4 Fistula of salivary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.5 Sialolithiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.6 Mucocele of salivary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.7 Disturbances of salivary secretion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.8 Other diseases of salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.9 Disease of salivary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K12 Stomatitis and related lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K12.0 Recurrent oral aphthae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K12.1 Other forms of stomatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K12.2 Cellulitis and abscess of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K12.3 Oral mucositis (ulcerative) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13 Other diseases of lip and oral mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.0 Diseases of lips 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.1 Cheek and lip biting 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.2 Leukoplakia and other disturbances of oral epithelium, including tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.3 Hairy leukoplakia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.4 Granuloma and granuloma-like lesions of oral mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.5 Oral submucous fibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.6 Irritative hyperplasia of oral mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.7 Other and unspecified lesions of oral mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14 Diseases of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.0 Glossitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.1 Geographic tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.2 Median rhomboid glossitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.3 Hypertrophy of tongue papillae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.4 Atrophy of tongue papillae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.5 Plicated tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.6 Glossodynia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.8 Other diseases of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.9 Disease of tongue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K20 Oesophagitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K21 Gastro-oesophageal reflux disease © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 352 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K21.0 Gastro-oesophageal reflux disease with oesophagitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K21.9 Gastro-oesophageal reflux disease without oesophagitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22 Other diseases of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.0 Achalasia of cardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.1 Ulcer of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.2 Oesophageal obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.3 Perforation of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.4 Dyskinesia of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.5 Diverticulum of oesophagus, acquired 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.6 Gastro-oesophageal laceration- haemorrhage syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.7 Barrett oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.8 Other specified diseases of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.9 Disease of oesophagus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K23 Disorders of oesophagus in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K23.0 Tuberculous oesophagitisA18.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K23.1 Megaoesophagus in Chagas diseaseB57.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K23.8 Disorders of oesophagus in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25 Gastric ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25.0 Gastric ulcer; Acute with haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25.1 Gastric ulcer; Acute with perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25.2 Gastric ulcer; Acute with both haemorrhage and perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25.3 Gastric ulcer; Acute without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25.4 Gastric ulcer; Chronic or unspecified with haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25.5 Gastric ulcer; Chronic or unspecified with perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25.6 Gastric ulcer; Chronic or unspecified with both haemorrhage and perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25.7 Gastric ulcer; Chronic without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25.9 Gastric ulcer; Unspecified as acute or chronic, without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26 Duodenal ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26.0 Duodenal ulcer; Acute with haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26.1 Duodenal ulcer; Acute with perforation

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 353 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26.2 Duodenal ulcer; Acute with both haemorrhage and perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26.3 Duodenal ulcer; Acute without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26.4 Duodenal ulcer; Chronic or unspecified with haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26.5 Duodenal ulcer; Chronic or unspecified with perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26.6 Duodenal ulcer; Chronic or unspecified with both haemorrhage and perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26.7 Duodenal ulcer; Chronic without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26.9 Duodenal ulcer; Unspecified as acute or chronic, without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27 Peptic ulcer, site unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27.0 Peptic ulcer, site unspecified; Acute with haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27.1 Peptic ulcer, site unspecified; Acute with perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27.2 Peptic ulcer, site unspecified; Acute with both haemorrhage and perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27.3 Peptic ulcer, site unspecified; Acute without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27.4 Peptic ulcer, site unspecified; Chronic or unspecified with haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27.5 Peptic ulcer, site unspecified; Chronic or unspecified with perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27.6 Peptic ulcer, site unspecified; Chronic or unspecified with both haemorrhage and perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27.7 Peptic ulcer, site unspecified; Chronic without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27.9 Peptic ulcer, site unspecified; Unspecified as acute or chronic, without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28 Gastrojejunal ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28.0 Gastrojejunal ulcer; Acute with haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28.1 Gastrojejunal ulcer; Acute with perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28.2 Gastrojejunal ulcer; Acute with both haemorrhage and perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28.3 Gastrojejunal ulcer; Acute without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28.4 Gastrojejunal ulcer; Chronic or unspecified with haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28.5 Gastrojejunal ulcer; Chronic or unspecified with perforation © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 354 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28.6 Gastrojejunal ulcer; Chronic or unspecified with both haemorrhage and perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28.7 Gastrojejunal ulcer; Chronic without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28.9 Gastrojejunal ulcer; Unspecified as acute or chronic, without haemorrhage or perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29 Gastritis and duodenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.0 Acute haemorrhagic gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.1 Other acute gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.2 Alcoholic gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.3 Chronic superficial gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.4 Chronic atrophic gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.5 Chronic gastritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.6 Other gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.7 Gastritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.8 Duodenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.9 Gastroduodenitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K30 Functional dyspepsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31 Other diseases of stomach and duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.0 Acute dilatation of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.1 Adult hypertrophic pyloric stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.2 Hourglass stricture and stenosis of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.3 Pylorospasm, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.4 Gastric diverticulum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.5 Obstruction of duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.6 Fistula of stomach and duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.7 Polyp of stomach and duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.8 Other specified diseases of stomach and duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.9 Disease of stomach and duodenum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K35 Acute appendicitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K35.2 Acute appendicitis with generalized peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K35.3 Acute appendicitis with localized peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K35.8 Acute appendicitis, other and unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K36 Other appendicitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K37 Unspecified appendicitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38 Other diseases of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.0 Hyperplasia of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.1 Appendicular concretions © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 355 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.2 Diverticulum of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.3 Fistula of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.8 Other specified diseases of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.9 Disease of appendix, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40 Inguinal hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.0 Bilateral inguinal hernia, with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.1 Bilateral inguinal hernia, with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.2 Bilateral inguinal hernia, without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.4 Unilateral or unspecified inguinal hernia, with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41 Femoral hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.0 Bilateral femoral hernia, with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.1 Bilateral femoral hernia, with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.2 Bilateral femoral hernia, without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.4 Unilateral or unspecified femoral hernia, with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K42 Umbilical hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K42.0 Umbilical hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K42.1 Umbilical hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K42.9 Umbilical hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43 Ventral hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.0 Incisional hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.1 Incisional hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.2 Incisional hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.3 Parastomal hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.4 Parastomal hernia with gangrene

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 356 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.5 Parastomal hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.6 Other and unspecified ventral hernia with obstruction without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.7 Other and unspecified ventral hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.9 Other and unspecified ventral hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K44 Diaphragmatic hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K44.0 Diaphragmatic hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K44.1 Diaphragmatic hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K44.9 Diaphragmatic hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K45 Other abdominal hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K45.0 Other specified abdominal hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K45.1 Other specified abdominal hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K45.8 Other specified abdominal hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K46 Unspecified abdominal hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K46.0 Unspecified abdominal hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K46.1 Unspecified abdominal hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K46.9 Unspecified abdominal hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50 Crohn disease [regional enteritis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50.0 Crohn disease of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50.1 Crohn disease of large intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50.8 Other Crohn disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50.9 Crohn disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.0 Ulcerative (chronic) pancolitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.2 Ulcerative (chronic) proctitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.3 Ulcerative (chronic) rectosigmoiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.4 Inflammatory polyps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.5 Left sided colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.8 Other ulcerative colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.9 Ulcerative colitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52 Other noninfective gastroenteritis and colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.0 Gastroenteritis and colitis due to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.1 Toxic gastroenteritis and colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.2 Allergic and dietetic gastroenteritis and colitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 357 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.3 Indeterminate colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.8 Other specified noninfective gastroenteritis and colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.9 Noninfective gastroenteritis and colitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55 Vascular disorders of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55.0 Acute vascular disorders of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55.1 Chronic vascular disorders of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55.2 Angiodysplasia of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55.8 Other vascular disorders of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55.9 Vascular disorder of intestine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56 Paralytic ileus and intestinal obstruction without hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.0 Paralytic ileus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.1 Intussusception 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.2 Volvulus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.3 Gallstone ileus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.4 Other impaction of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.5 Intestinal adhesions [bands] with obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.6 Other and unspecified intestinal obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.7 Ileus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57 Diverticular disease of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.0 Diverticular disease of small intestine with perforation and abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.1 Diverticular disease of small intestine without perforation or abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.2 Diverticular disease of large intestine with perforation and abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.3 Diverticular disease of large intestine without perforation or abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.4 Diverticular disease of both small and large intestine with perforation and abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.5 Diverticular disease of both small and large intestine without perforation or abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.8 Diverticular disease of intestine, part unspecified, with perforation and abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.9 Diverticular disease of intestine, part unspecified, without perforation or abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K58 Irritable bowel syndrome

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 358 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K58.0 Irritable bowel syndrome with diarrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K58.9 Irritable bowel syndrome without diarrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59 Other functional intestinal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.0 Constipation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.1 Functional diarrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.2 Neurogenic bowel, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.3 Megacolon, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.4 Anal spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.8 Other specified functional intestinal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.9 Functional intestinal disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60 Fissure and fistula of anal and rectal regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.0 Acute anal fissure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.1 Chronic anal fissure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.2 Anal fissure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.3 Anal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.4 Rectal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.5 Anorectal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61 Abscess of anal and rectal regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61.0 Anal abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61.1 Rectal abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61.2 Anorectal abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61.3 Ischiorectal abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61.4 Intrasphincteric abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62 Other diseases of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.0 Anal polyp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.1 Rectal polyp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.2 Anal prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.3 Rectal prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.4 Stenosis of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.5 Haemorrhage of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.6 Ulcer of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.7 Radiation proctitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.8 Other specified diseases of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.9 Disease of anus and rectum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63 Other diseases of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.0 Abscess of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.1 Perforation of intestine (nontraumatic)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 359 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.2 Fistula of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.3 Ulcer of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.4 Enteroptosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.5 Polyp of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.8 Other specified diseases of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.9 Disease of intestine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64 Haemorrhoids and perianal venous thrombosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.0 First degree haemorrhoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.1 Second degree haemorrhoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.2 Third degree haemorrhoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.3 Fourth degree haemorrhoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.4 Residual haemorrhoidal skin tags 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.5 Perianal venous thrombosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.8 Other specified haemorrhoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.9 Haemorrhoids, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K65 Peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K65.0 Acute peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K65.8 Other peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K65.9 Peritonitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K66 Other disorders of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K66.0 Peritoneal adhesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K66.1 Haemoperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K66.8 Other specified disorders of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K66.9 Disorder of peritoneum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67 Disorders of peritoneum in infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67.0 Chlamydial peritonitisA74.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67.1 Gonococcal peritonitisA54.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67.2 Syphilitic peritonitisA52.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67.3 Tuberculous peritonitisA18.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67.8 Other disorders of peritoneum in infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70 Alcoholic liver disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.0 Alcoholic fatty liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.1 Alcoholic hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.2 Alcoholic fibrosis and sclerosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.3 Alcoholic of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.4 Alcoholic hepatic failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.9 Alcoholic liver disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71 Toxic liver disease

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 360 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.0 Toxic liver disease with cholestasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.1 Toxic liver disease with hepatic necrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.2 Toxic liver disease with acute hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.3 Toxic liver disease with chronic persistent hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.4 Toxic liver disease with chronic lobular hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.5 Toxic liver disease with chronic active hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.6 Toxic liver disease with hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.7 Toxic liver disease with fibrosis and cirrhosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.8 Toxic liver disease with other disorders of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.9 Toxic liver disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K72 Hepatic failure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K72.0 Acute and subacute hepatic failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K72.1 Chronic hepatic failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K72.9 Hepatic failure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73 Chronic hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73.0 Chronic persistent hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73.1 Chronic lobular hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73.2 Chronic active hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73.8 Other chronic hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73.9 Chronic hepatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74 Fibrosis and cirrhosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.0 Hepatic fibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.1 Hepatic sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.2 Hepatic fibrosis with hepatic sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.3 Primary biliary cirrhosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.4 Secondary biliary cirrhosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.5 Biliary cirrhosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.6 Other and unspecified cirrhosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75 Other inflammatory liver diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.0 Abscess of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.1 Phlebitis of portal vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.2 Nonspecific reactive hepatitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 361 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.3 Granulomatous hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.4 Autoimmune hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.8 Other specified inflammatory liver diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.9 Inflammatory liver disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76 Other diseases of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.0 Fatty (change of) liver, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.1 Chronic passive congestion of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.2 Central haemorrhagic necrosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.3 Infarction of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.4 Peliosis hepatis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.5 Hepatic veno-occlusive disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.6 Portal hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.7 Hepatorenal syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.8 Other specified diseases of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.9 Liver disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K77 Liver disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K77.8 Liver disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80 Cholelithiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.0 Calculus of gallbladder with acute cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.1 Calculus of gallbladder with other cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.2 Calculus of gallbladder without cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.3 Calculus of bile duct with cholangitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.4 Calculus of bile duct with cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.5 Calculus of bile duct without cholangitis or cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.8 Other cholelithiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K81 Cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K81.0 Acute cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K81.1 Chronic cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K81.8 Other cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K81.9 Cholecystitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82 Other diseases of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.0 Obstruction of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.1 Hydrops of gallbladder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 362 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.2 Perforation of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.3 Fistula of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.4 Cholesterolosis of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.8 Other specified diseases of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.9 Disease of gallbladder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83 Other diseases of biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.0 Cholangitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.1 Obstruction of bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.2 Perforation of bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.3 Fistula of bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.4 Spasm of sphincter of Oddi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.5 Biliary cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.8 Other specified diseases of biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.9 Disease of biliary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85 Acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.0 Idiopathic acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.1 Biliary acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.2 Alcohol-induced acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.3 Drug-induced acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.8 Other acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.9 Acute pancreatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86 Other diseases of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.0 Alcohol-induced 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.1 Other chronic pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.2 Cyst of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.3 Pseudocyst of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.8 Other specified diseases of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.9 Disease of pancreas, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K87.1 Disorders of pancreas in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90 Intestinal malabsorption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.0 Coeliac disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.1 Tropical sprue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.2 Blind loop syndrome, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.3 Pancreatic steatorrhoea

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 363 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.4 Malabsorption due to intolerance, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.8 Other intestinal malabsorption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.9 Intestinal malabsorption, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91 Postprocedural disorders of digestive system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.0 Vomiting following gastrointestinal surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.1 Postgastric surgery syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.2 Postsurgical malabsorption, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.3 Postoperative intestinal obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.4 Colostomy and enterostomy malfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.5 Postcholecystectomy syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.8 Other postprocedural disorders of digestive system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.9 Postprocedural disorder of digestive system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92 Other diseases of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92.0 Haematemesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92.1 Melaena 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92.2 Gastrointestinal haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92.8 Other specified diseases of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92.9 Disease of digestive system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K93 Disorders of other digestive organs in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glandsA18.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K93.1 Megacolon in Chagas diseaseB57.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K93.8 Disorders of other specified digestive organs in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L00 Staphylococcal scalded skin syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L01 Impetigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L01.0 Impetigo [any organism] [any site] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L01.1 Impetiginization of other dermatoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02 Cutaneous abscess, furuncle and carbuncle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.0 Cutaneous abscess, furuncle and carbuncle of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.1 Cutaneous abscess, furuncle and carbuncle of neck

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 364 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.2 Cutaneous abscess, furuncle and carbuncle of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.3 Cutaneous abscess, furuncle and carbuncle of buttock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.4 Cutaneous abscess, furuncle and carbuncle of limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.8 Cutaneous abscess, furuncle and carbuncle of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03 Cellulitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.0 Cellulitis of finger and toe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.1 Cellulitis of other parts of limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.2 Cellulitis of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.3 Cellulitis of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.8 Cellulitis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.9 Cellulitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04 Acute lymphadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.0 Acute lymphadenitis of face, head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.1 Acute lymphadenitis of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.2 Acute lymphadenitis of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.3 Acute lymphadenitis of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.8 Acute lymphadenitis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.9 Acute lymphadenitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L05 Pilonidal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L05.0 Pilonidal cyst with abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L05.9 Pilonidal cyst without abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L08 Other local infections of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L08.0 Pyoderma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L08.1 Erythrasma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L08.8 Other specified local infections of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L08.9 Local infection of skin and subcutaneous tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10 Pemphigus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.0 Pemphigus vulgaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.1 Pemphigus vegetans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.2 Pemphigus foliaceus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.3 Brazilian pemphigus [fogo selvagem] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.4 Pemphigus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.5 Drug-induced pemphigus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.8 Other pemphigus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.9 Pemphigus, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 365 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L11 Other acantholytic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L11.0 Acquired keratosis follicularis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L11.1 Transient acantholytic dermatosis [Grover] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L11.8 Other specified acantholytic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L11.9 Acantholytic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12 Pemphigoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.0 Bullous pemphigoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.1 Cicatricial pemphigoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.2 Chronic bullous disease of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.3 Acquired epidermolysis bullosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.8 Other pemphigoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.9 Pemphigoid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L13 Other bullous disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L13.0 Dermatitis herpetiformis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L13.1 Subcorneal pustular dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L13.8 Other specified bullous disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L13.9 Bullous disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L14 Bullous disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L20 Atopic dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L20.0 Besnier prurigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L20.8 Other atopic dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L20.9 Atopic dermatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L21 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L21.0 Seborrhoea capitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L21.1 Seborrhoeic infantile dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L21.8 Other seborrhoeic dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L21.9 Seborrhoeic dermatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L22 Diaper [napkin] dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23 Allergic contact dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.0 Allergic contact dermatitis due to 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.1 Allergic contact dermatitis due to adhesives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.2 Allergic contact dermatitis due to cosmetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.3 Allergic contact dermatitis due to drugs in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.4 Allergic contact dermatitis due to 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.5 Allergic contact dermatitis due to other chemical products 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.6 Allergic contact dermatitis due to food in contact with skin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 366 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.7 Allergic contact dermatitis due to plants, except food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.8 Allergic contact dermatitis due to other agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.9 Allergic contact dermatitis, unspecified cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24 Irritant contact dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.0 Irritant contact dermatitis due to detergents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.1 Irritant contact dermatitis due to oils and greases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.2 Irritant contact dermatitis due to solvents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.3 Irritant contact dermatitis due to cosmetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.4 Irritant contact dermatitis due to drugs in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.5 Irritant contact dermatitis due to other chemical products 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.6 Irritant contact dermatitis due to food in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.7 Irritant contact dermatitis due to plants, except food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.8 Irritant contact dermatitis due to other agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.9 Irritant contact dermatitis, unspecified cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25 Unspecified contact dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.0 Unspecified contact dermatitis due to cosmetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.1 Unspecified contact dermatitis due to drugs in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.2 Unspecified contact dermatitis due to dyes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.3 Unspecified contact dermatitis due to other chemical products 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.4 Unspecified contact dermatitis due to food in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.5 Unspecified contact dermatitis due to plants, except food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.8 Unspecified contact dermatitis due to other agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.9 Unspecified contact dermatitis, unspecified cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L26 Exfoliative dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27 Dermatitis due to substances taken internally 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27.0 Generalized skin eruption due to drugs and medicaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27.1 Localized skin eruption due to drugs and medicaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27.2 Dermatitis due to ingested food © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 367 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27.8 Dermatitis due to other substances taken internally 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27.9 Dermatitis due to unspecified substance taken internally 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L28 Lichen simplex chronicus and prurigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L28.0 Lichen simplex chronicus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L28.1 Prurigo nodularis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L28.2 Other prurigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29 Pruritus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.0 Pruritus ani 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.1 Pruritus scroti 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.2 Pruritus vulvae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.3 Anogenital pruritus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.8 Other pruritus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.9 Pruritus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30 Other dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.0 Nummular dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.1 Dyshidrosis [pompholyx] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.2 Cutaneous autosensitization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.3 Infective dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.4 Erythema intertrigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.5 Pityriasis alba 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.8 Other specified dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.9 Dermatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40 Psoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.0 Psoriasis vulgaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.1 Generalized pustular psoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.2 Acrodermatitis continua 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.3 Pustulosis palmaris et plantaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.4 Guttate psoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.5 Arthropathic psoriasisM07.0- M07.3M09.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.8 Other psoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.9 Psoriasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41 Parapsoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.0 Pityriasis lichenoides et varioliformis acuta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.1 Pityriasis lichenoides chronica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.3 Small plaque parapsoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.4 Large plaque parapsoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.5 Retiform parapsoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.8 Other parapsoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.9 Parapsoriasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L42 Pityriasis rosea © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 368 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43 Lichen planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.0 Hypertrophic lichen planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.1 Bullous lichen planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.2 Lichenoid drug reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.3 Subacute (active) lichen planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.8 Other lichen planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.9 Lichen planus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44 Other papulosquamous disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.0 Pityriasis rubra pilaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.1 Lichen nitidus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.2 Lichen striatus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.3 Lichen ruber moniliformis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.4 Infantile papular acrodermatitis [Giannotti-Crosti] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.8 Other specified papulosquamous disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.9 Papulosquamous disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L45 Papulosquamous disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50 Urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.0 Allergic urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.1 Idiopathic urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.2 Urticaria due to cold and heat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.3 Dermatographic urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.4 Vibratory urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.5 urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.6 Contact urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.8 Other urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.9 Urticaria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51 Erythema multiforme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51.0 Nonbullous erythema multiforme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51.1 Bullous erythema multiforme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51.2 Toxic epidermal necrolysis [Lyell] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51.8 Other erythema multiforme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51.9 Erythema multiforme, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L52 Erythema nodosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53 Other erythematous conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.0 Toxic erythema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.1 Erythema annulare centrifugum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.2 Erythema marginatum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.3 Other chronic figurate erythema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.8 Other specified erythematous conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.9 Erythematous condition, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 369 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L54 Erythema in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L54.0 Erythema marginatum in acute rheumatic feverI00 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L54.8 Erythema in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55 Sunburn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55.0 Sunburn of first degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55.1 Sunburn of second degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55.2 Sunburn of third degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55.8 Other sunburn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55.9 Sunburn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56 Other acute skin changes due to ultraviolet radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.0 Drug phototoxic response 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.1 Drug photoallergic response 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.2 Photocontact dermatitis [berloque dermatitis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.4 Polymorphous light eruption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.8 Other specified acute skin changes due to ultraviolet radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.9 Acute skin change due to ultraviolet radiation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57 Skin changes due to chronic exposure to nonionizing radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.1 Actinic reticuloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.2 Cutis rhomboidalis nuchae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.3 Poikiloderma of Civatte 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.4 Cutis laxa senilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.5 Actinic granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.8 Other skin changes due to chronic exposure to nonionizing radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.9 Skin changes due to chronic exposure to nonionizing radiation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L58 Radiodermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L58.0 Acute radiodermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L58.1 Chronic radiodermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L58.9 Radiodermatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L59 Other disorders of skin and subcutaneous tissue related to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L59.0 Erythema ab igne [dermatitis ab igne] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 370 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60 Nail disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.0 Ingrowing nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.1 Onycholysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.2 Onychogryphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.3 Nail dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.4 Beau lines 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.5 Yellow nail syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.8 Other nail disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.9 Nail disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L62 Nail disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L62.0 Clubbed nail pachydermoperiostosisM89.4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L62.8 Nail disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63 Alopecia areata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63.0 Alopecia (capitis) totalis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63.1 Alopecia universalis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63.2 Ophiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63.8 Other alopecia areata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63.9 Alopecia areata, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L64 Androgenic alopecia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L64.0 Drug-induced androgenic alopecia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L64.8 Other androgenic alopecia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L64.9 Androgenic alopecia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65 Other nonscarring hair loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65.0 Telogen effluvium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65.1 Anagen effluvium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65.2 Alopecia mucinosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65.8 Other specified nonscarring hair loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65.9 Nonscarring hair loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66 Cicatricial alopecia [scarring hair loss] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.0 Pseudopelade 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.1 Lichen planopilaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.2 Folliculitis decalvans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.3 Perifolliculitis capitis abscedens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.4 Folliculitis ulerythematosa reticulata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.8 Other cicatricial alopecia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.9 Cicatricial alopecia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L67 Hair colour and hair shaft abnormalities © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 371 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L67.0 Trichorrhexis nodosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L67.1 Variations in hair colour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L67.8 Other hair colour and hair shaft abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L67.9 Hair colour and hair shaft abnormality, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.0 Hirsutism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.1 Acquired hypertrichosis lanuginosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.2 Localized hypertrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.3 Polytrichia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.8 Other hypertrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.9 Hypertrichosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70 Acne 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.0 Acne vulgaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.1 Acne conglobata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.2 Acne varioliformis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.3 Acne tropica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.4 Infantile acne 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.5 Acné excoriée 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.8 Other acne 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.9 Acne, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L71 Rosacea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L71.0 Perioral dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L71.1 Rhinophyma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L71.8 Other rosacea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L71.9 Rosacea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72 Follicular cysts of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72.0 Epidermal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72.1 Trichilemmal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72.2 Steatocystoma multiplex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72.8 Other follicular cysts of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73 Other follicular disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73.0 Acne keloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73.1 Pseudofolliculitis barbae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73.2 Hidradenitis suppurativa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73.8 Other specified follicular disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73.9 Follicular disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74 Eccrine sweat disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.0 Miliaria rubra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.1 Miliaria crystallina © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 372 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.2 Miliaria profunda 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.3 Miliaria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.4 Anhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.8 Other eccrine sweat disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.9 Eccrine sweat disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75 Apocrine sweat disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75.0 Bromhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75.1 Chromhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75.2 Apocrine miliaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75.8 Other apocrine sweat disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75.9 Apocrine sweat disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L80 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81 Other disorders of pigmentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.0 Postinflammatory hyperpigmentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.1 Chloasma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.2 Freckles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.3 Café au lait spots 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.4 Other hyperpigmentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.5 Leukoderma, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.6 Other disorders of diminished melanin formation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.7 Pigmented purpuric dermatosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.8 Other specified disorders of pigmentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.9 Disorder of pigmentation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L82 Seborrhoeic keratosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L83 Acanthosis nigricans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L84 Corns and callosities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85 Other epidermal thickening 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.0 Acquired ichthyosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.1 Acquired keratosis [keratoderma] palmaris et plantaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.2 Keratosis punctata (palmaris et plantaris) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.3 Xerosis cutis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.8 Other specified epidermal thickening 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.9 Epidermal thickening, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L86 Keratoderma in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87 Transepidermal elimination disorders

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 373 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87.0 Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87.1 Reactive perforating collagenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87.2 Elastosis perforans serpiginosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87.8 Other transepidermal elimination disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87.9 Transepidermal elimination disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L88 Pyoderma gangrenosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89 Decubitus ulcer and pressure area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89.0 Stage I decubitus ulcer and pressure area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89.1 Stage II decubitus ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89.2 Stage III decubitus ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89.3 Stage IV decubitus ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89.9 Decubitus ulcer and pressure area, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90 Atrophic disorders of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.0 Lichen sclerosus et atrophicus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.1 Anetoderma of Schweninger-Buzzi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.2 Anetoderma of Jadassohn-Pellizzari 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.3 Atrophoderma of Pasini and Pierini 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.4 Acrodermatitis chronica atrophicans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.5 Scar conditions and fibrosis of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.6 Striae atrophicae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.8 Other atrophic disorders of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.9 Atrophic disorder of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L91 Hypertrophic disorders of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L91.0 Hypertrophic scar 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L91.8 Other hypertrophic disorders of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L91.9 Hypertrophic disorder of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92 Granulomatous disorders of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.0 Granuloma annulare 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.1 Necrobiosis lipoidica, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.2 Granuloma faciale [eosinophilic granuloma of skin] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.3 Foreign body granuloma of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.8 Other granulomatous disorders of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L93 erythematosus

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 374 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L93.0 Discoid lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L93.1 Subacute cutaneous lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L93.2 Other local lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94 Other localized connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.0 Localized scleroderma [morphea] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.1 Linear scleroderma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.2 Calcinosis cutis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.3 Sclerodactyly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.4 Gottron papules 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.5 Poikiloderma vasculare atrophicans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.6 Ainhum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.8 Other specified localized connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.9 Localized connective tissue disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L95 Vasculitis limited to skin, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L95.0 Livedoid vasculitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L95.1 Erythema elevatum diutinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L95.8 Other vasculitis limited to skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L95.9 Vasculitis limited to skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L97 Ulcer of lower limb, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.0 Pyogenic granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.1 Factitial dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.2 Febrile neutrophilic dermatosis [Sweet] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.3 Eosinophilic cellulitis [Wells] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.4 Chronic ulcer of skin, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.5 Mucinosis of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.6 Other infiltrative disorders of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.7 Excessive and redundant skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.8 Other specified disorders of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.9 Disorder of skin and subcutaneous tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L99.0 Amyloidosis of skinE85.-

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 375 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L99.8 Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00 Pyogenic arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00.0 Staphylococcal arthritis and polyarthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00.1 Pneumococcal arthritis and polyarthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00.2 Other streptococcal arthritis and polyarthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00.8 Arthritis and polyarthritis due to other specified bacterial agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00.9 Pyogenic arthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01 Direct infections of joint in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.0 Meningococcal arthritisA39.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.1 Tuberculous arthritisA18.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.2 Arthritis in Lyme diseaseA69.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.3 Arthritis in other bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.4 Rubella arthritisB06.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.5 Arthritis in other viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.6 Arthritis in mycosesB35-B49 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.8 Arthritis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02 Reactive arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.0 Arthropathy following intestinal bypass 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.1 Postdysenteric arthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.2 Postimmunization arthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.3 Reiter disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.8 Other reactive arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.9 Reactive arthropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M03 Postinfective and reactive arthropathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M03.0 Postmeningococcal arthritisA39.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M03.1 Postinfective arthropathy in syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M03.2 Other postinfectious arthropathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M03.6 Reactive arthropathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05 Seropositive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.0 Felty syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.1 Rheumatoid lung diseaseJ99.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.2 Rheumatoid vasculitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 376 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.3 Rheumatoid arthritis with involvement of other organs and systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.8 Other seropositive rheumatoid arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.9 Seropositive rheumatoid arthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06 Other rheumatoid arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.0 Seronegative rheumatoid arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.1 Adult-onset Still disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.2 Rheumatoid bursitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.3 Rheumatoid nodule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.4 Inflammatory polyarthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.8 Other specified rheumatoid arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.9 Rheumatoid arthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07 Psoriatic and enteropathic arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.0 Distal interphalangeal psoriatic arthropathyL40.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.1 Arthritis mutilansL40.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.2 Psoriatic spondylitisL40.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.3 Other psoriatic arthropathiesL40.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.4 Arthropathy in Crohn disease [regional enteritis]K50.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.5 Arthropathy in ulcerative colitisK51.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.6 Other enteropathic arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08 Juvenile arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.0 Juvenile rheumatoid arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.1 Juvenile ankylosing spondylitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.2 Juvenile arthritis with systemic onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.3 Juvenile polyarthritis (seronegative) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.4 Pauciarticular juvenile arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.8 Other juvenile arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.9 Juvenile arthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M09 Juvenile arthritis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M09.0 Juvenile arthritis in psoriasisL40.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M09.1 Juvenile arthritis in Crohn disease [regional enteritis]K50.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M09.2 Juvenile arthritis in ulcerative colitisK51.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M09.8 Juvenile arthritis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.0 Idiopathic gout 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.1 Lead-induced gout 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.2 Drug-induced gout © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 377 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.3 Gout due to impairment of renal function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.4 Other secondary gout 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.9 Gout, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11 Other crystal arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11.0 Hydroxyapatite deposition disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11.1 Familial chondrocalcinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11.2 Other chondrocalcinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11.8 Other specified crystal arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11.9 Crystal arthropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12 Other specific arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.0 Chronic postrheumatic arthropathy [Jaccoud] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.1 Kaschin-Beck disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.2 Villonodular synovitis (pigmented) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.3 Palindromic rheumatism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.4 Intermittent hydrarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.5 Traumatic arthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.8 Other specific arthropathies, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M13 Other arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M13.0 Polyarthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M13.1 Monoarthritis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M13.8 Other specified arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M13.9 Arthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14 Arthropathies in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.0 Gouty arthropathy due to enzyme defects and other inherited disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.1 Crystal arthropathy in other metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.2 Diabetic arthropathyE10-E14 with common fourth character .6 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.3 Lipoid dermatoarthritisE78.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.4 Arthropathy in amyloidosisE85.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.5 Arthropathies in other endocrine, nutritional and metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.6 Neuropathic arthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.8 Arthropathies in other specified diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15 Polyarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.0 Primary generalized (osteo)arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.1 Heberden nodes (with arthropathy) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.2 Bouchard nodes (with arthropathy) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.3 Secondary multiple arthrosis © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 378 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.4 Erosive (osteo)arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.8 Other polyarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.9 Polyarthrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16 Coxarthrosis [arthrosis of hip] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.0 Primary coxarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.1 Other primary coxarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.2 Coxarthrosis resulting from dysplasia, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.3 Other dysplastic coxarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.4 Post-traumatic coxarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.5 Other post-traumatic coxarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.6 Other secondary coxarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.7 Other secondary coxarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.9 Coxarthrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17 Gonarthrosis [arthrosis of knee] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.0 Primary gonarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.1 Other primary gonarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.2 Post-traumatic gonarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.3 Other post-traumatic gonarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.4 Other secondary gonarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.5 Other secondary gonarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.9 Gonarthrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18 Arthrosis of first carpometacarpal joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.0 Primary arthrosis of first carpometacarpal joints, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.1 Other primary arthrosis of first carpometacarpal joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.2 Post-traumatic arthrosis of first carpometacarpal joints, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.3 Other post-traumatic arthrosis of first carpometacarpal joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.4 Other secondary arthrosis of first carpometacarpal joints, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.5 Other secondary arthrosis of first carpometacarpal joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.9 Arthrosis of first carpometacarpal joint, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19 Other arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19.0 Primary arthrosis of other joints 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19.1 Post-traumatic arthrosis of other joints 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19.2 Other secondary arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19.8 Other specified arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19.9 Arthrosis, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 379 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20 Acquired deformities of fingers and toes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.0 Deformity of finger(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.1 Hallux valgus (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.2 Hallux rigidus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.3 Other deformity of hallux (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.4 Other hammer toe(s) (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.5 Other deformities of toe(s) (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.6 Acquired deformity of toe(s), unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21 Other acquired deformities of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.0 Valgus deformity, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.1 Varus deformity, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.2 Flexion deformity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.3 Wrist or foot drop (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.4 Flat foot [pes planus] (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.6 Other acquired deformities of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.7 Unequal limb length (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.8 Other specified acquired deformities of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.9 Acquired deformity of limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22 Disorders of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.0 Recurrent dislocation of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.1 Recurrent subluxation of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.2 Patellofemoral disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.3 Other derangements of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.4 Chondromalacia patellae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.8 Other disorders of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.9 Disorder of patella, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23 Internal derangement of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.0 Cystic meniscus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.1 Discoid meniscus (congenital) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.2 Derangement of meniscus due to old tear or injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.3 Other meniscus derangements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.4 Loose body in knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.5 Chronic instability of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.6 Other spontaneous disruption of ligament(s) of knee

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 380 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.8 Other internal derangements of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.9 Internal derangement of knee, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24 Other specific joint derangements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.0 Loose body in joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.1 Other articular cartilage disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.2 Disorder of ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.3 Pathological dislocation and subluxation of joint, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.4 Recurrent dislocation and subluxation of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.5 Contracture of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.6 Ankylosis of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.7 Protrusio acetabuli 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.8 Other specific joint derangements, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.9 Joint derangement, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25 Other joint disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.0 Haemarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.1 Fistula of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.2 Flail joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.3 Other instability of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.4 Effusion of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.5 Pain in joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.6 Stiffness of joint, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.7 Osteophyte 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.8 Other specified joint disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.9 Joint disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30 Polyarteritis nodosa and related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30.0 Polyarteritis nodosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30.1 Polyarteritis with lung involvement [Churg-Strauss] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30.2 Juvenile polyarteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30.3 Mucocutaneous lymph node syndrome [Kawasaki] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30.8 Other conditions related to polyarteritis nodosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31 Other necrotizing vasculopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.0 Hypersensitivity angiitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.1 Thrombotic microangiopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.2 Lethal midline granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.3 Wegener granulomatosis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 381 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.4 Aortic arch syndrome [Takayasu] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.5 Giant cell arteritis with polymyalgia rheumatica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.6 Other giant cell arteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.7 Microscopic polyangiitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.8 Other specified necrotizing vasculopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.9 Necrotizing vasculopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M32 Systemic lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M32.0 Drug-induced systemic lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M32.1 Systemic lupus erythematosus with organ or system involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M32.8 Other forms of systemic lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M32.9 Systemic lupus erythematosus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M33 Dermatopolymyositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M33.0 Juvenile dermatomyositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M33.1 Other dermatomyositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M33.2 Polymyositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M33.9 Dermatopolymyositis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34 Systemic sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34.0 Progressive systemic sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34.1 CR(E)ST syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34.2 Systemic sclerosis induced by drugs and chemicals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34.8 Other forms of systemic sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34.9 Systemic sclerosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35 Other systemic involvement of connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.0 Sicca syndrome [Sjögren] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.1 Other overlap syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.2 Behçet disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.3 Polymyalgia rheumatica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.4 Diffuse (eosinophilic) fasciitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.5 Multifocal fibrosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.6 Relapsing panniculitis [Weber- Christian] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.7 Hypermobility syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.8 Other specified systemic involvement of connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.9 Systemic involvement of connective tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36 Systemic disorders of connective tissue in diseases classified elsewhere

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 382 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.0 Dermato(poly)myositis in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.1 Arthropathy in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.2 Haemophilic arthropathyD66-D68 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.3 Arthropathy in other blood disordersD50-D76 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.4 Arthropathy in hypersensitivity reactions classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.8 Systemic disorders of connective tissue in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40 Kyphosis and lordosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.0 Postural kyphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.1 Other secondary kyphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.2 Other and unspecified kyphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.3 Flatback syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.4 Other lordosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.5 Lordosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41 Scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.0 Infantile idiopathic scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.1 Juvenile idiopathic scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.2 Other idiopathic scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.3 Thoracogenic scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.4 Neuromuscular scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.5 Other secondary scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.8 Other forms of scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.9 Scoliosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M42 Spinal osteochondrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M42.0 Juvenile osteochondrosis of spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M42.1 Adult osteochondrosis of spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M42.9 Spinal osteochondrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43 Other deforming dorsopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.0 Spondylolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.1 Spondylolisthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.2 Other fusion of spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.3 Recurrent atlantoaxial subluxation with myelopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.4 Other recurrent atlantoaxial subluxation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.5 Other recurrent vertebral subluxation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.6 Torticollis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.8 Other specified deforming dorsopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.9 Deforming dorsopathy, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 383 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M45 Ankylosing spondylitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46 Other inflammatory spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.0 Spinal enthesopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.1 Sacroiliitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.2 Osteomyelitis of vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.3 Infection of intervertebral disc (pyogenic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.4 Discitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.5 Other infective spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.8 Other specified inflammatory spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.9 Inflammatory spondylopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47 Spondylosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47.0 Anterior spinal and vertebral artery compression syndromesG99.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47.1 Other spondylosis with myelopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47.2 Other spondylosis with radiculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47.8 Other spondylosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47.9 Spondylosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48 Other spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.0 Spinal stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.1 Ankylosing hyperostosis [Forestier] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.2 Kissing spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.3 Traumatic spondylopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.4 Fatigue fracture of vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.5 Collapsed vertebra, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.8 Other specified spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.9 Spondylopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49 Spondylopathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.0 Tuberculosis of spineA18.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.1 Brucella spondylitisA23.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.2 Enterobacterial spondylitisA01-A04 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.3 Spondylopathy in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.4 Neuropathic spondylopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.5 Collapsed vertebra in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.8 Spondylopathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50 Cervical disc disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.0 Cervical disc disorder with myelopathyG99.2

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 384 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.1 Cervical disc disorder with radiculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.2 Other cervical disc displacement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.3 Other cervical disc degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.8 Other cervical disc disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.9 Cervical disc disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51 Other intervertebral disc disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.0 Lumbar and other intervertebral disc disorders with myelopathyG99.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.1 Lumbar and other intervertebral disc disorders with radiculopathyG55.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.2 Other specified intervertebral disc displacement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.3 Other specified intervertebral disc degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.4 Schmorl nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.8 Other specified intervertebral disc disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.9 Intervertebral disc disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53 Other dorsopathies, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.0 Cervicocranial syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.1 Cervicobrachial syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.2 Spinal instabilities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.3 Sacrococcygeal disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.8 Other specified dorsopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.9 Dorsopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54 Dorsalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.0 Panniculitis affecting regions of neck and back 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.1 Radiculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.2 Cervicalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.3 Sciatica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.4 Lumbago with sciatica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.5 Low back pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.6 Pain in thoracic spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.8 Other dorsalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.9 Dorsalgia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60 Myositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60.0 Infective myositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60.1 Interstitial myositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60.2 Foreign body granuloma of soft tissue, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60.8 Other myositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60.9 Myositis, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 385 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61 Calcification and ossification of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.0 Myositis ossificans traumatica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.1 Myositis ossificans progressiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.2 Paralytic calcification and ossification of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.3 Calcification and ossification of muscles associated with burns 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.4 Other calcification of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.5 Other ossification of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.9 Calcification and ossification of muscle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62 Other disorders of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.0 Diastasis of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.1 Other rupture of muscle (nontraumatic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.2 Ischaemic infarction of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.3 Immobility syndrome (paraplegic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.4 Contracture of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.5 Muscle wasting and atrophy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.6 Muscle strain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.8 Other specified disorders of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.9 Disorder of muscle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63 Disorders of muscle in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63.0 Myositis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63.1 Myositis in protozoal and parasitic infections classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63.2 Myositis in other infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63.3 Myositis in sarcoidosisD86.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63.8 Other disorders of muscle in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65 Synovitis and tenosynovitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.0 Abscess of tendon sheath 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.1 Other infective (teno)synovitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.2 Calcific tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.3 Trigger finger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.4 Radial styloid tenosynovitis [de Quervain] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.8 Other synovitis and tenosynovitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.9 Synovitis and tenosynovitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66 Spontaneous rupture of synovium and tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.0 Rupture of popliteal cyst

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 386 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.1 Rupture of synovium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.2 Spontaneous rupture of extensor tendons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.3 Spontaneous rupture of flexor tendons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.4 Spontaneous rupture of other tendons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.5 Spontaneous rupture of unspecified tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67 Other disorders of synovium and tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.0 Short Achilles tendon (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.1 Other contracture of tendon (sheath) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.2 Synovial hypertrophy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.3 Transient synovitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.4 Ganglion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.8 Other specified disorders of synovium and tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.9 Disorder of synovium and tendon, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M68 Disorders of synovium and tendon in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M68.0 Synovitis and tenosynovitis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M68.8 Other disorders of synovium and tendon in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70 Soft tissue disorders related to use, overuse and pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.0 Chronic crepitant synovitis of hand and wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.1 Bursitis of hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.2 Olecranon bursitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.3 Other bursitis of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.4 Prepatellar bursitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.5 Other bursitis of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.6 Trochanteric bursitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.7 Other bursitis of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.8 Other soft tissue disorders related to use, overuse and pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.9 Unspecified soft tissue disorder related to use, overuse and pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71 Other bursopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.0 Abscess of bursa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.1 Other infective bursitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.2 Synovial cyst of popliteal space [Baker] © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 387 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.3 Other bursal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.4 Calcium deposit in bursa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.5 Other bursitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.8 Other specified bursopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.9 Bursopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72 Fibroblastic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.0 Palmar fascial fibromatosis [Dupuytren] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.1 Knuckle pads 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.2 Plantar fascial fibromatosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.4 Pseudosarcomatous fibromatosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.6 Necrotizing fasciitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.8 Other fibroblastic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.9 Fibroblastic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M73 Soft tissue disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M73.0 Gonococcal bursitisA54.4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M73.1 Syphilitic bursitisA52.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M73.8 Other soft tissue disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75 Shoulder lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.0 Adhesive capsulitis of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.1 Rotator cuff syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.2 Bicipital tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.3 Calcific tendinitis of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.4 Impingement syndrome of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.5 Bursitis of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.8 Other shoulder lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.9 Shoulder lesion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76 Enthesopathies of lower limb, excluding foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.0 Gluteal tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.1 Psoas tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.2 Iliac crest spur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.3 Iliotibial band syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.4 Tibial collateral bursitis [Pellegrini- Stieda] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.5 Patellar tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.6 Achilles tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.7 Peroneal tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.8 Other enthesopathies of lower limb, excluding foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.9 Enthesopathy of lower limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77 Other enthesopathies © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 388 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.0 Medial epicondylitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.1 Lateral epicondylitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.2 Periarthritis of wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.3 Calcaneal spur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.4 Metatarsalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.5 Other enthesopathy of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.8 Other enthesopathies, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.9 Enthesopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79 Other soft tissue disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.0 Rheumatism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.1 Myalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.2 Neuralgia and neuritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.3 Panniculitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.4 Hypertrophy of (infrapatellar) fat pad 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.5 Residual foreign body in soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.6 Pain in limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.8 Other specified soft tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.9 Soft tissue disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80 Osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.0 Postmenopausal osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.1 Postoophorectomy osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.2 Osteoporosis of disuse with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.3 Postsurgical malabsorption osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.4 Drug-induced osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.5 Idiopathic osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.8 Other osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.9 Unspecified osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81 Osteoporosis without pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.0 Postmenopausal osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.1 Postoophorectomy osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.2 Osteoporosis of disuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.3 Postsurgical malabsorption osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.4 Drug-induced osteoporosis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 389 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.5 Idiopathic osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.6 Localized osteoporosis [Lequesne] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.8 Other osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.9 Osteoporosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M82 Osteoporosis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M82.0 Osteoporosis in multiple myelomatosisC90.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M82.1 Osteoporosis in endocrine disordersE00-E34 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M82.8 Osteoporosis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83 Adult osteomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.0 Puerperal osteomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.1 Senile osteomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.2 Adult osteomalacia due to malabsorption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.3 Adult osteomalacia due to malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.4 Aluminium bone disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.5 Other drug-induced osteomalacia in adults 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.8 Other adult osteomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.9 Adult osteomalacia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84 Disorders of continuity of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.0 Malunion of fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.1 Nonunion of fracture [pseudarthrosis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.2 Delayed union of fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.3 Stress fracture, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.4 Pathological fracture, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.8 Other disorders of continuity of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.9 Disorder of continuity of bone, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85 Other disorders of bone density and structure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.0 Fibrous dysplasia (monostotic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.1 Skeletal fluorosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.2 Hyperostosis of skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.3 Osteitis condensans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.4 Solitary bone cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.5 Aneurysmal bone cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.6 Other cyst of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.8 Other specified disorders of bone density and structure

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 390 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.9 Disorder of bone density and structure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86 Osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.0 Acute haematogenous osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.1 Other acute osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.2 Subacute osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.3 Chronic multifocal osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.4 Chronic osteomyelitis with draining sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.5 Other chronic haematogenous osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.6 Other chronic osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.8 Other osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.9 Osteomyelitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87 Osteonecrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.0 Idiopathic aseptic necrosis of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.1 Osteonecrosis due to drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.2 Osteonecrosis due to previous trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.3 Other secondary osteonecrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.8 Other osteonecrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.9 Osteonecrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M88 Paget disease of bone [osteitis deformans] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M88.0 Paget disease of skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M88.8 Paget disease of other bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M88.9 Paget disease of bone, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89 Other disorders of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.0 Algoneurodystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.1 Epiphyseal arrest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.2 Other disorders of bone development and growth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.3 Hypertrophy of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.4 Other hypertrophic osteoarthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.5 Osteolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.6 Osteopathy after poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.8 Other specified disorders of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.9 Disorder of bone, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90 Osteopathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.0 Tuberculosis of boneA18.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.1 Periostitis in other infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.2 Osteopathy in other infectious diseases classified elsewhere

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 391 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.3 Osteonecrosis in caisson diseaseT70.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.4 Osteonecrosis due to haemoglobinopathyD50-D64 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.5 Osteonecrosis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.6 Osteitis deformans in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.7 Fracture of bone in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.8 Osteopathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91 Juvenile osteochondrosis of hip and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.0 Juvenile osteochondrosis of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.1 Juvenile osteochondrosis of head of femur [Legg-Calvé-Perthes] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.2 Coxa plana 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.3 Pseudocoxalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.8 Other juvenile osteochondrosis of hip and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.9 Juvenile osteochondrosis of hip and pelvis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92 Other juvenile osteochondrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.0 Juvenile osteochondrosis of humerus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.1 Juvenile osteochondrosis of radius and ulna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.2 Juvenile osteochondrosis of hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.3 Other juvenile osteochondrosis of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.4 Juvenile osteochondrosis of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.5 Juvenile osteochondrosis of tibia and fibula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.6 Juvenile osteochondrosis of tarsus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.7 Juvenile osteochondrosis of metatarsus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.8 Other specified juvenile osteochondrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.9 Juvenile osteochondrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93 Other osteochondropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93.0 Slipped upper femoral epiphysis (nontraumatic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93.1 Kienböck disease of adults 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93.2 Osteochondritis dissecans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93.8 Other specified osteochondropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93.9 Osteochondropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94 Other disorders of cartilage © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 392 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.0 Chondrocostal junction syndrome [Tietze] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.1 Relapsing polychondritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.2 Chondromalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.3 Chondrolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.8 Other specified disorders of cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.9 Disorder of cartilage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95 Other acquired deformities of musculoskeletal system and connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.0 Acquired deformity of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.1 Cauliflower ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.2 Other acquired deformity of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.3 Acquired deformity of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.4 Acquired deformity of chest and rib 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.5 Acquired deformity of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.8 Other specified acquired deformities of musculoskeletal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.9 Acquired deformity of musculoskeletal system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96 Postprocedural musculoskeletal disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.0 Pseudarthrosis after fusion or arthrodesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.1 Postlaminectomy syndrome, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.2 Postradiation kyphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.3 Postlaminectomy kyphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.4 Postsurgical lordosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.5 Postradiation scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.8 Other postprocedural musculoskeletal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.9 Postprocedural musculoskeletal disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99 Biomechanical lesions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.0 Segmental and somatic dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.1 Subluxation complex (vertebral) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.2 Subluxation stenosis of neural canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.3 Osseous stenosis of neural canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.4 Connective tissue stenosis of neural canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.5 Intervertebral disc stenosis of neural canal

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 393 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.6 Osseous and subluxation stenosis of intervertebral foramina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.7 Connective tissue and disc stenosis of intervertebral foramina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.8 Other biomechanical lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.9 Biomechanical lesion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00 Acute nephritic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00.0 Acute nephritic syndrome; Minor glomerular abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00.1 Acute nephritic syndrome; Focal and segmental glomerular lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00.2 Acute nephritic syndrome; Diffuse membranous glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00.3 Acute nephritic syndrome; Diffuse mesangial proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00.4 Acute nephritic syndrome; Diffuse endocapillary proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00.5 Acute nephritic syndrome; Diffuse mesangiocapillary glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00.6 Acute nephritic syndrome; Dense deposit disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00.7 Acute nephritic syndrome; Diffuse crescentic glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00.8 Acute nephritic syndrome; Other 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00.9 Acute nephritic syndrome; Unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01 Rapidly progressive nephritic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01.0 Rapidly progressive nephritic syndrome; Minor glomerular abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01.1 Rapidly progressive nephritic syndrome; Focal and segmental glomerular lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01.2 Rapidly progressive nephritic syndrome; Diffuse membranous glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01.3 Rapidly progressive nephritic syndrome; Diffuse mesangial proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01.4 Rapidly progressive nephritic syndrome; Diffuse endocapillary proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01.5 Rapidly progressive nephritic syndrome; Diffuse mesangiocapillary glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01.6 Rapidly progressive nephritic syndrome; Dense deposit disease

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 394 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01.7 Rapidly progressive nephritic syndrome; Diffuse crescentic glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01.8 Rapidly progressive nephritic syndrome; Other 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01.9 Rapidly progressive nephritic syndrome; Unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02 Recurrent and persistent haematuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02.0 Recurrent and persistent haematuria; Minor glomerular abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02.1 Recurrent and persistent haematuria; Focal and segmental glomerular lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02.2 Recurrent and persistent haematuria; Diffuse membranous glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02.3 Recurrent and persistent haematuria; Diffuse mesangial proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02.4 Recurrent and persistent haematuria; Diffuse endocapillary proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02.5 Recurrent and persistent haematuria; Diffuse mesangiocapillary glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02.6 Recurrent and persistent haematuria; Dense deposit disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02.7 Recurrent and persistent haematuria; Diffuse crescentic glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02.8 Recurrent and persistent haematuria; Other 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02.9 Recurrent and persistent haematuria; Unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03 Chronic nephritic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03.0 Chronic nephritic syndrome; Minor glomerular abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03.1 Chronic nephritic syndrome; Focal and segmental glomerular lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03.2 Chronic nephritic syndrome; Diffuse membranous glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03.3 Chronic nephritic syndrome; Diffuse mesangial proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03.4 Chronic nephritic syndrome; Diffuse endocapillary proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03.5 Chronic nephritic syndrome; Diffuse mesangiocapillary glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03.6 Chronic nephritic syndrome; Dense deposit disease © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 395 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03.7 Chronic nephritic syndrome; Diffuse crescentic glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03.8 Chronic nephritic syndrome; Other 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03.9 Chronic nephritic syndrome; Unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04 Nephrotic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04.0 Nephrotic syndrome; Minor glomerular abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04.1 Nephrotic syndrome; Focal and segmental glomerular lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04.2 Nephrotic syndrome; Diffuse membranous glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04.3 Nephrotic syndrome; Diffuse mesangial proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04.4 Nephrotic syndrome; Diffuse endocapillary proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04.5 Nephrotic syndrome; Diffuse mesangiocapillary glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04.6 Nephrotic syndrome; Dense deposit disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04.7 Nephrotic syndrome; Diffuse crescentic glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04.8 Nephrotic syndrome; Other 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04.9 Nephrotic syndrome; Unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05 Unspecified nephritic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05.0 Unspecified nephritic syndrome; Minor glomerular abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05.1 Unspecified nephritic syndrome; Focal and segmental glomerular lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05.2 Unspecified nephritic syndrome; Diffuse membranous glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05.3 Unspecified nephritic syndrome; Diffuse mesangial proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05.4 Unspecified nephritic syndrome; Diffuse endocapillary proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05.5 Unspecified nephritic syndrome; Diffuse mesangiocapillary glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05.6 Unspecified nephritic syndrome; Dense deposit disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05.7 Unspecified nephritic syndrome; Diffuse crescentic glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05.8 Unspecified nephritic syndrome; Other

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 396 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05.9 Unspecified nephritic syndrome; Unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06 Isolated proteinuria with specified morphological lesion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06.0 Isolated proteinuria with specified morphological lesion; Minor glomerular abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06.1 Isolated proteinuria with specified morphological lesion; Focal and segmental glomerular lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06.2 Isolated proteinuria with specified morphological lesion; Diffuse membranous glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06.3 Isolated proteinuria with specified morphological lesion; Diffuse mesangial proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06.4 Isolated proteinuria with specified morphological lesion; Diffuse endocapillary proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06.5 Isolated proteinuria with specified morphological lesion; Diffuse mesangiocapillary glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06.6 Isolated proteinuria with specified morphological lesion; Dense deposit disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06.7 Isolated proteinuria with specified morphological lesion; Diffuse crescentic glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06.8 Isolated proteinuria with specified morphological lesion; Other 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06.9 Isolated proteinuria with specified morphological lesion; Unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07 Hereditary nephropathy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07.0 Hereditary nephropathy, not elsewhere classified; Minor glomerular abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07.1 Hereditary nephropathy, not elsewhere classified; Focal and segmental glomerular lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07.2 Hereditary nephropathy, not elsewhere classified; Diffuse membranous glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07.3 Hereditary nephropathy, not elsewhere classified; Diffuse mesangial proliferative glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07.4 Hereditary nephropathy, not elsewhere classified; Diffuse endocapillary proliferative glomerulonephritis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 397 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07.5 Hereditary nephropathy, not elsewhere classified; Diffuse mesangiocapillary glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07.6 Hereditary nephropathy, not elsewhere classified; Dense deposit disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07.7 Hereditary nephropathy, not elsewhere classified; Diffuse crescentic glomerulonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07.8 Hereditary nephropathy, not elsewhere classified; Other 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07.9 Hereditary nephropathy, not elsewhere classified; Unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08 Glomerular disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.1 Glomerular disorders in neoplastic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.3 Glomerular disorders in diabetes mellitusE10-E14 with common fourth character .2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.5 Glomerular disorders in systemic connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.8 Glomerular disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N10 Acute tubulo-interstitial nephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N11 Chronic tubulo-interstitial nephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N11.0 Nonobstructive reflux-associated chronic pyelonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N11.1 Chronic obstructive pyelonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N11.8 Other chronic tubulo-interstitial nephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N11.9 Chronic tubulo-interstitial nephritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N12 Tubulo-interstitial nephritis, not specified as acute or chronic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13 Obstructive and reflux uropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.0 Hydronephrosis with ureteropelvic junction obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.2 Hydronephrosis with renal and ureteral calculous obstruction

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 398 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.3 Other and unspecified hydronephrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.4 Hydroureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.5 Kinking and stricture of ureter without hydronephrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.6 Pyonephrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.7 Vesicoureteral-reflux-associated uropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.8 Other obstructive and reflux uropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.9 Obstructive and reflux uropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14.0 nephropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14.1 Nephropathy induced by other drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14.2 Nephropathy induced by unspecified drug, medicament or biological substance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14.3 Nephropathy induced by heavy metals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14.4 Toxic nephropathy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N15 Other renal tubulo-interstitial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N15.0 Balkan nephropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N15.1 Renal and perinephric abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N15.8 Other specified renal tubulo- interstitial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N15.9 Renal tubulo-interstitial disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16 Renal tubulo-interstitial disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.1 Renal tubulo-interstitial disorders in neoplastic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.3 Renal tubulo-interstitial disorders in metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.5 Renal tubulo-interstitial disorders in transplant rejectionT86.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 399 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17 Acute renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17.0 Acute renal failure with tubular necrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17.1 Acute renal failure with acute cortical necrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17.2 Acute renal failure with medullary necrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17.8 Other acute renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17.9 Acute renal failure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18 Chronic kidney disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.1 Chronic kidney disease, stage 1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.2 Chronic kidney disease, stage 2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.3 Chronic kidney disease, stage 3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.4 Chronic kidney disease, stage 4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.5 Chronic kidney disease, stage 5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.9 Chronic kidney disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N19 Unspecified kidney failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20 Calculus of kidney and ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20.0 Calculus of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20.1 Calculus of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20.2 Calculus of kidney with calculus of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20.9 Urinary calculus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N21 Calculus of lower urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N21.0 Calculus in bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N21.1 Calculus in urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N21.8 Other lower urinary tract calculus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N21.9 Calculus of lower urinary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N22 Calculus of urinary tract in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N22.0 Urinary calculus in schistosomiasis [bilharziasis]B65.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N22.8 Calculus of urinary tract in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N23 Unspecified renal colic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25 Disorders resulting from impaired renal tubular function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25.0 Renal osteodystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25.1 Nephrogenic diabetes insipidus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25.8 Other disorders resulting from impaired renal tubular function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25.9 Disorder resulting from impaired renal tubular function, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N26 Unspecified contracted kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N27 Small kidney of unknown cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N27.0 Small kidney, unilateral © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 400 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N27.1 Small kidney, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N27.9 Small kidney, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N28 Other disorders of kidney and ureter, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N28.0 Ischaemia and infarction of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N28.1 Cyst of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N28.8 Other specified disorders of kidney and ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N28.9 Disorder of kidney and ureter, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N29 Other disorders of kidney and ureter in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N29.0 Late syphilis of kidneyA52.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N29.1 Other disorders of kidney and ureter in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N29.8 Other disorders of kidney and ureter in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30 Cystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.0 Acute cystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.1 Interstitial cystitis (chronic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.2 Other chronic cystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.3 Trigonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.4 Irradiation cystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.8 Other cystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.9 Cystitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31 Neuromuscular dysfunction of bladder, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31.0 Uninhibited neuropathic bladder, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31.1 Reflex neuropathic bladder, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31.2 Flaccid neuropathic bladder, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31.8 Other neuromuscular dysfunction of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31.9 Neuromuscular dysfunction of bladder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32 Other disorders of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.0 Bladder-neck obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.1 Vesicointestinal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.2 Vesical fistula, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.3 Diverticulum of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.4 Rupture of bladder, nontraumatic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.8 Other specified disorders of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.9 Bladder disorder, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 401 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N33 Bladder disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N33.0 Tuberculous cystitisA18.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N33.8 Bladder disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N34 Urethritis and urethral syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N34.0 Urethral abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N34.1 Nonspecific urethritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N34.2 Other urethritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N34.3 Urethral syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N35 Urethral stricture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N35.0 Post-traumatic urethral stricture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N35.1 Postinfective urethral stricture, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N35.8 Other urethral stricture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N35.9 Urethral stricture, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36 Other disorders of urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.0 Urethral fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.1 Urethral diverticulum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.2 Urethral caruncle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.3 Prolapsed urethral mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.8 Other specified disorders of urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.9 Urethral disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N37 Urethral disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N37.0 Urethritis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N37.8 Other urethral disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39 Other disorders of urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.0 Urinary tract infection, site not specified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.1 Persistent proteinuria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.2 Orthostatic proteinuria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.3 Stress incontinence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.4 Other specified urinary incontinence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.8 Other specified disorders of urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.9 Disorder of urinary system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N40 Hyperplasia of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41 Inflammatory diseases of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.0 Acute prostatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.1 Chronic prostatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.2 Abscess of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.3 Prostatocystitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 402 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.8 Other inflammatory diseases of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.9 Inflammatory disease of prostate, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42 Other disorders of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.0 Calculus of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.1 Congestion and haemorrhage of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.2 Atrophy of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.3 Dysplasia of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.8 Other specified disorders of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.9 Disorder of prostate, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43 Hydrocele and spermatocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43.0 Encysted hydrocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43.1 Infected hydrocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43.2 Other hydrocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43.3 Hydrocele, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43.4 Spermatocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N44 Torsion of testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N45 Orchitis and epididymitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N46 Male infertility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N47 Redundant prepuce, phimosis and paraphimosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48 Other disorders of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.0 Leukoplakia of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.1 Balanoposthitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.2 Other inflammatory disorders of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.3 Priapism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.4 Impotence of organic origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.5 Ulcer of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.6 Induratio penis plastica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.8 Other specified disorders of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.9 Disorder of penis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49 Inflammatory disorders of male genital organs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49.0 Inflammatory disorders of seminal vesicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49.2 Inflammatory disorders of scrotum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 403 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49.8 Inflammatory disorders of other specified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49.9 Inflammatory disorder of unspecified male genital organ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N50 Other disorders of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N50.0 Atrophy of testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N50.1 Vascular disorders of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N50.8 Other specified disorders of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N50.9 Disorder of male genital organs, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N51 Disorders of male genital organs in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N51.0 Disorders of prostate in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N51.1 Disorders of testis and epididymis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N51.2 Balanitis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N51.8 Other disorders of male genital organs in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60 Benign mammary dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.0 Solitary cyst of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.1 Diffuse cystic mastopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.2 Fibroadenosis of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.3 Fibrosclerosis of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.4 Mammary duct ectasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.8 Other benign mammary dysplasias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.9 Benign mammary dysplasia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N61 Inflammatory disorders of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N62 Hypertrophy of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N63 Unspecified lump in breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64 Other disorders of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.0 Fissure and fistula of nipple 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.1 Fat necrosis of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.2 Atrophy of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.3 Galactorrhoea not associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.4 Mastodynia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.5 Other signs and symptoms in breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.8 Other specified disorders of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.9 Disorder of breast, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N70 Salpingitis and oophoritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N70.0 Acute salpingitis and oophoritis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 404 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N70.1 Chronic salpingitis and oophoritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N70.9 Salpingitis and oophoritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N71 Inflammatory disease of uterus, except cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N71.0 Acute inflammatory disease of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N71.1 Chronic inflammatory disease of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N71.9 Inflammatory disease of uterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N72 Inflammatory disease of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73 Other female pelvic inflammatory diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.0 Acute parametritis and pelvic cellulitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.1 Chronic parametritis and pelvic cellulitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.2 Unspecified parametritis and pelvic cellulitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.3 Female acute pelvic peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.4 Female chronic pelvic peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.5 Female pelvic peritonitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.6 Female pelvic peritoneal adhesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.8 Other specified female pelvic inflammatory diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.9 Female pelvic inflammatory disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74 Female pelvic inflammatory disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.0 Tuberculous infection of cervix uteriA18.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.1 Female tuberculous pelvic inflammatory diseaseA18.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.2 Female syphilitic pelvic inflammatory diseaseA51.4A52.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.3 Female gonococcal pelvic inflammatory diseaseA54.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.4 Female chlamydial pelvic inflammatory diseaseA56.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N75 Diseases of Bartholin gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N75.0 Cyst of Bartholin gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N75.1 Abscess of Bartholin gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N75.8 Other diseases of Bartholin gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N75.9 Disease of Bartholin gland, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 405 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76 Other inflammation of vagina and vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.0 Acute vaginitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.1 Subacute and chronic vaginitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.2 Acute vulvitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.3 Subacute and chronic vulvitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.4 Abscess of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.5 Ulceration of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.6 Ulceration of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.8 Other specified inflammation of vagina and vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80 Endometriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.0 Endometriosis of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.1 Endometriosis of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.2 Endometriosis of fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.3 Endometriosis of pelvic peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.4 Endometriosis of rectovaginal septum and vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.5 Endometriosis of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.6 Endometriosis in cutaneous scar 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.8 Other endometriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.9 Endometriosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81 Female genital prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.0 Female urethrocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.1 Cystocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.2 Incomplete uterovaginal prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.3 Complete uterovaginal prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.4 Uterovaginal prolapse, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.5 Vaginal enterocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.6 Rectocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.8 Other female genital prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.9 Female genital prolapse, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82 Fistulae involving female genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.0 Vesicovaginal fistula © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 406 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.1 Other female urinary-genital tract fistulae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.2 Fistula of vagina to small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.3 Fistula of vagina to large intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.4 Other female intestinal-genital tract fistulae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.5 Female genital tract-skin fistulae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.8 Other female genital tract fistulae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.9 Female genital tract fistula, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83 Noninflammatory disorders of ovary, fallopian tube and broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.0 Follicular cyst of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.1 Corpus luteum cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.2 Other and unspecified ovarian cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.3 Acquired atrophy of ovary and fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.4 Prolapse and hernia of ovary and fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.5 Torsion of ovary, ovarian pedicle and fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.6 Haematosalpinx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.7 Haematoma of broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.8 Other noninflammatory disorders of ovary, fallopian tube and broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.9 Noninflammatory disorder of ovary, fallopian tube and broad ligament, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84 Polyp of female genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.0 Polyp of corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.1 Polyp of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.2 Polyp of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.3 Polyp of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.8 Polyp of other parts of female genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.9 Polyp of female genital tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85 Other noninflammatory disorders of uterus, except cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.0 Endometrial glandular hyperplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.1 Endometrial adenomatous hyperplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.2 Hypertrophy of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.3 Subinvolution of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.4 Malposition of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.5 Inversion of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.6 Intrauterine synechiae

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 407 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.7 Haematometra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.8 Other specified noninflammatory disorders of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.9 Noninflammatory disorder of uterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N86 Erosion and ectropion of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N87 Dysplasia of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N87.0 Mild cervical dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N87.1 Moderate cervical dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N87.2 Severe cervical dysplasia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N87.9 Dysplasia of cervix uteri, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88 Other noninflammatory disorders of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.0 Leukoplakia of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.1 Old laceration of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.2 Stricture and stenosis of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.3 Incompetence of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.4 Hypertrophic elongation of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.8 Other specified noninflammatory disorders of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.9 Noninflammatory disorder of cervix uteri, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89 Other noninflammatory disorders of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.0 Mild vaginal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.1 Moderate vaginal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.2 Severe vaginal dysplasia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.3 Dysplasia of vagina, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.4 Leukoplakia of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.5 Stricture and atresia of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.6 Tight hymenal ring 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.7 Haematocolpos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.8 Other specified noninflammatory disorders of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.9 Noninflammatory disorder of vagina, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90 Other noninflammatory disorders of vulva and perineum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.0 Mild vulvar dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.1 Moderate vulvar dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.2 Severe vulvar dysplasia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.3 Dysplasia of vulva, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.4 Leukoplakia of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.5 Atrophy of vulva © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 408 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.6 Hypertrophy of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.7 Vulvar cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.8 Other specified noninflammatory disorders of vulva and perineum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.9 Noninflammatory disorder of vulva and perineum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91 Absent, scanty and rare menstruation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.0 Primary amenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.1 Secondary amenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.2 Amenorrhoea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.3 Primary oligomenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.4 Secondary oligomenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.5 Oligomenorrhoea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92 Excessive, frequent and irregular menstruation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.0 Excessive and frequent menstruation with regular cycle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.1 Excessive and frequent menstruation with irregular cycle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.2 Excessive menstruation at puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.3 Ovulation bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.4 Excessive bleeding in the premenopausal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.5 Other specified irregular menstruation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.6 Irregular menstruation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N93 Other abnormal uterine and vaginal bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N93.0 Postcoital and contact bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N93.8 Other specified abnormal uterine and vaginal bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N93.9 Abnormal uterine and vaginal bleeding, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94 Pain and other conditions associated with female genital organs and menstrual cycle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.0 Mittelschmerz 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.1 Dyspareunia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.2 Vaginismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.3 Premenstrual tension syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.4 Primary dysmenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.5 Secondary dysmenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.6 Dysmenorrhoea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.8 Other specified conditions associated with female genital organs and menstrual cycle

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 409 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.9 Unspecified condition associated with female genital organs and menstrual cycle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95 Menopausal and other perimenopausal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.0 Postmenopausal bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.1 Menopausal and female climacteric states 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.2 Postmenopausal atrophic vaginitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.3 States associated with artificial menopause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.8 Other specified menopausal and perimenopausal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.9 Menopausal and perimenopausal disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N96 Habitual aborter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97 Female infertility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.0 Female infertility associated with anovulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.1 Female infertility of tubal origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.2 Female infertility of uterine origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.3 Female infertility of cervical origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.4 Female infertility associated with male factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.8 Female infertility of other origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.9 Female infertility, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98 Complications associated with artificial fertilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.0 Infection associated with artificial insemination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.1 Hyperstimulation of ovaries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.2 Complications of attempted introduction of fertilized ovum following in vitro fertilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.3 Complications of attempted introduction of embryo in embryo transfer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.8 Other complications associated with artificial fertilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.9 Complication associated with artificial fertilization, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99 Postprocedural disorders of genitourinary system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.0 Postprocedural renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.1 Postprocedural urethral stricture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.2 Postoperative adhesions of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.3 Prolapse of vaginal vault after hysterectomy

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 410 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.4 Postprocedural pelvic peritoneal adhesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.5 Malfunction of external stoma of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.8 Other postprocedural disorders of genitourinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.9 Postprocedural disorder of genitourinary system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00 Ectopic pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00.0 Abdominal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00.1 Tubal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00.2 Ovarian pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00.8 Other ectopic pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00.9 Ectopic pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O01 Hydatidiform mole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O01.0 Classical hydatidiform mole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O01.1 Incomplete and partial hydatidiform mole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O01.9 Hydatidiform mole, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O02 Other abnormal products of conception 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O02.0 Blighted ovum and nonhydatidiform mole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O02.1 Missed abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O02.8 Other specified abnormal products of conception 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O02.9 Abnormal product of conception, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03 Spontaneous abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03.0 Spontaneous abortion; Incomplete, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03.1 Spontaneous abortion; Incomplete, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03.2 Spontaneous abortion; Incomplete, complicated by embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03.3 Spontaneous abortion; Incomplete, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03.4 Spontaneous abortion; Incomplete, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03.5 Spontaneous abortion; Complete or unspecified, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03.6 Spontaneous abortion; Complete or unspecified, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03.7 Spontaneous abortion; Complete or unspecified, complicated by embolism

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 411 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03.8 Spontaneous abortion; Complete or unspecified, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03.9 Spontaneous abortion; Complete or unspecified, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04 Medical abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04.0 Medical abortion; Incomplete, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04.1 Medical abortion; Incomplete, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04.2 Medical abortion; Incomplete, complicated by embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04.3 Medical abortion; Incomplete, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04.4 Medical abortion; Incomplete, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04.5 Medical abortion; Complete or unspecified, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04.6 Medical abortion; Complete or unspecified, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04.7 Medical abortion; Complete or unspecified, complicated by embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04.8 Medical abortion; Complete or unspecified, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04.9 Medical abortion; Complete or unspecified, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05 Other abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05.0 Other abortion; Incomplete, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05.1 Other abortion; Incomplete, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05.2 Other abortion; Incomplete, complicated by embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05.3 Other abortion; Incomplete, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05.4 Other abortion; Incomplete, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05.5 Other abortion; Complete or unspecified, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05.6 Other abortion; Complete or unspecified, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05.7 Other abortion; Complete or unspecified, complicated by embolism

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 412 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05.8 Other abortion; Complete or unspecified, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05.9 Other abortion; Complete or unspecified, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06 Unspecified abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06.0 Unspecified abortion; Incomplete, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06.1 Unspecified abortion; Incomplete, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06.2 Unspecified abortion; Incomplete, complicated by embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06.3 Unspecified abortion; Incomplete, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06.4 Unspecified abortion; Incomplete, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06.5 Unspecified abortion; Complete or unspecified, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06.6 Unspecified abortion; Complete or unspecified, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06.7 Unspecified abortion; Complete or unspecified, complicated by embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06.8 Unspecified abortion; Complete or unspecified, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06.9 Unspecified abortion; Complete or unspecified, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07 Failed attempted abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.0 Failed medical abortion, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.1 Failed medical abortion, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.2 Failed medical abortion, complicated by embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.3 Failed medical abortion, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.4 Failed medical abortion, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.5 Other and unspecified failed attempted abortion, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.6 Other and unspecified failed attempted abortion, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.7 Other and unspecified failed attempted abortion, complicated by embolism © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 413 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.8 Other and unspecified failed attempted abortion, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.9 Other and unspecified failed attempted abortion, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08 Complications following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.0 Genital tract and pelvic infection following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.1 Delayed or excessive haemorrhage following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.2 Embolism following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.3 Shock following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.4 Renal failure following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.5 Metabolic disorders following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.6 Damage to pelvic organs and tissues following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.7 Other venous complications following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.8 Other complications following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.9 Complication following abortion and ectopic and molar pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.0 Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.1 Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.2 Pre-existing hypertensive renal disease complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.3 Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.4 Pre-existing secondary hypertension complicating pregnancy, childbirth and the puerperium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 414 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.9 Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O11 Pre-eclampsia superimposed on chronic hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O12.0 Gestational oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O12.1 Gestational proteinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O12.2 Gestational oedema with proteinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O13 Gestational [pregnancy-induced] hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O14 Pre-eclampsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O14.0 Mild to moderate pre-eclampsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O14.1 Severe pre-eclampsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O14.2 HELLP syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O14.9 Pre-eclampsia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O15 Eclampsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O15.0 Eclampsia in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O15.1 Eclampsia in labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O15.2 Eclampsia in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O15.9 Eclampsia, unspecified as to time period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O16 Unspecified maternal hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O20 Haemorrhage in early pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O20.0 Threatened abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O20.8 Other haemorrhage in early pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O20.9 Haemorrhage in early pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21 Excessive vomiting in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21.0 Mild hyperemesis gravidarum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21.1 Hyperemesis gravidarum with metabolic disturbance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21.2 Late vomiting of pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21.8 Other vomiting complicating pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21.9 Vomiting of pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22 Venous complications and haemorrhoids in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.0 Varicose veins of lower extremity in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.1 Genital varices in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.2 Superficial thrombophlebitis in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.3 Deep phlebothrombosis in pregnancy © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 415 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.4 Haemorrhoids in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.5 Cerebral venous thrombosis in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.8 Other venous complications in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.9 Venous complication in pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23 Infections of genitourinary tract in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.0 Infections of kidney in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.1 Infections of bladder in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.2 Infections of urethra in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.3 Infections of other parts of urinary tract in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.4 Unspecified infection of urinary tract in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.5 Infections of the genital tract in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.9 Other and unspecified genitourinary tract infection in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24 Diabetes mellitus in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.0 Diabetes mellitus in pregnancy: Pre- existing diabetes mellitus, insulin- dependent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.1 Diabetes mellitus in pregnancy: Pre- existing diabetes mellitus, non- insulin-dependent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.2 Diabetes mellitus in pregnancy: Pre- existing malnutrition-related diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.3 Diabetes mellitus in pregnancy: Pre- existing diabetes mellitus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.4 Diabetes mellitus arising in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.9 Diabetes mellitus in pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O25 Malnutrition in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26 Maternal care for other conditions predominantly related to pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.0 Excessive weight gain in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.1 Low weight gain in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.2 Pregnancy care of habitual aborter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.3 Retained intrauterine contraceptive device in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.4 Herpes gestationis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.5 Maternal hypotension syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.6 Liver disorders in pregnancy, childbirth and the puerperium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 416 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.7 Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.8 Other specified pregnancy-related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.9 Pregnancy-related condition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28 Abnormal findings on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.0 Abnormal haematological finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.1 Abnormal biochemical finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.2 Abnormal cytological finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.3 Abnormal ultrasonic finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.4 Abnormal radiological finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.5 Abnormal chromosomal and genetic finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.8 Other abnormal findings on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.9 Abnormal finding on antenatal screening of mother, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29 Complications of anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.0 Pulmonary complications of anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.1 Cardiac complications of anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.2 Central nervous system complications of anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.3 Toxic reaction to local anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.4 Spinal and epidural anaesthesia- induced headache during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.5 Other complications of spinal and epidural anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.6 Failed or difficult intubation during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.8 Other complications of anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.9 Complication of anaesthesia during pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30 Multiple gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30.0 Twin pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30.1 Triplet pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30.2 Quadruplet pregnancy

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 417 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30.8 Other multiple gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30.9 Multiple gestation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O31 Complications specific to multiple gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O31.0 Papyraceous fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O31.1 Continuing pregnancy after abortion of one fetus or more 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O31.2 Continuing pregnancy after intrauterine death of one fetus or more 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O31.8 Other complications specific to multiple gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32 Maternal care for known or suspected malpresentation of fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.0 Maternal care for unstable lie 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.1 Maternal care for breech presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.2 Maternal care for transverse and oblique lie 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.3 Maternal care for face, brow and chin presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.4 Maternal care for high head at term 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.5 Maternal care for multiple gestation with malpresentation of one fetus or more 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.6 Maternal care for compound presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.8 Maternal care for other malpresentation of fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.9 Maternal care for malpresentation of fetus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33 Maternal care for known or suspected disproportion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.0 Maternal care for disproportion due to deformity of maternal pelvic bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.1 Maternal care for disproportion due to generally contracted pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.2 Maternal care for disproportion due to inlet contraction of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.3 Maternal care for disproportion due to outlet contraction of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.4 Maternal care for disproportion of mixed maternal and fetal origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.5 Maternal care for disproportion due to unusually large fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.6 Maternal care for disproportion due to hydrocephalic fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.7 Maternal care for disproportion due to other fetal deformities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.8 Maternal care for disproportion of other origin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 418 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.9 Maternal care for disproportion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34 Maternal care for known or suspected abnormality of pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.0 Maternal care for congenital malformation of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.1 Maternal care for tumour of corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.2 Maternal care due to uterine scar from previous surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.3 Maternal care for cervical incompetence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.4 Maternal care for other abnormalities of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.5 Maternal care for other abnormalities of gravid uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.6 Maternal care for abnormality of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.7 Maternal care for abnormality of vulva and perineum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.8 Maternal care for other abnormalities of pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.9 Maternal care for abnormality of pelvic organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35 Maternal care for known or suspected fetal abnormality and damage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.0 Maternal care for (suspected) central nervous system malformation in fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.1 Maternal care for (suspected) chromosomal abnormality in fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.2 Maternal care for (suspected) hereditary disease in fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.3 Maternal care for (suspected) damage to fetus from viral disease in mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.4 Maternal care for (suspected) damage to fetus from alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.5 Maternal care for (suspected) damage to fetus by drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.6 Maternal care for (suspected) damage to fetus by radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.7 Maternal care for (suspected) damage to fetus by other medical procedures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.8 Maternal care for other (suspected) fetal abnormality and damage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.9 Maternal care for (suspected) fetal abnormality and damage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36 Maternal care for other known or suspected fetal problems © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 419 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.0 Maternal care for rhesus isoimmunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.1 Maternal care for other isoimmunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.2 Maternal care for hydrops fetalis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.3 Maternal care for signs of fetal hypoxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.4 Maternal care for intrauterine death 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.5 Maternal care for poor fetal growth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.6 Maternal care for excessive fetal growth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.7 Maternal care for viable fetus in abdominal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.8 Maternal care for other specified fetal problems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.9 Maternal care for fetal problem, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O40 Polyhydramnios 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O41 Other disorders of amniotic fluid and membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O41.0 Oligohydramnios 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O41.1 Infection of amniotic sac and membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O41.8 Other specified disorders of amniotic fluid and membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O41.9 Disorder of amniotic fluid and membranes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O42 Premature rupture of membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O42.0 Premature rupture of membranes, onset of labour within 24 hours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O42.1 Premature rupture of membranes, onset of labour after 24 hours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O42.2 Premature rupture of membranes, labour delayed by therapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O42.9 Premature rupture of membranes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43 Placental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43.0 Placental transfusion syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43.1 Malformation of placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43.2 Morbidly adherent placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43.8 Other placental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43.9 Placental disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O44 Placenta praevia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O44.0 Placenta praevia specified as without haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O44.1 Placenta praevia with haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O45 Premature separation of placenta [abruptio placentae]

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 420 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O45.0 Premature separation of placenta with coagulation defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O45.8 Other premature separation of placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O45.9 Premature separation of placenta, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O46 Antepartum haemorrhage, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O46.0 Antepartum haemorrhage with coagulation defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O46.8 Other antepartum haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O46.9 Antepartum haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O47 False labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O47.0 False labour before 37 completed weeks of gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O47.1 False labour at or after 37 completed weeks of gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O47.9 False labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O48 Prolonged pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60 Preterm labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60.0 Preterm labour without delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60.1 Preterm spontaneous labour with preterm delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60.2 Preterm spontaneous labour with term delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60.3 Preterm delivery without spontaneous labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O61 Failed induction of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O61.0 Failed medical induction of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O61.1 Failed instrumental induction of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O61.8 Other failed induction of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O61.9 Failed induction of labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62 Abnormalities of forces of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.0 Primary inadequate contractions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.1 Secondary uterine inertia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.2 Other uterine inertia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.3 Precipitate labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.4 Hypertonic, incoordinate, and prolonged uterine contractions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.8 Other abnormalities of forces of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.9 Abnormality of forces of labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O63 Long labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O63.0 Prolonged first stage (of labour) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O63.1 Prolonged second stage (of labour) © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 421 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O63.2 Delayed delivery of second twin, triplet, etc. 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O63.9 Long labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64 Obstructed labour due to malposition and malpresentation of fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.0 Obstructed labour due to incomplete rotation of fetal head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.1 Obstructed labour due to breech presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.2 Obstructed labour due to face presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.3 Obstructed labour due to brow presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.4 Obstructed labour due to shoulder presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.5 Obstructed labour due to compound presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.8 Obstructed labour due to other malposition and malpresentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.9 Obstructed labour due to malposition and malpresentation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65 Obstructed labour due to maternal pelvic abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.0 Obstructed labour due to deformed pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.1 Obstructed labour due to generally contracted pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.2 Obstructed labour due to pelvic inlet contraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.3 Obstructed labour due to pelvic outlet and mid-cavity contraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.4 Obstructed labour due to fetopelvic disproportion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.5 Obstructed labour due to abnormality of maternal pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.8 Obstructed labour due to other maternal pelvic abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.9 Obstructed labour due to maternal pelvic abnormality, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66 Other obstructed labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.0 Obstructed labour due to shoulder dystocia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.1 Obstructed labour due to locked twins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.2 Obstructed labour due to unusually large fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.3 Obstructed labour due to other abnormalities of fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.4 Failed trial of labour, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 422 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.5 Failed application of vacuum extractor and forceps, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.8 Other specified obstructed labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.9 Obstructed labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O67.0 Intrapartum haemorrhage with coagulation defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O67.8 Other intrapartum haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O67.9 Intrapartum haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68 Labour and delivery complicated by fetal stress [distress] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.0 Labour and delivery complicated by fetal heart rate anomaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.1 Labour and delivery complicated by meconium in amniotic fluid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.2 Labour and delivery complicated by fetal heart rate anomaly with meconium in amniotic fluid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.3 Labour and delivery complicated by biochemical evidence of fetal stress 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.8 Labour and delivery complicated by other evidence of fetal stress 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.9 Labour and delivery complicated by fetal stress, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69 Labour and delivery complicated by umbilical cord complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.0 Labour and delivery complicated by prolapse of cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.1 Labour and delivery complicated by cord around neck, with compression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.2 Labour and delivery complicated by other cord entanglement, with compression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.3 Labour and delivery complicated by short cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.4 Labour and delivery complicated by vasa praevia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.5 Labour and delivery complicated by vascular lesion of cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.8 Labour and delivery complicated by other cord complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.9 Labour and delivery complicated by cord complication, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70 Perineal laceration during delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70.0 First degree perineal laceration during delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70.1 Second degree perineal laceration during delivery

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 423 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70.2 Third degree perineal laceration during delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70.3 Fourth degree perineal laceration during delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70.9 Perineal laceration during delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71 Other obstetric trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.0 Rupture of uterus before onset of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.1 Rupture of uterus during labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.2 Postpartum inversion of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.3 Obstetric laceration of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.4 Obstetric high vaginal laceration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.5 Other obstetric injury to pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.6 Obstetric damage to pelvic joints and ligaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.7 Obstetric haematoma of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.8 Other specified obstetric trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.9 Obstetric trauma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O72 Postpartum haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O72.0 Third-stage haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O72.1 Other immediate postpartum haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O72.2 Delayed and secondary postpartum haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O72.3 Postpartum coagulation defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O73 Retained placenta and membranes, without haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O73.0 Retained placenta without haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O73.1 Retained portions of placenta and membranes, without haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74 Complications of anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.0 Aspiration pneumonitis due to anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.1 Other pulmonary complications of anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.2 Cardiac complications of anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.3 Central nervous system complications of anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.4 Toxic reaction to local anaesthesia during labour and delivery

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 424 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.5 Spinal and epidural anaesthesia- induced headache during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.6 Other complications of spinal and epidural anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.7 Failed or difficult intubation during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.8 Other complications of anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.9 Complication of anaesthesia during labour and delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75 Other complications of labour and delivery, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.0 Maternal distress during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.1 Shock during or following labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.2 Pyrexia during labour, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.3 Other infection during labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.4 Other complications of obstetric surgery and procedures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.5 Delayed delivery after artificial rupture of membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.7 Vaginal delivery following previous caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.8 Other specified complications of labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.9 Complication of labour and delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80 Single spontaneous delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80.0 Spontaneous vertex delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80.1 Spontaneous breech delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80.8 Other single spontaneous delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80.9 Single spontaneous delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81 Single delivery by forceps and vacuum extractor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.0 Low forceps delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.1 Mid-cavity forceps delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.2 Mid-cavity forceps with rotation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.3 Other and unspecified forceps delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.4 Vacuum extractor delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.5 Delivery by combination of forceps and vacuum extractor

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 425 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82 Single delivery by caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82.0 Delivery by elective caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82.1 Delivery by emergency caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82.2 Delivery by caesarean hysterectomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82.8 Other single delivery by caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82.9 Delivery by caesarean section, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83 Other assisted single delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.0 Breech extraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.1 Other assisted breech delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.2 Other manipulation-assisted delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.3 Delivery of viable fetus in abdominal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.4 Destructive operation for delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.8 Other specified assisted single delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.9 Assisted single delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84 Multiple delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84.0 Multiple delivery, all spontaneous 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84.1 Multiple delivery, all by forceps and vacuum extractor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84.2 Multiple delivery, all by caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84.8 Other multiple delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84.9 Multiple delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O85 Puerperal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86 Other puerperal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.0 Infection of obstetric surgical wound 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.1 Other infection of genital tract following delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.2 Urinary tract infection following delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.3 Other genitourinary tract infections following delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.4 Pyrexia of unknown origin following delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.8 Other specified puerperal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87 Venous complications and haemorrhoids in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.0 Superficial thrombophlebitis in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.1 Deep phlebothrombosis in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.2 Haemorrhoids in the puerperium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 426 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.3 Cerebral venous thrombosis in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.8 Other venous complications in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.9 Venous complication in the puerperium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88 Obstetric embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88.0 Obstetric air embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88.1 Amniotic fluid embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88.2 Obstetric blood-clot embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88.3 Obstetric pyaemic and septic embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88.8 Other obstetric embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89 Complications of anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.0 Pulmonary complications of anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.1 Cardiac complications of anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.2 Central nervous system complications of anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.3 Toxic reaction to local anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.4 Spinal and epidural anaesthesia- induced headache during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.5 Other complications of spinal and epidural anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.6 Failed or difficult intubation during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.8 Other complications of anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.9 Complication of anaesthesia during the puerperium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90 Complications of the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.0 Disruption of caesarean section wound 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.1 Disruption of perineal obstetric wound 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.2 Haematoma of obstetric wound 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.3 Cardiomyopathy in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.4 Postpartum acute renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.5 Postpartum thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.8 Other complications of the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.9 Complication of the puerperium, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 427 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O91 Infections of breast associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O91.0 Infection of nipple associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O91.1 Abscess of breast associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O91.2 Nonpurulent mastitis associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92 Other disorders of breast and lactation associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.0 Retracted nipple associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.1 Cracked nipple associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.2 Other and unspecified disorders of breast associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.3 Agalactia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.4 Hypogalactia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.5 Suppressed lactation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.6 Galactorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.7 Other and unspecified disorders of lactation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O94 Sequelae of complication of pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O95 Obstetric death of unspecified cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O96.0 Death from direct obstetric cause occurring more than 42 days but less than one year after delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O96.1 Death from indirect obstetric cause occurring more than 42 days but less than one year after delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O96.9 Death from unspecified obstetric cause occurring more than 42 days but less than one year after delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O97 Death from sequelae of obstetric causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O97.0 Death from sequelae of direct obstetric cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O97.1 Death from sequelae of indirect obstetric cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O97.9 Death from sequelae of obstetric cause, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 428 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.0 Tuberculosis complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.1 Syphilis complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.2 Gonorrhoea complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.3 Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.4 Viral hepatitis complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.5 Other viral diseases complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.6 Protozoal diseases complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.7 Human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.8 Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.9 Unspecified maternal infectious or parasitic disease complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.0 Anaemia complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 429 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00 Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.0 Fetus and newborn affected by maternal hypertensive disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.1 Fetus and newborn affected by maternal renal and urinary tract diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.2 Fetus and newborn affected by maternal infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.3 Fetus and newborn affected by other maternal circulatory and respiratory diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.4 Fetus and newborn affected by maternal nutritional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.5 Fetus and newborn affected by maternal injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.6 Fetus and newborn affected by surgical procedure on mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.7 Fetus and newborn affected by other medical procedures on mother, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.8 Fetus and newborn affected by other maternal conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.9 Fetus and newborn affected by unspecified maternal condition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01 Fetus and newborn affected by maternal complications of pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.0 Fetus and newborn affected by incompetent cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.1 Fetus and newborn affected by premature rupture of membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.2 Fetus and newborn affected by oligohydramnios 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.3 Fetus and newborn affected by polyhydramnios 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.4 Fetus and newborn affected by ectopic pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.5 Fetus and newborn affected by multiple pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.6 Fetus and newborn affected by maternal death

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 430 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.7 Fetus and newborn affected by malpresentation before labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.8 Fetus and newborn affected by other maternal complications of pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.9 Fetus and newborn affected by maternal complication of pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02 Fetus and newborn affected by complications of placenta, cord and membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.0 Fetus and newborn affected by placenta praevia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.1 Fetus and newborn affected by other forms of placental separation and haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.2 Fetus and newborn affected by other and unspecified morphological and functional abnormalities of placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.3 Fetus and newborn affected by placental transfusion syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.4 Fetus and newborn affected by prolapsed cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.5 Fetus and newborn affected by other compression of umbilical cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.6 Fetus and newborn affected by other and unspecified conditions of umbilical cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.7 Fetus and newborn affected by chorioamnionitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.8 Fetus and newborn affected by other abnormalities of membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.9 Fetus and newborn affected by abnormality of membranes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03 Fetus and newborn affected by other complications of labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.0 Fetus and newborn affected by breech delivery and extraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.1 Fetus and newborn affected by other malpresentation, malposition and disproportion during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.2 Fetus and newborn affected by forceps delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.3 Fetus and newborn affected by delivery by vacuum extractor [ventouse] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.4 Fetus and newborn affected by caesarean delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.5 Fetus and newborn affected by precipitate delivery

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 431 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.6 Fetus and newborn affected by abnormal uterine contractions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.8 Fetus and newborn affected by other specified complications of labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.9 Fetus and newborn affected by complication of labour and delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04 Fetus and newborn affected by noxious influences transmitted via placenta or breast milk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.0 Fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.1 Fetus and newborn affected by other maternal medication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.2 Fetus and newborn affected by maternal use of tobacco 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.3 Fetus and newborn affected by maternal use of alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.4 Fetus and newborn affected by maternal use of drugs of addiction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.5 Fetus and newborn affected by maternal use of nutritional chemical substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.6 Fetus and newborn affected by maternal exposure to environmental chemical substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.8 Fetus and newborn affected by other maternal noxious influences 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.9 Fetus and newborn affected by maternal noxious influence, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05 Slow fetal growth and fetal malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05.0 Light for gestational age 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05.1 Small for gestational age 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05.2 Fetal malnutrition without mention of light or small for gestational age 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05.9 Slow fetal growth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P07 Disorders related to short gestation and low birth weight, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P07.0 Extremely low birth weight 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P07.1 Other low birth weight 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P07.2 Extreme immaturity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P07.3 Other preterm infants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P08 Disorders related to long gestation and high birth weight 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P08.0 Exceptionally large baby 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P08.1 Other heavy for gestational age infants

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 432 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P08.2 Post-term infant, not heavy for gestational age 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10 Intracranial laceration and haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.0 Subdural haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.1 Cerebral haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.2 Intraventricular haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.3 Subarachnoid haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.4 Tentorial tear due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.8 Other intracranial lacerations and haemorrhages due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.9 Unspecified intracranial laceration and haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11 Other birth injuries to central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.0 Cerebral oedema due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.1 Other specified brain damage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.2 Unspecified brain damage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.3 Birth injury to facial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.4 Birth injury to other cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.5 Birth injury to spine and spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.9 Birth injury to central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12 Birth injury to scalp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.0 Cephalhaematoma due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.1 Chignon due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.2 Epicranial subaponeurotic haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.3 Bruising of scalp due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.4 Monitoring injury of scalp of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.8 Other birth injuries to scalp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.9 Birth injury to scalp, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13 Birth injury to skeleton 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.0 Fracture of skull due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.1 Other birth injuries to skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.2 Birth injury to femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.3 Birth injury to other long bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.4 Fracture of clavicle due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.8 Birth injuries to other parts of skeleton

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 433 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.9 Birth injury to skeleton, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14 Birth injury to peripheral nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.0 Erb paralysis due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.1 Klumpke paralysis due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.2 Phrenic nerve paralysis due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.3 Other brachial plexus birth injuries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.8 Birth injuries to other parts of peripheral nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.9 Birth injury to peripheral nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15 Other birth injuries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.0 Birth injury to liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.1 Birth injury to spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.2 Sternomastoid injury due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.3 Birth injury to eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.4 Birth injury to face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.5 Birth injury to external genitalia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.6 Subcutaneous fat necrosis due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.8 Other specified birth injuries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.9 Birth injury, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P20 Intrauterine hypoxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P20.0 Intrauterine hypoxia first noted before onset of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P20.1 Intrauterine hypoxia first noted during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P20.9 Intrauterine hypoxia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P21 Birth asphyxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P21.0 Severe birth asphyxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P21.1 Mild and moderate birth asphyxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P21.9 Birth asphyxia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P22 Respiratory distress of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P22.0 Respiratory distress syndrome of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P22.1 Transient tachypnoea of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P22.8 Other respiratory distress of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P22.9 Respiratory distress of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23 Congenital pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.0 Congenital pneumonia due to viral agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.1 Congenital pneumonia due to Chlamydia

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 434 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.2 Congenital pneumonia due to staphylococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.3 Congenital pneumonia due to streptococcus, group B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.4 Congenital pneumonia due to Escherichia coli 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.5 Congenital pneumonia due to Pseudomonas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.6 Congenital pneumonia due to other bacterial agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.8 Congenital pneumonia due to other organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.9 Congenital pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24 Neonatal aspiration syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.0 Neonatal aspiration of meconium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.1 Neonatal aspiration of amniotic fluid and mucus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.2 Neonatal aspiration of blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.3 Neonatal aspiration of milk and regurgitated food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.8 Other neonatal aspiration syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.9 Neonatal aspiration syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25 Interstitial emphysema and related conditions originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25.0 Interstitial emphysema originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25.1 Pneumothorax originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25.2 Pneumomediastinum originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25.3 Pneumopericardium originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25.8 Other conditions related to interstitial emphysema originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P26 Pulmonary haemorrhage originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P26.0 Tracheobronchial haemorrhage originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P26.1 Massive pulmonary haemorrhage originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P26.8 Other pulmonary haemorrhages originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P26.9 Unspecified pulmonary haemorrhage originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P27 Chronic respiratory disease originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P27.0 Wilson-Mikity syndrome

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 435 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P27.1 Bronchopulmonary dysplasia originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P27.8 Other chronic respiratory diseases originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P27.9 Unspecified chronic respiratory disease originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28 Other respiratory conditions originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.0 Primary atelectasis of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.1 Other and unspecified atelectasis of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.2 Cyanotic attacks of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.3 Primary sleep apnoea of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.4 Other apnoea of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.5 Respiratory failure of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.8 Other specified respiratory conditions of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.9 Respiratory condition of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29 Cardiovascular disorders originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.0 Neonatal cardiac failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.1 Neonatal cardiac dysrhythmia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.2 Neonatal hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.3 Persistent fetal circulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.4 Transient myocardial ischaemia of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.8 Other cardiovascular disorders originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.9 Cardiovascular disorder originating in the perinatal period, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35 Congenital viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.0 Congenital rubella syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.1 Congenital cytomegalovirus infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.2 Congenital herpesviral [herpes simplex] infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.3 Congenital viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.8 Other congenital viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.9 Congenital viral disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36 Bacterial sepsis of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.0 Sepsis of newborn due to streptococcus, group B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.1 Sepsis of newborn due to other and unspecified streptococci 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.2 Sepsis of newborn due to Staphylococcus aureus

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 436 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.3 Sepsis of newborn due to other and unspecified staphylococci 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.4 Sepsis of newborn due to Escherichia coli 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.5 Sepsis of newborn due to anaerobes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.8 Other bacterial sepsis of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.9 Bacterial sepsis of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37 Other congenital infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.0 Congenital tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.1 Congenital toxoplasmosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.2 Neonatal (disseminated) listeriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.3 Congenital falciparum malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.4 Other congenital malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.5 Neonatal candidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.8 Other specified congenital infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.9 Congenital infectious and parasitic disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P38 Omphalitis of newborn with or without mild haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39 Other infections specific to the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.0 Neonatal infective mastitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.1 Neonatal conjunctivitis and dacryocystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.2 Intra-amniotic infection of fetus, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.3 Neonatal urinary tract infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.4 Neonatal skin infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.8 Other specified infections specific to the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.9 Infection specific to the perinatal period, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50 Fetal blood loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.0 Fetal blood loss from vasa praevia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.1 Fetal blood loss from ruptured cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.2 Fetal blood loss from placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.3 Haemorrhage into co-twin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.4 Haemorrhage into maternal circulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.5 Fetal blood loss from cut end of co- twin's cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.8 Other fetal blood loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.9 Fetal blood loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P51 Umbilical haemorrhage of newborn

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 437 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P51.0 Massive umbilical haemorrhage of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P51.8 Other umbilical haemorrhages of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P51.9 Umbilical haemorrhage of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52 Intracranial nontraumatic haemorrhage of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.0 Intraventricular (nontraumatic) haemorrhage, grade 1, of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.1 Intraventricular (nontraumatic) haemorrhage, grade 2, of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.2 Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.3 Unspecified intraventricular (nontraumatic) haemorrhage of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.4 Intracerebral (nontraumatic) haemorrhage of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.5 Subarachnoid (nontraumatic) haemorrhage of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.6 Cerebellar (nontraumatic) and posterior fossa haemorrhage of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.8 Other intracranial (nontraumatic) haemorrhages of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.9 Intracranial (nontraumatic) haemorrhage of fetus and newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P53 Haemorrhagic disease of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54 Other neonatal haemorrhages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.0 Neonatal haematemesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.1 Neonatal melaena 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.2 Neonatal rectal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.3 Other neonatal gastrointestinal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.4 Neonatal adrenal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.5 Neonatal cutaneous haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.6 Neonatal vaginal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.8 Other specified neonatal haemorrhages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.9 Neonatal haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P55 Haemolytic disease of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P55.0 Rh isoimmunization of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P55.1 ABO isoimmunization of fetus and newborn

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 438 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P55.8 Other haemolytic diseases of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P55.9 Haemolytic disease of fetus and newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P56 Hydrops fetalis due to haemolytic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P56.0 Hydrops fetalis due to isoimmunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P56.9 Hydrops fetalis due to other and unspecified haemolytic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P57 Kernicterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P57.0 Kernicterus due to isoimmunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P57.8 Other specified kernicterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P57.9 Kernicterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58 Neonatal jaundice due to other excessive haemolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.0 Neonatal jaundice due to bruising 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.1 Neonatal jaundice due to bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.2 Neonatal jaundice due to infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.3 Neonatal jaundice due to polycythaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.4 Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.5 Neonatal jaundice due to swallowed maternal blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.8 Neonatal jaundice due to other specified excessive haemolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.9 Neonatal jaundice due to excessive haemolysis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59 Neonatal jaundice from other and unspecified causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.0 Neonatal jaundice associated with preterm delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.1 Inspissated bile syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.2 Neonatal jaundice from other and unspecified hepatocellular damage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.3 Neonatal jaundice from breast milk inhibitor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.8 Neonatal jaundice from other specified causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.9 Neonatal jaundice, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P60 Disseminated intravascular coagulation of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61 Other perinatal haematological disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.0 Transient neonatal thrombocytopenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.1 Polycythaemia neonatorum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.2 Anaemia of prematurity

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 439 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.3 Congenital anaemia from fetal blood loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.4 Other congenital anaemias, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.5 Transient neonatal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.6 Other transient neonatal disorders of coagulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.8 Other specified perinatal haematological disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.9 Perinatal haematological disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70 Transitory disorders of carbohydrate metabolism specific to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.0 Syndrome of infant of mother with gestational diabetes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.1 Syndrome of infant of a diabetic mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.2 Neonatal diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.3 Iatrogenic neonatal hypoglycaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.4 Other neonatal hypoglycaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.8 Other transitory disorders of carbohydrate metabolism of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.9 Transitory disorder of carbohydrate metabolism of fetus and newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71 Transitory neonatal disorders of calcium and magnesium metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.0 Cow milk hypocalcaemia in newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.1 Other neonatal hypocalcaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.2 Neonatal hypomagnesaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.3 Neonatal tetany without calcium or magnesium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.4 Transitory neonatal hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.8 Other transitory neonatal disorders of calcium and magnesium metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.9 Transitory neonatal disorder of calcium and magnesium metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72 Other transitory neonatal endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72.0 Neonatal goitre, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72.1 Transitory neonatal hyperthyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72.2 Other transitory neonatal disorders of thyroid function, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72.8 Other specified transitory neonatal endocrine disorders

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 440 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72.9 Transitory neonatal endocrine disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74 Other transitory neonatal electrolyte and metabolic disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.0 Late metabolic acidosis of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.1 Dehydration of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.2 Disturbances of sodium balance of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.3 Disturbances of potassium balance of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.4 Other transitory electrolyte disturbances of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.5 Transitory tyrosinaemia of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.8 Other transitory metabolic disturbances of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.9 Transitory metabolic disturbance of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P75 Meconium ileus in cystic fibrosisE84.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76 Other intestinal obstruction of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76.0 Meconium plug syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76.1 Transitory ileus of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76.2 Intestinal obstruction due to inspissated milk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76.8 Other specified intestinal obstruction of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76.9 Intestinal obstruction of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P77 Necrotizing enterocolitis of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78 Other perinatal digestive system disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.0 Perinatal intestinal perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.1 Other neonatal peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.2 Neonatal haematemesis and melaena due to swallowed maternal blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.3 Noninfective neonatal diarrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.8 Other specified perinatal digestive system disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.9 Perinatal digestive system disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P80 Hypothermia of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P80.0 Cold injury syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P80.8 Other hypothermia of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P80.9 Hypothermia of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P81 Other disturbances of temperature regulation of newborn

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 441 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P81.0 Environmental hyperthermia of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P81.8 Other specified disturbances of temperature regulation of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P81.9 Disturbance of temperature regulation of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83 Other conditions of integument specific to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.0 Sclerema neonatorum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.1 Neonatal erythema toxicum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.2 Hydrops fetalis not due to haemolytic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.3 Other and unspecified oedema specific to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.4 Breast engorgement of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.5 Congenital hydrocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.6 Umbilical polyp of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.8 Other specified conditions of integument specific to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.9 Condition of integument specific to fetus and newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P90 Convulsions of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91 Other disturbances of cerebral status of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.0 Neonatal cerebral ischaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.1 Acquired periventricular cysts of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.2 Neonatal cerebral leukomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.3 Neonatal cerebral irritability 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.4 Neonatal cerebral depression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.5 Neonatal coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.6 Hypoxic ischaemic encephalopathy of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.7 Acquired hydrocephalus of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.8 Other specified disturbances of cerebral status of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.9 Disturbance of cerebral status of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92 Feeding problems of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.0 Vomiting in newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.1 Regurgitation and rumination in newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.2 Slow feeding of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.3 Underfeeding of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.4 Overfeeding of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.5 Neonatal difficulty in feeding at breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.8 Other feeding problems of newborn © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 442 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.9 Feeding problem of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P93 Reactions and intoxications due to drugs administered to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94 Disorders of muscle tone of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94.0 Transient neonatal myasthenia gravis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94.1 Congenital hypertonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94.2 Congenital hypotonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94.8 Other disorders of muscle tone of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94.9 Disorder of muscle tone of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P95 Fetal death of unspecified cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96 Other conditions originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.0 Congenital renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.1 Neonatal withdrawal symptoms from maternal use of drugs of addiction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.2 Withdrawal symptoms from therapeutic use of drugs in newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.3 Wide cranial sutures of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.4 Termination of pregnancy, affecting fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.5 Complications of intrauterine procedures, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.8 Other specified conditions originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.9 Condition originating in the perinatal period, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q00 Anencephaly and similar malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q00.0 Anencephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q00.1 Craniorachischisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q00.2 Iniencephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01 Encephalocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01.0 Frontal encephalocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01.1 Nasofrontal encephalocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01.2 Occipital encephalocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01.8 Encephalocele of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01.9 Encephalocele, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q02 Microcephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q03 Congenital hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q03.0 Malformations of aqueduct of Sylvius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q03.1 Atresia of foramina of Magendie and Luschka

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 443 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q03.8 Other congenital hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q03.9 Congenital hydrocephalus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04 Other congenital malformations of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.0 Congenital malformations of corpus callosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.1 Arhinencephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.2 Holoprosencephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.3 Other reduction deformities of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.4 Septo-optic dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.5 Megalencephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.6 Congenital cerebral cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.8 Other specified congenital malformations of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.9 Congenital malformation of brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05 Spina bifida 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.0 Cervical spina bifida with hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.1 Thoracic spina bifida with hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.2 Lumbar spina bifida with hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.3 Sacral spina bifida with hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.4 Unspecified spina bifida with hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.5 Cervical spina bifida without hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.6 Thoracic spina bifida without hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.7 Lumbar spina bifida without hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.8 Sacral spina bifida without hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.9 Spina bifida, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06 Other congenital malformations of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.0 Amyelia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.1 Hypoplasia and dysplasia of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.2 Diastematomyelia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.3 Other congenital cauda equina malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.4 Hydromyelia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.8 Other specified congenital malformations of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.9 Congenital malformation of spinal cord, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 444 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q07 Other congenital malformations of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q07.0 Arnold-Chiari syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q07.8 Other specified congenital malformations of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q07.9 Congenital malformation of nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10 Congenital malformations of eyelid, lacrimal apparatus and orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.0 Congenital ptosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.1 Congenital ectropion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.2 Congenital entropion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.3 Other congenital malformations of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.4 Absence and agenesis of lacrimal apparatus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.5 Congenital stenosis and stricture of lacrimal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.6 Other congenital malformations of lacrimal apparatus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.7 Congenital malformation of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q11 Anophthalmos, microphthalmos and macrophthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q11.0 Cystic eyeball 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q11.1 Other anophthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q11.2 Microphthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q11.3 Macrophthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12 Congenital lens malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.0 Congenital cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.1 Congenital displaced lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.2 Coloboma of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.3 Congenital aphakia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.4 Spherophakia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.8 Other congenital lens malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.9 Congenital lens malformation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13 Congenital malformations of anterior segment of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.0 Coloboma of iris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.1 Absence of iris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.2 Other congenital malformations of iris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.3 Congenital corneal opacity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.4 Other congenital corneal malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.5 Blue sclera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.8 Other congenital malformations of anterior segment of eye

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 445 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.9 Congenital malformation of anterior segment of eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14 Congenital malformations of posterior segment of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.0 Congenital malformation of vitreous humour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.1 Congenital malformation of retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.2 Congenital malformation of optic disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.3 Congenital malformation of choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.8 Other congenital malformations of posterior segment of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.9 Congenital malformation of posterior segment of eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q15 Other congenital malformations of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q15.0 Congenital glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q15.8 Other specified congenital malformations of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q15.9 Congenital malformation of eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16 Congenital malformations of ear causing impairment of hearing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.0 Congenital absence of (ear) auricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.1 Congenital absence, atresia and stricture of auditory canal (external) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.2 Absence of eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.3 Congenital malformation of ear ossicles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.4 Other congenital malformations of middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.5 Congenital malformation of inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.9 Congenital malformation of ear causing impairment of hearing, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17 Other congenital malformations of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.0 Accessory auricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.1 Macrotia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.2 Microtia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.3 Other misshapen ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.4 Misplaced ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.5 Prominent ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.8 Other specified congenital malformations of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.9 Congenital malformation of ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18 Other congenital malformations of face and neck

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 446 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.0 Sinus, fistula and cyst of branchial cleft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.1 Preauricular sinus and cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.2 Other branchial cleft malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.3 Webbing of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.4 Macrostomia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.5 Microstomia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.6 Macrocheilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.7 Microcheilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.8 Other specified congenital malformations of face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.9 Congenital malformation of face and neck, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20 Congenital malformations of cardiac chambers and connections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.0 Common arterial trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.1 Double outlet right ventricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.2 Double outlet left ventricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.3 Discordant ventriculoarterial connection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.4 Double inlet ventricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.5 Discordant atrioventricular connection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.6 Isomerism of atrial appendages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.8 Other congenital malformations of cardiac chambers and connections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.9 Congenital malformation of cardiac chambers and connections, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21 Congenital malformations of cardiac septa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.0 Ventricular septal defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.1 Atrial septal defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.2 Atrioventricular septal defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.3 Tetralogy of Fallot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.4 Aortopulmonary septal defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.8 Other congenital malformations of cardiac septa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.9 Congenital malformation of cardiac septum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22 Congenital malformations of pulmonary and tricuspid valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.0 Pulmonary valve atresia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.1 Congenital pulmonary valve stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.2 Congenital pulmonary valve insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.3 Other congenital malformations of pulmonary valve © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 447 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.4 Congenital tricuspid stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.5 Ebstein anomaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.6 Hypoplastic right heart syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.8 Other congenital malformations of tricuspid valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.9 Congenital malformation of tricuspid valve, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23 Congenital malformations of aortic and mitral valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.0 Congenital stenosis of aortic valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.1 Congenital insufficiency of aortic valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.2 Congenital mitral stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.3 Congenital mitral insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.4 Hypoplastic left heart syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.8 Other congenital malformations of aortic and mitral valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.9 Congenital malformation of aortic and mitral valves, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24 Other congenital malformations of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.0 Dextrocardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.1 Laevocardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.2 Cor triatriatum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.3 Pulmonary infundibular stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.4 Congenital subaortic stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.5 Malformation of coronary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.6 Congenital heart block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.8 Other specified congenital malformations of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.9 Congenital malformation of heart, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25 Congenital malformations of great arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.0 Patent ductus arteriosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.1 Coarctation of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.2 Atresia of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.3 Stenosis of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.4 Other congenital malformations of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.5 Atresia of pulmonary artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.6 Stenosis of pulmonary artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.7 Other congenital malformations of pulmonary artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.8 Other congenital malformations of great arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.9 Congenital malformation of great arteries, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 448 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26 Congenital malformations of great veins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.0 Congenital stenosis of vena cava 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.1 Persistent left superior vena cava 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.2 Total anomalous pulmonary venous connection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.3 Partial anomalous pulmonary venous connection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.4 Anomalous pulmonary venous connection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.5 Anomalous portal venous connection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.6 Portal vein-hepatic artery fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.8 Other congenital malformations of great veins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.9 Congenital malformation of great vein, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27 Other congenital malformations of peripheral vascular system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.0 Congenital absence and hypoplasia of umbilical artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.1 Congenital renal artery stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.2 Other congenital malformations of renal artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.3 Peripheral arteriovenous malformation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.4 Congenital phlebectasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.8 Other specified congenital malformations of peripheral vascular system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.9 Congenital malformation of peripheral vascular system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28 Other congenital malformations of circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.0 Arteriovenous malformation of precerebral vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.1 Other malformations of precerebral vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.2 Arteriovenous malformation of cerebral vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.3 Other malformations of cerebral vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.8 Other specified congenital malformations of circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.9 Congenital malformation of circulatory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30 Congenital malformations of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.0 Choanal atresia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.1 Agenesis and underdevelopment of nose

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 449 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.2 Fissured, notched and cleft nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.3 Congenital perforated nasal septum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.8 Other congenital malformations of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.9 Congenital malformation of nose, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31 Congenital malformations of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.0 Web of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.1 Congenital subglottic stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.2 Laryngeal hypoplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.3 Laryngocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.5 Congenital laryngomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.8 Other congenital malformations of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.9 Congenital malformation of larynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32 Congenital malformations of trachea and bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32.0 Congenital tracheomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32.1 Other congenital malformations of trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32.2 Congenital bronchomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32.3 Congenital stenosis of bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32.4 Other congenital malformations of bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33 Congenital malformations of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.0 Congenital cystic lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.1 Accessory lobe of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.2 Sequestration of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.3 Agenesis of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.4 Congenital bronchiectasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.5 Ectopic tissue in lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.6 Hypoplasia and dysplasia of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.8 Other congenital malformations of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.9 Congenital malformation of lung, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q34 Other congenital malformations of respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q34.0 Anomaly of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q34.1 Congenital cyst of mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q34.8 Other specified congenital malformations of respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q34.9 Congenital malformation of respiratory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35 Cleft palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35.1 Cleft hard palate

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 450 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35.3 Cleft soft palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35.5 Cleft hard palate with cleft soft palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35.7 Cleft uvula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35.9 Cleft palate, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q36 Cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q36.0 Cleft lip, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q36.1 Cleft lip, median 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q36.9 Cleft lip, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37 Cleft palate with cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.0 Cleft hard palate with bilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.1 Cleft hard palate with unilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.2 Cleft soft palate with bilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.3 Cleft soft palate with unilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.4 Cleft hard and soft palate with bilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.5 Cleft hard and soft palate with unilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.8 Unspecified cleft palate with bilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.9 Unspecified cleft palate with unilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38 Other congenital malformations of tongue, mouth and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.0 Congenital malformations of lips, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.1 Ankyloglossia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.2 Macroglossia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.3 Other congenital malformations of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.4 Congenital malformations of salivary glands and ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.5 Congenital malformations of palate, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.6 Other congenital malformations of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.7 Pharyngeal pouch 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.8 Other congenital malformations of pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39 Congenital malformations of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.0 Atresia of oesophagus without fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.1 Atresia of oesophagus with tracheo- oesophageal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.2 Congenital tracheo-oesophageal fistula without atresia © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 451 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.3 Congenital stenosis and stricture of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.4 Oesophageal web 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.5 Congenital dilatation of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.6 Diverticulum of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.8 Other congenital malformations of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.9 Congenital malformation of oesophagus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40 Other congenital malformations of upper alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.0 Congenital hypertrophic pyloric stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.1 Congenital hiatus hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.2 Other specified congenital malformations of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.3 Congenital malformation of stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.8 Other specified congenital malformations of upper alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.9 Congenital malformation of upper alimentary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41 Congenital absence, atresia and stenosis of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41.0 Congenital absence, atresia and stenosis of duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41.1 Congenital absence, atresia and stenosis of jejunum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41.2 Congenital absence, atresia and stenosis of ileum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41.8 Congenital absence, atresia and stenosis of other specified parts of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41.9 Congenital absence, atresia and stenosis of small intestine, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42 Congenital absence, atresia and stenosis of large intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.0 Congenital absence, atresia and stenosis of rectum with fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.1 Congenital absence, atresia and stenosis of rectum without fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.2 Congenital absence, atresia and stenosis of anus with fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.3 Congenital absence, atresia and stenosis of anus without fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.8 Congenital absence, atresia and stenosis of other parts of large intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.9 Congenital absence, atresia and stenosis of large intestine, part unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 452 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43 Other congenital malformations of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.0 Meckel diverticulum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.1 Hirschsprung disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.2 Other congenital functional disorders of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.3 Congenital malformations of intestinal fixation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.4 Duplication of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.5 Ectopic anus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.6 Congenital fistula of rectum and anus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.7 Persistent cloaca 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.8 Other specified congenital malformations of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.9 Congenital malformation of intestine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44 Congenital malformations of gallbladder, bile ducts and liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.0 Agenesis, aplasia and hypoplasia of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.1 Other congenital malformations of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.2 Atresia of bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.3 Congenital stenosis and stricture of bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.4 Choledochal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.5 Other congenital malformations of bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.6 Cystic disease of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.7 Other congenital malformations of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45 Other congenital malformations of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.0 Agenesis, aplasia and hypoplasia of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.1 Annular pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.2 Congenital pancreatic cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.3 Other congenital malformations of pancreas and pancreatic duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.8 Other specified congenital malformations of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.9 Congenital malformation of digestive system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50 Congenital malformations of ovaries, fallopian tubes and broad ligaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.0 Congenital absence of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.1 Developmental ovarian cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.2 Congenital torsion of ovary © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 453 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.3 Other congenital malformations of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.4 Embryonic cyst of fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.5 Embryonic cyst of broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.6 Other congenital malformations of fallopian tube and broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51 Congenital malformations of uterus and cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.0 Agenesis and aplasia of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.1 Doubling of uterus with doubling of cervix and vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.2 Other doubling of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.3 Bicornate uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.4 Unicornate uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.5 Agenesis and aplasia of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.6 Embryonic cyst of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.7 Congenital fistulae between uterus and digestive and urinary tracts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.8 Other congenital malformations of uterus and cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.9 Congenital malformation of uterus and cervix, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52 Other congenital malformations of female genitalia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.0 Congenital absence of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.1 Doubling of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.2 Congenital rectovaginal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.3 Imperforate hymen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.4 Other congenital malformations of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.5 Fusion of labia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.6 Congenital malformation of clitoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.7 Other congenital malformations of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.8 Other specified congenital malformations of female genitalia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.9 Congenital malformation of female genitalia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q53 Undescended testicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q53.0 Ectopic testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q53.1 Undescended testicle, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q53.2 Undescended testicle, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q53.9 Undescended testicle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54 Hypospadias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.0 Hypospadias, balanic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.1 Hypospadias, penile 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.2 Hypospadias, penoscrotal

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 454 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.3 Hypospadias, perineal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.4 Congenital chordee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.8 Other hypospadias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.9 Hypospadias, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55 Other congenital malformations of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.0 Absence and aplasia of testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.1 Hypoplasia of testis and scrotum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.2 Other congenital malformations of testis and scrotum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.3 Atresia of vas deferens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.4 Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.5 Congenital absence and aplasia of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.6 Other congenital malformations of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.8 Other specified congenital malformations of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.9 Congenital malformation of male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56 Indeterminate sex and pseudohermaphroditism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56.0 Hermaphroditism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56.1 Male pseudohermaphroditism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56.2 Female pseudohermaphroditism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56.3 Pseudohermaphroditism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56.4 Indeterminate sex, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60 Renal agenesis and other reduction defects of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.0 Renal agenesis, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.1 Renal agenesis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.2 Renal agenesis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.3 Renal hypoplasia, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.4 Renal hypoplasia, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.5 Renal hypoplasia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.6 Potter syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61 Cystic kidney disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.0 Congenital single renal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.1 Polycystic kidney, autosomal recessive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.2 Polycystic kidney, autosomal dominant

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 455 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.3 Polycystic kidney, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.4 Renal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.5 Medullary cystic kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.8 Other cystic kidney diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.9 Cystic kidney disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.0 Congenital hydronephrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.1 Atresia and stenosis of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.2 Congenital megaloureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.3 Other obstructive defects of renal pelvis and ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.4 Agenesis of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.5 Duplication of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.6 Malposition of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.7 Congenital vesico-uretero-renal reflux 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.8 Other congenital malformations of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63 Other congenital malformations of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.0 Accessory kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.1 Lobulated, fused and horseshoe kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.2 Ectopic kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.3 Hyperplastic and giant kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.8 Other specified congenital malformations of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.9 Congenital malformation of kidney, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64 Other congenital malformations of urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.0 Epispadias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.1 Exstrophy of urinary bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.2 Congenital posterior urethral valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.3 Other atresia and stenosis of urethra and bladder neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.4 Malformation of urachus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.5 Congenital absence of bladder and urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.6 Congenital diverticulum of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.7 Other congenital malformations of bladder and urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.8 Other specified congenital malformations of urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.9 Congenital malformation of urinary system, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 456 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65 Congenital deformities of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.0 Congenital dislocation of hip, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.1 Congenital dislocation of hip, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.2 Congenital dislocation of hip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.3 Congenital subluxation of hip, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.4 Congenital subluxation of hip, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.5 Congenital subluxation of hip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.6 Unstable hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.8 Other congenital deformities of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.9 Congenital deformity of hip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66 Congenital deformities of feet 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.0 Talipes equinovarus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.1 Talipes calcaneovarus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.2 Metatarsus varus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.3 Other congenital varus deformities of feet 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.4 Talipes calcaneovalgus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.5 Congenital pes planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.6 Other congenital valgus deformities of feet 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.7 Pes cavus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.8 Other congenital deformities of feet 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.9 Congenital deformity of feet, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67 Congenital musculoskeletal deformities of head, face, spine and chest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.0 Facial asymmetry 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.1 Compression facies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.2 Dolichocephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.3 Plagiocephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.4 Other congenital deformities of skull, face and jaw 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.5 Congenital deformity of spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.6 Pectus excavatum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.7 Pectus carinatum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.8 Other congenital deformities of chest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68 Other congenital musculoskeletal deformities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.0 Congenital deformity of sternocleidomastoid muscle © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 457 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.1 Congenital deformity of hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.2 Congenital deformity of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.3 Congenital bowing of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.4 Congenital bowing of tibia and fibula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.5 Congenital bowing of long bones of leg, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.8 Other specified congenital musculoskeletal deformities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q69 Polydactyly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q69.0 Accessory finger(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q69.1 Accessory thumb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q69.2 Accessory toe(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q69.9 Polydactyly, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70 Syndactyly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.0 Fused fingers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.1 Webbed fingers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.2 Fused toes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.3 Webbed toes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.4 Polysyndactyly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.9 Syndactyly, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71 Reduction defects of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.0 Congenital complete absence of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.1 Congenital absence of upper arm and forearm with hand present 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.2 Congenital absence of both forearm and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.3 Congenital absence of hand and finger(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.4 Longitudinal reduction defect of radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.5 Longitudinal reduction defect of ulna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.6 Lobster-claw hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.8 Other reduction defects of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.9 Reduction defect of upper limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72 Reduction defects of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.0 Congenital complete absence of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.1 Congenital absence of thigh and lower leg with foot present 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.2 Congenital absence of both lower leg and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.3 Congenital absence of foot and toe(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.4 Longitudinal reduction defect of femur

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 458 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.5 Longitudinal reduction defect of tibia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.6 Longitudinal reduction defect of fibula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.7 Split foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.8 Other reduction defects of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.9 Reduction defect of lower limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q73 Reduction defects of unspecified limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q73.0 Congenital absence of unspecified limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q73.1 Phocomelia, unspecified limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q73.8 Other reduction defects of unspecified limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74 Other congenital malformations of limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.0 Other congenital malformations of upper limb(s), including shoulder girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.1 Congenital malformation of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.2 Other congenital malformations of lower limb(s), including pelvic girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.3 Arthrogryposis multiplex congenita 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.8 Other specified congenital malformations of limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.9 Unspecified congenital malformation of limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75 Other congenital malformations of skull and face bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.0 Craniosynostosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.1 Craniofacial dysostosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.2 Hypertelorism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.3 Macrocephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.4 Mandibulofacial dysostosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.5 Oculomandibular dysostosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.8 Other specified congenital malformations of skull and face bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.9 Congenital malformation of skull and face bones, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76 Congenital malformations of spine and bony thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.0 Spina bifida occulta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.1 Klippel-Feil syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.2 Congenital spondylolisthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.3 Congenital scoliosis due to congenital bony malformation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.4 Other congenital malformations of spine, not associated with scoliosis © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 459 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.5 Cervical rib 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.6 Other congenital malformations of ribs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.7 Congenital malformation of sternum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.8 Other congenital malformations of bony thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.9 Congenital malformation of bony thorax, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77 Osteochondrodysplasia with defects of growth of tubular bones and spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.0 Achondrogenesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.1 Thanatophoric short stature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.2 Short rib syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.3 Chondrodysplasia punctata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.4 Achondroplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.5 Dystrophic dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.6 Chondroectodermal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.7 Spondyloepiphyseal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.8 Other osteochondrodysplasia with defects of growth of tubular bones and spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.9 Osteochondrodysplasia with defects of growth of tubular bones and spine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78 Other osteochondrodysplasias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.0 Osteogenesis imperfecta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.1 Polyostotic fibrous dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.2 Osteopetrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.3 Progressive diaphyseal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.4 Enchondromatosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.5 Metaphyseal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.6 Multiple congenital exostoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.8 Other specified osteochondrodysplasias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.9 Osteochondrodysplasia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79 Congenital malformations of the musculoskeletal system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.0 Congenital diaphragmatic hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.1 Other congenital malformations of diaphragm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.2 Exomphalos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.3 Gastroschisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.4 Prune belly syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.5 Other congenital malformations of abdominal wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.6 Ehlers-Danlos syndrome

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 460 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.8 Other congenital malformations of musculoskeletal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.9 Congenital malformation of musculoskeletal system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80 Congenital ichthyosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.0 Ichthyosis vulgaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.1 X-linked ichthyosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.2 Lamellar ichthyosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.3 Congenital bullous ichthyosiform erythroderma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.4 Harlequin fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.8 Other congenital ichthyosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.9 Congenital ichthyosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81 Epidermolysis bullosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81.0 Epidermolysis bullosa simplex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81.1 Epidermolysis bullosa letalis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81.2 Epidermolysis bullosa dystrophica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81.8 Other epidermolysis bullosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81.9 Epidermolysis bullosa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82 Other congenital malformations of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.0 Hereditary lymphoedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.2 Mastocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.3 Incontinentia pigmenti 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.4 Ectodermal dysplasia (anhidrotic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.5 Congenital non-neoplastic naevus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.8 Other specified congenital malformations of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.9 Congenital malformation of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83 Congenital malformations of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.0 Congenital absence of breast with absent nipple 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.1 Accessory breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.2 Absent nipple 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.3 Accessory nipple 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.8 Other congenital malformations of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.9 Congenital malformation of breast, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84 Other congenital malformations of integument 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.0 Congenital alopecia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.1 Congenital morphological disturbances of hair, not elsewhere classified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 461 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.2 Other congenital malformations of hair 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.3 Anonychia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.4 Congenital leukonychia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.5 Enlarged and hypertrophic nails 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.6 Other congenital malformations of nails 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.8 Other specified congenital malformations of integument 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.9 Congenital malformation of integument, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q85 Phakomatoses, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q85.0 Neurofibromatosis (nonmalignant) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q85.1 Tuberous sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q85.8 Other phakomatoses, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q85.9 Phakomatosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q86.0 Fetal alcohol syndrome (dysmorphic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q86.1 Fetal hydantoin syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q86.2 Dysmorphism due to warfarin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q86.8 Other congenital malformation syndromes due to known exogenous causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87 Other specified congenital malformation syndromes affecting multiple systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.0 Congenital malformation syndromes predominantly affecting facial appearance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.1 Congenital malformation syndromes predominantly associated with short stature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.2 Congenital malformation syndromes predominantly involving limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.3 Congenital malformation syndromes involving early overgrowth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.4 Marfan syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.5 Other congenital malformation syndromes with other skeletal changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.8 Other specified congenital malformation syndromes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89 Other congenital malformations, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.0 Congenital malformations of spleen

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 462 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.1 Congenital malformations of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.2 Congenital malformations of other endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.3 Situs inversus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.4 Conjoined twins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.7 Multiple congenital malformations, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.8 Other specified congenital malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.9 Congenital malformation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90 Down syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90.0 Trisomy 21, meiotic nondisjunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90.1 Trisomy 21, mosaicism (mitotic nondisjunction) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90.2 Trisomy 21, translocation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90.9 Down syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91 Edwards syndrome and Patau syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.0 Trisomy 18, meiotic nondisjunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.1 Trisomy 18, mosaicism (mitotic nondisjunction) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.2 Trisomy 18, translocation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.3 Edwards syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.4 Trisomy 13, meiotic nondisjunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.5 Trisomy 13, mosaicism (mitotic nondisjunction) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.6 Trisomy 13, translocation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.7 Patau syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92 Other trisomies and partial trisomies of the autosomes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.0 Whole chromosome trisomy, meiotic nondisjunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.1 Whole chromosome trisomy, mosaicism (mitotic nondisjunction) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.2 Major partial trisomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.3 Minor partial trisomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.4 Duplications seen only at prometaphase 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.5 Duplications with other complex rearrangements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.6 Extra marker chromosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.7 Triploidy and polyploidy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.8 Other specified trisomies and partial trisomies of autosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.9 Trisomy and partial trisomy of autosomes, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 463 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93 Monosomies and deletions from the autosomes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.0 Whole chromosome monosomy, meiotic nondisjunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.1 Whole chromosome monosomy, mosaicism (mitotic nondisjunction) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.2 Chromosome replaced with ring or dicentric 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.3 Deletion of short arm of chromosome 4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.4 Deletion of short arm of chromosome 5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.5 Other deletions of part of a chromosome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.6 Deletions seen only at prometaphase 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.7 Deletions with other complex rearrangements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.8 Other deletions from the autosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.9 Deletion from autosomes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95 Balanced rearrangements and structural markers, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.0 Balanced translocation and insertion in normal individual 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.1 Chromosome inversion in normal individual 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.2 Balanced autosomal rearrangement in abnormal individual 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.3 Balanced sex/autosomal rearrangement in abnormal individual 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.4 Individuals with marker heterochromatin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.5 Individuals with autosomal fragile site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.8 Other balanced rearrangements and structural markers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.9 Balanced rearrangement and structural marker, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96 Turner syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.0 Karyotype 45,X 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.1 Karyotype 46,X iso (Xq) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.2 Karyotype 46,X with abnormal sex chromosome, except iso (Xq) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.3 Mosaicism, 45,X/46,XX or XY 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.4 Mosaicism, 45,X/other cell line(s) with abnormal sex chromosome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.8 Other variants of Turner syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.9 Turner syndrome, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 464 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97 Other sex chromosome abnormalities, female phenotype, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.0 Karyotype 47,XXX 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.1 Female with more than three X chromosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.2 Mosaicism, lines with various numbers of X chromosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.3 Female with 46,XY karyotype 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.8 Other specified sex chromosome abnormalities, female phenotype 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.9 Sex chromosome abnormality, female phenotype, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98 Other sex chromosome abnormalities, male phenotype, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.0 Klinefelter syndrome karyotype 47,XXY 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.1 Klinefelter syndrome, male with more than two X chromosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.2 Klinefelter syndrome, male with 46,XX karyotype 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.3 Other male with 46,XX karyotype 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.4 Klinefelter syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.5 Karyotype 47,XYY 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.6 Male with structurally abnormal sex chromosome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.7 Male with sex chromosome mosaicism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.8 Other specified sex chromosome abnormalities, male phenotype 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.9 Sex chromosome abnormality, male phenotype, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99 Other chromosome abnormalities, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99.0 Chimera 46,XX/46,XY 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99.1 46,XX true hermaphrodite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99.2 Fragile X chromosome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99.8 Other specified chromosome abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99.9 Chromosomal abnormality, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00 Abnormalities of heart beat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00.0 Tachycardia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00.1 Bradycardia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00.2 Palpitations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00.8 Other and unspecified abnormalities of heart beat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R01 Cardiac murmurs and other cardiac sounds

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 465 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R01.0 Benign and innocent cardiac murmurs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R01.1 Cardiac murmur, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R01.2 Other cardiac sounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R02 Gangrene, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R03 Abnormal blood-pressure reading, without diagnosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R03.0 Elevated blood-pressure reading, without diagnosis of hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R03.1 Nonspecific low blood-pressure reading 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04 Haemorrhage from respiratory passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04.0 Epistaxis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04.1 Haemorrhage from throat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04.2 Haemoptysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04.8 Haemorrhage from other sites in respiratory passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04.9 Haemorrhage from respiratory passages, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R05 Cough 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06 Abnormalities of breathing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.0 Dyspnoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.1 Stridor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.2 Wheezing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.3 Periodic breathing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.4 Hyperventilation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.5 Mouth breathing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.6 Hiccough 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.7 Sneezing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.8 Other and unspecified abnormalities of breathing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07 Pain in throat and chest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07.0 Pain in throat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07.1 Chest pain on breathing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07.2 Precordial pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07.3 Other chest pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07.4 Chest pain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09 Other symptoms and signs involving the circulatory and respiratory systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09.0 Asphyxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09.1 Pleurisy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09.2 Respiratory arrest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09.3 Abnormal sputum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 466 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10 Abdominal and pelvic pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10.0 Acute abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10.1 Pain localized to upper abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10.2 Pelvic and perineal pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10.3 Pain localized to other parts of lower abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10.4 Other and unspecified abdominal pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R11 Nausea and vomiting 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R12 Heartburn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R13 Dysphagia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R14 Flatulence and related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R15 Faecal incontinence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R16 Hepatomegaly and splenomegaly, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R16.0 Hepatomegaly, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R16.1 Splenomegaly, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R16.2 Hepatomegaly with splenomegaly, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R17 Unspecified jaundice 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R18 Ascites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19 Other symptoms and signs involving the digestive system and abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.0 Intra-abdominal and pelvic swelling, mass and lump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.1 Abnormal bowel sounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.2 Visible peristalsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.3 Abdominal rigidity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.4 Change in bowel habit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.5 Other faecal abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.6 Halitosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.8 Other specified symptoms and signs involving the digestive system and abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20 Disturbances of skin sensation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20.0 Anaesthesia of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20.1 Hypoaesthesia of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20.2 Paraesthesia of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20.3 Hyperaesthesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20.8 Other and unspecified disturbances of skin sensation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R21 Rash and other nonspecific skin eruption

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 467 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22 Localized swelling, mass and lump of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.0 Localized swelling, mass and lump, head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.1 Localized swelling, mass and lump, neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.2 Localized swelling, mass and lump, trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.3 Localized swelling, mass and lump, upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.4 Localized swelling, mass and lump, lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.7 Localized swelling, mass and lump, multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.9 Localized swelling, mass and lump, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23 Other skin changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.0 Cyanosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.1 Pallor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.2 Flushing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.3 Spontaneous ecchymoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.4 Changes in skin texture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.8 Other and unspecified skin changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25 Abnormal involuntary movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25.0 Abnormal head movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25.1 Tremor, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25.2 Cramp and spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25.3 Fasciculation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25.8 Other and unspecified abnormal involuntary movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26 Abnormalities of gait and mobility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26.0 Ataxic gait 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26.1 Paralytic gait 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26.2 Difficulty in walking, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26.3 Immobility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26.8 Other and unspecified abnormalities of gait and mobility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R27 Other lack of coordination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R27.0 Ataxia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R27.8 Other and unspecified lack of coordination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29 Other symptoms and signs involving the nervous and musculoskeletal systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.0 Tetany 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.1 Meningismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.2 Abnormal reflex

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 468 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.3 Abnormal posture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.4 Clicking hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.6 Tendency to fall, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R30 Pain associated with micturition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R30.0 Dysuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R30.1 Vesical tenesmus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R30.9 Painful micturition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R31 Unspecified haematuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R32 Unspecified urinary incontinence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R33 Retention of urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R34 Anuria and oliguria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R35 Polyuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R36 Urethral discharge 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R39 Other symptoms and signs involving the urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R39.0 Extravasation of urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R39.1 Other difficulties with micturition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R39.2 Extrarenal uraemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R39.8 Other and unspecified symptoms and signs involving the urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R40 Somnolence, stupor and coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R40.0 Somnolence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R40.1 Stupor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R40.2 Coma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41 Other symptoms and signs involving cognitive functions and awareness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41.0 Disorientation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41.1 Anterograde amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41.2 Retrograde amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41.3 Other amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R42 Dizziness and giddiness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R43 Disturbances of smell and 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R43.0 Anosmia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R43.1 Parosmia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R43.2 Parageusia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R43.8 Other and unspecified disturbances of smell and taste 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44 Other symptoms and signs involving general sensations and perceptions © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 469 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44.0 Auditory hallucinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44.1 Visual hallucinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44.2 Other hallucinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44.3 Hallucinations, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45 Symptoms and signs involving emotional state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.0 Nervousness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.1 Restlessness and agitation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.2 Unhappiness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.3 Demoralization and apathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.4 Irritability and anger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.5 Hostility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.6 Physical violence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.7 State of emotional shock and stress, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.8 Other symptoms and signs involving emotional state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46 Symptoms and signs involving appearance and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.0 Very low level of personal hygiene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.1 Bizarre personal appearance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.2 Strange and inexplicable behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.3 Overactivity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.4 Slowness and poor responsiveness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.5 Suspiciousness and marked evasiveness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.6 Undue concern and preoccupation with stressful events 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.7 Verbosity and circumstantial detail obscuring reason for contact 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.8 Other symptoms and signs involving appearance and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R47 Speech disturbances, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R47.0 Dysphasia and aphasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R47.1 Dysarthria and anarthria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R47.8 Other and unspecified speech disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R48.0 Dyslexia and alexia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R48.1 Agnosia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R48.2 Apraxia

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 470 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R48.8 Other and unspecified symbolic dysfunctions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R49 Voice disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R49.0 Dysphonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R49.1 Aphonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R49.2 Hypernasality and hyponasality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R49.8 Other and unspecified voice disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R50 Fever of other and unknown origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R50.2 Drug-induced fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R50.8 Other specified fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R50.9 Fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R51 Headache 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R52 Pain, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R52.0 Acute pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R52.1 Chronic intractable pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R52.2 Other 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R52.9 Pain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R53 Malaise and fatigue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R54 Senility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R55 Syncope and collapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R56 Convulsions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R56.0 Febrile convulsions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R56.8 Other and unspecified convulsions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57 Shock, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57.0 Cardiogenic shock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57.1 Hypovolaemic shock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57.2 Septic shock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57.8 Other shock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57.9 Shock, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R58 Haemorrhage, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R59 Enlarged lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R59.0 Localized enlarged lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R59.1 Generalized enlarged lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R59.9 Enlarged lymph nodes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R60 Oedema, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R60.0 Localized oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R60.1 Generalized oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R60.9 Oedema, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R61 Hyperhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R61.0 Localized hyperhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R61.1 Generalized hyperhidrosis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 471 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R61.9 Hyperhidrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R62 Lack of expected normal physiological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R62.0 Delayed milestone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R62.8 Other lack of expected normal physiological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R62.9 Lack of expected normal physiological development, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63 Symptoms and signs concerning food and fluid intake 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.0 Anorexia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.1 Polydipsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.2 Polyphagia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.3 Feeding difficulties and mismanagement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.4 Abnormal weight loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.5 Abnormal weight gain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.6 Insufficient intake of food and due to self neglect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.8 Other symptoms and signs concerning food and fluid intake 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R64 Cachexia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65 Systemic Inflammatory Response Syndrome [SIRS] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65.0 Systemic Inflammatory Response Syndrome of infectious origin without organ failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65.1 Systemic Inflammatory Response Syndrome of infectious origin with organ failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65.2 Systemic Inflammatory Response Syndrome of non-infectious origin without organ failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65.3 Systemic Inflammatory Response Syndrome of non-infectious origin with organ failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65.9 Systemic Inflammatory Response Syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68 Other general symptoms and signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68.0 Hypothermia, not associated with low environmental temperature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68.1 Nonspecific symptoms peculiar to infancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68.2 Dry mouth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68.3 Clubbing of fingers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68.8 Other specified general symptoms and signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R69 Unknown and unspecified causes of morbidity

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 472 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R70.0 Elevated erythrocyte sedimentation rate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R70.1 Abnormal plasma viscosity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R71 Abnormality of red blood cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R72 Abnormality of white blood cells, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R73 Elevated blood glucose level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R73.0 Abnormal glucose tolerance test 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R73.9 Hyperglycaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R74 Abnormal serum enzyme levels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R74.0 Elevation of levels of transaminase and lactic acid dehydrogenase [LDH] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R74.8 Abnormal levels of other serum enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R74.9 Abnormal level of unspecified serum enzyme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R75 Laboratory evidence of human immunodeficiency virus [HIV] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76 Other abnormal immunological findings in serum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76.0 Raised antibody titre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76.1 Abnormal reaction to tuberculin test 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76.2 False-positive serological test for syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76.8 Other specified abnormal immunological findings in serum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76.9 Abnormal immunological finding in serum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77 Other abnormalities of plasma proteins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77.0 Abnormality of albumin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77.1 Abnormality of globulin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77.2 Abnormality of alphafetoprotein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77.8 Other specified abnormalities of plasma proteins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77.9 Abnormality of plasma protein, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78 Findings of drugs and other substances, not normally found in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.0 Finding of alcohol in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.1 Finding of drug in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.2 Finding of cocaine in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.3 Finding of hallucinogen in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.4 Finding of other drugs of addictive potential in blood © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 473 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.5 Finding of psychotropic drug in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.6 Finding of steroid agent in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.7 Finding of abnormal level of heavy metals in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.8 Finding of other specified substances, not normally found in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.9 Finding of unspecified substance, not normally found in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R79 Other abnormal findings of blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R79.0 Abnormal level of blood mineral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R79.8 Other specified abnormal findings of blood chemistry 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R79.9 Abnormal finding of blood chemistry, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R80 Isolated proteinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R81 Glycosuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82 Other abnormal findings in urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.0 Chyluria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.1 Myoglobinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.2 Biliuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.3 Haemoglobinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.4 Acetonuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.5 Elevated urine levels of drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.7 Abnormal findings on microbiological examination of urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.8 Abnormal findings on cytological and histological examination of urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.9 Other and unspecified abnormal findings in urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83 Abnormal findings in cerebrospinal fluid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83.0 Abnormal findings in cerebrospinal fluid; Abnormal level of enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83.1 Abnormal findings in cerebrospinal fluid; Abnormal level of hormones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83.2 Abnormal findings in cerebrospinal fluid; Abnormal level of other drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83.3 Abnormal findings in cerebrospinal fluid; Abnormal level of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83.4 Abnormal findings in cerebrospinal fluid; Abnormal immunological findings © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 474 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83.5 Abnormal findings in cerebrospinal fluid; Abnormal microbiological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83.6 Abnormal findings in cerebrospinal fluid; Abnormal cytological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83.7 Abnormal findings in cerebrospinal fluid; Abnormal histological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83.8 Abnormal findings in cerebrospinal fluid; Other abnormal findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83.9 Abnormal findings in cerebrospinal fluid; Unspecified abnormal finding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84 Abnormal findings in specimens from respiratory organs and thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84.0 Abnormal findings in specimens from respiratory organs and thorax; Abnormal level of enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84.1 Abnormal findings in specimens from respiratory organs and thorax; Abnormal level of hormones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84.2 Abnormal findings in specimens from respiratory organs and thorax; Abnormal level of other drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84.3 Abnormal findings in specimens from respiratory organs and thorax; Abnormal level of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84.4 Abnormal findings in specimens from respiratory organs and thorax; Abnormal immunological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84.5 Abnormal findings in specimens from respiratory organs and thorax; Abnormal microbiological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84.6 Abnormal findings in specimens from respiratory organs and thorax; Abnormal cytological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84.7 Abnormal findings in specimens from respiratory organs and thorax; Abnormal histological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84.8 Abnormal findings in specimens from respiratory organs and thorax; Other abnormal findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84.9 Abnormal findings in specimens from respiratory organs and thorax; Unspecified abnormal finding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85 Abnormal findings in specimens from digestive organs and abdominal cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85.0 Abnormal findings in specimens from digestive organs and abdominal cavity; Abnormal level of enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85.1 Abnormal findings in specimens from digestive organs and abdominal cavity; Abnormal level of hormones © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 475 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85.2 Abnormal findings in specimens from digestive organs and abdominal cavity; Abnormal level of other drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85.3 Abnormal findings in specimens from digestive organs and abdominal cavity; Abnormal level of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85.4 Abnormal findings in specimens from digestive organs and abdominal cavity; Abnormal immunological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85.5 Abnormal findings in specimens from digestive organs and abdominal cavity; Abnormal microbiological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85.6 Abnormal findings in specimens from digestive organs and abdominal cavity; Abnormal cytological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85.7 Abnormal findings in specimens from digestive organs and abdominal cavity; Abnormal histological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85.8 Abnormal findings in specimens from digestive organs and abdominal cavity; Other abnormal findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85.9 Abnormal findings in specimens from digestive organs and abdominal cavity; Unspecified abnormal finding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86 Abnormal findings in specimens from male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86.0 Abnormal findings in specimens from male genital organs; Abnormal level of enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86.1 Abnormal findings in specimens from male genital organs; Abnormal level of hormones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86.2 Abnormal findings in specimens from male genital organs; Abnormal level of other drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86.3 Abnormal findings in specimens from male genital organs; Abnormal level of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86.4 Abnormal findings in specimens from male genital organs; Abnormal immunological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86.5 Abnormal findings in specimens from male genital organs; Abnormal microbiological findings

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 476 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86.6 Abnormal findings in specimens from male genital organs; Abnormal cytological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86.7 Abnormal findings in specimens from male genital organs; Abnormal histological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86.8 Abnormal findings in specimens from male genital organs; Other abnormal findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86.9 Abnormal findings in specimens from male genital organs; Unspecified abnormal finding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87 Abnormal findings in specimens from female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87.0 Abnormal findings in specimens from female genital organs; Abnormal level of enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87.1 Abnormal findings in specimens from female genital organs; Abnormal level of hormones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87.2 Abnormal findings in specimens from female genital organs; Abnormal level of other drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87.3 Abnormal findings in specimens from female genital organs; Abnormal level of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87.4 Abnormal findings in specimens from female genital organs; Abnormal immunological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87.5 Abnormal findings in specimens from female genital organs; Abnormal microbiological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87.6 Abnormal findings in specimens from female genital organs; Abnormal cytological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87.7 Abnormal findings in specimens from female genital organs; Abnormal histological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87.8 Abnormal findings in specimens from female genital organs; Other abnormal findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87.9 Abnormal findings in specimens from female genital organs; Unspecified abnormal finding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89 Abnormal findings in specimens from other organs, systems and tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89.0 Abnormal findings in specimens from other organs, systems and tissues; Abnormal level of enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89.1 Abnormal findings in specimens from other organs, systems and tissues; Abnormal level of hormones

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 477 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89.2 Abnormal findings in specimens from other organs, systems and tissues; Abnormal level of other drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89.3 Abnormal findings in specimens from other organs, systems and tissues; Abnormal level of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89.4 Abnormal findings in specimens from other organs, systems and tissues; Abnormal immunological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89.5 Abnormal findings in specimens from other organs, systems and tissues; Abnormal microbiological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89.6 Abnormal findings in specimens from other organs, systems and tissues; Abnormal cytological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89.7 Abnormal findings in specimens from other organs, systems and tissues; Abnormal histological findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89.8 Abnormal findings in specimens from other organs, systems and tissues; Other abnormal findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89.9 Abnormal findings in specimens from other organs, systems and tissues; Unspecified abnormal finding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R90 Abnormal findings on diagnostic imaging of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R90.0 Intracranial space-occupying lesion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R90.8 Other abnormal findings on diagnostic imaging of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R91 Abnormal findings on diagnostic imaging of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R92 Abnormal findings on diagnostic imaging of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93 Abnormal findings on diagnostic imaging of other body structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 478 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.4 Abnormal findings on diagnostic imaging of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.6 Abnormal findings on diagnostic imaging of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.8 Abnormal findings on diagnostic imaging of other specified body structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94 Abnormal results of function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.0 Abnormal results of function studies of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.1 Abnormal results of function studies of peripheral nervous system and special senses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.2 Abnormal results of pulmonary function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.3 Abnormal results of cardiovascular function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.4 Abnormal results of kidney function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.5 Abnormal results of liver function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.6 Abnormal results of thyroid function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.7 Abnormal results of other endocrine function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.8 Abnormal results of function studies of other organs and systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R95 Sudden infant death syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R95.0 Sudden infant death syndrome with mention of autopsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R95.9 Sudden infant death syndrome without mention of autopsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R96 Other sudden death, cause unknown 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R96.0 Instantaneous death 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R96.1 Death occurring less than 24 hours from onset of symptoms, not otherwise explained 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R98 Unattended death 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R99 Other ill-defined and unspecified causes of mortality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00 Superficial injury of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.0 Superficial injury of scalp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.1 Contusion of eyelid and periocular area

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 479 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.2 Other superficial injuries of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.3 Superficial injury of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.4 Superficial injury of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.5 Superficial injury of lip and oral cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.7 Multiple superficial injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.8 Superficial injury of other parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.9 Superficial injury of head, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01 Open wound of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.0 Open wound of scalp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.1 Open wound of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.2 Open wound of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.3 Open wound of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.4 Open wound of cheek and temporomandibular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.5 Open wound of lip and oral cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.7 Multiple open wounds of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.8 Open wound of other parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.9 Open wound of head, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02 Fracture of skull and facial bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.0 Fracture of vault of skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.1 Fracture of base of skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.2 Fracture of nasal bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.3 Fracture of orbital floor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.4 Fracture of malar and maxillary bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.5 Fracture of tooth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.6 Fracture of mandible 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.7 Multiple fractures involving skull and facial bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.8 Fractures of other skull and facial bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.9 Fracture of skull and facial bones, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03 Dislocation, sprain and strain of joints and ligaments of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.0 Dislocation of jaw 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.1 Dislocation of septal cartilage of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.2 Dislocation of tooth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.3 Dislocation of other and unspecified parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.4 Sprain and strain of jaw

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 480 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.5 Sprain and strain of joints and ligaments of other and unspecified parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04 Injury of cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.0 Injury of optic nerve and pathways 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.1 Injury of oculomotor nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.2 Injury of trochlear nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.3 Injury of trigeminal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.4 Injury of abducent nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.5 Injury of facial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.6 Injury of acoustic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.7 Injury of accessory nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.8 Injury of other cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.9 Injury of unspecified cranial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05 Injury of eye and orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.1 Contusion of eyeball and orbital tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.3 Ocular laceration without prolapse or loss of intraocular tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.4 Penetrating wound of orbit with or without foreign body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.5 Penetrating wound of eyeball with foreign body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.6 Penetrating wound of eyeball without foreign body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.7 Avulsion of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.8 Other injuries of eye and orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.9 Injury of eye and orbit, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06 Intracranial injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.0 Concussion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.1 Traumatic cerebral oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.2 Diffuse brain injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.3 Focal brain injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.4 Epidural haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.5 Traumatic subdural haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.6 Traumatic subarachnoid haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.7 Intracranial injury with prolonged coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.8 Other intracranial injuries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.9 Intracranial injury, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S07 Crushing injury of head

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 481 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S07.0 Crushing injury of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S07.1 Crushing injury of skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S07.8 Crushing injury of other parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S07.9 Crushing injury of head, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S08 Traumatic amputation of part of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S08.0 Avulsion of scalp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S08.1 Traumatic amputation of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S08.8 Traumatic amputation of other parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S08.9 Traumatic amputation of unspecified part of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09 Other and unspecified injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.0 Injury of blood vessels of head, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.1 Injury of muscle and tendon of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.2 Traumatic rupture of ear drum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.7 Multiple injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.8 Other specified injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.9 Unspecified injury of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10 Superficial injury of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10.0 Contusion of throat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10.1 Other and unspecified superficial injuries of throat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10.7 Multiple superficial injuries of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10.8 Superficial injury of other parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10.9 Superficial injury of neck, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11 Open wound of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.0 Open wound involving larynx and trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.1 Open wound involving thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.2 Open wound involving pharynx and cervical oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.7 Multiple open wounds of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.8 Open wound of other parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.9 Open wound of neck, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12 Fracture of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.0 Fracture of first cervical vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.1 Fracture of second cervical vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.2 Fracture of other specified cervical vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.7 Multiple fractures of cervical spine

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 482 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.8 Fracture of other parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.9 Fracture of neck, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13 Dislocation, sprain and strain of joints and ligaments at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.0 Traumatic rupture of cervical intervertebral disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.1 Dislocation of cervical vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.2 Dislocation of other and unspecified parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.3 Multiple dislocations of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.4 Sprain and strain of cervical spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.5 Sprain and strain of thyroid region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.6 Sprain and strain of joints and ligaments of other and unspecified parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14 Injury of nerves and spinal cord at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.0 Concussion and oedema of cervical spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.1 Other and unspecified injuries of cervical spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.2 Injury of nerve root of cervical spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.3 Injury of brachial plexus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.4 Injury of peripheral nerves of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.5 Injury of cervical sympathetic nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.6 Injury of other and unspecified nerves of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15 Injury of blood vessels at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.0 Injury of carotid artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.1 Injury of vertebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.2 Injury of external jugular vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.3 Injury of internal jugular vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.7 Injury of multiple blood vessels at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.8 Injury of other blood vessels at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.9 Injury of unspecified blood vessel at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S16 Injury of muscle and tendon at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S17 Crushing injury of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S17.0 Crushing injury of larynx and trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S17.8 Crushing injury of other parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S17.9 Crushing injury of neck, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S18 Traumatic amputation at neck level

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 483 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S19 Other and unspecified injuries of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S19.7 Multiple injuries of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S19.8 Other specified injuries of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S19.9 Unspecified injury of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20 Superficial injury of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.0 Contusion of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.1 Other and unspecified superficial injuries of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.2 Contusion of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.3 Other superficial injuries of front wall of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.4 Other superficial injuries of back wall of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.7 Multiple superficial injuries of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.8 Superficial injury of other and unspecified parts of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21 Open wound of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.0 Open wound of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.1 Open wound of front wall of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.2 Open wound of back wall of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.7 Multiple open wounds of thoracic wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.8 Open wound of other parts of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.9 Open wound of thorax, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22 Fracture of rib(s), sternum and thoracic spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.0 Fracture of thoracic vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.1 Multiple fractures of thoracic spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.2 Fracture of sternum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.3 Fracture of rib 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.4 Multiple fractures of ribs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.5 Flail chest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.8 Fracture of other parts of bony thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.9 Fracture of bony thorax, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23 Dislocation, sprain and strain of joints and ligaments of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.0 Traumatic rupture of thoracic intervertebral disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.1 Dislocation of thoracic vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.2 Dislocation of other and unspecified parts of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.3 Sprain and strain of thoracic spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.4 Sprain and strain of ribs and sternum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 484 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.5 Sprain and strain of other and unspecified parts of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24 Injury of nerves and spinal cord at thorax level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.0 Concussion and oedema of thoracic spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.1 Other and unspecified injuries of thoracic spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.2 Injury of nerve root of thoracic spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.3 Injury of peripheral nerves of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.4 Injury of thoracic sympathetic nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.5 Injury of other nerves of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.6 Injury of unspecified nerve of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25 Injury of blood vessels of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.0 Injury of thoracic aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.1 Injury of innominate or subclavian artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.2 Injury of superior vena cava 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.3 Injury of innominate or subclavian vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.4 Injury of pulmonary blood vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.5 Injury of intercostal blood vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.7 Injury of multiple blood vessels of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.8 Injury of other blood vessels of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.9 Injury of unspecified blood vessel of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S26 Injury of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S26.0 Injury of heart with haemopericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S26.8 Other injuries of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S26.9 Injury of heart, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27 Injury of other and unspecified intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.0 Traumatic pneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.1 Traumatic haemothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.2 Traumatic haemopneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.3 Other injuries of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.4 Injury of bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.5 Injury of thoracic trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.6 Injury of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.7 Multiple injuries of intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.8 Injury of other specified intrathoracic organs

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 485 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.9 Injury of unspecified intrathoracic organ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S28 Crushing injury of thorax and traumatic amputation of part of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S28.0 Crushed chest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S28.1 Traumatic amputation of part of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S29 Other and unspecified injuries of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S29.0 Injury of muscle and tendon at thorax level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S29.7 Multiple injuries of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S29.8 Other specified injuries of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S29.9 Unspecified injury of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30 Superficial injury of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.0 Contusion of lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.1 Contusion of abdominal wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.2 Contusion of external genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.7 Multiple superficial injuries of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.8 Other superficial injuries of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31 Open wound of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.0 Open wound of lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.1 Open wound of abdominal wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.2 Open wound of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.3 Open wound of scrotum and testes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.4 Open wound of vagina and vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.5 Open wound of other and unspecified external genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.7 Multiple open wounds of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.8 Open wound of other and unspecified parts of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32 Fracture of lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.0 Fracture of lumbar vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.1 Fracture of sacrum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.2 Fracture of coccyx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.3 Fracture of ilium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.4 Fracture of acetabulum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.5 Fracture of pubis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.7 Multiple fractures of lumbar spine and pelvis © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 486 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.0 Traumatic rupture of lumbar intervertebral disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.1 Dislocation of lumbar vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.2 Dislocation of sacroiliac and sacrococcygeal joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.3 Dislocation of other and unspecified parts of lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.4 Traumatic rupture of symphysis pubis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.5 Sprain and strain of lumbar spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.6 Sprain and strain of sacroiliac joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.7 Sprain and strain of other and unspecified parts of lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.0 Concussion and oedema of lumbar spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.1 Other injury of lumbar spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.2 Injury of nerve root of lumbar and sacral spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.3 Injury of cauda equina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.4 Injury of lumbosacral plexus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.5 Injury of lumbar, sacral and pelvic sympathetic nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.6 Injury of peripheral nerve(s) of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.8 Injury of other and unspecified nerves at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35 Injury of blood vessels at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.0 Injury of abdominal aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.1 Injury of inferior vena cava 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.2 Injury of coeliac or mesenteric artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.3 Injury of portal or splenic vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.4 Injury of renal blood vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.5 Injury of iliac blood vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.7 Injury of multiple blood vessels at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.8 Injury of other blood vessels at abdomen, lower back and pelvis level

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 487 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.9 Injury of unspecified blood vessel at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36 Injury of intra-abdominal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.0 Injury of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.1 Injury of liver or gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.2 Injury of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.3 Injury of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.4 Injury of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.5 Injury of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.6 Injury of rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.7 Injury of multiple intra-abdominal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.8 Injury of other intra-abdominal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.9 Injury of unspecified intra-abdominal organ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37 Injury of urinary and pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.0 Injury of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.1 Injury of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.2 Injury of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.3 Injury of urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.4 Injury of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.5 Injury of fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.6 Injury of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.7 Injury of multiple pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.8 Injury of other pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.9 Injury of unspecified pelvic organ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S38.0 Crushing injury of external genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S38.1 Crushing injury of other and unspecified parts of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S38.2 Traumatic amputation of external genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S38.3 Traumatic amputation of other and unspecified parts of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39 Other and unspecified injuries of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39.0 Injury of muscle and tendon of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39.6 Injury of intra-abdominal organ(s) with pelvic organ(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39.7 Other multiple injuries of abdomen, lower back and pelvis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 488 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39.8 Other specified injuries of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39.9 Unspecified injury of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40 Superficial injury of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40.0 Contusion of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40.7 Multiple superficial injuries of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40.8 Other superficial injuries of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40.9 Superficial injury of shoulder and upper arm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S41 Open wound of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S41.0 Open wound of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S41.1 Open wound of upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S41.7 Multiple open wounds of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S41.8 Open wound of other and unspecified parts of shoulder girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42 Fracture of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.0 Fracture of clavicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.1 Fracture of scapula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.2 Fracture of upper end of humerus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.3 Fracture of shaft of humerus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.4 Fracture of lower end of humerus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.7 Multiple fractures of clavicle, scapula and humerus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.8 Fracture of other parts of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.9 Fracture of shoulder girdle, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.0 Dislocation of shoulder joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.1 Dislocation of acromioclavicular joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.2 Dislocation of sternoclavicular joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.3 Dislocation of other and unspecified parts of shoulder girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.4 Sprain and strain of shoulder joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.5 Sprain and strain of acromioclavicular joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.6 Sprain and strain of sternoclavicular joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.7 Sprain and strain of other and unspecified parts of shoulder girdle

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 489 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44 Injury of nerves at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.0 Injury of ulnar nerve at upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.1 Injury of median nerve at upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.2 Injury of radial nerve at upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.3 Injury of axillary nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.4 Injury of musculocutaneous nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.5 Injury of cutaneous sensory nerve at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.7 Injury of multiple nerves at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.8 Injury of other nerves at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.9 Injury of unspecified nerve at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45 Injury of blood vessels at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.0 Injury of axillary artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.1 Injury of brachial artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.2 Injury of axillary or brachial vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.3 Injury of superficial vein at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.7 Injury of multiple blood vessels at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.8 Injury of other blood vessels at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.9 Injury of unspecified blood vessel at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46 Injury of muscle and tendon at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.0 Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.1 Injury of muscle and tendon of long head of biceps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.2 Injury of muscle and tendon of other parts of biceps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.3 Injury of muscle and tendon of triceps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.7 Injury of multiple muscles and tendons at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.8 Injury of other muscles and tendons at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.9 Injury of unspecified muscle and tendon at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S47 Crushing injury of shoulder and upper arm

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 490 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S48 Traumatic amputation of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S48.0 Traumatic amputation at shoulder joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S48.1 Traumatic amputation at level between shoulder and elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S48.9 Traumatic amputation of shoulder and upper arm, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S49 Other and unspecified injuries of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S49.7 Multiple injuries of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S49.8 Other specified injuries of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S49.9 Unspecified injury of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50 Superficial injury of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50.0 Contusion of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50.1 Contusion of other and unspecified parts of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50.7 Multiple superficial injuries of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50.8 Other superficial injuries of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50.9 Superficial injury of forearm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S51 Open wound of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S51.0 Open wound of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S51.7 Multiple open wounds of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S51.8 Open wound of other parts of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S51.9 Open wound of forearm, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52 Fracture of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.0 Fracture of upper end of ulna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.1 Fracture of upper end of radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.2 Fracture of shaft of ulna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.3 Fracture of shaft of radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.4 Fracture of shafts of both ulna and radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.5 Fracture of lower end of radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.6 Fracture of lower end of both ulna and radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.7 Multiple fractures of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.8 Fracture of other parts of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.9 Fracture of forearm, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53 Dislocation, sprain and strain of joints and ligaments of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53.0 Dislocation of radial head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53.1 Dislocation of elbow, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 491 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53.2 Traumatic rupture of radial collateral ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53.3 Traumatic rupture of ulnar collateral ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53.4 Sprain and strain of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54 Injury of nerves at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.0 Injury of ulnar nerve at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.1 Injury of median nerve at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.2 Injury of radial nerve at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.3 Injury of cutaneous sensory nerve at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.7 Injury of multiple nerves at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.8 Injury of other nerves at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.9 Injury of unspecified nerve at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55 Injury of blood vessels at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.0 Injury of ulnar artery at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.1 Injury of radial artery at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.2 Injury of vein at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.7 Injury of multiple blood vessels at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.8 Injury of other blood vessels at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.9 Injury of unspecified blood vessel at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56 Injury of muscle and tendon at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.0 Injury of flexor muscle and tendon of thumb at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.1 Injury of long flexor muscle and tendon of other finger(s) at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.2 Injury of other flexor muscle and tendon at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.3 Injury of extensor or abductor muscles and tendons of thumb at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.4 Injury of extensor muscle and tendon of other finger(s) at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.5 Injury of other extensor muscle and tendon at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.7 Injury of multiple muscles and tendons at forearm level

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 492 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.8 Injury of other and unspecified muscles and tendons at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S57 Crushing injury of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S57.0 Crushing injury of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S57.8 Crushing injury of other parts of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S57.9 Crushing injury of forearm, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S58 Traumatic amputation of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S58.0 Traumatic amputation at elbow level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S58.1 Traumatic amputation at level between elbow and wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S58.9 Traumatic amputation of forearm, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S59 Other and unspecified injuries of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S59.7 Multiple injuries of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S59.8 Other specified injuries of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S59.9 Unspecified injury of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60 Superficial injury of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.0 Contusion of finger(s) without damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.1 Contusion of finger(s) with damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.2 Contusion of other parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.7 Multiple superficial injuries of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.8 Other superficial injuries of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.9 Superficial injury of wrist and hand, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61 Open wound of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61.0 Open wound of finger(s) without damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61.1 Open wound of finger(s) with damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61.7 Multiple open wounds of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61.8 Open wound of other parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61.9 Open wound of wrist and hand, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62 Fracture at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.0 Fracture of navicular [scaphoid] bone of hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.1 Fracture of other carpal bone(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.2 Fracture of first metacarpal bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.3 Fracture of other metacarpal bone © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 493 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.4 Multiple fractures of metacarpal bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.5 Fracture of thumb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.6 Fracture of other finger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.7 Multiple fractures of fingers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.8 Fracture of other and unspecified parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.0 Dislocation of wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.1 Dislocation of finger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.2 Multiple dislocations of fingers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.3 Traumatic rupture of ligament of wrist and carpus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.5 Sprain and strain of wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.6 Sprain and strain of finger(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.7 Sprain and strain of other and unspecified parts of hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64 Injury of nerves at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.0 Injury of ulnar nerve at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.1 Injury of median nerve at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.2 Injury of radial nerve at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.3 Injury of digital nerve of thumb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.4 Injury of digital nerve of other finger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.7 Injury of multiple nerves at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.8 Injury of other nerves at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.9 Injury of unspecified nerve at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65 Injury of blood vessels at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.0 Injury of ulnar artery at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.1 Injury of radial artery at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.2 Injury of superficial palmar arch 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.3 Injury of deep palmar arch 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.4 Injury of blood vessel(s) of thumb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.5 Injury of blood vessel(s) of other finger

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 494 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.7 Injury of multiple blood vessels at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.8 Injury of other blood vessels at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.9 Injury of unspecified blood vessel at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66 Injury of muscle and tendon at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.4 Injury of intrinsic muscle and tendon of thumb at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.5 Injury of intrinsic muscle and tendon of other finger at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.6 Injury of multiple flexor muscles and tendons at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.8 Injury of other muscles and tendons at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.9 Injury of unspecified muscle and tendon at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S67 Crushing injury of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S67.0 Crushing injury of thumb and other finger(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S67.8 Crushing injury of other and unspecified parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68 Traumatic amputation of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.0 Traumatic amputation of thumb (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.1 Traumatic amputation of other single finger (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.2 Traumatic amputation of two or more fingers alone (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.3 Combined traumatic amputation of (part of) finger(s) with other parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.4 Traumatic amputation of hand at wrist level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.8 Traumatic amputation of other parts of wrist and hand

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 495 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.9 Traumatic amputation of wrist and hand, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S69 Other and unspecified injuries of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S69.7 Multiple injuries of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S69.8 Other specified injuries of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S69.9 Unspecified injury of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70 Superficial injury of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70.0 Contusion of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70.1 Contusion of thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70.7 Multiple superficial injuries of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70.8 Other superficial injuries of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70.9 Superficial injury of hip and thigh, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S71 Open wound of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S71.0 Open wound of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S71.1 Open wound of thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S71.7 Multiple open wounds of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S71.8 Open wound of other and unspecified parts of pelvic girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72 Fracture of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.0 Fracture of neck of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.1 Pertrochanteric fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.2 Subtrochanteric fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.3 Fracture of shaft of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.4 Fracture of lower end of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.7 Multiple fractures of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.8 Fractures of other parts of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.9 Fracture of femur, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S73 Dislocation, sprain and strain of joint and ligaments of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S73.0 Dislocation of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S73.1 Sprain and strain of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74 Injury of nerves at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.0 Injury of sciatic nerve at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.1 Injury of femoral nerve at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.2 Injury of cutaneous sensory nerve at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.7 Injury of multiple nerves at hip and thigh level

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 496 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.8 Injury of other nerves at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.9 Injury of unspecified nerve at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75 Injury of blood vessels at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.0 Injury of femoral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.1 Injury of femoral vein at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.2 Injury of greater saphenous vein at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.7 Injury of multiple blood vessels at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.8 Injury of other blood vessels at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.9 Injury of unspecified blood vessel at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76 Injury of muscle and tendon at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.0 Injury of muscle and tendon of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.1 Injury of quadriceps muscle and tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.2 Injury of adductor muscle and tendon of thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.3 Injury of muscle and tendon of the posterior muscle group at thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.4 Injury of other and unspecified muscles and tendons at thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.7 Injury of multiple muscles and tendons at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S77 Crushing injury of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S77.0 Crushing injury of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S77.1 Crushing injury of thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S77.2 Crushing injury of hip with thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S78 Traumatic amputation of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S78.0 Traumatic amputation at hip joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S78.1 Traumatic amputation at level between hip and knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S78.9 Traumatic amputation of hip and thigh, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S79 Other and unspecified injuries of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S79.7 Multiple injuries of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S79.8 Other specified injuries of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S79.9 Unspecified injury of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80 Superficial injury of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80.0 Contusion of knee

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 497 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80.1 Contusion of other and unspecified parts of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80.7 Multiple superficial injuries of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80.8 Other superficial injuries of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80.9 Superficial injury of lower leg, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S81 Open wound of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S81.0 Open wound of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S81.7 Multiple open wounds of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S81.8 Open wound of other parts of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S81.9 Open wound of lower leg, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82 Fracture of lower leg, including ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.0 Fracture of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.1 Fracture of upper end of tibia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.2 Fracture of shaft of tibia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.3 Fracture of lower end of tibia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.4 Fracture of fibula alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.5 Fracture of medial malleolus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.6 Fracture of lateral malleolus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.7 Multiple fractures of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.8 Fractures of other parts of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.9 Fracture of lower leg, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83 Dislocation, sprain and strain of joints and ligaments of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.0 Dislocation of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.1 Dislocation of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.2 Tear of meniscus, current 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.3 Tear of articular cartilage of knee, current 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.4 Sprain and strain involving (fibular)(tibial) collateral ligament of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.5 Sprain and strain involving (anterior)(posterior) cruciate ligament of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.6 Sprain and strain of other and unspecified parts of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.7 Injury to multiple structures of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84 Injury of nerves at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.0 Injury of tibial nerve at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.1 Injury of peroneal nerve at lower leg level

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 498 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.2 Injury of cutaneous sensory nerve at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.7 Injury of multiple nerves at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.8 Injury of other nerves at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.9 Injury of unspecified nerve at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85 Injury of blood vessels at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.0 Injury of popliteal artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.1 Injury of (anterior)(posterior) tibial artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.2 Injury of peroneal artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.3 Injury of greater saphenous vein at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.4 Injury of lesser saphenous vein at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.5 Injury of popliteal vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.7 Injury of multiple blood vessels at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.8 Injury of other blood vessels at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.9 Injury of unspecified blood vessel at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86 Injury of muscle and tendon at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.0 Injury of Achilles tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.1 Injury of other muscle(s) and tendon(s) of posterior muscle group at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.2 Injury of muscle(s) and tendon(s) of anterior muscle group at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.3 Injury of muscle(s) and tendon(s) of peroneal muscle group at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.7 Injury of multiple muscles and tendons at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.8 Injury of other muscles and tendons at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.9 Injury of unspecified muscle and tendon at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S87 Crushing injury of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S87.0 Crushing injury of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S87.8 Crushing injury of other and unspecified parts of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S88 Traumatic amputation of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S88.0 Traumatic amputation at knee level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S88.1 Traumatic amputation at level between knee and ankle

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 499 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S88.9 Traumatic amputation of lower leg, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S89 Other and unspecified injuries of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S89.7 Multiple injuries of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S89.8 Other specified injuries of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S89.9 Unspecified injury of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90 Superficial injury of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.0 Contusion of ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.1 Contusion of toe(s) without damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.2 Contusion of toe(s) with damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.3 Contusion of other and unspecified parts of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.7 Multiple superficial injuries of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.8 Other superficial injuries of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.9 Superficial injury of ankle and foot, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91 Open wound of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91.0 Open wound of ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91.1 Open wound of toe(s) without damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91.2 Open wound of toe(s) with damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91.3 Open wound of other parts of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91.7 Multiple open wounds of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92 Fracture of foot, except ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.0 Fracture of calcaneus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.1 Fracture of talus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.2 Fracture of other tarsal bone(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.3 Fracture of metatarsal bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.4 Fracture of great toe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.5 Fracture of other toe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.7 Multiple fractures of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.9 Fracture of foot, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.0 Dislocation of ankle joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.1 Dislocation of toe(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.2 Rupture of ligaments at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.3 Dislocation of other and unspecified parts of foot

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 500 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.4 Sprain and strain of ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.5 Sprain and strain of toe(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.6 Sprain and strain of other and unspecified parts of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94 Injury of nerves at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.0 Injury of lateral plantar nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.1 Injury of medial plantar nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.2 Injury of deep peroneal nerve at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.3 Injury of cutaneous sensory nerve at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.7 Injury of multiple nerves at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.8 Injury of other nerves at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.9 Injury of unspecified nerve at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95 Injury of blood vessels at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.0 Injury of dorsal artery of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.1 Injury of plantar artery of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.2 Injury of dorsal vein of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.7 Injury of multiple blood vessels at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.8 Injury of other blood vessels at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.9 Injury of unspecified blood vessel at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96 Injury of muscle and tendon at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.0 Injury of muscle and tendon of long flexor muscle of toe at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.1 Injury of muscle and tendon of long extensor muscle of toe at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.2 Injury of intrinsic muscle and tendon at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.7 Injury of multiple muscles and tendons at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.8 Injury of other muscles and tendons at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.9 Injury of unspecified muscle and tendon at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S97 Crushing injury of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S97.0 Crushing injury of ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S97.1 Crushing injury of toe(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S97.8 Crushing injury of other parts of ankle and foot

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 501 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98 Traumatic amputation of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98.0 Traumatic amputation of foot at ankle level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98.1 Traumatic amputation of one toe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98.2 Traumatic amputation of two or more toes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98.3 Traumatic amputation of other parts of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98.4 Traumatic amputation of foot, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S99 Other and unspecified injuries of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S99.7 Multiple injuries of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S99.8 Other specified injuries of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S99.9 Unspecified injury of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00 Superficial injuries involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.0 Superficial injuries involving head with neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.1 Superficial injuries involving thorax with abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.2 Superficial injuries involving multiple regions of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.3 Superficial injuries involving multiple regions of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.6 Superficial injuries involving multiple regions of upper limb(s) with lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.8 Superficial injuries involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.9 Multiple superficial injuries, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01 Open wounds involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.0 Open wounds involving head with neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.1 Open wounds involving thorax with abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.2 Open wounds involving multiple regions of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.3 Open wounds involving multiple regions of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.6 Open wounds involving multiple regions of upper limb(s) with lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.8 Open wounds involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.9 Multiple open wounds, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 502 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02 Fractures involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.0 Fractures involving head with neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.1 Fractures involving thorax with lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.2 Fractures involving multiple regions of one upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.3 Fractures involving multiple regions of one lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.4 Fractures involving multiple regions of both upper limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.5 Fractures involving multiple regions of both lower limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.6 Fractures involving multiple regions of upper limb(s) with lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.7 Fractures involving thorax with lower back and pelvis with limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.8 Fractures involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.9 Multiple fractures, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03 Dislocations, sprains and strains involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.0 Dislocations, sprains and strains involving head with neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.1 Dislocations, sprains and strains involving thorax with lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.2 Dislocations, sprains and strains involving multiple regions of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.3 Dislocations, sprains and strains involving multiple regions of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.4 Dislocations, sprains and strains involving multiple regions of upper limb(s) with lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.8 Dislocations, sprains and strains involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.9 Multiple dislocations, sprains and strains, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04 Crushing injuries involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.0 Crushing injuries involving head with neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.1 Crushing injuries involving thorax with abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.2 Crushing injuries involving multiple regions of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.3 Crushing injuries involving multiple regions of lower limb(s)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 503 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.4 Crushing injuries involving multiple regions of upper limb(s) with lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.7 Crushing injuries of thorax with abdomen, lower back and pelvis with limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.8 Crushing injuries involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.9 Multiple crushing injuries, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05 Traumatic amputations involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.0 Traumatic amputation of both hands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.1 Traumatic amputation of one hand and other arm [any level, except hand] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.2 Traumatic amputation of both arms [any level] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.3 Traumatic amputation of both feet 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.4 Traumatic amputation of one foot and other leg [any level, except foot] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.5 Traumatic amputation of both legs [any level] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.6 Traumatic amputation of upper and lower limbs, any combination [any level] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.8 Traumatic amputations involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.9 Multiple traumatic amputations, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06 Other injuries involving multiple body regions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.0 Injuries of brain and cranial nerves with injuries of nerves and spinal cord at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.1 Injuries of nerves and spinal cord involving other multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.2 Injuries of nerves involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.3 Injuries of blood vessels involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.4 Injuries of muscles and tendons involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.5 Injuries of intrathoracic organs with intra-abdominal and pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.8 Other specified injuries involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T07 Unspecified multiple injuries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T08 Fracture of spine, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09 Other injuries of spine and trunk, level unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 504 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.0 Superficial injury of trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.1 Open wound of trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.2 Dislocation, sprain and strain of unspecified joint and ligament of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.3 Injury of spinal cord, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.4 Injury of unspecified nerve, spinal nerve root and plexus of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.5 Injury of unspecified muscle and tendon of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.6 Traumatic amputation of trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.8 Other specified injuries of trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.9 Unspecified injury of trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T10 Fracture of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11 Other injuries of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.0 Superficial injury of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.1 Open wound of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.2 Dislocation, sprain and strain of unspecified joint and ligament of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.3 Injury of unspecified nerve of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.4 Injury of unspecified blood vessel of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.5 Injury of unspecified muscle and tendon of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.6 Traumatic amputation of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.8 Other specified injuries of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.9 Unspecified injury of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T12 Fracture of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13 Other injuries of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.0 Superficial injury of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.1 Open wound of lower limb, level unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 505 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.2 Dislocation, sprain and strain of unspecified joint and ligament of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.3 Injury of unspecified nerve of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.4 Injury of unspecified blood vessel of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.5 Injury of unspecified muscle and tendon of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.6 Traumatic amputation of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.8 Other specified injuries of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.9 Unspecified injury of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14 Injury of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.0 Superficial injury of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.1 Open wound of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.2 Fracture of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.3 Dislocation, sprain and strain of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.4 Injury of nerve(s) of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.5 Injury of blood vessel(s) of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.6 Injury of muscles and tendons of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.7 Crushing injury and traumatic amputation of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.8 Other injuries of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.9 Injury, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15 Foreign body on external eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15.0 Foreign body in cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15.1 Foreign body in conjunctival sac 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15.8 Foreign body in other and multiple parts of external eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15.9 Foreign body on external eye, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T16 Foreign body in ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17 Foreign body in respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.0 Foreign body in nasal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.1 Foreign body in nostril 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.2 Foreign body in pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.3 Foreign body in larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.4 Foreign body in trachea

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 506 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.5 Foreign body in bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.8 Foreign body in other and multiple parts of respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.9 Foreign body in respiratory tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18 Foreign body in alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.0 Foreign body in mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.1 Foreign body in oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.2 Foreign body in stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.3 Foreign body in small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.4 Foreign body in colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.5 Foreign body in anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.8 Foreign body in other and multiple parts of alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.9 Foreign body in alimentary tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19 Foreign body in genitourinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.0 Foreign body in urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.1 Foreign body in bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.2 Foreign body in vulva and vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.3 Foreign body in uterus [any part] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.8 Foreign body in other and multiple parts of genitourinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.9 Foreign body in genitourinary tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20 Burn and corrosion of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.0 Burn of unspecified degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.1 Burn of first degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.2 Burn of second degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.3 Burn of third degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.4 Corrosion of unspecified degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.5 Corrosion of first degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.6 Corrosion of second degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.7 Corrosion of third degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21 Burn and corrosion of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.0 Burn of unspecified degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.1 Burn of first degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.2 Burn of second degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.3 Burn of third degree of trunk

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 507 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.4 Corrosion of unspecified degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.5 Corrosion of first degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.6 Corrosion of second degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.7 Corrosion of third degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22 Burn and corrosion of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23 Burn and corrosion of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.0 Burn of unspecified degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.1 Burn of first degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.2 Burn of second degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.3 Burn of third degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.4 Corrosion of unspecified degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.5 Corrosion of first degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.6 Corrosion of second degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.7 Corrosion of third degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24 Burn and corrosion of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 508 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.1 Burn of first degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.2 Burn of second degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.3 Burn of third degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25 Burn and corrosion of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.0 Burn of unspecified degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.1 Burn of first degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.2 Burn of second degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.3 Burn of third degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.4 Corrosion of unspecified degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.5 Corrosion of first degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.6 Corrosion of second degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.7 Corrosion of third degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26 Burn and corrosion confined to eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.0 Burn of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.1 Burn of cornea and conjunctival sac 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.2 Burn with resulting rupture and destruction of eyeball 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.3 Burn of other parts of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.4 Burn of eye and adnexa, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.5 Corrosion of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.6 Corrosion of cornea and conjunctival sac 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.7 Corrosion with resulting rupture and destruction of eyeball 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.8 Corrosion of other parts of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.9 Corrosion of eye and adnexa, part unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 509 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27 Burn and corrosion of respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.0 Burn of larynx and trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.1 Burn involving larynx and trachea with lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.2 Burn of other parts of respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.3 Burn of respiratory tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.4 Corrosion of larynx and trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.5 Corrosion involving larynx and trachea with lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.6 Corrosion of other parts of respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.7 Corrosion of respiratory tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28 Burn and corrosion of other internal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.0 Burn of mouth and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.1 Burn of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.2 Burn of other parts of alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.3 Burn of internal genitourinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.4 Burn of other and unspecified internal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.5 Corrosion of mouth and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.6 Corrosion of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.7 Corrosion of other parts of alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.8 Corrosion of internal genitourinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.9 Corrosion of other and unspecified internal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29 Burns and corrosions of multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.0 Burns of multiple regions, unspecified degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.1 Burns of multiple regions, no more than first-degree burns mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.2 Burns of multiple regions, no more than second-degree burns mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.3 Burns of multiple regions, at least one burn of third degree mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.4 Corrosions of multiple regions, unspecified degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.5 Corrosions of multiple regions, no more than first-degree corrosions mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.6 Corrosions of multiple regions, no more than second-degree corrosions mentioned © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 510 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.7 Corrosions of multiple regions, at least one corrosion of third degree mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30 Burn and corrosion, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.0 Burn of unspecified body region, unspecified degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.1 Burn of first degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.2 Burn of second degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.3 Burn of third degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.4 Corrosion of unspecified body region, unspecified degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.5 Corrosion of first degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.6 Corrosion of second degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.7 Corrosion of third degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31 Burns classified according to extent of body surface involved 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.0 Burns involving less than 10% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.1 Burns involving 10-19% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.2 Burns involving 20-29% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.3 Burns involving 30-39% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.4 Burns involving 40-49% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.5 Burns involving 50-59% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.6 Burns involving 60-69% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.7 Burns involving 70-79% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.8 Burns involving 80-89% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.9 Burns involving 90% or more of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32 Corrosions classified according to extent of body surface involved 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.0 Corrosions involving less than 10% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.1 Corrosions involving 10-19% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.2 Corrosions involving 20-29% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.3 Corrosions involving 30-39% of body surface © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 511 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.4 Corrosions involving 40-49% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.5 Corrosions involving 50-59% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.6 Corrosions involving 60-69% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.7 Corrosions involving 70-79% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.8 Corrosions involving 80-89% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.9 Corrosions involving 90% or more of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33 Superficial frostbite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.0 Superficial frostbite of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.1 Superficial frostbite of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.2 Superficial frostbite of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.3 Superficial frostbite of abdominal wall, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.4 Superficial frostbite of arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.5 Superficial frostbite of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.6 Superficial frostbite of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.7 Superficial frostbite of knee and lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.8 Superficial frostbite of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.9 Superficial frostbite of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34 Frostbite with tissue necrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.0 Frostbite with tissue necrosis of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.1 Frostbite with tissue necrosis of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.2 Frostbite with tissue necrosis of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.3 Frostbite with tissue necrosis of abdominal wall, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.4 Frostbite with tissue necrosis of arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.5 Frostbite with tissue necrosis of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.6 Frostbite with tissue necrosis of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.7 Frostbite with tissue necrosis of knee and lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.8 Frostbite with tissue necrosis of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.9 Frostbite with tissue necrosis of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35 Frostbite involving multiple body regions and unspecified frostbite

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 512 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.0 Superficial frostbite involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.1 Frostbite with tissue necrosis involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.2 Unspecified frostbite of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.3 Unspecified frostbite of thorax, abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.4 Unspecified frostbite of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.5 Unspecified frostbite of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.6 Unspecified frostbite involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.7 Unspecified frostbite of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36 Poisoning by systemic antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.0 Poisoning: Penicillins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.1 Poisoning: Cefalosporins and other beta-lactam antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.2 Poisoning: Chloramphenicol group 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.3 Poisoning: Macrolides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.4 Poisoning: Tetracyclines 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.5 Poisoning: Aminoglycosides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.6 Poisoning: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.7 Poisoning: antibiotics, systemically used 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.8 Poisoning: Other systemic antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.9 Poisoning: Systemic , unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37 Poisoning by other systemic anti- infectives and 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.0 Poisoning: Sulfonamides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.1 Poisoning: drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.2 Poisoning: Antimalarials and drugs acting on other blood protozoa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.3 Poisoning: Other drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.4 Poisoning: Anthelminthics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.5 Poisoning: Antiviral drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.8 Poisoning: Other specified systemic anti-infectives and antiparasitics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.9 Poisoning: Systemic anti-infective and antiparasitic, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.0 Poisoning: Glucocorticoids and synthetic analogues

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 513 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.1 Poisoning: Thyroid hormones and substitutes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.2 Poisoning: Antithyroid drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.3 Poisoning: Insulin and oral hypoglycaemic [antidiabetic] drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.4 Poisoning: Oral contraceptives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.5 Poisoning: Other estrogens and progestogens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.6 Poisoning: Antigonadotrophins, , antiandrogens, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.7 Poisoning: Androgens and anabolic congeners 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.8 Poisoning: Other and unspecified hormones and their synthetic substitutes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.9 Poisoning: Other and unspecified hormone antagonists 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.0 Poisoning: Salicylates 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.1 Poisoning: 4-Aminophenol derivatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.2 Poisoning: Pyrazolone derivatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.3 Poisoning: Other anti- inflammatory drugs [NSAID] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.4 Poisoning: Antirheumatics, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.8 Poisoning: Other nonopioid analgesics and antipyretics, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.9 Poisoning: Nonopioid analgesic, and antirheumatic, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40 Poisoning by narcotics and psychodysleptics [hallucinogens] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.0 Poisoning: Opium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.1 Poisoning: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.2 Poisoning: Other opioids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.3 Poisoning: Methadone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.4 Poisoning: Other synthetic narcotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.5 Poisoning: Cocaine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.6 Poisoning: Other and unspecified narcotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.7 Poisoning: (derivatives) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.8 Poisoning: Lysergide [LSD] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.9 Poisoning: Other and unspecified psychodysleptics [hallucinogens] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41 Poisoning by anaesthetics and therapeutic gases

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 514 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.0 Poisoning: Inhaled anaesthetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.1 Poisoning: Intravenous anaesthetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.2 Poisoning: Other and unspecified general anaesthetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.3 Poisoning: Local anaesthetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.4 Poisoning: Anaesthetic, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.5 Poisoning: Therapeutic gases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42 Poisoning by antiepileptic, - and antiparkinsonism drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.0 Poisoning: Hydantoin derivatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.1 Poisoning: Iminostilbenes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.2 Poisoning: and 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.3 Poisoning: Barbiturates 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.4 Poisoning: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.5 Poisoning: Mixed antiepileptics, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.6 Poisoning: Other antiepileptic and sedative-hypnotic drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.7 Poisoning: Antiepileptic and sedative-hypnotic drugs, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.8 Poisoning: Antiparkinsonism drugs and other central muscle-tone depressants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43 Poisoning by psychotropic drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.0 Poisoning: and tetracyclic antidepressants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.1 Poisoning: Monoamine-oxidase- inhibitor antidepressants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.2 Poisoning: Other and unspecified antidepressants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.3 Poisoning: Phenothiazine antipsychotics and neuroleptics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.4 Poisoning: Butyrophenone and thioxanthene neuroleptics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.5 Poisoning: Other and unspecified antipsychotics and neuroleptics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.6 Poisoning: Psychostimulants with abuse potential 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.8 Poisoning: Other psychotropic drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.9 Poisoning: Psychotropic drug, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44 Poisoning by drugs primarily affecting the autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.0 Poisoning: Anticholinesterase agents

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 515 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.1 Poisoning: Other parasympathomimetics [] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.2 Poisoning: Ganglionic blocking drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.3 Poisoning: Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.4 Poisoning: Predominantly alpha- adrenoreceptor agonists, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.5 Poisoning: Predominantly beta- adrenoreceptor agonists, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.6 Poisoning: Alpha-adrenoreceptor antagonists, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.7 Poisoning: Beta-adrenoreceptor antagonists, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.8 Poisoning: Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.9 Poisoning: Other and unspecified drugs primarily affecting the autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.0 Poisoning: Antiallergic and drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.1 Poisoning: Antineoplastic and immunosuppressive drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.2 Poisoning: Vitamins, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.3 Poisoning: Enzymes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.4 Poisoning: Iron and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.5 Poisoning: Anticoagulants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.6 Poisoning: -affecting drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.7 Poisoning: Anticoagulant antagonists, vitamin K and other coagulants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.8 Poisoning: Other primarily systemic and haematological agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.9 Poisoning: Primarily systemic and haematological agent, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46 Poisoning by agents primarily affecting the cardiovascular system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.0 Poisoning: Cardiac- glycosides and drugs of similar action © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 516 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.1 Poisoning: Calcium-channel blockers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.2 Poisoning: Other antidysrhythmic drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.3 Poisoning: Coronary vasodilators, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.4 Poisoning: Angiotensin-converting- enzyme inhibitors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.5 Poisoning: Other antihypertensive drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.6 Poisoning: Antihyperlipidaemic and antiarteriosclerotic drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.7 Poisoning: Peripheral vasodilators 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.8 Poisoning: Antivaricose drugs, including sclerosing agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.9 Poisoning: Other and unspecified agents primarily affecting the cardiovascular system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47 Poisoning by agents primarily affecting the gastrointestinal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.0 Poisoning: Histamine H2-receptor antagonists 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.1 Poisoning: Other antacids and anti- gastric-secretion drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.2 Poisoning: Stimulant laxatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.3 Poisoning: and osmotic laxatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.4 Poisoning: Other laxatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.5 Poisoning: Digestants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.6 Poisoning: drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.7 Poisoning: Emetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.8 Poisoning: Other agents primarily affecting the gastrointestinal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.9 Poisoning: Agent primarily affecting the gastrointestinal system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.0 Poisoning: Oxytocic drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.1 Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.2 Poisoning: Other and unspecified agents primarily acting on muscles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.3 Poisoning: Antitussives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.4 Poisoning: Expectorants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.5 Poisoning: Anti-common-cold drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.6 Poisoning: Antiasthmatics, not elsewhere classified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 517 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.7 Poisoning: Other and unspecified agents primarily acting on the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.0 Poisoning: Local antifungal, anti- infective and anti-inflammatory drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.1 Poisoning: Antipruritics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.2 Poisoning: Local astringents and local detergents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.3 Poisoning: Emollients, demulcents and protectants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.4 Poisoning: , keratoplastics and other hair treatment drugs and preparations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.5 Poisoning: Ophthalmological drugs and preparations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.6 Poisoning: Otorhinolaryngological drugs and preparations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.7 Poisoning: Dental drugs, topically applied 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.8 Poisoning: Other topical agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.9 Poisoning: Topical agent, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.0 Poisoning: Mineralocorticoids and their antagonists 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.1 Poisoning: Loop [high-ceiling] diuretics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.2 Poisoning: Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.3 Poisoning: Electrolytic, caloric and water-balance agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.4 Poisoning: Drugs affecting uric acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.5 Poisoning: Appetite depressants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.6 Poisoning: Antidotes and chelating agents, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.7 Poisoning: Analeptics and opioid receptor antagonists 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.8 Poisoning: Diagnostic agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.9 Poisoning: Other and unspecified drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51 Toxic effect of alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.0 Toxic effect: Ethanol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 518 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.1 Toxic effect: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.2 Toxic effect: 2-Propanol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.3 Toxic effect: Fusel oil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.8 Toxic effect: Other alcohols 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.9 Toxic effect: Alcohol, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52 Toxic effect of organic solvents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.0 Toxic effect: Petroleum products 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.1 Toxic effect: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.2 Toxic effect: Homologues of benzene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.3 Toxic effect: Glycols 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.4 Toxic effect: Ketones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.8 Toxic effect: Other organic solvents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.9 Toxic effect: Organic solvent, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.0 Toxic effect: Carbon tetrachloride 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.1 Toxic effect: Chloroform 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.2 Toxic effect: Trichloroethylene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.3 Toxic effect: Tetrachloroethylene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.4 Toxic effect: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.5 Toxic effect: Chlorofluorocarbons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.6 Toxic effect: Other halogen derivatives of aliphatic hydrocarbons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.7 Toxic effect: Other halogen derivatives of aromatic hydrocarbons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.9 Toxic effect: Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54 Toxic effect of corrosive substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54.0 Toxic effect: Phenol and phenol homologues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54.1 Toxic effect: Other corrosive organic compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54.2 Toxic effect: Corrosive acids and acid-like substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54.3 Toxic effect: Corrosive alkalis and alkali-like substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54.9 Toxic effect: Corrosive substance, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T55 Toxic effect of soaps and detergents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56 Toxic effect of metals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.0 Toxic effect: Lead and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.1 Toxic effect: Mercury and its compounds © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 519 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.2 Toxic effect: Chromium and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.3 Toxic effect: Cadmium and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.4 Toxic effect: Copper and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.5 Toxic effect: Zinc and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.6 Toxic effect: Tin and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.7 Toxic effect: Beryllium and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.8 Toxic effect: Other metals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.9 Toxic effect: Metal, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57 Toxic effect of other inorganic substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.0 Toxic effect: Arsenic and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.1 Toxic effect: Phosphorus and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.2 Toxic effect: Manganese and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.3 Toxic effect: Hydrogen cyanide 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.8 Toxic effect: Other specified inorganic substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.9 Toxic effect: Inorganic substance, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T58 Toxic effect of carbon monoxide 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59 Toxic effect of other gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.0 Toxic effect: Nitrogen oxides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.1 Toxic effect: Sulfur dioxide 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.2 Toxic effect: Formaldehyde 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.3 Toxic effect: Lacrimogenic gas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.4 Toxic effect: Chlorine gas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.5 Toxic effect: gas and hydrogen fluoride 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.6 Toxic effect: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.7 Toxic effect: Carbon dioxide 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.8 Toxic effect: Other specified gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.9 Toxic effect: Gases, fumes and vapours, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60 Toxic effect of pesticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.0 Toxic effect: Organophosphate and insecticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.1 Toxic effect: Halogenated insecticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.2 Toxic effect: Other insecticides

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 520 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.3 Toxic effect: Herbicides and fungicides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.4 Toxic effect: Rodenticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.8 Toxic effect: Other pesticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.9 Toxic effect: Pesticide, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61 Toxic effect of noxious substances eaten as seafood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61.0 Toxic effect: Ciguatera fish poisoning 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61.1 Toxic effect: Scombroid fish poisoning 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61.2 Toxic effect: Other fish and shellfish poisoning 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61.8 Toxic effect: Toxic effect of other seafoods 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61.9 Toxic effect: Toxic effect of unspecified seafood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62 Toxic effect of other noxious substances eaten as food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62.0 Toxic effect: Ingested mushrooms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62.1 Toxic effect: Ingested berries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62.2 Toxic effect: Other ingested (parts of) plant(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62.8 Toxic effect: Other specified noxious substances eaten as food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62.9 Toxic effect: Noxious substance eaten as food, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63 Toxic effect of contact with venomous animals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.0 Toxic effect: Snake venom 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.1 Toxic effect: Venom of other reptiles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.2 Toxic effect: Venom of scorpion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.3 Toxic effect: Venom of spider 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.4 Toxic effect: Venom of other arthropods 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.5 Toxic effect: Toxic effect of contact with fish 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.6 Toxic effect: Toxic effect of contact with other marine animals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.8 Toxic effect: Toxic effect of contact with other venomous animals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.9 Toxic effect: Toxic effect of contact with unspecified venomous animal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T64 Toxic effect of aflatoxin and other mycotoxin food contaminants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65 Toxic effect of other and unspecified substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.0 Toxic effect: Cyanides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.1 Toxic effect: Strychnine and its salts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.2 Toxic effect: Tobacco and nicotine © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 521 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.3 Toxic effect: Nitroderivatives and aminoderivatives of benzene and its homologues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.4 Toxic effect: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.5 Toxic effect: and other nitric acids and esters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.6 Toxic effect: Paints and dyes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.8 Toxic effect: Toxic effect of other specified substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.9 Toxic effect: Toxic effect of unspecified substance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T66 Unspecified effects of radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67 Effects of heat and light 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.0 Heatstroke and sunstroke 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.1 Heat syncope 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.2 Heat cramp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.3 Heat exhaustion, anhydrotic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.4 Heat exhaustion due to salt depletion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.5 Heat exhaustion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.6 Heat fatigue, transient 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.7 Heat oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.8 Other effects of heat and light 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.9 Effect of heat and light, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T68 Hypothermia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T69 Other effects of reduced temperature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T69.0 Immersion hand and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T69.1 Chilblains 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T69.8 Other specified effects of reduced temperature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T69.9 Effect of reduced temperature, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70 Effects of air pressure and water pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.0 Otitic barotrauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.1 Sinus barotrauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.2 Other and unspecified effects of high altitude 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.3 Caisson disease [decompression sickness] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.4 Effects of high-pressure fluids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.8 Other effects of air pressure and water pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.9 Effect of air pressure and water pressure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T71 Asphyxiation

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 522 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73 Effects of other deprivation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.0 Effects of hunger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.1 Effects of thirst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.2 Exhaustion due to exposure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.3 Exhaustion due to excessive exertion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.8 Other effects of deprivation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.9 Effect of deprivation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74 Maltreatment syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.0 Neglect or abandonment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.1 Physical abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.2 Sexual abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.3 Psychological abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.8 Other maltreatment syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.9 Maltreatment syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75 Effects of other external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.0 Effects of lightning 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.1 Drowning and nonfatal submersion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.2 Effects of vibration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.3 Motion sickness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.4 Effects of electric current 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.8 Other specified effects of external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78 Adverse effects, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.0 Anaphylactic shock due to adverse food reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.1 Other adverse food reactions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.2 Anaphylactic shock, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.3 Angioneurotic oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.4 Allergy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.8 Other adverse effects, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.9 Adverse effect, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79 Certain early complications of trauma, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.0 Air embolism (traumatic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.1 Fat embolism (traumatic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.2 Traumatic secondary and recurrent haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.3 Post-traumatic wound infection, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.4 Traumatic shock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.5 Traumatic anuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.6 Traumatic ischaemia of muscle

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 523 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.7 Traumatic subcutaneous emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.8 Other early complications of trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.9 Unspecified early complication of trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80 Complications following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.0 Air embolism following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.1 Vascular complications following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.2 Infections following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.3 ABO incompatibility reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.4 Rh incompatibility reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.5 Anaphylactic shock due to serum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.6 Other serum reactions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.8 Other complications following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.9 Unspecified complication following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81 Complications of procedures, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.0 Haemorrhage and haematoma complicating a procedure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.1 Shock during or resulting from a procedure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.2 Accidental puncture and laceration during a procedure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.3 Disruption of operation wound, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.4 Infection following a procedure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.5 Foreign body accidentally left in body cavity or operation wound following a procedure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.6 Acute reaction to foreign substance accidentally left during a procedure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.7 Vascular complications following a procedure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.8 Other complications of procedures, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.9 Unspecified complication of procedure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82 Complications of cardiac and vascular prosthetic devices, implants and grafts

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 524 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.0 Mechanical complication of heart valve prosthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.1 Mechanical complication of cardiac electronic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.2 Mechanical complication of coronary artery bypass and valve grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.3 Mechanical complication of other vascular grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.4 Mechanical complication of vascular dialysis catheter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.5 Mechanical complication of other cardiac and vascular devices and implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.8 Other specified complications of cardiac and vascular prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.9 Unspecified complication of cardiac and vascular prosthetic device, implant and graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83 Complications of genitourinary prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.0 Mechanical complication of urinary (indwelling) catheter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.1 Mechanical complication of other urinary devices and implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.2 Mechanical complication of graft of urinary organ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.3 Mechanical complication of intrauterine contraceptive device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.8 Other complications of genitourinary prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.9 Unspecified complication of genitourinary prosthetic device, implant and graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84 Complications of internal orthopaedic prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.0 Mechanical complication of internal joint prosthesis © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 525 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.1 Mechanical complication of internal fixation device of bones of limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.2 Mechanical complication of internal fixation device of other bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.3 Mechanical complication of other bone devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.4 Mechanical complication of other internal orthopaedic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.5 Infection and inflammatory reaction due to internal joint prosthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.6 Infection and inflammatory reaction due to internal fixation device [any site] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.7 Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.8 Other complications of internal orthopaedic prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.9 Unspecified complication of internal orthopaedic prosthetic device, implant and graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85 Complications of other internal prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.0 Mechanical complication of ventricular intracranial (communicating) shunt 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.1 Mechanical complication of implanted electronic stimulator of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.2 Mechanical complication of intraocular lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.3 Mechanical complication of other ocular prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.4 Mechanical complication of breast prosthesis and implant 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.5 Mechanical complication of gastrointestinal prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.8 Other complications of internal prosthetic devices, implants and grafts, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.9 Unspecified complication of internal prosthetic device, implant and graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86 Failure and rejection of transplanted organs and tissues © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 526 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.0 Bone-marrow transplant rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.1 Kidney transplant failure and rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.2 Heart transplant failure and rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.3 Heart-lung transplant failure and rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.4 Liver transplant failure and rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.8 Failure and rejection of other transplanted organs and tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.9 Failure and rejection of unspecified transplanted organ and tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87 Complications peculiar to reattachment and amputation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.0 Complications of reattached (part of) upper extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.1 Complications of reattached (part of) lower extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.2 Complications of other reattached body part 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.3 Neuroma of amputation stump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.4 Infection of amputation stump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.5 Necrosis of amputation stump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.6 Other and unspecified complications of amputation stump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88 Other complications of surgical and medical care, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.0 Infection following immunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.1 Other complications following immunization, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.2 Shock due to anaesthesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.3 Malignant hyperthermia due to anaesthesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.4 Failed or difficult intubation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.5 Other complications of anaesthesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.6 Anaphylactic shock due to adverse effect of correct drug or medicament properly administered 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.7 Unspecified adverse effect of drug or medicament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.8 Other specified complications of surgical and medical care, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.9 Complication of surgical and medical care, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90 Sequelae of injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.0 Sequelae of superficial injury of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.1 Sequelae of open wound of head

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 527 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.2 Sequelae of fracture of skull and facial bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.3 Sequelae of injury of cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.4 Sequelae of injury of eye and orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.5 Sequelae of intracranial injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.8 Sequelae of other specified injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.9 Sequelae of unspecified injury of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91 Sequelae of injuries of neck and trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.0 Sequelae of superficial injury and open wound of neck and trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.1 Sequelae of fracture of spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.2 Sequelae of other fracture of thorax and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.3 Sequelae of injury of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.4 Sequelae of injury of intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.5 Sequelae of injury of intra- abdominal and pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.8 Sequelae of other specified injuries of neck and trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.9 Sequelae of unspecified injury of neck and trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92 Sequelae of injuries of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.0 Sequelae of open wound of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.1 Sequelae of fracture of arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.2 Sequelae of fracture at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.3 Sequelae of dislocation, sprain and strain of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.4 Sequelae of injury of nerve of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.5 Sequelae of injury of muscle and tendon of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.6 Sequelae of crushing injury and traumatic amputation of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.8 Sequelae of other specified injuries of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.9 Sequelae of unspecified injury of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93 Sequelae of injuries of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.0 Sequelae of open wound of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.1 Sequelae of fracture of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.2 Sequelae of other fractures of lower limb

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 528 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.3 Sequelae of dislocation, sprain and strain of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.4 Sequelae of injury of nerve of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.5 Sequelae of injury of muscle and tendon of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.6 Sequelae of crushing injury and traumatic amputation of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.8 Sequelae of other specified injuries of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.9 Sequelae of unspecified injury of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T94 Sequelae of injuries involving multiple and unspecified body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T94.0 Sequelae of injuries involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T94.1 Sequelae of injuries, not specified by body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95 Sequelae of burns, corrosions and frostbite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.0 Sequelae of burn, corrosion and frostbite of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.1 Sequelae of burn, corrosion and frostbite of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.2 Sequelae of burn, corrosion and frostbite of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.3 Sequelae of burn, corrosion and frostbite of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.4 Sequelae of burn and corrosion classifiable only according to extent of body surface involved 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.8 Sequelae of other specified burn, corrosion and frostbite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.9 Sequelae of unspecified burn, corrosion and frostbite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T96 Sequelae of poisoning by drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T98 Sequelae of other and unspecified effects of external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T98.0 Sequelae of effects of foreign body entering through natural orifice 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T98.1 Sequelae of other and unspecified effects of external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T98.2 Sequelae of certain early complications of trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T98.3 Sequelae of complications of surgical and medical care, not elsewhere classified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 529 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U04 Severe acute respiratory syndrome [SARS] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U04.9 Severe acute respiratory syndrome [SARS], unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06 Emergency use of U06 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.0 Emergency use of U06.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.1 Emergency use of U06.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.2 Emergency use of U06.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.3 Emergency use of U06.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.4 Emergency use of U06.4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.5 Emergency use of U06.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.6 Emergency use of U06.6 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.7 Emergency use of U06.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.8 Emergency use of U06.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.9 Emergency use of U06.9 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07 Emergency use of U07 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.0 Emergency use of U07.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.1 Emergency use of U07.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.2 Emergency use of U07.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.3 Emergency use of U07.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.4 Emergency use of U07.4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.5 Emergency use of U07.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.6 Emergency use of U07.6 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.7 Emergency use of U07.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.8 Emergency use of U07.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.9 Emergency use of U07.9 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82 Resistance to betalactam antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82.0 Resistance to penicillin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82.1 Resistance to methicillin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82.2 Extended spectrum betalactamase (ESBL) resistance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82.8 Resistance to other betalactam antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82.9 Resistance to betalactam antibiotics, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83 Resistance to other antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.0 Resistance to vancomycin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.1 Resistance to other vancomycin related antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.2 Resistance to quinolones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.7 Resistance to multiple antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.8 Resistance to other single specified antibiotic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.9 Resistance to unspecified antibiotic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84 Resistance to other antimicrobial drugs © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 530 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.0 Resistance to antiparasitic drug(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.1 Resistance to antifungal drug(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.2 Resistance to (s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.3 Resistance to tuberculostatic drug(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.7 Resistance to multiple antimicrobial drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.8 Resistance to other specified antimicrobial drug 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.9 Resistance to unspecified antimicrobial drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U85 Resistance to antineoplastic drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00 General examination and investigation of persons without complaint and reported diagnosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.0 General medical examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.1 Routine child health examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.2 Examination for period of rapid growth in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.3 Examination for adolescent development state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.4 General psychiatric examination, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.5 Examination of potential donor of organ and tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.6 Examination for normal comparison and control in clinical research programme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.8 Other general examinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01 Other special examinations and investigations of persons without complaint or reported diagnosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.0 Examination of eyes and vision 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.1 Examination of ears and hearing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.2 Dental examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.3 Examination of blood pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.4 Gynaecological examination (general)(routine) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.5 Diagnostic skin and sensitization tests 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.6 Radiological examination, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.7 Laboratory examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.8 Other specified special examinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.9 Special examination, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02 Examination and encounter for administrative purposes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.0 Examination for admission to educational institution

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 531 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.1 Pre-employment examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.2 Examination for admission to residential institutions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.3 Examination for recruitment to armed forces 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.4 Examination for driving licence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.5 Examination for participation in sport 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.6 Examination for insurance purposes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.7 Issue of medical certificate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.8 Other examinations for administrative purposes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.9 Examination for administrative purposes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03 Medical observation and evaluation for suspected diseases and conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.0 Observation for suspected tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.1 Observation for suspected malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.2 Observation for suspected mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.3 Observation for suspected nervous system disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.4 Observation for suspected myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.5 Observation for other suspected cardiovascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.6 Observation for suspected toxic effect from ingested substance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.8 Observation for other suspected diseases and conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.9 Observation for suspected disease or condition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04 Examination and observation for other reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.0 Blood-alcohol and blood-drug test 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.1 Examination and observation following transport accident 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.2 Examination and observation following work accident 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.3 Examination and observation following other accident 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.4 Examination and observation following alleged rape and seduction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.5 Examination and observation following other inflicted injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.6 General psychiatric examination, requested by authority 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.8 Examination and observation for other specified reasons

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 532 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.9 Examination and observation for unspecified reason 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08 Follow-up examination after treatment for malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.0 Follow-up examination after surgery for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.1 Follow-up examination after radiotherapy for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.2 Follow-up examination after for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.7 Follow-up examination after combined treatment for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.8 Follow-up examination after other treatment for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09 Follow-up examination after treatment for conditions other than malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.0 Follow-up examination after surgery for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.1 Follow-up examination after radiotherapy for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.2 Follow-up examination after chemotherapy for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.3 Follow-up examination after psychotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.4 Follow-up examination after treatment of fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.7 Follow-up examination after combined treatment for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.8 Follow-up examination after other treatment for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.9 Follow-up examination after unspecified treatment for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10 Routine general health check-up of defined subpopulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10.0 Occupational health examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10.1 Routine general health check-up of inhabitants of institutions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10.2 Routine general health check-up of armed forces 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10.3 Routine general health check-up of sports teams 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10.8 Routine general health check-up of other defined subpopulations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11 Special screening examination for infectious and parasitic diseases © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 533 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.0 Special screening examination for intestinal infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.1 Special screening examination for respiratory tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.2 Special screening examination for other bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.4 Special screening examination for human immunodeficiency virus [HIV] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.5 Special screening examination for other viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.6 Special screening examination for other protozoal diseases and helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.8 Special screening examination for other infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.9 Special screening examination for infectious and parasitic diseases, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12 Special screening examination for neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.0 Special screening examination for neoplasm of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.1 Special screening examination for neoplasm of intestinal tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.2 Special screening examination for neoplasm of respiratory organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.3 Special screening examination for neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.4 Special screening examination for neoplasm of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.5 Special screening examination for neoplasm of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.6 Special screening examination for neoplasm of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.8 Special screening examination for neoplasms of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.9 Special screening examination for neoplasm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13 Special screening examination for other diseases and disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.0 Special screening examination for diseases of the blood and blood- forming organs and certain disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.1 Special screening examination for diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.2 Special screening examination for nutritional disorders

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 534 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.3 Special screening examination for mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.4 Special screening examination for certain developmental disorders in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.5 Special screening examination for eye and ear disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.6 Special screening examination for cardiovascular disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.7 Special screening examination for congenital malformations, deformations and chromosomal abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.8 Special screening examination for other specified diseases and disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.9 Special screening examination, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20 Contact with and exposure to communicable diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.0 Contact with and exposure to intestinal infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.1 Contact with and exposure to tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.3 Contact with and exposure to rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.4 Contact with and exposure to rubella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.5 Contact with and exposure to viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.6 Contact with and exposure to human immunodeficiency virus [HIV] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.8 Contact with and exposure to other communicable diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.9 Contact with and exposure to unspecified communicable disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z21 Asymptomatic human immunodeficiency virus [HIV] infection status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22 Carrier of infectious disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.0 Carrier of typhoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.1 Carrier of other intestinal infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.2 Carrier of diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.3 Carrier of other specified bacterial diseases

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 535 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.4 Carrier of infections with a predominantly sexual mode of transmission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.6 Carrier of human T-lymphotropic virus type- 1 [HTLV-1] infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.8 Carrier of other infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.9 Carrier of infectious disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23 Need for immunization against single bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.0 Need for immunization against cholera alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.1 Need for immunization against typhoid-paratyphoid alone [TAB] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.2 Need for immunization against tuberculosis [BCG] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.3 Need for immunization against plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.4 Need for immunization against tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.5 Need for immunization against tetanus alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.6 Need for immunization against diphtheria alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.7 Need for immunization against pertussis alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.8 Need for immunization against other single bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24 Need for immunization against certain single viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.0 Need for immunization against poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.1 Need for immunization against arthropod-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.2 Need for immunization against rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.3 Need for immunization against yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.4 Need for immunization against measles alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.5 Need for immunization against rubella alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.6 Need for immunization against viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z25 Need for immunization against other single viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z25.0 Need for immunization against mumps alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z25.1 Need for immunization against influenza 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z25.8 Need for immunization against other specified single viral diseases

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 536 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z26 Need for immunization against other single infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z26.0 Need for immunization against leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z26.8 Need for immunization against other specified single infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z26.9 Need for immunization against unspecified infectious disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27 Need for immunization against combinations of infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.0 Need for immunization against cholera with typhoid-paratyphoid [cholera + TAB] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.1 Need for immunization against diphtheria-tetanus-pertussis, combined [DTP] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.2 Need for immunization against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.3 Need for immunization against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.4 Need for immunization against measles-mumps-rubella [MMR] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.8 Need for immunization against other combinations of infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.9 Need for immunization against unspecified combinations of infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28 Immunization not carried out 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28.0 Immunization not carried out because of contraindication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28.1 Immunization not carried out because of patient's decision for reasons of belief or group pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28.2 Immunization not carried out because of patient's decision for other and unspecified reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28.8 Immunization not carried out for other reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28.9 Immunization not carried out for unspecified reason 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29 Need for other prophylactic measures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29.0 Isolation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29.1 Prophylactic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29.2 Other prophylactic chemotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29.8 Other specified prophylactic measures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29.9 Prophylactic measure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30 Contraceptive management 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.0 General counselling and advice on contraception © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 537 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.1 Insertion of (intrauterine) contraceptive device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.2 Sterilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.3 Menstrual extraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.4 Surveillance of contraceptive drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.5 Surveillance of (intrauterine) contraceptive device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.8 Other contraceptive management 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.9 Contraceptive management, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31 Procreative management 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.0 Tuboplasty or vasoplasty after previous sterilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.1 Artificial insemination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.2 In vitrofertilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.3 Other assisted fertilization methods 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.4 Procreative investigation and testing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.5 Genetic counselling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.6 General counselling and advice on procreation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.8 Other procreative management 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.9 Procreative management, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z32 Pregnancy examination and test 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z32.0 Pregnancy, not (yet) confirmed 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z32.1 Pregnancy confirmed 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z33 Pregnant state, incidental 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z34 Supervision of normal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z34.0 Supervision of normal first pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z34.8 Supervision of other normal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z34.9 Supervision of normal pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35 Supervision of high-risk pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.0 Supervision of pregnancy with history of infertility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.1 Supervision of pregnancy with history of abortive outcome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.3 Supervision of pregnancy with history of insufficient antenatal care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.4 Supervision of pregnancy with grand multiparity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.5 Supervision of elderly primigravida 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.6 Supervision of very young primigravida © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 538 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.7 Supervision of high-risk pregnancy due to social problems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.8 Supervision of other high-risk pregnancies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.9 Supervision of high-risk pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36 Antenatal screening 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.0 Antenatal screening for chromosomal anomalies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.1 Antenatal screening for raised alphafetoprotein level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.2 Other antenatal screening based on amniocentesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.3 Antenatal screening for malformations using ultrasound and other physical methods 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.4 Antenatal screening for fetal growth retardation using ultrasound and other physical methods 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.5 Antenatal screening for isoimmunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.8 Other antenatal screening 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.9 Antenatal screening, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37 Outcome of delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.0 Single live birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.1 Single stillbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.2 Twins, both liveborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.3 Twins, one liveborn and one stillborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.4 Twins, both stillborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.5 Other multiple births, all liveborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.6 Other multiple births, some liveborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.7 Other multiple births, all stillborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.9 Outcome of delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38 Liveborn infants according to place of birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.0 Singleton, born in hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.1 Singleton, born outside hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.2 Singleton, unspecified as to place of birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.3 Twin, born in hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.4 Twin, born outside hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.5 Twin, unspecified as to place of birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.6 Other multiple, born in hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.7 Other multiple, born outside hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.8 Other multiple, unspecified as to place of birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z39 Postpartum care and examination

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 539 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z39.0 Care and examination immediately after delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z39.1 Care and examination of lactating mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z39.2 Routine postpartum follow-up 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z40 Prophylactic surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z40.8 Other prophylactic surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z40.9 Prophylactic surgery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41 Procedures for purposes other than remedying health state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.0 Hair transplant 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.1 Other plastic surgery for unacceptable cosmetic appearance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.2 Routine and ritual circumcision 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.3 Ear piercing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.8 Other procedures for purposes other than remedying health state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.9 Procedure for purposes other than remedying health state, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42 Follow-up care involving plastic surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.0 Follow-up care involving plastic surgery of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.1 Follow-up care involving plastic surgery of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.2 Follow-up care involving plastic surgery of other parts of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.3 Follow-up care involving plastic surgery of upper extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.4 Follow-up care involving plastic surgery of lower extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.8 Follow-up care involving plastic surgery of other body part 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.9 Follow-up care involving plastic surgery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43 Attention to artificial openings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.0 Attention to tracheostomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.1 Attention to gastrostomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.2 Attention to ileostomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.3 Attention to colostomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.4 Attention to other artificial openings of digestive tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.5 Attention to cystostomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.6 Attention to other artificial openings of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.7 Attention to artificial vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.8 Attention to other artificial openings

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 540 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.9 Attention to unspecified artificial opening 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44 Fitting and adjustment of external prosthetic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.0 Fitting and adjustment of artificial arm (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.1 Fitting and adjustment of artificial leg (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.2 Fitting and adjustment of artificial eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.3 Fitting and adjustment of external breast prosthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.8 Fitting and adjustment of other external prosthetic devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.9 Fitting and adjustment of unspecified external prosthetic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45 Adjustment and management of implanted device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.0 Adjustment and management of cardiac devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.1 Adjustment and management of infusion pump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.2 Adjustment and management of vascular access device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.3 Adjustment and management of implanted hearing device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.8 Adjustment and management of other implanted devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.9 Adjustment and management of unspecified implanted device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46 Fitting and adjustment of other devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.0 Fitting and adjustment of spectacles and contact lenses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.1 Fitting and adjustment of hearing aid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.2 Fitting and adjustment of other devices related to nervous system and special senses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.3 Fitting and adjustment of dental prosthetic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.4 Fitting and adjustment of orthodontic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.5 Fitting and adjustment of ileostomy and other intestinal appliances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.6 Fitting and adjustment of urinary device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.7 Fitting and adjustment of orthopaedic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.8 Fitting and adjustment of other specified devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.9 Fitting and adjustment of unspecified device © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 541 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z47 Other orthopaedic follow-up care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z47.0 Follow-up care involving removal of fracture plate and other internal fixation device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z47.8 Other specified orthopaedic follow- up care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z47.9 Orthopaedic follow-up care, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z48 Other surgical follow-up care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z48.0 Attention to surgical dressings and sutures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z48.8 Other specified surgical follow-up care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z48.9 Surgical follow-up care, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z49 Care involving dialysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z49.0 Preparatory care for dialysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z49.1 Extracorporeal dialysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z49.2 Other dialysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50 Care involving use of rehabilitation procedures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.0 Cardiac rehabilitation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.1 Other physical therapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.2 Alcohol rehabilitation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.3 Drug rehabilitation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.4 Psychotherapy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.5 Speech therapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.6 Orthoptic training 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.8 Care involving use of other rehabilitation procedures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.9 Care involving use of rehabilitation procedure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51 Other medical care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.0 Radiotherapy session 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.1 Chemotherapy session for neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.2 Other chemotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.3 Blood transfusion (without reported diagnosis) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.4 Preparatory care for subsequent treatment, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.5 Palliative care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.6 Desensitization to allergens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.8 Other specified medical care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.9 Medical care, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 542 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52 Donors of organs and tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.0 Blood donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.1 Skin donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.2 Bone donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.3 Bone marrow donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.4 Kidney donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.5 Cornea donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.6 Liver donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.7 Heart donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.8 Donor of other organs and tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.9 Donor of unspecified organ or tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53 Persons encountering health services for specific procedures, not carried out 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53.0 Procedure not carried out because of contraindication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53.1 Procedure not carried out because of patient's decision for reasons of belief and group pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53.2 Procedure not carried out because of patient's decision for other and unspecified reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53.8 Procedure not carried out for other reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53.9 Procedure not carried out, unspecified reason 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54 Convalescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.0 Convalescence following surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.1 Convalescence following radiotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.2 Convalescence following chemotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.3 Convalescence following psychotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.4 Convalescence following treatment of fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.7 Convalescence following combined treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.8 Convalescence following other treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.9 Convalescence following unspecified treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55 Problems related to education and literacy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.0 Illiteracy and low-level literacy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.1 Schooling unavailable and unattainable 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.2 Failed examinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.3 Underachievement in school

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 543 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.4 Educational maladjustment and discord with teachers and classmates 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.8 Other problems related to education and literacy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.9 Problem related to education and literacy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56 Problems related to employment and unemployment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.0 Unemployment, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.1 Change of job 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.2 Threat of job loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.3 Stressful work schedule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.4 Discord with boss and workmates 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.5 Uncongenial work 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.6 Other physical and mental strain related to work 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.7 Other and unspecified problems related to employment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57 Occupational exposure to risk- factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.0 Occupational exposure to noise 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.1 Occupational exposure to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.2 Occupational exposure to dust 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.3 Occupational exposure to other air contaminants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.4 Occupational exposure to toxic agents in agriculture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.5 Occupational exposure to toxic agents in other industries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.6 Occupational exposure to extreme temperature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.7 Occupational exposure to vibration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.8 Occupational exposure to other risk- factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.9 Occupational exposure to unspecified risk-factor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58 Problems related to physical environment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.0 Exposure to noise 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.1 Exposure to air pollution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.2 Exposure to water pollution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.3 Exposure to soil pollution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.4 Exposure to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.5 Exposure to other pollution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.6 Inadequate drinking-water supply 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.7 Exposure to tobacco smoke 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.8 Other problems related to physical environment © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 544 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.9 Problem related to physical environment, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59 Problems related to housing and economic circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.0 Homelessness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.1 Inadequate housing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.2 Discord with neighbours, lodgers and landlord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.3 Problems related to living in residential institution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.4 Lack of adequate food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.5 Extreme poverty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.6 Low income 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.7 Insufficient social insurance and welfare support 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.8 Other problems related to housing and economic circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.9 Problem related to housing and economic circumstances, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60 Problems related to social environment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.0 Problems of adjustment to life-cycle transitions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.1 Atypical parenting situation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.2 Living alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.3 Acculturation difficulty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.4 Social exclusion and rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.5 Target of perceived adverse discrimination and persecution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.8 Other problems related to social environment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.9 Problem related to social environment, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61 Problems related to negative life events in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.0 Loss of love relationship in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.1 Removal from home in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.2 Altered pattern of family relationships in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.3 Events resulting in loss of self- esteem in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.4 Problems related to alleged sexual abuse of child by person within primary support group 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.6 Problems related to alleged physical abuse of child © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 545 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.7 Personal frightening experience in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.8 Other negative life events in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.9 Negative life event in childhood, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62 Other problems related to upbringing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.0 Inadequate parental supervision and control 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.1 Parental overprotection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.2 Institutional upbringing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.3 Hostility towards and scapegoating of child 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.4 Emotional neglect of child 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.5 Other problems related to neglect in upbringing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.6 Inappropriate parental pressure and other abnormal qualities of upbringing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.8 Other specified problems related to upbringing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.9 Problem related to upbringing, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63 Other problems related to primary support group, including family circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.0 Problems in relationship with spouse or partner 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.1 Problems in relationship with parents and in-laws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.2 Inadequate family support 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.3 Absence of family member 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.4 Disappearance and death of family member 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.5 Disruption of family by separation and divorce 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.6 Dependent relative needing care at home 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.7 Other stressful life events affecting family and household 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.8 Other specified problems related to primary support group 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.9 Problem related to primary support group, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64 Problems related to certain psychosocial circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64.0 Problems related to unwanted pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64.1 Problems related to multiparity

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 546 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64.4 Discord with counsellors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65 Problems related to other psychosocial circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.0 Conviction in civil and criminal proceedings without imprisonment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.1 Imprisonment and other incarceration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.2 Problems related to release from prison 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.3 Problems related to other legal circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.4 Victim of crime and terrorism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.5 Exposure to disaster, war and other hostilities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.8 Other specified problems related to psychosocial circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.9 Problem related to unspecified psychosocial circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70 Counselling related to sexual attitude, behaviour and orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.0 Counselling related to sexual attitude 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.1 Counselling related to patient's sexual behaviour and orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.2 Counselling related to sexual behaviour and orientation of third party 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.3 Counselling related to combined concerns regarding sexual attitude, behaviour and orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.8 Other sex counselling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.9 Sex counselling, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.0 Person consulting on behalf of another person 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.1 Person with feared complaint in whom no diagnosis is made 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.2 Person consulting for explanation of investigation findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.3 Dietary counselling and surveillance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.4 Alcohol abuse counselling and surveillance

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 547 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.5 Drug abuse counselling and surveillance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.6 Tobacco abuse counselling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.7 Human immunodeficiency virus [HIV] counselling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.8 Other specified counselling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.9 Counselling, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72 Problems related to lifestyle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.0 Tobacco use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.1 Alcohol use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.2 Drug use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.3 Lack of physical exercise 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.4 Inappropriate diet and eating habits 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.5 High-risk sexual behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.6 Gambling and betting 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.8 Other problems related to lifestyle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.9 Problem related to lifestyle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73 Problems related to life- management difficulty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.0 Burn-out 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.1 Accentuation of personality traits 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.2 Lack of relaxation and leisure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.3 Stress, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.4 Inadequate social skills, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.5 Social role conflict, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.6 Limitation of activities due to disability 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.8 Other problems related to life- management difficulty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.9 Problem related to life-management difficulty, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74 Problems related to care-provider dependency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.0 Need for assistance due to reduced mobility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.1 Need for assistance with personal care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.2 Need for assistance at home and no other household member able to render care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.3 Need for continuous supervision 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.8 Other problems related to care- provider dependency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.9 Problem related to care-provider dependency, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 548 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75 Problems related to medical facilities and other health care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.0 Medical services not available in home 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.1 Person awaiting admission to adequate facility elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.2 Other waiting period for investigation and treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.3 Unavailability and inaccessibility of health-care facilities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.4 Unavailability and inaccessibility of other helping agencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.5 Holiday relief care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.8 Other problems related to medical facilities and other health care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.9 Unspecified problem related to medical facilities and other health care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76 Persons encountering health services in other circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.0 Issue of repeat prescription 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.1 Health supervision and care of foundling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.2 Health supervision and care of other healthy infant and child 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.3 Healthy person accompanying sick person 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.4 Other boarder in health-care facility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.5 Malingerer [conscious simulation] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.8 Persons encountering health services in other specified circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.9 Person encountering health services in unspecified circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80 Family history of malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.0 Family history of malignant neoplasm of digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.3 Family history of malignant neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.4 Family history of malignant neoplasm of genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.5 Family history of malignant neoplasm of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.6 Family history of leukaemia

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 549 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.7 Family history of other malignant neoplasms of lymphoid, haematopoietic and related tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.8 Family history of malignant neoplasm of other organs or systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.9 Family history of malignant neoplasm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81 Family history of mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.0 Family history of mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.1 Family history of alcohol abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.2 Family history of tobacco abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.3 Family history of other psychoactive substance abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.4 Family history of other substance abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.8 Family history of other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82 Family history of certain disabilities and chronic diseases leading to disablement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.0 Family history of epilepsy and other diseases of the nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.1 Family history of blindness and visual loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.2 Family history of deafness and hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.3 Family history of stroke 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.4 Family history of ischaemic heart disease and other diseases of the circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.5 Family history of asthma and other chronic lower respiratory diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.6 Family history of arthritis and other diseases of the musculoskeletal system and connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.7 Family history of congenital malformations, deformations and chromosomal abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.8 Family history of other disabilities and chronic diseases leading to disablement, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83 Family history of other specific disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.0 Family history of human immunodeficiency virus [HIV] disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.1 Family history of other infectious and parasitic diseases

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 550 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.2 Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.3 Family history of diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.4 Family history of other endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.5 Family history of eye and ear disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.6 Family history of diseases of the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.7 Family history of diseases of the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84 Family history of other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84.0 Family history of diseases of the skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84.1 Family history of disorders of kidney and ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84.2 Family history of other diseases of the genitourinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84.3 Family history of consanguinity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84.8 Family history of other specified conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85 Personal history of malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.0 Personal history of malignant neoplasm of digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.3 Personal history of malignant neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.4 Personal history of malignant neoplasm of genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.5 Personal history of malignant neoplasm of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.6 Personal history of leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.8 Personal history of malignant neoplasms of other organs and systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.9 Personal history of malignant neoplasm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86 Personal history of certain other diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.0 Personal history of other neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.1 Personal history of infectious and parasitic diseases © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 551 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.2 Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.3 Personal history of endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.4 Personal history of psychoactive substance abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.5 Personal history of other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.6 Personal history of diseases of the nervous system and sense organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.7 Personal history of diseases of the circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87 Personal history of other diseases and conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.0 Personal history of diseases of the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.1 Personal history of diseases of the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.2 Personal history of diseases of the skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.3 Personal history of diseases of the musculoskeletal system and connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.4 Personal history of diseases of the genitourinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.5 Personal history of complications of pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.6 Personal history of certain conditions arising in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.8 Personal history of other specified conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88 Personal history of allergy to drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.0 Personal history of allergy to penicillin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.1 Personal history of allergy to other antibiotic agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.2 Personal history of allergy to sulfonamides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.3 Personal history of allergy to other anti-infective agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.4 Personal history of allergy to anaesthetic agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.5 Personal history of allergy to narcotic agent

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 552 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.6 Personal history of allergy to analgesic agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.7 Personal history of allergy to serum and vaccine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.8 Personal history of allergy to other drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89 Acquired absence of limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.0 Acquired absence of finger(s) [including thumb], unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.1 Acquired absence of hand and wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.2 Acquired absence of upper limb above wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.3 Acquired absence of both upper limbs [any level] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.4 Acquired absence of foot and ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.5 Acquired absence of leg at or below knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.6 Acquired absence of leg above knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.7 Acquired absence of both lower limbs [any level, except toes alone] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.8 Acquired absence of upper and lower limbs [any level] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.9 Acquired absence of limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90 Acquired absence of organs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.0 Acquired absence of part of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.1 Acquired absence of breast(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.2 Acquired absence of lung [part of] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.3 Acquired absence of part of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.4 Acquired absence of other parts of digestive tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.5 Acquired absence of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.6 Acquired absence of other organs of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.7 Acquired absence of genital organ(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.8 Acquired absence of other organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91 Personal history of risk-factors, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.0 Personal history of allergy, other than to drugs and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.1 Personal history of noncompliance with medical treatment and regimen

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 553 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.2 Personal history of poor personal hygiene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.3 Personal history of unhealthy sleep- wake schedule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.4 Personal history of psychological trauma, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.5 Personal history of self-harm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.6 Personal history of other physical trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.7 Personal history of female genital mutilation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.8 Personal history of other specified risk-factors, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92 Personal history of medical treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.0 Personal history of contraception 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.1 Personal history of long-term (current) use of anticoagulants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.2 Personal history of long-term (current) use of other medicaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.3 Personal history of irradiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.4 Personal history of major surgery, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.5 Personal history of rehabilitation measures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.6 Personal history of chemotherapy for neoplastic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.8 Personal history of other medical treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.9 Personal history of medical treatment, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93 Artificial opening status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.0 Tracheostomy status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.1 Gastrostomy status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.2 Ileostomy status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.3 Colostomy status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.4 Other artificial openings of status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.5 Cystostomy status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.6 Other artificial openings of urinary tract status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.8 Other artificial opening status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.9 Artificial opening status, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94 Transplanted organ and tissue status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.0 Kidney transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.1 Heart transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.2 Lung transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.3 Heart and lungs transplant status

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 554 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.4 Liver transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.5 Skin transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.6 Bone transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.7 Corneal transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.8 Other transplanted organ and tissue status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.9 Transplanted organ and tissue status, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95 Presence of cardiac and vascular implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.0 Presence of electronic cardiac devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.1 Presence of aortocoronary bypass graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.2 Presence of prosthetic heart valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.3 Presence of xenogenic heart valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.4 Presence of other heart-valve replacement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.5 Presence of coronary angioplasty implant and graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.8 Presence of other cardiac and vascular implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.9 Presence of cardiac and vascular implant and graft, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96 Presence of other functional implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.0 Presence of urogenital implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.1 Presence of intraocular lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.2 Presence of otological and audiological implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.3 Presence of artificial larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.4 Presence of endocrine implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.5 Presence of tooth-root and mandibular implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.6 Presence of orthopaedic joint implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.7 Presence of other bone and tendon implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.8 Presence of other specified functional implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.9 Presence of functional implant, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97 Presence of other devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.0 Presence of artificial eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.1 Presence of artificial limb (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.2 Presence of dental prosthetic device (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.3 Presence of spectacles and contact lenses © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 555 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.4 Presence of external hearing-aid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.5 Presence of (intrauterine) contraceptive device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.8 Presence of other specified devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z98 Other postsurgical states 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z98.0 Intestinal bypass and anastomosis status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z98.1 Arthrodesis status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z98.2 Presence of cerebrospinal fluid drainage device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z98.8 Other specified postsurgical states 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99 Dependence on enabling machines and devices, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.0 Dependence on aspirator 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.1 Dependence on respirator 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.2 Dependence on renal dialysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.3 Dependence on wheelchair 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.4 Dependence on artificial heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.8 Dependence on other enabling machines and devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.9 Dependence on unspecified enabling machine and device

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 556 of 624 Service Provider MTC epSOSLanguage

epSOSLanguage

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.6

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 1dd183a6-6d2b-4a9d-8f5d- 2017-03 af-NA Afrikaans-NAMIBIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 af-ZA Afrikaans-SOUTH AFRICA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ak-GH Akan-GHANA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 am-ET Amharic-ETHIOPIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-AE Arabic-UNITED ARAB EMIRATES be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-BH Arabic-BAHRAIN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-DJ Arabic-DJIBOUTI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-DZ Arabic-ALGERIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-EG Arabic-EGYPT be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-EH Arabic-WESTERN SAHARA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-ER Arabic-ERITREA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-IL Arabic-ISRAEL be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-IQ Arabic-IRAQ be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-JO Arabic-JORDAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-KM Arabic-COMOROS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-KW Arabic-KUWAIT be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-LB Arabic-LEBANON be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-LY Arabic-LIBYA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-MA Arabic-MOROCCO be09d6bb5a6e

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 557 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-MR Arabic-MAURITANIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-OM Arabic-OMAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-PS Arabic-PALESTINE, STATE OF be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-QA Arabic-QATAR be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-SA Arabic-SAUDI ARABIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-SD Arabic-SUDAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-SO Arabic-SOMALIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-SS Arabic-SOUTH SUDAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-SY Arabic-SYRIAN ARAB REPUBLIC be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-TD Arabic-CHAD be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-TN Arabic-TUNISIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ar-YE Arabic-YEMEN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 as-IN Assamese-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 az-AZ Azerbaijani-AZERBAIJAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 be-BY Belarusian-BELARUS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 bg-BG Bulgarian-BULGARIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 bm-ML Bambara-MALI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 bn-BD Bengali-BANGLADESH be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 bn-IN Bengali-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 bo-CN Tibetan-CHINA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 bo-IN Tibetan-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 br-FR Breton-FRANCE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 bs-BA Bosnian-BOSNIA AND be09d6bb5a6e HERZEGOVINA 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ca-AD Catalan; Valencian-ANDORRA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ca-ES Catalan; Valencian-SPAIN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ca-FR Catalan; Valencian-FRANCE be09d6bb5a6e

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 558 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 ca-IT Catalan; Valencian-ITALY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 cs-CZ Czech-CZECH REPUBLIC be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 cy-GB Welsh-UNITED KINGDOM OF be09d6bb5a6e GREAT BRITAIN AND NORTHERN IRELAND 1dd183a6-6d2b-4a9d-8f5d- 2017-03 da-DK Danish-DENMARK be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 da-GL Danish-GREENLAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 de-AT German-AUSTRIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 de-BE German-BELGIUM be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 de-CH German-SWITZERLAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 de-DE German-GERMANY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 de-LI German-LIECHTENSTEIN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 de-LU German-LUXEMBOURG be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 dz-BT Dzongkha-BHUTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ee-GH Ewe-GHANA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ee-TG Ewe-TOGO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 el-CY Greek, Modern (1453-)-CYPRUS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 el-GR Greek, Modern (1453-)-GREECE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-AG English-ANTIGUA AND BARBUDA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-AI English-ANGUILLA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-AS English-AMERICAN SAMOA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-AU English-AUSTRALIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-BB English-BARBADOS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-BE English-BELGIUM be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-BM English-BERMUDA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-BS English-BAHAMAS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-BW English-BOTSWANA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-BZ English-BELIZE be09d6bb5a6e © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 559 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-CA English-CANADA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-CC English-COCOS (KEELING) be09d6bb5a6e ISLANDS 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-CK English-COOK ISLANDS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-CM English-CAMEROON be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-CX English-CHRISTMAS ISLAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-DM English-DOMINICA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-ER English-ERITREA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-FJ English-FIJI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-FK English-FALKLAND ISLANDS be09d6bb5a6e (MALVINAS) 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-FM English-MICRONESIA be09d6bb5a6e (FEDERATED STATES OF) 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-GB English-UNITED KINGDOM OF be09d6bb5a6e GREAT BRITAIN AND NORTHERN IRELAND 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-GD English-GRENADA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-GG English-GUERNSEY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-GH English-GHANA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-GI English-GIBRALTAR be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-GM English-GAMBIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-GU English-GUAM be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-GY English-GUYANA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-HK English-HONG KONG be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-IE English-IRELAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-IM English-ISLE OF MAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-IN English-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-IO English-BRITISH INDIAN OCEAN be09d6bb5a6e TERRITORY 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-JE English-JERSEY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-JM English-JAMAICA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-KE English-KENYA be09d6bb5a6e © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 560 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-KI English-KIRIBATI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-KN English-SAINT KITTS AND NEVIS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-KY English-CAYMAN ISLANDS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-LC English-SAINT LUCIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-LR English-LIBERIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-LS English-LESOTHO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-MG English-MADAGASCAR be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-MH English-MARSHALL ISLANDS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-MO English-MACAO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-MP English-NORTHERN MARIANA be09d6bb5a6e ISLANDS 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-MS English-MONTSERRAT be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-MT English-MALTA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-MU English-MAURITIUS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-MW English-MALAWI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-MY English-MALAYSIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-NA English-NAMIBIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-NF English-NORFOLK ISLAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-NG English-NIGERIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-NR English-NAURU be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-NU English-NIUE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-NZ English-NEW ZEALAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-PG English-PAPUA NEW GUINEA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-PH English-PHILIPPINES be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-PK English-PAKISTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-PN English-PITCAIRN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-PR English-PUERTO RICO be09d6bb5a6e

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 561 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-PW English-PALAU be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-RW English-RWANDA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-SB English-SOLOMON ISLANDS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-SC English-SEYCHELLES be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-SD English-SUDAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-SG English-SINGAPORE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-SH English-SAINT HELENA, be09d6bb5a6e ASCENSION AND TRISTAN DA CUNHA 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-SL English-SIERRA LEONE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-SS English-SOUTH SUDAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-SX English-SINT MAARTEN (DUTCH be09d6bb5a6e PART) 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-SZ English-SWAZILAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-TC English-TURKS AND CAICOS be09d6bb5a6e ISLANDS 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-TK English-TOKELAU be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-TO English-TONGA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-TT English-TRINIDAD AND TOBAGO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-TV English-TUVALU be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-TZ English-TANZANIA, UNITED be09d6bb5a6e REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-UG English-UGANDA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-UM English-UNITED STATES MINOR be09d6bb5a6e OUTLYING ISLANDS 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-US English-UNITED STATES OF be09d6bb5a6e AMERICA 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-VC English-SAINT VINCENT AND THE be09d6bb5a6e GRENADINES 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-VG English-VIRGIN ISLANDS, BRITISH be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-VI English-VIRGIN ISLANDS, U.S. be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-VU English-VANUATU be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-WS English-SAMOA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-ZA English-SOUTH AFRICA be09d6bb5a6e © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 562 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-ZM English-ZAMBIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 en-ZW English-ZIMBABWE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-AR Spanish; Castilian-ARGENTINA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-BO Spanish; Castilian-BOLIVIA be09d6bb5a6e (PLURINATIONAL STATE OF) 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-CL Spanish; Castilian-CHILE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-CO Spanish; Castilian-COLOMBIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-CR Spanish; Castilian-COSTA RICA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-CU Spanish; Castilian-CUBA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-DO Spanish; Castilian-DOMINICAN be09d6bb5a6e REPUBLIC 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-EC Spanish; Castilian-ECUADOR be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-ES Spanish; Castilian-SPAIN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-GQ Spanish; Castilian-EQUATORIAL be09d6bb5a6e GUINEA 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-GT Spanish; Castilian-GUATEMALA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-HN Spanish; Castilian-HONDURAS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-MX Spanish; Castilian-MEXICO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-NI Spanish; Castilian-NICARAGUA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-PA Spanish; Castilian-PANAMA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-PE Spanish; Castilian-PERU be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-PH Spanish; Castilian-PHILIPPINES be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-PR Spanish; Castilian-PUERTO RICO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-PY Spanish; Castilian-PARAGUAY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-SV Spanish; Castilian-EL SALVADOR be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-US Spanish; Castilian-UNITED be09d6bb5a6e STATES OF AMERICA 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-UY Spanish; Castilian-URUGUAY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 es-VE Spanish; Castilian-VENEZUELA be09d6bb5a6e (BOLIVARIAN REPUBLIC OF) 1dd183a6-6d2b-4a9d-8f5d- 2017-03 et-EE Estonian-ESTONIA be09d6bb5a6e

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 563 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 eu-ES Basque; Basque County-SPAIN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fa-AF Persian-AFGHANISTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fa-IR Persian-IRAN (ISLAMIC REPUBLIC be09d6bb5a6e OF) 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ff-CM Fulah-CAMEROON be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ff-GN Fulah-GUINEA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ff-MR Fulah-MAURITANIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ff-SN Fulah-SENEGAL be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fi-FI Finnish-FINLAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fo-FO Faroese-FAROE ISLANDS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-BE French-BELGIUM be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-BF French-BURKINA FASO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-BI French-BURUNDI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-BJ French-BENIN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-BL French-SAINT BARTHÉLEMY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-CA French-CANADA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-CD French-CONGO, DEMOCRATIC be09d6bb5a6e REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-CF French-CENTRAL AFRICAN be09d6bb5a6e REPUBLIC 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-CG French-CONGO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-CH French-SWITZERLAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-CI French-COTE D'IVOIRE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-CM French-CAMEROON be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-DJ French-DJIBOUTI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-DZ French-ALGERIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-FR French-FRANCE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-GA French-GABON be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-GF French-FRENCH GUIANA be09d6bb5a6e

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 564 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-GN French-GUINEA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-GP French-GUADELOUPE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-GQ French-EQUATORIAL GUINEA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-HT French-HAITI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-KM French-COMOROS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-LU French-LUXEMBOURG be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-MA French-MOROCCO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-MC French-MONACO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-MF French-SAINT MARTIN (FRENCH be09d6bb5a6e PART) 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-MG French-MADAGASCAR be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-ML French-MALI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-MQ French-MARTINIQUE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-MR French-MAURITANIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-MU French-MAURITIUS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-NC French-NEW CALEDONIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-NE French-NIGER be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-PF French-FRENCH POLYNESIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-PM French-SAINT PIERRE AND be09d6bb5a6e MIQUELON 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-RE French-REUNION be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-RW French-RWANDA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-SC French-SEYCHELLES be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-SN French-SENEGAL be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-SY French-SYRIAN ARAB REPUBLIC be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-TD French-CHAD be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-TG French-TOGO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-TN French-TUNISIA be09d6bb5a6e

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 565 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-VU French-VANUATU be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-WF French-WALLIS AND FUTUNA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fr-YT French-MAYOTTE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 fy-NL Western Frisian-NETHERLANDS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ga-IE Irish-IRELAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 gd-GB Gaelic; Scottish Gaelic-UNITED be09d6bb5a6e KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND 1dd183a6-6d2b-4a9d-8f5d- 2017-03 gl-ES Galician; Galicia-SPAIN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 gu-IN Gujarati-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 gv-IM Manx-ISLE OF MAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ha-GH Hausa-GHANA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ha-NE Hausa-NIGER be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ha-NG Hausa-NIGERIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 he-IL Hebrew-ISRAEL be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 hi-IN Hindi-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 hr-BA Croatian-BOSNIA AND be09d6bb5a6e HERZEGOVINA 1dd183a6-6d2b-4a9d-8f5d- 2017-03 hr-HR Croatian-CROATIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 hu-HU Hungarian-HUNGARY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 hy-AM Armenian-ARMENIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 id-ID Indonesian-INDONESIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ig-NG Igbo-NIGERIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ii-CN Sichuan Yi; Nuosu-CHINA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 is-IS Icelandic-ICELAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 it-CH Italian-SWITZERLAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 it-IT Italian-ITALY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 it-SM Italian-SAN MARINO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ja-JP Japanese-JAPAN be09d6bb5a6e © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 566 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 ka-GE Georgian-GEORGIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ki-KE Kikuyu; Gikuyu-KENYA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 kk-KZ Kazakh-KAZAKHSTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 kl-GL Kalaallisut; Greenlandic- be09d6bb5a6e GREENLAND 1dd183a6-6d2b-4a9d-8f5d- 2017-03 km-KH Central Khmer-CAMBODIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 kn-IN Kannada-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ko-KP Korean-KOREA (DEMOCRATIC be09d6bb5a6e PEOPLE'S REPUBLIC OF) 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ko-KR Korean-KOREA, REPUBLIC OF be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ks-IN Kashmiri-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 kw-GB Cornish-UNITED KINGDOM OF be09d6bb5a6e GREAT BRITAIN AND NORTHERN IRELAND 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ky-KG Kirghiz; Kyrgyz-KYRGYZSTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 lb-LU Luxembourgish; Letzeburgesch- be09d6bb5a6e LUXEMBOURG 1dd183a6-6d2b-4a9d-8f5d- 2017-03 lg-UG Ganda-UGANDA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ln-AO Lingala-ANGOLA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ln-CD Lingala-CONGO, DEMOCRATIC be09d6bb5a6e REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ln-CF Lingala-CENTRAL AFRICAN be09d6bb5a6e REPUBLIC 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ln-CG Lingala-CONGO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 lo-LA Lao-LAO PEOPLE'S DEMOCRATIC be09d6bb5a6e REPUBLIC 1dd183a6-6d2b-4a9d-8f5d- 2017-03 lt-LT Lithuanian-LITHUANIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 lu-CD Luba-Katanga-CONGO, be09d6bb5a6e DEMOCRATIC REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d- 2017-03 lv-LV Latvian-LATVIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 mg-MG Malagasy-MADAGASCAR be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 mk-MK Macedonian-MACEDONIA, THE be09d6bb5a6e FORMER YUGOSLAV REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ml-IN Malayalam-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 mn-MN Mongolian-MONGOLIA be09d6bb5a6e

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 567 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 mr-IN Marathi-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ms-BN Malay-BRUNEI DARUSSALAM be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ms-MY Malay-MALAYSIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ms-SG Malay-SINGAPORE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 mt-MT Maltese-MALTA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 my-MM Burmese-MYANMAR be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nb-NO Bokmål, Norwegian; Norwegian be09d6bb5a6e Bokmål-NORWAY 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nb-SJ Bokmål, Norwegian; Norwegian be09d6bb5a6e Bokmål-SVALBARD AND JAN MAYEN 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nd-ZW Ndebele, North; North Ndebele- be09d6bb5a6e ZIMBABWE 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ne-IN Nepali-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ne-NP Nepali-NEPAL be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nl-AW Dutch; Flemish-ARUBA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nl-BE Dutch; Flemish-BELGIUM be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nl-BQ Dutch; Flemish-BONAIRE, SINT be09d6bb5a6e EUSTATIUS AND SABA 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nl-CW Dutch; Flemish-CURAÇAO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nl-NL Dutch; Flemish-NETHERLANDS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nl-SR Dutch; Flemish-SURINAME be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nl-SX Dutch; Flemish-SINT MAARTEN be09d6bb5a6e (DUTCH PART) 1dd183a6-6d2b-4a9d-8f5d- 2017-03 nn-NO Norwegian Nynorsk; Nynorsk, be09d6bb5a6e Norwegian-NORWAY 1dd183a6-6d2b-4a9d-8f5d- 2017-03 om-ET Oromo-ETHIOPIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 om-KE Oromo-KENYA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 or-IN Oriya-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 os-GE Ossetian; Ossetic-GEORGIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 os-RU Ossetian; Ossetic-RUSSIAN be09d6bb5a6e FEDERATION 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pa-IN Panjabi; Punjabi-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pa-PK Panjabi; Punjabi-PAKISTAN be09d6bb5a6e © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 568 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 pl-PL Polish-POLAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ps-AF Pushto; Pashto-AFGHANISTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pt-AO Portuguese-ANGOLA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pt-BR Portuguese-BRAZIL be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pt-CV Portuguese-CAPE VERDE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pt-GW Portuguese-GUINEA-BISSAU be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pt-MO Portuguese-MACAO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pt-MZ Portuguese-MOZAMBIQUE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pt-PT Portuguese-PORTUGAL be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pt-ST Portuguese-SAO TOME AND be09d6bb5a6e PRINCIPE 1dd183a6-6d2b-4a9d-8f5d- 2017-03 pt-TL Portuguese-TIMOR-LESTE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 qu-BO Quechua-BOLIVIA be09d6bb5a6e (PLURINATIONAL STATE OF) 1dd183a6-6d2b-4a9d-8f5d- 2017-03 qu-EC Quechua-ECUADOR be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 qu-PE Quechua-PERU be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 rm-CH Romansh-SWITZERLAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 rn-BI Rundi-BURUNDI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ro-MD Romanian; Moldavian; Moldovan- be09d6bb5a6e MOLDOVA, REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ro-RO Romanian; Moldavian; Moldovan- be09d6bb5a6e ROMANIA 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ru-BY Russian-BELARUS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ru-KG Russian-KYRGYZSTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ru-KZ Russian-KAZAKHSTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ru-MD Russian-MOLDOVA, REPUBLIC OF be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ru-RU Russian-RUSSIAN FEDERATION be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ru-UA Russian-UKRAINE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 rw-RW Kinyarwanda-RWANDA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 se-FI Northern Sami-FINLAND be09d6bb5a6e

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 569 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 se-NO Northern Sami-NORWAY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 se-SE Northern Sami-SWEDEN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sg-CF Sango-CENTRAL AFRICAN be09d6bb5a6e REPUBLIC 1dd183a6-6d2b-4a9d-8f5d- 2017-03 si-LK Sinhala; Sinhalese-SRI LANKA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sk-SK Slovak-SLOVAKIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sl-SI Slovenian-SLOVENIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sn-ZW Shona-ZIMBABWE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 so-DJ Somali-DJIBOUTI be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 so-ET Somali-ETHIOPIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 so-KE Somali-KENYA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 so-SO Somali-SOMALIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sq-AL Albanian-ALBANIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sq-MK Albanian-MACEDONIA, THE be09d6bb5a6e FORMER YUGOSLAV REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sr-BA Serbian-BOSNIA AND be09d6bb5a6e HERZEGOVINA 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sr-ME Serbian-MONTENEGRO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sr-RS Serbian-SERBIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sv-AX Swedish-ÅLAND ISLANDS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sv-FI Swedish-FINLAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sv-SE Swedish-SWEDEN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sw-CD Swahili-CONGO, DEMOCRATIC be09d6bb5a6e REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sw-KE Swahili-KENYA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sw-TZ Swahili-TANZANIA, UNITED be09d6bb5a6e REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d- 2017-03 sw-UG Swahili-UGANDA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ta-IN Tamil-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ta-LK Tamil-SRI LANKA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ta-MY Tamil-MALAYSIA be09d6bb5a6e © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 570 of 624 Service Provider MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d- 2017-03 ta-SG Tamil-SINGAPORE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 te-IN Telugu-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 th-TH Thai-THAILAND be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ti-ER Tigrinya-ERITREA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ti-ET Tigrinya-ETHIOPIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 to-TO Tonga (Tonga Islands)-TONGA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 tr-CY Turkish-CYPRUS be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 tr-TR Turkish-TURKEY be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ug-CN Uighur; Uyghur-CHINA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 uk-UA Ukrainian-UKRAINE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ur-IN Urdu-INDIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 ur-PK Urdu-PAKISTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 uz-AF Uzbek-AFGHANISTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 uz-UZ Uzbek-UZBEKISTAN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 vi-VN Vietnamese-VIET NAM be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 yo-BJ Yoruba-BENIN be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 yo-NG Yoruba-NIGERIA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 zh-CN Chinese-CHINA be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 zh-HK Chinese-HONG KONG be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 zh-MO Chinese-MACAO be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 zh-SG Chinese-SINGAPORE be09d6bb5a6e 1dd183a6-6d2b-4a9d-8f5d- 2017-03 zh-TW Chinese-TAIWAN, PROVINCE OF be09d6bb5a6e CHINA 1dd183a6-6d2b-4a9d-8f5d- 2017-03 zu-ZA Zulu-SOUTH AFRICA be09d6bb5a6e

TRANSCODINGS

MVC NATIONAL CODE SYSTEM

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 571 of 624 Service Provider MTC epSOSLanguage

Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 572 of 624 Service Provider MTC epSOSMedicalDevices

epSOSMedicalDevices

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.8

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 102303004 Vascular prosthesis 2.16.840.1.113883.6.96 2016-07 102314001 Embolisation coil 2.16.840.1.113883.6.96 2016-07 118374007 Silicone implant 2.16.840.1.113883.6.96 2016-07 118382007 Neuropacemaker device 2.16.840.1.113883.6.96 2016-07 118425005 Ventricular reservoir 2.16.840.1.113883.6.96 2016-07 17107009 Mitral valve prosthesis 2.16.840.1.113883.6.96 2016-07 2282003 Breast prosthesis 2.16.840.1.113883.6.96 2016-07 24073000 Artificial cardiac valve prosthesis 2.16.840.1.113883.6.96 2016-07 257275005 Spinal cage 2.16.840.1.113883.6.96 2016-07 257282009 Non-valved conduit 2.16.840.1.113883.6.96 2016-07 257283004 Valved cardiac conduit 2.16.840.1.113883.6.96 2016-07 257343005 Xenograft cardiac valve 2.16.840.1.113883.6.96 2016-07 257366006 JJ-stent 2.16.840.1.113883.6.96 2016-07 258593008 Ventricular shunt 2.16.840.1.113883.6.96 2016-07 264824009 Cardiac conduit 2.16.840.1.113883.6.96 2016-07 268460000 Intrauterine contraceptive device 2.16.840.1.113883.6.96 2016-07 271003 Bone plate 2.16.840.1.113883.6.96 2016-07 272245008 Maxillofacial prosthesis/appliance 2.16.840.1.113883.6.96 2016-07 286558002 Ureteric stent 2.16.840.1.113883.6.96 2016-07 286576009 Urethral stent 2.16.840.1.113883.6.96 2016-07 303277008 Fallopian tube prosthesis 2.16.840.1.113883.6.96 2016-07 303490004 Cardiovascular implant 2.16.840.1.113883.6.96 2016-07 303497001 Urogenital implant 2.16.840.1.113883.6.96 2016-07 303499003 Gastrointestinal implant 2.16.840.1.113883.6.96 2016-07 303500007 Auditory implant 2.16.840.1.113883.6.96 2016-07 303503009 Musculoskeletal implant 2.16.840.1.113883.6.96 2016-07 303515008 Orbital implant 2.16.840.1.113883.6.96 2016-07 303533002 Hip joint implant 2.16.840.1.113883.6.96 2016-07 303608005 Ophthalmological implant 2.16.840.1.113883.6.96 2016-07 303617005 Vascular implant 2.16.840.1.113883.6.96 2016-07 303618000 Nervous system implant 2.16.840.1.113883.6.96 2016-07 303619008 Cardiac implant

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 573 of 624 Service Provider MTC epSOSMedicalDevices

2.16.840.1.113883.6.96 2016-07 303726000 Shoulder joint prosthesis 2.16.840.1.113883.6.96 2016-07 303947005 Rod fixation system 2.16.840.1.113883.6.96 2016-07 304070008 Body wall implant 2.16.840.1.113883.6.96 2016-07 304120007 Total hip replacement prosthesis 2.16.840.1.113883.6.96 2016-07 304121006 Femoral head prosthesis 2.16.840.1.113883.6.96 2016-07 304124003 Shoulder joint implant 2.16.840.1.113883.6.96 2016-07 304184000 Ankle joint implant 2.16.840.1.113883.6.96 2016-07 304185004 Foot joint implant 2.16.840.1.113883.6.96 2016-07 304186003 Hand joint implant 2.16.840.1.113883.6.96 2016-07 31031000 Orthopaedic internal fixation system 2.16.840.1.113883.6.96 2016-07 314523008 Joint implant 2.16.840.1.113883.6.96 2016-07 360041000 Implanted drug delivery system 2.16.840.1.113883.6.96 2016-07 360046005 Arterial stent 2.16.840.1.113883.6.96 2016-07 360058005 Intraventricular pump 2.16.840.1.113883.6.96 2016-07 360070009 Laryngeal implant 2.16.840.1.113883.6.96 2016-07 360100007 Tracheal stent 2.16.840.1.113883.6.96 2016-07 360117000 Gastric bubble 2.16.840.1.113883.6.96 2016-07 360123005 Biliary stent 2.16.840.1.113883.6.96 2016-07 360145006 Bone prosthesis 2.16.840.1.113883.6.96 2016-07 360329004 Dacron graft 2.16.840.1.113883.6.96 2016-07 413766009 Carotid stent 2.16.840.1.113883.6.96 2016-07 414580007 Laryngeal keel 2.16.840.1.113883.6.96 2016-07 421168009 Eye sphere implant 2.16.840.1.113883.6.96 2016-07 423449009 Pulmonary valve prosthesis, device 2.16.840.1.113883.6.96 2016-07 424921004 Permanent cardiac pacemaker, device 2.16.840.1.113883.6.96 2016-07 429798007 Artificial vertebral disc 2.16.840.1.113883.6.96 2016-07 43252007 Cochlear prosthesis 2.16.840.1.113883.6.96 2016-07 45633005 Peritoneal dialyser 2.16.840.1.113883.6.96 2016-07 63112008 Bone wire 2.16.840.1.113883.6.96 2016-07 63289001 Surgical metal nail, device 2.16.840.1.113883.6.96 2016-07 67270000 Hip prosthesis 2.16.840.1.113883.6.96 2016-07 68183006 Bone screw 2.16.840.1.113883.6.96 2016-07 72506001 Implantable defibrillator 2.16.840.1.113883.6.96 2016-07 74444006 Limb prosthesis 2.16.840.1.113883.6.96 2016-07 77444004 Bone pin 2.16.840.1.113883.6.96 2016-07 77777004 Bone staple 2.16.840.1.113883.6.96 2016-07 84683006 Aortic valve prosthesis 2.16.840.1.113883.6.96 2016-07 90134004 Metal periosteal implant

TRANSCODINGS

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 574 of 624 Service Provider MTC epSOSMedicalDevices

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 575 of 624 Service Provider MTC epSOSNullFavor

epSOSNullFavor

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.37

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1008 913-20091020 ASKU asked but unknown demandé mais inconnu 2.16.840.1.113883.5.1008 913-20091020 MSK masked masqué 2.16.840.1.113883.5.1008 913-20091020 NA not applicable non applicable 2.16.840.1.113883.5.1008 913-20091020 NASK not asked non demandé 2.16.840.1.113883.5.1008 913-20091020 NAV temporarily unavailable temporairement indisponible 2.16.840.1.113883.5.1008 913-20091020 NI NoInformation Pas d'information 2.16.840.1.113883.5.1008 913-20091020 NINF negative infinity infini négatif 2.16.840.1.113883.5.1008 913-20091020 OTH other autre 2.16.840.1.113883.5.1008 913-20091020 PINF positive infinity infini positif 2.16.840.1.113883.5.1008 913-20091020 TRC trace 2.16.840.1.113883.5.1008 913-20091020 UNK unknown inconnu

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 576 of 624 Service Provider MTC epSOSPackage

epSOSPackage

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.3

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 0.4.0.127.0.16.1.1.2.1 2017-04-14 13059000 Unit-dose blister 0.4.0.127.0.16.1.1.2.1 2017-04-14 30000500 Administration system 0.4.0.127.0.16.1.1.2.1 2017-04-14 30001000 Ampoule 0.4.0.127.0.16.1.1.2.1 2017-04-14 30002000 Applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30004000 Bag 0.4.0.127.0.16.1.1.2.1 2017-04-14 30006000 Barrel 0.4.0.127.0.16.1.1.2.1 2017-04-14 30007000 Blister 0.4.0.127.0.16.1.1.2.1 2017-04-14 30008000 Bottle 0.4.0.127.0.16.1.1.2.1 2017-04-14 30009000 Box 0.4.0.127.0.16.1.1.2.1 2017-04-14 30010000 Brush 0.4.0.127.0.16.1.1.2.1 2017-04-14 30011000 Brush applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30012000 Cannula 0.4.0.127.0.16.1.1.2.1 2017-04-14 30013000 Cap 0.4.0.127.0.16.1.1.2.1 2017-04-14 30014000 Cartridge 0.4.0.127.0.16.1.1.2.1 2017-04-14 30015000 Child-resistant closure 0.4.0.127.0.16.1.1.2.1 2017-04-14 30015500 Container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30016000 Cup 0.4.0.127.0.16.1.1.2.1 2017-04-14 30017000 Dabbing applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30018200 Dose dispenser 0.4.0.127.0.16.1.1.2.1 2017-04-14 30018300 Dose-dispenser cartridge 0.4.0.127.0.16.1.1.2.1 2017-04-14 30019000 Dredging applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30020000 Dredging container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30022000 Dropper applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30023000 Dropper container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30023005 Fixed cryogenic vessel 0.4.0.127.0.16.1.1.2.1 2017-04-14 30024000 Gas cylinder 0.4.0.127.0.16.1.1.2.1 2017-04-14 30026500 Inhaler 0.4.0.127.0.16.1.1.2.1 2017-04-14 30028000 Injection needle 0.4.0.127.0.16.1.1.2.1 2017-04-14 30029000 Injection syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 30032000 Jar 0.4.0.127.0.16.1.1.2.1 2017-04-14 30033000 Measuring device 0.4.0.127.0.16.1.1.2.1 2017-04-14 30034000 Measuring spoon

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 577 of 624 Service Provider MTC epSOSPackage

0.4.0.127.0.16.1.1.2.1 2017-04-14 30035000 Metering pump 0.4.0.127.0.16.1.1.2.1 2017-04-14 30036000 Metering valve 0.4.0.127.0.16.1.1.2.1 2017-04-14 30036005 Mobile cryogenic vessel 0.4.0.127.0.16.1.1.2.1 2017-04-14 30037000 Mouthpiece 0.4.0.127.0.16.1.1.2.1 2017-04-14 30038000 Multidose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30039000 Multidose container with airless pump 0.4.0.127.0.16.1.1.2.1 2017-04-14 30039400 Multidose container with metering pump 0.4.0.127.0.16.1.1.2.1 2017-04-14 30039500 Multidose container with pump 0.4.0.127.0.16.1.1.2.1 2017-04-14 30040000 Multipuncturer 0.4.0.127.0.16.1.1.2.1 2017-04-14 30041000 Nasal applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30042000 Nebuliser 0.4.0.127.0.16.1.1.2.1 2017-04-14 30043000 Needle applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30043500 Needle-free injector 0.4.0.127.0.16.1.1.2.1 2017-04-14 30044000 Nozzle 0.4.0.127.0.16.1.1.2.1 2017-04-14 30045000 Oral syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 30046000 Pipette 0.4.0.127.0.16.1.1.2.1 2017-04-14 30047000 Pipette applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30049000 Pre-filled gastroenteral tube 0.4.0.127.0.16.1.1.2.1 2017-04-14 30050000 Pre-filled pen 0.4.0.127.0.16.1.1.2.1 2017-04-14 30051000 Pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 30052000 Pressurised container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30053000 Prick test applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30053500 Roll-on container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30054000 Sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 30056000 Screw cap 0.4.0.127.0.16.1.1.2.1 2017-04-14 30057000 Single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30058000 Spatula 0.4.0.127.0.16.1.1.2.1 2017-04-14 30060000 Spray container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30061000 Spray pump 0.4.0.127.0.16.1.1.2.1 2017-04-14 30062000 Spray valve 0.4.0.127.0.16.1.1.2.1 2017-04-14 30064000 Stopper 0.4.0.127.0.16.1.1.2.1 2017-04-14 30064500 Straw 0.4.0.127.0.16.1.1.2.1 2017-04-14 30065000 Strip 0.4.0.127.0.16.1.1.2.1 2017-04-14 30066000 Tablet container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30067000 Tube 0.4.0.127.0.16.1.1.2.1 2017-04-14 30069000 Vial

TRANSCODINGS

MVC NATIONAL CODE SYSTEM

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 578 of 624 Service Provider MTC epSOSPackage

Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 579 of 624 Service Provider MTC epSOSPersonalRelationship

epSOSPersonalRelationship

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.38

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.111 913-20091020 AUNT aunt tante 2.16.840.1.113883.5.111 913-20091020 CHILD Child Enfant 2.16.840.1.113883.5.111 913-20091020 CHLDADOPT adopted child enfant adopté 2.16.840.1.113883.5.111 913-20091020 CHLDFOST foster child 2.16.840.1.113883.5.111 913-20091020 CHLDINLAW child in-law 2.16.840.1.113883.5.111 913-20091020 COUSN cousin cousin 2.16.840.1.113883.5.111 913-20091020 DAU natural daughter 2.16.840.1.113883.5.111 913-20091020 DAUADOPT adopted daughter fille adopté 2.16.840.1.113883.5.111 913-20091020 DAUC Daughter Soeur 2.16.840.1.113883.5.111 913-20091020 DAUFOST foster daughter 2.16.840.1.113883.5.111 913-20091020 DAUINLAW daughter in-law 2.16.840.1.113883.5.111 913-20091020 DOMPART domestic partner concubin 2.16.840.1.113883.5.111 913-20091020 FAMMEMB Family Member Membre de la Famille 2.16.840.1.113883.5.111 913-20091020 FRND unrelated friend connaissance 2.16.840.1.113883.5.111 913-20091020 FTH Father Père 2.16.840.1.113883.5.111 913-20091020 FTHINLAW father-in-law 2.16.840.1.113883.5.111 913-20091020 GGRPRN great grandparent arrière grand parents 2.16.840.1.113883.5.111 913-20091020 GRNDCHILD grandchild petit enfant 2.16.840.1.113883.5.111 913-20091020 GRPRN Grandparent Grand Parents 2.16.840.1.113883.5.111 913-20091020 MTH Mother Mère 2.16.840.1.113883.5.111 913-20091020 MTHINLAW mother-in-law 2.16.840.1.113883.5.111 913-20091020 NBOR neighbor voisin 2.16.840.1.113883.5.111 913-20091020 NCHILD natural child 2.16.840.1.113883.5.111 913-20091020 NIENEPH niece/nephew nièce/neveu 2.16.840.1.113883.5.111 913-20091020 PRN Parent Parents 2.16.840.1.113883.5.111 913-20091020 PRNINLAW parent in-law 2.16.840.1.113883.5.111 913-20091020 ROOM Roommate Voisin de chambre 2.16.840.1.113883.5.111 913-20091020 SIB Sibling 2.16.840.1.113883.5.111 913-20091020 SIGOTHR significant other 2.16.840.1.113883.5.111 913-20091020 SON natural son fils 2.16.840.1.113883.5.111 913-20091020 SONADOPT adopted son fils adopté 2.16.840.1.113883.5.111 913-20091020 SONC son fils

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 580 of 624 Service Provider MTC epSOSPersonalRelationship

2.16.840.1.113883.5.111 913-20091020 SONFOST foster son 2.16.840.1.113883.5.111 913-20091020 SONINLAW son in-law 2.16.840.1.113883.5.111 913-20091020 SPS spouse épouse 2.16.840.1.113883.5.111 913-20091020 STPCHLD step child 2.16.840.1.113883.5.111 913-20091020 STPDAU stepdaughter 2.16.840.1.113883.5.111 913-20091020 STPSON stepson 2.16.840.1.113883.5.111 913-20091020 UNCLE uncle oncle

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 581 of 624 Service Provider MTC epSOSPregnancyInformation

epSOSPregnancyInformation

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.9

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.1 2.59 11778-8 Delivery date Estimated 2.16.840.1.113883.6.1 2.59 11779-6 Delivery date Estimated from last menstrual period 2.16.840.1.113883.6.1 2.59 11780-4 Delivery date Estimated from ovulation date

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 582 of 624 Service Provider MTC epSOSProcedures

epSOSProcedures

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.10

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 10458001 Evacuation of intracerebral haematoma 2.16.840.1.113883.6.96 2016-07 107907001 Operative procedure on digestive system 2.16.840.1.113883.6.96 2016-07 108021004 Operative procedure on male genitourinary system 2.16.840.1.113883.6.96 2016-07 10847001 Bronchoscopy 2.16.840.1.113883.6.96 2016-07 112698002 Operation on joint 2.16.840.1.113883.6.96 2016-07 112727005 Revision of hip replacement 2.16.840.1.113883.6.96 2016-07 112802009 Cardiovascular surgical procedure 2.16.840.1.113883.6.96 2016-07 112828007 Femoral-popliteal artery bypass graft 2.16.840.1.113883.6.96 2016-07 11466000 Caesarean section 2.16.840.1.113883.6.96 2016-07 118675001 Procedure on female genital system 2.16.840.1.113883.6.96 2016-07 118683007 Procedure on ear and related structures 2.16.840.1.113883.6.96 2016-07 118716003 Procedure on foot 2.16.840.1.113883.6.96 2016-07 118795000 Procedure on pleura 2.16.840.1.113883.6.96 2016-07 118804001 Procedure on blood vessel 2.16.840.1.113883.6.96 2016-07 118831003 Procedure on intestine 2.16.840.1.113883.6.96 2016-07 118949002 Procedure on extremity 2.16.840.1.113883.6.96 2016-07 118950002 Procedure on head AND/OR neck 2.16.840.1.113883.6.96 2016-07 118955007 Implantation to cardiovascular Implantation sur le système cardio- system vascuaire 2.16.840.1.113883.6.96 2016-07 119922005 Biliary tract endoscopy 2.16.840.1.113883.6.96 2016-07 122470005 Reduction of closed fracture 2.16.840.1.113883.6.96 2016-07 122471009 Reduction of open fracture 2.16.840.1.113883.6.96 2016-07 12658000 Operation on female genital organs 2.16.840.1.113883.6.96 2016-07 133864008 Lithotripsy 2.16.840.1.113883.6.96 2016-07 13619001 Thyroidectomy 2.16.840.1.113883.6.96 2016-07 15018006 Laparoscopic repair of inguinal hernia 2.16.840.1.113883.6.96 2016-07 16545005 Operation on nervous system 2.16.840.1.113883.6.96 2016-07 173171007 Lobectomy of lung

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 583 of 624 Service Provider MTC epSOSProcedures

2.16.840.1.113883.6.96 2016-07 173422009 Tonsillectomy 2.16.840.1.113883.6.96 2016-07 19063003 Arthroplasty of knee 2.16.840.1.113883.6.96 2016-07 21371007 Operation on abdominal region 2.16.840.1.113883.6.96 2016-07 232632009 Wedge excision of lung 2.16.840.1.113883.6.96 2016-07 232717009 Coronary artery bypass graft 2.16.840.1.113883.6.96 2016-07 234336002 Haemopoietic stem cell transplant 2.16.840.1.113883.6.96 2016-07 236886002 Hysterectomy 2.16.840.1.113883.6.96 2016-07 236887006 Laparoscopic hysterectomy 2.16.840.1.113883.6.96 2016-07 23968004 Colectomy 2.16.840.1.113883.6.96 2016-07 250980009 Cardioversion 2.16.840.1.113883.6.96 2016-07 257822003 Extracapsular extraction 2.16.840.1.113883.6.96 2016-07 26476002 Operation on bronchus 2.16.840.1.113883.6.96 2016-07 265703000 Jaw and temporomandibular joint operations 2.16.840.1.113883.6.96 2016-07 287310004 Lung tumour excision 2.16.840.1.113883.6.96 2016-07 302343007 Insertion of prosthesis for breast 2.16.840.1.113883.6.96 2016-07 30904006 Vascular surgery procedure 2.16.840.1.113883.6.96 2016-07 312775003 Debridement of ulcer 2.16.840.1.113883.6.96 2016-07 3418002 Chondrectomy of spine 2.16.840.1.113883.6.96 2016-07 34969007 Operation on retroperitoneum 2.16.840.1.113883.6.96 2016-07 359612003 Implantation of cochlear prosthetic device 2.16.840.1.113883.6.96 2016-07 359623004 Total lobectomy of lung 2.16.840.1.113883.6.96 2016-07 36228007 Ophthalmic examination and evaluation 2.16.840.1.113883.6.96 2016-07 363187007 Limb operation 2.16.840.1.113883.6.96 2016-07 370611004 Excision of malignant neoplasm 2.16.840.1.113883.6.96 2016-07 373353005 Surgical procedure on eye proper 2.16.840.1.113883.6.96 2016-07 37508003 Operation on neck 2.16.840.1.113883.6.96 2016-07 38102005 Cholecystectomy 2.16.840.1.113883.6.96 2016-07 384723003 mastectomy 2.16.840.1.113883.6.96 2016-07 385487005 Surgical procedure on thorax 2.16.840.1.113883.6.96 2016-07 385488000 Surgical procedure on chest wall 2.16.840.1.113883.6.96 2016-07 386638009 Obstetric operation 2.16.840.1.113883.6.96 2016-07 386765006 Operation on mediastinum 2.16.840.1.113883.6.96 2016-07 387714009 Operation on lung 2.16.840.1.113883.6.96 2016-07 392011001 Operation on skin 2.16.840.1.113883.6.96 2016-07 392048005 Operation on urinary system 2.16.840.1.113883.6.96 2016-07 392090004 Operation on breast 2.16.840.1.113883.6.96 2016-07 392236004 Operative procedure on spinal structure 2.16.840.1.113883.6.96 2016-07 397956004 Prosthetic arthroplasty of the hip 2.16.840.1.113883.6.96 2016-07 405525004 Repair of aneurysm of abdominal aorta 2.16.840.1.113883.6.96 2016-07 423827005 Endoscopy © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 584 of 624 Service Provider MTC epSOSProcedures

2.16.840.1.113883.6.96 2016-07 426153007 Insertion of artificial airway 2.16.840.1.113883.6.96 2016-07 429639007 Percutaneous transluminal balloon angioplasty with insertion of stent into coronary artery 2.16.840.1.113883.6.96 2016-07 441612006 Repair of infrarenal abdominal aortic aneurysm with insertion of endovascular stent 2.16.840.1.113883.6.96 2016-07 44558001 Repair of inguinal hernia 2.16.840.1.113883.6.96 2016-07 45595009 Laparoscopic cholecystectomy 2.16.840.1.113883.6.96 2016-07 46116005 Excision of malignant tumour of breast 2.16.840.1.113883.6.96 2016-07 47534009 Decompression of median nerve 2.16.840.1.113883.6.96 2016-07 4770005 Colporrhaphy for repair of urethrocele 2.16.840.1.113883.6.96 2016-07 49509003 Operation on lymphatic structure 2.16.840.1.113883.6.96 2016-07 53266006 Operation on diaphragm 2.16.840.1.113883.6.96 2016-07 54885007 Extraction of cataract 2.16.840.1.113883.6.96 2016-07 56361007 Excision of soft tissue 2.16.840.1.113883.6.96 2016-07 57168000 Operation on bone 2.16.840.1.113883.6.96 2016-07 59300005 Operation on spleen 2.16.840.1.113883.6.96 2016-07 59712006 Evacuation of subdural haematoma 2.16.840.1.113883.6.96 2016-07 6025007 Laparoscopic appendicectomy 2.16.840.1.113883.6.96 2016-07 63016009 Complete cystectomy 2.16.840.1.113883.6.96 2016-07 64253000 Implantation of heart assist system 2.16.840.1.113883.6.96 2016-07 64368001 Partial mastectomy 2.16.840.1.113883.6.96 2016-07 66951008 Carotid endarterectomy 2.16.840.1.113883.6.96 2016-07 70183006 Subcutaneous mastectomy 2.16.840.1.113883.6.96 2016-07 70536003 Transplant of kidney 2.16.840.1.113883.6.96 2016-07 73761001 Colonoscopy 2.16.840.1.113883.6.96 2016-07 76810006 Diagnostic dilation and curettage of uterus 2.16.840.1.113883.6.96 2016-07 78418002 Operation on heart and pericardium 2.16.840.1.113883.6.96 2016-07 80146002 Appendicectomy 2.16.840.1.113883.6.96 2016-07 84877006 Arthroscopy of knee with meniscus repair 2.16.840.1.113883.6.96 2016-07 85548006 Episiotomy 2.16.840.1.113883.6.96 2016-07 85921004 Puncture procedure 2.16.840.1.113883.6.96 2016-07 86273004 Biopsy 2.16.840.1.113883.6.96 2016-07 86749008 Stripping and ligation 2.16.840.1.113883.6.96 2016-07 86800006 Operation on trachea 2.16.840.1.113883.6.96 2016-07 90199006 Transurethral prostatectomy 2.16.840.1.113883.6.96 2016-07 90470006 Prostatectomy 2.16.840.1.113883.6.96 2016-07 9888007 Excision of intracranial lesion

TRANSCODINGS

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 585 of 624 Service Provider MTC epSOSProcedures

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 586 of 624 Service Provider MTC epSOSReactionAllergy

epSOSReactionAllergy

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.11

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 126485001 Urticaria 2.16.840.1.113883.6.96 2016-07 162290004 Dry eyes 2.16.840.1.113883.6.96 2016-07 195967001 Asthma 2.16.840.1.113883.6.96 2016-07 1985008 Vomitus 2.16.840.1.113883.6.96 2016-07 23924001 Tight chest 2.16.840.1.113883.6.96 2016-07 24079001 Atopic dermatitis 2.16.840.1.113883.6.96 2016-07 247472004 Weal 2.16.840.1.113883.6.96 2016-07 267036007 Dyspnoea 2.16.840.1.113883.6.96 2016-07 271757001 Papular eruption 2.16.840.1.113883.6.96 2016-07 271759003 Bullous eruption 2.16.840.1.113883.6.96 2016-07 31996006 Vasculitis 2.16.840.1.113883.6.96 2016-07 359610006 Ocular hyperaemia 2.16.840.1.113883.6.96 2016-07 39579001 2.16.840.1.113883.6.96 2016-07 410430005 Cardiorespiratory arrest 2.16.840.1.113883.6.96 2016-07 41291007 Angio-oedema 2.16.840.1.113883.6.96 2016-07 418363000 Itching of skin 2.16.840.1.113883.6.96 2016-07 422587007 Nausea 2.16.840.1.113883.6.96 2016-07 43116000 Eczema 2.16.840.1.113883.6.96 2016-07 4386001 Bronchospasm 2.16.840.1.113883.6.96 2016-07 49727002 Cough 2.16.840.1.113883.6.96 2016-07 51599000 Oedema of larynx 2.16.840.1.113883.6.96 2016-07 62315008 Diarrhoea 2.16.840.1.113883.6.96 2016-07 698247007 Cardiac arrhythmia 2.16.840.1.113883.6.96 2016-07 70076002 Rhinitis 2.16.840.1.113883.6.96 2016-07 702809001 Drug reaction with eosinophilia and systemic symptoms 2.16.840.1.113883.6.96 2016-07 73442001 Stevens-Johnson syndrome 2.16.840.1.113883.6.96 2016-07 76067001 Sneezing 2.16.840.1.113883.6.96 2016-07 91175000 2.16.840.1.113883.6.96 2016-07 9826008 Conjunctivitis

TRANSCODINGS

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 587 of 624 Service Provider MTC epSOSReactionAllergy

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 588 of 624 Service Provider MTC epSOSResolutionOutcome

epSOSResolutionOutcome

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.30

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 161045001 Disability - severe 2.16.840.1.113883.6.96 2016-07 161901003 Chronic sick 2.16.840.1.113883.6.96 2016-07 162467007 Free of symptoms 2.16.840.1.113883.6.96 2016-07 21134002 Disability 2.16.840.1.113883.6.96 2016-07 271593001 Moribund 2.16.840.1.113883.6.96 2016-07 313386006 Patient in remission 2.16.840.1.113883.6.96 2016-07 419099009 Dead 2.16.840.1.113883.6.96 2016-07 81323004 Normal general body function

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 589 of 624 Service Provider MTC epSOSRoleClass

epSOSRoleClass

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.39

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.110 913-20091020 ECON emergency contact 2.16.840.1.113883.5.110 913-20091020 NOK next of kin

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 590 of 624 Service Provider MTC epSOSRouteofAdministration

epSOSRouteofAdministration

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.12

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 0.4.0.127.0.16.1.1.2.1 2017-04-14 20001000 Auricular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20002500 Buccal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20003000 Cutaneous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20004000 Dental use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20006000 Endocervical use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20007000 Endosinusial use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20008000 Endotracheopulmonary use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20009000 Epidural use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20010000 Epilesional use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20011000 Extraamniotic use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20011500 Extracorporeal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20013000 Gastroenteral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20013500 Gastric use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20014000 Gingival use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20015000 Haemodialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 20015500 Implantation 0.4.0.127.0.16.1.1.2.1 2017-04-14 20019500 Infiltration 0.4.0.127.0.16.1.1.2.1 2017-04-14 20020000 Inhalation use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20021000 Intestinal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20022000 Intraamniotic use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20023000 Intraarterial use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20024000 Intraarticular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20025000 Intrabursal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20025500 Intracameral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20026000 Intracardiac use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20026500 Intracartilaginous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20027000 Intracavernous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20027010 Intracerebral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20028000 Intracervical use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20028300 Intracholangiopancreatic use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20028500 Intracisternal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20029000 Intracoronary use

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 591 of 624 Service Provider MTC epSOSRouteofAdministration

0.4.0.127.0.16.1.1.2.1 2017-04-14 20030000 Intradermal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20031000 Intradiscal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20031500 Intraepidermal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20031700 Intraglandular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20032000 Intralesional use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20033000 Intralymphatic use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20035000 Intramuscular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20036000 Intraocular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20036500 Intraosseous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20037000 Intrapericardial use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20038000 Intraperitoneal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20039000 Intrapleural use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20039200 Intraportal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20039500 Intraprostatic use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20041000 Intrasternal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20042000 Intrathecal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20043000 Intratumoral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20044000 Intrauterine use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20045000 Intravenous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20046000 Intravesical use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20047000 Intravitreal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20047500 Iontophoresis 0.4.0.127.0.16.1.1.2.1 2017-04-14 20048000 Laryngopharyngeal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20049000 Nasal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20051000 Ocular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20053000 Oral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20054000 Oromucosal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20055000 Oropharyngeal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20057000 Periarticular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20058000 Perineural use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20059000 Periodontal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20059300 Periosseous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20059400 Peritumoral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20059500 Posterior juxtascleral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20061000 Rectal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20061500 Retrobulbar use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20062000 Route of administration not applicable 0.4.0.127.0.16.1.1.2.1 2017-04-14 20063000 Skin scarification 0.4.0.127.0.16.1.1.2.1 2017-04-14 20065000 Subconjunctival use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20066000 Subcutaneous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20067000 Sublingual use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20067500 Submucosal use

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 592 of 624 Service Provider MTC epSOSRouteofAdministration

0.4.0.127.0.16.1.1.2.1 2017-04-14 20070000 Transdermal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20071000 Urethral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20072000 Vaginal use

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 593 of 624 Service Provider MTC epSOSSections

epSOSSections

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.26

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.1 2.59 10160-0 History of Medication use Narrative Historique des prises de médicaments 2.16.840.1.113883.6.1 2.59 10162-6 History of pregnancies Narrative Historique de Grossesse 2.16.840.1.113883.6.1 2.59 10164-2 History of Present illness Narrative Historique de Maladies Actuelles 2.16.840.1.113883.6.1 2.59 11348-0 History of Past illness Narrative Historique des maladies soignées 2.16.840.1.113883.6.1 2.59 11369-6 History of Immunization Narrative Historique Immunitaire 2.16.840.1.113883.6.1 2.59 11450-4 Problem list - Reported Problèmes 2.16.840.1.113883.6.1 2.59 18776-5 Plan of care note 2.16.840.1.113883.6.1 2.59 29554-3 Procedure Narrative Intervention 2.16.840.1.113883.6.1 2.59 29762-2 Social history Narrative Historique Social 2.16.840.1.113883.6.1 2.59 30954-2 Relevant diagnostic tests/laboratory Données Diagnostic test/laboratoire data Narrative importantes 2.16.840.1.113883.6.1 2.59 46264-8 History of medical device use Historique des équipements médicaux utilisés 2.16.840.1.113883.6.1 2.59 47420-5 Functional status assessment note 2.16.840.1.113883.6.1 2.59 47519-4 History of Procedures Document Historique des interventions 2.16.840.1.113883.6.1 2.59 48765-2 Allergies and adverse reactions Allergies, effets indésirables, Document alertes 2.16.840.1.113883.6.1 2.59 57828-6 Prescription list Liste des prescriptions 2.16.840.1.113883.6.1 2.59 60590-7 Medication dispensed.brief Dispensation médicamenteuse Document 2.16.840.1.113883.6.1 2.59 8716-3 Vital signs Signes Vitaux

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 594 of 624 Service Provider MTC epSOSSeverity

epSOSSeverity

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.13

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 24484000 Severe 2.16.840.1.113883.6.96 2016-07 255604002 Mild 2.16.840.1.113883.6.96 2016-07 371923003 Mild to moderate 2.16.840.1.113883.6.96 2016-07 371924009 Moderate to severe 2.16.840.1.113883.6.96 2016-07 442452003 Life threatening severity 2.16.840.1.113883.6.96 2016-07 6736007 Moderate

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 595 of 624 Service Provider MTC epSOSSocialHistory

epSOSSocialHistory

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.14

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 160573003 Alcohol intake 2.16.840.1.113883.6.96 2016-07 228272008 Health-related behaviour 2.16.840.1.113883.6.96 2016-07 229819007 Tobacco use and exposure 2.16.840.1.113883.6.96 2016-07 256235009 Exercise 2.16.840.1.113883.6.96 2016-07 363908000 Details of drug misuse behaviour 2.16.840.1.113883.6.96 2016-07 364393001 Nutritional observable 2.16.840.1.113883.6.96 2016-07 364703007 Employment detail 2.16.840.1.113883.6.96 2016-07 425400000 Toxic exposure status

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 596 of 624 Service Provider MTC epSOSStatusCode

epSOSStatusCode

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.15

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 255227004 Recurrent Récurrent 2.16.840.1.113883.6.96 2016-07 410516002 Known absent Absence connu 2.16.840.1.113883.6.96 2016-07 413322009 Problem resolved Problème résolus 2.16.840.1.113883.6.96 2016-07 415684004 Suspected Suspecté 2.16.840.1.113883.6.96 2016-07 55561003 Active Actif 2.16.840.1.113883.6.96 2016-07 7087005 Intermittent Intermittent 2.16.840.1.113883.6.96 2016-07 73425007 Inactive Inactif 2.16.840.1.113883.6.96 2016-07 90734009 Chronic Chonique

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 597 of 624 Service Provider MTC epSOSSubstitutionCode

epSOSSubstitutionCode

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.7

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1070 913-20091020 G generic 2.16.840.1.113883.5.1070 913-20091020 N none 2.16.840.1.113883.5.1070 913-20091020 TE therapeutic

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 598 of 624 Service Provider MTC epSOSTelecomAddress

epSOSTelecomAddress

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.40

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1119 913-20091020 AS answering service 2.16.840.1.113883.5.1119 913-20091020 EC emergency contact contact urgence 2.16.840.1.113883.5.1119 913-20091020 H home address adresse personnel 2.16.840.1.113883.5.1119 913-20091020 HP primary home adresse principale 2.16.840.1.113883.5.1119 913-20091020 HV vacation home lieu de vacances 2.16.840.1.113883.5.1119 913-20091020 MC mobile contact mobile 2.16.840.1.113883.5.1119 913-20091020 PG pager 2.16.840.1.113883.5.1119 913-20091020 WP work place lieu de travail

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 599 of 624 Service Provider MTC epSOSTimingEvent

epSOSTimingEvent

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.41

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.139 913-20091020 AC before meal (from lat. ante cibus) avant le repas 2.16.840.1.113883.5.139 913-20091020 ACD before lunch (from lat. ante cibus avant le déjeuner diurnus) 2.16.840.1.113883.5.139 913-20091020 ACM before breakfast (from lat. ante avant le petit déjeuner cibus matutinus) 2.16.840.1.113883.5.139 913-20091020 ACV before dinner (from lat. ante cibus avant le dinner vespertinus) 2.16.840.1.113883.5.139 913-20091020 HS Prior to beginning a regular period of extended sleep (this would exclude naps). Note that this might occur at different times of day depending on a person's regular sleep schedule. 2.16.840.1.113883.5.139 913-20091020 IC between meals (from lat. inter cibus) entre les repas 2.16.840.1.113883.5.139 913-20091020 ICD between lunch and dinner avant le déjeuner et le dinner 2.16.840.1.113883.5.139 913-20091020 ICM between breakfast and lunch entre le petit déjeuner et le déjeuner 2.16.840.1.113883.5.139 913-20091020 ICV between dinner and the hour of entre le dinner et le coucher sleep 2.16.840.1.113883.5.139 913-20091020 PC after meal (from lat. post cibus) après le repas 2.16.840.1.113883.5.139 913-20091020 PCD after lunch (from lat. post cibus après le déjeuner diurnus) 2.16.840.1.113883.5.139 913-20091020 PCM after breakfast (from lat. post cibus après le petit déjeuner matutinus) 2.16.840.1.113883.5.139 913-20091020 PCV after dinner (from lat. post cibus après le dinner vespertinus)

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 600 of 624 Service Provider MTC epSOSUnits

epSOSUnits

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.16

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 1.3.6.1.4.1.12009.10.3.1 1.4 % percent 1.3.6.1.4.1.12009.10.3.1 1.4 %{Hb} percent hemoglobin 1.3.6.1.4.1.12009.10.3.1 1.4 %{RBCs} percent of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 %{WBCs} percent of white blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 %{abnormal} percent abnormal 1.3.6.1.4.1.12009.10.3.1 1.4 %{activity} percent activity 1.3.6.1.4.1.12009.10.3.1 1.4 %{aggregation} percent aggregation 1.3.6.1.4.1.12009.10.3.1 1.4 %{at_60_min} percent at 60 minute 1.3.6.1.4.1.12009.10.3.1 1.4 %{bacteria} percent of bacteria 1.3.6.1.4.1.12009.10.3.1 1.4 %{basal_activity} percent basal activity 1.3.6.1.4.1.12009.10.3.1 1.4 %{baseline} percent of baseline 1.3.6.1.4.1.12009.10.3.1 1.4 %{binding} percent binding 1.3.6.1.4.1.12009.10.3.1 1.4 %{blockade} percent blockade 1.3.6.1.4.1.12009.10.3.1 1.4 %{blocked} percent blocked 1.3.6.1.4.1.12009.10.3.1 1.4 %{bound} percent bound 1.3.6.1.4.1.12009.10.3.1 1.4 %{breakdown} percent breakdown 1.3.6.1.4.1.12009.10.3.1 1.4 %{cells} percent of cells 1.3.6.1.4.1.12009.10.3.1 1.4 %{deficient} percent deficient 1.3.6.1.4.1.12009.10.3.1 1.4 %{dose} percent dose 1.3.6.1.4.1.12009.10.3.1 1.4 %{excretion} percent excretion 1.3.6.1.4.1.12009.10.3.1 1.4 %{hemolysis} percent hemolysis 1.3.6.1.4.1.12009.10.3.1 1.4 %{index} percent index 1.3.6.1.4.1.12009.10.3.1 1.4 %{inhibition} percent inhibition 1.3.6.1.4.1.12009.10.3.1 1.4 %{loss_AChR} percent loss of 1.3.6.1.4.1.12009.10.3.1 1.4 %{loss} percent loss 1.3.6.1.4.1.12009.10.3.1 1.4 %{lysis} percent lysis 1.3.6.1.4.1.12009.10.3.1 1.4 %{normal} percent normal 1.3.6.1.4.1.12009.10.3.1 1.4 %{penetration} percent penetration 1.3.6.1.4.1.12009.10.3.1 1.4 %{pooled_plasma} percent normal pooled plasma 1.3.6.1.4.1.12009.10.3.1 1.4 %{positive} percent positive 1.3.6.1.4.1.12009.10.3.1 1.4 %{reactive} percent reactive

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 601 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 %{recovery} percent recovery 1.3.6.1.4.1.12009.10.3.1 1.4 %{reference} percent reference 1.3.6.1.4.1.12009.10.3.1 1.4 %{relative} relative percent 1.3.6.1.4.1.12009.10.3.1 1.4 %{residual} percent residual 1.3.6.1.4.1.12009.10.3.1 1.4 %{saturation} percent saturation 1.3.6.1.4.1.12009.10.3.1 1.4 %{total} percent total 1.3.6.1.4.1.12009.10.3.1 1.4 %{uptake} percent uptake 1.3.6.1.4.1.12009.10.3.1 1.4 %{viable} percent viable 1.3.6.1.4.1.12009.10.3.1 1.4 %{vol} percent by volume 1.3.6.1.4.1.12009.10.3.1 1.4 /(12.h) per twelve hour 1.3.6.1.4.1.12009.10.3.1 1.4 /10*10 per 10 billion 1.3.6.1.4.1.12009.10.3.1 1.4 /10*12 per trillion 1.3.6.1.4.1.12009.10.3.1 1.4 /10*12{RBCs} per trillion red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 /10*3 per thousand 1.3.6.1.4.1.12009.10.3.1 1.4 /10*3{RBCs} per thousand red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 /10*4{RBCs} per 10 thousand red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 /10*6 per million 1.3.6.1.4.1.12009.10.3.1 1.4 /10*9 per billion 1.3.6.1.4.1.12009.10.3.1 1.4 /100 per 100 1.3.6.1.4.1.12009.10.3.1 1.4 /100{WBCs} per 100 white blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 /100{cells} per 100 cells 1.3.6.1.4.1.12009.10.3.1 1.4 /100{neutrophils} per 100 neutrophils 1.3.6.1.4.1.12009.10.3.1 1.4 /100{spermatozoa} per 100 spermatozoa 1.3.6.1.4.1.12009.10.3.1 1.4 /L per liter 1.3.6.1.4.1.12009.10.3.1 1.4 /U per enzyme unit 1.3.6.1.4.1.12009.10.3.1 1.4 /[HPF] per high power field 1.3.6.1.4.1.12009.10.3.1 1.4 /[IU] per international unit 1.3.6.1.4.1.12009.10.3.1 1.4 /[LPF] per low power field 1.3.6.1.4.1.12009.10.3.1 1.4 /[arb'U] per arbitrary unit 1.3.6.1.4.1.12009.10.3.1 1.4 /a per year 1.3.6.1.4.1.12009.10.3.1 1.4 /cm[H2O] per centimeter of water 1.3.6.1.4.1.12009.10.3.1 1.4 /d per day 1.3.6.1.4.1.12009.10.3.1 1.4 /dL per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 /g per gram 1.3.6.1.4.1.12009.10.3.1 1.4 /g{Hb} per gram of hemoglobin 1.3.6.1.4.1.12009.10.3.1 1.4 /g{creat} per gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 /g{tot_nit} per gram of total nitrogen 1.3.6.1.4.1.12009.10.3.1 1.4 /g{tot_prot} per gram of total protein 1.3.6.1.4.1.12009.10.3.1 1.4 /g{wet_tis} per gram of wet tissue 1.3.6.1.4.1.12009.10.3.1 1.4 /h per hour 1.3.6.1.4.1.12009.10.3.1 1.4 /kg per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 /kg{body_wt} per kilogram of body weight 1.3.6.1.4.1.12009.10.3.1 1.4 /m2 per square meter © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 602 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 /m3 per cubic meter 1.3.6.1.4.1.12009.10.3.1 1.4 /mL per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 /mg per milligram 1.3.6.1.4.1.12009.10.3.1 1.4 /min per minute 1.3.6.1.4.1.12009.10.3.1 1.4 /mm per millimeter 1.3.6.1.4.1.12009.10.3.1 1.4 /mmol{creat} per millimole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 /mo per month 1.3.6.1.4.1.12009.10.3.1 1.4 /s per second 1.3.6.1.4.1.12009.10.3.1 1.4 /uL per microliter 1.3.6.1.4.1.12009.10.3.1 1.4 /wk per week 1.3.6.1.4.1.12009.10.3.1 1.4 /{OIF} per oil immersion field 1.3.6.1.4.1.12009.10.3.1 1.4 /{entity} per entity 1.3.6.1.4.1.12009.10.3.1 1.4 10*12/L trillion per liter 1.3.6.1.4.1.12009.10.3.1 1.4 10*3 thousand 1.3.6.1.4.1.12009.10.3.1 1.4 10*3/L thousand per liter 1.3.6.1.4.1.12009.10.3.1 1.4 10*3/mL thousand per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 10*3/uL thousand per microliter 1.3.6.1.4.1.12009.10.3.1 1.4 10*3{RBCs} thousand red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 10*3{copies}/mL thousand copies per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 10*4/uL 10 thousand per microliter 1.3.6.1.4.1.12009.10.3.1 1.4 10*5 one hundred thousand 1.3.6.1.4.1.12009.10.3.1 1.4 10*6 million 1.3.6.1.4.1.12009.10.3.1 1.4 10*6.[CFU]/L million colony forming unit per liter 1.3.6.1.4.1.12009.10.3.1 1.4 10*6.[IU] million international unit 1.3.6.1.4.1.12009.10.3.1 1.4 10*6/(24.h) million per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 10*6/L million per liter 1.3.6.1.4.1.12009.10.3.1 1.4 10*6/kg million per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 10*6/mL million per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 10*6/uL million per microliter 1.3.6.1.4.1.12009.10.3.1 1.4 10*8 100 million 1.3.6.1.4.1.12009.10.3.1 1.4 10*9/L billion per liter 1.3.6.1.4.1.12009.10.3.1 1.4 10*9/mL billion per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 10*9/uL billion per microliter 1.3.6.1.4.1.12009.10.3.1 1.4 10.L/(min.m2) 10 liter per minute per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 10.L/min 10 liter per minute 1.3.6.1.4.1.12009.10.3.1 1.4 10.uN.s/(cm5.m2) 10 micronewton second per centimeter to the fifth power per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 24.h 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 A ampere 1.3.6.1.4.1.12009.10.3.1 1.4 A/m ampere per meter 1.3.6.1.4.1.12009.10.3.1 1.4 Bq Becquerel 1.3.6.1.4.1.12009.10.3.1 1.4 Cel degree Celsius 1.3.6.1.4.1.12009.10.3.1 1.4 F Farad © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 603 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 Gy Gray 1.3.6.1.4.1.12009.10.3.1 1.4 H Henry 1.3.6.1.4.1.12009.10.3.1 1.4 Hz Hertz 1.3.6.1.4.1.12009.10.3.1 1.4 J joule 1.3.6.1.4.1.12009.10.3.1 1.4 J/L joule per liter 1.3.6.1.4.1.12009.10.3.1 1.4 K degree Kelvin 1.3.6.1.4.1.12009.10.3.1 1.4 K/W degree Kelvin per Watt 1.3.6.1.4.1.12009.10.3.1 1.4 L liter 1.3.6.1.4.1.12009.10.3.1 1.4 L/(24.h) liter per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 L/(8.h) liter per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 L/(min.m2) liter per minute per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 L/L liter per liter 1.3.6.1.4.1.12009.10.3.1 1.4 L/d liter per day 1.3.6.1.4.1.12009.10.3.1 1.4 L/h liter per hour 1.3.6.1.4.1.12009.10.3.1 1.4 L/kg liter per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 L/min liter per minute 1.3.6.1.4.1.12009.10.3.1 1.4 L/s liter per second 1.3.6.1.4.1.12009.10.3.1 1.4 L/s/s2 liter per second per square second 1.3.6.1.4.1.12009.10.3.1 1.4 Ms megasecond 1.3.6.1.4.1.12009.10.3.1 1.4 N Newton 1.3.6.1.4.1.12009.10.3.1 1.4 N.cm Newton centimeter 1.3.6.1.4.1.12009.10.3.1 1.4 N.s Newton second 1.3.6.1.4.1.12009.10.3.1 1.4 Ohm Ohm 1.3.6.1.4.1.12009.10.3.1 1.4 Ohm.m Ohm meter 1.3.6.1.4.1.12009.10.3.1 1.4 Pa Pascal 1.3.6.1.4.1.12009.10.3.1 1.4 S Siemens 1.3.6.1.4.1.12009.10.3.1 1.4 Sv Sievert 1.3.6.1.4.1.12009.10.3.1 1.4 T Tesla 1.3.6.1.4.1.12009.10.3.1 1.4 Torr Torr 1.3.6.1.4.1.12009.10.3.1 1.4 U enzyme unit 1.3.6.1.4.1.12009.10.3.1 1.4 U/(10.g){feces} enzyme unit per 10 gram of feces 1.3.6.1.4.1.12009.10.3.1 1.4 U/(12.h) enzyme unit per 12 hour 1.3.6.1.4.1.12009.10.3.1 1.4 U/(2.h) enzyme unit per 2 hour 1.3.6.1.4.1.12009.10.3.1 1.4 U/(24.h) enzyme unit per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 U/10 enzyme unit per 10 1.3.6.1.4.1.12009.10.3.1 1.4 U/10*10 enzyme unit per 10 billion 1.3.6.1.4.1.12009.10.3.1 1.4 U/10*10{cells} enzyme unit per 10 billion cells 1.3.6.1.4.1.12009.10.3.1 1.4 U/10*12 enzyme unit per trillion 1.3.6.1.4.1.12009.10.3.1 1.4 U/10*12{RBCs} enzyme unit per trillion red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 U/10*6 enzyme unit per million 1.3.6.1.4.1.12009.10.3.1 1.4 U/10*9 enzyme unit per billion 1.3.6.1.4.1.12009.10.3.1 1.4 U/L enzyme unit per liter

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 604 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 U/d enzyme unit per day 1.3.6.1.4.1.12009.10.3.1 1.4 U/dL enzyme unit per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 U/g enzyme unit per gram 1.3.6.1.4.1.12009.10.3.1 1.4 U/g{Hb} enzyme unit per gram of hemoglobin 1.3.6.1.4.1.12009.10.3.1 1.4 U/g{creat} enzyme unit per gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 U/g{protein} enzyme unit per gram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 U/h enzyme unit per hour 1.3.6.1.4.1.12009.10.3.1 1.4 U/kg{Hb} enzyme unit per kilogram of hemoglobin 1.3.6.1.4.1.12009.10.3.1 1.4 U/mL enzyme unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 U/mL{RBCs} enzyme unit per milliliter of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 U/min enzyme unit per minute 1.3.6.1.4.1.12009.10.3.1 1.4 U/mmol{creat} enzyme unit per millimole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 U/s enzyme unit per second 1.3.6.1.4.1.12009.10.3.1 1.4 U{25Cel}/L enzyme unit per liter at 25 deg Celsius 1.3.6.1.4.1.12009.10.3.1 1.4 U{37Cel}/L enzyme unit per liter at 37 deg Celsius 1.3.6.1.4.1.12009.10.3.1 1.4 V volt 1.3.6.1.4.1.12009.10.3.1 1.4 Wb Weber 1.3.6.1.4.1.12009.10.3.1 1.4 [APL'U] IgA anticardiolipin unit** 1.3.6.1.4.1.12009.10.3.1 1.4 [APL'U]/mL IgA anticardiolipin unit per milliliter** 1.3.6.1.4.1.12009.10.3.1 1.4 [AU] allergy unit 1.3.6.1.4.1.12009.10.3.1 1.4 [CFU] colony forming unit 1.3.6.1.4.1.12009.10.3.1 1.4 [CFU]/L colony forming unit per liter 1.3.6.1.4.1.12009.10.3.1 1.4 [CFU]/mL colony forming unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 [Ch] French (catheter gauge) 1.3.6.1.4.1.12009.10.3.1 1.4 [GPL'U] IgG anticardiolipin unit** 1.3.6.1.4.1.12009.10.3.1 1.4 [GPL'U]/mL IgG anticardiolipin unit per milliliter** 1.3.6.1.4.1.12009.10.3.1 1.4 [HPF] high power field 1.3.6.1.4.1.12009.10.3.1 1.4 [IU] international unit 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/(2.h) international unit per 2 hour 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/(24.h) international unit per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/10*9{RBCs} international unit per billion red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/L international unit per liter 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/L{37Cel} international unit per liter at 37 degrees Celsius 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/d international unit per day 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/dL international unit per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/g international unit per gram 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/g{Hb} international unit per gram of hemoglobin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 605 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/h international unit per hour 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/kg international unit per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/kg/d international unit per kilogram per day 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/mL international unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/mg{creat} international unit per milligram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 [IU]/min international unit per minute 1.3.6.1.4.1.12009.10.3.1 1.4 [LPF] low power field 1.3.6.1.4.1.12009.10.3.1 1.4 [MPL'U] IgM anticardiolipin unit** 1.3.6.1.4.1.12009.10.3.1 1.4 [MPL'U]/mL IgM anticardiolipin unit per milliliter** 1.3.6.1.4.1.12009.10.3.1 1.4 [arb'U] arbitrary unit 1.3.6.1.4.1.12009.10.3.1 1.4 [arb'U]/mL arbitrary unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 [bdsk'U] Bodansky unit 1.3.6.1.4.1.12009.10.3.1 1.4 [beth'U] Bethesda unit 1.3.6.1.4.1.12009.10.3.1 1.4 [cin_i] cubic inch (international) 1.3.6.1.4.1.12009.10.3.1 1.4 [degF] degree Fahrenheit 1.3.6.1.4.1.12009.10.3.1 1.4 [dr_av] dram (US and British) 1.3.6.1.4.1.12009.10.3.1 1.4 [drp] drop (1/12 milliliter) 1.3.6.1.4.1.12009.10.3.1 1.4 [foz_us] fluid ounce (US) 1.3.6.1.4.1.12009.10.3.1 1.4 [ft_i] foot (international) 1.3.6.1.4.1.12009.10.3.1 1.4 [gal_us] gallon (US) 1.3.6.1.4.1.12009.10.3.1 1.4 [in_i'H2O] inch (international) of water 1.3.6.1.4.1.12009.10.3.1 1.4 [in_i] inch (international) 1.3.6.1.4.1.12009.10.3.1 1.4 [ka'U] King Armstrong unit 1.3.6.1.4.1.12009.10.3.1 1.4 [knk'U] Kunkel unit 1.3.6.1.4.1.12009.10.3.1 1.4 [lb_av] pound (US and British) 1.3.6.1.4.1.12009.10.3.1 1.4 [mclg'U] Maclagan unit 1.3.6.1.4.1.12009.10.3.1 1.4 [mi_i] mile (international) 1.3.6.1.4.1.12009.10.3.1 1.4 [oz_av] ounce (US and British) 1.3.6.1.4.1.12009.10.3.1 1.4 [oz_tr] Troy ounce 1.3.6.1.4.1.12009.10.3.1 1.4 [pH] pH 1.3.6.1.4.1.12009.10.3.1 1.4 [ppb] part per billion 1.3.6.1.4.1.12009.10.3.1 1.4 [ppm] part per million 1.3.6.1.4.1.12009.10.3.1 1.4 [ppm]{v/v} part per million in volume per volume 1.3.6.1.4.1.12009.10.3.1 1.4 [ppth] part per thousand 1.3.6.1.4.1.12009.10.3.1 1.4 [pptr] part per trillion 1.3.6.1.4.1.12009.10.3.1 1.4 [psi] pound per square inch 1.3.6.1.4.1.12009.10.3.1 1.4 [pt_us] pint (US) 1.3.6.1.4.1.12009.10.3.1 1.4 [qt_us] quart (US) 1.3.6.1.4.1.12009.10.3.1 1.4 [sft_i] square foot (international) 1.3.6.1.4.1.12009.10.3.1 1.4 [sin_i] square inch (international) 1.3.6.1.4.1.12009.10.3.1 1.4 [syd_i] square yard (international)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 606 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 [tb'U] tuberculin unit 1.3.6.1.4.1.12009.10.3.1 1.4 [tbs_us] tablespoon (US) 1.3.6.1.4.1.12009.10.3.1 1.4 [todd'U] Todd unit 1.3.6.1.4.1.12009.10.3.1 1.4 [tsp_us] teaspoon (US) 1.3.6.1.4.1.12009.10.3.1 1.4 [yd_i] yard (international) 1.3.6.1.4.1.12009.10.3.1 1.4 a year 1.3.6.1.4.1.12009.10.3.1 1.4 ag/{cell} attogram per cell 1.3.6.1.4.1.12009.10.3.1 1.4 atm atmosphere 1.3.6.1.4.1.12009.10.3.1 1.4 bar bar 1.3.6.1.4.1.12009.10.3.1 1.4 cL centiliter 1.3.6.1.4.1.12009.10.3.1 1.4 cP centipoise 1.3.6.1.4.1.12009.10.3.1 1.4 cSt centistoke 1.3.6.1.4.1.12009.10.3.1 1.4 cal calorie 1.3.6.1.4.1.12009.10.3.1 1.4 cg centigram 1.3.6.1.4.1.12009.10.3.1 1.4 cm centimeter 1.3.6.1.4.1.12009.10.3.1 1.4 cm2 square centimeter 1.3.6.1.4.1.12009.10.3.1 1.4 cm2/s square centimeter per second 1.3.6.1.4.1.12009.10.3.1 1.4 cm[H2O] centimeter of water 1.3.6.1.4.1.12009.10.3.1 1.4 cm[H2O]/L/s centimeter of water per liter per second 1.3.6.1.4.1.12009.10.3.1 1.4 cm[H2O]/s/m centimeter of water per second per meter 1.3.6.1.4.1.12009.10.3.1 1.4 cm[Hg] centimeter of mercury 1.3.6.1.4.1.12009.10.3.1 1.4 d day 1.3.6.1.4.1.12009.10.3.1 1.4 dB decibel 1.3.6.1.4.1.12009.10.3.1 1.4 dL deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 daL/min dekaliter per minute 1.3.6.1.4.1.12009.10.3.1 1.4 daL/min/m2 dekaliter per minute per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 deg degree (plane angle) 1.3.6.1.4.1.12009.10.3.1 1.4 deg/s degree per second 1.3.6.1.4.1.12009.10.3.1 1.4 dg decigram 1.3.6.1.4.1.12009.10.3.1 1.4 dm decimeter 1.3.6.1.4.1.12009.10.3.1 1.4 dm2/s2 square decimeter per square second 1.3.6.1.4.1.12009.10.3.1 1.4 dyn.s/(cm.m2) dyne second per centimeter per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 dyn.s/cm dyne second per centimeter 1.3.6.1.4.1.12009.10.3.1 1.4 eV electron Volt 1.3.6.1.4.1.12009.10.3.1 1.4 eq equivalent 1.3.6.1.4.1.12009.10.3.1 1.4 eq/L equivalent per liter 1.3.6.1.4.1.12009.10.3.1 1.4 eq/mL equivalent per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 eq/mmol equivalent per millimole 1.3.6.1.4.1.12009.10.3.1 1.4 eq/umol equivalent per micromole 1.3.6.1.4.1.12009.10.3.1 1.4 erg erg © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 607 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 fL femtoliter 1.3.6.1.4.1.12009.10.3.1 1.4 fg femtogram 1.3.6.1.4.1.12009.10.3.1 1.4 fm femtometer 1.3.6.1.4.1.12009.10.3.1 1.4 fmol femtomole 1.3.6.1.4.1.12009.10.3.1 1.4 fmol/L femtomole per liter 1.3.6.1.4.1.12009.10.3.1 1.4 fmol/g femtomole per gram 1.3.6.1.4.1.12009.10.3.1 1.4 fmol/mL femtomole per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 fmol/mg femtomole per milligram 1.3.6.1.4.1.12009.10.3.1 1.4 fmol/mg{cyt_prot} femtomole per milligram of cytosol protein 1.3.6.1.4.1.12009.10.3.1 1.4 fmol/mg{prot} femtomole per milligram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 g gram 1.3.6.1.4.1.12009.10.3.1 1.4 g.m gram meter 1.3.6.1.4.1.12009.10.3.1 1.4 g.m/{beat} gram meter per heart beat 1.3.6.1.4.1.12009.10.3.1 1.4 g/(100.g) gram per 100 gram 1.3.6.1.4.1.12009.10.3.1 1.4 g/(12.h) gram per 12 hour 1.3.6.1.4.1.12009.10.3.1 1.4 g/(24.h) gram per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 g/(3.d) gram per 3 days 1.3.6.1.4.1.12009.10.3.1 1.4 g/(4.h) gram per 4 hour 1.3.6.1.4.1.12009.10.3.1 1.4 g/(48.h) gram per 48 hour 1.3.6.1.4.1.12009.10.3.1 1.4 g/(5.h) gram per 5 hour 1.3.6.1.4.1.12009.10.3.1 1.4 g/(6.h) gram per 6 hour 1.3.6.1.4.1.12009.10.3.1 1.4 g/(72.h) gram per 72 hour 1.3.6.1.4.1.12009.10.3.1 1.4 g/(8.h){shift} gram per 8 hour shift 1.3.6.1.4.1.12009.10.3.1 1.4 g/L gram per liter 1.3.6.1.4.1.12009.10.3.1 1.4 g/cm3 gram per cubic centimeter 1.3.6.1.4.1.12009.10.3.1 1.4 g/d gram per day 1.3.6.1.4.1.12009.10.3.1 1.4 g/dL gram per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 g/g gram per gram 1.3.6.1.4.1.12009.10.3.1 1.4 g/g{creat} gram per gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 g/g{globulin} gram per gram of globulin 1.3.6.1.4.1.12009.10.3.1 1.4 g/g{tissue} gram per gram of tissue 1.3.6.1.4.1.12009.10.3.1 1.4 g/h gram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 g/h/m2 gram per hour per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 g/kg gram per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 g/kg/(8.h) gram per kilogram per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 g/kg/(8.h){shift} gram per kilogram per 8 hour shift 1.3.6.1.4.1.12009.10.3.1 1.4 g/kg/d gram per kilogram per day 1.3.6.1.4.1.12009.10.3.1 1.4 g/kg/h gram per kilogram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 g/kg/min gram per kilogram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 g/m2 gram per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 g/mL gram per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 g/mg gram per milligram

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 608 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 g/min gram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 g/mmol gram per millimole 1.3.6.1.4.1.12009.10.3.1 1.4 g/mol{creat} gram per mole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 g/{specimen} gram per specimen 1.3.6.1.4.1.12009.10.3.1 1.4 g/{total_output} gram per total output 1.3.6.1.4.1.12009.10.3.1 1.4 g/{total_weight} gram per total weight 1.3.6.1.4.1.12009.10.3.1 1.4 g{Hb} gram of hemoglobin 1.3.6.1.4.1.12009.10.3.1 1.4 g{creat} gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 g{total_nit} gram of total nitrogen 1.3.6.1.4.1.12009.10.3.1 1.4 g{total_prot} gram of total protein 1.3.6.1.4.1.12009.10.3.1 1.4 g{wet_tissue} gram of wet tissue 1.3.6.1.4.1.12009.10.3.1 1.4 h hour 1.3.6.1.4.1.12009.10.3.1 1.4 kL kiloliter 1.3.6.1.4.1.12009.10.3.1 1.4 kPa kilopascal 1.3.6.1.4.1.12009.10.3.1 1.4 kU kilo enzyme unit 1.3.6.1.4.1.12009.10.3.1 1.4 kU/L kilo enzyme unit per liter 1.3.6.1.4.1.12009.10.3.1 1.4 kU/L{class} kilo enzyme unit per liter class 1.3.6.1.4.1.12009.10.3.1 1.4 kU/g kilo enzyme unit per gram 1.3.6.1.4.1.12009.10.3.1 1.4 kU/mL kilo enzyme unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 k[IU]/L kilo international unit per liter 1.3.6.1.4.1.12009.10.3.1 1.4 k[IU]/mL kilo international unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 kat katal 1.3.6.1.4.1.12009.10.3.1 1.4 kat/L katal per liter 1.3.6.1.4.1.12009.10.3.1 1.4 kat/kg katal per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 kcal kilocalorie 1.3.6.1.4.1.12009.10.3.1 1.4 kcal/[oz_av] kilocalorie per ounce (US & British) 1.3.6.1.4.1.12009.10.3.1 1.4 kcal/d kilocalorie per day 1.3.6.1.4.1.12009.10.3.1 1.4 kcal/h kilocalorie per hour 1.3.6.1.4.1.12009.10.3.1 1.4 kcal/kg/(24.h) kilocalorie per kilogram per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 kg kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 kg.m/s kilogram meter per second 1.3.6.1.4.1.12009.10.3.1 1.4 kg/(s.m2) kilogram per second per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 kg/L kilogram per liter 1.3.6.1.4.1.12009.10.3.1 1.4 kg/h kilogram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 kg/m2 kilogram per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 kg/m3 kilogram per cubic meter 1.3.6.1.4.1.12009.10.3.1 1.4 kg/min kilogram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 kg/mol kilogram per mole 1.3.6.1.4.1.12009.10.3.1 1.4 kg/s kilogram per second 1.3.6.1.4.1.12009.10.3.1 1.4 km kilometer 1.3.6.1.4.1.12009.10.3.1 1.4 ks kilosecond 1.3.6.1.4.1.12009.10.3.1 1.4 lm lumen

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 609 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 lm.m2 lumen square meter 1.3.6.1.4.1.12009.10.3.1 1.4 m meter 1.3.6.1.4.1.12009.10.3.1 1.4 m/s meter per second 1.3.6.1.4.1.12009.10.3.1 1.4 m/s2 meter per square second 1.3.6.1.4.1.12009.10.3.1 1.4 m2 square meter 1.3.6.1.4.1.12009.10.3.1 1.4 m2/s square meter per second 1.3.6.1.4.1.12009.10.3.1 1.4 m3/s cubic meter per second 1.3.6.1.4.1.12009.10.3.1 1.4 mA milliampere 1.3.6.1.4.1.12009.10.3.1 1.4 mL milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 mL/(10.h) milliliter per 10 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/(12.h) milliliter per 12 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/(2.h) milliliter per 2 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/(24.h) milliliter per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/(4.h) milliliter per 4 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/(5.h) milliliter per 5 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/(6.h) milliliter per 6 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/(72.h) milliliter per 72 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/(8.h) milliliter per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/(8.h)/kg milliliter per 8 hour per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 mL/[sin_i] milliliter per square inch (international) 1.3.6.1.4.1.12009.10.3.1 1.4 mL/cm[H2O] milliliter per centimeter of water 1.3.6.1.4.1.12009.10.3.1 1.4 mL/d milliliter per day 1.3.6.1.4.1.12009.10.3.1 1.4 mL/dL milliliter per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 mL/h milliliter per hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/kg milliliter per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 mL/kg/(8.h) milliliter per kilogram per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/kg/d milliliter per kilogram per day 1.3.6.1.4.1.12009.10.3.1 1.4 mL/kg/h milliliter per kilogram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 mL/kg/min milliliter per kilogram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 mL/m2 milliliter per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 mL/mbar milliliter per millibar 1.3.6.1.4.1.12009.10.3.1 1.4 mL/min milliliter per minute 1.3.6.1.4.1.12009.10.3.1 1.4 mL/min/m2 milliliter per minute per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 mL/min/{1.73_m2} milliliter per minute per 1.73 square meter 1.3.6.1.4.1.12009.10.3.1 1.4 mL/mm milliliter per millimeter 1.3.6.1.4.1.12009.10.3.1 1.4 mL/s milliliter per second 1.3.6.1.4.1.12009.10.3.1 1.4 mL/{beat} milliliter per heart beat 1.3.6.1.4.1.12009.10.3.1 1.4 mL/{beat}/m2 milliliter per heart beat per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 mL{fetal_RBCs} milliliter of fetal red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 mPa millipascal

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 610 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 mPa.s millipascal second 1.3.6.1.4.1.12009.10.3.1 1.4 mU/L milli enzyme unit per liter 1.3.6.1.4.1.12009.10.3.1 1.4 mU/g milli enzyme unit per gram 1.3.6.1.4.1.12009.10.3.1 1.4 mU/g{Hb} milli enzyme unit per gram of hemoglobin 1.3.6.1.4.1.12009.10.3.1 1.4 mU/g{prot} milli enzyme unit per gram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 mU/mL milli enzyme unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 mU/mL/min milli enzyme unit per milliliter per minute 1.3.6.1.4.1.12009.10.3.1 1.4 mU/mg milli enzyme unit per milligram 1.3.6.1.4.1.12009.10.3.1 1.4 mU/mg{creat} milli enzyme unit per milligram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 mU/mmol{RBCs} milli enzyme unit per millimole of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 mU/mmol{creat} milli enzyme unit per millimole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 mV millivolt 1.3.6.1.4.1.12009.10.3.1 1.4 m[IU]/L milli international unit per liter 1.3.6.1.4.1.12009.10.3.1 1.4 m[IU]/mL milli international unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 mbar millibar 1.3.6.1.4.1.12009.10.3.1 1.4 mbar.s/L millibar second per liter 1.3.6.1.4.1.12009.10.3.1 1.4 mbar/L/s millibar per liter per second 1.3.6.1.4.1.12009.10.3.1 1.4 meq milliequivalent 1.3.6.1.4.1.12009.10.3.1 1.4 meq/(2.h) milliequivalent per 2 hour 1.3.6.1.4.1.12009.10.3.1 1.4 meq/(24.h) milliequivalent per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 meq/(8.h) milliequivalent per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 meq/L milliequivalent per liter 1.3.6.1.4.1.12009.10.3.1 1.4 meq/d milliequivalent per day 1.3.6.1.4.1.12009.10.3.1 1.4 meq/dL milliequivalent per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 meq/g milliequivalent per gram 1.3.6.1.4.1.12009.10.3.1 1.4 meq/g{creat} milliequivalent per gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 meq/h milliequivalent per hour 1.3.6.1.4.1.12009.10.3.1 1.4 meq/kg milliequivalent per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 meq/kg/h milliequivalent per kilogram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 meq/m2 milliequivalent per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 meq/mL milliequivalent per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 meq/min milliequivalent per minute 1.3.6.1.4.1.12009.10.3.1 1.4 meq/{specimen} milliequivalent per specimen 1.3.6.1.4.1.12009.10.3.1 1.4 meq/{total_volume} milliequivalent per total volume 1.3.6.1.4.1.12009.10.3.1 1.4 mg milligram 1.3.6.1.4.1.12009.10.3.1 1.4 mg/(10.h) milligram per 10 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mg/(12.h) milligram per 12 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mg/(2.h) milligram per 2 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mg/(24.h) milligram per 24 hour

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 611 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 mg/(6.h) milligram per 6 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mg/(72.h) milligram per 72 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mg/(8.h) milligram per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mg/L milligram per liter 1.3.6.1.4.1.12009.10.3.1 1.4 mg/L{RBCs} milligram per liter of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 mg/d milligram per day 1.3.6.1.4.1.12009.10.3.1 1.4 mg/d/{1.73_m2} milligram per day per 1.73 square meter 1.3.6.1.4.1.12009.10.3.1 1.4 mg/dL milligram per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 mg/dL{RBCs} milligram per deciliter of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 mg/g milligram per gram 1.3.6.1.4.1.12009.10.3.1 1.4 mg/g{creat} milligram per gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 mg/g{dry_tissue} milligram per gram of dry tissue 1.3.6.1.4.1.12009.10.3.1 1.4 mg/g{feces} milligram per gram of feces 1.3.6.1.4.1.12009.10.3.1 1.4 mg/g{tissue} milligram per gram of tissue 1.3.6.1.4.1.12009.10.3.1 1.4 mg/g{wet_tissue} milligram per gram of wet tissue 1.3.6.1.4.1.12009.10.3.1 1.4 mg/h milligram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 mg/kg milligram per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 mg/kg/(8.h) milligram per kilogram per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mg/kg/d milligram per kilogram per day 1.3.6.1.4.1.12009.10.3.1 1.4 mg/kg/h milligram per kilogram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 mg/kg/min milligram per kilogram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 mg/m2 milligram per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 mg/m3 milligram per cubic meter 1.3.6.1.4.1.12009.10.3.1 1.4 mg/mL milligram per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 mg/mg milligram per milligram 1.3.6.1.4.1.12009.10.3.1 1.4 mg/mg{creat} milligram per milligram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 mg/min milligram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 mg/mmol milligram per millimole 1.3.6.1.4.1.12009.10.3.1 1.4 mg/mmol{creat} milligram per millimole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 mg/wk milligram per week 1.3.6.1.4.1.12009.10.3.1 1.4 mg/{collection} milligram per collection 1.3.6.1.4.1.12009.10.3.1 1.4 mg/{specimen} milligram per specimen 1.3.6.1.4.1.12009.10.3.1 1.4 mg/{total_output} milligram per total output 1.3.6.1.4.1.12009.10.3.1 1.4 mg/{total_volume} milligram per total volume 1.3.6.1.4.1.12009.10.3.1 1.4 mg{FEU}/L milligram fibrinogen equivalent unit per liter 1.3.6.1.4.1.12009.10.3.1 1.4 min minute 1.3.6.1.4.1.12009.10.3.1 1.4 mm millimeter 1.3.6.1.4.1.12009.10.3.1 1.4 mm/h millimeter per hour 1.3.6.1.4.1.12009.10.3.1 1.4 mm/min millimeter per minute 1.3.6.1.4.1.12009.10.3.1 1.4 mm2 square millimeter 1.3.6.1.4.1.12009.10.3.1 1.4 mm[H2O] millimeter of water

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 612 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 mm[Hg] millimeter of mercury 1.3.6.1.4.1.12009.10.3.1 1.4 mmol millimole 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/(12.h) millimole per 12 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/(2.h) millimole per 2 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/(24.h) millimole per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/(5.h) millimole per 5 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/(6.h) millimole per 6 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/(8.h) millimole per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/L millimole per liter 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/L{RBCs} millimole per liter of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/d millimole per day 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/dL millimole per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/g millimole per gram 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/g{creat} millimole per gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/h millimole per hour 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/h/mg{Hb} millimole per hour per milligram of hemoglobin 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/h/mg{prot} millimole per hour per milligram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/kg millimole per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/kg/(8.h) millimole per kilogram per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/kg/d millimole per kilogram per day 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/kg/h millimole per kilogram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/kg/min millimole per kilogram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/m2 millimole per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/min millimole per minute 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/mmol millimole per millimole 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/mmol{creat} millimole per millmole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/mmol{urea} millimole per millimole of urea 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/mol millimole per mole 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/mol{creat} millimole per mole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/s/L millimole per second per liter 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/{ejaculate} millimole per ejaculate 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/{specimen} millimole per specimen 1.3.6.1.4.1.12009.10.3.1 1.4 mmol/{total_vol} millimole per total volume 1.3.6.1.4.1.12009.10.3.1 1.4 mo month 1.3.6.1.4.1.12009.10.3.1 1.4 mol mole 1.3.6.1.4.1.12009.10.3.1 1.4 mol/L mole per liter 1.3.6.1.4.1.12009.10.3.1 1.4 mol/kg mole per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 mol/kg/s mole per kilogram per second 1.3.6.1.4.1.12009.10.3.1 1.4 mol/m3 mole per cubic meter 1.3.6.1.4.1.12009.10.3.1 1.4 mol/mL mole per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 mol/mol mole per mole 1.3.6.1.4.1.12009.10.3.1 1.4 mol/s mole per second © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 613 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 mosm milliosmole 1.3.6.1.4.1.12009.10.3.1 1.4 mosm/L milliosmole per liter 1.3.6.1.4.1.12009.10.3.1 1.4 mosm/kg milliosmole per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 ms millisecond 1.3.6.1.4.1.12009.10.3.1 1.4 nL nanoliter 1.3.6.1.4.1.12009.10.3.1 1.4 nU/mL nanoenzyme unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 nU/{RBC} nanoenzyme unit per 1.3.6.1.4.1.12009.10.3.1 1.4 ng nanogram 1.3.6.1.4.1.12009.10.3.1 1.4 ng/(24.h) nanogram per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 ng/(8.h) nanogram per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 ng/10*6 nanogram per million 1.3.6.1.4.1.12009.10.3.1 1.4 ng/10*6{RBCs} nanogram per million red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 ng/L nanogram per liter 1.3.6.1.4.1.12009.10.3.1 1.4 ng/U nanogram per enzyme unit 1.3.6.1.4.1.12009.10.3.1 1.4 ng/d nanogram per day 1.3.6.1.4.1.12009.10.3.1 1.4 ng/dL nanogram per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 ng/g nanogram per gram 1.3.6.1.4.1.12009.10.3.1 1.4 ng/g{creat} nanogram per gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 ng/h nanogram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 ng/kg nanogram per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 ng/kg/(8.h) nanogram per kilogram per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 ng/kg/h nanogram per kilogram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 ng/kg/min nanogram per kilogram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 ng/m2 nanogram per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 ng/mL nanogram per millliiter 1.3.6.1.4.1.12009.10.3.1 1.4 ng/mL/h nanogram per milliliter per hour 1.3.6.1.4.1.12009.10.3.1 1.4 ng/mL{RBCs} nanogram per milliliter of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 ng/mg nanogram per milligram 1.3.6.1.4.1.12009.10.3.1 1.4 ng/mg/h nanogram per milligram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 ng/mg{creat} nanogram per milligram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 ng/mg{prot} nanogram per milligram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 ng/min nanogram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 ng/s nanogram per second 1.3.6.1.4.1.12009.10.3.1 1.4 ng{FEU}/mL nanogram fibrinogen equivalent unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 nkat nanokatal 1.3.6.1.4.1.12009.10.3.1 1.4 nm nanometer 1.3.6.1.4.1.12009.10.3.1 1.4 nm/s/L nanometer per second per liter 1.3.6.1.4.1.12009.10.3.1 1.4 nmol nanomole 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/(24.h) nanomole per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/L nanomole per liter

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 614 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 nmol/L/mmol{creat} nanomole per liter per millimole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/L{RBCs} nanomole per liter of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/d nanomole per day 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/dL nanomole per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/dL{GF} nanomole per deciliter of glomerular filtrate 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/g nanomole per gram 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/g{creat} nanomole per gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/g{dry_wt} nanomole per gram of dry weight 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/h/L nanomole per hour per liter 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/h/mg{prot} nanomole per hour per milligram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/m/mg{prot} nanomole per meter per milligram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mL nanomole per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mL/h nanomole per milliliter per hour 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mL/min nanomole per milliliter per minute 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mg nanomole per milligram 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mg/h nanomole per milligram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mg{creat} nanomole per milligram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mg{prot} nanomole per milligram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mg{prot}/h nanomole per milligram of protein per hour 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/min nanomole per minute 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/min/10*6{cells} nanomole per minute per million cells 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/min/mL nanomole per minute per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/min/mg{Hb} nanomole per minute per milligram of hemoglobin 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/min/mg{prot} nanomole per minute per milligram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mmol nanomole per millimole 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mmol{creat} nanomole per millimole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/mol nanomole per mole 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/nmol nanomole per nanomole 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/s nanomole per second 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/s/L nanomole per second per liter 1.3.6.1.4.1.12009.10.3.1 1.4 nmol/umol{creat} nanomole per micromole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 nmol{ATP} nanomole of ATP 1.3.6.1.4.1.12009.10.3.1 1.4 nmol{BCE} nanomole bone collagen equivalent 1.3.6.1.4.1.12009.10.3.1 1.4 nmol{BCE}/L nanomole bone collagen equivalent per liter 1.3.6.1.4.1.12009.10.3.1 1.4 ns nanosecond 1.3.6.1.4.1.12009.10.3.1 1.4 osm osmole

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 615 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 osm/L osmole per liter 1.3.6.1.4.1.12009.10.3.1 1.4 osm/kg osmole per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 pA picoampere 1.3.6.1.4.1.12009.10.3.1 1.4 pL picoliter 1.3.6.1.4.1.12009.10.3.1 1.4 pT picotesla 1.3.6.1.4.1.12009.10.3.1 1.4 pg picogram 1.3.6.1.4.1.12009.10.3.1 1.4 pg/L picogram per liter 1.3.6.1.4.1.12009.10.3.1 1.4 pg/dL picogram per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 pg/mL picogram per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 pg/mg picogram per milligram 1.3.6.1.4.1.12009.10.3.1 1.4 pg/mg{creat} picogram per milligram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 pg/mm picogram per millimeter 1.3.6.1.4.1.12009.10.3.1 1.4 pg/{RBC} picogram per red blood cell 1.3.6.1.4.1.12009.10.3.1 1.4 pg/{cell} picogram per cell 1.3.6.1.4.1.12009.10.3.1 1.4 pkat picokatal 1.3.6.1.4.1.12009.10.3.1 1.4 pm picometer 1.3.6.1.4.1.12009.10.3.1 1.4 pmol picomole 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/(24.h) picomole per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/L picomole per liter 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/d picomole per day 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/dL picomole per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/g picomole per gram 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/h/mL picomole per hour per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/h/mg{prot} picomole per hour per milligram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/mL picomole per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/mg{prot} picomole per milligram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/min picomole per minute 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/min/mg{prot} picomole per minute per milligram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/mmol{creat} picomole per millimole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/umol picomole per micromole 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/umol{creat} picomole per micromole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 pmol/{RBC} picomole per red blood cell 1.3.6.1.4.1.12009.10.3.1 1.4 ps picosecond 1.3.6.1.4.1.12009.10.3.1 1.4 s second 1.3.6.1.4.1.12009.10.3.1 1.4 s/{control} second per control 1.3.6.1.4.1.12009.10.3.1 1.4 t metric ton 1.3.6.1.4.1.12009.10.3.1 1.4 uL microliter 1.3.6.1.4.1.12009.10.3.1 1.4 uL/(2.h) microliter per 2 hour 1.3.6.1.4.1.12009.10.3.1 1.4 uL/h microliter per hour 1.3.6.1.4.1.12009.10.3.1 1.4 uOhm microOhm 1.3.6.1.4.1.12009.10.3.1 1.4 uU/L micro enzyme unit per liter

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 616 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 uU/g micro enzyme unit per gram 1.3.6.1.4.1.12009.10.3.1 1.4 uU/mL micro enzyme unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 uV microvolt 1.3.6.1.4.1.12009.10.3.1 1.4 u[IU] micro international unit 1.3.6.1.4.1.12009.10.3.1 1.4 u[IU]/L microinternational unit per liter 1.3.6.1.4.1.12009.10.3.1 1.4 u[IU]/mL micro international unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 ueq microequivalent 1.3.6.1.4.1.12009.10.3.1 1.4 ueq/L microequivalent per liter 1.3.6.1.4.1.12009.10.3.1 1.4 ueq/mL microequivalent per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 ug microgram 1.3.6.1.4.1.12009.10.3.1 1.4 ug/(100.g) microgram per 100 gram 1.3.6.1.4.1.12009.10.3.1 1.4 ug/(24.h) microgram per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 ug/(8.h) microgram per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 ug/L microgram per liter 1.3.6.1.4.1.12009.10.3.1 1.4 ug/L/(24.h) microgram per liter per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 ug/L{RBCs} microgram per liter of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 ug/[sft_i] microgram per square foot (international) 1.3.6.1.4.1.12009.10.3.1 1.4 ug/d microgram per day 1.3.6.1.4.1.12009.10.3.1 1.4 ug/dL microgram per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 ug/dL{RBCs} microgram per deciliter of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 ug/g microgram per gram 1.3.6.1.4.1.12009.10.3.1 1.4 ug/g{Hb} microgram per gram of hemoglobin 1.3.6.1.4.1.12009.10.3.1 1.4 ug/g{creat} microgram per gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 ug/g{dry_tissue} microgram per gram of dry tissue 1.3.6.1.4.1.12009.10.3.1 1.4 ug/g{dry_wt} microgram per gram of dry weight 1.3.6.1.4.1.12009.10.3.1 1.4 ug/g{feces} microgram per gram of feces 1.3.6.1.4.1.12009.10.3.1 1.4 ug/g{hair} microgram per gram of hair 1.3.6.1.4.1.12009.10.3.1 1.4 ug/g{tissue} microgram per gram of tissue 1.3.6.1.4.1.12009.10.3.1 1.4 ug/h microgram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 ug/kg microgram per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 ug/kg/(8.h) microgram per kilogram per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 ug/kg/d microgram per kilogram per day 1.3.6.1.4.1.12009.10.3.1 1.4 ug/kg/h microgram per kilogram per hour 1.3.6.1.4.1.12009.10.3.1 1.4 ug/kg/min microgram per kilogram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 ug/m2 microgram per square meter 1.3.6.1.4.1.12009.10.3.1 1.4 ug/m3 microgram per cubic meter 1.3.6.1.4.1.12009.10.3.1 1.4 ug/mL microgram per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 ug/mL{class} microgram per milliliter class 1.3.6.1.4.1.12009.10.3.1 1.4 ug/mL{eqv} microgram per milliliter equivalent 1.3.6.1.4.1.12009.10.3.1 1.4 ug/mg microgram per milligram 1.3.6.1.4.1.12009.10.3.1 1.4 ug/mg{creat} microgram per milligram of creatinine

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 617 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 ug/min microgram per minute 1.3.6.1.4.1.12009.10.3.1 1.4 ug/mmol microgram per millimole 1.3.6.1.4.1.12009.10.3.1 1.4 ug/mmol{creat} microgram per millimole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 ug/ng microgram per nanogram 1.3.6.1.4.1.12009.10.3.1 1.4 ug/{specimen} microgram per specimen 1.3.6.1.4.1.12009.10.3.1 1.4 ug{FEU}/mL microgram fibrinogen equivalent unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 ukat microkatal 1.3.6.1.4.1.12009.10.3.1 1.4 um micrometer 1.3.6.1.4.1.12009.10.3.1 1.4 um/s microns per second 1.3.6.1.4.1.12009.10.3.1 1.4 umol micromole 1.3.6.1.4.1.12009.10.3.1 1.4 umol/(2.h) micromole per 2 hour 1.3.6.1.4.1.12009.10.3.1 1.4 umol/(24.h) micromole per 24 hour 1.3.6.1.4.1.12009.10.3.1 1.4 umol/(8.h) micromole per 8 hour 1.3.6.1.4.1.12009.10.3.1 1.4 umol/L micromole per liter 1.3.6.1.4.1.12009.10.3.1 1.4 umol/L/h micromole per liter per hour 1.3.6.1.4.1.12009.10.3.1 1.4 umol/L{RBCs} micromole per liter of red blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 umol/d micromole per day 1.3.6.1.4.1.12009.10.3.1 1.4 umol/dL micromole per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 umol/dL{GF} micromole per deciliter of glomerular filtrate 1.3.6.1.4.1.12009.10.3.1 1.4 umol/g micromole per gram 1.3.6.1.4.1.12009.10.3.1 1.4 umol/g{Hb} micromole per gram of hemoglobin 1.3.6.1.4.1.12009.10.3.1 1.4 umol/g{creat} micromole per gram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 umol/h micromole per hour 1.3.6.1.4.1.12009.10.3.1 1.4 umol/kg micromole per kilogram 1.3.6.1.4.1.12009.10.3.1 1.4 umol/kg{feces} micromole per kilogram of feces 1.3.6.1.4.1.12009.10.3.1 1.4 umol/mL micromole per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 umol/mL/min micromole per milliliter per minute 1.3.6.1.4.1.12009.10.3.1 1.4 umol/mg micromole per milligram 1.3.6.1.4.1.12009.10.3.1 1.4 umol/mg{creat} micromole per milligram of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 umol/min micromole per minute 1.3.6.1.4.1.12009.10.3.1 1.4 umol/min/L micromole per minute per liter 1.3.6.1.4.1.12009.10.3.1 1.4 umol/min/g micromole per minute per gram 1.3.6.1.4.1.12009.10.3.1 1.4 umol/min/g{mucosa} micromole per minute per gram of mucosa 1.3.6.1.4.1.12009.10.3.1 1.4 umol/min/g{prot} micromole per minute per gram of protein 1.3.6.1.4.1.12009.10.3.1 1.4 umol/mmol micromole per millimole 1.3.6.1.4.1.12009.10.3.1 1.4 umol/mmol{creat} micromole per millimole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 umol/mol micromole per mole 1.3.6.1.4.1.12009.10.3.1 1.4 umol/mol{Hb} micromole per mole of hemoglobin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 618 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 umol/mol{creat} micromole per mole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 umol/umol micromole per micromole 1.3.6.1.4.1.12009.10.3.1 1.4 umol/umol{creat} micromole per micromole of creatinine 1.3.6.1.4.1.12009.10.3.1 1.4 umol{BCE}/mol micromole bone collagen equivalent per mole 1.3.6.1.4.1.12009.10.3.1 1.4 us microsecond 1.3.6.1.4.1.12009.10.3.1 1.4 wk week 1.3.6.1.4.1.12009.10.3.1 1.4 {#} number 1.3.6.1.4.1.12009.10.3.1 1.4 {#}/L number per liter 1.3.6.1.4.1.12009.10.3.1 1.4 {#}/[HPF] number per high power field 1.3.6.1.4.1.12009.10.3.1 1.4 {#}/[LPF] number per low power field 1.3.6.1.4.1.12009.10.3.1 1.4 {#}/mL number per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 {#}/min number per minute 1.3.6.1.4.1.12009.10.3.1 1.4 {#}/uL number per microliter 1.3.6.1.4.1.12009.10.3.1 1.4 {#}/{platelet} per platelet 1.3.6.1.4.1.12009.10.3.1 1.4 {AHF'U} American Hospital Formulary unit 1.3.6.1.4.1.12009.10.3.1 1.4 {APS'U} IgA antiphosphatidylserine unit 1.3.6.1.4.1.12009.10.3.1 1.4 {ARU} response unit 1.3.6.1.4.1.12009.10.3.1 1.4 {CAE'U} complement activity enzyme unit 1.3.6.1.4.1.12009.10.3.1 1.4 {CAG_repeats} CAG trinucleotide repeats 1.3.6.1.4.1.12009.10.3.1 1.4 {CH100'U} complement CH100 unit 1.3.6.1.4.1.12009.10.3.1 1.4 {CPM} counts per minute 1.3.6.1.4.1.12009.10.3.1 1.4 {CPM}/10*3{cell} counts per minute per thousand cells 1.3.6.1.4.1.12009.10.3.1 1.4 {EIA'U} EIA unit 1.3.6.1.4.1.12009.10.3.1 1.4 {EIA'U}/U EIA unit per enzyme unit 1.3.6.1.4.1.12009.10.3.1 1.4 {EIA_index} EIA index 1.3.6.1.4.1.12009.10.3.1 1.4 {EIA_titer} EIA titer 1.3.6.1.4.1.12009.10.3.1 1.4 {ELISA'U} ELISA unit 1.3.6.1.4.1.12009.10.3.1 1.4 {EV} EIA value 1.3.6.1.4.1.12009.10.3.1 1.4 {Ehrlich'U} Ehrlich unit 1.3.6.1.4.1.12009.10.3.1 1.4 {Ehrlich'U}/(2.h) Ehrlich unit per 2 hour 1.3.6.1.4.1.12009.10.3.1 1.4 {Ehrlich'U}/100.g Ehrlich unit per 100 gram 1.3.6.1.4.1.12009.10.3.1 1.4 {Ehrlich'U}/d Ehrlich unit per day 1.3.6.1.4.1.12009.10.3.1 1.4 {Ehrlich'U}/dL Ehrlich unit per deciliter 1.3.6.1.4.1.12009.10.3.1 1.4 {FIU} fluorescent intensity unit 1.3.6.1.4.1.12009.10.3.1 1.4 {GAA_repeats} GAA trinucleotide repeats 1.3.6.1.4.1.12009.10.3.1 1.4 {GPS'U} IgG antiphosphatidylserine unit 1.3.6.1.4.1.12009.10.3.1 1.4 {Globules}/[HPF] globules (drops) per high power field 1.3.6.1.4.1.12009.10.3.1 1.4 {HA_titer} influenza hemagglutination titer 1.3.6.1.4.1.12009.10.3.1 1.4 {IFA_index} immunofluorescence assay index 1.3.6.1.4.1.12009.10.3.1 1.4 {IFA_titer} Immunofluorescence assay titer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 619 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 {INR} international normalized ratio 1.3.6.1.4.1.12009.10.3.1 1.4 {ISR} immune status ratio 1.3.6.1.4.1.12009.10.3.1 1.4 {ImmuneComplex'U} immune complex unit 1.3.6.1.4.1.12009.10.3.1 1.4 {JDF'U} Juvenile Diabetes Foundation unit 1.3.6.1.4.1.12009.10.3.1 1.4 {JDF'U}/L Juvenile Diabetes Foundation unit per liter 1.3.6.1.4.1.12009.10.3.1 1.4 {KCT'U} kaolin clotting time 1.3.6.1.4.1.12009.10.3.1 1.4 {KRONU'U}/mL Kronus unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 {Log_IU} log (base 10) international unit 1.3.6.1.4.1.12009.10.3.1 1.4 {Log_IU}/mL log (base 10) international unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 {Log_copies}/mL log (base 10) copies per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 {Log} log base 10 1.3.6.1.4.1.12009.10.3.1 1.4 {Lyme_index_value} Lyme index value 1.3.6.1.4.1.12009.10.3.1 1.4 {M.o.M} multiple of the median 1.3.6.1.4.1.12009.10.3.1 1.4 {MPS'U} IgM antiphosphatidylserine unit 1.3.6.1.4.1.12009.10.3.1 1.4 {MPS'U}/mL IgM antiphosphatidylserine unit per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 {OD_unit} optical density unit 1.3.6.1.4.1.12009.10.3.1 1.4 {Pan_Bio'U} panbio unit 1.3.6.1.4.1.12009.10.3.1 1.4 {RBC}/uL red blood cell per microliter 1.3.6.1.4.1.12009.10.3.1 1.4 {Rubella_virus} rubella virus 1.3.6.1.4.1.12009.10.3.1 1.4 {STDV} standard deviation 1.3.6.1.4.1.12009.10.3.1 1.4 {TSI_index} thyroid-stimulating immunoglobulin index 1.3.6.1.4.1.12009.10.3.1 1.4 {WBCs} white blood cells 1.3.6.1.4.1.12009.10.3.1 1.4 {absorbance} absorbance 1.3.6.1.4.1.12009.10.3.1 1.4 {activity} activity 1.3.6.1.4.1.12009.10.3.1 1.4 {beats}/min heart beats per minute 1.3.6.1.4.1.12009.10.3.1 1.4 {binding_index} binding index 1.3.6.1.4.1.12009.10.3.1 1.4 {cells} cells 1.3.6.1.4.1.12009.10.3.1 1.4 {cells}/[HPF] cells per high power field 1.3.6.1.4.1.12009.10.3.1 1.4 {cells}/uL cells per microliter 1.3.6.1.4.1.12009.10.3.1 1.4 {clock_time} clock time e.g 12:30PM 1.3.6.1.4.1.12009.10.3.1 1.4 {copies} copies 1.3.6.1.4.1.12009.10.3.1 1.4 {copies}/mL copies per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 {copies}/ug copies per microgram 1.3.6.1.4.1.12009.10.3.1 1.4 {count} count 1.3.6.1.4.1.12009.10.3.1 1.4 {delta_OD} change in (delta) optical density 1.3.6.1.4.1.12009.10.3.1 1.4 {dilution} dilution 1.3.6.1.4.1.12009.10.3.1 1.4 {fraction} fraction 1.3.6.1.4.1.12009.10.3.1 1.4 {genomes}/mL genomes per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 {index_val} index value 1.3.6.1.4.1.12009.10.3.1 1.4 {minidrop}/min minidrop per minute

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 620 of 624 Service Provider MTC epSOSUnits

1.3.6.1.4.1.12009.10.3.1 1.4 {minidrop}/s minidrop per second 1.3.6.1.4.1.12009.10.3.1 1.4 {mm/dd/yyyy} month-day-year 1.3.6.1.4.1.12009.10.3.1 1.4 {mutation} mutation 1.3.6.1.4.1.12009.10.3.1 1.4 {percentile} percentile 1.3.6.1.4.1.12009.10.3.1 1.4 {phenotype} phenotype 1.3.6.1.4.1.12009.10.3.1 1.4 {ratio} ratio 1.3.6.1.4.1.12009.10.3.1 1.4 {rel_saturation} relative saturation 1.3.6.1.4.1.12009.10.3.1 1.4 {s_co_ratio} signal to cutoff ratio 1.3.6.1.4.1.12009.10.3.1 1.4 {saturation} saturation 1.3.6.1.4.1.12009.10.3.1 1.4 {shift} shift 1.3.6.1.4.1.12009.10.3.1 1.4 {spermatozoa}/mL spermatozoa per milliliter 1.3.6.1.4.1.12009.10.3.1 1.4 {titer} titer

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 621 of 624 Service Provider MTC epSOSVaccine

epSOSVaccine

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.28

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 108729007 Varicella vaccine 2.16.840.1.113883.6.96 2016-07 111164008 Poliovirus vaccine 2.16.840.1.113883.6.96 2016-07 116077000 Rotavirus vaccine 2.16.840.1.113883.6.96 2016-07 14745005 Hepatitis A virus vaccine 2.16.840.1.113883.6.96 2016-07 33234009 Smallpox vaccine 2.16.840.1.113883.6.96 2016-07 333598008 Pneumococcal vaccine 2.16.840.1.113883.6.96 2016-07 333606008 2.16.840.1.113883.6.96 2016-07 333621002 2.16.840.1.113883.6.96 2016-07 333680004 Haemophilus influenzae Type b vaccine 2.16.840.1.113883.6.96 2016-07 333697005 Japanese B encephalitis vaccine 2.16.840.1.113883.6.96 2016-07 333699008 Tick-borne encephalitis vaccine 2.16.840.1.113883.6.96 2016-07 333702001 Hepatitis A+B vaccine 2.16.840.1.113883.6.96 2016-07 34689006 Hepatitis B virus vaccine 2.16.840.1.113883.6.96 2016-07 350327004 Diphtheria + tetanus vaccine 2.16.840.1.113883.6.96 2016-07 35736007 Cholera vaccine 2.16.840.1.113883.6.96 2016-07 386012008 Measles vaccine 2.16.840.1.113883.6.96 2016-07 386013003 Rubella vaccine 2.16.840.1.113883.6.96 2016-07 414004005 Diphtheria + tetanus + pertussis + poliomyelitis + haemophilus influenzae b vaccine 2.16.840.1.113883.6.96 2016-07 414005006 Diphtheria + tetanus + pertussis + poliomyelitis vaccine 2.16.840.1.113883.6.96 2016-07 420538001 Tuberculosis vaccine 2.16.840.1.113883.6.96 2016-07 421245007 Diphtheria + pertussis + tetanus vaccine 2.16.840.1.113883.6.96 2016-07 423531006 Meningococcus vaccine 2.16.840.1.113883.6.96 2016-07 424519000 Human papillomavirus vaccine 2.16.840.1.113883.6.96 2016-07 427036009 Influenza virus H5N1 vaccine 2.16.840.1.113883.6.96 2016-07 428214002 Diphtheria vaccine 2.16.840.1.113883.6.96 2016-07 46233009 Influenza virus vaccine (product) 2.16.840.1.113883.6.96 2016-07 56844000 Yellow fever vaccine 2.16.840.1.113883.6.96 2016-07 61153008 Measles + Mumps + Rubella vaccine

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 622 of 624 Service Provider MTC epSOSVaccine

2.16.840.1.113883.6.96 2016-07 61602008 Pertussis vaccine 2.16.840.1.113883.6.96 2016-07 89428009 Typhoid vaccine 2.16.840.1.113883.6.96 2016-07 90043005 Mumps live virus vaccine

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 623 of 624 Service Provider MTC

End Of Document

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 624 of 624 Service Provider